Patient ID	Treatment type	Type of ICI treatment	Age at diagnosis	Sex	Cancer type	Year of diagnosis	Stage at diagnosis	Days between diagnosis and MSK-IMPACT sample	TMB (mutations/Mb)	MSI status	Temozolomide treatment prior to MSK-IMPACT sample	Chemotherapy or Radiotherapy prior to MSK-IMPACT sample	Dominant mutational signature	Mutations in DNA damage repair pathways	Only 1 line of therapy received	Vital status	Overall Survival from diagnosis (Months)	Time from diagnosis to ICI treatment (Months)	ICB.binary
1	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2016	III	46	34.2		No	No	Signature.7	ARID1A | MRE11A | RAD50	No	0	34.6		0
2	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	15	9.8	Stable	No	No	Signature.4	MRE11A	No	1	2.2		0
3	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	6.9	Stable	No	Yes or Unknown			No	1	5.82		0
4	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	25.63		0
5	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	34	0.9	Stable	No	No			Yes	0	16.62		0
6	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	20	0.9		No	No			Yes	0	37.03		0
7	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	56	12.8		No	No	Signature.29		Yes	0	37.75		0
8	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	I	286	0	Stable	No	Yes or Unknown			Yes	0	18.76		0
9	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	I	61	32.5	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA2 | FANCC | MSH2	Yes	0	42.91		0
10	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	0	4.4	Stable	No	No		BRCA2	No	0	26.02		0
11	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	1	Stable	No	No			No	0	54.31		0
12	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2016	IV	903	7	Stable	No	No	Signature.1	ATR	No	0	38.83		0
13	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	9	1.8		No	No			Yes	0	32		0
14	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	19	1.8	Stable	No	Yes or Unknown			No	0	24.11		0
15	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	221	7.9	Stable	No	Yes or Unknown	Signature.3	BLM	No	0	11.7		0
16	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	120	31.6	Stable	No	Yes or Unknown	Signature.4	ATR | SLX4	No	0	28.81		0
17	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	35	11.8	Stable	No	No	Signature.4		No	0	34.04		0
18	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	106	1.8	Stable	No	No			Yes	0	28.09		0
19	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	623	2.6	Stable	No	Yes or Unknown			No	0	36.93		0
20	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	38	0.9	Stable	No	Yes or Unknown	Signature.6		Yes	0	17.51		0
21	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	63	0.9	Stable	No	Yes or Unknown			Yes	0	27.79		0
22	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	2.6		No	No			No	0	32.16		0
23	Non-ICI treated	Never received ICI	86 - 90	Female	Breast	2016	IV	41	4.9	Stable	No	Yes or Unknown			Yes	1	4.01		0
24	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	IV	0	6.1	Stable	No	Yes or Unknown			No	1	8.34		0
25	Non-ICI treated	Never received ICI	86 - 90	Male	Breast	2016	II	41	1	Stable	No	No			Yes	0	19.32		0
26	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	47	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	19.12		0
27	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	43	19.7	Stable	No	No	Signature.4	RAD50	No	0	42.64		0
28	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		23	7.9		Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | PMS1	No	1	19.38		0
29	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	55	3.5		No	Yes or Unknown			Yes	0	39.39		0
30	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	III	31	31.6	Unstable	No	No	Signature.6	BRCA2 | MSH3 | PALB2	No	1	21.03		0
31	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	0	23.69		0
32	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	48	7	Stable	No	No	Signature.1	ARID1A | ERCC2	No	0	15.93		0
33	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	2.6	Stable	No	No			No	0	28.48		0
34	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	6.1	Stable	No	Yes or Unknown			No	0	28.68		0
35	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	35	5.3		No	Yes or Unknown			No	0	38.44		0
36	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	21	6.9	Stable	No	No	Signature.4	RAD50	No	0	21.91		0
37	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3.5	Stable	No	No		BRCA2	No	0	36.17		0
38	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	38	382.7	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | MSH3 | MSH6 | NBN | PALB2 | PARP1 | RAD52 | SLX4 | TP53BP1	No	0	8.94		0
39	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown	Signature.30		Yes	0	10.78		0
40	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	51	0.9		No	No			No	0	36.37		0
41	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	I	0	7.9	Indeterminate	No	No	Signature.16		Yes	0	11.24		0
42	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	0	1.8		No	No			No	0	33.31		0
43	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	0	45.3	Indeterminate	No	Yes or Unknown	Signature.1	ERCC5 | MSH6 | PMS2 | RAD50	No	0	43.89		0
44	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	30	0	Stable	No	No			No	0	16.79		0
45	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	454	1.8	Stable	No	No			No	0	30.88		0
46	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	0	0.9	Stable	No	No		CHEK2	No	1	17.38		0
47	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	I	79	57.1	Unstable	No	No	Signature.6	ARID1A | CHEK1 | MLH1 | MSH3 | NBN | PALB2 | XRCC2	No	0	15.41		0
48	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	77	0.9	Stable	No	No		BRCA2	No	0	22.21		0
49	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	71	1.8	Stable	No	No			Yes	0	14.09		0
50	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	20	4.4	Stable	No	Yes or Unknown			No	0	27.99		0
51	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	III	161	0	Stable	No	Yes or Unknown			No	0	48.36		0
52	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	0	12.3	Stable	No	No	Signature.7	TP53BP1	Yes	0	13.4		0
53	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	33	2.6		No	No			No	0	4.04		0
54	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	II	1277	4.4	Stable	No	Yes or Unknown			No	1	42.71		0
55	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2016	IV	40	7.9		No	No		ARID1A	No	1	25.53		0
56	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	18.66		0
57	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	II	0	1	Stable	No	No			No	0	38.6		0
58	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	I	851	2.6	Stable	No	Yes or Unknown			No	1	46.36		0
59	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	IV	23	0.9		No	No			No	0	18.04		0
60	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	35	0.9		No	No			Yes	0	34		0
61	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016		944	29	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ERCC2	Yes	0	39.03		0
62	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	0	4.9	Stable	No	No			No	0	42.48		0
63	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	II	31	4.4	Stable	No	No			Yes	0	13.14		0
64	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2018	I	122	0	Stable	No	Yes or Unknown			Yes	0	10.41		0
65	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	III	53	1.8		No	No		BRCA2	Yes	0	41.66		0
66	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	16	5.3	Stable	No	No	Signature.8	ATM	No	0	20.9		0
67	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	33	2.6		No	No			No	0	32.23		0
68	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	16	7		No	No	Signature.10		No	0	32.56		0
69	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	31	3.5	Stable	No	No		BRCA2	No	0	14.32		0
70	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	23	9.8		No	No	Signature.13		No	0	26.55		0
71	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	22	2.6		No	Yes or Unknown			No	0	24.74		0
72	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2016	I	0	2.6		No	No			No	0	23		0
73	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	22.93		0
74	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	389	4.4		No	Yes or Unknown	Signature.2		Yes	1	18.1		0
75	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	23	8.8	Stable	No	No		ARID1A	No	0	27.73		0
76	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	4.4	Stable	No	No		MUTYH	No	0	38.41		0
77	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	1183	5.3	Stable	No	Yes or Unknown			No	0	40.41		0
78	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	21	2.6	Stable	No	No			No	0	13.54		0
79	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	8	3.5		No	No	Signature.6	NBN	Yes	0	27.07		0
80	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	64	0	Stable	No	No			Yes	0	38.28		0
81	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	10	4.4		No	No			Yes	0	28.75		0
82	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	II	40	21.9	Unstable	No	No	Signature.26	ARID1A | NBN | PMS2	No	0	27.53		0
83	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	40	3.5	Stable	No	No			Yes	0	48.07		0
84	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	13	79	Stable	No	No	Signature.10	ATM | ATR | BRCA1 | BRCA2 | ERCC4 | FANCA | MSH2 | NBN | PALB2	No	0	26.51		0
85	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	I	116	0.9	Stable	No	Yes or Unknown			Yes	0	42.78		0
86	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	868	4.4	Stable	No	Yes or Unknown		NTHL1	No	0	43.96		0
87	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	2	Stable	No	No			No	0	46.62		0
88	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	30	4.4	Stable	No	No			Yes	0	22.54		0
89	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	IV	98	2	Stable	No	Yes or Unknown			No	1	29.11		0
90	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	0	27.37		0
91	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	35	8.8		No	No	Signature.24		No	0	10.35		0
92	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	III	0	3.9	Stable	No	No			No	0	38.31		0
93	Non-ICI treated	Never received ICI	81 - 85	Female	Bladder	2018		227	12.3	Stable	No	No	Signature.13	BRCA2	No	0	13.11		0
94	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.34		0
95	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	0	3.5	Stable	No	No	Signature.1		No	0	19.75		0
96	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	553	1.8	Stable	No	Yes or Unknown			No	0	21.19		0
97	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	7	6.9	Stable	No	No		ATR	No	1	12.35		0
98	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	8	7	Stable	No	No			No	0	22.21		0
99	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	37	2		No	Yes or Unknown			Yes	0	30.39		0
100	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	17	8.8		No	No	Signature.13	ARID1A | FANCA	Yes	0	30.69		0
101	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2018		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.25		0
102	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	13	4.4	Stable	No	No	Signature.1		No	0	12.35		0
103	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	298	0		No	Yes or Unknown	Signature.5		No	0	18.99		0
104	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	46	4.4	Stable	No	No			No	0	21.29		0
105	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2018	III	8	1.8	Stable	No	No			Yes	0	16.07		0
106	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	0	16.53		0
107	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	18	3.5	Stable	No	No			Yes	0	22.97		0
108	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	36	3.5	Stable	No	No	Signature.2		Yes	0	13.37		0
109	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	19	0.9	Stable	No	Yes or Unknown			No	0	34.96		0
110	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	32	80.7	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | BRIP1 | CHEK2 | ERCC5 | MRE11A | MSH2 | MSH3 | MSH6 | MUTYH | SLX4 | TP53BP1	Yes	0	26.41		0
111	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	17	1.8	Stable	No	No			Yes	0	9.53		0
112	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	6.9	Stable	No	No	Signature.4		No	0	39.29		0
113	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	18	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	21.32		0
114	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	29	2.6	Stable	No	No			No	0	16.62		0
115	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	17	1.8		No	Yes or Unknown		BRCA2	No	0	31.57		0
116	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	2.6	Stable	No	No			No	0	28.25		0
117	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	56	5.3	Stable	No	No			No	0	11.2		0
118	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	6	5.3	Stable	No	No			No	0	27.93		0
119	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	2.6		No	No			Yes	0	30.03		0
120	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	7	Stable	No	Yes or Unknown	Signature.13	MRE11A	No	0	40.71		0
121	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	0	4.4		No	No	Signature.3		No	0	35.65		0
122	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	37	4.9	Stable	No	Yes or Unknown			No	0	49.74		0
123	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	55	1	Stable	No	No			Yes	0	15.01		0
124	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	I	71	9.7	Stable	No	Yes or Unknown		ARID1A	Yes	0	35.68		0
125	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	30	2.6	Stable	No	Yes or Unknown	Signature.1		Yes	0	18.89		0
126	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	II	23	2	Stable	No	No			No	1	32.1		0
127	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	48	6.1	Stable	No	No	Signature.1	ARID1A	Yes	0	18.07		0
128	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	7	3	Stable	No	No	Signature.4		No	0	41.46		0
129	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			No	0	2.4		0
130	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	II	55	4.4	Stable	No	No			No	0	27.5		0
131	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	I	0	8.9	Stable	No	No	Signature.13		No	1	19.09		0
132	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	61	1.8	Stable	No	Yes or Unknown		ERCC2	Yes	0	26.12		0
133	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2018		0	3.5	Stable	No	No			No	1	1.74		0
134	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	IV	140	2		No	Yes or Unknown		PALB2	No	1	12.62		0
135	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	24	1.8	Stable	No	No			Yes	0	20.17		0
136	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	17	8.9	Stable	No	No	Signature.3		Yes	1	1.51		0
137	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	39	15.8	Stable	No	No	Signature.2		No	1	33.48		0
138	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	30	0.9	Stable	No	No			No	0	22.51		0
139	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	25	4.9	Stable	No	Yes or Unknown			No	0	42.71		0
140	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	375	6.1	Stable	No	Yes or Unknown	Signature.18		No	1	6.97		0
141	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	I	0	7	Stable	No	Yes or Unknown		MSH2	No	0	20.96		0
142	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	8	1	Stable	No	No			No	0	47.44		0
143	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	49	2.6		No	No			Yes	0	40.34		0
144	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		0	7		No	No		ERCC5	No	1	12.98		0
145	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	21	4.4	Stable	No	Yes or Unknown		ARID1A	No	1	22.08		0
146	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	3.9	Stable	No	No		CHEK2	No	0	35.68		0
147	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	20	7.9	Stable	No	No	Signature.2	PARP1 | RAD50	No	0	21.68		0
148	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2017	II	17	5.3	Stable	No	No			No	1	12.98		0
149	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2018	I	0	5.3	Stable	No	No			Yes	0	17.25		0
150	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	I	22	7.9		No	No	Signature.3		No	0	25.49		0
151	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	16	5.9	Stable	No	No	Signature.13	PARP1	No	1	10.81		0
152	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	55	3	Stable	No	No			Yes	0	38.24		0
153	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	16	0.9	Stable	No	Yes or Unknown			Yes	0	23.39		0
154	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	9.8	Stable	No	No		ARID1A | ATM	Yes	1	2.4		0
155	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	29	4.9	Stable	No	Yes or Unknown			No	0	37.26		0
156	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	17	2.6	Stable	No	No			No	0	25.99		0
157	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0.9		No	No			No	0	29.67		0
158	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	II	0	1.8		No	No		ARID1A	Yes	0	33.48		0
159	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	2	Stable	No	No			Yes	0	39.03		0
160	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	36	1.8	Stable	No	No			Yes	0	25.63		0
161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	6.1		No	No		RAD51C	No	0	35.45		0
162	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	8.8		No	No	Signature.6		No	0	7.75		0
163	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	III	90	0.9	Stable	No	No			No	0	46.92		0
164	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	99	14	Stable	No	Yes or Unknown	Signature.4	ATR | MSH6	Yes	0	20.86		0
165	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	41	1.8		No	No			Yes	0	33.05		0
166	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	0	9.8	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	16.16		0
167	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	3.9	Stable	No	No			Yes	1	11.79		0
168	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	20	48.3	Unstable	No	No	Signature.6	ARID1A | BRCA2 | MLH1 | MSH2	No	0	13.14		0
169	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	908	0.9	Stable	No	Yes or Unknown			No	0	37.49		0
170	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	24	1.8		No	No		BRCA2	No	0	26.78		0
171	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	89	1.8	Stable	No	No			No	0	25.95		0
172	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	57	13.2	Stable	No	No	Signature.4	XRCC2	No	0	12.52		0
173	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	13.7		0
174	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	44	4.4		No	Yes or Unknown			No	0	35.68		0
175	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	51	3.5	Stable	No	Yes or Unknown			No	0	14.09		0
176	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	IV	61	3.9	Stable	No	Yes or Unknown			No	1	3.61		0
177	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	30	0		No	Yes or Unknown			Yes	0	29.93		0
178	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	17	2	Stable	No	No			No	0	40.54		0
179	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	0	3.5	Stable	No	No	Signature.8	BRCA1 | ERCC4	No	0	10.32		0
180	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	30	1.8		No	Yes or Unknown			Yes	0	36.3		0
181	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	1273	5.3	Stable	No	Yes or Unknown	Signature.8		No	0	47.97		0
182	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	8	12.3		No	Yes or Unknown	Signature.4		No	1	1.41		0
183	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	III	355	2.6	Stable	No	Yes or Unknown			No	1	22.28		0
184	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	I	32	26.6	Unstable	No	No	Signature.6	ARID1A	Yes	0	46.39		0
185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	52	0.9	Stable	No	Yes or Unknown			Yes	0	36.07		0
186	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	II	0	0		No	No			Yes	0	48.13		0
187	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	18	1	Stable	No	No			Yes	0	34.96		0
188	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	6	5.9	Stable	No	No			No	1	20.57		0
189	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	15	12.3		No	No	Signature.5	BRCA2 | MRE11A | MSH2	Yes	0	3.38		0
190	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	20	1	Stable	No	No			Yes	0	35.19		0
191	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	5.3	Stable	No	No		BRCA2 | MSH2	Yes	0	24.34		0
192	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	57	3.9	Stable	No	No			No	0	26.25		0
193	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	IV	9	6.1	Stable	No	No			No	1	6.51		0
194	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	22	1.8		No	No			No	0	28.29		0
195	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	II	8	1.8	Stable	No	No			No	0	32.2		0
196	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	44	4.4		No	No	Signature.1		No	0	13.63		0
197	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	0	10.8	Stable	No	Yes or Unknown	Signature.20	BRCA2	Yes	0	26.09		0
198	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	61	1.8		No	No	Signature.30		Yes	0	32.2		0
199	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	14	1	Stable	No	No			No	1	20.93		0
200	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	0	0.9	Stable	No	No			No	0	16.3		0
201	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	0	4.4	Stable	No	Yes or Unknown			No	1	33.94		0
202	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	I	11	1.8	Stable	No	No			No	1	8.74		0
203	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		7	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	0	27.5		0
204	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	0	15.8	Stable	No	No	Signature.13	ERCC2	No	0	19.45		0
205	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	IV	11	3.5	Stable	No	No	Signature.5		No	0	47.84		0
206	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	26	11.8	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	6.28		0
207	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	20	5.3	Stable	No	No	Signature.2	ATM	No	0	18.3		0
208	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	0	7.9	Stable	No	No			No	0	9.95		0
209	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	54	1.8		No	Yes or Unknown			Yes	0	27.47		0
210	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2015	IV	1	10.5		No	No	Signature.2	ARID1A | FANCA	Yes	0	43.89		0
211	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	27	0.9	Stable	No	No			No	0	13.9		0
212	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	0	4.4	Stable	No	No		BLM | BRCA2 | BRIP1	No	0	18.14		0
213	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	5	6.1	Stable	No	No		ARID1A	Yes	0	1.28		0
214	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	II	196	4.4	Stable	No	Yes or Unknown			No	0	11.89		0
215	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	I	47	7.9	Stable	No	No			No	1	7.03		0
216	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	IV	66	2	Stable	No	No	Signature.5		No	1	5.49		0
217	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	33	24.6	Unstable	No	No	Signature.6	ARID1A	No	0	41.89		0
218	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	4.4	Stable	No	No		CHEK2	No	0	10.55		0
219	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	28	5.9	Stable	No	No			Yes	1	15.08		0
220	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	32	3.9		No	Yes or Unknown			No	0	22.57		0
221	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	1.8		No	No			Yes	0	30.55		0
222	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	48	3.5	Indeterminate	No	No			No	0	32.62		0
223	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	III	21	65.9	Unstable	No	No	Signature.6	ATM | BLM | FANCA | FANCC | MSH6 | MUTYH	Yes	0	25.63		0
224	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	18	2.6	Stable	No	No			Yes	0	16.26		0
225	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2015	II	0	6.1		No	Yes or Unknown		ARID1A	No	1	25.63		0
226	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	6.1		No	No	Signature.4		No	0	34.89		0
227	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	975	3.5		No	Yes or Unknown	Signature.1		No	0	42.87		0
228	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	13	1		No	No			Yes	0	30.85		0
229	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	29	6.1		No	No			No	0	38.28		0
230	Non-ICI treated	Never received ICI	91 - 95	Female	Ovarian	2015	IV	13	4.4	Stable	No	No		ERCC5	No	0	30.16		0
231	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	5.3	Stable	No	No		ERCC3	Yes	0	19.22		0
232	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	0	3		No	No			No	0	19.84		0
233	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	73	3	Stable	No	No			No	1	15.77		0
234	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	0	9.7	Indeterminate	No	No	Signature.3	MUTYH	No	0	20.5		0
235	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	0	6.1	Stable	No	Yes or Unknown			No	1	18.14		0
236	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2015	IV	184	7.9	Stable	No	Yes or Unknown	Signature.7		No	1	14.62		0
237	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	14	2.6	Stable	No	No			No	0	21.85		0
238	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	74	3.5	Stable	No	No	Signature.2		No	0	38.37		0
239	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	64	1.8	Stable	No	No			No	0	5.75		0
240	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	I	1382	3.5	Stable	No	No			No	0	52.34		0
241	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	19	2.6		No	Yes or Unknown		BRCA2	No	0	34.96		0
242	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	260	2.6	Stable	No	No			Yes	0	24.71		0
243	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	30	5.3	Stable	No	No			No	0	6.83		0
244	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	16	5.9		No	No			No	0	36.8		0
245	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	18	2	Stable	No	No			No	1	13.01		0
246	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	0	0	Stable	No	No			Yes	0	22.44		0
247	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2015	II	857	0	Stable	No	Yes or Unknown			No	0	54.74		0
248	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	154	19.3	Stable	No	Yes or Unknown	Signature.4	ARID1A | ATM	No	0	18.2		0
249	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	14	5.9	Stable	No	No			No	1	42.41		0
250	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	20	0.9	Stable	No	No			Yes	0	22.31		0
251	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	22	2.6		No	No			No	0	46.29		0
252	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	70	0.9	Stable	No	Yes or Unknown			No	0	15.67		0
253	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	36	1.8	Stable	No	Yes or Unknown			No	0	26.02		0
254	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	II	0	2.6	Stable	No	No		ARID1A	Yes	0	18.89		0
255	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	II	0	4.4	Stable	No	No			No	0	12.62		0
256	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	39	7		No	Yes or Unknown			No	0	45.8		0
257	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	125	10.5	Stable	No	No	Signature.13	PMS2	No	1	9.2		0
258	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	112	3	Stable	No	Yes or Unknown			No	0	40.44		0
259	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	17	0.9	Stable	No	Yes or Unknown			Yes	0	6.31		0
260	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2018	IV	120	0	Stable	No	Yes or Unknown			Yes	0	10.78		0
261	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	22	8.9	Stable	No	No		ATM	Yes	0	41.59		0
262	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	57	12.8	Indeterminate	No	No	Signature.4		No	1	3.71		0
263	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	36	13.2	Stable	No	No	Signature.1		No	0	2.46		0
264	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	II	10	8.8	Stable	No	No	Signature.29	ARID1A	Yes	0	11.79		0
265	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	122	1.8	Stable	No	No			Yes	0	18.04		0
266	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	26	0.9	Stable	No	No		ARID1A	No	0	17.74		0
267	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	85	3		No	No			No	0	38.01		0
268	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	8	2.6	Stable	No	Yes or Unknown			No	1	6.41		0
269	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	IV	0	74.6	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | ERCC2 | ERCC5 | MLH1 | MSH3	No	0	21.39		0
270	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	16	3.9	Stable	No	No			No	0	40.25		0
271	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	125	0.9	Stable	No	Yes or Unknown			No	1	16.82		0
272	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	19	5.9	Stable	No	No			No	0	41.95		0
273	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2018	III	0	43	Unstable	No	No	Signature.6	ATM | MSH3 | XRCC2	Yes	0	16.53		0
274	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.45		0
275	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	2.6	Stable	No	No			No	0	29.24		0
276	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	236	4.4	Stable	No	Yes or Unknown			No	0	20.6		0
277	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	33	3.5		No	No		ARID1A	No	0	37.49		0
278	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	25	3.5		No	No			No	0	37.88		0
279	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	36	3.5	Stable	No	No			Yes	0	25.59		0
280	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2017	I	0	0	Stable	No	No			No	0	18.66		0
281	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	82	0	Stable	No	No			No	0	47.18		0
282	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	1	11.76		0
283	Non-ICI treated	Never received ICI	51 - 55	Female	Bladder	2017	II	0	8.8	Stable	No	No	Signature.3		Yes	0	29.83		0
284	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	36	5.3	Stable	No	No			Yes	0	27.37		0
285	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2015		81	11.8	Stable	No	No	Signature.13		Yes	0	42.18		0
286	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	II	12	49.2	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | PMS1 | RAD50 | RAD52	No	0	43.66		0
287	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	I	23	2.6		No	No			No	0	39.82		0
288	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	54	4.9	Stable	No	No		RAD50	No	0	50.27		0
289	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2017	I	0	5.3	Stable	No	No		CHEK2	No	0	19.81		0
290	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	7	Stable	No	No			No	1	7.72		0
291	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018	II	30	0	Stable	No	Yes or Unknown			No	0	9.89		0
292	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	98	0		No	No			No	0	35.12		0
293	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	42	4.4	Stable	No	No			No	0	38.9		0
294	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	36	10.5	Stable	No	No	Signature.4		No	0	23.33		0
295	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	III	38	7.9	Stable	No	No			No	1	4.67		0
296	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	IV	28	3.5	Stable	No	Yes or Unknown			No	0	48.95		0
297	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	56	0		No	No			No	0	29.27		0
298	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	12	2.6		No	No			Yes	0	15.34		0
299	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		47	3	Stable	No	No			No	0	50.3		0
300	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		176	0	Stable	No	No	Signature.3		No	0	18.1		0
301	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	5	3	Stable	No	No			Yes	0	38.18		0
302	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	26	3.9	Stable	No	No		FANCA	No	0	49.91		0
303	Non-ICI treated	Never received ICI	91 - 95	Male	SCLC	2016	II	44	5.9	Stable	No	No	Signature.27		No	1	35.48		0
304	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	10	5.3	Stable	No	No		PMS2	No	0	22.57		0
305	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	157	0.9	Stable	No	Yes or Unknown			No	0	30.42		0
306	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	12	0.9		No	Yes or Unknown			No	0	25.4		0
307	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	18	24.6	Stable	No	No	Signature.4		No	1	12.71		0
308	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	34	1	Stable	No	Yes or Unknown			No	0	37.85		0
309	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	49	1.8	Stable	No	Yes or Unknown			No	0	19.98		0
310	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	II	65	4.9	Stable	No	Yes or Unknown		ERCC4	No	0	39.36		0
311	Non-ICI treated	Never received ICI	31 - 35	Male	Esophageal	2016	III	0	3.9	Stable	No	No			Yes	0	39.06		0
312	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	III	16	1.8	Stable	No	No			No	1	16.43		0
313	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	13	5.9	Stable	No	No			No	1	31.74		0
314	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		No	1	10.84		0
315	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	3.9	Stable	No	No			Yes	0	39.39		0
316	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	0	0	Stable	No	No			Yes	0	34.56		0
317	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	I	164	1.8	Stable	No	Yes or Unknown		CHEK2	No	1	31.57		0
318	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2015	III	80	0	Stable	No	Yes or Unknown			Yes	0	49.81		0
319	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		BLM	No	0	24.38		0
320	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	24.34		0
321	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	197	10.5		No	No	Signature.4	SLX4	No	0	31.51		0
322	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	I	16	0.9	Stable	No	No			No	0	7.39		0
323	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	II	46	1.8		No	No			No	0	42.02		0
324	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	570	1.8	Stable	No	Yes or Unknown			No	0	41.2		0
325	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	8	0.9	Stable	No	No			No	1	17.94		0
326	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	25	2.6	Stable	No	No			No	0	27.56		0
327	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	III	252	7.9		No	Yes or Unknown	Signature.5	CHEK2	Yes	0	21.88		0
328	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	34	1.8	Stable	No	No		BRCA1 | CHEK2	No	0	12.94		0
329	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	2	Stable	No	No			No	0	38.37		0
330	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	147	2.6	Stable	No	Yes or Unknown			No	0	25.86		0
331	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	I	20	0.9	Stable	No	No			No	0	20.9		0
332	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2016	III	412	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A | BLM	Yes	1	32		0
333	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	46	0	Stable	No	No			No	0	36.04		0
334	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	15	3	Stable	No	No			No	0	7.29		0
335	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	55	0.9	Stable	No	No			No	0	33.97		0
336	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	19	3.5	Stable	No	No			Yes	0	7.79		0
337	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	48	5.9	Stable	No	No	Signature.4		No	1	31.9		0
338	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	6	9.7		No	No	Signature.4	BRIP1	Yes	1	6.47		0
339	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	2	Stable	No	No			Yes	0	28.19		0
340	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	114	6.1	Stable	No	Yes or Unknown			Yes	0	37.29		0
341	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	8	6.1	Stable	No	No	Signature.3	BRCA1	No	0	6.9		0
342	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	32	2.6	Stable	No	Yes or Unknown	Signature.5		No	0	9.53		0
343	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	131	1.8	Stable	No	Yes or Unknown		BRIP1	No	0	12.55		0
344	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	14	1.8	Stable	No	No			No	0	10.25		0
345	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	IV	159	6.1		No	Yes or Unknown	Signature.17	ARID1A	No	1	9		0
346	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	22	0.9		No	No			Yes	0	26.38		0
347	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	20	2.6	Stable	No	No			Yes	0	24.57		0
348	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2015	II	55	0	Stable	No	No			No	0	49.02		0
349	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	4.4		0
350	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	14	4.4	Stable	No	No			Yes	0	14.72		0
351	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	III	0	3.5	Stable	No	No		ARID1A	Yes	0	39.29		0
352	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	26	6.1	Stable	No	No	Signature.4	MRE11A	No	0	16.69		0
353	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	24	3.5		No	No			No	0	33.35		0
354	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	11	5.9	Stable	No	No			No	1	8.15		0
355	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	III	0	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	16.82		0
356	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	50	2.6		No	No			No	0	29.7		0
357	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	I	37	56.2	Unstable	No	No	Signature.6	ARID1A | MLH1 | MRE11A | MSH3 | RAD50	No	0	12.91		0
358	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2016	IV	0	7.9	Stable	No	No	Signature.5		Yes	0	37.82		0
359	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	24	5.3	Stable	No	No			No	0	36.21		0
360	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	34	2	Stable	No	No			No	0	38.8		0
361	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	6.1	Stable	No	No	Signature.1		No	1	27.4		0
362	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		0	5.3		No	No			No	1	11.63		0
363	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	22	12.8	Stable	No	No	Signature.1	ARID1A	No	0	37.45		0
364	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017		11	3.5	Stable	No	No			No	1	7.82		0
365	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	21	4.4		No	No	Signature.29		No	1	1.51		0
366	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	III	6	7	Stable	No	No	Signature.3	MUTYH | SLX4	No	0	9.82		0
367	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	113	12.3	Stable	No	Yes or Unknown	Signature.30	NTHL1	Yes	0	10.58		0
368	Non-ICI treated	Never received ICI	46 - 50	Female	Renal	2016	I	3	0.9	Stable	No	No			No	0	24.15		0
369	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		1	4.9	Stable	No	Yes or Unknown			No	1	17.22		0
370	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	27	5.3	Stable	No	Yes or Unknown		SLX4	Yes	0	7.82		0
371	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		57	0		No	No			No	0	23.23		0
372	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	I	24	0.9	Stable	No	No			No	0	13.47		0
373	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	14	3.5	Stable	No	No			No	1	12.42		0
374	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2016	III	0	1.8	Stable	No	No			No	1	11.96		0
375	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	2.6	Stable	No	No		BRCA1	No	0	17.94		0
376	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	3.5		No	No		CHEK2 | TP53BP1	No	0	31.77		0
377	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	100	0	Stable	No	No			No	0	6.93		0
378	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	II	47	7	Stable	No	No	Signature.1		No	0	25.33		0
379	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	0	4.4	Stable	No	No	Signature.3	RAD54L	No	0	27.5		0
380	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	I	22	1	Stable	No	Yes or Unknown			No	0	47.84		0
381	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	9	3.5	Stable	No	Yes or Unknown	Signature.1		No	0	13.54		0
382	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	2.6	Stable	No	Yes or Unknown			No	0	24.74		0
383	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	I	42	6.1	Stable	No	No			No	0	12.91		0
384	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	18	1.8	Stable	No	No			No	0	30.92		0
385	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	IV	0	3.5		No	No	Signature.1		No	1	5.72		0
386	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	I	22	3.5		No	No		ARID1A	No	0	34.2		0
387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	59	1.8	Stable	No	No		BRCA1 | BRCA2	No	0	32.2		0
388	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	207	1.8		No	Yes or Unknown			No	1	30.92		0
389	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	1	0.9	Stable	No	No			Yes	1	2.4		0
390	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	26	3.5	Stable	No	No			Yes	0	23.36		0
391	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	62	6.1	Stable	No	No	Signature.3	BRCA2	No	0	25.49		0
392	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	29	2.6	Stable	No	Yes or Unknown		ATM	No	0	26.64		0
393	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	14	2	Stable	No	No		ATM	No	0	39.59		0
394	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	3.9		No	Yes or Unknown			No	0	36.27		0
395	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	27	3.5	Stable	No	No			No	0	25.59		0
396	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	III	0	1	Stable	No	No			No	0	40.44		0
397	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	I	3	3.5	Stable	No	No		MSH3	Yes	0	15.18		0
398	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	49	0.9	Stable	No	No			No	0	16.95		0
399	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	5.3	Stable	No	Yes or Unknown		RAD50	No	0	12.12		0
400	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	29	0.9		No	No			No	0	29.44		0
401	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	21	4.4	Stable	No	No			No	0	6.67		0
402	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	35	15.8	Stable	No	No	Signature.4	ATR	No	0	24.15		0
403	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	22	1	Stable	No	No			Yes	0	35.45		0
404	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	13	3.9	Stable	No	No			Yes	0	36.8		0
405	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	27	4.4	Stable	No	Yes or Unknown			No	0	28.91		0
406	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	IV	113	4.9	Stable	No	Yes or Unknown			No	1	17.12		0
407	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	13	1	Stable	No	Yes or Unknown			Yes	0	12.62		0
408	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	9	4.9	Stable	No	No			No	1	47.87		0
409	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	1.8	Stable	No	No			Yes	0	10.12		0
410	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	12	3	Stable	No	No			No	1	40.84		0
411	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2018	IV	0	4.4	Stable	No	No		BLM | SLX4	No	0	7.69		0
412	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	0	24.6		No	Yes or Unknown	Signature.4		No	1	31.74		0
413	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	31	1.8	Stable	No	No			Yes	0	24.21		0
414	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	10	2	Stable	No	No		BRCA2	Yes	1	1.84		0
415	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	I	0	0		No	No			No	0	36.21		0
416	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016		0	3	Stable	No	No			Yes	0	32.85		0
417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	2		No	No			No	0	34.92		0
418	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	6.1	Stable	No	No		BRCA2	No	0	31.8		0
419	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	24	1.8	Stable	No	No			Yes	0	25.03		0
420	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	18	5.3		No	No	Signature.2		Yes	0	30.85		0
421	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	69	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	22.41		0
422	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	1324	7	Stable	No	Yes or Unknown	Signature.29		No	0	52.7		0
423	Non-ICI treated	Never received ICI	91 - 95	Male	Pancreatic	2017	IV	18	4.4	Stable	No	No	Signature.3	BRCA1 | MRE11A	No	0	3.22		0
424	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	2.6	Stable	No	No		ARID1A	No	0	10.51		0
425	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	IV	0	4.4	Stable	No	No			No	1	6.05		0
426	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	9	6.1		No	No		ATM	No	1	19.94		0
427	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016		0	0.9		No	No			Yes	0	32.89		0
428	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2018		19	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	14.09		0
429	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	41	5.9	Stable	No	No			Yes	0	39.56		0
430	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	29	1	Stable	No	No			No	0	47.44		0
431	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	1500	4.4	Stable	No	No			No	0	50.83		0
432	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	28	9.7	Stable	No	No	Signature.1		No	0	29.86		0
433	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	26.78		0
434	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	10	5.3	Stable	No	No		ARID1A	No	0	20.86		0
435	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	28	3.5	Stable	No	No		PMS1	Yes	0	24.54		0
436	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	41	0.9	Stable	No	No	Signature.1		Yes	0	16.53		0
437	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	156	5.3	Stable	No	Yes or Unknown		RAD52	No	0	22.24		0
438	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	0	4.9		No	No			Yes	1	7		0
439	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	II	27	0	Stable	No	No			Yes	0	48.23		0
440	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	56	31.6	Unstable	No	No	Signature.1	ERCC5	No	0	35.35		0
441	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	10	1.8	Stable	No	No			No	0	20.37		0
442	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	36	14.9	Stable	No	No	Signature.10	ATM | MSH3	Yes	0	32.26		0
443	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	27	5.3		No	No	Signature.3	PMS1	No	0	35.42		0
444	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	13	4.4	Stable	No	No	Signature.1		No	0	15.61		0
445	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		0	1	Stable	No	No			No	0	48.46		0
446	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	33	3.5	Stable	No	Yes or Unknown			No	0	13.31		0
447	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	III	133	2.6		No	Yes or Unknown			No	1	10.81		0
448	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	23	0.9	Stable	No	No			No	0	36.07		0
449	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2018	IV	19	2.6	Stable	No	No	Signature.30	BRCA2	No	0	15.77		0
450	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	643	3.5	Stable	No	Yes or Unknown			No	0	49.51		0
451	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	87	5.3	Stable	No	No			Yes	0	16		0
452	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	257	4.9		No	Yes or Unknown	Signature.5	PALB2	Yes	0	43.24		0
453	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	20	3.5	Stable	No	No			Yes	0	40.77		0
454	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	26	37.4	Unstable	No	No	Signature.15	ARID1A | ATM | MLH1 | MUTYH	No	1	9.3		0
455	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	I	19	6.1		No	Yes or Unknown			No	0	36.47		0
456	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	II	1249	1.8	Stable	No	No			No	0	43.73		0
457	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	28	9.7	Stable	No	No	Signature.1		No	1	7.49		0
458	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	15	2.6		No	No			No	0	34.73		0
459	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4	Stable	No	No			No	0	23.43		0
460	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	7	Stable	No	No		ARID1A	Yes	0	30.42		0
461	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	33	2.6	Stable	No	Yes or Unknown			No	0	21.09		0
462	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	I	18	6.9	Stable	No	No	Signature.1	ERCC3 | MUTYH	No	0	46.92		0
463	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	52.7		0
464	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	0	6.1	Stable	No	No	Signature.29		No	1	19.19		0
465	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	0	2.6	Stable	No	No			Yes	1	10.09		0
466	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	15	2.6	Stable	No	No			Yes	0	15.74		0
467	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	34	0	Stable	No	No			No	0	9.17		0
468	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	23	5.3	Stable	No	Yes or Unknown			No	0	27.17		0
469	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	15	0	Stable	No	No			No	0	8.25		0
470	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	50	2.6	Stable	No	No			No	0	17.05		0
471	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	10.09		0
472	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2017	I	514	1.8	Stable	No	No			No	0	27.7		0
473	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	0	6.1	Stable	No	No	Signature.13	BRCA2	No	0	25.49		0
474	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	8	5.3	Stable	No	Yes or Unknown			No	1	21.72		0
475	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	34	3.5		No	No			Yes	0	30.92		0
476	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	37	1.8	Stable	No	No			Yes	0	12.39		0
477	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2015	I	1171	0.9	Stable	No	No			No	0	44.65		0
478	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	60	4.9	Stable	No	No		ARID1A	No	0	22.08		0
479	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	40	2	Stable	No	No			Yes	1	7.2		0
480	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	20	0		No	No			Yes	0	30.55		0
481	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	27	1.8	Stable	No	No			No	0	41.23		0
482	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	III	0	3.9	Stable	No	No			No	0	36.73		0
483	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	52	13.8		No	No	Signature.4	ATM | NBN	No	1	27.07		0
484	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	12	4.9	Stable	No	Yes or Unknown		ATM | BRCA1	No	1	27.33		0
485	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	III	0	0		No	No			No	0	33.74		0
486	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	38	6.9	Stable	No	No	Signature.4	MSH2	Yes	1	15.18		0
487	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	36	2.6	Stable	No	Yes or Unknown			No	0	13.14		0
488	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	4.9	Stable	No	No	Signature.13		Yes	1	3.48		0
489	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	185	8.8	Stable	No	Yes or Unknown		FANCA	No	0	19.19		0
490	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	10	10.8	Indeterminate	No	No	Signature.4	BRIP1	No	1	1.05		0
491	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	III	0	2.6		No	No	Signature.4		No	0	34.92		0
492	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.1	BRCA2 | RAD50	No	0	7.62		0
493	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	9	7	Stable	No	No	Signature.30		No	1	9.07		0
494	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	2	12.3		No	No	Signature.4	FANCA	No	1	4.73		0
495	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	20	0.9	Stable	No	No			Yes	0	38.64		0
496	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	9	4.4	Stable	No	No		TP53BP1	No	0	22.18		0
497	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		0	3	Stable	No	No			No	1	12.29		0
498	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	10	7.9	Stable	No	No			No	0	17.12		0
499	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	27	1.8		No	No			Yes	0	45.86		0
500	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2015		158	4.9	Stable	No	No			No	1	6.51		0
501	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	2.6	Stable	No	No		PALB2	Yes	0	9.86		0
502	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	1		No	No			No	0	31.97		0
503	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	II	42	0.9	Stable	No	No			No	0	49.15		0
504	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	II	43	10.5	Stable	No	No	Signature.4		Yes	0	10.15		0
505	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	8	29		No	No	Signature.4	BRCA2 | ERCC3 | TP53BP1	No	0	24.15		0
506	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	193	2	Stable	No	Yes or Unknown		BRCA2	No	0	49.35		0
507	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	III	0	14.9		No	No	Signature.13	ARID1A	No	1	21.45		0
508	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	24	10.5	Stable	No	No	Signature.1		No	0	10.09		0
509	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	29	2	Stable	No	No			No	0	36.57		0
510	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	II	0	6.1		No	Yes or Unknown	Signature.3		No	0	38.18		0
511	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	18	1.8	Stable	No	No			No	0	18.96		0
512	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	0	0		No	No			No	0	6.18		0
513	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2017	III	0	5.3	Stable	No	No	Signature.2		Yes	0	24.9		0
514	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	9	7.9	Stable	No	No	Signature.13		Yes	1	43.6		0
515	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		208	12.8	Stable	No	No		ARID1A | BRCA2 | FANCA	No	0	51.68		0
516	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015		733	4.4	Stable	No	No			Yes	0	51.91		0
517	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	III	292	3.5	Stable	No	No			Yes	0	26.58		0
518	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	II	12	0	Stable	No	No			No	0	13.77		0
519	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	7.03		0
520	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	81	1	Stable	No	No			No	0	50.96		0
521	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	32	6.1	Stable	No	No		ARID1A	No	0	14.72		0
522	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	19	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	39.23		0
523	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	III	0	5.9	Stable	No	No	Signature.3	ERCC5 | PARP1	No	0	48.72		0
524	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	11.01		0
525	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	10	11.4	Stable	No	No	Signature.1		Yes	0	10.25		0
526	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	33	1.8	Stable	No	No			Yes	0	50.76		0
527	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	II	29	3	Stable	No	No		BRCA2	No	1	11.83		0
528	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	I	0	5.3	Stable	No	No			No	0	17.54		0
529	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2018	IV	0	7.9	Stable	No	No			No	0	14.19		0
530	Non-ICI treated	Never received ICI	76 - 80	Male	Renal	2015	III	0	0	Stable	No	No			No	0	55.16		0
531	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	III	43	0	Stable	No	No			No	0	51.71		0
532	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	44	6.1	Stable	No	No	Signature.26		No	0	28.35		0
533	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	II	1100	0.9	Stable	No	Yes or Unknown			No	0	54.83		0
534	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	0	4.9	Stable	No	No			No	1	8.57		0
535	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	0	3.5	Stable	No	Yes or Unknown			Yes	1	8.64		0
536	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		1551	1.8	Stable	No	No			No	0	55.03		0
537	Non-ICI treated	Never received ICI	46 - 50	Male	Ovarian	2017		548	4.4	Stable	No	Yes or Unknown			No	0	27.6		0
538	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	832	4.4	Stable	No	No			No	0	52.47		0
539	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		0	3.9	Stable	No	No			Yes	0	9.86		0
540	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	10	2	Stable	No	No			Yes	0	54.41		0
541	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2015	III	43	3	Stable	No	No			No	0	53.49		0
542	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	7	Stable	No	No	Signature.1		No	1	43.73		0
543	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	III	0	3.9	Stable	No	No			No	1	22.93		0
544	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	0	0	Stable	No	Yes or Unknown			No	1	15.08		0
545	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2015	I	0	1	Stable	No	No			No	1	18.27		0
546	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	12.35		0
547	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	0	3	Stable	No	No	Signature.1		Yes	1	11.5		0
548	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	615	6.1	Stable	No	Yes or Unknown			No	0	55.06		0
549	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	87	0	Stable	No	Yes or Unknown			No	0	54.41		0
550	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	0	6.9	Stable	No	No	Signature.1	ERCC2	Yes	0	54.97		0
551	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	0	3	Stable	No	No			No	0	49.05		0
552	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	12	3	Stable	No	No			No	1	8.64		0
553	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	0	3	Indeterminate	No	No	Signature.13		No	1	8.97		0
554	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	1084	3.5	Stable	No	No			No	0	47.93		0
555	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	35	19.7	Stable	No	No	Signature.4	BRIP1	No	0	48.13		0
556	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	III	1457	5.3	Stable	No	Yes or Unknown			No	0	55.2		0
557	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	II	0	0	Stable	No	No			No	0	51.91		0
558	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	18	2	Stable	No	Yes or Unknown			No	1	27.14		0
559	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	18	3	Stable	No	No			No	1	54.37		0
560	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	12	6.9	Stable	No	No			No	0	54.9		0
561	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	36	2	Stable	No	No			No	0	49.28		0
562	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1470	12.3	Stable	No	Yes or Unknown	Signature.2		No	0	54.24		0
563	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	22	4.9	Stable	No	No			Yes	0	52.24		0
564	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	IV	0	6.9	Stable	No	Yes or Unknown	Signature.5		No	1	16.76		0
565	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2015	I	0	2.6		No	No			No	0	48.95		0
566	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.94		0
567	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	15	4.9	Stable	No	Yes or Unknown			No	1	39.49		0
568	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	4.9	Stable	No	No	Signature.4	ATR | ERCC3	Yes	1	3.15		0
569	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	IV	39	11.8	Stable	No	No	Signature.2	ARID1A | BRCA1 | MDC1	Yes	1	23.23		0
570	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	35	5.3	Stable	No	Yes or Unknown	Signature.7		Yes	0	9.43		0
571	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2015	III	599	2.6	Stable	No	Yes or Unknown	Signature.24		No	1	40.05		0
572	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2015	I	0	3	Stable	No	No			No	0	47.87		0
573	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	II	0	3.9	Stable	No	Yes or Unknown		ARID1A	No	1	10.28		0
574	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	85	3.9	Stable	No	Yes or Unknown			No	1	7.69		0
575	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	6	4.4	Stable	No	No		ARID1A	No	0	29.17		0
576	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	150	15.7	Stable	No	Yes or Unknown	Signature.8		No	1	5.65		0
577	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	11	3.9	Stable	No	No			No	1	23.39		0
578	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	1649	0.9	Stable	No	Yes or Unknown			No	0	54.51		0
579	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	30	2	Stable	No	No		ARID1A	No	0	27.7		0
580	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	III	13	5.3	Stable	No	Yes or Unknown			No	0	55.16		0
581	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	16	4.9	Stable	No	Yes or Unknown		BRCA1	No	1	31.01		0
582	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	0	3	Stable	No	No		ARID1A | CHEK2	No	1	19.45		0
583	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2015	I	7	1	Stable	No	No			No	0	50.79		0
584	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1359	0	Stable	No	Yes or Unknown	Signature.30		No	0	54.11		0
585	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	52	0.9		No	Yes or Unknown	Signature.1		No	1	53.68		0
586	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	0	3	Stable	No	Yes or Unknown			No	1	5.95		0
587	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	45	3.9	Stable	No	No		ERCC4	Yes	0	50.1		0
588	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	47	3	Stable	No	No			No	0	11.73		0
589	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	I	49	3.5	Stable	No	No			No	0	55.23		0
590	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	I	0	1.8	Stable	No	No			Yes	0	55.16		0
591	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	III	0	7.9		No	No	Signature.5	BRCA2 | MSH6	No	0	29.7		0
592	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	0	4.4	Stable	No	No			No	1	26.61		0
593	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	5	7.9	Stable	No	Yes or Unknown	Signature.9		No	0	42.81		0
594	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	0	4.9	Stable	No	No	Signature.3	BRCA2	No	1	19.25		0
595	Non-ICI treated	Never received ICI	36 - 40	Female	Gastric	2015	I	61	0		No	No			Yes	0	51.09		0
596	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	27	18.7	Stable	No	No	Signature.4	RAD50	No	0	44.94		0
597	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2015	IV	29	3	Stable	No	Yes or Unknown			No	0	53.98		0
598	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	7	0	Stable	No	Yes or Unknown		CHEK2	No	1	30.92		0
599	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	26	0	Stable	No	No			No	1	32.56		0
600	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	0	5.9	Stable	No	No	Signature.1		No	0	18.6		0
601	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	III	26	1.8	Stable	No	No			No	1	51.68		0
602	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	32	7.9	Stable	No	No	Signature.4		Yes	1	12.45		0
603	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	140	5.9	Stable	No	Yes or Unknown	Signature.1		No	0	11.24		0
604	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	25	3.9	Stable	No	Yes or Unknown			No	1	16.79		0
605	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015		0	0	Stable	No	No			Yes	0	33.97		0
606	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	544	3		No	Yes or Unknown			No	1	20.96		0
607	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	IV	38	8.9	Stable	No	No	Signature.13	BRCA2	Yes	1	4.83		0
608	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	3	1	Stable	No	Yes or Unknown			No	1	29.86		0
609	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	18.79		0
610	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	IV	0	0	Stable	No	No			No	0	54.44		0
611	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	0	32.5	Stable	No	No	Signature.4	ARID1A | MRE11A	No	1	6.18		0
612	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	0	1.8		No	No			No	0	26.51		0
613	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	46	2	Stable	No	No			No	0	54.8		0
614	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	19	13.8	Stable	No	No	Signature.1	ATM	No	1	49.68		0
615	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	II	83	2	Stable	No	No			Yes	0	51.55		0
616	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	235	1.8	Stable	No	Yes or Unknown			No	0	53.26		0
617	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2015	III	243	3	Stable	No	Yes or Unknown			Yes	0	49.64		0
618	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	4.9	Stable	No	No			Yes	0	53.62		0
619	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	910	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	54.34		0
620	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2015	I	69	2	Stable	No	No			No	0	45.96		0
621	Non-ICI treated	Never received ICI	66 - 70	Female	Head & Neck	2015	IV	773	3.5	Stable	No	Yes or Unknown		MSH2	No	0	54.28		0
622	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	127	1		No	Yes or Unknown			No	1	43.73		0
623	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	67	0	Stable	No	No			Yes	0	54.87		0
624	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	33	14.8	Stable	No	No	Signature.7		Yes	0	51.91		0
625	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	41	13.2		No	No	Signature.11	FANCA	No	0	51.58		0
626	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	49	2	Stable	No	Yes or Unknown			Yes	0	53.13		0
627	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2015		10	3	Stable	Yes or Unknown	Yes or Unknown			No	0	9.36		0
628	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	8.9	Stable	No	No	Signature.1		No	1	9.53		0
629	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	464	4.4		No	Yes or Unknown		NBN	No	1	40.67		0
630	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	182	3	Stable	No	Yes or Unknown			No	0	50.33		0
631	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	56	9.8	Stable	No	No	Signature.29		No	1	12.06		0
632	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	III	2	4.9	Stable	No	No			No	1	14.82		0
633	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	78	0.9		No	No			No	0	53.49		0
634	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	III	1254	1.8	Stable	No	No	Signature.3		No	0	43.66		0
635	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	8	11.8	Stable	No	No	Signature.4	BRCA1	No	1	4.01		0
636	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		2	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	25.63		0
637	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	39	4.9	Stable	No	No			No	0	22.11		0
638	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	40	33.4	Stable	No	Yes or Unknown	Signature.4		Yes	0	26.35		0
639	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	131	3.9	Stable	No	No		ATM	Yes	0	52.67		0
640	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	II	170	0	Stable	No	Yes or Unknown		BRCA1	No	1	32.79		0
641	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	1	Stable	No	No			No	0	50.83		0
642	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	75	4.4	Stable	No	No		MDC1	No	1	51.65		0
643	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	68	1	Stable	No	Yes or Unknown			No	0	54.41		0
644	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	24	9.8	Stable	No	No	Signature.4	CHEK2	No	0	6.77		0
645	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	1156	0.9	Stable	No	No			No	0	49.91		0
646	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	42	8.9	Stable	No	No	Signature.13	BLM | PALB2	Yes	0	40.8		0
647	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	II	108	0	Stable	No	No			No	0	38.01		0
648	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	1288	3.5	Stable	No	Yes or Unknown		PALB2	No	0	50.37		0
649	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	35	0	Stable	No	No			Yes	1	6.01		0
650	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015		7	3	Stable	No	No			Yes	1	8.15		0
651	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	152	6.9	Stable	No	Yes or Unknown	Signature.4	PALB2	No	1	15.97		0
652	Non-ICI treated	Never received ICI	61 - 65	Male	SCLC	2015	IV	136	12.8	Stable	No	Yes or Unknown	Signature.4		No	1	15.34		0
653	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	III	1	6.9	Stable	No	No			No	0	7.66		0
654	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	0	4.9	Stable	No	No		BLM	No	1	51.88		0
655	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	34	4.9	Stable	No	Yes or Unknown			No	0	54.14		0
656	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	IV	250	3	Stable	No	Yes or Unknown		ARID1A	No	1	19.65		0
657	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	I	0	3	Stable	No	No			No	0	50.07		0
658	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	III	29	0	Stable	No	No			No	0	53.75		0
659	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	2	Stable	No	No			No	0	53.62		0
660	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	15	3.5	Stable	No	Yes or Unknown		BLM	No	1	39.46		0
661	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	0	5.3		No	No			No	1	30.98		0
662	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	33	0	Stable	No	No			No	0	53.52		0
663	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	53	2	Stable	No	No			No	0	13.93		0
664	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	218	3	Stable	No	Yes or Unknown	Signature.9		No	1	11.27		0
665	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	1540	4.4	Stable	No	No	Signature.4		No	0	54.24		0
666	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	921	0		No	Yes or Unknown			No	1	40.74		0
667	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	673	4.4		No	Yes or Unknown			No	0	54.11		0
668	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	34	6.9	Stable	No	No			No	0	54.37		0
669	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	1	21.9	Indeterminate	No	Yes or Unknown	Signature.2	ERCC4 | MLH1 | MUTYH	No	1	36.76		0
670	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	51	3	Stable	No	No			No	0	23.39		0
671	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	23	19.7	Stable	No	Yes or Unknown	Signature.2	ARID1A | RAD51C	No	1	14.78		0
672	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		6	2	Stable	Yes or Unknown	Yes or Unknown			No	1	12.71		0
673	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2015	IV	0	17.7	Stable	No	No	Signature.7		No	0	45.7		0
674	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	3	4.9	Stable	No	No		ARID1A	Yes	1	25.59		0
675	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	16	9.8	Stable	No	No	Signature.4		No	0	53.32		0
676	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	III	36	3.9	Stable	No	Yes or Unknown	Signature.16		No	1	34.43		0
677	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	41	4.9	Stable	No	Yes or Unknown			No	0	53.72		0
678	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	336	0	Stable	No	Yes or Unknown			Yes	0	51.81		0
679	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	388	3	Stable	No	Yes or Unknown			No	0	25.3		0
680	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	21.75		0
681	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	22	6.1	Stable	No	No	Signature.3	ARID1A	No	1	44.65		0
682	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	II	0	2	Stable	No	Yes or Unknown			Yes	0	51.84		0
683	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	49.94		0
684	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	30	9.8	Stable	No	No	Signature.4	MUTYH	No	1	1.38		0
685	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	I	29	0.9		No	No			No	0	45.08		0
686	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	294	13.8	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	17.81		0
687	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	21	3.9	Stable	No	No			No	1	32.69		0
688	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2015	IV	0	0	Stable	No	No			No	1	19.58		0
689	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	0	3.5		No	Yes or Unknown		ATM	No	1	22.64		0
690	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	25	9.8	Stable	No	No	Signature.1		No	0	46.72		0
691	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	931	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	53.65		0
692	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	71	1	Stable	No	No			No	0	50.43		0
693	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	363	10.8	Stable	No	Yes or Unknown	Signature.1		No	0	53.75		0
694	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2015	II	45	1	Stable	No	No			No	0	48.69		0
695	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	53	1.8	Stable	No	No			Yes	0	53.98		0
696	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	II	0	59	Unstable	No	No	Signature.6	ARID1A | ATM	Yes	0	50.56		0
697	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	357	1	Stable	No	Yes or Unknown			Yes	1	13.54		0
698	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	18	3	Stable	No	Yes or Unknown			Yes	0	51.88		0
699	Non-ICI treated	Never received ICI	86 - 90	Female	Head & Neck	2015	IV	36	10.8	Stable	No	No	Signature.2		Yes	1	18.63		0
700	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	193	5.3	Stable	No	Yes or Unknown			No	0	53.95		0
701	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	I	721	0.9	Stable	No	No			Yes	0	52.76		0
702	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	35	3	Stable	No	Yes or Unknown			No	0	53.62		0
703	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	0	4.9	Stable	No	Yes or Unknown			No	0	54.64		0
704	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	6	1	Stable	No	No			No	1	11.73		0
705	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	85	5.9	Stable	No	Yes or Unknown			No	1	42.18		0
706	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	I	0	0	Stable	No	No			Yes	0	2.76		0
707	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	II	29	3.9	Stable	No	No			No	0	47.97		0
708	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	0	1	Stable	No	No		ARID1A	No	0	47.34		0
709	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	III	152	3	Stable	No	Yes or Unknown			No	0	52.17		0
710	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	22	4.9	Stable	No	No			No	1	16.3		0
711	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown		FANCA	No	1	25.49		0
712	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	1419	3.5	Stable	No	Yes or Unknown			No	0	54.14		0
713	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	III	40	2.6		No	Yes or Unknown		ATR	No	0	53.16		0
714	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	II	31	0	Stable	No	Yes or Unknown			Yes	0	47.05		0
715	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	1394	0	Stable	No	Yes or Unknown			No	0	52.7		0
716	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	99	3.5	Stable	No	No			No	0	53.98		0
717	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	26	4.4	Stable	No	No			No	0	52.86		0
718	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2015	III	1205	5.3	Stable	No	No	Signature.7		No	0	52.01		0
719	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	20	4.9	Stable	No	No			No	1	29.63		0
720	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	375	3.9	Stable	No	Yes or Unknown			No	1	31.05		0
721	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	8	4.9	Stable	No	No			No	1	47.77		0
722	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	378	3.9	Stable	No	Yes or Unknown			No	1	28.42		0
723	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	0	3.5	Stable	No	No		BRCA1	No	0	52.37		0
724	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	26.25		0
725	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	84	4.9	Indeterminate	No	Yes or Unknown			Yes	1	10.41		0
726	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	100	3	Indeterminate	No	Yes or Unknown		MDC1	No	1	9.76		0
727	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	IV	0	5.9	Stable	No	No	Signature.1	ARID1A	No	1	10.12		0
728	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	174	0.9	Stable	No	Yes or Unknown			No	1	37.19		0
729	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	II	12	5.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	53.26		0
730	Non-ICI treated	Never received ICI	46 - 50	Male	Renal	2015	III	0	0	Stable	No	No			No	0	49.94		0
731	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	52.99		0
732	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	14	5.9	Stable	No	No			No	1	2.07		0
733	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	4.9	Stable	No	No			Yes	1	27.14		0
734	Non-ICI treated	Never received ICI	15-Nov	Male	CNS	2015		9	1	Stable	No	No			No	0	13.63		0
735	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	166	2.6		No	No	Signature.5	XRCC2	No	0	53.09		0
736	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	34	2	Stable	No	Yes or Unknown			No	1	26.41		0
737	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	3	3.9	Stable	No	No			Yes	1	8.28		0
738	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	IV	1170	7	Stable	No	Yes or Unknown	Signature.1		No	0	52.21		0
739	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	1088	1.8	Stable	No	Yes or Unknown			No	0	52.07		0
740	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	56	5.9	Stable	No	No			No	1	3.38		0
741	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			Yes	0	53.36		0
742	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	15	6.9	Stable	No	No	Signature.2		No	1	12.35		0
743	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	971	2.6	Stable	No	Yes or Unknown		BRCA2	Yes	0	36.17		0
744	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	172	7.9	Stable	No	Yes or Unknown	Signature.6		No	1	12.06		0
745	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	7	5.9	Stable	No	No	Signature.10		No	1	7.06		0
746	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	92	5.3	Stable	No	Yes or Unknown			No	0	53.52		0
747	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	571	7.9		No	Yes or Unknown	Signature.26	TP53BP1	No	0	52.6		0
748	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2015	II	0	4.9	Stable	No	No		RAD50	No	1	29.24		0
749	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	36	3	Stable	No	No			No	1	46.88		0
750	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	22	4.9	Stable	No	No			No	1	11.3		0
751	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	0	5.9	Stable	No	No		FANCA	No	0	50.43		0
752	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	40	7.9	Stable	No	No		ERCC5	Yes	0	32.62		0
753	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	67	3.5	Stable	No	No		BRCA2	No	0	50.92		0
754	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	I	521	6.9	Stable	No	Yes or Unknown			Yes	0	50.63		0
755	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	0	3	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	1	47.34		0
756	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		RAD50	No	0	52.9		0
757	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2015	I	0	5.3	Stable	No	No			Yes	0	50.33		0
758	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	35	21.6	Stable	No	No	Signature.4	ERCC2	No	1	6.83		0
759	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		7	3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	15.7		0
760	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	11	2	Stable	No	No			Yes	0	51.88		0
761	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	III	0	0	Stable	No	No			Yes	1	10.84		0
762	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	6	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	52.76		0
763	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	0	1	Stable	No	No			No	1	18.07		0
764	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.30		No	1	12.16		0
765	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	104	5.9	Stable	No	Yes or Unknown			Yes	0	51.29		0
766	Non-ICI treated	Never received ICI	36 - 40	Male	NSCLC	2015	IV	412	2	Stable	No	Yes or Unknown			No	1	24.38		0
767	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	14.8	Stable	No	No	Signature.4		Yes	1	1.87		0
768	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	I	10	2	Stable	No	Yes or Unknown			No	0	53.06		0
769	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	17	8.9	Stable	No	No	Signature.24		Yes	1	7		0
770	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	220	10.8	Stable	No	Yes or Unknown	Signature.29		No	1	11.73		0
771	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	28	11.8	Stable	No	No	Signature.4		No	0	51.52		0
772	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	18	0.9	Stable	No	No			No	0	53.13		0
773	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	19.98		0
774	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	41.3	Unstable	No	No	Signature.6		Yes	1	13.27		0
775	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	164	2.6	Stable	No	No			No	0	41.59		0
776	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2015	III	53	317.7	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | MDC1 | MLH1 | MSH3 | MSH6 | NBN | PALB2 | PMS2 | RAD50 | RAD51C | RAD54L | TP53BP1	No	0	53.32		0
777	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	7	3	Stable	No	No	Signature.12		No	0	48.89		0
778	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2015	IV	24	10.8	Stable	No	No	Signature.24		No	1	15.51		0
779	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	574	1.8		No	Yes or Unknown	Signature.3	BRCA1	No	1	36.44		0
780	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	25	3.9	Stable	No	No			No	0	49.35		0
781	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	48	21.6		No	Yes or Unknown	Signature.4		No	0	51.98		0
782	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	46	5.3		No	No			No	1	21.16		0
783	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	961	0.9	Stable	No	Yes or Unknown			No	1	33.77		0
784	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	164	1	Stable	No	Yes or Unknown			No	1	45.47		0
785	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	IV	32	5.9	Stable	No	Yes or Unknown		ARID1A	Yes	1	6.31		0
786	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	IV	18	0	Stable	No	No			Yes	0	48.26		0
787	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	126	3	Stable	No	Yes or Unknown			No	1	10.45		0
788	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	10	1	Stable	No	No			Yes	0	54.05		0
789	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	145	2	Stable	No	Yes or Unknown			Yes	0	24.8		0
790	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	II	718	4.4	Stable	No	Yes or Unknown	Signature.13		No	1	42.05		0
791	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	IV	10	4.9	Stable	No	No		ARID1A	No	1	2.99		0
792	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	11	7.9	Stable	No	Yes or Unknown	Signature.2		No	1	5.45		0
793	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	22	14.8	Stable	No	No	Signature.4	ATM	Yes	1	1.77		0
794	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	69	7	Stable	No	Yes or Unknown			No	0	45.08		0
795	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2015	III	62	6.9	Stable	No	No		ARID1A	No	1	7.33		0
796	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	1	15.7	Stable	No	Yes or Unknown	Signature.4	ERCC4	No	1	12.29		0
797	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	0	39.4	Stable	No	No	Signature.4		Yes	0	52.47		0
798	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	243	7.9	Stable	No	Yes or Unknown			Yes	0	51.42		0
799	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2015	III	27	0	Stable	No	No			No	1	8.9		0
800	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	IV	49	0	Stable	No	No			No	1	25.69		0
801	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2015	IV	0	6.9	Stable	No	No	Signature.4		No	1	15.64		0
802	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	II	31	143.6	Stable	No	Yes or Unknown	Signature.10	ATM | ATR | FANCC | MLH1 | MRE11A | MSH2 | RAD54L | XRCC2	Yes	0	51.55		0
803	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	267	4.4	Stable	No	Yes or Unknown			No	1	34.66		0
804	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	IV	61	1	Stable	No	No			Yes	1	5.75		0
805	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	28	3.9	Stable	No	No	Signature.1		No	0	52.9		0
806	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	41	6.9	Stable	No	No	Signature.1		No	1	15.41		0
807	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2015	I	0	1	Stable	No	No			No	0	48.72		0
808	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		1223	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	51.52		0
809	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	823	4.4	Stable	No	Yes or Unknown	Signature.5	BRCA2 | RAD52	No	1	30		0
810	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	29	7.9	Stable	No	No	Signature.1		No	1	14.16		0
811	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2015	IV	0	29.5	Stable	No	No	Signature.5	BRCA2 | ERCC2 | ERCC4	Yes	0	48.2		0
812	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	IV	0	3.9	Stable	No	No		RAD50	Yes	1	16.59		0
813	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2015	II	19	3.9	Stable	No	No			No	0	49.35		0
814	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		5	4.9		No	No	Signature.1		No	1	10.09		0
815	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2015	IV	21	2	Stable	No	No			No	0	52.27		0
816	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	1422	8.8	Stable	No	Yes or Unknown	Signature.4	RAD50	Yes	0	47.24		0
817	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	0	3	Stable	No	No		ATM	No	1	51.52		0
818	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	13	3.9	Stable	No	No		XRCC2	No	1	33.18		0
819	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	I	636	4.4		No	Yes or Unknown		MUTYH	No	0	52.99		0
820	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	22	3.9	Stable	No	Yes or Unknown			No	0	53.49		0
821	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	II	118	0	Stable	Yes or Unknown	Yes or Unknown			Yes	0	40.28		0
822	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	26	4.9	Stable	No	Yes or Unknown			No	0	27.1		0
823	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	II	52	12.8	Stable	No	No	Signature.24	PARP1 | PMS2	Yes	0	40.44		0
824	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	29	5.9	Stable	No	No			Yes	0	6.74		0
825	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	II	30	4.9	Stable	No	No			No	1	21.55		0
826	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	1149	4.4	Stable	No	Yes or Unknown			No	0	49.51		0
827	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	IV	35	16.7	Stable	No	Yes or Unknown	Signature.13	ARID1A | MSH3 | PALB2	No	0	53.13		0
828	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015		0	0	Stable	No	No			No	0	28.48		0
829	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	0	5.3	Stable	No	No	Signature.3		No	0	52.47		0
830	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	655	0.9		No	Yes or Unknown			No	1	28.85		0
831	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown	Signature.20		No	0	51.06		0
832	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	44	0	Stable	No	No			No	0	50.2		0
833	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	39	3.9	Stable	No	No			Yes	0	52.34		0
834	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	980	3.5	Stable	No	Yes or Unknown		MSH6	No	1	47.28		0
835	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	45	5.9	Stable	No	Yes or Unknown		MDC1	No	1	12.16		0
836	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	III	0	1	Stable	No	Yes or Unknown			Yes	1	10.38		0
837	Non-ICI treated	Never received ICI	41 - 45	Female	Bladder	2015	I	6	409.3	Stable	No	No	Signature.14	ARID1A | ATM | BLM | BRCA1 | BRCA2 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | FANCC | MDC1 | MLH1 | MSH2 | MSH6 | NBN | PALB2 | RAD51C | RAD54L | XRCC2	Yes	0	17.94		0
838	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	III	20	2.6	Stable	No	No	Signature.24		No	0	52.57		0
839	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	II	0	5.9	Stable	No	No		CHEK1	No	1	17.22		0
840	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	38	13.8	Stable	No	No	Signature.4		Yes	1	21.72		0
841	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	1	16.07		0
842	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.11		0
843	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2015	IV	150	0	Stable	No	No			Yes	1	33.87		0
844	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	56	0	Stable	No	No			No	0	49.51		0
845	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	24.8		0
846	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	51.75		0
847	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	43	58	Unstable	No	No	Signature.1	BLM | ERCC3 | MRE11A | MSH2 | RAD50	Yes	0	42.09		0
848	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2015	IV	0	3.9	Stable	No	No	Signature.1		Yes	0	52.57		0
849	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	72	3.9	Stable	No	No			Yes	1	36.6		0
850	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	93	3.9	Stable	No	No			No	0	26.05		0
851	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	I	24	8.9	Stable	No	No			Yes	0	37.52		0
852	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	1	9.8	Stable	No	No			No	1	12.48		0
853	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2015	III	133	4.9	Stable	No	Yes or Unknown	Signature.1		No	1	5.52		0
854	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	387	3	Stable	No	Yes or Unknown			No	1	18.63		0
855	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.13	BRCA2	No	0	52.11		0
856	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2015	I	27	5.9	Stable	No	No		ARID1A	No	0	49.64		0
857	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	IV	0	7.9	Stable	No	No	Signature.2		No	1	23.26		0
858	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	II	0	6.9	Stable	No	No	Signature.3		No	0	51.38		0
859	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	IV	1068	2.6	Stable	No	Yes or Unknown			No	0	52.21		0
860	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2015	IV	527	6.1	Stable	No	Yes or Unknown			No	0	51.15		0
861	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	37	4.9	Stable	No	Yes or Unknown			No	1	10.09		0
862	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	III	129	13.8	Stable	No	Yes or Unknown	Signature.4		No	1	15.64		0
863	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	17	5.9	Stable	No	No			Yes	0	46.75		0
864	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	35	10.8	Stable	No	No	Signature.16	ATM	No	0	49.45		0
865	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	5	8.9	Stable	No	No	Signature.24	ARID1A	Yes	0	39.66		0
866	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015	II	14	23.6	Stable	No	No	Signature.13	ARID1A | BRCA2 | ERCC3	Yes	0	52.63		0
867	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	679	2.6	Stable	No	Yes or Unknown			No	0	52.24		0
868	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2015	IV	128	2	Stable	No	No			No	1	12.42		0
869	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	12	10.8	Stable	No	No	Signature.29		No	1	28.85		0
870	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	I	0	0.9		No	No			No	0	48.85		0
871	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	84	4.9	Stable	No	Yes or Unknown		PMS2	No	0	48.62		0
872	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	0	4.9	Stable	No	No	Signature.3	NBN	No	0	51.84		0
873	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	855	2.6	Stable	No	Yes or Unknown			No	0	54.31		0
874	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	995	27.2	Stable	No	No	Signature.4	PMS1	No	0	45.6		0
875	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	II	92	2	Stable	No	Yes or Unknown			No	0	51.55		0
876	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	584	5.3		No	Yes or Unknown	Signature.6	ATR	No	1	22.37		0
877	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	0	1	Stable	No	No			No	0	48.36		0
878	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	378	8.9	Indeterminate	No	No	Signature.13	BRCA2	No	1	19.12		0
879	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2015	III	9	4.9	Stable	No	No			No	0	52.04		0
880	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	65	1	Stable	No	Yes or Unknown			No	0	52.63		0
881	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	III	40	2	Stable	No	Yes or Unknown			Yes	0	51.65		0
882	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	38	7.9	Stable	No	No	Signature.5	PARP1	Yes	1	8.21		0
883	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	41	7.9	Stable	No	No	Signature.4	PARP1	No	0	41.13		0
884	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	304	2	Stable	No	Yes or Unknown		ARID1A	No	0	49.68		0
885	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	20	5.9	Stable	No	No			No	0	37.95		0
886	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		69	11.8	Stable	No	No	Signature.13	CHEK2	No	0	52.01		0
887	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	0	2	Stable	No	Yes or Unknown			No	1	40.97		0
888	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2015	I	0	62.3	Unstable	No	No	Signature.1	ARID1A | MSH2 | PALB2 | SLX4	Yes	0	42.41		0
889	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	1	31.77		0
890	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	47	0		No	No	Signature.1		Yes	1	12.12		0
891	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1024	1.8	Stable	No	Yes or Unknown		BRCA2	No	1	45.9		0
892	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			No	0	13.8		0
893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	28	3	Stable	No	Yes or Unknown		ARID1A	No	1	30.42		0
894	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	15	7.9	Stable	No	No	Signature.24		No	1	3.19		0
895	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	III	31	0	Stable	No	Yes or Unknown			No	1	33.54		0
896	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	273	4.9	Stable	No	No			No	1	25.1		0
897	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	IV	0	4.9	Stable	No	Yes or Unknown			Yes	1	8.67		0
898	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	7	Stable	No	No		MRE11A	No	1	29.37		0
899	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	32	4.9	Stable	No	No			No	1	1.54		0
900	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	15	10.8	Stable	No	No	Signature.18		No	1	2.56		0
901	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2015	II	0	5.9	Stable	No	No			Yes	0	41		0
902	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	19.09		0
903	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	653	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	23.06		0
904	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	160	2	Stable	No	Yes or Unknown			No	0	44.78		0
905	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	1209	0	Stable	No	Yes or Unknown			No	0	51.52		0
906	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	0	5.9	Stable	No	No			Yes	0	13.31		0
907	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	9	2	Stable	No	No	Signature.5		No	1	23.2		0
908	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	562	10.5	Stable	No	No	Signature.4		Yes	0	45.5		0
909	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	0	4.4	Stable	No	No	Signature.3		No	1	40.8		0
910	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			No	1	12.09		0
911	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	IV	575	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	41.1		0
912	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1188	1.8	Stable	No	Yes or Unknown			No	0	51.15		0
913	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	133	0	Stable	No	Yes or Unknown			Yes	0	48.85		0
914	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	II	0	3.9	Stable	No	No			No	1	25.13		0
915	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	0	0	Stable	No	No			No	0	50.69		0
916	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	45	0	Stable	No	No			Yes	0	51.02		0
917	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2015	IV	0	1	Stable	No	No			No	1	5.03		0
918	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2015		0	4.9	Stable	No	No			No	0	2.76		0
919	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2015	IV	0	3.9	Stable	No	No			Yes	1	8.87		0
920	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	16	3	Stable	No	No		ARID1A	No	0	8.74		0
921	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015		68	8.9	Stable	No	No		MSH2	No	1	7.62		0
922	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	2	3	Stable	No	Yes or Unknown	Signature.4		No	0	53.19		0
923	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	5.9	Stable	No	Yes or Unknown		FANCA	No	1	7.98		0
924	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	I	30	7	Stable	No	No	Signature.4	ERCC5	No	0	22.57		0
925	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	IV	339	5.9	Stable	No	Yes or Unknown		ARID1A | ATM	No	1	19.32		0
926	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	14	3	Stable	No	No			No	0	50.73		0
927	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	18	2	Stable	No	No			No	1	17.77		0
928	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	IV	0	38.4	Unstable	No	No	Signature.6	BRCA1 | BRCA2 | MDC1 | MLH1 | NBN | PARP1 | RAD54L	No	1	7.69		0
929	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	14	3.5	Stable	No	No			No	0	47.47		0
930	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	29	4.9	Stable	No	No	Signature.4		No	0	47.9		0
931	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	3	Stable	No	No			Yes	0	1.94		0
932	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2015	IV	28	3	Stable	No	No			Yes	1	1.94		0
933	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2015		1	0.9	Stable	No	Yes or Unknown			No	0	51.35		0
934	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	II	623	0.9	Stable	No	Yes or Unknown			No	0	50.6		0
935	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	9.8	Stable	No	No	Signature.5	MLH1	Yes	1	3.15		0
936	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	IV	122	16.7	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA2 | MDC1	No	0	52.7		0
937	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2015	IV	749	1.8	Stable	No	Yes or Unknown		FANCC	No	1	42.25		0
938	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	II	111	4.9	Stable	No	No			No	0	49.38		0
939	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	5	3.9	Stable	No	No		BRCA2	No	1	25.2		0
940	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	0	5.9	Stable	No	Yes or Unknown		ERCC5	No	1	12.16		0
941	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	190	0	Stable	No	Yes or Unknown			No	0	49.08		0
942	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	27	5.9	Stable	No	No	Signature.1		No	1	14.26		0
943	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	I	15	15.7	Stable	No	No	Signature.29	RAD50	No	0	48.82		0
944	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	2	Stable	No	Yes or Unknown		CHEK2	No	0	51.02		0
945	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	0	4.4	Stable	No	No			No	0	49.87		0
946	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	52	2	Stable	No	No			No	0	47.61		0
947	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2015	III	0	11.4	Stable	No	No	Signature.28	ARID1A | ATM | ERCC2	No	0	50.83		0
948	Non-ICI treated	Never received ICI	56 - 60	Female	Renal	2015	IV	9	4.9	Stable	No	Yes or Unknown			No	1	8.9		0
949	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2015	IV	0	7.9	Stable	No	No		ARID1A	Yes	0	50.53		0
950	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	14	0.9	Stable	No	No			Yes	0	51.42		0
951	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	41	3	Stable	No	No		ATM | MDC1	No	0	50.79		0
952	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	0	1	Stable	No	Yes or Unknown			No	0	44.06		0
953	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	5.9	Stable	No	No	Signature.4	ARID1A	No	0	37.78		0
954	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	21	3	Stable	No	No			No	1	17.58		0
955	Non-ICI treated	Never received ICI	10-Jun	Male	Cutaneous Melanoma 	2015	III	0	2	Stable	No	No			No	0	52.17		0
956	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	7.9	Stable	No	No	Signature.1		Yes	1	2.86		0
957	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	715	5.3	Stable	No	Yes or Unknown	Signature.8		No	0	51.81		0
958	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	91	0.9	Stable	No	Yes or Unknown		BRCA2	No	1	39.85		0
959	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	17	7.9	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	0	52.9		0
960	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	1200	3.5	Stable	No	Yes or Unknown		CHEK2	No	1	46.98		0
961	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	232	5.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	47.28		0
962	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	9	5.9	Stable	No	No	Signature.30		No	1	15.24		0
963	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	II	8	3	Stable	No	Yes or Unknown	Signature.3		No	0	48.59		0
964	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	I	25	6.9	Stable	No	No		ARID1A	No	0	27.6		0
965	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	14	2	Stable	No	Yes or Unknown			No	0	48.72		0
966	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	11	1	Stable	No	Yes or Unknown			No	0	45.44		0
967	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		15	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	6.47		0
968	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	9	2	Stable	No	No			Yes	1	4.44		0
969	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	II	445	7.9		No	Yes or Unknown	Signature.4	ATM	No	1	26.51		0
970	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	III	21	1	Stable	No	Yes or Unknown			Yes	0	47.05		0
971	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2015	IV	42	13.8	Stable	No	Yes or Unknown	Signature.7	ATM	No	1	6.97		0
972	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	58	0.9	Stable	No	No			No	0	45.8		0
973	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	I	37	3.9	Stable	No	No		MUTYH	No	0	42.41		0
974	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.12	BRIP1	No	1	2.83		0
975	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	18	3.5		No	No			No	0	50.92		0
976	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	IV	15	5.9	Stable	No	No	Signature.24	BRCA2	No	1	23.95		0
977	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2015		22	8.9	Stable	No	No	Signature.11		No	0	36.34		0
978	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	33	0	Stable	No	No			Yes	0	51.32		0
979	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	155	2.6	Stable	No	Yes or Unknown			Yes	0	49.28		0
980	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	II	169	3.5	Indeterminate	No	Yes or Unknown	Signature.3		No	1	35.06		0
981	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2015	I	0	2	Stable	No	Yes or Unknown			Yes	0	42.09		0
982	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	185	11.8	Stable	No	No	Signature.6		No	0	33.25		0
983	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown			Yes	0	48.66		0
984	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	14	10.8	Stable	No	No	Signature.4		No	0	49.51		0
985	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	I	1441	7.9	Stable	No	Yes or Unknown	Signature.2		No	0	51.94		0
986	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	63	4.9	Stable	No	No			Yes	0	51.52		0
987	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	IV	19	3.9	Stable	No	Yes or Unknown	Signature.1		No	1	17.45		0
988	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	56	2	Stable	No	No			Yes	0	50.89		0
989	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	76	3	Stable	No	No			No	1	24.18		0
990	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	27	7.9		No	No	Signature.17	ATM	No	1	25.13		0
991	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	19.15		0
992	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	160	0	Stable	No	No			No	0	23.75		0
993	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	1260	0.9	Stable	No	Yes or Unknown		ATM	No	1	47.97		0
994	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		28	1	Stable	Yes or Unknown	Yes or Unknown			Yes	1	16.3		0
995	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	48	0	Stable	No	No			No	0	36.24		0
996	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	434	7.9	Stable	No	Yes or Unknown	Signature.17	RAD50	No	1	16.3		0
997	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	21.62		0
998	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	19	3.9	Stable	No	No		ARID1A	No	1	10.74		0
999	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2015	II	34	6.9	Stable	No	No	Signature.13	ATR	Yes	0	46.46		0
1000	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	50.79		0
1001	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	I	31	71.8	Unstable	No	No	Signature.6	ARID1A | BRCA2 | ERCC3 | MSH6 | NBN	No	0	39.23		0
1002	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	507	3.5	Stable	No	Yes or Unknown	Signature.8	BRIP1	No	0	51.35		0
1003	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	10	12.8	Stable	No	No	Signature.4	MUTYH	Yes	0	51.12		0
1004	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	I	16	33.4	Unstable	No	No	Signature.6	ARID1A | ATM | MDC1 | XRCC2	No	0	45.21		0
1005	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	III	602	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	51.45		0
1006	Non-ICI treated	Never received ICI	81 - 85	Male	Head & Neck	2015	IV	200	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	7.16		0
1007	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	40	20.2		No	No	Signature.1	MSH2 | XRCC2	Yes	0	46.46		0
1008	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	7		No	Yes or Unknown			No	0	50.14		0
1009	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015		1080	0.9	Stable	No	Yes or Unknown			No	0	50.14		0
1010	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	5	6.9	Stable	No	No	Signature.1	MDC1 | RAD54L	No	1	17.22		0
1011	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	III	0	1	Stable	No	No			Yes	0	47.24		0
1012	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	0	2	Stable	No	No		MLH1	No	0	49.15		0
1013	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	0	6.9	Stable	No	No	Signature.4	RAD50	No	0	42.74		0
1014	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	15	3	Stable	No	No			Yes	1	4.37		0
1015	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		21	3	Stable	Yes or Unknown	Yes or Unknown			Yes	1	20.11		0
1016	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	1155	3.5	Stable	No	Yes or Unknown			No	0	54.54		0
1017	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	0	1	Stable	No	No			Yes	0	49.05		0
1018	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	99	3.9	Stable	No	Yes or Unknown		ARID1A	Yes	1	4.47		0
1019	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	65	0	Stable	No	No			No	0	47.77		0
1020	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	II	700	8.8	Stable	No	Yes or Unknown	Signature.6	BRCA1	No	1	50.56		0
1021	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	21	2	Stable	No	Yes or Unknown			No	0	14.46		0
1022	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	266	3.9	Stable	No	Yes or Unknown			No	0	51.55		0
1023	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	181	4.9	Stable	No	Yes or Unknown			No	1	12.71		0
1024	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	II	142	0	Stable	No	Yes or Unknown			No	0	51.12		0
1025	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	34	10.8	Stable	No	No	Signature.13	BRCA2 | FANCC	Yes	1	22.64		0
1026	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	II	75	2	Stable	No	No			No	0	21.98		0
1027	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	III	28	7.9		No	No	Signature.1		No	1	27.53		0
1028	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	1.8		No	Yes or Unknown			No	1	39.16		0
1029	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	5	8.9	Stable	No	No	Signature.2	RAD50	Yes	1	4.6		0
1030	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	485	2.6		No	Yes or Unknown			No	1	28.39		0
1031	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	III	56	3.5		No	Yes or Unknown			No	1	27.79		0
1032	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	369	5.3		No	Yes or Unknown		BRCA2	No	1	30.26		0
1033	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	II	265	57.1	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | MLH1 | MSH6 | PALB2	No	0	44.62		0
1034	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	I	26	67.9	Unstable	No	No	Signature.6	ARID1A | ERCC3 | FANCA | MRE11A | MSH6 | PALB2	No	0	45.14		0
1035	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	81	3	Stable	No	Yes or Unknown			No	1	42.02		0
1036	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	21	2	Stable	No	No			No	0	48.56		0
1037	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.4	ATM	No	0	51.48		0
1038	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	II	15	4.9	Stable	No	No			Yes	0	49.31		0
1039	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	1101	2.6	Stable	No	Yes or Unknown		ARID1A | CHEK2	No	0	47.93		0
1040	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	78	11.8	Stable	No	No	Signature.29	ATR	No	0	46.92		0
1041	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No			No	1	16.92		0
1042	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	0	3.9	Stable	No	No			No	1	14.62		0
1043	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	107	3.5	Stable	No	Yes or Unknown			No	0	51.15		0
1044	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2015	IV	881	0	Stable	No	Yes or Unknown			No	1	34.56		0
1045	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		0	1	Stable	No	No			No	0	46.95		0
1046	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	25	0.9	Stable	No	No		BLM	No	1	36.47		0
1047	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	37	1.8	Stable	No	Yes or Unknown			No	0	51.98		0
1048	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	7	1.8		No	No			No	1	34.2		0
1049	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	1161	7	Stable	No	Yes or Unknown	Signature.4		No	0	50.5		0
1050	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	14.8	Stable	No	No	Signature.24	ATR | BRCA1	Yes	1	20.73		0
1051	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2015	IV	34	0	Stable	No	No			No	1	12.88		0
1052	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.2		No	1	11.3		0
1053	Non-ICI treated	Never received ICI	36 - 40	Male	Renal	2015	I	31	3	Stable	No	No		NBN	No	0	47.47		0
1054	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2015		0	1	Stable	No	No			No	0	38.44		0
1055	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	III	0	3	Stable	No	No			No	1	25.33		0
1056	Non-ICI treated	Never received ICI	26 - 30	Female	Pancreatic	2015	IV	56	1	Stable	Yes or Unknown	Yes or Unknown			No	1	11.43		0
1057	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	III	0	5.3		No	No			No	1	25.86		0
1058	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	4	4.9	Stable	No	No			No	1	44.25		0
1059	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	33	5.9	Stable	No	No			Yes	0	49.08		0
1060	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	174	2	Stable	No	Yes or Unknown			No	0	52.86		0
1061	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	14	9.8	Stable	No	No	Signature.4		No	1	9.2		0
1062	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	24	1	Stable	No	No			No	0	42.58		0
1063	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	61	3.9	Stable	No	Yes or Unknown			No	0	49.71		0
1064	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	28	7.9	Stable	No	No	Signature.13		No	1	19.02		0
1065	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	28	3.9	Stable	No	Yes or Unknown			No	1	31.61		0
1066	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	IV	7	1.8		No	No			Yes	0	50.27		0
1067	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	626	0.9	Stable	No	No			No	0	46.42		0
1068	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2015		0	0	Stable	No	No			No	0	44.62		0
1069	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	26	3.9	Stable	No	No			No	1	5.19		0
1070	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015		0	3.9	Stable	No	No			Yes	0	35.06		0
1071	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	1	3.9	Stable	No	No			No	1	26.41		0
1072	Non-ICI treated	Never received ICI	51 - 55	Female	SCLC	2015	II	0	6.9	Indeterminate	No	No	Signature.3		Yes	0	49.15		0
1073	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	15	3	Stable	No	Yes or Unknown			No	1	16.62		0
1074	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	1177	22.8	Stable	No	Yes or Unknown	Signature.1	MSH2 | TP53BP1	No	1	40.84		0
1075	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	III	0	7.9		No	Yes or Unknown	Signature.30	ARID1A	No	1	28.32		0
1076	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	396	3	Stable	No	Yes or Unknown	Signature.5	ATM	No	0	24.02		0
1077	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	1127	1.8	Stable	No	Yes or Unknown			No	0	49.54		0
1078	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	I	1218	3.5	Stable	No	No	Signature.5		No	0	50.6		0
1079	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	0	1.8	Stable	No	Yes or Unknown			No	0	50.23		0
1080	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	13	7.9	Stable	No	No	Signature.3		No	0	50.2		0
1081	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	15	3	Stable	No	No			No	1	44.02		0
1082	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	26	19.7	Stable	No	Yes or Unknown	Signature.4		Yes	1	3.35		0
1083	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2015	IV	22	7.9		No	No	Signature.13		Yes	0	37.65		0
1084	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	IV	55	3.5	Stable	No	No	Signature.6	ATM | NBN	No	0	51.02		0
1085	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	245	3.9	Stable	No	Yes or Unknown			No	0	26.41		0
1086	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2015	IV	14	10.8	Stable	No	No	Signature.17		Yes	1	7.85		0
1087	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		7	4.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	18.96		0
1088	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	IV	0	0	Stable	No	No			No	0	51.32		0
1089	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	1102	9.7	Stable	No	Yes or Unknown	Signature.1	BRCA2 | TP53BP1	No	0	50.43		0
1090	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	12	4.9	Stable	No	No			No	1	13.54		0
1091	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2015	II	35	342.4	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC3 | FANCA | MDC1 | MRE11A | MSH2 | MUTYH | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD51C | RAD52	Yes	0	46.82		0
1092	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	189	6.9	Stable	No	Yes or Unknown			Yes	0	49.94		0
1093	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	II	1375	0.9	Stable	No	Yes or Unknown			No	0	50.2		0
1094	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		10	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	14.78		0
1095	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	198	3.9	Stable	No	Yes or Unknown			No	1	13.47		0
1096	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	IV	57	1	Stable	No	No			No	0	51.06		0
1097	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2015	III	33	5.9	Stable	No	Yes or Unknown			Yes	1	7.62		0
1098	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	0	9.8	Stable	No	Yes or Unknown			No	0	51.09		0
1099	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	142	0	Stable	No	Yes or Unknown			Yes	1	10.25		0
1100	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	15.31		0
1101	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	18	6.9	Stable	No	No	Signature.13		Yes	0	48.03		0
1102	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	17	7	Stable	No	No	Signature.3		Yes	0	48.53		0
1103	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	24	1.8		No	No			Yes	0	49.81		0
1104	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		1	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	RAD50	Yes	1	13.04		0
1105	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2015		41	5.9	Stable	No	Yes or Unknown			No	1	13.6		0
1106	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2015	IV	103	17.7	Stable	No	Yes or Unknown	Signature.2	ATR	Yes	1	21.78		0
1107	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	II	300	6.1		No	Yes or Unknown	Signature.13		No	1	33.45		0
1108	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	14	3.5	Stable	No	Yes or Unknown			No	0	49.15		0
1109	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	0	4.9	Stable	No	No	Signature.9	ARID1A	No	1	25.43		0
1110	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4		Yes	1	7.85		0
1111	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	III	773	0	Stable	No	Yes or Unknown			Yes	0	34.96		0
1112	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	0	50.83		0
1113	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	IV	0	5.3	Indeterminate	No	No	Signature.1		No	0	48.53		0
1114	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	3.5		Yes or Unknown	Yes or Unknown			Yes	0	51.09		0
1115	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	II	27	25.6	Stable	No	No	Signature.4		No	0	47.93		0
1116	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	III	1356	3.5	Stable	No	Yes or Unknown			No	0	50.07		0
1117	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	II	19	2	Stable	No	No			Yes	0	47.87		0
1118	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	17	4.4	Stable	No	No		ARID1A	No	0	49.74		0
1119	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	III	122	2.6		No	Yes or Unknown			No	1	21.88		0
1120	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2015	IV	0	6.9	Stable	No	No			No	1	17.97		0
1121	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	25	1.8		No	No			No	0	31.44		0
1122	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	840	6.1	Stable	No	Yes or Unknown			No	0	49.05		0
1123	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	III	21	2	Stable	No	No		BRCA1	No	0	15.54		0
1124	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	6.9	Indeterminate	No	No	Signature.1	RAD52	No	1	7.43		0
1125	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No			No	1	16.49		0
1126	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	IV	65	1.8		No	Yes or Unknown			Yes	0	50.43		0
1127	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2015	IV	0	3	Stable	No	No			Yes	0	11.4		0
1128	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	I	32	2	Stable	No	Yes or Unknown			No	1	49.18		0
1129	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	10.8		No	No		ATM	No	1	21.98		0
1130	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	0	2	Stable	No	Yes or Unknown			Yes	0	50.33		0
1131	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	III	802	4.4	Stable	No	No			No	0	45.96		0
1132	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3.5		No	No		BRCA1 | MUTYH	No	1	23.23		0
1133	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	II	28	50.2	Unstable	No	No	Signature.1	ARID1A | MDC1 | MSH2	No	0	47.8		0
1134	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	II	29	7.9	Stable	No	No			No	0	45.08		0
1135	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	2	5.9	Indeterminate	No	No	Signature.1		Yes	1	8.31		0
1136	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.44		0
1137	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	1051	1.8	Stable	No	Yes or Unknown			No	0	51.98		0
1138	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	III	164	0.9		No	Yes or Unknown		ATM	No	1	29.93		0
1139	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	1197	2.6	Stable	No	Yes or Unknown			No	0	49.87		0
1140	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	III	46	19.3	Unstable	No	No	Signature.6	ARID1A	No	0	51.71		0
1141	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2015	II	155	3	Stable	No	Yes or Unknown			No	1	12.29		0
1142	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	67	3.9	Stable	No	No			Yes	0	47.28		0
1143	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	52	3.9	Stable	No	No			No	0	31.8		0
1144	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	28	1	Stable	No	Yes or Unknown			No	1	21.32		0
1145	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	12	2	Stable	No	No			Yes	1	12.19		0
1146	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	18.17		0
1147	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	217	6.9	Stable	No	Yes or Unknown	Signature.1		No	0	50.14		0
1148	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	48	3.5	Stable	No	No			No	0	39.26		0
1149	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			No	0	28.12		0
1150	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	0	17.6	Stable	No	No	Signature.13	BRCA1	No	1	19.06		0
1151	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	3	14.8	Stable	No	Yes or Unknown	Signature.2	ARID1A | ERCC3	Yes	1	5.13		0
1152	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	IV	0	8.9	Stable	No	No	Signature.6	ARID1A	No	1	25.13		0
1153	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.29	ARID1A	Yes	0	32.85		0
1154	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	211	2.6	Stable	No	Yes or Unknown			No	0	49.74		0
1155	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	10.09		0
1156	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2015	IV	14	6.9	Indeterminate	No	No	Signature.1		No	0	47.54		0
1157	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	10	5.3	Stable	No	No		ERCC2	Yes	0	13.8		0
1158	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	III	0	1	Stable	No	Yes or Unknown			No	1	13.6		0
1159	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	5	13.8	Indeterminate	No	No	Signature.1		Yes	1	7.36		0
1160	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	15	3	Stable	No	Yes or Unknown			No	0	43.76		0
1161	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	107	2.6	Stable	No	Yes or Unknown			No	0	49.74		0
1162	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	IV	0	1	Stable	No	No			No	0	48.56		0
1163	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	34	13.2		No	No	Signature.13	ARID1A | ATM	No	0	36.96		0
1164	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2015		455	1.8		No	Yes or Unknown			No	0	48.72		0
1165	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	252	3.9	Stable	No	Yes or Unknown		ARID1A	No	1	11.33		0
1166	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	0	2	Stable	No	No			No	0	49.81		0
1167	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	20	6.9	Stable	No	No	Signature.24	PALB2 | PMS2	No	0	44.45		0
1168	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	131	1	Stable	No	Yes or Unknown			Yes	0	47.57		0
1169	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	47	2	Stable	No	Yes or Unknown			No	0	24.77		0
1170	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	95	1	Stable	No	No			No	0	47.77		0
1171	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	0	2	Stable	No	No	Signature.16		No	1	7.23		0
1172	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	0	2	Stable	No	No			No	0	37.29		0
1173	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	28	3.9	Stable	No	Yes or Unknown		ATM | RAD54L	Yes	0	46.36		0
1174	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	25	2	Stable	No	No	Signature.29		No	1	19.94		0
1175	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	II	26	3	Stable	No	No			No	1	47.05		0
1176	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2015	III	639	4.4	Stable	No	Yes or Unknown			No	1	48.3		0
1177	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	95	2	Stable	No	Yes or Unknown		BRCA2	No	0	49.68		0
1178	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	II	1312	3.5	Stable	No	Yes or Unknown			No	0	50.79		0
1179	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	10.8	Stable	No	No			No	1	12.94		0
1180	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	IV	0	4.9	Stable	No	Yes or Unknown		RAD51	Yes	0	47.28		0
1181	Non-ICI treated	Never received ICI	56 - 60	Female	SCLC	2015	IV	0	16.7	Stable	No	No	Signature.4	ATM | BLM | CHEK2 | PMS1	No	1	41.07		0
1182	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	11	1	Stable	No	No			No	1	10.22		0
1183	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	83	1	Stable	No	Yes or Unknown			Yes	0	45.08		0
1184	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	34	3	Stable	No	No		FANCA	No	1	2		0
1185	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	65	3.9	Stable	No	No		ATM | PMS1	Yes	1	27.37		0
1186	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	154	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	47.93		0
1187	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	39	3.9	Stable	No	No			No	1	20.11		0
1188	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	22	4.9	Indeterminate	No	No	Signature.16	ATM	No	1	21.65		0
1189	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	0	1	Stable	No	No		ARID1A	No	0	49.64		0
1190	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	0	Stable	No	No			Yes	1	7.69		0
1191	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2015	I	154	0	Stable	No	Yes or Unknown			No	0	49.74		0
1192	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	42	29.5	Stable	No	Yes or Unknown	Signature.4		Yes	0	38.64		0
1193	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	III	0	4.9	Stable	No	No		ARID1A | ERCC3	Yes	1	3.29		0
1194	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	21	2	Stable	No	No			No	0	50.33		0
1195	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	IV	41	2	Stable	No	No			No	1	16.95		0
1196	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	62	0.9	Stable	No	Yes or Unknown			No	0	50.4		0
1197	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	II	19	7	Stable	No	No		BRCA2	No	0	47.64		0
1198	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	IV	79	1	Stable	No	Yes or Unknown			No	1	4.37		0
1199	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016		0	0		No	No			No	0	34.3		0
1200	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	27	3.9	Stable	No	No		RAD50	No	1	25.07		0
1201	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	1234	4.4	Stable	No	Yes or Unknown			No	0	53.88		0
1202	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	III	169	1	Stable	No	Yes or Unknown			No	1	21.68		0
1203	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	26	3	Stable	No	No			No	1	5.65		0
1204	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	1518	1.8	Stable	No	Yes or Unknown			No	0	50.99		0
1205	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	473	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	31.01		0
1206	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	11	4.9	Stable	No	No			No	1	18.99		0
1207	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	155	1	Stable	No	Yes or Unknown			No	1	10.58		0
1208	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	0	4.9	Stable	No	No		ARID1A	Yes	1	11.27		0
1209	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	II	38	62	Unstable	No	No	Signature.1	ARID1A | MSH2 | PALB2 | PMS2	No	0	39.23		0
1210	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	IV	36	1	Stable	No	Yes or Unknown			No	1	16.85		0
1211	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	0	1.8	Stable	No	No			No	1	31.64		0
1212	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	14	7.9	Stable	No	No			No	1	15.74		0
1213	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	12	7.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	5.95		0
1214	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	980	15.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	Yes	0	48.3		0
1215	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	III	0	46.2	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | BRCA2	Yes	0	38.05		0
1216	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		3	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	5.91		0
1217	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	153	0	Stable	No	Yes or Unknown			No	1	35.38		0
1218	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	10	0	Stable	No	No			Yes	1	12.16		0
1219	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	1	Stable	No	No			Yes	1	4.8		0
1220	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	0	2	Stable	No	No			No	0	45.44		0
1221	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.25	MSH6	No	1	12.91		0
1222	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	II	103	0	Stable	No	No			No	0	46.42		0
1223	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2015	IV	33	2	Stable	No	No			No	1	10.35		0
1224	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	216	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	33.08		0
1225	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	607	2.6	Stable	No	Yes or Unknown			No	1	46.52		0
1226	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	46	2	Stable	No	No			No	0	14.23		0
1227	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	848	1.8	Stable	No	Yes or Unknown		ATM | BRCA2	No	1	41.26		0
1228	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	1237	0	Stable	No	Yes or Unknown			No	0	47.41		0
1229	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	61	3.9	Stable	No	Yes or Unknown		ATM | PMS1	No	0	49.51		0
1230	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	III	582	3.5		No	Yes or Unknown			No	1	28.29		0
1231	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		12	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	49.22		0
1232	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	I	16	42.3	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | MSH2 | MUTYH	No	0	48.13		0
1233	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	4.9	Indeterminate	Yes or Unknown	Yes or Unknown		ARID1A	No	1	20.44		0
1234	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	41	1.8		No	No			No	1	23.92		0
1235	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	21	3	Stable	No	Yes or Unknown		ARID1A	No	1	14.82		0
1236	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2015	IV	21	11.8	Stable	No	No	Signature.24		Yes	1	3.45		0
1237	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	33	58	Unstable	No	No	Signature.6	ATM | BRIP1 | MDC1 | MSH6 | PMS2	Yes	0	49.58		0
1238	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	650	1.8	Stable	No	Yes or Unknown			No	0	47.08		0
1239	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	2	4.9	Stable	No	Yes or Unknown			No	1	15.84		0
1240	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	248	3.9	Stable	No	Yes or Unknown			No	0	26.51		0
1241	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	IV	71	5.9	Stable	No	No	Signature.14		No	1	12.29		0
1242	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	12	3	Stable	No	No			Yes	1	25.79		0
1243	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	165	1.8	Stable	No	No			No	0	47.41		0
1244	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	3	Stable	No	No			Yes	0	48.85		0
1245	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	16	4.9	Stable	No	No			Yes	1	29.6		0
1246	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	370	6.9	Stable	No	No		ARID1A	No	1	26.15		0
1247	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	0	2	Stable	No	No			No	0	49.87		0
1248	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	III	169	5.3	Stable	No	No			Yes	0	46.26		0
1249	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	34	3.9	Stable	No	No			No	0	41.69		0
1250	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	I	554	0	Stable	No	No			No	0	47.74		0
1251	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	92	3.9	Stable	No	No			No	0	11.47		0
1252	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	169	8.9	Stable	No	Yes or Unknown	Signature.8		No	1	13.63		0
1253	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		0	1	Stable	No	No			No	1	38.97		0
1254	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	III	1261	1.8	Stable	No	Yes or Unknown		ARID1A	No	1	47.77		0
1255	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2015	III	8	5.9	Stable	No	No	Signature.4		Yes	1	9.79		0
1256	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2015		9	1.8		Yes or Unknown	Yes or Unknown			No	0	42.87		0
1257	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	9	4.9	Stable	No	No			Yes	0	48.36		0
1258	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	48	3	Stable	No	No			No	0	45.01		0
1259	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	2	7.9	Stable	No	No	Signature.16		No	1	15.54		0
1260	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	III	1226	3.5	Stable	No	Yes or Unknown		BRIP1	No	0	48.99		0
1261	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	120	5.9	Stable	No	Yes or Unknown	Signature.9	ERCC2 | MSH6	No	0	49.28		0
1262	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	25	3.9	Stable	No	No			No	1	26.51		0
1263	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	231	3	Indeterminate	Yes or Unknown	Yes or Unknown			No	0	48.16		0
1264	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	II	62	0	Stable	No	No			No	0	48.76		0
1265	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	III	17	6.9	Stable	No	No			No	1	22.34		0
1266	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	III	250	0		No	No			No	1	52.04		0
1267	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	II	1293	5.3	Stable	No	Yes or Unknown			No	0	48.49		0
1268	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	2	Stable	No	Yes or Unknown	Signature.2		No	1	25.63		0
1269	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	32	3	Stable	No	No			Yes	0	51.02		0
1270	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	147	2	Stable	No	No			No	0	47.18		0
1271	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	1252	1.8	Stable	No	Yes or Unknown			No	0	46.23		0
1272	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	III	13	15.7	Stable	No	No	Signature.13	ARID1A | ATM | BRCA2 | RAD50	No	1	2.27		0
1273	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2015	II	22	4.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	33.28		0
1274	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	1	Stable	No	No			No	1	44.09		0
1275	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	III	879	1.8	Stable	No	Yes or Unknown			No	0	48.33		0
1276	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	II	30	52.1	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MSH6 | NBN | PALB2 | PARP1	No	1	17.77		0
1277	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	317	4.4		No	Yes or Unknown	Signature.22	FANCA	No	1	23.46		0
1278	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	30	4.4	Stable	No	Yes or Unknown			No	1	44.45		0
1279	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		5	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	8.21		0
1280	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2015	IV	848	3.5	Stable	No	Yes or Unknown		ERCC4	No	0	48.95		0
1281	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2015	II	23	2	Stable	No	No			No	0	48.69		0
1282	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	IV	143	1	Stable	Yes or Unknown	Yes or Unknown			No	1	29.4		0
1283	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	15	8.9	Stable	No	No	Signature.4		Yes	1	6.01		0
1284	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	6	16.7	Stable	No	Yes or Unknown	Signature.2		No	1	17.45		0
1285	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	IV	46	4.9	Stable	No	No			No	1	5.85		0
1286	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.19		0
1287	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	59	5.3	Stable	No	No		ATR	Yes	0	28.81		0
1288	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	21	3	Stable	No	No			No	0	48.39		0
1289	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	II	75	4.9	Stable	No	No			No	0	50.17		0
1290	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	0	3.5	Stable	No	No			No	0	49.41		0
1291	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	0	0	Stable	No	No			Yes	0	48.69		0
1292	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	6.9	Stable	No	No		BRIP1	No	0	28.58		0
1293	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015		77	5.9	Stable	No	No	Signature.19	ARID1A	No	1	11.96		0
1294	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015		70	6.1		No	No	Signature.1		No	1	21.42		0
1295	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2016	I	26	2.6		No	No			No	0	31.21		0
1296	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	119	3.9	Stable	No	No			No	0	38.83		0
1297	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	1615	1.8	Stable	No	Yes or Unknown			No	0	47.93		0
1298	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	85	3.9	Stable	No	No			No	0	48.76		0
1299	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	47	3.9	Stable	No	No			No	0	46.55		0
1300	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	153	2	Stable	No	Yes or Unknown			No	0	18.4		0
1301	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2015	IV	26	8.9	Stable	No	No	Signature.29		Yes	1	15.21		0
1302	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	II	15	2	Stable	No	Yes or Unknown			No	1	37.75		0
1303	Non-ICI treated	Never received ICI	46 - 50	Female	SCLC	2015	IV	1	10.8	Indeterminate	No	No	Signature.4	ARID1A | ATR	No	1	12.88		0
1304	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		18	1	Stable	Yes or Unknown	Yes or Unknown			No	1	12.42		0
1305	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	I	366	6.1	Stable	No	No		ARID1A	Yes	0	46.52		0
1306	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	21	3	Stable	No	Yes or Unknown		ARID1A	No	1	11.4		0
1307	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	42	7.9	Stable	No	No	Signature.4		No	0	46.88		0
1308	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	IV	623	1.8	Stable	No	Yes or Unknown			No	1	38.31		0
1309	Non-ICI treated	Never received ICI	61 - 65	Male	SCLC	2015	IV	0	2	Stable	No	No	Signature.4		Yes	1	4.76		0
1310	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	III	960	3.5	Stable	No	Yes or Unknown	Signature.2		Yes	1	39.75		0
1311	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	6	5.9	Stable	No	No		BRCA1 | MDC1	No	1	28.52		0
1312	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	359	12.8	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	44.94		0
1313	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2015	IV	30	6.9	Stable	No	No	Signature.4		No	1	11.96		0
1314	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	I	28	3.9	Stable	No	No		RAD50	Yes	0	42.91		0
1315	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	11	3	Stable	No	No			Yes	0	48.82		0
1316	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	19	4.9	Stable	No	Yes or Unknown			No	1	17.08		0
1317	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	37	1.8		No	Yes or Unknown	Signature.1		Yes	1	28.68		0
1318	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	21	2	Stable	No	Yes or Unknown			No	0	48.2		0
1319	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	8	3	Stable	No	No			No	1	24.44		0
1320	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	1	11.4	Stable	No	No	Signature.1		No	0	49.02		0
1321	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	5.9	Stable	No	No			No	0	21.85		0
1322	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2015	III	0	1	Stable	No	No			No	1	12.12		0
1323	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	III	0	7.9	Stable	No	No	Signature.4	MRE11A	No	1	10.25		0
1324	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	IV	0	6.9	Stable	No	No			No	1	21.65		0
1325	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2015	II	0	0	Stable	No	No			No	0	41.2		0
1326	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	4.9	Stable	No	No			No	0	46.78		0
1327	Non-ICI treated	Never received ICI	21 - 25	Male	Gastric	2015	III	154	1	Stable	No	Yes or Unknown			No	1	20.11		0
1328	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	26	3	Stable	No	No			No	1	32.26		0
1329	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	IV	26	4.9	Stable	No	Yes or Unknown			No	0	49.35		0
1330	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	3	Stable	No	No			No	0	50.63		0
1331	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	0	0	Stable	No	No			No	0	47.84		0
1332	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	247	2	Stable	No	Yes or Unknown			Yes	0	46.52		0
1333	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	4	5.9	Stable	No	No	Signature.1		No	1	31.47		0
1334	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	640	4.4	Stable	No	Yes or Unknown			No	0	49.05		0
1335	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	84	1	Stable	No	Yes or Unknown			No	1	44.55		0
1336	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	0	2	Stable	No	No			Yes	0	43.7		0
1337	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	0	4.9	Stable	No	No			Yes	0	48.23		0
1338	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2015	IV	0	2.6		No	No			Yes	1	34.96		0
1339	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	I	473	0		No	No			No	0	46.95		0
1340	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	295	22.6	Stable	No	Yes or Unknown	Signature.13	BLM | BRCA2 | BRIP1 | RAD54L	No	1	26.55		0
1341	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2015	III	71	6.1	Indeterminate	No	No			No	1	44.62		0
1342	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	IV	21	8.9	Stable	No	No	Signature.1	ARID1A	No	1	9.86		0
1343	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	48	2	Stable	No	Yes or Unknown			No	0	39.79		0
1344	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	30	4.9	Stable	No	Yes or Unknown		BRCA1	No	0	48.36		0
1345	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	0	3.9	Stable	No	No			No	1	24.41		0
1346	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	3	1	Stable	No	Yes or Unknown			No	0	48		0
1347	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	34	3	Stable	No	No			No	1	14.46		0
1348	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	323	6.1		No	Yes or Unknown			Yes	0	46.49		0
1349	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	0	2.6	Stable	No	Yes or Unknown			No	0	45.67		0
1350	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2015	IV	136	6.9	Stable	No	Yes or Unknown	Signature.1	ARID1A | PMS1	No	1	41.46		0
1351	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	III	19	58	Unstable	No	No	Signature.6	BLM | CHEK2 | MSH2 | NBN	No	0	46.19		0
1352	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	13	5.9	Stable	No	No	Signature.4		Yes	0	49.61		0
1353	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	I	0	5.9	Stable	No	No	Signature.1	BRCA1	No	0	49.74		0
1354	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	21	3	Stable	No	No			No	1	18.83		0
1355	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	0	3	Stable	No	No			No	0	44.22		0
1356	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	1	2	Stable	No	Yes or Unknown			No	0	48.39		0
1357	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2015	IV	99	3.9	Stable	No	Yes or Unknown			No	1	6.41		0
1358	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	I	0	1	Stable	No	No			No	0	42.74		0
1359	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	I	0	4.9	Stable	No	Yes or Unknown			Yes	0	45.5		0
1360	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	155	3	Stable	No	Yes or Unknown			No	1	28.71		0
1361	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2015	II	1372	6.1	Stable	No	No		ARID1A	No	0	46.69		0
1362	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	6	3.9	Stable	No	Yes or Unknown			No	1	10.09		0
1363	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	32	7.9	Stable	No	No		ATR | MSH6	No	1	23.75		0
1364	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	186	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	31.9		0
1365	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	78	3.9	Stable	No	No		MUTYH	No	1	17.91		0
1366	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	9	4.9	Stable	No	No			Yes	0	8.21		0
1367	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	II	0	3.9	Stable	No	No			No	0	49.45		0
1368	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	21.82		0
1369	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	1	2	Stable	No	No			No	1	6.41		0
1370	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2015	IV	0	10.8	Stable	No	No	Signature.1		No	1	17.54		0
1371	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2015	III	1377	7	Stable	No	No	Signature.13	ARID1A	Yes	0	48.69		0
1372	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	9	54.1	Unstable	No	No	Signature.6	ARID1A | BRCA2 | ERCC5 | MSH6 | RAD50	No	0	42.32		0
1373	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	794	2.6	Stable	No	Yes or Unknown		ARID1A	No	0	47.51		0
1374	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	71	3	Stable	No	No			No	0	42.64		0
1375	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	0	3.9	Stable	No	No			No	0	17.97		0
1376	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	23	356.1	Stable	No	No	Signature.10	ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | ERCC2 | ERCC4 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | MSH6 | MUTYH | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD51 | RAD51C | RAD52 | RAD54L | XRCC2	No	0	33.35		0
1377	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2015	I	1437	3.5	Stable	No	No	Signature.24	BRCA1	Yes	0	48.2		0
1378	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2015		0	0	Stable	No	No			No	0	47.05		0
1379	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	III	30	2	Stable	No	No			Yes	0	46.72		0
1380	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	27	11.8	Stable	No	No	Signature.4	ARID1A	No	0	45.31		0
1381	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	III	39	5.3	Stable	No	No			No	0	47.24		0
1382	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	III	501	4.4	Stable	No	Yes or Unknown	Signature.1	ERCC5	Yes	0	26.15		0
1383	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	II	7	4.9	Stable	No	No		MSH6	No	0	48.56		0
1384	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	II	807	5.3	Stable	No	No			Yes	0	45.34		0
1385	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	262	5.9	Stable	No	Yes or Unknown	Signature.30	ERCC2	No	1	21.72		0
1386	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	III	20	3	Stable	No	No		ARID1A	No	1	20.73		0
1387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3.9		No	No			No	1	49.77		0
1388	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	75	1	Stable	No	No			No	1	42.68		0
1389	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	132	2.6	Stable	No	No			Yes	0	48.99		0
1390	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	III	867	4.4	Stable	No	Yes or Unknown			No	1	33.05		0
1391	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2015	III	195	2	Stable	No	Yes or Unknown			No	1	33.25		0
1392	Non-ICI treated	Never received ICI	61 - 65	Male	Cutaneous Melanoma 	2015	I	23	29.5	Stable	No	No	Signature.7	ARID1A | MUTYH	No	0	41.86		0
1393	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	215	5.9	Stable	No	Yes or Unknown			No	1	12.75		0
1394	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2015	I	94	0.9	Stable	No	Yes or Unknown			No	0	48.76		0
1395	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2015	IV	3	2	Stable	No	No			No	1	9.63		0
1396	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	27	6.9	Stable	No	No	Signature.4		No	0	40.64		0
1397	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	11	5.9	Stable	No	No	Signature.15		No	1	9.03		0
1398	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2015	IV	7	1	Stable	No	No		PALB2	No	1	11.1		0
1399	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	56	2	Stable	No	Yes or Unknown			No	0	49.08		0
1400	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.5	MRE11A	No	1	35.55		0
1401	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	1366	5.3	Stable	No	Yes or Unknown			No	0	48.53		0
1402	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	12	7.9	Stable	No	No		BRCA2 | FANCA	No	1	26.68		0
1403	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	28	6.1	Indeterminate	No	No		ATM	No	1	46.42		0
1404	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	56	4.9	Stable	No	Yes or Unknown			Yes	1	4.44		0
1405	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2015	III	169	8.9	Stable	No	Yes or Unknown	Signature.6	MSH2 | RAD54L	No	0	44.94		0
1406	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	4	6.9	Stable	No	No			No	0	48.2		0
1407	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	20.76		0
1408	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	959	1.8	Stable	No	Yes or Unknown			No	0	49.68		0
1409	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		0	2	Stable	No	No			Yes	0	31.41		0
1410	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	402	4.4		No	Yes or Unknown	Signature.3		No	1	16.49		0
1411	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	4.4		No	No			Yes	1	21.98		0
1412	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2015	II	0	2.6		No	Yes or Unknown			No	1	16.53		0
1413	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	346	1	Stable	No	Yes or Unknown			No	1	21.68		0
1414	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	16	5.3	Stable	No	No		ATM	Yes	0	16.56		0
1415	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2015	IV	13	1	Stable	No	Yes or Unknown			No	1	35.55		0
1416	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	77	3	Stable	No	No			Yes	0	46.85		0
1417	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	0	6.9	Stable	No	No	Signature.6		Yes	0	13.24		0
1418	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	161	22.6	Stable	No	Yes or Unknown	Signature.4	MUTYH	No	0	48.23		0
1419	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	152	3	Stable	No	Yes or Unknown			No	0	41.23		0
1420	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	126	14	Stable	No	Yes or Unknown	Signature.13	ARID1A | BRCA2 | MDC1	No	0	17.35		0
1421	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	54	1	Stable	No	No			Yes	0	45.7		0
1422	Non-ICI treated	Never received ICI	31 - 35	Male	NSCLC	2015	IV	45	2	Stable	No	Yes or Unknown		MLH1	No	0	46.59		0
1423	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2015	II	1168	2.6	Stable	No	Yes or Unknown	Signature.5		No	0	48.79		0
1424	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	IV	152	0		No	Yes or Unknown			No	0	43.86		0
1425	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	30	4.9	Stable	No	No			No	1	17.64		0
1426	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	0	64.9	Unstable	No	No	Signature.1	ARID1A | ATM | MRE11A | MSH2	Yes	0	47.31		0
1427	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	4.9	Stable	No	No	Signature.13	ATR	Yes	1	4.7		0
1428	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	38	5.9	Stable	No	No	Signature.3		Yes	1	3.52		0
1429	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	0	9.8	Stable	No	No	Signature.4		No	0	36.83		0
1430	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		5	5.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	32		0
1431	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown			No	1	16.76		0
1432	Non-ICI treated	Never received ICI	66 - 70	Female	Esophageal	2015	III	0	5.9	Stable	No	No		ARID1A	Yes	0	37.22		0
1433	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	85	3.9	Stable	No	No			No	0	48.49		0
1434	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	III	1022	7.9	Stable	No	Yes or Unknown		MRE11A	No	0	48.33		0
1435	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	1421	10.5	Stable	No	Yes or Unknown	Signature.30		No	0	48.26		0
1436	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2015	IV	2	4.9	Stable	No	Yes or Unknown	Signature.9		No	1	10.55		0
1437	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	4	2	Stable	No	No			No	1	25.99		0
1438	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	0	2.6		No	No			No	0	47.05		0
1439	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	43	5.9	Stable	No	No	Signature.24	BRCA2	No	0	47.44		0
1440	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	0	5.9	Stable	No	No	Signature.4		Yes	1	5.72		0
1441	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	7	25.5		No	No	Signature.6	ARID1A | ATR | MSH6 | TP53BP1	Yes	0	29.01		0
1442	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	IV	23	2.6	Stable	No	No			Yes	0	52.01		0
1443	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	49.48		0
1444	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	III	51	7.9	Stable	No	No	Signature.24	BRIP1 | MRE11A | PMS1	Yes	0	44.12		0
1445	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	38	7.9	Stable	No	No			No	0	39.82		0
1446	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	7	2	Stable	No	No			No	1	8.71		0
1447	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	4.9	Stable	No	Yes or Unknown		RAD54L	No	0	48.36		0
1448	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	II	699	2.6	Stable	No	Yes or Unknown			No	0	48.26		0
1449	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	239	8.9	Stable	No	Yes or Unknown	Signature.10		No	0	49.28		0
1450	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	407	7		No	Yes or Unknown	Signature.3		No	1	18.73		0
1451	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	0	77.7	Unstable	No	No	Signature.6	ATM | BLM | BRCA2 | ERCC5 | MDC1 | NBN | RAD50	No	0	45.8		0
1452	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2015	IV	0	4.9	Stable	No	No	Signature.29	PARP1	Yes	1	5.42		0
1453	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	III	1006	2.6	Stable	No	Yes or Unknown		ERCC2	No	0	47.15		0
1454	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	3	Stable	No	No		ATM	No	1	6.34		0
1455	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	13.9		0
1456	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	IV	0	8.9	Stable	No	No	Signature.1		Yes	0	46		0
1457	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	II	45	3	Stable	No	Yes or Unknown			No	0	44.12		0
1458	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	III	13	1.8	Stable	No	No			No	1	41.63		0
1459	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	II	23	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	26.02		0
1460	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	6	1	Stable	No	Yes or Unknown			Yes	0	18.86		0
1461	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	13	5.9	Stable	No	No			No	0	11.7		0
1462	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	IV	22	2	Stable	No	No			No	0	47.61		0
1463	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.1		No	0	25.49		0
1464	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	III	1165	0.9	Stable	No	Yes or Unknown			Yes	0	47.11		0
1465	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	69	3	Stable	No	Yes or Unknown			No	0	47.08		0
1466	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		1	2	Stable	Yes or Unknown	Yes or Unknown			No	1	21.49		0
1467	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		3	0	Stable	Yes or Unknown	Yes or Unknown			Yes	0	47.15		0
1468	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2015		33	5.9	Stable	No	No			Yes	0	46.59		0
1469	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	56	2	Stable	No	No			No	0	42.81		0
1470	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2015	IV	48	6.9	Stable	No	No	Signature.29	BRCA1 | RAD50	No	1	4.37		0
1471	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	44.16		0
1472	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	112	9.8	Stable	No	No	Signature.1	ATM	No	0	19.22		0
1473	Non-ICI treated	Never received ICI	41 - 45	Female	Renal	2015	I	0	1	Stable	No	No			No	0	6.28		0
1474	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	1.8		No	Yes or Unknown			No	1	23.69		0
1475	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	III	404	5.3		No	Yes or Unknown	Signature.3		No	1	27.01		0
1476	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	409	7.9		No	Yes or Unknown	Signature.1		No	1	22.05		0
1477	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	I	0	4.9	Stable	No	No			No	0	43.66		0
1478	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	4	7.9	Stable	No	No		ERCC4	Yes	1	8.08		0
1479	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	24	1	Stable	No	No			No	1	16.59		0
1480	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	230	0	Stable	No	No			Yes	0	48.23		0
1481	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015		17	6.9	Stable	No	No			Yes	0	43.37		0
1482	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2015	III	34	6.1	Stable	No	No		ARID1A	No	1	23.43		0
1483	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	III	148	30.5	Stable	No	No	Signature.4	ARID1A | ATM	No	0	16.43		0
1484	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	31	4.4	Stable	No	No		MDC1	No	0	22.93		0
1485	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	91	6.9	Stable	No	Yes or Unknown	Signature.4		No	1	9.46		0
1486	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	47	3	Stable	No	No			No	0	45.08		0
1487	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	116	5.3	Stable	No	Yes or Unknown			No	0	46.65		0
1488	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	II	25	2	Stable	No	Yes or Unknown		RAD54L	No	1	15.51		0
1489	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	46	3	Stable	No	Yes or Unknown			No	0	47.47		0
1490	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	III	0	4.9	Indeterminate	No	No	Signature.4		Yes	0	47.28		0
1491	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	IV	291	3	Stable	No	Yes or Unknown		BRCA2	No	1	17.74		0
1492	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	0	8.9	Stable	No	No	Signature.1		No	0	48.33		0
1493	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	0	4.9	Stable	No	No	Signature.4		Yes	0	44.85		0
1494	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	0	3.9	Stable	No	No			No	1	10.35		0
1495	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	99	3.9	Stable	No	Yes or Unknown		BLM | BRCA2	No	0	48.03		0
1496	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2015	III	41	12.8	Stable	No	Yes or Unknown	Signature.1		Yes	0	46.39		0
1497	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2015	III	14	4.9	Stable	No	No	Signature.1		Yes	1	17.25		0
1498	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2015	III	337	6.1		No	Yes or Unknown	Signature.18		No	1	16.95		0
1499	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2015	III	0	1	Stable	No	No			No	0	47.11		0
1500	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	118	3.9	Stable	No	Yes or Unknown			Yes	1	12.09		0
1501	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	136	4.9	Stable	No	Yes or Unknown			No	1	4.83		0
1502	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	60	6.9	Stable	No	No	Signature.8		No	0	47.7		0
1503	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	32	3	Stable	No	No			No	1	17.22		0
1504	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	659	4.4	Stable	No	Yes or Unknown	Signature.2		No	1	27.93		0
1505	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	I	104	0	Stable	No	No			No	0	38.44		0
1506	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	27	3.5	Stable	No	No		BRCA1	No	1	37.75		0
1507	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2015	IV	70	4.9	Stable	No	Yes or Unknown		ATM	No	1	8.21		0
1508	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	0	2.6		No	Yes or Unknown			Yes	0	46.92		0
1509	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	17	2.6	Stable	No	Yes or Unknown			No	1	41.72		0
1510	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	III	250	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.6		No	1	18.23		0
1511	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2015		48	1	Stable	No	No			No	0	35.15		0
1512	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	28	2	Stable	No	Yes or Unknown			No	0	33.15		0
1513	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2015	II	0	3.5	Stable	No	No	Signature.9	ARID1A | RAD50	No	1	37.26		0
1514	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	II	77	1	Stable	No	No			No	0	46.85		0
1515	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	1104	1.8	Stable	No	Yes or Unknown		BLM	No	0	46.36		0
1516	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	30	4.9	Stable	No	No			No	1	12.19		0
1517	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	III	131	2	Stable	No	Yes or Unknown			No	0	42.05		0
1518	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	71	12.8	Stable	No	No	Signature.4	PALB2	No	0	38.24		0
1519	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	46.65		0
1520	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	24	5.3	Stable	No	No		BRCA2	Yes	0	45.5		0
1521	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	I	22	8.9	Stable	No	No	Signature.1		No	0	30.16		0
1522	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2015	IV	6	6.9	Stable	No	Yes or Unknown		ARID1A	No	1	16.72		0
1523	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	21	7.9	Stable	No	Yes or Unknown			No	0	47.41		0
1524	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2015	IV	0	5.9	Stable	No	No			Yes	1	9.1		0
1525	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	35	2.6	Stable	No	Yes or Unknown		ARID1A	No	1	3.25		0
1526	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	6	0.9	Stable	No	Yes or Unknown			No	1	29.21		0
1527	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATM | NBN	Yes	1	36.5		0
1528	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	22	2.6		No	No			No	0	24.97		0
1529	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	28	3.5		No	Yes or Unknown			No	0	33.68		0
1530	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	1024	2.6	Stable	No	Yes or Unknown			Yes	0	42.78		0
1531	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	158	1	Stable	No	No			No	0	44.58		0
1532	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	II	0	0	Stable	No	No			No	0	42.18		0
1533	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	IV	18	2	Stable	No	No			Yes	1	1.25		0
1534	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	1092	0.9	Stable	No	Yes or Unknown			No	0	47.64		0
1535	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	15	5.9	Stable	No	No	Signature.4		Yes	1	4.34		0
1536	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2015	IV	192	2	Stable	No	Yes or Unknown			No	1	25.13		0
1537	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2015		0	4.9	Stable	No	No			Yes	1	20.5		0
1538	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2015	II	145	0	Stable	No	No			No	0	43.07		0
1539	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	44	1	Stable	No	No			Yes	0	10.51		0
1540	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	32	5.9	Stable	No	No		ATM | ERCC3	No	0	46.69		0
1541	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	III	150	0.9		No	Yes or Unknown			Yes	0	46.88		0
1542	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2015	IV	278	3	Stable	No	Yes or Unknown			No	1	13.08		0
1543	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	21.19		0
1544	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	35	2	Stable	No	Yes or Unknown		RAD54L	No	1	24.57		0
1545	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	36	3.9	Stable	No	No			No	0	45.04		0
1546	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	II	237	5.3	Stable	No	Yes or Unknown		CHEK2	No	0	45.9		0
1547	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	30	1	Stable	No	No			No	1	30.82		0
1548	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		73	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	27.53		0
1549	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	45.83		0
1550	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	182	12.8	Stable	No	Yes or Unknown	Signature.4	BLM	No	0	41.59		0
1551	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	133	8.9	Stable	No	Yes or Unknown	Signature.5		No	1	9.23		0
1552	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	12	1	Stable	No	No			No	0	46.65		0
1553	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	I	22	1	Stable	No	No			No	0	44.32		0
1554	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		5	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	46.98		0
1555	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2015	II	29	7.9	Stable	No	No	Signature.1		No	0	42.05		0
1556	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	193	0	Stable	No	No			No	0	48.79		0
1557	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	III	27	8.9		No	No			No	1	20.96		0
1558	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	27	5.9	Stable	No	Yes or Unknown			No	1	28.16		0
1559	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	96	3.5	Stable	No	Yes or Unknown			No	1	32.03		0
1560	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	1	Stable	No	Yes or Unknown			No	1	16.13		0
1561	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	I	915	2.6	Stable	No	No			No	1	43.83		0
1562	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	2	5.9	Stable	No	No			No	1	23.26		0
1563	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	I	0	2	Stable	No	No			No	0	41.72		0
1564	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2015	II	25	2.6	Indeterminate	No	Yes or Unknown			No	0	48.46		0
1565	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	14	2	Stable	No	No			No	0	17.28		0
1566	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	26	4.4	Stable	No	No			No	0	12.35		0
1567	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	0	5.9	Stable	No	No			No	0	36.57		0
1568	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	16	4.4	Stable	No	No			Yes	0	43.89		0
1569	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	No			No	1	22.64		0
1570	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	II	89	3.5	Stable	No	No			Yes	0	27.89		0
1571	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	IV	37	1	Stable	No	No			No	1	20.14		0
1572	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	34	0	Stable	No	No			No	1	20.76		0
1573	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	22	16.7	Stable	No	No	Signature.1	FANCA | MLH1 | RAD52	No	1	8.71		0
1574	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	II	24	74.8	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | BRCA2 | ERCC4 | FANCA | MLH1 | MRE11A | RAD51	No	0	45.9		0
1575	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	28	2	Stable	No	No			No	0	28.32		0
1576	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	I	951	0	Stable	No	No			Yes	0	46.65		0
1577	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2015		67	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	38.05		0
1578	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2015	IV	1098	16.7	Stable	No	Yes or Unknown	Signature.30	BLM | MSH3	Yes	0	45.77		0
1579	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	44	4.9	Stable	No	No			No	0	42.51		0
1580	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	0	1.8	Indeterminate	No	No	Signature.1		No	1	42.91		0
1581	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	54	3	Stable	No	No			No	1	29.17		0
1582	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	25	5.9	Stable	No	No	Signature.20	MRE11A	No	1	39.98		0
1583	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	3	Stable	No	No			No	0	46.75		0
1584	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	III	22	0	Stable	No	No			Yes	1	16.39		0
1585	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	161	3	Stable	No	Yes or Unknown		ARID1A	No	0	12.88		0
1586	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2015	IV	2	0	Stable	No	No			No	0	25.69		0
1587	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	II	29	1.8		No	No			Yes	0	44.52		0
1588	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	863	4.4	Stable	No	Yes or Unknown			No	0	47.9		0
1589	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	24	3	Stable	No	No			Yes	1	6.41		0
1590	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	2	0.9		No	No			No	1	13.77		0
1591	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	61	3	Stable	No	No			No	0	48.36		0
1592	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015	I	0	0	Stable	No	No			No	0	34.17		0
1593	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	3	18.7	Indeterminate	No	No	Signature.4	BRCA1 | CHEK2	No	1	1.54		0
1594	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2015	III	77	5.3	Stable	No	No		CHEK2	Yes	0	48.03		0
1595	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	II	58	9.8	Stable	No	Yes or Unknown	Signature.26		No	1	13.96		0
1596	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	II	21	1.8		No	No		BRCA1	No	0	30.59		0
1597	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	59	3	Stable	No	No			Yes	0	43.83		0
1598	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2015		0	9.8	Stable	No	No			No	0	42.12		0
1599	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	42	2.6		No	Yes or Unknown			No	0	36.86		0
1600	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2015		41	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	42.87		0
1601	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	42	3.9	Stable	No	No			No	0	42.81		0
1602	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	35	3	Stable	No	No			No	0	47.21		0
1603	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	53	4.4		No	Yes or Unknown			Yes	0	37.62		0
1604	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	0	5.3	Indeterminate	No	No	Signature.6		No	1	28.22		0
1605	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	51	2	Stable	No	Yes or Unknown			No	0	4.4		0
1606	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	III	12	36.4	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1	Yes	0	42.12		0
1607	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	22	1.8		No	No		MSH3	Yes	0	41.92		0
1608	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	IV	0	2	Stable	No	Yes or Unknown			No	0	45.31		0
1609	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	10	5.9	Stable	No	No		ERCC2	No	1	16.23		0
1610	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2015	III	23	2.6	Stable	No	No			No	0	31.44		0
1611	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	23	15.8		No	No	Signature.26		Yes	0	41.33		0
1612	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	III	0	29	Unstable	No	No	Signature.6	ARID1A | ATR	Yes	0	46.75		0
1613	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	III	81	2	Stable	No	No			No	0	46.69		0
1614	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	27	3.9	Stable	No	No			No	1	24.71		0
1615	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	32	2	Stable	No	No			No	0	37.78		0
1616	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	0	0	Stable	No	No			No	0	13.04		0
1617	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	1272	3.5	Stable	No	Yes or Unknown	Signature.29	ARID1A | ATM	No	0	46.13		0
1618	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	118	1.8	Stable	No	Yes or Unknown			No	0	45.86		0
1619	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	55	2.6		No	No			No	0	26.18		0
1620	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	3.5	Stable	No	Yes or Unknown			No	0	28.94		0
1621	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	599	2.6	Stable	No	Yes or Unknown			No	0	42.87		0
1622	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	37	5.9	Stable	No	Yes or Unknown			No	0	45.27		0
1623	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	3	Stable	No	Yes or Unknown			No	0	47.38		0
1624	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	31	6.9	Stable	No	No	Signature.30		Yes	1	14.42		0
1625	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	III	151	3.9	Stable	No	Yes or Unknown		ATM	Yes	1	12.58		0
1626	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	428	2.6		No	No			No	0	46.88		0
1627	Non-ICI treated	Never received ICI	26 - 30	Female	Head & Neck	2015	II	14	2	Stable	No	No			No	0	6.83		0
1628	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2015	III	19	5.9	Stable	No	No			No	0	45.27		0
1629	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	255	2	Stable	No	Yes or Unknown			No	1	24.44		0
1630	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	0	3.9	Stable	No	No			No	1	8.97		0
1631	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	11	1	Stable	No	No			Yes	1	8.94		0
1632	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2015	III	282	1	Stable	No	Yes or Unknown		ARID1A	Yes	1	19.84		0
1633	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	0	14.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	13.67		0
1634	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	441	0.9		No	Yes or Unknown			No	1	18.4		0
1635	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	16	3	Stable	No	No		ARID1A | CHEK2	No	1	14.78		0
1636	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	IV	36	1	Stable	No	No			No	0	46.09		0
1637	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	I	21	0	Stable	No	No			No	0	45.83		0
1638	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2015	III	41	6.9	Stable	No	No	Signature.7		No	0	18.89		0
1639	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	0	0		No	No		MUTYH	No	1	36.47		0
1640	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	II	0	1	Stable	No	Yes or Unknown			No	0	45.54		0
1641	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2015	II	622	1.8	Stable	No	No			No	0	27.24		0
1642	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		41	2	Indeterminate	No	No			No	1	28.88		0
1643	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	34	2	Stable	No	No			No	1	19.12		0
1644	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	44	2.6		No	No			Yes	0	42.81		0
1645	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	II	69	1	Stable	No	No			No	0	3.25		0
1646	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	216	6.9	Stable	No	Yes or Unknown	Signature.1		No	1	17.58		0
1647	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	0	7.9	Stable	No	Yes or Unknown			No	0	23.89		0
1648	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	48	9.8	Stable	No	No	Signature.1		No	1	15.61		0
1649	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2015	I	32	3.5		No	No			Yes	1	44.62		0
1650	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			No	1	40.67		0
1651	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	24	8.9	Stable	No	No	Signature.1		No	1	20.47		0
1652	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2015	IV	271	1	Stable	No	Yes or Unknown			No	1	33.25		0
1653	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	0	4.9	Stable	No	No			No	1	16.59		0
1654	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	21	3.9	Stable	No	No			Yes	0	9.26		0
1655	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	II	46	21.6	Stable	No	No	Signature.4	BRCA2	Yes	0	43.33		0
1656	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	III	224	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	46.16		0
1657	Non-ICI treated	Never received ICI	46 - 50	Female	Head & Neck	2015	II	112	8.9	Stable	No	No	Signature.16		No	1	13.5		0
1658	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2015	IV	116	3.9	Stable	No	No			Yes	0	26.51		0
1659	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	32	3	Stable	No	No		BLM	No	0	46.06		0
1660	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	52	2	Stable	No	Yes or Unknown			No	1	17.71		0
1661	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	42.45		0
1662	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	II	241	0	Stable	No	Yes or Unknown			No	0	37.98		0
1663	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	I	40	5.3	Stable	No	No			No	0	44.48		0
1664	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	III	21	6.9	Stable	No	No		BLM	Yes	0	42.81		0
1665	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2015		0	3	Stable	No	No			No	1	7.82		0
1666	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015	I	0	3	Stable	No	No			No	1	2.63		0
1667	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	I	29	3.9	Stable	No	No			Yes	1	38.67		0
1668	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	462	4.4		No	Yes or Unknown		BRCA2	No	0	46.72		0
1669	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	46	8.9	Stable	No	No	Signature.1		Yes	0	46.49		0
1670	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	29	20.7	Stable	No	No	Signature.13	CHEK2	Yes	1	5.85		0
1671	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	6	4.9	Stable	No	No			No	1	24.21		0
1672	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	25.59		0
1673	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	1	2	Stable	No	No		ARID1A	Yes	1	5.29		0
1674	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	0	9.8	Stable	No	No	Signature.1		No	1	11.96		0
1675	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	109	5.9	Stable	No	Yes or Unknown			No	0	46.32		0
1676	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	26	3	Stable	No	Yes or Unknown			No	1	18.83		0
1677	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	29	3.5		No	Yes or Unknown			Yes	0	44.12		0
1678	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATR	Yes	1	2.86		0
1679	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	18	3	Stable	No	No			No	0	5.91		0
1680	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	6.9	Stable	No	No		BRCA2 | ERCC3	No	1	19.22		0
1681	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2015	I	1039	1.8	Stable	No	No			No	0	41.72		0
1682	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015		0	0	Stable	No	No			No	0	43.96		0
1683	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2015	III	140	2	Stable	No	Yes or Unknown			No	0	46		0
1684	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	13	1.8		No	Yes or Unknown			No	0	45.24		0
1685	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	0	7.9	Stable	No	No	Signature.1		Yes	0	44.68		0
1686	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	57	1	Stable	No	No		BRCA2	No	0	45.8		0
1687	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2015	IV	0	1	Stable	No	No			No	1	8.9		0
1688	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	559	0.9	Indeterminate	No	Yes or Unknown			Yes	1	25.49		0
1689	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2015	IV	17	0.9	Indeterminate	No	No			No	1	28.19		0
1690	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	I	42	1	Stable	No	Yes or Unknown			No	0	45.54		0
1691	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	113	3.9	Stable	No	No			No	1	26.74		0
1692	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	58	1.8		No	No			No	0	42.09		0
1693	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	16	6.9	Stable	No	No			No	1	9.59		0
1694	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	28	2	Stable	No	Yes or Unknown			No	0	45.73		0
1695	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	572	1.8	Stable	No	Yes or Unknown			Yes	0	36.99		0
1696	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	III	281	7	Stable	No	Yes or Unknown			No	0	45.86		0
1697	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2015	IV	8	4.9	Stable	No	No			No	1	10.05		0
1698	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	55	3	Stable	No	Yes or Unknown			No	1	27.14		0
1699	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2015	III	32	3.5	Stable	No	Yes or Unknown			No	0	46.09		0
1700	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	0	3	Stable	No	No			Yes	0	3.29		0
1701	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	1	3.9	Stable	No	No			Yes	1	6.21		0
1702	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	12	3.9	Stable	No	No			Yes	1	13.57		0
1703	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	39	1.8		No	No			No	0	39.1		0
1704	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	36	2.6		No	No			No	0	42.87		0
1705	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	II	33	7.9	Stable	No	No			No	1	18.99		0
1706	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	3	3	Indeterminate	No	No			No	1	35.52		0
1707	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	III	86	0		No	Yes or Unknown			No	1	21.75		0
1708	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	IV	974	3.5	Stable	No	Yes or Unknown			No	1	43.79		0
1709	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	IV	34	6.9	Stable	No	No		BRIP1	No	1	7.56		0
1710	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	2	4.9	Stable	No	No		ARID1A	No	1	9.13		0
1711	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	1	Stable	No	No	Signature.15		Yes	1	4.4		0
1712	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	II	47	4.9	Stable	No	No	Signature.1		Yes	0	45.54		0
1713	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	III	66	1	Stable	No	Yes or Unknown			Yes	0	43.83		0
1714	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2015		17	6.9	Stable	No	No			No	0	3.52		0
1715	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2015	IV	0	3	Stable	No	No			No	1	23.39		0
1716	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	0	10.8	Stable	No	No	Signature.1		Yes	1	1.94		0
1717	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	IV	20	3	Stable	No	No			No	1	14.39		0
1718	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	148	0	Stable	No	No			No	0	19.78		0
1719	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	155	5.9	Stable	No	Yes or Unknown			Yes	0	40.21		0
1720	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	I	50	6.9	Stable	No	No	Signature.4	MDC1	No	0	43.93		0
1721	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	606	3.5	Stable	No	Yes or Unknown			No	1	39.56		0
1722	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2015		5	0	Stable	Yes or Unknown	Yes or Unknown			No	1	12.85		0
1723	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	4	6.1	Stable	No	No	Signature.5		No	1	25.17		0
1724	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		MDC1	No	1	15.21		0
1725	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	36	4.4	Stable	No	Yes or Unknown		SLX4	No	0	47.38		0
1726	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	IV	19	6.9	Stable	No	No	Signature.4	NBN	Yes	1	4.5		0
1727	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	24.9		0
1728	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2015	III	14	3	Stable	No	No			Yes	1	8.28		0
1729	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	127	4.9	Stable	No	No		ATM	No	0	30.39		0
1730	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	III	34	0.9		No	No			No	0	42.94		0
1731	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	IV	23	4.4	Stable	No	No	Signature.2		Yes	0	5.09		0
1732	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	III	0	5.3	Stable	No	No	Signature.1		No	1	18.89		0
1733	Non-ICI treated	Never received ICI	21 - 25	Male	Hepatobiliary	2015	IV	0	12.8	Stable	No	Yes or Unknown	Signature.6	ARID1A	Yes	0	23.06		0
1734	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	II	173	12.8	Stable	No	No	Signature.4		No	1	14.09		0
1735	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2015	I	29	0	Stable	No	No			No	0	44.58		0
1736	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	22	12.8	Stable	No	No	Signature.1	ARID1A	No	1	4.57		0
1737	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	146	0	Stable	No	Yes or Unknown			No	0	46.16		0
1738	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2015	IV	0	10.8	Stable	No	No	Signature.3	BRCA2	No	1	29.37		0
1739	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	28	17.7	Stable	No	No	Signature.4	ARID1A | BRCA2 | BRIP1 | XRCC2	No	1	8.41		0
1740	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	52	21.6	Stable	No	No	Signature.4		Yes	1	3.22		0
1741	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	III	1145	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	40.94		0
1742	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2015	IV	0	1	Stable	No	No			No	1	43.4		0
1743	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2015	IV	269	4.9	Stable	No	Yes or Unknown			Yes	1	10.32		0
1744	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	18	3.9	Stable	No	No	Signature.2		No	1	10.41		0
1745	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2015	IV	0	5.9	Stable	No	No	Signature.4	FANCA	No	1	9.1		0
1746	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	0.9	Stable	No	No			No	0	40.84		0
1747	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2015	I	0	4.9	Stable	No	No	Signature.1	ERCC2	No	0	46.42		0
1748	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	0	12.8	Stable	No	No	Signature.4	ERCC3 | MDC1	Yes	1	33.35		0
1749	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	II	25	6.1	Stable	No	No		ATM	No	1	34.56		0
1750	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	0	4.9	Stable	No	No		FANCA	No	0	45.27		0
1751	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2015	IV	4	24.6	Unstable	No	No	Signature.4	BRCA1 | MLH1 | PALB2 | RAD50	Yes	0	41.4		0
1752	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	31	7.9	Stable	No	No	Signature.1		No	0	45.63		0
1753	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			Yes	1	29.27		0
1754	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	18	0	Stable	No	No			Yes	0	45.5		0
1755	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	2	6.9	Stable	No	Yes or Unknown	Signature.26		No	1	22.41		0
1756	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2015	IV	627	0.9	Stable	No	Yes or Unknown			No	0	47.74		0
1757	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.2		No	0	45.77		0
1758	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2015	I	62	1.8	Stable	No	No			No	1	15.7		0
1759	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	42	2	Stable	No	Yes or Unknown			No	0	45.37		0
1760	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	14	4.9	Stable	No	Yes or Unknown		ATM	No	1	36.11		0
1761	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	41	1	Stable	No	Yes or Unknown		MUTYH	No	0	45.77		0
1762	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	30	3	Stable	No	Yes or Unknown			No	1	27.89		0
1763	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015		138	1.8	Stable	No	Yes or Unknown			Yes	1	36.11		0
1764	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2015	IV	0	3	Stable	No	No			No	1	8.15		0
1765	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	15	3	Stable	No	Yes or Unknown		MUTYH	No	0	45.8		0
1766	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2015	II	0	2	Stable	No	No			No	0	30.52		0
1767	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		94	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	8.84		0
1768	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		8	2	Stable	No	No			No	1	20.83		0
1769	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	156	4.4	Stable	No	Yes or Unknown			No	0	45.54		0
1770	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	No			No	1	28.88		0
1771	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2015	IV	70	6.1	Stable	No	No	Signature.26		No	0	47.7		0
1772	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	I	15	4.9	Stable	No	No	Signature.13		No	1	13.24		0
1773	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2015	IV	0	4.9	Stable	No	No	Signature.14	ARID1A	Yes	1	2.2		0
1774	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	7	2.6		No	No		ATM	No	1	11.99		0
1775	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	IV	125	2	Stable	No	Yes or Unknown			No	1	37.91		0
1776	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	IV	15	3.9	Stable	No	No		ARID1A	No	1	12.65		0
1777	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	63	4.9	Stable	No	No	Signature.4		No	1	17.25		0
1778	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	117	6.1	Indeterminate	No	Yes or Unknown	Signature.26		No	1	26.41		0
1779	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	125	0	Stable	No	Yes or Unknown			No	1	12.85		0
1780	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	5.9	Stable	Yes or Unknown	Yes or Unknown		ERCC2	Yes	1	13.21		0
1781	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	49	3.9	Stable	No	Yes or Unknown			No	0	17.61		0
1782	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2015	IV	15	5.9	Stable	No	No			No	1	27.24		0
1783	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2015		8	5.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	3.88		0
1784	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	35	0.9	Stable	No	Yes or Unknown			No	1	33.31		0
1785	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2015	IV	56	5.9	Stable	No	No	Signature.7	MRE11A	No	1	24.48		0
1786	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	30	6.1	Stable	No	No		CHEK1	No	1	38.08		0
1787	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	848	2.6	Stable	No	Yes or Unknown		MDC1	No	0	34.63		0
1788	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2015	III	40	7.9		No	Yes or Unknown	Signature.7		Yes	0	45.31		0
1789	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	28	1	Stable	No	No			No	0	30.55		0
1790	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	9	1	Stable	No	Yes or Unknown			Yes	0	41		0
1791	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	19	6.9	Stable	No	No			No	0	45.24		0
1792	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	247	5.9	Stable	No	No			Yes	1	46.82		0
1793	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	476	3.5	Stable	No	Yes or Unknown			No	0	45.34		0
1794	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	0	0.9	Stable	No	No			No	0	48.62		0
1795	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	29	9.8	Stable	No	No	Signature.4	BLM	No	0	44.85		0
1796	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	III	0	1	Stable	No	Yes or Unknown			No	0	43.79		0
1797	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	55	8.9	Stable	No	No	Signature.8		No	0	38.8		0
1798	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	0	3	Stable	No	No			No	0	44.85		0
1799	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	IV	202	3	Stable	No	Yes or Unknown			No	0	44.48		0
1800	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	III	943	4.4	Stable	No	Yes or Unknown	Signature.1		Yes	0	39.1		0
1801	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	10.8	Stable	No	No	Signature.24	BRCA2 | ERCC5	No	0	45.24		0
1802	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	0	4.9	Stable	No	No			No	1	40.21		0
1803	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	III	0	3.5		No	Yes or Unknown			No	0	44.35		0
1804	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	8	1	Stable	No	No		ARID1A	No	1	39.82		0
1805	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	0	11.8		No	No	Signature.1		Yes	0	45.08		0
1806	Non-ICI treated	Never received ICI	26 - 30	Female	Gastric	2015	IV	19	1	Stable	No	No		ATM	No	1	10.28		0
1807	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	17	14	Stable	No	No	Signature.4	ATM | BRCA1	No	0	25.49		0
1808	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2015	IV	30	4.9	Stable	No	Yes or Unknown			No	0	44.55		0
1809	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2015	III	0	1	Stable	No	No			Yes	0	6.74		0
1810	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	98	9.7	Stable	No	Yes or Unknown	Signature.6	MDC1	No	1	18.6		0
1811	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	7	3	Stable	No	No			No	1	13.04		0
1812	Non-ICI treated	Never received ICI	61 - 65	Male	Cutaneous Melanoma 	2015	I	861	31.6	Stable	No	No	Signature.7	ATR	No	0	28.55		0
1813	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2015	III	0	3		No	No	Signature.3	ARID1A	No	1	25.43		0
1814	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	7	0	Stable	No	No		CHEK2	No	1	24.61		0
1815	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	1	4.9	Stable	No	No			No	1	15.84		0
1816	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	1	5.3	Stable	No	No			No	1	34.14		0
1817	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	96	0	Stable	No	No			No	0	45.01		0
1818	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	2	3	Stable	No	No		MLH1	No	1	10.97		0
1819	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2015	I	1198	3.5	Stable	No	No			Yes	0	44.91		0
1820	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	II	30	37.4	Unstable	No	No	Signature.15	ARID1A | RAD52	No	0	44.78		0
1821	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	35	5.9	Stable	No	Yes or Unknown		RAD51C	No	0	45.54		0
1822	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	3	Stable	No	Yes or Unknown			Yes	0	45.04		0
1823	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	0	1	Stable	No	No			No	0	41.86		0
1824	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	73	1.8		No	No			No	0	43.6		0
1825	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	442	7	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	45.17		0
1826	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	IV	0	6.9	Stable	No	No	Signature.4		Yes	1	23.29		0
1827	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	IV	0	9.7		Yes or Unknown	Yes or Unknown	Signature.1	MDC1 | MUTYH	No	0	44.91		0
1828	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	58	2.6		No	Yes or Unknown			Yes	0	36.53		0
1829	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	II	565	2.6	Stable	No	Yes or Unknown			No	1	20.83		0
1830	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	3.9	Stable	No	No			No	0	45.11		0
1831	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	18.96		0
1832	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	0	37.4	Stable	No	No	Signature.4	BRCA1 | ERCC5	No	0	43.43		0
1833	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	35	1.8		No	No			No	0	10.87		0
1834	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2015	IV	605	6.1	Stable	No	Yes or Unknown			No	1	35.71		0
1835	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015		75	1	Stable	No	Yes or Unknown			No	1	27.4		0
1836	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	33	3	Stable	No	No		PARP1	No	0	37.03		0
1837	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2015	IV	0	7.9	Stable	No	Yes or Unknown	Signature.17	ARID1A	No	1	9.82		0
1838	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	351	1.8	Stable	No	Yes or Unknown			No	1	41.03		0
1839	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2015	IV	0	8.9	Stable	No	No	Signature.19	ARID1A | BRCA2	Yes	1	3.22		0
1840	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2015	II	903	12.3	Stable	No	No	Signature.2	ARID1A | ATM	No	0	43.96		0
1841	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	III	39	6.9	Stable	No	No	Signature.4		No	0	30.03		0
1842	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2017	III	12	2.6	Stable	No	Yes or Unknown			No	0	26.48		0
1843	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	No			No	0	25.92		0
1844	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2015	III	119	0.9	Stable	No	Yes or Unknown			No	0	45.54		0
1845	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	48	2	Stable	No	No			No	1	8.05		0
1846	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2015		10	0	Stable	No	No			No	0	48.66		0
1847	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2015	IV	15	1.8		No	No			No	0	44.58		0
1848	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	0	4.9	Stable	No	No	Signature.1		No	1	7.75		0
1849	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	23	0	Stable	No	Yes or Unknown			No	1	2.63		0
1850	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	II	209	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	13.01		0
1851	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	8.97		0
1852	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	0	6.9	Stable	No	No	Signature.9		No	1	9.86		0
1853	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	1	7.9	Stable	No	Yes or Unknown			No	0	39.69		0
1854	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	1047	4.4	Stable	No	Yes or Unknown	Signature.2		No	0	46.32		0
1855	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	14	6.9	Stable	No	Yes or Unknown	Signature.3	ARID1A	Yes	0	20.04		0
1856	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	0	5.3	Stable	No	No	Signature.1		No	1	21.29		0
1857	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2015	II	15	3.9	Indeterminate	No	No		PALB2	No	1	13.31		0
1858	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	154	0.9	Stable	No	Yes or Unknown		BRCA1	No	0	45.96		0
1859	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	50	3	Stable	No	Yes or Unknown			No	0	46.23		0
1860	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	II	9	3		No	No			No	0	24.21		0
1861	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	I	46	0.9	Stable	No	Yes or Unknown			No	0	43.63		0
1862	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015		272	3.5		No	Yes or Unknown			No	0	44.39		0
1863	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	49	3	Stable	No	No			No	1	13.14		0
1864	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	33	5.9	Stable	No	No			No	0	42.78		0
1865	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	560	2.6	Stable	No	No			No	0	29.67		0
1866	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	85	3.9	Stable	No	No			No	1	43.63		0
1867	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2015		7	3.5		Yes or Unknown	Yes or Unknown			Yes	0	43.66		0
1868	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2015	IV	103	0.9	Stable	No	Yes or Unknown			No	1	39.59		0
1869	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	3	Stable	No	No		MLH1	No	0	43.56		0
1870	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	154	2	Stable	No	Yes or Unknown			No	1	9.2		0
1871	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		5	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	44.94		0
1872	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	I	38	2	Stable	No	No			No	0	36.21		0
1873	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	172	3.5		No	Yes or Unknown			No	0	42.45		0
1874	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	399	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	45.73		0
1875	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	II	128	3.5	Stable	No	Yes or Unknown			No	0	47.84		0
1876	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	I	38	0	Stable	No	No			No	0	27.43		0
1877	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2015		16	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.8		No	0	44.55		0
1878	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	267	0.9		No	Yes or Unknown			No	1	16.23		0
1879	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	III	871	6.1	Stable	No	Yes or Unknown		ERCC4	No	0	43.83		0
1880	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2015		20	2	Stable	No	No		FANCA	No	0	42.38		0
1881	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	II	47	9.8	Stable	No	No		ARID1A	Yes	1	9.33		0
1882	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2015	III	9	3.5		No	No			Yes	1	21.03		0
1883	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2015	I	16	27.5	Unstable	No	No	Signature.1	ERCC5 | MDC1 | NBN	No	0	25.72		0
1884	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2015	I	41	0.9		No	No			Yes	0	41.03		0
1885	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.9	Stable	No	No			Yes	0	44.06		0
1886	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	31	4.9	Stable	No	No			Yes	0	28.81		0
1887	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	13	3.5	Stable	No	No	Signature.1		No	0	45.27		0
1888	Non-ICI treated	Never received ICI	0 - 5	Female	Pancreatic	2015	II	8	1	Stable	No	No			No	0	44.16		0
1889	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	IV	9	3.9	Stable	No	Yes or Unknown			No	1	23.66		0
1890	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	106	1.8		No	No			No	0	18.3		0
1891	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	7.9	Stable	No	No	Signature.1	ATM	No	1	4.9		0
1892	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	36	4.4	Stable	No	No			No	0	25.99		0
1893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	36	3.5	Stable	No	No			No	0	40.84		0
1894	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2015	IV	37	4.9	Stable	No	No			Yes	1	12.62		0
1895	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	74	2.6		No	No			No	0	45.73		0
1896	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	11.8		No	No	Signature.1		No	0	29.57		0
1897	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2015		8	3.9	Stable	No	No			Yes	1	5.75		0
1898	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	19	3	Stable	No	No			No	1	9.26		0
1899	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	0	4.9	Stable	No	No			No	0	45.08		0
1900	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	97	8.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	41.13		0
1901	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2015	II	165	23.6	Stable	No	No	Signature.4	ARID1A	No	0	6.64		0
1902	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2015	IV	21	2	Stable	No	No			No	0	6.08		0
1903	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	20	6.1		No	No		ARID1A | BRCA1	No	0	30.62		0
1904	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	677	3.5	Stable	No	Yes or Unknown			No	1	33.94		0
1905	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2015	IV	305	8.8		No	Yes or Unknown	Signature.8	ERCC2	No	1	14.55		0
1906	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	III	0	6.9	Stable	No	No	Signature.1	ERCC3	No	1	7.85		0
1907	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2015	IV	0	2.6		No	Yes or Unknown			No	1	20.01		0
1908	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2015	II	0	3.9	Stable	No	No			Yes	0	41.53		0
1909	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	8	4.9	Stable	No	No			No	1	21.95		0
1910	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	957	2.6	Stable	No	Yes or Unknown			No	0	44.09		0
1911	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	I	53	5.9	Stable	No	No	Signature.29		No	0	39.95		0
1912	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2015	IV	21	1.8		No	No			No	0	44.62		0
1913	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	47	0.9	Stable	No	Yes or Unknown			No	1	38.7		0
1914	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	63	4.9	Stable	No	No		ATM	Yes	0	36.86		0
1915	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015	IV	0	1	Stable	No	No			Yes	1	4.24		0
1916	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2015	II	921	10.5	Stable	No	No	Signature.13		Yes	1	41.63		0
1917	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	III	13	9.8	Stable	No	No	Signature.4		No	0	42.32		0
1918	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2015	III	198	3	Stable	No	Yes or Unknown			No	1	16.13		0
1919	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	45	3.9	Stable	No	No		MSH6	No	1	11.96		0
1920	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	201	3.5	Stable	No	Yes or Unknown		XRCC2	No	0	44.12		0
1921	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	III	1295	6.1	Stable	No	Yes or Unknown	Signature.9	BRCA1	Yes	0	43.43		0
1922	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	III	0	0	Stable	No	No			No	0	41.26		0
1923	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	108	3.9	Stable	No	Yes or Unknown			No	1	25.07		0
1924	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	51	7	Stable	No	No			Yes	0	41.72		0
1925	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	600	7	Stable	No	No		TP53BP1	No	0	44.06		0
1926	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	7	1	Stable	No	Yes or Unknown			No	0	43.76		0
1927	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2015	I	20	3		No	No	Signature.5		No	0	42.78		0
1928	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	4.6		0
1929	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	III	0	4.9	Stable	No	No	Signature.14	MDC1	No	1	7.69		0
1930	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2015	I	42	3	Stable	No	No			No	1	11.63		0
1931	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	29	36.4	Stable	No	No	Signature.4	MSH2 | PARP1	No	1	12.29		0
1932	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2015	IV	34	3.5	Stable	No	No			No	0	44.35		0
1933	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2015	IV	2	4.9	Stable	No	No			No	0	24.8		0
1934	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	II	42	78.7	Unstable	No	No	Signature.6	BRCA1 | ERCC5 | MSH2 | NBN | RAD52	No	0	46.98		0
1935	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	IV	1320	1.8	Stable	No	Yes or Unknown			No	0	48.53		0
1936	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	553	6.1	Stable	No	Yes or Unknown		ATM	No	0	43.93		0
1937	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	92	6.9	Stable	No	Yes or Unknown			No	1	17.64		0
1938	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	15	0	Stable	No	No			No	1	7.2		0
1939	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2015	IV	38	1	Indeterminate	No	No			Yes	1	10.94		0
1940	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	IV	64	7		No	Yes or Unknown	Signature.5	MUTYH	No	1	19.38		0
1941	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	IV	22	4.9	Stable	No	No		ARID1A	No	1	4.8		0
1942	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	69	3.5		No	No			Yes	0	40.64		0
1943	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2015	III	127	2.6		No	Yes or Unknown			No	0	43.4		0
1944	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	0	5.9	Stable	No	Yes or Unknown		RAD54L	No	1	28.19		0
1945	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	IV	4	11.8	Stable	No	No	Signature.4	FANCA	Yes	1	1.68		0
1946	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	IV	0	0	Stable	No	Yes or Unknown			No	0	43.99		0
1947	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.4	ATM | BRCA1	Yes	1	3.48		0
1948	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	1126	0.9	Stable	No	Yes or Unknown	Signature.1		No	0	44.32		0
1949	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	91	2	Stable	No	Yes or Unknown			No	1	12.52		0
1950	Non-ICI treated	Never received ICI	61 - 65	Female	Renal	2016	I	0	2	Stable	No	No			No	0	15.64		0
1951	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	460	6.1	Stable	No	Yes or Unknown	Signature.1	RAD50	No	1	33.54		0
1952	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.24	ATM	Yes	1	22.9		0
1953	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	60	2	Stable	No	Yes or Unknown			No	1	15.64		0
1954	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	3.5		No	No	Signature.18		No	0	35.29		0
1955	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	II	0	3.9	Stable	No	No			No	1	34.46		0
1956	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	IV	56	57.1	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BLM | BRCA2 | CHEK1	No	1	5.62		0
1957	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2015	IV	392	2.6	Stable	No	Yes or Unknown		BRCA1 | CHEK2 | RAD50	No	1	43.17		0
1958	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	II	1078	2.6	Stable	No	Yes or Unknown		BRCA1 | FANCA	No	1	41.13		0
1959	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2015	III	439	7.9	Stable	No	Yes or Unknown	Signature.7		No	0	44.12		0
1960	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2015	IV	226	0	Stable	No	Yes or Unknown			No	1	12.75		0
1961	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	34	2	Stable	No	Yes or Unknown			No	0	20.04		0
1962	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	I	35	6.9	Stable	No	No			No	0	35.91		0
1963	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	II	24	4.9	Stable	No	No			No	0	35.84		0
1964	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	I	58	19.3		No	No	Signature.13		No	0	39.36		0
1965	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	0.9		No	No	Signature.5		No	0	35.32		0
1966	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	II	557	0.9	Stable	No	No			No	0	37.03		0
1967	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	I	50	5.3		No	Yes or Unknown			No	0	38.01		0
1968	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	I	29	3.5		No	No			No	0	42.35		0
1969	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2015	IV	10	7.9	Stable	No	No	Signature.16	ATM	No	1	9.66		0
1970	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	11	3	Stable	No	No			No	1	19.81		0
1971	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2015	IV	62	1.8	Stable	No	No			Yes	0	39.95		0
1972	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	I	0	0	Stable	No	No			No	0	30.62		0
1973	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	4	3.9	Stable	No	Yes or Unknown		BRCA1	No	0	6.34		0
1974	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	II	229	3	Stable	No	Yes or Unknown			No	1	33.18		0
1975	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	IV	40	1	Stable	No	No			Yes	0	7.16		0
1976	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	II	26	4.9	Stable	No	No	Signature.1	BRIP1	No	0	44.48		0
1977	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	II	0	1	Stable	No	No			No	0	41.99		0
1978	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	52	5.3		No	No		BRIP1	No	0	28.16		0
1979	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2015	III	21	5.9	Stable	No	No			No	0	9.33		0
1980	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	5	8.9	Stable	No	No	Signature.3	ATM	Yes	1	18.4		0
1981	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	IV	92	10.8	Stable	No	No	Signature.24		No	1	25.56		0
1982	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	III	14	3	Stable	No	No			Yes	0	43.27		0
1983	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2015	IV	0	8.9	Stable	No	No	Signature.1		Yes	1	1.87		0
1984	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	IV	0	6.1		No	No	Signature.11	ARID1A | NTHL1	No	1	23		0
1985	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	IV	14	0	Stable	No	No			Yes	1	1.64		0
1986	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	IV	7	0	Stable	No	Yes or Unknown			Yes	0	43.76		0
1987	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2015	IV	14	2	Stable	No	Yes or Unknown		CHEK2	No	1	7.29		0
1988	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	III	19	4.9	Stable	No	No			Yes	0	44.12		0
1989	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	26	4.4	Stable	No	Yes or Unknown	Signature.19		No	0	46.69		0
1990	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2015	IV	4	5.9	Stable	No	No			No	1	5.82		0
1991	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2015	III	35	2	Stable	No	No			No	0	42.58		0
1992	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2015	III	0	6.9		No	No	Signature.30	BRCA1	No	0	39.49		0
1993	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2015	IV	20	10.8	Stable	No	No	Signature.2		No	1	8.8		0
1994	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	IV	48	3	Stable	No	No			No	0	9.26		0
1995	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2015	IV	32	4.9	Stable	No	No			No	0	44.94		0
1996	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2015	III	0	0.9	Stable	No	No			Yes	0	43.4		0
1997	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	III	0	2.6	Stable	No	No			No	0	44.06		0
1998	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2015	IV	43	10.8	Indeterminate	No	No	Signature.3		No	1	2.4		0
1999	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	III	45	3	Stable	No	No			No	0	43.17		0
2000	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	III	230	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	28.55		0
2001	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	0	2.6	Stable	No	No			No	0	44.45		0
2002	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	67	9.8	Stable	No	No	Signature.4	ARID1A	No	0	36.37		0
2003	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	33	2.6		No	No			No	0	31.54		0
2004	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	2	6.1	Stable	No	Yes or Unknown		BRCA2	No	0	12.25		0
2005	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2015	IV	120	10.8	Stable	No	Yes or Unknown	Signature.3		No	1	6.64		0
2006	Non-ICI treated	Never received ICI	81 - 85	Female	Gastric	2015	III	47	3.5	Stable	No	No			Yes	0	42.78		0
2007	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	144	3.9	Stable	No	Yes or Unknown	Signature.24	PMS1	No	1	15.11		0
2008	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	0	10.8	Stable	No	No	Signature.4		No	1	1.51		0
2009	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2015	IV	100	1	Stable	No	No			No	1	9.4		0
2010	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	40	4.9	Stable	No	Yes or Unknown		ATM	No	0	44.42		0
2011	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	42	0.9		No	Yes or Unknown			No	0	43.7		0
2012	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2015		8	4.9	Stable	No	No		ATM	No	0	38.8		0
2013	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	24	2	Stable	No	No			Yes	0	43.04		0
2014	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	III	918	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	42.68		0
2015	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2015	IV	58	22.6	Stable	No	Yes or Unknown	Signature.4		No	1	10.78		0
2016	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2015	IV	0	19.7	Indeterminate	No	No	Signature.4	ARID1A | ATR	No	1	7.92		0
2017	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	I	58	1.8		No	Yes or Unknown			No	0	41.72		0
2018	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	IV	29	3	Stable	No	Yes or Unknown			No	0	36.11		0
2019	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	34	4.9	Stable	No	No			No	0	41.23		0
2020	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	47	7.9	Stable	No	No	Signature.4	BRCA1 | BRIP1	No	1	2.37		0
2021	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	II	29	2	Stable	No	No			No	0	43.07		0
2022	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	IV	21	3	Stable	No	No			No	1	28.39		0
2023	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2015	II	857	1.8	Stable	No	Yes or Unknown		BRCA1	No	0	46.19		0
2024	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	IV	5	3.9	Stable	No	No			No	1	9.76		0
2025	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2015	I	70	3.9	Stable	No	No			No	1	9.07		0
2026	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2015	III	325	3.5		No	Yes or Unknown			No	1	11.73		0
2027	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		9	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	37.72		0
2028	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2015	II	715	4.4	Stable	No	Yes or Unknown			Yes	0	50.46		0
2029	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2015	III	6	4.9	Stable	No	No			No	1	19.61		0
2030	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	3	3.9	Stable	No	No	Signature.1		No	1	18.07		0
2031	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	9	1	Stable	No	Yes or Unknown			No	0	43.5		0
2032	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	I	68	3.5	Stable	No	No			No	0	39.92		0
2033	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	424	29	Stable	No	Yes or Unknown	Signature.6	MSH3 | RAD50	No	0	27.89		0
2034	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	II	0	2	Stable	No	No			Yes	0	40.74		0
2035	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2015	I	710	1.8	Stable	No	No	Signature.1		Yes	0	42.09		0
2036	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	II	90	6.9	Stable	No	No	Signature.5		No	1	3.42		0
2037	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	4.9	Stable	No	No			No	1	12.09		0
2038	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	II	8	3	Stable	No	No			No	1	8.84		0
2039	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	II	36	1	Stable	No	Yes or Unknown			No	0	42.64		0
2040	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2015	II	13	3	Stable	No	No			No	1	11.33		0
2041	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	20.17		0
2042	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2015	IV	7	1.8		No	No			No	1	16.13		0
2043	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	23	3	Stable	No	No			No	1	29.04		0
2044	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2016	IV	0	10.8	Stable	No	No	Signature.5		Yes	1	24.15		0
2045	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2015	IV	56	0	Stable	No	No			No	0	29.8		0
2046	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2015	II	0	0		No	No			No	0	43.01		0
2047	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2015	III	31	3.5	Stable	No	No		SLX4	Yes	0	42.97		0
2048	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	726	1.8	Stable	No	Yes or Unknown			Yes	1	34.37		0
2049	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2015	III	0	14.8	Stable	No	No	Signature.2	BRCA1 | MDC1	Yes	1	2.73		0
2050	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.2		No	0	42.78		0
2051	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2015	IV	435	2.6	Stable	No	Yes or Unknown			No	1	35.29		0
2052	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	III	161	4.9	Stable	No	No			No	1	18.56		0
2053	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	10.8	Stable	No	No	Signature.4	MDC1	No	1	2.63		0
2054	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	134	0.9	Stable	No	No			Yes	0	43.04		0
2055	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2015	III	0	1	Stable	No	No			No	0	40.54		0
2056	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2015	IV	175	3	Stable	No	Yes or Unknown			No	0	42.97		0
2057	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	50	1.8	Stable	No	Yes or Unknown		ATM | MUTYH	No	0	44.39		0
2058	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2015	III	186	0	Stable	No	Yes or Unknown		PMS2	Yes	0	41.99		0
2059	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2015	IV	260	2.6		No	Yes or Unknown			No	0	43.04		0
2060	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	III	0	8.9	Stable	No	No	Signature.1		Yes	1	6.9		0
2061	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	II	0	5.9	Indeterminate	No	No		MDC1	No	0	39.56		0
2062	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	I	57	0		No	No			No	0	39.79		0
2063	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2015	III	0	5.9	Stable	No	Yes or Unknown			No	0	43.24		0
2064	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	0	Stable	No	No			No	0	38.87		0
2065	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2015	IV	66	6.9	Stable	No	Yes or Unknown	Signature.25	BRCA1	No	1	17.18		0
2066	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	232	8.8	Stable	No	Yes or Unknown	Signature.6	PALB2	No	1	37.68		0
2067	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		9	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	37.55		0
2068	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016		0	0	Stable	No	No			No	0	37.62		0
2069	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2015	IV	0	5.9	Stable	No	No		ARID1A	Yes	0	40.71		0
2070	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2015	IV	24	4.9	Stable	No	No			No	1	12.78		0
2071	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2015	I	50	2.6	Stable	No	No			No	0	40.8		0
2072	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	19	2	Stable	No	No			No	0	41.4		0
2073	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2015	IV	9	3	Stable	No	No		BRCA1	Yes	0	2.17		0
2074	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2015		0	3.9	Stable	No	No		ARID1A	Yes	1	1.51		0
2075	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	12	3.5		No	Yes or Unknown	Signature.19		No	0	43.04		0
2076	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	II	50	15.7	Stable	No	No	Signature.4	BRCA2 | FANCA	No	0	39.52		0
2077	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	II	860	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	29.47		0
2078	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2015	IV	0	0	Stable	No	No			No	1	28.91		0
2079	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	3.9	Stable	No	No			No	1	4.37		0
2080	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	2	6.9	Stable	No	No	Signature.6		Yes	0	41.49		0
2081	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2015	III	380	3.5	Stable	No	Yes or Unknown			No	0	43.5		0
2082	Non-ICI treated	Never received ICI	21 - 25	Male	Hepatobiliary	2016	III	28	0.9		No	No			Yes	1	26.91		0
2083	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	I	26	0.9		No	Yes or Unknown			No	0	42.78		0
2084	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2015	IV	482	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	37.13		0
2085	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2015	IV	1	3.9	Stable	No	No			No	1	18.17		0
2086	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	514	7.9	Stable	No	No	Signature.1		No	0	46.65		0
2087	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2015	IV	61	1	Stable	No	No			Yes	0	43.63		0
2088	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	44	5.3		No	No		ARID1A	No	1	14.29		0
2089	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2015	III	36	7	Stable	No	No	Signature.6		No	1	32.43		0
2090	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	29	2	Stable	No	No		ARID1A	Yes	0	42.51		0
2091	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	II	36	6.9	Stable	No	No	Signature.2	ARID1A	No	0	37.65		0
2092	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	671	2.6	Stable	No	No		MUTYH	No	0	43.17		0
2093	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2015	II	0	6.1	Stable	No	No	Signature.1		Yes	0	44.85		0
2094	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	5.9	Stable	No	No			No	1	6.31		0
2095	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2016	IV	145	0	Stable	No	Yes or Unknown			Yes	0	41.82		0
2096	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	4.9	Stable	No	No	Signature.4		No	1	8.9		0
2097	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2015	IV	54	1	Stable	No	No		ARID1A	No	0	43.3		0
2098	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	II	29	6.9	Stable	No	No	Signature.1		Yes	0	39.52		0
2099	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2015	IV	35	3	Stable	No	Yes or Unknown			No	0	44.29		0
2100	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	29	7.9		No	No			No	0	42.55		0
2101	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	II	52	3	Stable	No	No			No	0	44.45		0
2102	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2015	IV	161	3	Stable	No	No			No	0	35.71		0
2103	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2016		0	0.9	Stable	No	No			No	0	42.02		0
2104	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2015	II	21	2	Stable	No	No			No	1	19.65		0
2105	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	88	2.6	Stable	No	Yes or Unknown			No	1	31.01		0
2106	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	0.9		No	Yes or Unknown			Yes	0	42.41		0
2107	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	0	4.9	Stable	No	No			No	1	12.94		0
2108	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	23	1	Stable	No	No			No	1	25.26		0
2109	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2015	I	50	3.9	Stable	No	No			No	0	38.7		0
2110	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	40	1.8		No	No			No	0	37.45		0
2111	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	22	3.9	Stable	No	Yes or Unknown	Signature.9		Yes	0	27.04		0
2112	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	255	1.8	Stable	No	Yes or Unknown			Yes	1	24.25		0
2113	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	I	239	0.9		No	Yes or Unknown			No	1	28.58		0
2114	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	7	12.8	Stable	No	No	Signature.1		No	0	42.78		0
2115	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2015	IV	0	5.3	Stable	No	Yes or Unknown	Signature.5		No	0	23.59		0
2116	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	I	225	5.3		No	Yes or Unknown	Signature.3		No	0	38.47		0
2117	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2016	I	864	5.3	Stable	No	Yes or Unknown		ARID1A | PALB2	Yes	0	41.4		0
2118	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	45	1	Stable	No	Yes or Unknown			No	0	41.92		0
2119	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3.5		No	Yes or Unknown			No	0	42.91		0
2120	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	I	34	5.9	Stable	No	No	Signature.4	BRCA2	No	0	38.87		0
2121	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	2	Stable	No	No			No	1	23.56		0
2122	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	919	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	41.59		0
2123	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	1	3	Stable	No	Yes or Unknown			No	0	40.51		0
2124	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	0	2	Stable	No	No			No	1	3.78		0
2125	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	III	94	0		No	Yes or Unknown			No	1	37.13		0
2126	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	34	5.9	Stable	No	No		ARID1A | BRCA2	No	0	42.68		0
2127	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		0	3	Stable	No	No			No	0	7.89		0
2128	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	3.9	Stable	No	No			No	1	13.6		0
2129	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	1	Stable	No	No			No	0	40.44		0
2130	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	57	1.8	Stable	No	No			No	0	42.41		0
2131	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2015	IV	66	8.9	Stable	No	No	Signature.1	ATM	No	1	12.12		0
2132	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	45	0		No	Yes or Unknown			Yes	0	36.7		0
2133	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	892	1.8	Stable	No	Yes or Unknown			No	0	42.78		0
2134	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2016	IV	22	3	Stable	No	No			No	1	5.36		0
2135	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2015	IV	10	2	Stable	No	No			No	0	43.7		0
2136	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	40	3.9	Stable	No	No			Yes	0	41.03		0
2137	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	119	6.9	Stable	No	No			No	0	29.04		0
2138	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2015	IV	0	3.9	Indeterminate	No	No	Signature.1		No	1	9.79		0
2139	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	42	38.4	Unstable	No	No	Signature.6	MLH1 | PALB2	No	0	41.1		0
2140	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	87	3	Stable	No	No			Yes	0	38.31		0
2141	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2015	IV	43	0.9	Stable	No	No			No	0	43.33		0
2142	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	7	3.5		No	Yes or Unknown	Signature.1		No	1	19.94		0
2143	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	16	7.9		No	No	Signature.13	ATR	No	0	38.24		0
2144	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		14	0	Stable	No	No			Yes	0	42.28		0
2145	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2015	III	97	1	Indeterminate	No	Yes or Unknown			No	1	5.59		0
2146	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	15.7	Stable	No	Yes or Unknown	Signature.4		No	1	1.94		0
2147	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	28	3.5		No	No			No	0	24.34		0
2148	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	46	3	Stable	No	No		ERCC4	No	0	36.3		0
2149	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	35	1.8		No	No			No	0	39.89		0
2150	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	27	22.6	Stable	No	Yes or Unknown	Signature.2	CHEK2	No	0	42.48		0
2151	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2015	II	37	25.6	Unstable	No	No	Signature.6	ARID1A	No	0	23.29		0
2152	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	18	10.8	Stable	No	No	Signature.1		No	1	16.95		0
2153	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	II	12	2	Stable	No	No			No	0	12.42		0
2154	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	II	28	7.9	Stable	No	No		BLM	Yes	0	24.44		0
2155	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	0	3.9	Stable	No	Yes or Unknown		BRCA2	No	0	40.57		0
2156	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2015	IV	58	3.9	Stable	No	No			Yes	1	8.8		0
2157	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	16	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	32.03		0
2158	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	IV	0	0	Stable	No	Yes or Unknown			No	0	42.22		0
2159	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	2	Stable	No	No			Yes	0	22.57		0
2160	Non-ICI treated	Never received ICI	86 - 90	Male	Bladder	2016	IV	17	84.6	Unstable	No	No	Signature.6	ARID1A | BRCA1 | CHEK2 | MDC1 | MSH2 | NBN	No	0	30.82		0
2161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2015	IV	7	3.9	Stable	No	Yes or Unknown	Signature.5	BRCA2	No	1	11.79		0
2162	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	166	3.9		No	Yes or Unknown	Signature.26		No	0	42.51		0
2163	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	1	Stable	No	No			Yes	0	38.57		0
2164	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	386	5.3	Stable	No	Yes or Unknown	Signature.9		No	1	28.25		0
2165	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	177	0	Stable	No	Yes or Unknown			No	1	6.97		0
2166	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	22	3	Stable	No	No			No	0	27.83		0
2167	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	46	4.9	Stable	No	No	Signature.5		Yes	1	7.89		0
2168	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	0	3.9	Stable	No	No	Signature.18	ATM	No	0	42.38		0
2169	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	III	0	4.4	Stable	No	No			No	1	27.5		0
2170	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	14	3.9	Stable	No	No			No	0	16.89		0
2171	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	186	0		No	No			Yes	0	41.79		0
2172	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	2	2	Stable	No	Yes or Unknown			No	1	14.92		0
2173	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	III	671	7.9	Indeterminate	No	Yes or Unknown	Signature.17		No	1	24.31		0
2174	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	14	5.9	Stable	No	No	Signature.1		No	0	17.68		0
2175	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	IV	199	3.5		No	Yes or Unknown			No	1	13.96		0
2176	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	2.6		No	Yes or Unknown			No	0	24.21		0
2177	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	6	2	Stable	No	No			No	1	9.53		0
2178	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	37.75		0
2179	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2015	II	99	25.6	Indeterminate	No	Yes or Unknown	Signature.6	ARID1A | ATR | RAD54L	Yes	0	43.83		0
2180	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2015	IV	16	5.9	Stable	No	No	Signature.1	BRCA1	Yes	0	43.56		0
2181	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	57	0	Stable	No	Yes or Unknown			Yes	0	32.46		0
2182	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	44	1.8		No	Yes or Unknown			No	0	41.53		0
2183	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	21	14.8	Stable	No	Yes or Unknown	Signature.1		Yes	1	8.34		0
2184	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	26	2	Stable	No	Yes or Unknown			No	1	28.02		0
2185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	0	4.4		No	No			Yes	0	39.92		0
2186	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	68	6.9	Stable	No	No	Signature.13		Yes	1	39.75		0
2187	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	19	4.9	Stable	No	No	Signature.4		Yes	0	42.55		0
2188	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2015	IV	307	5.9	Stable	No	No			No	0	50.79		0
2189	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	0	1	Stable	No	Yes or Unknown		BRCA2	Yes	0	38.44		0
2190	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.4		Yes	1	20.3		0
2191	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	46	7		No	No			Yes	0	37.85		0
2192	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	28	23.6	Stable	No	No	Signature.4	ARID1A | BLM | MSH2	Yes	0	42.32		0
2193	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	II	24	4.9	Stable	No	No	Signature.1		No	0	40.21		0
2194	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	I	121	3	Stable	No	No			Yes	1	30.06		0
2195	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	15	4.9	Stable	No	No			No	1	10.38		0
2196	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	0	3.9	Stable	No	No		ATM	No	0	32.59		0
2197	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	787	1.8	Stable	No	Yes or Unknown			No	0	41.89		0
2198	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	15	68.5	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC2 | MRE11A | MSH2 | MUTYH	Yes	0	41.66		0
2199	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	17	1	Stable	No	No			No	0	40.67		0
2200	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	85	1	Stable	No	No			No	0	8.57		0
2201	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	49	3	Stable	No	Yes or Unknown			Yes	0	27.5		0
2202	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2015		450	1.8	Stable	No	No			No	0	36.63		0
2203	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	I	26	8.9	Stable	No	No	Signature.1		No	0	25.49		0
2204	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	28	11.8	Stable	No	No	Signature.13	ERCC5 | PARP1	No	1	3.91		0
2205	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		9	3	Stable	Yes or Unknown	Yes or Unknown			No	1	9.79		0
2206	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	III	4	17.7		No	No	Signature.13	ARID1A | FANCA	No	1	8.87		0
2207	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	22	1	Stable	No	No			Yes	0	40.71		0
2208	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	31	37.4	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BRIP1 | MSH6	Yes	0	37.78		0
2209	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	104	2.6	Stable	No	Yes or Unknown			No	0	42.32		0
2210	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	40	6.1		No	No			No	0	40.21		0
2211	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2016		551	1.8	Stable	No	Yes or Unknown			No	1	37.68		0
2212	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2015	IV	115	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	19.75		0
2213	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	678	1.8	Stable	No	Yes or Unknown			No	0	42.48		0
2214	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	0	6.9	Stable	No	Yes or Unknown			No	1	32.2		0
2215	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	I	0	0		No	No			No	0	40.05		0
2216	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	III	1163	9.7	Stable	No	Yes or Unknown	Signature.1	ATM	No	0	44.55		0
2217	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	2		No	No			No	0	42.55		0
2218	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	12	3.5		No	Yes or Unknown			Yes	0	37.65		0
2219	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	8	4.9	Stable	No	No			No	1	19.65		0
2220	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	679	6.1	Stable	No	Yes or Unknown	Signature.8		No	1	29.57		0
2221	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	20.47		0
2222	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	36	2	Indeterminate	No	Yes or Unknown			No	0	7.16		0
2223	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	23	3	Stable	No	Yes or Unknown			Yes	1	13.9		0
2224	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2017	I	54	0.9	Stable	No	No			No	0	27.24		0
2225	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	37.72		0
2226	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	24	3.5		No	No	Signature.13		No	0	35.22		0
2227	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	202	0		No	Yes or Unknown			No	0	41.36		0
2228	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	0	0.9	Stable	No	No			No	1	18.89		0
2229	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	24	3	Stable	No	No			No	0	41.07		0
2230	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	0	Stable	No	Yes or Unknown		BRCA2	No	0	41.4		0
2231	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	99	1.8	Stable	No	No			Yes	0	29.54		0
2232	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	3	5.9	Stable	No	No	Signature.8		Yes	0	39.72		0
2233	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	0	6.9	Stable	No	No			No	0	41.56		0
2234	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2015	IV	204	8.9	Stable	No	No		ATR | NBN	No	1	38.11		0
2235	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016	IV	63	2	Stable	No	Yes or Unknown			No	1	6.67		0
2236	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	III	49	0	Stable	No	No		CHEK2	No	0	40.9		0
2237	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	29	7.9	Stable	No	No	Signature.22	BRCA2	No	0	37.03		0
2238	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	I	433	9.7	Stable	No	No	Signature.1	MUTYH	No	0	42.94		0
2239	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	651	1.8	Stable	No	Yes or Unknown			No	0	41.92		0
2240	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	54	1.8		No	No			Yes	0	40.57		0
2241	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	3	2	Stable	No	No			No	0	41.56		0
2242	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	560	11.4	Stable	No	Yes or Unknown	Signature.17	ATR	Yes	0	40.21		0
2243	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2015	I	93	6.9	Stable	No	No			No	0	7.59		0
2244	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	55	2	Stable	No	No			No	0	13.8		0
2245	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	515	3.5	Stable	No	Yes or Unknown		ARID1A	No	1	21.22		0
2246	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	35	5.9	Stable	No	Yes or Unknown			No	1	10.84		0
2247	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	26	5.9	Stable	No	No	Signature.4		Yes	1	8.11		0
2248	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	15	1.8		No	Yes or Unknown			No	0	36.34		0
2249	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2015	I	82	3	Stable	No	No			No	0	40.74		0
2250	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	13	3	Stable	No	No			No	1	7.46		0
2251	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	250	6.1	Stable	No	Yes or Unknown			No	1	35.09		0
2252	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	IV	17	5.9		No	No	Signature.5		No	1	6.51		0
2253	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	13	1	Stable	No	No			Yes	1	4.27		0
2254	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	III	29	4.9	Stable	No	No			Yes	1	17.64		0
2255	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	22	3	Stable	No	Yes or Unknown			No	0	42.09		0
2256	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	II	9	1.8	Stable	No	No		MUTYH	No	0	41.23		0
2257	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	26	4.4		No	No			Yes	0	41.79		0
2258	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	1	Stable	No	No			No	0	41.53		0
2259	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	160	3.9	Stable	No	Yes or Unknown	Signature.4		Yes	0	41.56		0
2260	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	18	2	Stable	No	No			No	0	39.92		0
2261	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2016	I	245	2.6	Stable	No	No			No	0	32.49		0
2262	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	5.9	Stable	No	No	Signature.18	ATM	No	0	37.52		0
2263	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	43	3	Stable	No	Yes or Unknown			No	1	9.36		0
2264	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	13	8.9	Stable	No	No		ARID1A	Yes	1	6.34		0
2265	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	6.9	Stable	No	No			No	1	8.94		0
2266	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	42.15		0
2267	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	II	0	10.8	Indeterminate	No	No	Signature.1		No	0	37.68		0
2268	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2016		36	0		No	No			No	0	39.03		0
2269	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2015	IV	14	2	Stable	No	No			Yes	0	28.58		0
2270	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	III	27	4.9	Stable	No	No	Signature.3	FANCA	Yes	1	12.02		0
2271	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016		90	0	Stable	No	Yes or Unknown		MUTYH	No	1	34.92		0
2272	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	846	3.5	Stable	No	Yes or Unknown			No	1	32.62		0
2273	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	33	5.3	Stable	No	No	Signature.3		No	1	36.34		0
2274	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	26	3.9	Stable	No	No			No	1	5.22		0
2275	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	8.9	Stable	No	No	Signature.4	ATM | CHEK1 | ERCC5	No	0	21.42		0
2276	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	I	55	2	Stable	No	No		CHEK2	No	0	42.28		0
2277	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	85	1	Stable	No	No			No	0	40.44		0
2278	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	31	4.9	Stable	No	Yes or Unknown			No	0	38.41		0
2279	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	49	10.8	Stable	No	No	Signature.2		No	1	16.62		0
2280	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2016	I	29	2	Stable	No	No			No	0	7.52		0
2281	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2015	III	125	3	Stable	No	Yes or Unknown			No	0	41.33		0
2282	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	37	5.3		No	No	Signature.16		Yes	0	35.65		0
2283	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	46	3	Stable	No	No		CHEK2	No	0	41.33		0
2284	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	4	3.9	Stable	No	No			Yes	0	32.56		0
2285	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2015	IV	38	3.5	Stable	No	No			Yes	0	42.45		0
2286	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	39	17.7	Stable	No	No	Signature.13	ARID1A | BRCA1	No	1	2.04		0
2287	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		24	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATR	No	1	14.26		0
2288	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	20	3.5		No	No			No	0	38.18		0
2289	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2016		168	7.9		Yes or Unknown	Yes or Unknown			No	0	41.86		0
2290	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	21	4.9	Stable	No	No	Signature.5		No	1	24.21		0
2291	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	32	1	Stable	No	No			No	1	8.11		0
2292	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	2	Stable	No	No			No	0	36.5		0
2293	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	III	56	5.9	Stable	No	No			Yes	1	8.54		0
2294	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	27	3.5		No	Yes or Unknown			No	0	40.44		0
2295	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	I	251	0		No	Yes or Unknown			Yes	0	41.17		0
2296	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	13	1	Stable	No	No			No	0	41.92		0
2297	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	8	3	Stable	No	No			No	0	41.86		0
2298	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	4.4	Stable	No	No			No	0	37.68		0
2299	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	12	2.6	Stable	No	No			No	0	41.79		0
2300	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	134	1.8		No	Yes or Unknown			No	1	34.37		0
2301	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	3	Stable	No	Yes or Unknown	Signature.8		No	0	24.9		0
2302	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	92	1	Stable	No	No			No	0	40.8		0
2303	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	387	4.4	Stable	No	Yes or Unknown		MLH1	No	0	42.74		0
2304	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	0	57.1	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | MSH2	Yes	0	39.16		0
2305	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	I	72	2	Stable	No	No			No	0	28.58		0
2306	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	1077	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	41.66		0
2307	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	8.9	Stable	No	No			No	0	40.57		0
2308	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		54	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	5.91		0
2309	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2015	IV	178	0.9		No	No			Yes	0	45.4		0
2310	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	386	1.8	Stable	No	Yes or Unknown			No	1	32.82		0
2311	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	6	1	Stable	No	No			No	1	9.07		0
2312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	1130	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	41.79		0
2313	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2015	IV	7	1	Stable	No	Yes or Unknown	Signature.16		No	0	43.27		0
2314	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	12.8	Indeterminate	No	Yes or Unknown	Signature.24	ATM	No	1	5.88		0
2315	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2016		0	3	Stable	Yes or Unknown	Yes or Unknown			No	0	40.67		0
2316	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	9.8	Stable	No	No	Signature.4	PMS1	No	0	36.83		0
2317	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	I	21	4.4	Stable	No	No		ARID1A	No	0	41.89		0
2318	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	IV	13	8.9	Stable	No	No	Signature.18	ARID1A	No	1	11.7		0
2319	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	0	1.8	Stable	No	No			No	1	14.09		0
2320	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	III	29	3	Stable	No	No			Yes	0	36.73		0
2321	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		9	1	Stable	No	No			No	0	39.66		0
2322	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	28	7.9		No	No	Signature.2	ARID1A	No	0	41.36		0
2323	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	25.6	Indeterminate	No	No	Signature.4	ATM | RAD50	No	0	5.19		0
2324	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	III	29	5.9	Indeterminate	No	No	Signature.30		No	0	42.12		0
2325	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	34	1.8		No	No			Yes	0	40.21		0
2326	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	57	3.9	Stable	No	No			No	1	7.59		0
2327	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	0	5.9	Indeterminate	No	No		BRCA1	No	0	12.39		0
2328	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	III	203	2.6		No	Yes or Unknown		ATM	Yes	0	41.23		0
2329	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2015	II	456	3.5	Stable	No	No			Yes	0	50		0
2330	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	16	1.8	Stable	No	Yes or Unknown		BRCA2	No	0	39.92		0
2331	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	2	3	Stable	No	No			No	1	8.87		0
2332	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2016	IV	435	5.3	Stable	No	Yes or Unknown	Signature.30	ATM	Yes	0	40.97		0
2333	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	0	1	Stable	No	No			No	1	19.91		0
2334	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2016	IV	15	0.9	Stable	No	No			Yes	1	15.08		0
2335	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2015	IV	184	3.5	Stable	No	No			No	0	45.5		0
2336	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	II	0	0	Stable	No	No			No	0	40.87		0
2337	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	5	2	Stable	No	No			No	0	39.13		0
2338	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	21	7		No	No	Signature.3		No	0	40.21		0
2339	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	58	3	Stable	No	Yes or Unknown			No	0	41.72		0
2340	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	21	3	Stable	No	No			No	0	41.03		0
2341	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		3	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	41.07		0
2342	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016		0	3	Stable	No	No			No	0	34.63		0
2343	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	42	3	Stable	No	Yes or Unknown			No	0	39.62		0
2344	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	519	1.8	Stable	No	Yes or Unknown	Signature.3		No	0	40.71		0
2345	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	9.46		0
2346	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	48	4.9	Stable	No	Yes or Unknown			No	1	10.32		0
2347	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	4.9	Stable	No	No			No	1	15.15		0
2348	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	III	48	5.3	Stable	No	No	Signature.11		No	1	34.43		0
2349	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	IV	0	3	Stable	No	No			Yes	0	11.99		0
2350	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	82	0	Stable	No	No			No	0	41.36		0
2351	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	64	1	Stable	No	Yes or Unknown			No	0	39.33		0
2352	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	1037	7.9	Stable	No	Yes or Unknown	Signature.3	MDC1 | PALB2	No	1	36.44		0
2353	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	47	0	Stable	No	Yes or Unknown			Yes	0	11.66		0
2354	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		42	2	Stable	No	No			No	0	24.84		0
2355	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	III	30	9.8	Stable	No	No			Yes	0	38.18		0
2356	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		71	0	Stable	No	No			No	0	38.21		0
2357	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	I	15	1.8	Indeterminate	No	No		ATM	No	0	39.1		0
2358	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	540	6.1	Stable	No	Yes or Unknown	Signature.4	BRCA2 | SLX4	No	0	41.49		0
2359	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	48	3.5		No	Yes or Unknown			No	0	41.3		0
2360	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	86	2	Stable	No	Yes or Unknown			No	1	12.94		0
2361	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	778	4.4	Stable	No	Yes or Unknown			No	0	39.75		0
2362	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	12.8	Stable	No	No	Signature.24		No	0	40.67		0
2363	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2016	IV	924	2.6	Stable	No	Yes or Unknown	Signature.1	ATM	No	1	40.31		0
2364	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	0	3.9	Stable	No	No			No	0	40.94		0
2365	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	6.1		No	No	Signature.13		No	0	38.93		0
2366	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	23	2	Stable	No	No			No	0	40.8		0
2367	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	28	3.9	Stable	No	No			No	1	24.9		0
2368	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	0	169.2	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC3 | MLH1 | MSH6 | PALB2 | RAD52 | RAD54L | XRCC2	No	0	9.3		0
2369	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	22	4.9	Stable	No	No			No	0	35.81		0
2370	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	29	63	Unstable	No	No	Signature.1	ARID1A | BRCA2 | FANCA | FANCC | MSH2 | NBN | RAD54L	Yes	0	42.18		0
2371	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		8	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.68		0
2372	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	12	1	Stable	No	Yes or Unknown			Yes	0	27.3		0
2373	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	352	5.3	Stable	No	Yes or Unknown	Signature.3		No	0	16.62		0
2374	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.2		Yes	1	3.52		0
2375	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	0	3.9	Stable	No	No			No	1	18.4		0
2376	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	14	3	Stable	No	Yes or Unknown			No	1	14.92		0
2377	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	47	3.9	Stable	No	No			No	1	12.39		0
2378	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		56	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	40.74		0
2379	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	0	2	Stable	No	No			No	1	28.02		0
2380	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	41	3.9	Stable	No	No			Yes	1	31.74		0
2381	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.29		No	1	13.14		0
2382	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	14	0	Stable	No	No			No	0	40.61		0
2383	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	18	8.9	Stable	No	No	Signature.16	ATM	No	1	3.12		0
2384	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	III	17	6.9	Stable	No	No			No	0	35.78		0
2385	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	34	3	Stable	No	Yes or Unknown			Yes	0	40.87		0
2386	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	5	2		No	No			No	1	7.75		0
2387	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2015	III	120	2	Stable	No	No			No	0	10.18		0
2388	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	II	0	2.6		No	No			No	0	36.99		0
2389	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	8	3.5	Stable	No	Yes or Unknown			No	1	34.27		0
2390	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	4	5.9	Stable	No	No			No	0	15.05		0
2391	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		16	1	Stable	Yes or Unknown	Yes or Unknown			No	1	12.52		0
2392	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	0	40.71		0
2393	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	23	0	Stable	No	No			No	0	41.13		0
2394	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	87	2.6	Stable	No	No		NBN	No	0	40.67		0
2395	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	21	6.1		No	No			No	0	41.2		0
2396	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	33	2.6	Stable	No	No		ARID1A | ATM	No	1	25.89		0
2397	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		0	3.9	Stable	No	No			Yes	0	40.61		0
2398	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	3	Stable	No	No			No	0	27.04		0
2399	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2016	II	8	1	Stable	No	No		ARID1A	Yes	0	37.95		0
2400	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	308	1.8	Stable	No	Yes or Unknown			No	0	41.03		0
2401	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	35	74.8	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC5 | MSH2 | RAD52	No	0	41.1		0
2402	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	I	49	5.9	Stable	No	Yes or Unknown	Signature.1		Yes	0	39.36		0
2403	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	1114	2.6	Stable	No	Yes or Unknown	Signature.19	ATM	No	0	40.31		0
2404	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	31	3.5	Stable	No	No			Yes	0	41.13		0
2405	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	0	4.9	Stable	No	No	Signature.4	ATM	Yes	0	39.59		0
2406	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	2	Stable	No	No			Yes	0	40.08		0
2407	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	78	1.8		No	No		BRCA2 | MUTYH	No	0	41.79		0
2408	Non-ICI treated	Never received ICI	31 - 35	Female	Gastric	2016	II	0	3	Stable	No	No			No	0	7.06		0
2409	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	830	5.3	Stable	No	Yes or Unknown	Signature.13	NBN	No	0	41.07		0
2410	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	328	15.8		No	Yes or Unknown	Signature.4	ERCC4	No	1	37.95		0
2411	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	4.9	Stable	No	Yes or Unknown			Yes	0	38.67		0
2412	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	55	24.6	Indeterminate	No	Yes or Unknown	Signature.13	ATM | BRCA2 | MLH1 | PMS1	No	0	41.07		0
2413	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	96	0.9	Stable	No	Yes or Unknown			No	1	32.1		0
2414	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	21.09		0
2415	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	17	0.9	Stable	No	No			No	1	36.44		0
2416	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	I	0	0	Stable	No	No			No	0	36.83		0
2417	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	801	4.4	Stable	No	Yes or Unknown		ERCC2	No	0	41.49		0
2418	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	6	6.9	Stable	No	No	Signature.1		No	1	10.84		0
2419	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		83	3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	34		0
2420	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	II	0	4.9	Stable	No	No			Yes	0	36.73		0
2421	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	22	1.8		No	Yes or Unknown			Yes	0	37.42		0
2422	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	18	0		No	No			No	0	38.93		0
2423	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2016		27	7.9	Stable	No	No	Signature.13	ARID1A | BLM | ERCC5	No	0	38.64		0
2424	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	8	14.8	Stable	No	No	Signature.4	ATM | PMS2	No	0	37.09		0
2425	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	III	0	3	Stable	No	No			No	1	20.4		0
2426	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	15	2	Stable	No	Yes or Unknown			No	1	20.76		0
2427	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	84	3.9	Stable	No	No			No	0	21.22		0
2428	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	I	43	15.7		No	No	Signature.5		No	0	41.2		0
2429	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		40	3	Stable	No	No			No	0	6.37		0
2430	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	IV	90	0	Stable	No	No			Yes	0	30.09		0
2431	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	4.4		No	No		MLH1 | RAD52	No	0	40.84		0
2432	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	14.8	Stable	No	No	Signature.29		Yes	0	1.02		0
2433	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	III	682	3.5	Stable	No	Yes or Unknown			No	0	33.81		0
2434	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	35	3	Stable	No	No			No	0	15.64		0
2435	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	0	Stable	No	No			Yes	1	4.37		0
2436	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	III	0	5.3	Stable	No	No		BRCA2	No	0	41		0
2437	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	3.9	Stable	No	Yes or Unknown			No	1	20.53		0
2438	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	10.8	Stable	No	No	Signature.13	BRIP1	Yes	0	37.91		0
2439	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	98	3	Stable	No	No			No	0	40.9		0
2440	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	44	1.8		No	No			Yes	0	39.39		0
2441	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	975	0.9	Stable	No	Yes or Unknown			No	0	40.97		0
2442	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	5.9	Indeterminate	No	No	Signature.16	BRCA2	No	0	15.51		0
2443	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2016		0	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	40.51		0
2444	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	0	1	Stable	No	No			Yes	0	37.29		0
2445	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	222	0.9		No	Yes or Unknown		ERCC5	No	0	41.1		0
2446	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	35	5.3	Stable	No	No		MLH1	No	0	41.59		0
2447	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	28	6.9	Stable	No	Yes or Unknown	Signature.7		No	0	38.6		0
2448	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	731	0	Stable	No	Yes or Unknown			No	0	41.36		0
2449	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	40	4.9	Stable	No	No			No	0	38.64		0
2450	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	0	78.7	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | PALB2 | RAD54L	Yes	0	35.61		0
2451	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	8	9.8	Stable	No	No	Signature.4	ATM	Yes	1	1.74		0
2452	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	798	7.9	Stable	No	Yes or Unknown	Signature.4		No	0	41.2		0
2453	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	27	2.6		No	No			No	0	38.8		0
2454	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	9	5.9	Stable	No	No	Signature.4		No	1	19.55		0
2455	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	18	4.9	Stable	No	No			No	0	40.51		0
2456	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	7	0	Stable	No	No			No	1	33.22		0
2457	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	0	4.9	Stable	No	No			Yes	1	2.23		0
2458	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2016	I	0	0		No	No			No	0	35.29		0
2459	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		2	15.7	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.12	ATM | NBN	No	1	21.95		0
2460	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016	IV	1	12.8	Indeterminate	No	No	Signature.29	ATM | BRIP1 | ERCC2	No	1	1.77		0
2461	Non-ICI treated	Never received ICI	15-Nov	Male	CNS	2016		0	1	Stable	No	No			No	0	39.95		0
2462	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2016	IV	0	4.9	Stable	No	Yes or Unknown			Yes	1	4.83		0
2463	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	5.9	Stable	No	No	Signature.3		No	1	16.43		0
2464	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	174	3.5		No	Yes or Unknown			No	0	41.3		0
2465	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	45.3	Stable	No	No	Signature.4	ARID1A | BLM | CHEK2 | PALB2	No	1	3.61		0
2466	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2016		5	0	Stable	Yes or Unknown	Yes or Unknown			No	1	18.66		0
2467	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	II	59	49.2	Unstable	No	No	Signature.6	FANCA | PALB2 | PARP1 | RAD52	No	0	38.9		0
2468	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	277	2.6		No	Yes or Unknown			No	0	40.84		0
2469	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	42	6.1	Stable	No	No			No	0	24.8		0
2470	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	22	2	Stable	No	No		ARID1A	No	0	36.24		0
2471	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	56	20.7	Stable	No	No	Signature.13	BLM	No	0	40.54		0
2472	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	23	5.9	Stable	No	No	Signature.1		Yes	0	39.36		0
2473	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	6.1		No	No			No	0	29.7		0
2474	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	3.9	Stable	No	No		ARID1A | ATM	No	1	4.17		0
2475	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	36	7.9	Stable	No	Yes or Unknown	Signature.13		Yes	0	38.18		0
2476	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	29	2.6		No	No		BRCA2	No	0	40.8		0
2477	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	3.5	Stable	No	No			No	0	35.88		0
2478	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	751	26.3	Stable	No	Yes or Unknown	Signature.26	ARID1A | ATM | RAD52	No	0	40.71		0
2479	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	282	10.5	Stable	No	Yes or Unknown	Signature.13	BRCA2	No	0	41.89		0
2480	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2016	IV	61	0	Stable	No	No			No	0	40.84		0
2481	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	42	3	Stable	No	Yes or Unknown			No	0	40.84		0
2482	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	8	3	Stable	No	Yes or Unknown			No	1	22.41		0
2483	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2016	IV	119	15.8	Stable	No	Yes or Unknown	Signature.2	ATR | BLM | MLH1 | MRE11A | MSH2 | RAD50	Yes	0	41.13		0
2484	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2016	I	53	1.8		No	No			No	0	22.14		0
2485	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	16	9.8	Indeterminate	No	No	Signature.29	PMS1	Yes	1	1.68		0
2486	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	42	10.8	Stable	No	No	Signature.4	BRCA1	No	0	34.96		0
2487	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	0	2	Stable	No	Yes or Unknown			No	0	37.13		0
2488	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3	Stable	No	Yes or Unknown			No	0	40.41		0
2489	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	IV	15	1	Stable	No	No			Yes	0	39.33		0
2490	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	21	0		No	No			Yes	0	36.63		0
2491	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	5.9	Stable	No	Yes or Unknown		ATM	No	1	28.94		0
2492	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	685	1.8	Stable	No	Yes or Unknown	Signature.5		No	0	40.05		0
2493	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	0	2		No	No			No	0	40.71		0
2494	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	10.8		No	No	Signature.5	BRCA1 | MUTYH | PMS1	Yes	1	26.84		0
2495	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	68	3.9	Stable	No	Yes or Unknown			No	0	38.14		0
2496	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	24	6.9	Stable	No	Yes or Unknown		ARID1A	No	0	27.37		0
2497	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	IV	0	2	Stable	No	No			No	1	26.78		0
2498	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	I	224	4.4	Stable	No	Yes or Unknown			Yes	0	37.32		0
2499	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2016	IV	17	7.9	Stable	No	No	Signature.5	BLM	No	1	31.15		0
2500	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	IV	100	0	Stable	No	No			Yes	0	29.08		0
2501	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	29.93		0
2502	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	32	7		No	No			Yes	0	39.75		0
2503	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3	Stable	No	No			Yes	0	39.06		0
2504	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	0	12.8	Stable	No	No		ARID1A	No	1	4.57		0
2505	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		1	8.9	Stable	No	No			Yes	0	39.66		0
2506	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2016	III	269	57.1		No	No	Signature.7	ATR | BRCA2 | MRE11A | SLX4 | TP53BP1	No	0	39.95		0
2507	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	103	3.5		No	No	Signature.1	ATR	No	1	40.51		0
2508	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	4.9	Stable	No	No			No	0	34.07		0
2509	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	31	2	Stable	No	Yes or Unknown	Signature.2		Yes	0	38.74		0
2510	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	14	4.9	Stable	No	No			Yes	0	35.25		0
2511	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	957	7.9	Stable	No	Yes or Unknown	Signature.6	BRCA1	No	0	40.94		0
2512	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	I	442	0.9	Stable	No	Yes or Unknown			No	0	40.9		0
2513	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	35	7	Stable	No	No			Yes	0	36.44		0
2514	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	59	3.5		No	Yes or Unknown		FANCA	Yes	0	37.95		0
2515	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		39	1	Stable	No	No			No	1	22.08		0
2516	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2016		14	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.5	FANCA	No	1	33.41		0
2517	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	55	2	Stable	No	No			No	1	19.75		0
2518	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	26	11.8	Stable	No	No		ARID1A	No	0	35.98		0
2519	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	57	4.9	Stable	No	No		ATR	No	0	37.36		0
2520	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	14	3	Stable	No	Yes or Unknown			Yes	0	26.64		0
2521	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	III	247	3.5	Stable	No	Yes or Unknown			No	0	27.04		0
2522	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2016	II	0	2	Stable	No	No			Yes	0	2.33		0
2523	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	31	4.9	Stable	No	No		ATM | PMS2	No	1	10.71		0
2524	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		5	5.9	Stable	Yes or Unknown	Yes or Unknown		ARID1A	Yes	0	39.43		0
2525	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	19	6.9	Stable	No	No		FANCA	No	1	1.54		0
2526	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	17	1		No	No			No	0	38.54		0
2527	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	28	3.9	Stable	No	Yes or Unknown			No	1	12.75		0
2528	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	21	0	Stable	No	No			Yes	1	4.47		0
2529	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	1.8		No	Yes or Unknown			No	1	21.52		0
2530	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	IV	34	2	Stable	No	No			No	0	1.54		0
2531	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	0	40.71		0
2532	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	9	236.1	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK2 | MDC1 | MSH2 | MSH6 | PALB2 | PMS1 | PMS2 | RAD50	Yes	0	36.5		0
2533	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	III	0	15.7	Indeterminate	No	No	Signature.24		Yes	0	29.47		0
2534	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2016		1	3	Stable	Yes or Unknown	Yes or Unknown			No	1	13.11		0
2535	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	21	6.9	Stable	No	No	Signature.1		Yes	1	28.45		0
2536	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	0	3	Stable	No	No		ATM	No	0	40.05		0
2537	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	0	2	Stable	No	No			Yes	0	39.1		0
2538	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2015		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	32.99		0
2539	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	II	40	59	Unstable	No	No	Signature.6	ATM | ERCC3 | MRE11A | PMS1	No	0	40.48		0
2540	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	10.8	Stable	No	No	Signature.1	MSH6	Yes	1	3.02		0
2541	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	83	4.9	Stable	No	No		ARID1A	Yes	1	16.16		0
2542	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	24	1	Stable	No	No			No	0	37.91		0
2543	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		15	1	Stable	No	No			No	1	10.61		0
2544	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	0	1.8	Stable	No	No			Yes	0	14.75		0
2545	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	1153	0.9	Stable	No	Yes or Unknown			No	0	40.38		0
2546	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	44	8.9	Indeterminate	No	No	Signature.4	ATM	Yes	1	5.26		0
2547	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	9.8	Stable	No	Yes or Unknown	Signature.18		Yes	1	2.76		0
2548	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	7	Stable	No	No	Signature.1		No	0	42.02		0
2549	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	I	425	7	Stable	No	Yes or Unknown			No	0	39.82		0
2550	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	35	0.9		No	No			No	0	36.96		0
2551	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	2	Stable	No	Yes or Unknown			Yes	0	19.84		0
2552	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	128	2.6		No	No	Signature.3		No	0	35.88		0
2553	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	3	8.9	Indeterminate	No	No	Signature.3	ATM	Yes	1	2.69		0
2554	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	II	20	2	Stable	No	No			No	1	10.58		0
2555	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		42	4.9	Stable	Yes or Unknown	Yes or Unknown		ERCC4	No	1	8.64		0
2556	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		1	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	20.01		0
2557	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		18	0		No	No			No	0	33.45		0
2558	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	9	26.6	Stable	No	No	Signature.18	ATM | FANCA | MRE11A | PALB2	No	0	39.62		0
2559	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	55	1	Stable	No	No			Yes	0	40.57		0
2560	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	28	4.4		No	No			No	0	38.47		0
2561	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	24	3	Stable	No	No			No	0	37.52		0
2562	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	69	8.9	Stable	No	No	Signature.29	ERCC2	No	0	3.52		0
2563	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	0	0	Stable	No	No			No	0	36.11		0
2564	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		0	2	Stable	No	No			No	1	20.83		0
2565	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2016	IV	126	6.1	Stable	No	No		ARID1A	Yes	1	20.67		0
2566	Non-ICI treated	Never received ICI	16 - 20	Male	Cutaneous Melanoma 	2016	II	58	0	Stable	No	No			No	0	35.94		0
2567	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	8	6.9	Stable	No	No	Signature.4		No	0	38.18		0
2568	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	0	Stable	No	No			No	0	37.32		0
2569	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	47	12.8	Stable	No	No	Signature.24		Yes	1	20.63		0
2570	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	59	2.6		No	No			Yes	0	39.13		0
2571	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	42	2	Stable	No	No			No	0	21.85		0
2572	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2016	III	32	6.9	Stable	No	No	Signature.24		Yes	0	36.47		0
2573	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	59	46.2	Stable	No	No	Signature.6	ARID1A | ATM | ATR | MLH1 | MUTYH	No	0	35.09		0
2574	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	37	5.3	Stable	No	No	Signature.3	ARID1A | MSH6	No	0	40.28		0
2575	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	43	4.9	Stable	No	No		ARID1A	No	0	38.77		0
2576	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	601	2.6	Stable	No	Yes or Unknown	Signature.1		No	0	39.98		0
2577	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2016	IV	7	3	Stable	No	Yes or Unknown			No	0	40.31		0
2578	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	175	0		No	No			No	0	39.79		0
2579	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	187	7	Stable	No	Yes or Unknown	Signature.25	ATM	No	1	20.57		0
2580	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	22	6.1		No	No			No	0	38.41		0
2581	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	17	4.9	Stable	No	No		BRCA1	No	0	37.03		0
2582	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	211	2.6	Stable	No	Yes or Unknown			No	0	40.25		0
2583	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	12	19.7	Stable	No	No	Signature.24	ATR | BRCA2 | CHEK2	No	1	11.53		0
2584	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	IV	26	1	Stable	No	No			No	0	20.24		0
2585	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	0	6.9	Stable	No	No		ARID1A	No	1	5.98		0
2586	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	20	57.9	Unstable	No	No	Signature.6	ARID1A | ATM | MSH3	No	0	8.41		0
2587	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016		503	0.9	Stable	No	Yes or Unknown			No	1	36.96		0
2588	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	0	4.4		No	No			No	1	13.17		0
2589	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	28	4.9	Stable	No	No	Signature.4		No	0	37.52		0
2590	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	114	1.8		No	No			No	0	15.28		0
2591	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	III	43	3.9	Stable	No	No			No	0	40.11		0
2592	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	IV	42	2.6	Stable	No	No			Yes	0	37.68		0
2593	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	I	13	1.8	Stable	No	No			No	0	40.21		0
2594	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	0	8.9	Stable	No	No		ARID1A	No	0	26.02		0
2595	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	132	4.9		No	Yes or Unknown			No	0	38.41		0
2596	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	4	1	Stable	No	No			No	0	39.56		0
2597	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	20	1	Stable	No	No			No	0	39.75		0
2598	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	36	0	Stable	No	No			No	0	35.84		0
2599	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	I	23	1	Stable	No	No			No	0	38.14		0
2600	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	III	30	0	Stable	No	No			No	0	37.75		0
2601	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	568	1.8	Stable	No	Yes or Unknown			No	0	38.01		0
2602	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	26	10.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	0	39.79		0
2603	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2016	I	37	3	Stable	No	No			No	0	15.61		0
2604	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	153	0	Stable	No	Yes or Unknown			No	0	34.4		0
2605	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	3	8.9	Indeterminate	No	No	Signature.4		No	0	12.65		0
2606	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	227	5.3		No	Yes or Unknown			No	1	26.87		0
2607	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	4.9	Stable	No	No			No	0	21.03		0
2608	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	III	749	2.6	Indeterminate	No	Yes or Unknown		ATR	No	0	40.25		0
2609	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	19	32.5	Stable	No	No	Signature.4		No	0	37.13		0
2610	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	19	6.9	Stable	No	No	Signature.13		No	0	37.91		0
2611	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	IV	0	11.4		No	No	Signature.3		No	0	8.84		0
2612	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	29	4.4		No	No		BRCA2	Yes	0	37.75		0
2613	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	3	5.9	Stable	No	No	Signature.1		No	1	23.13		0
2614	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	781	3.5	Stable	No	Yes or Unknown	Signature.6		No	0	41.56		0
2615	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	76	2	Stable	No	No			No	0	39.49		0
2616	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	22	1.8		No	No			No	0	39.03		0
2617	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	493	0.9	Stable	No	Yes or Unknown			No	1	26.18		0
2618	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	IV	18	8.9	Stable	No	Yes or Unknown	Signature.1		Yes	1	20.76		0
2619	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	580	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	25.95		0
2620	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	III	119	3.5	Stable	No	No			No	1	29.5		0
2621	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	4	10.8	Stable	No	No	Signature.1	ARID1A | ATM	Yes	0	10.35		0
2622	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	III	1005	0	Stable	No	No			Yes	1	35.48		0
2623	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	0	3	Stable	No	No			No	0	37.98		0
2624	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	554	0.9	Stable	No	Yes or Unknown			No	1	31.24		0
2625	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	I	58	3.9	Stable	No	Yes or Unknown			Yes	1	16.82		0
2626	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3	Stable	No	No			No	1	32.66		0
2627	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	1	17.84		0
2628	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	26	3	Stable	No	Yes or Unknown			No	0	37.19		0
2629	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	III	0	3.9	Stable	No	No			Yes	0	40.18		0
2630	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2016	IV	37	8.9	Stable	No	No	Signature.13	ATR	No	1	1.71		0
2631	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	1027	3.5	Stable	No	Yes or Unknown		BRCA2 | MDC1	No	0	39.75		0
2632	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	29	13.8	Stable	No	No	Signature.4	FANCA	Yes	1	12.16		0
2633	Non-ICI treated	Never received ICI	26 - 30	Female	Pancreatic	2016	IV	10	3.9	Stable	No	No		ARID1A	No	0	15.67		0
2634	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	IV	18	0	Stable	No	No			No	1	9.4		0
2635	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	IV	29	7.9	Indeterminate	No	Yes or Unknown	Signature.3		No	1	7.52		0
2636	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	3.9	Stable	No	No		ARID1A	No	0	15.38		0
2637	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2	Stable	No	No			No	0	38.67		0
2638	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		6	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	30.88		0
2639	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	8.9		Yes or Unknown	Yes or Unknown		ARID1A	No	0	23.2		0
2640	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2015	IV	12	6.9	Stable	No	No			No	1	18.99		0
2641	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	14	5.9	Stable	No	No	Signature.1		No	1	25.59		0
2642	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2016		1015	1.8	Stable	No	No		ATR	No	0	37.62		0
2643	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	21	112.2	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | ERCC4 | MRE11A | RAD50	No	0	38.21		0
2644	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	162	7.9		No	Yes or Unknown	Signature.3		No	1	7.03		0
2645	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	0	4.9	Stable	No	No	Signature.26	ATM	No	1	7.2		0
2646	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	42	3.5		No	No			No	0	38.34		0
2647	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	1	3	Stable	No	Yes or Unknown			No	0	37.13		0
2648	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2016	IV	0	1.8		No	No			No	1	14.52		0
2649	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	8	8.9	Stable	No	No	Signature.24		Yes	0	33.08		0
2650	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	22	3	Stable	No	Yes or Unknown			No	0	37.29		0
2651	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	IV	255	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	33.74		0
2652	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	56	4.9	Stable	No	No			No	0	25.56		0
2653	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	46	1	Stable	No	No			No	1	36.11		0
2654	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			No	0	40.74		0
2655	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	37	7.9	Stable	No	No	Signature.2		No	1	14.26		0
2656	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	266	0.9		No	Yes or Unknown			No	1	28.32		0
2657	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	21	7.9	Stable	No	No			Yes	1	4.9		0
2658	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	62	2.6		No	No			Yes	0	39.16		0
2659	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	0.9		No	Yes or Unknown			No	0	39.2		0
2660	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	2.6		No	No			Yes	0	18.73		0
2661	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	78	40.3	Unstable	No	No	Signature.6	ARID1A | BLM	No	0	5.36		0
2662	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2016	I	0	1		No	No			No	0	38.87		0
2663	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	35	3.5		No	No		RAD50	Yes	0	36.5		0
2664	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	69	0		No	No			Yes	0	39.13		0
2665	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	6	3	Stable	No	No			No	1	8.48		0
2666	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	89	3.5	Stable	No	Yes or Unknown		ERCC5 | PARP1	No	1	22.54		0
2667	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	6	3.9	Stable	No	Yes or Unknown			No	0	40.18		0
2668	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	267	1.8	Stable	No	No			No	0	40.67		0
2669	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	0	2	Stable	No	No			Yes	0	6.64		0
2670	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	63	12.8	Indeterminate	No	No	Signature.1	ARID1A | ATR	Yes	0	39.52		0
2671	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	0	3.5		No	No			No	1	10.87		0
2672	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	I	56	0.9		No	No			Yes	0	31.64		0
2673	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		3	3.9	Stable	No	No			No	1	2.3		0
2674	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	30	3	Stable	No	No			No	0	38.9		0
2675	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	15	242	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | MDC1 | MRE11A | MSH6 | NBN | PMS2 | RAD50 | RAD51C	Yes	0	39.56		0
2676	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	32	3.9	Stable	No	No			Yes	1	4.3		0
2677	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	70	0		No	No		PMS2	No	0	39.62		0
2678	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	4.9	Stable	No	No		ATM	No	0	26.48		0
2679	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	43	0	Stable	No	No			No	0	23.23		0
2680	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	5	3.9	Stable	No	Yes or Unknown			No	0	37.26		0
2681	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	II	50	4.9	Stable	No	Yes or Unknown			No	0	39.59		0
2682	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	IV	32	4.9	Stable	No	No		ATM	Yes	1	11.24		0
2683	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2016	II	0	42.1		No	Yes or Unknown	Signature.7	ATM | ATR	Yes	0	38.83		0
2684	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	III	0	3.9	Stable	No	No			Yes	0	37.26		0
2685	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	1	Stable	No	No			No	0	39.03		0
2686	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	28	0	Stable	No	No			No	0	38.44		0
2687	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	51	1	Stable	No	Yes or Unknown			Yes	0	8.34		0
2688	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	III	1	9.8	Stable	No	No	Signature.1	ERCC2	Yes	0	39.43		0
2689	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	39	1	Stable	No	No			No	0	30.52		0
2690	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	36	3.9	Stable	No	No			No	1	6.24		0
2691	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016		170	1.8		No	Yes or Unknown			No	0	37.49		0
2692	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	56	2.6		No	No			Yes	0	30.82		0
2693	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	0	4.9	Stable	No	No	Signature.1	ATM	Yes	1	3.61		0
2694	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	567	10.5	Stable	No	Yes or Unknown	Signature.13		No	1	38.01		0
2695	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	48	7.9	Stable	No	No		ARID1A	No	0	37.91		0
2696	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	37	27.5	Stable	No	No	Signature.4	FANCC	No	0	22.51		0
2697	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	26	2	Stable	No	Yes or Unknown			Yes	0	37.42		0
2698	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	49	1.8		No	No			No	0	38.87		0
2699	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	59	0.9		No	No			Yes	0	39.62		0
2700	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	127	0.9	Stable	No	No			No	0	42.81		0
2701	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	56	2	Stable	No	No			No	0	37.09		0
2702	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	0	78.7	Stable	No	No	Signature.10	ARID1A | ATM | ERCC3 | MDC1 | MSH6 | PALB2 | PMS1 | RAD50 | XRCC2	Yes	0	38.57		0
2703	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	36	220.4	Stable	No	No	Signature.1	ARID1A | ATM | BRCA2 | BRIP1 | CHEK1 | ERCC2 | ERCC3 | ERCC4 | MDC1 | MSH6 | MUTYH | PARP1 | RAD50	No	0	35.65		0
2704	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3	Stable	No	No			No	1	16.85		0
2705	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	8.9	Indeterminate	No	No	Signature.3		No	0	11.89		0
2706	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	6.9	Stable	No	No	Signature.1		No	1	23.72		0
2707	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	15	0	Stable	No	No			Yes	0	37.39		0
2708	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	23	4.9	Stable	No	Yes or Unknown			No	1	35.19		0
2709	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	0	3.5	Stable	No	No			No	0	38.64		0
2710	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2016	IV	0	6.9	Stable	No	No			No	1	11.86		0
2711	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	0	3.9	Indeterminate	No	No			No	0	39.1		0
2712	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	48	30.5	Unstable	No	No	Signature.6	ARID1A | PARP1	No	0	39.2		0
2713	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		72	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	35.48		0
2714	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	0	4.4		No	No			No	1	10.45		0
2715	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	181	30.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATR | MUTYH	No	0	11.7		0
2716	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	13	7.9	Stable	No	No	Signature.1		No	1	21.65		0
2717	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2016	IV	1	1		No	No		ATM	No	1	32.66		0
2718	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	668	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	37.75		0
2719	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	30	2	Stable	No	No		MUTYH	No	0	34.73		0
2720	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	23	2	Stable	No	No			No	0	35.91		0
2721	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	0	5.9	Stable	No	No			No	0	39.26		0
2722	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	0	3.9	Stable	No	Yes or Unknown			No	1	11.93		0
2723	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		18	3	Stable	Yes or Unknown	Yes or Unknown			No	1	28.42		0
2724	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	272	4.4		No	Yes or Unknown			No	1	29.04		0
2725	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	19	6.9	Stable	No	No			No	0	32.39		0
2726	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	16	3	Stable	No	No			No	1	16.03		0
2727	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	6.9	Stable	No	No	Signature.4		No	0	32.3		0
2728	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	9	8.8	Stable	No	No	Signature.15	ERCC2 | MSH3 | RAD54L	No	0	38.44		0
2729	Non-ICI treated	Never received ICI	46 - 50	Male	Bladder	2016	III	429	4.4	Stable	No	Yes or Unknown	Signature.13	SLX4	No	1	29.83		0
2730	Non-ICI treated	Never received ICI	26 - 30	Female	NSCLC	2016	IV	110	1.8		No	Yes or Unknown			No	0	39		0
2731	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	588	3.5	Stable	No	Yes or Unknown	Signature.3		No	1	36.24		0
2732	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	10	6.9	Indeterminate	No	No	Signature.3		No	1	14.13		0
2733	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	82	2	Stable	No	Yes or Unknown			No	0	33.05		0
2734	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	28	2	Stable	No	Yes or Unknown			Yes	0	38.77		0
2735	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	38	2		No	No		BRCA2	No	0	38.44		0
2736	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	0	4.4	Stable	No	No			Yes	0	40.54		0
2737	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	39.13		0
2738	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	16	3	Indeterminate	No	No			No	1	5.78		0
2739	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		20	3	Stable	No	No		BLM	No	1	28.09		0
2740	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	42	4.9	Stable	No	Yes or Unknown			Yes	0	33.51		0
2741	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		30	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	FANCA	Yes	1	17.25		0
2742	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016	IV	0	3.9	Stable	No	No			No	1	6.41		0
2743	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016	III	0	0.9		No	No			No	0	39.82		0
2744	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	16	7.9	Stable	No	No		ATM	Yes	0	38.34		0
2745	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	1063	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	36.3		0
2746	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	II	252	3.5	Stable	No	Yes or Unknown	Signature.9		No	1	32.82		0
2747	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	III	18	0.9	Stable	No	No			Yes	0	39		0
2748	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2016	III	48	6.1		No	No	Signature.1		No	0	39.29		0
2749	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	7	3.9	Stable	No	No	Signature.1		No	0	39.98		0
2750	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	27.1		0
2751	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	6	4.9	Stable	No	Yes or Unknown			No	0	38.6		0
2752	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	71	3	Stable	No	Yes or Unknown			No	0	39.1		0
2753	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2016	I	77	2	Stable	No	No			No	0	35.38		0
2754	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2016	IV	16	2.6		No	No			No	1	19.19		0
2755	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	63	1.8		No	No			No	0	39.89		0
2756	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	333	5.3	Stable	No	Yes or Unknown		ARID1A | BLM	No	1	18		0
2757	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	58	3	Stable	No	No			Yes	0	39.16		0
2758	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2016	II	859	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	34.96		0
2759	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	24	9.8	Stable	No	Yes or Unknown	Signature.2		No	0	39.2		0
2760	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	2.6	Stable	No	No			Yes	0	17.84		0
2761	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	6.67		0
2762	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	III	766	1.8	Indeterminate	No	Yes or Unknown	Signature.3		No	0	38.11		0
2763	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	0	3.5		No	Yes or Unknown		ERCC5	No	0	38.8		0
2764	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	16	3.9	Stable	No	No			No	1	12.35		0
2765	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	20	2	Stable	No	No			No	0	38.54		0
2766	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2015	IV	385	7.9	Stable	No	Yes or Unknown		ATM | BRCA1 | RAD54L	Yes	0	43.53		0
2767	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2016	II	4	18.7	Stable	No	No	Signature.13	ATM | BLM | ERCC4	Yes	0	37.95		0
2768	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	54	4.4		No	Yes or Unknown			Yes	0	39.1		0
2769	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	8.9	Stable	No	No	Signature.4		No	0	26.48		0
2770	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	1	Stable	No	No			No	1	9.89		0
2771	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	59	4.9	Stable	No	No	Signature.3		No	0	38.87		0
2772	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	18	394.1		No	No	Signature.8	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC4 | ERCC5 | FANCA | MDC1 | MRE11A | MSH2 | MSH3 | MSH6 | NBN | PALB2 | PARP1 | PMS1 | RAD51 | SLX4 | TP53BP1	Yes	0	36.93		0
2773	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	37	2.6	Stable	No	No			No	0	38.7		0
2774	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	75	15.8		No	Yes or Unknown	Signature.2	ARID1A	No	0	39.03		0
2775	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	108	1.8		No	No		NBN	Yes	0	39.52		0
2776	Non-ICI treated	Never received ICI	56 - 60	Male	Breast	2016	IV	34	3.5		No	No			No	0	39.29		0
2777	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		17	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	7.26		0
2778	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	275	6.1		No	Yes or Unknown			No	1	22.34		0
2779	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	17	12.8	Stable	No	No	Signature.13	ARID1A	No	0	11.79		0
2780	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	14	5.9	Stable	No	No		ERCC4	No	0	39.1		0
2781	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	57	3.5		No	No		ARID1A	No	0	37.13		0
2782	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	130	1.8		No	No			Yes	0	40.21		0
2783	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	II	0	8.9	Stable	No	Yes or Unknown	Signature.1		No	0	39.52		0
2784	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	28	2	Stable	No	Yes or Unknown			No	0	37.95		0
2785	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	44	10.8		No	No	Signature.26	ATM | RAD54L	No	1	5.65		0
2786	Non-ICI treated	Never received ICI	86 - 90	Female	SCLC	2016	III	0	16.7	Indeterminate	No	No	Signature.13		No	1	5.22		0
2787	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	34.4	Stable	No	No	Signature.4	ARID1A | ERCC3	No	1	7.16		0
2788	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	7	4.4	Stable	No	No			No	0	10.18		0
2789	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	0	0		No	No			No	0	38.7		0
2790	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	7	1.8		No	Yes or Unknown			No	0	36.83		0
2791	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2016	IV	72	6.1	Stable	No	Yes or Unknown			No	0	39.85		0
2792	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	143	6.1	Stable	No	Yes or Unknown		MSH6	No	0	36.01		0
2793	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	7	13.8	Indeterminate	No	No	Signature.29		No	1	0.85		0
2794	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2016	IV	0	0	Stable	No	No			No	1	7		0
2795	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	10.8	Stable	No	No	Signature.1		No	0	38.18		0
2796	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		76	3	Stable	No	No			No	0	38.7		0
2797	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2016		15	0	Stable	No	No			No	0	22.54		0
2798	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		10	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	11.37		0
2799	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	32	6.9	Stable	No	No	Signature.3		No	0	36.76		0
2800	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	3	9.8	Stable	No	No	Signature.1	CHEK2	No	1	18.6		0
2801	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		0	1.8	Stable	No	No			No	0	21.85		0
2802	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	25	5.9	Stable	No	No			No	0	23.29		0
2803	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	33	3	Stable	No	No			Yes	0	36.47		0
2804	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	II	20	0	Stable	No	No			No	0	33.91		0
2805	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	34.69		0
2806	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2016	IV	0	5.9	Stable	No	No			Yes	0	38.67		0
2807	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		20	5.9		Yes or Unknown	Yes or Unknown			Yes	0	38.8		0
2808	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	876	0.9	Stable	No	Yes or Unknown			No	0	39.33		0
2809	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	38	6.9	Stable	No	Yes or Unknown	Signature.12	ATM	No	1	13.73		0
2810	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	4.9	Stable	No	No	Signature.1		No	1	24.77		0
2811	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	8.9	Stable	No	No			Yes	1	1.18		0
2812	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	785	10.5	Stable	No	Yes or Unknown	Signature.2	BRCA1	No	0	38.31		0
2813	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	III	303	5.3	Stable	No	Yes or Unknown		BRCA2	No	1	19.29		0
2814	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	8.77		0
2815	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	2	Stable	No	No			No	0	18.6		0
2816	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	0	1.8	Stable	No	No	Signature.5		No	0	38.44		0
2817	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	108	4.4	Stable	No	No			No	0	38.37		0
2818	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	14	1	Stable	No	Yes or Unknown			No	1	6.14		0
2819	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	1	Stable	No	No			No	0	36.44		0
2820	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	29	5.9	Stable	No	Yes or Unknown			Yes	0	36.93		0
2821	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	41	6.9	Stable	No	Yes or Unknown			No	0	38.93		0
2822	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		10	3.9	Stable	No	No		BRIP1	No	1	9		0
2823	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	34	5.3	Stable	No	No			No	0	24.08		0
2824	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	0		No	No			No	0	36.21		0
2825	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	28	1	Stable	No	Yes or Unknown			No	0	36.3		0
2826	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	13	3.9	Stable	No	Yes or Unknown			Yes	0	36.67		0
2827	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	24	4.9	Stable	No	No		BRCA2	Yes	1	6.11		0
2828	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	200	5.3	Stable	No	Yes or Unknown			No	1	34.73		0
2829	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	9	5.3	Stable	No	No		BRCA2	Yes	0	38.9		0
2830	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	25	0	Stable	No	No			Yes	0	37.19		0
2831	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	0	Stable	No	Yes or Unknown			Yes	1	16.43		0
2832	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		25	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	11.27		0
2833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	49	3.5		No	No	Signature.4		Yes	0	35.06		0
2834	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		21	2	Stable	Yes or Unknown	Yes or Unknown			No	1	15.97		0
2835	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	0	8.8		No	No	Signature.4		No	0	30.09		0
2836	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	0		Yes or Unknown	Yes or Unknown			No	1	18.37		0
2837	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	49	11.8	Stable	No	No	Signature.1	ATM	No	0	29.86		0
2838	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	0	1	Stable	No	No		ATM	No	1	24.41		0
2839	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	3.9	Stable	No	Yes or Unknown		ARID1A | PALB2	No	0	37.75		0
2840	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	42	3	Stable	No	No			No	1	28.39		0
2841	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2016		63	3.9	Stable	No	No			No	1	3.91		0
2842	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	182	5.3	Stable	No	Yes or Unknown			No	0	37.68		0
2843	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	95	7		No	No	Signature.4	ARID1A	Yes	1	13.96		0
2844	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.15	MSH6	No	0	17.22		0
2845	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	0	37.22		0
2846	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	0	146.6	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC4 | FANCA | MRE11A | MSH6 | MUTYH | RAD50 | RAD54L	No	0	38.28		0
2847	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	0		No	No			No	0	32.2		0
2848	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	48	2	Stable	No	No		MUTYH	Yes	0	38.47		0
2849	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	30	4.9	Stable	No	No		ATM	No	0	36.9		0
2850	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016		0	1	Stable	No	No			Yes	0	7.98		0
2851	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	25	5.9	Stable	No	No	Signature.8		No	1	10.25		0
2852	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2015	IV	302	1.8		No	Yes or Unknown			Yes	0	11.96		0
2853	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	148	0		No	Yes or Unknown			No	0	38.8		0
2854	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016	I	70	0	Stable	No	No			Yes	0	35.48		0
2855	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	28	6.9	Stable	No	No	Signature.1		No	0	38.41		0
2856	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	29	3.9	Stable	No	No			Yes	0	37.22		0
2857	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	II	51	6.1	Stable	No	No			No	0	35.48		0
2858	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	26	2	Stable	No	No		ATM	No	0	38.08		0
2859	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	0	1.8	Stable	No	No			No	0	24.87		0
2860	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	I	0	0	Stable	No	No			Yes	0	36.67		0
2861	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	21	2	Stable	No	No			No	0	38.41		0
2862	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	19	52.1	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC3 | NBN | RAD54L	No	0	36.27		0
2863	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	46	3	Stable	No	Yes or Unknown			No	0	38.31		0
2864	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	20	3.9	Stable	No	No			No	0	36.67		0
2865	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	63	4.9		No	Yes or Unknown	Signature.3		No	0	38.14		0
2866	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	170	0.9	Stable	No	Yes or Unknown			No	1	20.4		0
2867	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	25	7.9	Stable	No	No	Signature.13		Yes	0	37.78		0
2868	Non-ICI treated	Never received ICI	31 - 35	Female	Head & Neck	2016	IV	100	3		No	No			Yes	0	39.36		0
2869	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	111	0.9	Stable	No	No			No	0	24.31		0
2870	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	III	51	3	Stable	No	No			No	1	6.77		0
2871	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	37.72		0
2872	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	27	2	Stable	No	Yes or Unknown			No	0	38.08		0
2873	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	4.4		No	No	Signature.1		No	1	10.78		0
2874	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	3.9	Stable	No	Yes or Unknown			No	0	38.74		0
2875	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	III	0	2	Stable	No	No			Yes	0	37.59		0
2876	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	II	22	2	Stable	No	No			No	0	5.03		0
2877	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	65	3		No	No			No	0	9.76		0
2878	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	II	673	0.9	Stable	No	Yes or Unknown			No	1	36.73		0
2879	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	26	1.8	Stable	No	No			No	0	35.52		0
2880	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	3.9	Stable	No	No			No	0	26.91		0
2881	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016		0	0	Stable	No	No			No	0	37.29		0
2882	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	2.4		0
2883	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	II	27	21.6	Stable	No	No	Signature.4		No	1	1.12		0
2884	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	57	0.9		No	No			No	0	36.76		0
2885	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	0	9.8	Stable	No	No	Signature.29	ATM	No	0	36.99		0
2886	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	46	3		No	No			Yes	1	5.55		0
2887	Non-ICI treated	Never received ICI	36 - 40	Female	Head & Neck	2016	III	29	3	Stable	No	No		ERCC5	No	0	24.44		0
2888	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	89	2.6	Stable	No	No			No	0	37.59		0
2889	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	8.9	Stable	No	No	Signature.1		No	1	23.72		0
2890	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	521	7	Stable	No	Yes or Unknown	Signature.8		No	1	32.53		0
2891	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	14	7.9	Stable	No	No	Signature.5		No	0	9.79		0
2892	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	12	7.9	Stable	No	No			No	0	26.94		0
2893	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	0	4.9	Stable	No	No			No	0	37.95		0
2894	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	35	4.9	Stable	No	No			No	1	19.88		0
2895	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	18	61	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1 | PALB2	Yes	0	15.87		0
2896	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	III	37	5.9	Stable	No	No	Signature.1		No	0	38.64		0
2897	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	167	7		No	Yes or Unknown	Signature.4		No	1	15.21		0
2898	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	70	58.8	Unstable	No	No	Signature.1	ARID1A | ERCC2 | MDC1 | MSH2 | SLX4	No	0	38.77		0
2899	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	1	0	Stable	No	No			No	0	27.83		0
2900	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	37	7	Stable	No	No		BRCA2	No	1	22.47		0
2901	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	248	2.6	Stable	No	Yes or Unknown			No	1	31.41		0
2902	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	35	15.8	Stable	No	No	Signature.2	ATR	Yes	1	9.59		0
2903	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	64	3.9	Stable	No	Yes or Unknown			No	1	23.82		0
2904	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2016		4	7.9	Stable	Yes or Unknown	Yes or Unknown			Yes	1	3.29		0
2905	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	1		No	No			No	0	34.37		0
2906	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	36	0	Stable	No	Yes or Unknown			Yes	0	34.2		0
2907	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	24	3.9	Stable	No	No			No	1	17.91		0
2908	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016		603	1.8	Stable	No	No			No	0	37.98		0
2909	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	III	301	0		No	Yes or Unknown			No	0	29.57		0
2910	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	43	0.9	Stable	No	No			Yes	0	32.49		0
2911	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2016	IV	42	1.8	Stable	No	No		FANCA	No	1	29.24		0
2912	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	1109	1.8	Stable	No	Yes or Unknown			No	0	38.97		0
2913	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	28	0	Stable	No	No			No	0	26.87		0
2914	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		8	2.6		No	No			Yes	1	15.64		0
2915	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	II	49	3.5		No	No			Yes	0	32.23		0
2916	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	0	10.8	Indeterminate	No	No	Signature.1		Yes	1	6.31		0
2917	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	87	7		No	Yes or Unknown	Signature.1		No	1	9.1		0
2918	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		17	7.9	Stable	No	No		BLM	No	0	38.28		0
2919	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	26	9.8	Stable	No	No	Signature.1		No	0	38.14		0
2920	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	0	1.8	Stable	No	No			No	0	38.21		0
2921	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	19	1.8		No	Yes or Unknown			No	0	38.14		0
2922	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	40	3.9		No	No			No	0	37.26		0
2923	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	0.9		No	No			No	0	37.88		0
2924	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	205	4.4	Stable	No	Yes or Unknown			No	1	16		0
2925	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	183	0	Stable	No	Yes or Unknown			No	1	30.82		0
2926	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	36	1	Stable	No	No			No	0	37.62		0
2927	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2016		2	2.6		Yes or Unknown	Yes or Unknown			Yes	1	12.94		0
2928	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2016	II	409	0.9	Stable	No	Yes or Unknown		BRCA2	No	0	37.22		0
2929	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		271	5.3		Yes or Unknown	Yes or Unknown			No	1	14.78		0
2930	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	39	5.3	Stable	No	Yes or Unknown			Yes	0	37.49		0
2931	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	22	1	Stable	No	No			No	0	29.93		0
2932	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	3	Indeterminate	No	No		ATM	No	0	37.03		0
2933	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	15	3.9	Stable	No	Yes or Unknown			Yes	0	34.86		0
2934	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	IV	39	2.6		No	Yes or Unknown			No	0	38.51		0
2935	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	40	8.9	Stable	No	No		PARP1	No	0	39.98		0
2936	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	94	0.9		No	Yes or Unknown			No	1	18.4		0
2937	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	36	3.9	Stable	No	No		ARID1A	No	0	37.59		0
2938	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	21	3	Stable	No	No			No	0	36.93		0
2939	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	43	3.9	Stable	No	No			No	0	38.08		0
2940	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	II	0	24.6		No	Yes or Unknown	Signature.4	ATM | MSH3	No	0	37.72		0
2941	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	24	6.1	Stable	No	No			No	1	20.83		0
2942	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2016	IV	20	8.9	Stable	No	Yes or Unknown	Signature.2	ATR	No	0	35.19		0
2943	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	66	3.9	Stable	No	No			No	1	17.41		0
2944	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	826	3.5	Stable	No	Yes or Unknown			No	0	37.95		0
2945	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	II	22	1		No	No		ARID1A	No	0	26.28		0
2946	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	0	2.6	Stable	No	No		ARID1A	Yes	0	22.83		0
2947	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2016	II	0	4.4		No	No	Signature.13	BRCA2	No	0	20.14		0
2948	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2016	IV	0	3	Stable	No	No			No	0	21.65		0
2949	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	III	0	3.5	Stable	No	Yes or Unknown			No	1	25.76		0
2950	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2016	I	0	5.3		No	No	Signature.10		Yes	0	36.21		0
2951	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	89	7.9		No	No	Signature.4	BRCA1	Yes	0	29.34		0
2952	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	64	4.9	Stable	No	Yes or Unknown			No	1	24.94		0
2953	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	III	57	11.4		No	No	Signature.6	TP53BP1	No	1	11.73		0
2954	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2016	III	41	18.7	Indeterminate	No	No	Signature.6	ARID1A | ATM | MDC1 | MLH1 | PALB2	No	0	33.94		0
2955	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	II	47	2.6		No	No			No	0	37.72		0
2956	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	12	4.9	Stable	No	No			No	1	21.68		0
2957	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	238	7.9		No	Yes or Unknown			No	1	16.49		0
2958	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	34	4.9	Stable	No	No			No	1	12.35		0
2959	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	58	0.9		No	No			No	0	37.26		0
2960	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	54	3.9	Stable	No	No			No	0	37.03		0
2961	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		37	5.9	Stable	No	No			No	1	10.71		0
2962	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			Yes	1	18.83		0
2963	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	2	3	Stable	No	No		MUTYH	No	1	15.8		0
2964	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	I	20	3.9	Stable	No	No			No	0	8.74		0
2965	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	34	4.9	Stable	No	No	Signature.29		Yes	1	4.14		0
2966	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	57	4.9		No	No		ARID1A	Yes	0	33.81		0
2967	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	11	6.1		No	Yes or Unknown			No	0	37.82		0
2968	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	3.5		No	No			No	0	32.99		0
2969	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	1033	3.5	Stable	No	Yes or Unknown			No	0	38.37		0
2970	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2016		0	5.9	Stable	No	No		BRCA2	No	1	10.05		0
2971	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	203	2.6		No	Yes or Unknown			No	0	38.24		0
2972	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	0	4.4	Stable	No	No			No	1	17.58		0
2973	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	42.3	Stable	No	No	Signature.4	ARID1A | BRIP1 | RAD51C	No	0	16.2		0
2974	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2016	II	76	0	Stable	No	No			No	0	39.33		0
2975	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	418	2.6	Stable	No	Yes or Unknown			No	0	37.52		0
2976	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	392	4.4	Stable	No	Yes or Unknown	Signature.6		No	1	39.69		0
2977	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	30	1	Stable	No	Yes or Unknown			Yes	0	30.69		0
2978	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	0	9.7	Stable	No	No	Signature.30		No	1	17.68		0
2979	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016		95	0	Stable	No	Yes or Unknown			No	0	39.23		0
2980	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2016	II	0	2		No	No	Signature.16		No	0	38.34		0
2981	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2015	IV	240	3		No	No			Yes	1	11.56		0
2982	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	30	3	Stable	No	No			Yes	1	20.57		0
2983	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	III	77	9.7		No	No	Signature.29	ATM | BRCA2	Yes	0	33.12		0
2984	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	308	0.9	Stable	No	Yes or Unknown			No	0	36.07		0
2985	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	III	17	7.9		No	No			No	0	15.41		0
2986	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2016		106	6.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	28.98		0
2987	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	25	0	Stable	No	Yes or Unknown			No	0	37.98		0
2988	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	211	2.6	Stable	No	Yes or Unknown			No	1	25.46		0
2989	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	35	0		No	No			No	1	27.27		0
2990	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	18	2.6	Stable	No	No			No	1	14.78		0
2991	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	30	6.9	Stable	No	No	Signature.18		Yes	1	1.81		0
2992	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	299	1.8		No	No			No	0	22.8		0
2993	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	3.9	Stable	No	Yes or Unknown			No	0	34.96		0
2994	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	0	4.4		No	No	Signature.1	RAD52	No	0	28.02		0
2995	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	10	7.9		No	No		BLM	No	1	16.23		0
2996	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	6.9	Stable	No	No		MSH2	No	0	1.84		0
2997	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	395	2.6	Stable	No	Yes or Unknown			No	1	23.26		0
2998	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	IV	0	17.7	Stable	No	No	Signature.13	ARID1A | ATR	Yes	0	35.35		0
2999	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	37	3.9		No	No	Signature.25	ATR	Yes	0	36.57		0
3000	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	118	0		No	Yes or Unknown			No	1	37.29		0
3001	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	5	3	Stable	No	Yes or Unknown			No	0	35.55		0
3002	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	27	9.7	Stable	No	No		ARID1A	No	0	29.11		0
3003	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	6	7	Stable	No	No	Signature.1	ARID1A	No	1	36.37		0
3004	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	III	71	3.5	Stable	No	No			No	0	38.74		0
3005	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	29	2.6		No	Yes or Unknown		MSH6	No	0	37.75		0
3006	Non-ICI treated	Never received ICI	76 - 80	Male	Head & Neck	2016	IV	0	6.9	Stable	No	No	Signature.1	ARID1A	Yes	0	35.19		0
3007	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	18.7	Stable	No	No	Signature.13	BRCA1 | BRCA2 | ERCC4	Yes	1	6.21		0
3008	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	0	3.5	Stable	No	No			No	0	36.67		0
3009	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	0	8.9		No	No	Signature.4		No	0	7.03		0
3010	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	41	9.8		No	No	Signature.24		No	0	29.27		0
3011	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	I	68	3.5		No	No	Signature.13	ATM	No	0	37.16		0
3012	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	6.9	Stable	No	No			No	0	37.75		0
3013	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2016	III	170	4.4	Stable	No	Yes or Unknown	Signature.17		Yes	1	17.12		0
3014	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	7.26		0
3015	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	0	3		No	Yes or Unknown			No	0	36.07		0
3016	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	IV	12	2	Stable	No	No		MUTYH	Yes	1	7		0
3017	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	7	7.9	Stable	No	No	Signature.29		No	1	4.07		0
3018	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	218	9.7	Stable	No	Yes or Unknown	Signature.3		No	1	33.64		0
3019	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	3.9	Stable	No	No		RAD50	No	1	21.42		0
3020	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	44	11.8	Stable	No	No	Signature.6	PMS2	No	1	11.27		0
3021	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	193	1		No	No			No	0	39.98		0
3022	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	9.8	Stable	No	No	Signature.4	MSH6	No	1	1.84		0
3023	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	0	10.8	Stable	No	No	Signature.1		Yes	0	11.73		0
3024	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	3	Stable	No	No			No	0	35.09		0
3025	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	152	11.4		No	Yes or Unknown	Signature.18	ARID1A | MLH1	Yes	0	30.16		0
3026	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3.9	Stable	No	No		ATR	Yes	0	36.4		0
3027	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	44	2.6	Stable	No	No			No	1	33.41		0
3028	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	28	3		No	No		PMS1	Yes	0	12.58		0
3029	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		15	0	Stable	No	No			No	0	33.51		0
3030	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	IV	0	14.8	Stable	No	Yes or Unknown	Signature.29	ARID1A	Yes	1	4.27		0
3031	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	160	1.8	Stable	No	Yes or Unknown			No	0	37.52		0
3032	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	30	2.6	Stable	No	No			No	1	22.74		0
3033	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	9	2		No	Yes or Unknown			Yes	1	1.68		0
3034	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2016	I	0	3.9		No	No		ARID1A | RAD50	Yes	1	34.1		0
3035	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	26	2.6		No	No			No	1	8.38		0
3036	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2016	IV	56	0.9	Stable	No	No			No	0	35.84		0
3037	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	33	5.3	Stable	No	No			No	0	35.88		0
3038	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2016	IV	2	7	Stable	No	No	Signature.1		No	1	19.25		0
3039	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	104	2.6		No	No			No	0	21.39		0
3040	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2016		0	2	Stable	No	No			Yes	0	37.59		0
3041	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	IV	69	2.6		No	No			No	1	13.67		0
3042	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	IV	227	5.3	Stable	No	Yes or Unknown			Yes	0	37.06		0
3043	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	19	4.9		No	No			No	1	11.47		0
3044	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	34	4.9	Stable	No	No			No	0	37.45		0
3045	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	7.9	Indeterminate	No	No			No	1	28.48		0
3046	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	112	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	37.42		0
3047	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	113	1.8		No	No			No	0	28.35		0
3048	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	35	4.4		No	No			No	0	36.96		0
3049	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	3.5		No	No	Signature.6		No	0	36.86		0
3050	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	1002	4.4	Stable	No	Yes or Unknown			No	0	37.26		0
3051	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	0	1.8		No	No			No	0	28.55		0
3052	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	665	4.4	Stable	No	Yes or Unknown			No	0	37.98		0
3053	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	I	47	5.3	Stable	No	No		MSH6	No	0	35.68		0
3054	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	44	4.4	Stable	No	No			Yes	0	34.92		0
3055	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	41	2.6	Stable	No	No			No	1	26.18		0
3056	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	27.24		0
3057	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	II	25	5.9		No	No	Signature.5		No	0	28.42		0
3058	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	3	3.9	Stable	No	No		RAD50	No	0	28.32		0
3059	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	41	0	Stable	No	Yes or Unknown			No	0	37.95		0
3060	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	18	7.9		No	No	Signature.4		No	0	34.73		0
3061	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	0	3.9		No	Yes or Unknown			No	1	18.73		0
3062	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	62	3.5		No	No			Yes	0	36.53		0
3063	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	I	0	0.9	Stable	No	No			No	0	28.91		0
3064	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	14	3.5		No	No		ARID1A	No	1	32.2		0
3065	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	36	7		No	No	Signature.5	ERCC2	No	1	7.46		0
3066	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	544	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	36.11		0
3067	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	II	0	0.9	Stable	No	No			Yes	0	34.56		0
3068	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	38	1		No	No			No	0	36.53		0
3069	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2016	III	15	23.7		No	No	Signature.7	BRCA2	No	0	34.99		0
3070	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	52	1.8	Stable	No	No			No	0	33.28		0
3071	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	31	3.9	Stable	No	No			No	0	37.52		0
3072	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	5	5.3	Stable	No	No	Signature.1		No	1	12.52		0
3073	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	56	1.8		No	No			No	0	37.29		0
3074	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	I	36	1		No	No			No	0	33.35		0
3075	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	I	407	7.9	Stable	No	No	Signature.1		No	0	13.96		0
3076	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	42	2.6		No	No			No	1	32.13		0
3077	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	0	0.9		No	No			Yes	0	5.03		0
3078	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2016	IV	47	2		No	No		BLM	No	0	37.49		0
3079	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	36	24.6	Unstable	No	No	Signature.6		Yes	0	30		0
3080	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	34	3		No	No			No	0	37.13		0
3081	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	IV	162	2.6		No	No			No	1	25.86		0
3082	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	26	2.6	Stable	No	No			Yes	0	36.07		0
3083	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	271	3.5	Stable	No	Yes or Unknown			No	0	36.5		0
3084	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2016	I	0	0		No	Yes or Unknown			Yes	0	30.78		0
3085	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2016		15	2	Stable	Yes or Unknown	Yes or Unknown			Yes	1	9.92		0
3086	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	I	62	2.6	Stable	No	No			No	0	32.82		0
3087	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2016	II	142	0		No	No			No	0	34.23		0
3088	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	32	1		No	Yes or Unknown			No	1	6.05		0
3089	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	8	5.9	Stable	No	No		ARID1A	No	0	36.96		0
3090	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	III	43	57.1	Unstable	No	No	Signature.1	ARID1A | ATR | ERCC2 | MDC1 | MSH2 | NBN	No	1	7.49		0
3091	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	0	2		No	No			No	0	27.6		0
3092	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	118	1.8		No	Yes or Unknown			No	1	9.99		0
3093	Non-ICI treated	Never received ICI	51 - 55	Female	SCLC	2016	IV	126	7.9		No	Yes or Unknown	Signature.4	ARID1A | NBN	No	1	7.85		0
3094	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	III	14	5.3	Stable	No	No			No	1	23.66		0
3095	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	1.8		No	No			No	0	33.81		0
3096	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	0.9		No	No	Signature.1		Yes	1	9.82		0
3097	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	34	0		No	Yes or Unknown			Yes	1	29.9		0
3098	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	II	80	4.4		No	Yes or Unknown		ARID1A | ATM	No	0	36.8		0
3099	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	0	6.1		No	No	Signature.16		Yes	0	36.5		0
3100	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	21	0	Stable	No	No			No	0	16.62		0
3101	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	I	163	0.9		No	No			No	0	39.59		0
3102	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	21	6.1		No	No			Yes	0	37.22		0
3103	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	177	7		No	No	Signature.4		No	0	20.99		0
3104	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	59	1		No	No			No	0	28.68		0
3105	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	35	4.4		No	No			No	0	36.34		0
3106	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	IV	0	3.9		No	No		RAD50	No	1	4.11		0
3107	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	41	2.6		No	No			No	0	36.9		0
3108	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2016	III	0	17.7	Stable	No	No	Signature.7	ATM | ATR	No	0	34.43		0
3109	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	2.6		No	No			Yes	0	33.31		0
3110	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	IV	20	0		No	No			No	1	18.33		0
3111	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	34	3	Stable	No	No			No	0	22.47		0
3112	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	I	25	0.9	Stable	No	No			No	1	33.81		0
3113	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	IV	294	0	Stable	No	Yes or Unknown			No	0	37.72		0
3114	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	II	376	0.9	Stable	No	Yes or Unknown			No	0	35.19		0
3115	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	II	7	4.4	Stable	No	No			Yes	0	36.6		0
3116	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	104	3.5	Stable	No	Yes or Unknown			No	0	37.22		0
3117	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	I	76	2.6		No	No			No	0	27.73		0
3118	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	25	1.8		No	No			No	0	36.6		0
3119	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	3		No	No			No	1	8.44		0
3120	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	4	3.9	Stable	No	No			No	1	6.83		0
3121	Non-ICI treated	Never received ICI	26 - 30	Female	Endometrial	2016	I	55	3.9	Stable	No	No			Yes	0	36.44		0
3122	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	14	2.6	Stable	No	Yes or Unknown			Yes	0	33.91		0
3123	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	0	3.9	Stable	No	No			No	1	1.35		0
3124	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	32	4.9	Stable	No	No			No	0	32.36		0
3125	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			Yes	0	37.06		0
3126	Non-ICI treated	Never received ICI	81 - 85	Female	Cutaneous Melanoma 	2016	I	42	0.9		No	No			No	0	26.41		0
3127	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	68	5.9		No	No			No	0	37.19		0
3128	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	62	8.9	Stable	No	No	Signature.5		No	0	8.9		0
3129	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	22	0		No	No			No	0	34.37		0
3130	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2016	II	28	39.5		No	No	Signature.7	ARID1A | ERCC5	No	0	6.18		0
3131	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	33	0	Stable	No	No			No	0	19.52		0
3132	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	79	27.2	Unstable	No	No	Signature.1	ARID1A | BLM | MRE11A | MSH3 | PMS2	Yes	0	37.98		0
3133	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	14	6.9		No	No	Signature.29	ARID1A	Yes	1	6.51		0
3134	Non-ICI treated	Never received ICI	36 - 40	Female	Bladder	2016	III	7	4.4		No	No			Yes	0	35.02		0
3135	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	IV	243	4.4	Stable	No	Yes or Unknown			No	0	36.7		0
3136	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	3		No	No	Signature.29		Yes	1	3.84		0
3137	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	0	1	Stable	No	No			No	1	7.16		0
3138	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	0	3	Stable	No	Yes or Unknown			No	1	5.49		0
3139	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	13	1		No	No			No	1	17.35		0
3140	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	428	6.1	Stable	No	Yes or Unknown		ATM	No	0	37.75		0
3141	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	6.37		0
3142	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	16	2		No	No			No	1	11.3		0
3143	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	0	4.4	Stable	No	No		ARID1A	No	0	34.3		0
3144	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	143	1.8	Stable	No	No			No	0	35.48		0
3145	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	32	9.7		No	No	Signature.5	ARID1A | ATR	No	1	19.38		0
3146	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	188	6.1	Stable	No	Yes or Unknown	Signature.1		No	1	19.84		0
3147	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	0		No	Yes or Unknown			No	0	37.85		0
3148	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016		165	0		No	Yes or Unknown			No	0	38.01		0
3149	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	66	2.6		No	Yes or Unknown	Signature.6	ARID1A	Yes	0	36.5		0
3150	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	173	0.9		No	No	Signature.1		Yes	1	14.85		0
3151	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	9	3.9	Stable	No	No	Signature.1		No	0	36.76		0
3152	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	752	2.6	Stable	No	No			No	1	34.43		0
3153	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	21	2.6		No	Yes or Unknown			No	1	13.44		0
3154	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	58	4.4		No	Yes or Unknown		RAD50	No	0	38.05		0
3155	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	41	0.9		No	No			No	0	33.58		0
3156	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	28	5.3		No	No			No	0	34.89		0
3157	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	7.9		No	No	Signature.5	ARID1A	No	0	36.17		0
3158	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	11	0.9	Stable	No	No			No	0	38.08		0
3159	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	421	0		No	No			Yes	0	33.71		0
3160	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	337	3.5	Stable	No	Yes or Unknown			No	1	30.95		0
3161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	61	5.3	Stable	No	Yes or Unknown		ERCC5	No	0	14.85		0
3162	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.9		No	No			No	1	22.18		0
3163	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	3	7	Stable	No	No	Signature.6	BRCA2	No	1	15.97		0
3164	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	39	10.5	Stable	No	No	Signature.3		No	1	25.89		0
3165	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	IV	19	3.5		No	No			No	0	37.55		0
3166	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	I	880	0.9	Stable	No	No			No	0	36.04		0
3167	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	III	87	34.2	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | MSH3 | MSH6 | NBN	Yes	0	34.2		0
3168	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	34	4.4	Stable	No	No		BRCA1	No	1	24.54		0
3169	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	30	9.7		No	Yes or Unknown	Signature.21	BRCA2 | MLH1 | MSH3	No	0	37.26		0
3170	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	36	9.8		No	No	Signature.18	RAD50	No	0	12.42		0
3171	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2015	IV	362	7	Stable	No	Yes or Unknown	Signature.1	ATM | MUTYH	No	0	22.9		0
3172	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	128	2.6	Stable	No	Yes or Unknown			No	0	37.72		0
3173	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	5	2.6		No	No			No	0	36.99		0
3174	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	84	3		No	No		ATM	No	1	19.22		0
3175	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	IV	10	19.3		No	No	Signature.16	ARID1A | CHEK2 | ERCC2 | FANCC	No	0	28.48		0
3176	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	15	5.3		No	Yes or Unknown			No	0	33.12		0
3177	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	II	0	0		No	No			No	1	17.48		0
3178	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	47	8.8		No	No	Signature.13		No	0	36.67		0
3179	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	3		No	No			No	1	18.33		0
3180	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	III	542	0	Stable	No	No			No	0	35.32		0
3181	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	22	3.9		No	No		PMS2	No	0	35.58		0
3182	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	128	0		No	No			No	0	36.21		0
3183	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		14	3.5		Yes or Unknown	Yes or Unknown			No	1	3.61		0
3184	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	3	3	Stable	No	No			No	0	35.98		0
3185	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	363	5.3	Stable	No	Yes or Unknown			No	0	16.62		0
3186	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	2.6	Stable	No	Yes or Unknown			No	0	36.76		0
3187	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	10.5	Stable	No	No		ARID1A	No	0	15.47		0
3188	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	27	16.7		No	Yes or Unknown	Signature.4	ATR | MDC1	Yes	1	1.64		0
3189	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	III	0	1		No	No			No	0	36.11		0
3190	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	36	3.5		No	Yes or Unknown			Yes	0	14.49		0
3191	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	3.5	Stable	No	No			No	1	10.12		0
3192	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	III	0	0.9		No	Yes or Unknown			No	0	36.76		0
3193	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	23	4.4		No	No			No	1	22.57		0
3194	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	254	4.4	Stable	No	Yes or Unknown			No	0	37.06		0
3195	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	0	12.55		0
3196	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	4.67		0
3197	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	III	4	2		No	No			No	1	11.24		0
3198	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	II	325	9.7	Stable	No	Yes or Unknown	Signature.9	PMS2	No	1	15.7		0
3199	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	71	3.5		No	No			No	0	37.45		0
3200	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	6.1		No	No	Signature.24	BLM	No	0	35.58		0
3201	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	I	0	8.8		No	No	Signature.1		No	1	30.42		0
3202	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	28	3	Indeterminate	No	No	Signature.9		No	0	37.68		0
3203	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	35	8.8		No	No		ARID1A	No	0	34.33		0
3204	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	5.3		No	No			No	0	25.69		0
3205	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	26	8.8	Stable	No	No	Signature.1		Yes	0	33.05		0
3206	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	40	6.1	Stable	No	No	Signature.1	MLH1	Yes	0	31.61		0
3207	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	14	4.9		No	No			No	0	37.49		0
3208	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	111	5.3	Stable	No	Yes or Unknown			No	1	25.49		0
3209	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	56	2.6		No	No			No	0	28.42		0
3210	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	25	1.8		No	No			No	1	9.3		0
3211	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	146	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	9.63		0
3212	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		0	3.9		Yes or Unknown	Yes or Unknown			No	1	7.49		0
3213	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	28	3.5	Stable	No	No			No	0	21.13		0
3214	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		11	2.6		Yes or Unknown	Yes or Unknown	Signature.5		No	1	14.06		0
3215	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	743	2.6	Stable	No	Yes or Unknown			No	0	36.67		0
3216	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	22	4.4	Stable	No	No			No	0	38.44		0
3217	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	II	0	5.3	Stable	No	No		MLH1	No	0	36.67		0
3218	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	30	65		No	Yes or Unknown	Signature.4	ATM | BRCA1 | BRCA2 | RAD54L	No	0	8.71		0
3219	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	20	3.5		No	No	Signature.7		Yes	0	27.14		0
3220	Non-ICI treated	Never received ICI	71 - 75	Female	Esophageal	2016	IV	10	7		No	No	Signature.1		No	0	36.7		0
3221	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016	I	0	7		No	No	Signature.5	ERCC4 | MSH6	No	0	36.86		0
3222	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	83	4.4		No	Yes or Unknown			No	0	32.3		0
3223	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	II	37	7		No	No			No	0	32.03		0
3224	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	30	4.4	Stable	No	No	Signature.1		No	0	9.86		0
3225	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2016		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	22.93		0
3226	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	28	6.1	Stable	No	No			No	0	17.02		0
3227	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	36	0.9		No	No			Yes	0	30.69		0
3228	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	71	3.5		No	No			No	0	35.65		0
3229	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	62	0.9		No	No			No	0	36.27		0
3230	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2016	III	54	6.1	Stable	No	No	Signature.1		No	0	21.03		0
3231	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	0	1.8		No	No			No	1	17.71		0
3232	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	20	7.9		No	Yes or Unknown			No	0	36.27		0
3233	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2016		14	5.3		Yes or Unknown	Yes or Unknown			Yes	1	8.8		0
3234	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	0	0.9		No	No			No	0	20.5		0
3235	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	30	1.8		No	No			No	0	36.6		0
3236	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	1.38		0
3237	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	5.3		No	No	Signature.1		Yes	1	7.39		0
3238	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	104	3.5	Stable	No	Yes or Unknown			No	1	23.62		0
3239	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	No			No	0	21.13		0
3240	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	21	5.3		No	No	Signature.24	ARID1A	No	1	23.85		0
3241	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	17	1.8	Stable	No	No			No	1	18.6		0
3242	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	II	0	8.8		No	Yes or Unknown	Signature.30		No	0	34.3		0
3243	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	2.6		No	Yes or Unknown			No	0	34.89		0
3244	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	0	2.6	Stable	No	No			No	1	31.74		0
3245	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	II	379	3.5	Stable	No	Yes or Unknown			No	1	18.92		0
3246	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	II	18	2.6	Stable	No	No			Yes	0	34.04		0
3247	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	III	0	1.8		No	No			Yes	0	36.34		0
3248	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	57	4.4		No	No			No	0	34.96		0
3249	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	523	7.9	Indeterminate	No	Yes or Unknown	Signature.19		No	1	32.23		0
3250	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	392	0.9	Stable	No	Yes or Unknown			No	0	29.83		0
3251	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.9		No	No		BRCA2	No	0	36.4		0
3252	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	16	4.4		No	Yes or Unknown			No	0	22.51		0
3253	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	35	4.4		No	No			No	0	35.91		0
3254	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	33	2.6		No	No			No	0	33.02		0
3255	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	164	7	Stable	No	Yes or Unknown		ARID1A	No	0	36.24		0
3256	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	0	6.1	Stable	No	No	Signature.19	ARID1A	No	0	37.06		0
3257	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	26	5.3	Stable	No	No	Signature.10	ATR	No	0	34.92		0
3258	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	49	4.4		No	Yes or Unknown		MSH3	No	0	36.14		0
3259	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	0	3.5		No	No			Yes	1	4.6		0
3260	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	8	1.8	Stable	No	No			Yes	0	9.72		0
3261	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	31	23.7	Unstable	No	No	Signature.6	ARID1A | ATM	Yes	0	20.24		0
3262	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	2.6		No	No			Yes	0	35.71		0
3263	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	32	5.3		No	No	Signature.29	ATM | ERCC5	No	1	2.63		0
3264	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	0	0.9		No	No			No	0	32.16		0
3265	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	16	8.8	Stable	No	No		ARID1A	No	0	21.42		0
3266	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	21	56.2	Unstable	No	No	Signature.6	ERCC5 | MSH3 | MSH6 | NBN | PARP1 | RAD50	Yes	0	34.46		0
3267	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	4.4		No	Yes or Unknown			No	1	11.17		0
3268	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016		0	0.9		No	No			No	0	26.51		0
3269	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	5.3	Stable	No	No	Signature.1	ATM | TP53BP1	No	1	25.69		0
3270	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	72	7	Stable	No	No	Signature.1		No	0	37.39		0
3271	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	169	1.8		No	Yes or Unknown			No	0	36.14		0
3272	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	29	3.5		No	No			No	1	7.92		0
3273	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	7		No	No	Signature.4	ARID1A | MLH1	No	0	33.68		0
3274	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	0	1.8		No	No			No	0	31.51		0
3275	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	52	1.8	Stable	No	No			No	0	35.25		0
3276	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	28	3.5		No	Yes or Unknown			No	0	33.38		0
3277	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	92	0.9	Stable	No	No			Yes	0	35.81		0
3278	Non-ICI treated	Never received ICI	16 - 20	Female	Renal	2016	IV	13	0.9		No	Yes or Unknown			No	0	30.85		0
3279	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	7	2		No	No			Yes	0	36.17		0
3280	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	43	1.8		No	No			No	0	26.09		0
3281	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	III	0	3.5		No	No			No	1	22.31		0
3282	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	213	0.9		No	No			Yes	0	13.08		0
3283	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	121	3.5	Stable	No	Yes or Unknown			No	0	36.21		0
3284	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	31	2.6		No	No			No	0	34.79		0
3285	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	4.4	Stable	No	No			No	0	34.56		0
3286	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2016	IV	0	1.8		No	No			Yes	0	36.53		0
3287	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2016		25	4.4		Yes or Unknown	Yes or Unknown		ERCC4	Yes	0	9.13		0
3288	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	22	1.8		No	No		ARID1A	No	0	36.07		0
3289	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	38	13.2	Unstable	No	No	Signature.1	ARID1A | MRE11A	No	0	33.22		0
3290	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	5	1.8		No	No	Signature.5		Yes	0	34.92		0
3291	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	44	1.8		No	No			No	0	35.61		0
3292	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	III	14	7	Stable	No	Yes or Unknown		MRE11A	No	0	35.35		0
3293	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	58	0.9		No	No			No	0	37.09		0
3294	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	II	779	1.8	Stable	No	No			No	0	29.9		0
3295	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	III	0	4.4		No	No	Signature.13		No	0	33.38		0
3296	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	0	0.9		No	No			No	1	21.36		0
3297	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	II	51	7	Stable	No	No			No	0	30.82		0
3298	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	40	1.8		No	No			No	1	11.99		0
3299	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	3.5		No	No		ARID1A	No	0	36.07		0
3300	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	3	7	Stable	No	No		TP53BP1	No	0	8.38		0
3301	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	59	3.5		No	No			No	1	4.07		0
3302	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	III	61	1.8		No	No			Yes	0	34.99		0
3303	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	0	1.8		No	No			No	0	35.58		0
3304	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	81	0.9		No	No			No	0	34.73		0
3305	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	43	5.3	Stable	No	No			Yes	0	20.83		0
3306	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	617	7	Stable	No	Yes or Unknown	Signature.15		No	0	36.27		0
3307	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	8	5.3		No	No	Signature.7		No	0	35.48		0
3308	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	6	3.5		No	No		ATM	No	1	17.81		0
3309	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2016	II	54	3.5		No	No		ARID1A	No	0	36.37		0
3310	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	I	0	0.9		No	No			No	0	34.1		0
3311	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	28	0		No	Yes or Unknown			No	0	35.98		0
3312	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	33	4.4		No	Yes or Unknown			Yes	0	35.81		0
3313	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	30	12.3		No	No	Signature.4		Yes	1	3.78		0
3314	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	45	1.8		No	No		ATM	No	0	35.98		0
3315	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	I	0	0.9		No	No			Yes	0	35.32		0
3316	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	0.9		No	No			No	0	30.32		0
3317	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	10.5		No	No	Signature.3	MDC1	No	0	14.65		0
3318	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	74	6.1		No	Yes or Unknown	Signature.4	NBN	No	1	4.21		0
3319	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	1	0		No	No			No	0	35.65		0
3320	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	40	4.4	Stable	No	No	Signature.13	BRCA2	No	0	29.8		0
3321	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	18	7	Stable	No	No			No	1	13.47		0
3322	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	28	44.8	Stable	No	No	Signature.6	ARID1A | ATM | ERCC2 | MSH6	No	0	6.24		0
3323	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	44	6.1		No	No	Signature.4	BRIP1	Yes	0	26.78		0
3324	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	16	3.5	Stable	No	No			Yes	0	34.76		0
3325	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	21	3.5	Stable	No	No		BRIP1 | SLX4	Yes	0	2.83		0
3326	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	35	7.9	Stable	No	No		ARID1A	No	0	30.03		0
3327	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	38	0		No	No			No	0	3.25		0
3328	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	35	12.3		No	No	Signature.13	MSH6	Yes	0	35.84		0
3329	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	III	343	6.1	Stable	No	No			Yes	0	35.84		0
3330	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		40	2.6		No	No			No	1	26.87		0
3331	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	35	0	Stable	No	No			Yes	0	36.11		0
3332	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	16	3.5	Stable	No	Yes or Unknown			No	0	35.75		0
3333	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2016	IV	39	3.5	Stable	No	Yes or Unknown			Yes	0	35.45		0
3334	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	0	8.8		No	No	Signature.4		No	0	24.97		0
3335	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	212	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	11.43		0
3336	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	116	3.5	Stable	No	Yes or Unknown			No	0	36.07		0
3337	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3.5		No	No		ATM	No	0	35.22		0
3338	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	168	1.8	Stable	No	Yes or Unknown			No	0	33.77		0
3339	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2016		11	2.6		No	No			No	0	20.73		0
3340	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	1.8		No	No			No	1	22.37		0
3341	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	III	16	2.6	Stable	No	No			No	0	35.45		0
3342	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2016		2	1.8		No	No			No	0	31.97		0
3343	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2016	IV	61	0	Stable	No	Yes or Unknown			No	0	33.64		0
3344	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	35	15.8	Indeterminate	No	No	Signature.1	ARID1A	No	0	23.33		0
3345	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	IV	4	4.4		No	No		BRCA2	No	0	35.81		0
3346	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	27	5.3		No	Yes or Unknown	Signature.3		No	0	32.95		0
3347	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	166	1.8	Stable	No	Yes or Unknown	Signature.13		No	0	33.35		0
3348	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	29	3.5		No	No			Yes	1	4.04		0
3349	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	48	3.5		No	Yes or Unknown			No	0	7.39		0
3350	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	26	51.8	Unstable	No	No	Signature.26	ARID1A | ATM | MSH3 | MSH6 | PMS2	No	0	32.43		0
3351	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	24	5.3		No	No		RAD51C	Yes	1	2.96		0
3352	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	67	3.5		No	No	Signature.3	BRCA2	No	0	31.08		0
3353	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	0	0.9		No	No			No	0	30.85		0
3354	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	20	2.6	Stable	No	No			No	0	35.09		0
3355	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	46	4.4		No	No	Signature.19		No	0	32.43		0
3356	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2016	IV	0	1.8		No	No		RAD50	Yes	0	3.25		0
3357	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	84	2.6		No	No		PMS1	Yes	0	8.25		0
3358	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	0	1.8	Stable	No	No			No	1	28.32		0
3359	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	30	0	Stable	No	No			No	0	35.22		0
3360	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	26	1.8		No	No			No	0	34.3		0
3361	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	6	2.6		No	No		NBN	No	1	12.85		0
3362	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	14	20.2		No	No	Signature.13	BRCA1 | FANCA | MSH3 | RAD54L	Yes	1	3.55		0
3363	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	37	3.5		No	No			No	0	24.18		0
3364	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	232	4.4	Stable	No	No		BRCA1	No	0	40.74		0
3365	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	149	7.9	Stable	No	No		ATM	No	1	24.48		0
3366	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	309	6.1	Stable	No	Yes or Unknown	Signature.24		Yes	1	24.15		0
3367	Non-ICI treated	Never received ICI	41 - 45	Male	Cutaneous Melanoma 	2016	III	23	11.4		No	No	Signature.7		No	0	31.28		0
3368	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	160	4.4	Stable	No	Yes or Unknown		BRCA2 | MSH6	No	1	34.86		0
3369	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	51	7	Stable	No	No	Signature.1		No	0	35.42		0
3370	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	888	2.6	Stable	No	Yes or Unknown			No	0	34.92		0
3371	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	24	4.4		No	No			Yes	0	32.3		0
3372	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	IV	229	0	Stable	No	Yes or Unknown			No	1	12.55		0
3373	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	II	914	4.4	Stable	No	Yes or Unknown			No	0	35.58		0
3374	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	29	0.9		No	No			Yes	0	29.7		0
3375	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2016	II	383	5.3	Stable	No	Yes or Unknown			No	1	18.89		0
3376	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	12	12.3		No	No	Signature.2		No	0	24.97		0
3377	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	0	5.3		No	No			No	0	12.75		0
3378	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	15	4.4	Stable	No	No	Signature.1		No	0	21.16		0
3379	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	8	2.6		No	No			Yes	1	4.17		0
3380	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	21	9.7		No	No	Signature.18	ERCC5	Yes	0	4.8		0
3381	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	202	0	Stable	No	Yes or Unknown			No	0	33.91		0
3382	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	522	7	Indeterminate	No	Yes or Unknown	Signature.1	SLX4	No	0	35.52		0
3383	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	181	0.9	Stable	No	Yes or Unknown			No	0	34.76		0
3384	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	0	4.4		No	No		BRIP1	Yes	1	4.83		0
3385	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	32	4.4	Stable	No	No			No	0	8.67		0
3386	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	567	2.6	Stable	No	Yes or Unknown		BRCA2 | XRCC2	No	0	35.45		0
3387	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2016	IV	13	36.9		No	No	Signature.4	MDC1 | MLH1 | PARP1 | TP53BP1	No	1	7.1		0
3388	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	36	3.5		No	Yes or Unknown		PARP1	No	0	35.61		0
3389	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	0	8.8		No	No	Signature.2		No	0	28.94		0
3390	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	7		No	No	Signature.18	ARID1A	Yes	1	4.07		0
3391	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	III	56	15.8		No	No	Signature.2		No	0	33.51		0
3392	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	39	0		No	No			No	1	22.54		0
3393	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	41	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	35.42		0
3394	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	42	8.8	Stable	No	No		SLX4	No	1	25.99		0
3395	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	2	3.5	Stable	No	No			No	1	10.09		0
3396	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	50	5.3		No	No			Yes	0	36.01		0
3397	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	1.8	Stable	No	No			No	0	33.51		0
3398	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	29	2.6		No	No			No	0	33.02		0
3399	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	IV	0	0.9		No	No			Yes	0	35.75		0
3400	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	38	1.8		No	Yes or Unknown			No	0	35.68		0
3401	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	III	520	6.1	Stable	No	Yes or Unknown			No	0	33.87		0
3402	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	3	3.5		No	No			Yes	1	8.97		0
3403	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	39	1.8		No	No			No	0	32.89		0
3404	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	43	0.9		No	Yes or Unknown			No	0	32		0
3405	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	0	4.4	Stable	No	No			Yes	0	34		0
3406	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	38	1.8		No	No			No	0	35.61		0
3407	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.15		No	1	3.22		0
3408	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	0	120.2	Stable	No	No	Signature.10	ARID1A | ATR | BRCA2 | ERCC2 | ERCC3 | MSH2 | PARP1 | RAD51	No	0	32.82		0
3409	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	38	6.1		No	Yes or Unknown		BRCA1	No	0	36.14		0
3410	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2016	II	32	81.6	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | CHEK2 | ERCC2 | MSH3 | MSH6 | PALB2 | RAD50 | TP53BP1	No	1	18.17		0
3411	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	270	3.5	Stable	No	Yes or Unknown		ATM	No	0	34.23		0
3412	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	33	6.1		No	No	Signature.13		No	0	27.96		0
3413	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	22	3.5	Stable	No	No		SLX4	No	0	34.99		0
3414	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	0	11.4		No	No	Signature.1	ARID1A	No	1	2.27		0
3415	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	IV	0	11.4		No	Yes or Unknown	Signature.13	BRCA1	No	1	5.32		0
3416	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	46	0	Stable	No	Yes or Unknown			No	0	35.15		0
3417	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	I	47	0.9		No	No			No	0	20.67		0
3418	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	35	1.8		No	No			No	0	31.54		0
3419	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	41	9.7		No	No	Signature.6	FANCA | NBN	Yes	0	35.61		0
3420	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	87	2.6	Stable	No	Yes or Unknown		BRCA1	No	1	30.65		0
3421	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No	Signature.5		No	0	11.63		0
3422	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	11	2.6	Stable	No	No			No	1	28.12		0
3423	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	50	4.4	Stable	No	Yes or Unknown			No	0	33.91		0
3424	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2016	IV	0	2.6		No	No			Yes	1	3.12		0
3425	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	II	55	4.4		No	No			No	1	25.99		0
3426	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	44	0	Stable	No	No			No	0	29.86		0
3427	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	2.6	Stable	No	No	Signature.1		No	1	9.99		0
3428	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	377	3.5	Stable	No	Yes or Unknown			No	0	35.88		0
3429	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	0	2.6	Stable	No	No			No	0	35.15		0
3430	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	0	30.7		No	No	Signature.1	PMS1 | RAD50	No	0	30.36		0
3431	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	4	10.5	Stable	No	No	Signature.1	ARID1A	No	0	36.27		0
3432	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		99	0		No	No			No	0	21.39		0
3433	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	22	10.5	Stable	No	No	Signature.1		Yes	0	34		0
3434	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	59	1.8		No	No		MLH1	No	0	33.35		0
3435	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	55	3.5		No	No		ARID1A	No	0	29.44		0
3436	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	20	2.6		No	No			No	0	24.54		0
3437	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	IV	0	4.4	Stable	No	Yes or Unknown			No	1	34.46		0
3438	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	IV	31	3.5		No	Yes or Unknown			No	0	33.81		0
3439	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	0	7	Stable	No	No	Signature.1		No	0	34.17		0
3440	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	0	3.5		No	Yes or Unknown		BRCA2	No	0	34.46		0
3441	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	I	0	0		No	No			No	0	22.31		0
3442	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2016	IV	28	3.5		No	No			Yes	0	17.51		0
3443	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	5	4.4		No	No	Signature.1		No	1	29.5		0
3444	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	20	2.6		No	No		ARID1A	No	1	7.43		0
3445	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	3	8.8	Stable	No	No	Signature.1		Yes	0	34.76		0
3446	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	47	7.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	21.88		0
3447	Non-ICI treated	Never received ICI	46 - 50	Female	Head & Neck	2016	I	27	0		No	Yes or Unknown			Yes	0	32.59		0
3448	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	58	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	34.99		0
3449	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	13	82.5	Indeterminate	No	No	Signature.4	ATM | ATR | BRCA1 | ERCC5 | MDC1 | MSH6 | PARP1 | SLX4	No	0	22.08		0
3450	Non-ICI treated	Never received ICI	56 - 60	Female	Renal	2016	IV	130	2.6	Stable	No	Yes or Unknown			No	1	11.56		0
3451	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	0	0.9		No	No			Yes	0	9.72		0
3452	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	2.6		No	Yes or Unknown			No	1	15.31		0
3453	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2016	II	162	93.9	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | CHEK1 | ERCC3 | MSH2 | MSH3 | MSH6	Yes	0	30.52		0
3454	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2015	II	168	0.9		No	Yes or Unknown			Yes	0	16.13		0
3455	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	31	1.8		No	Yes or Unknown			Yes	0	24.61		0
3456	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	30	3.5		No	No			No	1	31.84		0
3457	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	3.5		No	No			No	1	7.2		0
3458	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2016	IV	21	1.8	Stable	No	Yes or Unknown			No	0	34.56		0
3459	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	1.8		No	Yes or Unknown		ATM	No	0	31.61		0
3460	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	0	3.5	Stable	No	No		RAD54L	No	1	8.11		0
3461	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	1.8		No	Yes or Unknown			Yes	0	30.29		0
3462	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2016	IV	198	1.8	Stable	No	Yes or Unknown			No	1	20.47		0
3463	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2016	III	0	8.8		No	No	Signature.29		Yes	0	32.62		0
3464	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	52	1.8		No	No			Yes	0	34.96		0
3465	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	209	7	Stable	No	Yes or Unknown			No	0	17.02		0
3466	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2017	I	7	50	Indeterminate	No	No	Signature.1	ARID1A | ERCC4 | FANCA | MSH2 | MSH3 | MSH6	No	0	30.52		0
3467	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	638	17.6	Stable	No	Yes or Unknown	Signature.4	ERCC3	No	1	26.55		0
3468	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2016	I	0	11.4		No	No	Signature.2	ERCC3	No	0	32.2		0
3469	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	III	673	1.8	Stable	No	Yes or Unknown			No	0	28.25		0
3470	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	42	2.6		No	Yes or Unknown			No	0	25.17		0
3471	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	III	0	13.2		No	No	Signature.13	ERCC2	Yes	0	10.28		0
3472	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	2	3.5	Stable	No	No	Signature.19	BRCA1	Yes	0	33.12		0
3473	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	21	7		No	Yes or Unknown	Signature.5		Yes	0	33.51		0
3474	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			Yes	0	35.45		0
3475	Non-ICI treated	Never received ICI	15-Nov	Female	Renal	2016	II	4	0		No	No			No	0	33.94		0
3476	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	0	4.4		No	Yes or Unknown	Signature.1		No	0	34.96		0
3477	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	19	0		No	Yes or Unknown			No	0	34.99		0
3478	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	1	20.96		0
3479	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	224	13.2		No	No	Signature.2	ERCC2	No	0	30.16		0
3480	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	11	2.6	Stable	No	Yes or Unknown			No	1	22.21		0
3481	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	19	6.1	Stable	No	No	Signature.6		Yes	1	12.85		0
3482	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	1	2.6		No	Yes or Unknown	Signature.1		No	0	34.4		0
3483	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	29	12.3		No	No	Signature.29	PMS1	Yes	1	15.18		0
3484	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	10	6.1		No	No	Signature.2		No	1	12.35		0
3485	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2016	IV	2	5.3		No	Yes or Unknown		BRCA2	Yes	0	34.14		0
3486	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2016	III	868	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	36.07		0
3487	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	167	4.4	Stable	No	No		ERCC4	No	0	32.16		0
3488	Non-ICI treated	Never received ICI	26 - 30	Male	Hepatobiliary	2016	II	737	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	36.6		0
3489	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	IV	19	0		No	No			Yes	1	4.3		0
3490	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	0	1.8	Stable	No	No			No	0	33.12		0
3491	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	429	2.6	Stable	No	Yes or Unknown			No	0	40.02		0
3492	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	10	7.9	Stable	No	No	Signature.1		No	1	18.07		0
3493	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2016		1	0.9		No	Yes or Unknown	Signature.1		No	0	34.73		0
3494	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	0	4.4	Stable	No	No	Signature.13		No	1	21.03		0
3495	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	2.6		No	No			No	1	15.05		0
3496	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	0	0.9		No	Yes or Unknown			No	0	33.94		0
3497	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	0	5.3	Stable	No	No	Signature.3		No	0	35.12		0
3498	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	II	92	4.4		No	Yes or Unknown			No	0	34.66		0
3499	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	54	5.3		No	Yes or Unknown	Signature.5		No	0	35.48		0
3500	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	99	2.6	Stable	No	No			Yes	0	35.78		0
3501	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	30	4.4		No	No	Signature.3		No	0	29.5		0
3502	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	19	0.9		No	No			Yes	0	32.33		0
3503	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	I	22	10.5		No	No	Signature.13	BRCA2 | RAD51C	No	1	28.48		0
3504	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	IV	1	2.6		No	Yes or Unknown		ATM	No	0	35.15		0
3505	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	34	16.7		No	No	Signature.13	MSH2 | SLX4	No	0	34.53		0
3506	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2016	IV	62	9.7		No	Yes or Unknown	Signature.24		Yes	1	6.24		0
3507	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	2.6		No	No			Yes	0	17.28		0
3508	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	IV	22	2.6	Stable	No	Yes or Unknown			No	1	23.43		0
3509	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	30	0.9		No	No			No	0	32.03		0
3510	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2016	II	0	2.6		No	No			No	0	32.49		0
3511	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	51	4.4		No	Yes or Unknown		ARID1A	No	0	34.69		0
3512	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	III	841	5.3	Stable	No	No	Signature.30		No	0	34.27		0
3513	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	0	6.1		No	No			No	0	34.79		0
3514	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	IV	62	6.1	Stable	No	No			No	0	34.17		0
3515	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	19	4.4		No	No			No	1	18.1		0
3516	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	0	1.8		No	Yes or Unknown			No	0	37.55		0
3517	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	33	1.8		No	Yes or Unknown			No	0	32.2		0
3518	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	585	2.6	Stable	No	Yes or Unknown			No	0	35.09		0
3519	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	25	98.3	Stable	No	No	Signature.10	ARID1A | ATM | BRCA2 | CHEK2 | ERCC5 | MLH1 | MSH6 | NBN	No	0	34.73		0
3520	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	902	3.5	Stable	No	Yes or Unknown			No	0	32.56		0
3521	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	9	10.5		No	No	Signature.1	BRCA2	No	0	19.12		0
3522	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	49	3.5		No	No			Yes	0	34.99		0
3523	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2016	III	36	4.4	Stable	No	No			Yes	0	34.83		0
3524	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	35	6.1		No	No			No	1	10.71		0
3525	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2.6		No	No			No	0	23		0
3526	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	41	73.7	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC4 | ERCC5 | MDC1 | MRE11A | MSH6	No	0	33.41		0
3527	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	209	6.1	Stable	No	No			Yes	0	13.86		0
3528	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	25	3.5		No	No			No	0	27.37		0
3529	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	24	2.6	Stable	No	Yes or Unknown			No	0	34.86		0
3530	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	II	33	9.7		No	No	Signature.4		Yes	0	31.21		0
3531	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	64	6.1		No	No	Signature.24	CHEK2	No	1	3.19		0
3532	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	II	16	4.4		No	No		BRIP1	No	0	34.43		0
3533	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	630	3.5	Stable	No	Yes or Unknown	Signature.3	FANCA	Yes	0	24.94		0
3534	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	III	11	1.8		No	No			No	0	33.12		0
3535	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	40	1.8		No	No			No	0	7.79		0
3536	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	37	265.9	Indeterminate	No	No	Signature.10	ARID1A | ATM | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC2 | ERCC4 | ERCC5 | MDC1 | MRE11A | MSH2 | MSH6 | PARP1 | PMS2 | RAD54L | SLX4 | TP53BP1	Yes	0	31.05		0
3537	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	II	63	7.9	Stable	No	No	Signature.1		No	0	16.79		0
3538	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	71	7		No	No	Signature.13		No	0	35.71		0
3539	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	I	0	0.9		No	No			No	0	31.97		0
3540	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.3		Yes	0	34.43		0
3541	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2016	IV	0	5.3		No	No		ARID1A | BRCA2	No	0	34.53		0
3542	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	0	2.6		No	No			No	0	32.43		0
3543	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	0	6.1	Stable	No	No			No	1	12.85		0
3544	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	12	5.3	Stable	No	No			No	0	33.71		0
3545	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	1.8		No	Yes or Unknown			No	1	25.72		0
3546	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2016	IV	0	0.9		No	No			No	1	5.42		0
3547	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	21	0.9		No	No		NTHL1	No	0	34.53		0
3548	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2016	IV	0	7		No	Yes or Unknown	Signature.18	ARID1A	No	1	14.29		0
3549	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	11.4		No	No	Signature.3		Yes	1	2.66		0
3550	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	31	2.6	Stable	No	No			No	0	23.79		0
3551	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			No	1	11.96		0
3552	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	7		No	No			No	0	24.57		0
3553	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	33	1.8		No	No			No	0	29.34		0
3554	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	15	8.8	Stable	No	No	Signature.6		No	0	10.48		0
3555	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	10	10.5	Stable	No	No	Signature.1		No	1	12.75		0
3556	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	19	3.5		No	No			Yes	0	20.11		0
3557	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	15	7		No	No	Signature.4	ATR	No	1	2.99		0
3558	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	22	9.7	Stable	No	No			No	0	31.51		0
3559	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	7	2.6	Stable	No	Yes or Unknown			No	0	33.48		0
3560	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	488	0.9	Stable	No	Yes or Unknown			No	0	34.17		0
3561	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	III	34	7.9		No	No	Signature.4		Yes	0	28.78		0
3562	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	14	7		No	No	Signature.2	NBN	No	0	34.76		0
3563	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	77	1.8		No	No			No	0	20.4		0
3564	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	27	1.8		No	No			No	0	34.1		0
3565	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	32	4.4	Stable	No	No			Yes	0	34.79		0
3566	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	0	2.6		No	No	Signature.5		No	0	10.71		0
3567	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	2.6		No	No			No	0	28.22		0
3568	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	0.9	Stable	No	No			No	1	26.05		0
3569	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	28	1.8		No	No			Yes	0	34.23		0
3570	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	1.8		No	No			No	0	34.04		0
3571	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			Yes	1	28.81		0
3572	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	33	5.3	Stable	No	No			Yes	0	31.74		0
3573	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	III	45	2.6	Stable	No	No			No	1	30		0
3574	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		0	4.4	Stable	No	No			No	0	12.68		0
3575	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	0	7		No	No	Signature.4	ATM	Yes	0	34.07		0
3576	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	30	4.4		No	No		ATM	No	0	31.74		0
3577	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	0	10.5	Stable	No	No	Signature.17	PMS1	Yes	0	24.64		0
3578	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	12.06		0
3579	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	I	289	6.1	Stable	No	Yes or Unknown			Yes	0	35.02		0
3580	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	III	0	32.5		No	No	Signature.4	MRE11A	No	0	34.1		0
3581	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		16	3.5		Yes or Unknown	Yes or Unknown			Yes	1	3.52		0
3582	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	721	0		No	Yes or Unknown			No	1	30.69		0
3583	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	II	20	6.1		No	No	Signature.8	BRIP1	Yes	0	33.08		0
3584	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	26	1.8		No	No			No	0	33.22		0
3585	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	0	4.4	Stable	No	No	Signature.1	PARP1	No	0	34.63		0
3586	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	0	0		No	No	Signature.1		No	0	29.11		0
3587	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	52	1.8		No	No			No	0	30.16		0
3588	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	25	0.9		No	No			Yes	0	29.4		0
3589	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	834	7	Stable	No	Yes or Unknown	Signature.1		No	0	33.51		0
3590	Non-ICI treated	Never received ICI	31 - 35	Male	NSCLC	2016	IV	0	9.7		No	No	Signature.13		No	1	17.74		0
3591	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	5.3		No	No			No	1	23.52		0
3592	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	254	1.8	Stable	No	Yes or Unknown			No	1	16.85		0
3593	Non-ICI treated	Never received ICI	36 - 40	Female	Hepatobiliary	2016	IV	0	3.5		No	Yes or Unknown		ATM	No	0	34.3		0
3594	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2016	IV	14	4.4		No	No			No	1	7.66		0
3595	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	165	0	Stable	No	No			No	0	32.23		0
3596	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	II	113	7		No	Yes or Unknown	Signature.18		Yes	0	32.1		0
3597	Non-ICI treated	Never received ICI	66 - 70	Female	Esophageal	2016	II	362	4.4	Stable	No	No	Signature.5		No	0	23.69		0
3598	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	13	2.6		No	No			Yes	0	30.32		0
3599	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	430	1.8	Stable	No	Yes or Unknown			No	1	29.37		0
3600	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	I	32	2.6		No	No			No	0	33.97		0
3601	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	III	0	1.8	Stable	No	No			No	1	9.1		0
3602	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	28	5.3		No	No			No	0	7.2		0
3603	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	122	0		No	Yes or Unknown			Yes	0	18.69		0
3604	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	824	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	34.89		0
3605	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	31	2.6		No	No			No	0	33.74		0
3606	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	51	6.1	Stable	No	No		SLX4	No	0	31.9		0
3607	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	0	0.9		No	Yes or Unknown			No	0	24.64		0
3608	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	42	0		No	No			Yes	0	23.23		0
3609	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	70	1.8		No	No			No	0	34.46		0
3610	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	IV	206	7	Stable	No	Yes or Unknown			No	0	34.66		0
3611	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2016	IV	0	12.3		No	No	Signature.21	NBN	No	1	2.83		0
3612	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.6		No	1	25.13		0
3613	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown			No	1	11.07		0
3614	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	654	6.1	Stable	No	Yes or Unknown	Signature.1	MDC1	No	0	34.89		0
3615	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	34	7		No	No		FANCA	No	0	29.5		0
3616	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	3.5	Stable	No	No		ERCC5	No	1	27.99		0
3617	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	91	8.8	Stable	No	No	Signature.1	ATM	No	0	34.6		0
3618	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	2.6	Stable	No	No		BRCA2	No	1	28.62		0
3619	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	0	2.6	Stable	No	No	Signature.3		No	0	33.94		0
3620	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	137	29.8		No	Yes or Unknown	Signature.4		Yes	0	5.82		0
3621	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	IV	40	49.2	Unstable	No	No	Signature.6	ARID1A | ATR | ERCC5 | FANCA | PALB2 | RAD54L	No	1	6.01		0
3622	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	2.6		No	No			No	0	28.68		0
3623	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	582	0.9	Stable	No	Yes or Unknown			No	0	24.97		0
3624	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	I	188	2		No	No			No	0	32.92		0
3625	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	0	0		No	No			No	0	25.36		0
3626	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	0.9		No	No			No	0	28.75		0
3627	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	30	0.9		No	No			No	0	34		0
3628	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	2.6		No	No			No	0	29.21		0
3629	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2016	IV	0	0.9		No	No			No	0	34.4		0
3630	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	40	1.8		No	No			Yes	0	30.36		0
3631	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	18	54.4	Unstable	No	No	Signature.6	ARID1A | BRCA1 | MSH3 | MUTYH | RAD50 | TP53BP1	No	0	2.07		0
3632	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	23	0.9		No	No			Yes	0	31.7		0
3633	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2016	IV	224	0	Stable	No	Yes or Unknown			No	0	8.48		0
3634	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016		0	2.6		No	No			No	1	9.49		0
3635	Non-ICI treated	Never received ICI	46 - 50	Male	Bladder	2016	II	0	3.5		No	No	Signature.19	BRCA2	Yes	0	29.47		0
3636	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	II	39	1.8		No	No			No	0	34.96		0
3637	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	15	0		No	No			No	0	26.87		0
3638	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	33	12.3		No	No	Signature.8		No	0	32.59		0
3639	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	15	3.5	Stable	No	No			No	0	34.07		0
3640	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	33	3.5		No	No			Yes	0	34.43		0
3641	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	III	17	5.3	Stable	No	No		MUTYH	Yes	0	33.15		0
3642	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	966	3.5	Stable	No	No	Signature.13		No	0	32.85		0
3643	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	70	0	Stable	No	No			No	0	34.33		0
3644	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	14	3.5	Stable	No	No		ERCC4	No	1	12.81		0
3645	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	191	5.3	Stable	No	Yes or Unknown	Signature.1		Yes	1	7.98		0
3646	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	0	5.3	Stable	No	No	Signature.3	MUTYH	No	0	33.22		0
3647	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2016	IV	74	1.8		No	No			No	1	34.3		0
3648	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	III	5	105.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC4 | MSH2 | MSH6 | PALB2 | SLX4	No	0	34.2		0
3649	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	II	42	5.3		No	No			No	0	25.89		0
3650	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	I	0	7.9	Stable	No	No	Signature.4		No	0	32.69		0
3651	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2016	III	938	9.7	Stable	No	Yes or Unknown	Signature.1	ATR	No	0	34.6		0
3652	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2016	IV	1	2.6		No	No			Yes	0	16		0
3653	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	II	0	0.9		No	No			No	0	7.43		0
3654	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	IV	18	12.3		No	No	Signature.4	MSH2	Yes	1	7.89		0
3655	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	I	323	0.9	Stable	No	Yes or Unknown			Yes	0	19.09		0
3656	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	109	2.6	Stable	No	Yes or Unknown			No	1	5.29		0
3657	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	53	0.9		No	No			No	0	30.46		0
3658	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2016	III	136	1.8		No	Yes or Unknown		BRCA1	No	0	34.69		0
3659	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	I	0	4.4	Stable	No	No		CHEK2	No	0	23.39		0
3660	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	296	18.4	Stable	No	Yes or Unknown	Signature.29	ATM | ERCC2	Yes	0	17.08		0
3661	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	III	15	1.8	Stable	No	No			Yes	0	33.51		0
3662	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	216	21.1	Stable	No	No	Signature.6	ARID1A | ATM | MLH1	No	0	32.89		0
3663	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		13	3.5		Yes or Unknown	Yes or Unknown			No	1	4.8		0
3664	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	III	977	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	34.07		0
3665	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	40	0.9		No	No			Yes	0	16.59		0
3666	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	IV	7	3.5		No	No	Signature.1	ATM	No	1	9.99		0
3667	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	88	1.8	Stable	No	No			No	0	30.82		0
3668	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	375	6.1	Stable	No	Yes or Unknown	Signature.30		Yes	1	18.27		0
3669	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	48	1.8	Stable	No	No			Yes	0	31.87		0
3670	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	28	2.6		No	No			Yes	0	32.3		0
3671	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	203	0.9		No	No			No	0	39.66		0
3672	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	3.5		No	No			Yes	1	18.76		0
3673	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	II	6	3.5		No	No			Yes	0	32		0
3674	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	41	0.9		No	No			No	0	33.97		0
3675	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	0	3.5		No	No			No	1	11.63		0
3676	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	59	1.8	Stable	No	No			No	0	34.14		0
3677	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No			Yes	0	33.51		0
3678	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	3.5		No	No		TP53BP1	Yes	0	29.73		0
3679	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	53	0.9		No	No			Yes	0	30.62		0
3680	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	49	2.6	Stable	No	No			No	1	24.51		0
3681	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	27	4.4		No	Yes or Unknown			No	0	33.31		0
3682	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	23	3.5		No	No		ARID1A	Yes	0	29.77		0
3683	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		12	6.1		Yes or Unknown	Yes or Unknown			Yes	0	34.63		0
3684	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	20	6.1	Stable	No	No	Signature.3		Yes	0	34.17		0
3685	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	20	0.9		No	No			No	0	29.54		0
3686	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	54	2.6		No	Yes or Unknown			No	0	32.85		0
3687	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	0	7	Stable	No	No	Signature.1	ARID1A	Yes	0	19.88		0
3688	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	37	4.4	Stable	No	No			No	0	35.42		0
3689	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	194	3.5	Stable	No	Yes or Unknown			No	0	34		0
3690	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	40	4.4	Stable	No	No			No	0	33.84		0
3691	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2016	IV	0	4.4	Stable	No	No	Signature.1	ATR	Yes	1	2.79		0
3692	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2016	IV	0	0		No	No		CHEK2	No	1	10.68		0
3693	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	I	0	0		No	No		CHEK2	No	0	31.05		0
3694	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2016		41	1.8		Yes or Unknown	Yes or Unknown			Yes	0	34.04		0
3695	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	3	1.8		No	No			Yes	1	3.22		0
3696	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	2.6		No	No	Signature.15		No	1	32.56		0
3697	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	57	1.8		No	No			No	0	33.15		0
3698	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	IV	27	2.6		No	Yes or Unknown			No	1	6.01		0
3699	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	140	1.8		No	Yes or Unknown			No	0	37.55		0
3700	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	61	4.4		No	Yes or Unknown			No	0	13.7		0
3701	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	55	37.7	Unstable	No	No	Signature.6	ARID1A | ATR | BLM | ERCC5 | MSH3 | MSH6	No	0	34.17		0
3702	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	707	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	33.28		0
3703	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	29	2.6		No	No			No	0	30.85		0
3704	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	16	51.8	Unstable	No	No	Signature.6	ATM | ATR | RAD50 | RAD51	Yes	0	31.61		0
3705	Non-ICI treated	Never received ICI	10-Jun	Male	Renal	2016	IV	0	0		No	No			No	1	10.68		0
3706	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	0	1.8		No	No			No	0	23.79		0
3707	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	130	1.8	Stable	No	No			No	0	33.77		0
3708	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	5.3		No	Yes or Unknown			No	0	33.97		0
3709	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	34	7.9	Stable	No	No	Signature.13		Yes	0	33.74		0
3710	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2016	I	47	37.7	Unstable	No	No	Signature.6	BLM | BRCA1 | BRIP1 | MRE11A | SLX4	No	0	28.45		0
3711	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown	Signature.3		No	1	30.78		0
3712	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	40	3.5		No	Yes or Unknown			No	0	31.47		0
3713	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	I	0	3.5	Stable	No	No		BRCA2	No	0	33.38		0
3714	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		137	2.6		Yes or Unknown	Yes or Unknown			No	1	10.68		0
3715	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	718	7.9	Stable	No	Yes or Unknown	Signature.13		No	1	27.99		0
3716	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	I	0	0.9		No	No			No	0	30.78		0
3717	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2016	III	14	0.9		No	Yes or Unknown			Yes	0	33.38		0
3718	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	764	9.7	Stable	No	Yes or Unknown	Signature.3	CHEK1 | FANCA	No	0	31.7		0
3719	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	6	6.1		No	No			No	0	34.1		0
3720	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	52	3.5		No	No		ARID1A	Yes	0	33.41		0
3721	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2016	IV	0	6.1		No	No			No	1	6.8		0
3722	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		736	2.6	Stable	No	No		RAD50	No	0	32.16		0
3723	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	IV	195	9.7	Stable	No	Yes or Unknown		ARID1A	No	0	11.24		0
3724	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	II	0	1.8	Stable	No	No			No	0	32.2		0
3725	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	31	5.3		No	No		PALB2	No	0	10.91		0
3726	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	288	3.5	Stable	No	Yes or Unknown	Signature.3		No	1	11.27		0
3727	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	494	4.4	Stable	No	Yes or Unknown			No	0	33.48		0
3728	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	14	5.3	Stable	No	No	Signature.1	BRIP1 | MDC1	No	0	33.91		0
3729	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	40	4.4		No	Yes or Unknown			No	0	33.58		0
3730	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	7		No	No			No	0	23.06		0
3731	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	31	3.5		No	No			Yes	0	33.58		0
3732	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	II	29	1.8	Stable	No	Yes or Unknown			No	0	28.25		0
3733	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	24	4.4	Stable	No	Yes or Unknown		BLM	No	0	33.54		0
3734	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	II	21	5.3	Stable	No	No			Yes	0	21.39		0
3735	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	1014	15.8	Stable	No	Yes or Unknown	Signature.4	CHEK2	No	0	35.91		0
3736	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	0	0	Stable	No	Yes or Unknown			No	1	7.49		0
3737	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	29	7		No	No			No	0	32.43		0
3738	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2016	I	59	49.2	Stable	No	No	Signature.10	ATM | BLM | BRCA2 | CHEK2 | MSH6 | PALB2	No	0	24.94		0
3739	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		55	0		No	No			No	0	12.58		0
3740	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	0	7.9		No	No	Signature.4		No	0	24.54		0
3741	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	0	4.4	Stable	No	No			No	0	12.16		0
3742	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	III	0	3.5		No	No	Signature.5		No	1	17.28		0
3743	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2016	I	0	5.3	Stable	No	No			No	1	24.54		0
3744	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	21	2.6		No	Yes or Unknown			No	0	24.18		0
3745	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	3.5		No	No			No	1	18.07		0
3746	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	30	3.5		No	Yes or Unknown			No	0	33.84		0
3747	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	233	2.6	Stable	No	No			Yes	0	34.2		0
3748	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2016		11	4.4		No	No			Yes	0	30.88		0
3749	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016		692	1.8	Stable	No	No			No	0	32.92		0
3750	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	I	84	7.9	Stable	No	No	Signature.21	ERCC5 | FANCA | MSH3	No	0	31.93		0
3751	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	0	1.8	Stable	No	No			No	1	19.19		0
3752	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	0	2.6	Stable	No	Yes or Unknown			No	0	33.25		0
3753	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	92	0.9	Stable	No	No			No	0	32.13		0
3754	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	119	9.7	Stable	No	Yes or Unknown	Signature.4	ATR	No	0	33.87		0
3755	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2016	IV	20	0		No	No			Yes	0	33.08		0
3756	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	24	0.9		No	No		PMS2	No	0	33.25		0
3757	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	8	0.9		No	Yes or Unknown			No	0	33.87		0
3758	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	11	5.3		No	Yes or Unknown		BRCA2	No	0	27.27		0
3759	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016		0	0		No	No			No	0	30		0
3760	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	15	0		No	No			No	0	32.79		0
3761	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	25	3.5		No	No			No	0	29.67		0
3762	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	24	6.1	Stable	No	No	Signature.1		No	0	33.68		0
3763	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	29	6.1		No	No	Signature.1		No	1	10.74		0
3764	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2016	IV	66	7.9		No	Yes or Unknown	Signature.4		Yes	0	8.21		0
3765	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	I	22	6.1		No	No	Signature.24		No	0	26.78		0
3766	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	IV	191	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	24.25		0
3767	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	136	43.9		No	No	Signature.4	BRCA1 | ERCC3	No	0	32.69		0
3768	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	II	91	2.6		No	No			No	1	29.24		0
3769	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	8	11.4		No	Yes or Unknown	Signature.26	FANCA	No	0	33.22		0
3770	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	44	1.8	Stable	No	No			No	0	32.39		0
3771	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	55	3.5		No	No			Yes	0	32.95		0
3772	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	0	11.4	Stable	No	No	Signature.18	ARID1A | PALB2	No	0	20.99		0
3773	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	28	4.4	Stable	No	No			No	0	31.31		0
3774	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2016	IV	32	7.9		No	No	Signature.4	FANCA	Yes	0	17.91		0
3775	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	0	18.4		No	No	Signature.4		No	0	2.73		0
3776	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	5	10.5		No	No	Signature.4	BLM	Yes	0	34.17		0
3777	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		2	3.5		Yes or Unknown	Yes or Unknown		BRCA2	No	1	24.44		0
3778	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	327	21.9	Stable	No	Yes or Unknown	Signature.2	ATM | BLM | PMS1	No	0	33.54		0
3779	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	0	6.1	Stable	No	No		BRCA1	No	1	15.51		0
3780	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	0	2.6	Stable	No	No			No	1	33.61		0
3781	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	0.9		No	No			No	1	8.34		0
3782	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	II	105	0		No	Yes or Unknown			No	0	33.25		0
3783	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	III	0	0.9		No	No		MUTYH	No	1	19.12		0
3784	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	0	5.3		No	No	Signature.3		Yes	1	3.25		0
3785	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016	III	0	1.8	Stable	No	No			No	0	31.21		0
3786	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	13	4.4	Stable	No	No			No	1	21.65		0
3787	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	IV	31	1.8		No	Yes or Unknown			No	0	33.68		0
3788	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	63	2.6		No	No			Yes	0	31.47		0
3789	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	0.9	Stable	No	No			No	0	33.15		0
3790	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	0	3.5	Stable	No	No			No	1	18.76		0
3791	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	I	17	2.6		No	No			No	0	30.55		0
3792	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	26	12.3		No	No	Signature.4		No	1	2.37		0
3793	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	17	7.9	Stable	No	No		ARID1A	Yes	0	30.29		0
3794	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	26	0.9		No	Yes or Unknown			Yes	0	33.51		0
3795	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	43	5.9		No	Yes or Unknown		ARID1A | BRCA2	No	0	33.51		0
3796	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	III	0	2.6	Stable	No	No			Yes	0	29.93		0
3797	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	28	0.9		No	No			Yes	1	7.69		0
3798	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2016		176	0	Stable	No	No			No	0	16.92		0
3799	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	III	30	4.4		No	No			No	0	32.99		0
3800	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	236	0	Stable	No	Yes or Unknown			No	0	33.12		0
3801	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	37	2.6		No	No	Signature.13		Yes	1	3.48		0
3802	Non-ICI treated	Never received ICI	91 - 95	Female	Cutaneous Melanoma 	2016	II	308	2.6	Stable	No	No	Signature.5		No	0	33.77		0
3803	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	35	0.9		No	No			No	0	25.43		0
3804	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2016	II	9	3.5		No	Yes or Unknown			Yes	0	34.04		0
3805	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	41	1.8		No	Yes or Unknown			No	0	34.3		0
3806	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	0	2.6		No	No			Yes	0	32.07		0
3807	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	65	0	Stable	No	No			No	0	30.23		0
3808	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	2.6		No	No	Signature.5		No	0	33.64		0
3809	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	27	4.4	Stable	No	No			Yes	0	33.61		0
3810	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	8	7		No	No		ARID1A	No	0	32.95		0
3811	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	III	0	5.3	Stable	No	No			No	0	31.84		0
3812	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016		0	1.8		No	Yes or Unknown			No	0	17.38		0
3813	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	IV	55	1.8	Stable	No	No			Yes	0	6.44		0
3814	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	II	0	1.8		No	No			Yes	0	29.11		0
3815	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	39	23.7	Unstable	No	No	Signature.6	MRE11A | SLX4	No	1	30.92		0
3816	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	III	30	7	Stable	No	No	Signature.1	MDC1	No	0	33.94		0
3817	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	28	0.9		No	No			No	1	7.72		0
3818	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2016	IV	14	7		No	No		ATM	No	1	9.53		0
3819	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	48	2.6		No	No		BRCA1	Yes	0	32.43		0
3820	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2016	II	0	1.8		No	No			No	0	12.16		0
3821	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	41	4.4		No	No		ARID1A	Yes	0	32.69		0
3822	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	15	7.9		No	No	Signature.1	ARID1A	No	1	6.18		0
3823	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	III	0	0.9		No	No			No	0	33.08		0
3824	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	56	9.7	Stable	No	Yes or Unknown		BRCA2 | FANCA | MSH2	No	0	31.67		0
3825	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2015	II	470	1.8		No	No		PMS2	No	0	27.4		0
3826	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	117	5.3	Stable	No	No			Yes	0	34.53		0
3827	Non-ICI treated	Never received ICI	61 - 65	Male	Breast	2016	III	42	1.8		No	No			No	0	32.85		0
3828	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	III	99	10.5	Stable	No	No	Signature.2		Yes	1	22.64		0
3829	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	95	1.8		No	Yes or Unknown			No	0	28.71		0
3830	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	0	5.3	Indeterminate	No	No			Yes	1	9.69		0
3831	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		5	2.6		Yes or Unknown	Yes or Unknown			Yes	0	32.23		0
3832	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	30	1.8		No	No			No	0	24.64		0
3833	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	II	176	2.6	Stable	No	Yes or Unknown			No	1	27.3		0
3834	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	25	1.8		No	No		MUTYH	No	0	14.26		0
3835	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	2	4.4	Stable	No	No			No	0	26.28		0
3836	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2016	I	42	3.5		No	No			No	0	14.55		0
3837	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	III	21	1.8		No	No			No	0	32.79		0
3838	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	II	56	0		No	No			No	0	33.45		0
3839	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	183	0.9	Stable	No	No			No	1	21.75		0
3840	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	22	3.5		No	No			Yes	0	33.38		0
3841	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	78	13.2		No	Yes or Unknown	Signature.4	ARID1A	Yes	0	29.96		0
3842	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2016		2	0		No	No			No	1	28.06		0
3843	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2016	IV	30	1.8		No	No			No	1	10.22		0
3844	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	3.5	Stable	No	No	Signature.5	BRCA1	No	0	33.51		0
3845	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2015	IV	76	0.9	Stable	No	Yes or Unknown			No	1	20.83		0
3846	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2016	II	108	0	Stable	No	Yes or Unknown			No	0	32.07		0
3847	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	22	7	Stable	No	No		ATM	No	0	33.22		0
3848	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	17	0		No	No			No	0	29.5		0
3849	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2016	IV	20	14.9		No	No	Signature.13	ATR | ERCC2	No	0	31.01		0
3850	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	39	1.8		No	No			Yes	0	28.52		0
3851	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	77	6.1		No	No			No	0	32.82		0
3852	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	0	3.5		No	No			Yes	0	32.92		0
3853	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	18	0		No	Yes or Unknown			Yes	0	29.96		0
3854	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	0.9		No	No			No	0	29.9		0
3855	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	0	2.6		No	No			No	0	34		0
3856	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	99	0		No	Yes or Unknown			Yes	0	28.81		0
3857	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	III	0	0.9		No	No			No	0	32.69		0
3858	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	25	2.6	Stable	No	No			Yes	0	21.65		0
3859	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	32	2.6		No	Yes or Unknown			No	0	25.4		0
3860	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	42	0.9		No	No			Yes	0	30.65		0
3861	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2016	IV	0	0.9	Stable	No	Yes or Unknown			No	0	23.59		0
3862	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2016		28	1.8		No	No			Yes	0	29.77		0
3863	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	0	2.6		No	No			No	0	33.31		0
3864	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	IV	43	14		No	No	Signature.4	ERCC5 | XRCC2	No	1	4.86		0
3865	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2016		43	0.9		No	No			No	0	6.97		0
3866	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	65	3.9		No	No			Yes	0	33.28		0
3867	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2016	I	413	0.9	Stable	No	Yes or Unknown			No	1	14.69		0
3868	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2016		187	2.6	Stable	No	Yes or Unknown			No	1	11.4		0
3869	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2016	II	75	0.9		No	No			Yes	0	32.39		0
3870	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	2.6	Stable	No	No			No	0	34.76		0
3871	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	8.8		No	No	Signature.2	MSH6	No	1	5.55		0
3872	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	26	2.6		No	No			Yes	0	28.25		0
3873	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	4.4		No	No	Signature.1		Yes	0	31.74		0
3874	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	0	2.6		No	No			Yes	1	7.98		0
3875	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	33.77		0
3876	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	0	0	Stable	No	No			No	0	32.13		0
3877	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	29	4.4		No	Yes or Unknown	Signature.3	BRCA2 | ERCC2	No	0	33.35		0
3878	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	33.35		0
3879	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	36	1.8	Stable	No	No			No	0	33.05		0
3880	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	21	5.3	Stable	No	No		ARID1A	No	0	25.36		0
3881	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	100	2.6	Stable	No	No			No	0	22.54		0
3882	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	32	7.9		No	No	Signature.3		No	0	31.74		0
3883	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	42	5.3		No	No		BRIP1	No	0	26.18		0
3884	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	125	0.9	Stable	No	Yes or Unknown			No	1	23.16		0
3885	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	III	0	0.9	Stable	No	No			No	1	14.19		0
3886	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		8	3.5		No	No			No	1	4.27		0
3887	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	161	9.7	Stable	No	Yes or Unknown	Signature.1	ATR	No	0	35.38		0
3888	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	III	25	2.6	Stable	No	No			Yes	0	32.2		0
3889	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	III	142	3.5	Stable	No	No			No	0	32.49		0
3890	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2016	II	110	7.9	Stable	No	No	Signature.2		No	0	16.92		0
3891	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	48	5.3	Stable	No	No	Signature.1	ERCC3	Yes	0	33.28		0
3892	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2016	IV	59	5.3		No	No		MSH6	No	0	31.44		0
3893	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	40	3.5		No	Yes or Unknown			No	0	33.12		0
3894	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	25	3.5		No	No			No	0	33.15		0
3895	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	II	0	6.1		No	No		MLH1 | NBN	No	1	28.94		0
3896	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	II	126	4.4		No	No			No	1	24.9		0
3897	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016	I	0	0		No	No			Yes	0	29.57		0
3898	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	64	0.9		No	Yes or Unknown			No	0	33.15		0
3899	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	29	2.6		No	Yes or Unknown		ARID1A	No	0	32.85		0
3900	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2016		18	6.1		Yes or Unknown	Yes or Unknown	Signature.3	MRE11A	Yes	1	2.6		0
3901	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	28	6.9		No	Yes or Unknown	Signature.4	ATM	Yes	0	26.55		0
3902	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2016	III	22	5.3	Stable	No	No		BRCA1	Yes	0	28.02		0
3903	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	II	0	4.4		No	No			No	0	31.15		0
3904	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2016	IV	219	4.4	Indeterminate	No	Yes or Unknown	Signature.1		No	1	22.67		0
3905	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	832	7	Stable	No	Yes or Unknown	Signature.16	MLH1	No	0	33.54		0
3906	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	II	0	1.8		No	No			Yes	0	33.68		0
3907	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	868	0.9	Stable	No	Yes or Unknown			No	0	32.16		0
3908	Non-ICI treated	Never received ICI	66 - 70	Male	Head & Neck	2016	IV	32	3.5	Stable	No	No			No	0	32.72		0
3909	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	23	2.6		No	No			No	0	28.58		0
3910	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	IV	0	4.4		No	Yes or Unknown	Signature.13		No	0	32.95		0
3911	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	29	2.6		No	Yes or Unknown			No	0	32.43		0
3912	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	34	4.4	Stable	No	Yes or Unknown			No	0	34.76		0
3913	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	III	42	0.9		No	No			No	0	17.38		0
3914	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2016	IV	20	4.4		No	No			Yes	1	2.46		0
3915	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.1		No	1	19.91		0
3916	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	I	154	4.4	Stable	No	Yes or Unknown	Signature.24		No	0	32.07		0
3917	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	33	12.3		No	No	Signature.29	MDC1	Yes	1	9.23		0
3918	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	20	2.6	Stable	No	No			No	1	8.25		0
3919	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	21	2.6		No	No		ATM	No	0	32.62		0
3920	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	IV	1	1.8		No	No	Signature.19		No	1	12.45		0
3921	Non-ICI treated	Never received ICI	26 - 30	Male	Cutaneous Melanoma 	2016	III	15	20.2		No	No	Signature.7	ATR	No	0	33.51		0
3922	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	III	24	3.5	Stable	No	No			No	0	19.06		0
3923	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	67	1.8	Stable	No	No		BRCA2	No	0	35.88		0
3924	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	223	0		No	Yes or Unknown			No	0	33.12		0
3925	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	6.1	Stable	No	No			No	1	31.11		0
3926	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	169	22.8	Stable	No	Yes or Unknown	Signature.13	MSH2 | RAD51C	Yes	0	31.74		0
3927	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	32	2.6		No	No			No	0	29.63		0
3928	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	IV	71	3.5		No	No		ATM	No	1	4.7		0
3929	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2016	II	52	5.3	Stable	No	No			Yes	0	31.8		0
3930	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	IV	33	2.6		No	No		ARID1A	No	0	15.21		0
3931	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	47	0		No	No			Yes	0	22.37		0
3932	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	II	0	1.8		No	Yes or Unknown			No	0	32.62		0
3933	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	IV	0	5.3	Stable	No	No	Signature.6		No	1	19.78		0
3934	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	1	4.9		No	Yes or Unknown			No	0	33.28		0
3935	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		2	3.5	Stable	No	No	Signature.1		Yes	0	9.66		0
3936	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2016	II	26	1.8		No	No			No	0	31.84		0
3937	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	57	7.9	Stable	No	No		ARID1A	No	0	24.38		0
3938	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	560	0.9	Stable	No	Yes or Unknown			No	0	32.89		0
3939	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	45	7.9	Stable	No	No	Signature.1		No	0	5.13		0
3940	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	378	2.6		No	Yes or Unknown			Yes	0	1.71		0
3941	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	15	7		No	No	Signature.7	ARID1A	No	1	2.76		0
3942	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	0	5.3		No	No			No	1	8.25		0
3943	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	120	2.6	Stable	No	Yes or Unknown			No	0	33.12		0
3944	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	37	0.9		No	No			No	0	22.64		0
3945	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	4.4		No	Yes or Unknown		ATM	No	1	15.31		0
3946	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	1	2.6		No	Yes or Unknown			No	1	23.06		0
3947	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2016	IV	0	2.6		No	No			No	1	15.77		0
3948	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	35	1.8		No	No			Yes	0	32.72		0
3949	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	21	2.6	Stable	No	No			No	0	32.56		0
3950	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	79	1.8		No	Yes or Unknown			No	0	27.86		0
3951	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	31	3.5		No	No			No	0	27.83		0
3952	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	I	123	0	Stable	No	No			No	0	33.18		0
3953	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2016	IV	3	6.1		No	No	Signature.1		Yes	1	11.37		0
3954	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	657	5.3	Stable	No	Yes or Unknown	Signature.24	BRCA1	No	0	31.77		0
3955	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2016	IV	0	0.9		No	No			No	0	29.9		0
3956	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2016	IV	0	0.9	Stable	No	No			No	0	33.18		0
3957	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	III	361	4.4	Stable	No	Yes or Unknown	Signature.5		No	0	33.61		0
3958	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	II	0	12.3		No	No	Signature.3	BRCA1	No	1	14.95		0
3959	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	14	2.6	Stable	No	No		NBN	No	0	32.99		0
3960	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	2.6	Stable	No	Yes or Unknown		PMS1	No	0	32.66		0
3961	Non-ICI treated	Never received ICI	96 - 100	Female	Endometrial	2016	IV	48	2.6	Stable	No	No			Yes	0	32.39		0
3962	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2016	IV	0	3.5		No	No			No	1	20.53		0
3963	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	103	1.8		No	Yes or Unknown			No	1	15.57		0
3964	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2016	III	34	0.9	Indeterminate	No	No			Yes	1	13.93		0
3965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	II	0	7	Stable	No	No		PARP1	No	0	24.15		0
3966	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2016	IV	0	17.6		No	No	Signature.4	BRCA2 | MSH2 | PARP1	No	1	1.25		0
3967	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	12	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	33.97		0
3968	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	0	6.1	Stable	No	Yes or Unknown	Signature.2		No	0	31.74		0
3969	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	7.9	Stable	No	No	Signature.25		Yes	1	9.23		0
3970	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016	I	16	0		No	No			No	0	30.42		0
3971	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	339	1.8	Stable	No	Yes or Unknown			No	0	35.19		0
3972	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	27	0.9		No	No			Yes	0	24.48		0
3973	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2016	IV	5	2.6	Stable	No	No		ATM	No	1	8.71		0
3974	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	3.5		No	No			No	0	26.25		0
3975	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	8.8	Stable	No	No	Signature.30		No	1	24.71		0
3976	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2016	III	0	14		No	No	Signature.4	BLM | BRIP1	Yes	1	10.25		0
3977	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		14	4.4		Yes or Unknown	Yes or Unknown			Yes	0	32.23		0
3978	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	54	7.9		No	No	Signature.24	BRCA1	No	1	19.19		0
3979	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	25	1.8		No	No			Yes	0	31.01		0
3980	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	3	7	Stable	No	No	Signature.1	ATM	No	1	14.39		0
3981	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	38	40.4	Unstable	No	No	Signature.1	ARID1A	No	0	33.31		0
3982	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	44	3.5		No	No			Yes	0	30.13		0
3983	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	1.8		No	No			No	0	31.31		0
3984	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	26	0		No	Yes or Unknown			No	0	32.89		0
3985	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	58	4.4	Stable	No	No			No	0	32.16		0
3986	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	0	4.4		No	Yes or Unknown		PALB2	No	0	32.82		0
3987	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	134	27.2	Indeterminate	No	Yes or Unknown	Signature.1	ARID1A | SLX4	No	0	31.28		0
3988	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	639	7	Stable	No	Yes or Unknown	Signature.3		No	0	31.9		0
3989	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	I	244	0.9	Stable	No	No			No	1	20.57		0
3990	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	I	39	4.4		No	No			No	0	30.39		0
3991	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	130	0.9	Stable	No	Yes or Unknown			No	0	32.92		0
3992	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	6.1	Stable	No	No			Yes	1	5.55		0
3993	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		14	4.4		No	No			Yes	1	1.64		0
3994	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	41	2.6		No	No		MRE11A	Yes	0	27.6		0
3995	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	25	0		No	No			No	0	8.31		0
3996	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2016	I	20	0.9		No	No			No	0	26.55		0
3997	Non-ICI treated	Never received ICI	61 - 65	Female	Head & Neck	2016	IV	0	7		No	No	Signature.7		No	1	5.32		0
3998	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	0	32.66		0
3999	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2016	IV	0	7	Stable	No	No	Signature.3	BRCA1	No	0	31.51		0
4000	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		305	0	Stable	No	No			No	0	25.69		0
4001	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	26	6.1	Stable	No	No	Signature.4		No	1	27.01		0
4002	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	0	1.8		No	No			No	0	26.32		0
4003	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016	I	40	0.9		No	No			No	0	31.41		0
4004	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	109	2.6	Stable	No	Yes or Unknown		BLM	No	0	31.21		0
4005	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	148	2.6	Stable	No	Yes or Unknown			No	0	32.76		0
4006	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2016		4	3.5		Yes or Unknown	Yes or Unknown			Yes	0	8.08		0
4007	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	III	0	2.6	Stable	No	No			No	0	32.49		0
4008	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	I	15	7.9	Stable	No	No	Signature.4		Yes	0	32		0
4009	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2016	IV	0	2.6		No	No		BRCA1	Yes	0	28.98		0
4010	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	IV	0	3.5		No	No			No	1	24.21		0
4011	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2016	IV	0	8.8	Stable	No	No	Signature.13	MDC1 | MUTYH	No	0	23.89		0
4012	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2016		21	6.1	Stable	Yes or Unknown	Yes or Unknown		ARID1A	Yes	0	36.4		0
4013	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	7	7	Stable	No	No			No	0	32.82		0
4014	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	30	0.9		No	No			Yes	0	30.19		0
4015	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		226	0	Stable	No	No			No	0	34.43		0
4016	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	38	3.5	Stable	No	No			No	0	31.9		0
4017	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	III	0	4.4		No	No		ARID1A	No	0	32.1		0
4018	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2016		272	0		No	No			No	0	19.88		0
4019	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	III	0	2.6		No	Yes or Unknown			No	0	31.51		0
4020	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	20	5.3		No	Yes or Unknown			No	0	20.9		0
4021	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	22.8		No	No	Signature.4	BLM | NBN | RAD51C	Yes	1	4.76		0
4022	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	15	0.9		No	Yes or Unknown			No	0	32.53		0
4023	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2016	IV	162	0.9	Stable	No	Yes or Unknown			No	0	32.49		0
4024	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	29.17		0
4025	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	153	4.4	Stable	No	Yes or Unknown		ERCC2	No	1	23.39		0
4026	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	III	21	0.9	Stable	No	Yes or Unknown			No	0	30.59		0
4027	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	35	5.3	Stable	No	Yes or Unknown			No	0	32.62		0
4028	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	II	58	2.6		No	No			No	0	32.89		0
4029	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2016		2	1.8		No	No			No	1	11.6		0
4030	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	7	6.1	Stable	No	No			No	0	32.49		0
4031	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	III	23	15.8		No	No	Signature.6	ATR	No	1	4.63		0
4032	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	I	168	2.6	Stable	No	No			Yes	0	32.72		0
4033	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	II	184	0.9	Stable	No	Yes or Unknown		BLM	No	0	32.46		0
4034	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	III	28	4.4	Stable	No	No			No	0	32.66		0
4035	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	40	11.4		No	No	Signature.4	ATM | CHEK2 | ERCC4	No	0	17.41		0
4036	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	I	20	7		No	No	Signature.4		No	0	27.76		0
4037	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	18	4.4		No	No		BRCA1	Yes	0	2.76		0
4038	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	IV	12	10.5		No	No	Signature.3	BRCA1	No	1	23.2		0
4039	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	0	5.3		No	Yes or Unknown			No	0	34.6		0
4040	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	I	0	9.7		No	No	Signature.4		No	0	25.26		0
4041	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2016	IV	47	3.5	Stable	No	No	Signature.17	ARID1A	No	0	24.34		0
4042	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	IV	317	2.6	Stable	No	Yes or Unknown			No	1	32.13		0
4043	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	36	7		No	No	Signature.13		Yes	0	31.93		0
4044	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	I	35	4.4		No	No			Yes	0	31.93		0
4045	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	II	21	48.3	Unstable	No	No	Signature.1	ATM | BLM | MSH3 | NBN | PARP1	Yes	0	26.25		0
4046	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	22	3.5		No	No			Yes	1	3.78		0
4047	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	III	7	17.6		No	No	Signature.2	ARID1A	No	0	32.39		0
4048	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	17	1.8		No	No			No	0	31.8		0
4049	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	III	15	40.4	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MSH3 | MSH6	No	0	26.51		0
4050	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	II	152	4.4	Stable	No	No		ATM	Yes	0	31.31		0
4051	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2016	IV	5	45.6		No	No	Signature.7	ARID1A | MDC1 | RAD50 | RAD51C	No	0	0.89		0
4052	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	I	99	0.9		No	No			No	0	28.35		0
4053	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	71	10.5	Stable	No	No	Signature.1	ATR	No	0	32.72		0
4054	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2016	II	19	3.5		No	No			No	1	22.54		0
4055	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	II	65	7.9	Stable	No	No			No	0	32.95		0
4056	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	III	9	3.5		No	No			No	0	32.33		0
4057	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	3.5		No	No	Signature.30		No	0	30.13		0
4058	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	51	3.5		No	No			No	0	29.31		0
4059	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	24	3.5	Stable	No	No			Yes	0	22.87		0
4060	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2016	III	0	4.4	Stable	No	No		ARID1A	No	0	29.57		0
4061	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2016	IV	0	2.6	Stable	No	No			Yes	1	15.21		0
4062	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	II	0	1.8		No	No			No	0	31.51		0
4063	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	16	5.3	Stable	No	Yes or Unknown		SLX4	Yes	0	28.48		0
4064	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	55	1.8		No	Yes or Unknown			No	0	29.57		0
4065	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	2	4.4	Stable	No	No			No	1	7.33		0
4066	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	0	5.3		No	No			Yes	1	2.63		0
4067	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	No		ARID1A	No	1	8.51		0
4068	Non-ICI treated	Never received ICI	81 - 85	Male	CNS	2016		13	2.6		No	Yes or Unknown			Yes	1	4.73		0
4069	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	III	9	3.5		No	No			No	1	13.86		0
4070	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	710	7.9	Stable	No	Yes or Unknown	Signature.1	NTHL1	No	1	28.32		0
4071	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	44	2.6		No	No			No	0	31.61		0
4072	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	49	2.6		No	Yes or Unknown			Yes	0	32.89		0
4073	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	0.9	Stable	No	No			No	0	31.87		0
4074	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	0	5.3	Stable	No	No	Signature.3		No	0	32.46		0
4075	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2016	III	196	8.8	Stable	No	No	Signature.13		No	0	32.72		0
4076	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2016	IV	24	10.5		No	No	Signature.4	ERCC4	Yes	1	9.3		0
4077	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2016	III	29	1.8		No	No			No	0	27.63		0
4078	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	2	5.3	Stable	No	No		RAD50	No	1	7.95		0
4079	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	41	1.8		No	Yes or Unknown			Yes	0	32.2		0
4080	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	46	0	Stable	No	No			No	0	32.46		0
4081	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	III	812	6.1	Stable	No	Yes or Unknown	Signature.9	ARID1A	Yes	0	28.42		0
4082	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	II	0	9.7		No	No	Signature.29	ARID1A | BRCA2	No	0	2.27		0
4083	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	IV	66	0	Stable	No	No			No	1	25.03		0
4084	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2016	IV	7	5.3	Stable	No	No	Signature.19	SLX4	No	0	30.88		0
4085	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016		0	0		No	No			No	0	32.13		0
4086	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2016	IV	51	21.1	Stable	No	No	Signature.2	MDC1 | PARP1 | RAD54L	Yes	0	17.51		0
4087	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	IV	330	5.3	Stable	No	Yes or Unknown		BRCA1	No	1	22.08		0
4088	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	IV	70	3.5	Stable	No	No		MUTYH	No	0	30.95		0
4089	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2016	IV	17	0	Stable	No	No			No	0	24.48		0
4090	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	III	15	3.5	Stable	No	No			No	1	6.11		0
4091	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	26	2.6		No	No		SLX4	No	0	19.68		0
4092	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	35.1	Stable	No	No	Signature.4		No	1	4.9		0
4093	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	69	2.6	Stable	No	No			No	0	32		0
4094	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	III	103	0		No	Yes or Unknown			No	0	31.97		0
4095	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016		0	1.8		No	No			No	0	31.84		0
4096	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	9	2.6		No	Yes or Unknown		MUTYH	Yes	0	30.13		0
4097	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	IV	764	11.4	Indeterminate	No	Yes or Unknown	Signature.13	ATM | ATR | BLM	No	1	28.19		0
4098	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	0	5.3		No	No		ATM | CHEK1	Yes	1	8.21		0
4099	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2016	IV	21	5.3	Stable	No	No			No	0	8.9		0
4100	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2016	I	0	424.8	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | MUTYH | NTHL1 | PALB2 | PARP1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1	No	0	8.05		0
4101	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	0	5.3	Stable	No	No			No	0	32.59		0
4102	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2016	III	193	1.8	Stable	No	No			Yes	0	29.44		0
4103	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	I	7	2		No	No			No	0	1.02		0
4104	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	156	2.6	Stable	No	Yes or Unknown		ERCC4	No	0	29.4		0
4105	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	I	0	2.6		No	No		ATM	No	0	25.76		0
4106	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2016	IV	434	2.6	Stable	No	Yes or Unknown			No	1	24.77		0
4107	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	33	3.5		No	Yes or Unknown			No	0	31.7		0
4108	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2016	IV	0	0.9		No	No			No	0	29.96		0
4109	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		1	5.9		No	No			Yes	1	7.66		0
4110	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	IV	60	0.9		No	Yes or Unknown		XRCC2	Yes	0	32.33		0
4111	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	III	0	2.6	Stable	No	No			No	0	29.7		0
4112	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	111	0		No	Yes or Unknown			No	0	30.85		0
4113	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	0	6.9	Stable	No	No		ATM	No	0	32.3		0
4114	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	II	21	8.8		No	No	Signature.4		Yes	0	30.42		0
4115	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	23	9.8	Stable	No	No	Signature.1	ARID1A	No	0	32.07		0
4116	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		66	0		No	No			No	0	4.44		0
4117	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	II	0	4.4	Stable	No	No			No	0	26.64		0
4118	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	229	1.8	Stable	No	Yes or Unknown			Yes	0	23.03		0
4119	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	IV	21	2.6		No	No			No	0	32.07		0
4120	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	IV	14	3.5	Stable	No	No			No	0	31.57		0
4121	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	0	2.6	Stable	No	No			No	0	30.88		0
4122	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	III	153	7.9	Stable	No	Yes or Unknown	Signature.18	ATM	No	0	30.62		0
4123	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		0	3.9		Yes or Unknown	Yes or Unknown			No	1	10.05		0
4124	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	IV	8	2.6	Stable	No	No			No	0	25.56		0
4125	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	0	2.6		No	No			No	1	18.33		0
4126	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	IV	31	3.5		No	Yes or Unknown			No	0	31.93		0
4127	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	15	3.5		No	No			Yes	0	31.8		0
4128	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	I	146	2.6	Stable	No	Yes or Unknown			Yes	0	7.26		0
4129	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	47	4.4		No	Yes or Unknown		MUTYH	No	0	31.93		0
4130	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2016		4	4.4		Yes or Unknown	Yes or Unknown	Signature.1		No	0	9.59		0
4131	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	IV	26	4.4		No	No			No	0	31.31		0
4132	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	35	3.5	Stable	No	No			No	0	30.62		0
4133	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	195	4.4	Stable	No	Yes or Unknown			No	1	9.66		0
4134	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2016	II	49	3.5	Stable	No	No			No	0	31.47		0
4135	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	III	0	43	Unstable	No	No	Signature.6	ARID1A | BLM | MSH3 | NBN	Yes	0	31.93		0
4136	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	0	1.8		No	No			No	0	32.13		0
4137	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2016		45	1.8		No	No			No	0	24.94		0
4138	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	II	19	0.9		No	No			No	1	7.98		0
4139	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2016	III	53	5.3		No	No	Signature.13	TP53BP1	Yes	0	30.29		0
4140	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	401	3.5	Stable	No	No			No	0	26.55		0
4141	Non-ICI treated	Never received ICI	36 - 40	Female	Cutaneous Melanoma 	2016	III	20	2.6		No	No			No	0	2.66		0
4142	Non-ICI treated	Never received ICI	41 - 45	Female	Bladder	2016	II	0	12.3	Stable	No	No	Signature.13	ARID1A | ATR | MLH1	Yes	0	30.13		0
4143	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2016	IV	14	8.9	Stable	No	No	Signature.1		No	0	32.16		0
4144	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	IV	9	8.8		No	No	Signature.5	ARID1A | PALB2 | RAD50 | SLX4	No	0	27.37		0
4145	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	88	0	Stable	No	Yes or Unknown			No	0	31.74		0
4146	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2016	III	16	3.5		No	No			No	1	2.43		0
4147	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	31	2		No	Yes or Unknown			Yes	0	15.41		0
4148	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	IV	129	1.8		No	No			No	1	12.52		0
4149	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2016	II	36	13.2		No	Yes or Unknown	Signature.2	ARID1A | BRCA2 | SLX4	No	0	30.16		0
4150	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	20	1.8		No	No			No	0	31.84		0
4151	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	319	7.9	Stable	No	No	Signature.1	BRCA2	No	0	30.78		0
4152	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	IV	1	0.9	Stable	No	No		CHEK2 | MRE11A	No	0	31.7		0
4153	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2016	IV	22	3.5	Stable	No	No			No	1	28.25		0
4154	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2016	IV	0	1.8		No	No			No	1	11.79		0
4155	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	180	3.5	Stable	No	No			No	0	32.16		0
4156	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	8	2.6	Stable	No	Yes or Unknown			No	0	6.47		0
4157	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	15	5.9	Stable	No	No			Yes	0	31.67		0
4158	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	0	0	Stable	No	No			No	0	31.47		0
4159	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	922	2.6	Stable	No	No			No	0	31.15		0
4160	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	III	30	1.8	Stable	No	No			Yes	0	30.13		0
4161	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	3	1.8		No	No		ARID1A	No	0	31.44		0
4162	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	IV	6	8.8		No	No	Signature.3		No	1	2.92		0
4163	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2016	IV	43	7		No	No			Yes	1	3.12		0
4164	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	2.6		No	Yes or Unknown			No	0	31.24		0
4165	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2016	II	24	7.9		No	Yes or Unknown		ATM	No	0	30.59		0
4166	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2016		0	1.8		No	No	Signature.1	ARID1A | MSH6	Yes	0	29.9		0
4167	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2016	II	0	3		No	No			No	1	22.67		0
4168	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	51	2.6	Stable	No	Yes or Unknown			No	0	18.37		0
4169	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	10	2.6		No	No			No	1	26.05		0
4170	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2016	II	125	59.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BRIP1 | ERCC3 | MSH2 | SLX4	No	0	29.9		0
4171	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	36	2.6		No	No			No	0	30.55		0
4172	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2016	I	37	6.1	Stable	No	No		ARID1A	No	0	28.16		0
4173	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	II	115	1.8	Stable	No	No			No	0	31.31		0
4174	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2016	III	0	3.5	Stable	No	No			No	1	17.74		0
4175	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	709	5.3	Stable	No	Yes or Unknown			No	1	25.53		0
4176	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	133	5.3	Stable	No	Yes or Unknown			No	1	27.27		0
4177	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	41	3.5	Stable	No	Yes or Unknown		ATM	No	0	32.59		0
4178	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	47	0.9	Stable	No	No			No	0	31.97		0
4179	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	0	12.8		No	No	Signature.4	BRCA2 | RAD50	No	0	26.81		0
4180	Non-ICI treated	Never received ICI	91 - 95	Male	NSCLC	2016	II	0	14		No	No	Signature.4		No	1	12.12		0
4181	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	II	0	4.4	Stable	No	Yes or Unknown			No	0	31.61		0
4182	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	144	1.8	Stable	No	Yes or Unknown			No	1	27.63		0
4183	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2016		7	4.4		Yes or Unknown	Yes or Unknown			No	1	29.4		0
4184	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2016	IV	0	0.9		No	No			Yes	0	31.41		0
4185	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	III	0	3.5	Stable	No	No			No	0	31.31		0
4186	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2016	IV	58	14	Stable	No	Yes or Unknown	Signature.4	RAD50	No	1	14.29		0
4187	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	I	23	12.3		No	No	Signature.4		No	0	26.78		0
4188	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	23	1.8		No	No			No	0	26.05		0
4189	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	36	2.6		No	No			Yes	0	9.66		0
4190	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	14	0.9		No	No			No	0	30.85		0
4191	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	0	3		No	No			No	0	31.01		0
4192	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2016	I	17	3.5		No	No			No	0	27.83		0
4193	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2016	IV	2	0.9		No	No			No	1	28.88		0
4194	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	6.1		No	No			Yes	1	2.53		0
4195	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2017	II	44	0	Indeterminate	No	No			No	0	2.83		0
4196	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	III	31	2.6		No	Yes or Unknown			No	0	31.34		0
4197	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	66	303.7	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC3 | ERCC5 | FANCA | MDC1 | MSH2 | MSH3 | MSH6 | MUTYH | NBN | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	28.02		0
4198	Non-ICI treated	Never received ICI	76 - 80	Male	Breast	2016	I	230	0.9	Stable	No	Yes or Unknown			No	0	26.81		0
4199	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	0	314.2	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BRCA1 | BRCA2 | ERCC3 | MSH2 | MSH3 | MSH6 | NTHL1 | PARP1 | PMS1 | RAD50 | RAD51 | RAD51C | RAD54L | SLX4 | TP53BP1	No	0	26.09		0
4200	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	10	1.8		No	No			No	0	22.64		0
4201	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	III	0	2.6		No	No			Yes	0	31.87		0
4202	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2016	II	127	1.8	Stable	No	No			No	0	30.52		0
4203	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	III	288	7	Stable	No	Yes or Unknown	Signature.2		No	1	12.85		0
4204	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2016	I	24	2.6		No	No			No	0	31.31		0
4205	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2016	III	52	0.9		No	Yes or Unknown			No	0	31.87		0
4206	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2016	IV	0	5.3		No	Yes or Unknown		ATM	No	1	23.13		0
4207	Non-ICI treated	Never received ICI	86 - 90	Male	CNS	2016		31	8.8		No	No	Signature.1		Yes	0	13.6		0
4208	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2016	I	0	2.6		No	No			No	0	29.4		0
4209	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	IV	0	1.8	Stable	No	No			No	1	6.01		0
4210	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2016	I	77	4.4		No	No			No	0	27.79		0
4211	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	33	6.1	Stable	No	No	Signature.13	BRCA2	Yes	0	27.83		0
4212	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	IV	19	7	Stable	No	No		ARID1A	Yes	0	28.09		0
4213	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	0	4.4	Stable	No	No			No	1	23.59		0
4214	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2016	II	0	1.8	Stable	No	No			Yes	0	12.75		0
4215	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2016	IV	9	6.1		No	No	Signature.1		No	0	14.23		0
4216	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	I	41	37.7	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1	No	0	26.84		0
4217	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2016	IV	15	2		No	No		ATM	No	1	26.35		0
4218	Non-ICI treated	Never received ICI	41 - 45	Female	Hepatobiliary	2016	I	0	4.4	Stable	No	No			Yes	0	30.75		0
4219	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	31.74		0
4220	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	III	3	52.7	Unstable	No	No	Signature.6	ATM | BRCA2 | FANCA | MDC1 | MLH1 | MSH3	Yes	0	30.16		0
4221	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	127	1.8	Stable	No	Yes or Unknown			Yes	0	20.14		0
4222	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	23	5.3		No	Yes or Unknown			Yes	1	12.45		0
4223	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown		MUTYH	No	0	30.95		0
4224	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	35	0.9		No	No			Yes	0	5.03		0
4225	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2016	I	40	21.1	Unstable	No	No	Signature.6	ARID1A | TP53BP1	No	0	26.18		0
4226	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2016	I	0	3.5	Stable	No	No			No	0	30.78		0
4227	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		2	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	31.77		0
4228	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	III	28	1.8	Stable	No	No		ARID1A	No	0	30.65		0
4229	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2016	II	26	3.5	Stable	No	No			No	1	19.68		0
4230	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2016	II	142	58.8	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | BRIP1 | MLH1 | MUTYH	No	0	27.66		0
4231	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	IV	32	6.1		No	Yes or Unknown	Signature.3		No	0	31.21		0
4232	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	452	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	31.44		0
4233	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	8	3		No	No			Yes	1	0.72		0
4234	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	35	2.6		No	No			Yes	0	29.93		0
4235	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2016	IV	0	5.3	Stable	No	No			Yes	0	31.24		0
4236	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	IV	0	0.9		No	Yes or Unknown			No	1	14.19		0
4237	Non-ICI treated	Never received ICI	81 - 85	Male	Head & Neck	2016		85	0	Indeterminate	No	No			No	0	29.5		0
4238	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2016		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	1	12.78		0
4239	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		34	5.3		Yes or Unknown	Yes or Unknown			Yes	1	6.9		0
4240	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	IV	35	3.9		No	No			Yes	0	28.81		0
4241	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	IV	17	11.4		No	No	Signature.1	ATM | MSH3	Yes	1	7.1		0
4242	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	20	3.5	Stable	No	No			No	0	31.47		0
4243	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	II	0	9.7	Stable	No	No	Signature.7	FANCA	No	0	30.88		0
4244	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2016	III	33	4.4		No	No			Yes	0	27.63		0
4245	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	0	6.1	Stable	No	No		ARID1A	No	0	7.89		0
4246	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2016		0	2		Yes or Unknown	Yes or Unknown			Yes	0	5.49		0
4247	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	0	0	Stable	No	No			No	0	25.23		0
4248	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	40	14.9		No	No	Signature.4		No	0	28.98		0
4249	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	27	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	30.32		0
4250	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	II	45	4.4		No	No		MUTYH	Yes	0	27.14		0
4251	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	917	2.6	Stable	No	No			Yes	0	33.77		0
4252	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2016	I	49	0.9	Stable	No	No			No	0	27.17		0
4253	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2016	IV	0	6.1	Stable	No	No	Signature.1		No	1	3.38		0
4254	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2016	IV	42	2.6		No	Yes or Unknown			No	1	9.69		0
4255	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		0	3.5		Yes or Unknown	Yes or Unknown			No	1	16.23		0
4256	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	0	0.9	Stable	No	No			No	0	22.41		0
4257	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	III	31	9.7	Stable	No	No		ARID1A	No	0	30.59		0
4258	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	I	25	8.8	Stable	No	No		ATM	No	0	21.49		0
4259	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	0	5.3	Stable	No	No			No	1	23.39		0
4260	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	I	168	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	31.9		0
4261	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	6.1	Stable	No	No		ARID1A	No	1	14.26		0
4262	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	29.47		0
4263	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	15	3.9	Stable	No	No			Yes	0	28.71		0
4264	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2016	II	1	2.6		No	No	Signature.26	BRCA1	No	0	31.18		0
4265	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	I	39	63.2	Unstable	No	No	Signature.20	ARID1A | ATM | BRIP1 | MSH2 | MSH6 | RAD51C	Yes	0	29.93		0
4266	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	16	2.6		No	No		ATM | PARP1	Yes	1	18.3		0
4267	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2016	IV	0	8.8	Stable	No	No	Signature.1		No	0	30.92		0
4268	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	0	1.8	Stable	No	No			Yes	0	31.31		0
4269	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2016	II	55	1.8		No	No			No	0	22.9		0
4270	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2016	I	55	4.4	Stable	No	No		ARID1A	Yes	0	5.36		0
4271	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	29.08		0
4272	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	IV	8	1.8	Stable	No	Yes or Unknown			No	0	16.89		0
4273	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	IV	0	4.4	Stable	No	No			No	1	8.94		0
4274	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	24	2.6	Stable	No	No			No	0	10.41		0
4275	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2016	IV	0	2.6	Stable	No	No			No	0	32.53		0
4276	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	155	2.6	Stable	No	No			No	0	27.14		0
4277	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2016	III	20	2.6	Stable	No	No			No	0	25.92		0
4278	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2016		384	0.9	Stable	No	Yes or Unknown			No	0	30.26		0
4279	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	187	4.4	Stable	No	Yes or Unknown			No	0	30.32		0
4280	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	197	1.8	Stable	No	Yes or Unknown			No	0	31.08		0
4281	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017		642	3.5	Stable	No	No	Signature.19	CHEK2	No	1	24.57		0
4282	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	7	7	Stable	No	No	Signature.3		No	0	30.39		0
4283	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2016	I	32	15.8		No	No	Signature.3	BRCA2	No	0	25.95		0
4284	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	III	0	3.5	Stable	No	No			No	1	16.76		0
4285	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	0	3.5		No	No		CHEK2	No	0	24.02		0
4286	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	13	2.6		No	No			Yes	0	29.27		0
4287	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2016	II	431	7	Stable	No	Yes or Unknown	Signature.8		No	1	20.44		0
4288	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	120	0		No	Yes or Unknown			No	0	15.31		0
4289	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	41	6.1	Stable	No	No		BRCA2	No	1	24.8		0
4290	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0		No	No			No	0	30.62		0
4291	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		MSH6	No	0	29.93		0
4292	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	12	0.9		No	No			Yes	0	4.04		0
4293	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2016	I	41	4.4		No	No			No	0	32.07		0
4294	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	17	0.9		No	No			No	0	30.23		0
4295	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	II	17	6.1	Stable	No	No			No	0	31.01		0
4296	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	0	5.3		No	No		ARID1A	No	1	20.86		0
4297	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2017	I	23	7	Stable	No	No	Signature.16	ARID1A | PMS1	Yes	1	28.58		0
4298	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	26	0.9	Stable	No	No			No	0	26.09		0
4299	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2016		47	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	37.22		0
4300	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	53	20.2	Stable	No	No	Signature.4	BRCA2	Yes	0	30.65		0
4301	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	I	497	2.6	Stable	No	Yes or Unknown			No	1	20.9		0
4302	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2016		73	7		Yes or Unknown	Yes or Unknown	Signature.2		No	1	10.25		0
4303	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	674	2.6	Stable	No	Yes or Unknown		ARID1A	No	0	31.21		0
4304	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	23	2.6		No	No			No	0	27.4		0
4305	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	561	7	Stable	No	Yes or Unknown	Signature.1	BRCA1	No	0	31.74		0
4306	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	64	13.2	Stable	No	Yes or Unknown	Signature.2		No	1	16.03		0
4307	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	119	2.6	Stable	No	Yes or Unknown		MUTYH	Yes	0	29.24		0
4308	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	I	78	0.9	Stable	No	No			No	0	29.21		0
4309	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	46	3.5	Stable	No	No	Signature.1		Yes	1	9.66		0
4310	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2016	III	10	4.4	Stable	No	No		BLM	Yes	0	30.72		0
4311	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	455	7	Stable	No	Yes or Unknown	Signature.1		No	0	30.69		0
4312	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	33	1.8	Stable	No	No			Yes	0	29.17		0
4313	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2016	IV	0	4.4	Stable	No	No		CHEK2	No	1	11.43		0
4314	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	23	5.3	Stable	No	Yes or Unknown	Signature.24	MDC1	No	0	29.93		0
4315	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2016	IV	505	7	Stable	No	Yes or Unknown	Signature.3	BLM	No	0	31.77		0
4316	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	4.4		No	No		BRCA2	No	0	31.11		0
4317	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2016	IV	0	2.6		No	No			Yes	1	27.53		0
4318	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	0	30.75		0
4319	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	27	13.2		No	No	Signature.5	ATR | MSH6 | RAD54L	No	0	12.48		0
4320	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2016	IV	133	2.6	Stable	No	Yes or Unknown			Yes	1	15.38		0
4321	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	0	11.4	Stable	No	No	Signature.15		No	0	31.24		0
4322	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2016	I	53	42.1	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | CHEK2 | MSH3 | MSH6	No	0	17.74		0
4323	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2016	IV	0	7	Stable	No	No	Signature.1		No	0	31.44		0
4324	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	3.5	Stable	No	No			No	0	25.89		0
4325	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2016	I	27	39.5	Unstable	No	No	Signature.6	ARID1A | CHEK1 | MSH2 | PARP1	Yes	0	30.85		0
4326	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	14	6.1		No	No	Signature.4		No	1	1.94		0
4327	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	0	6.1	Stable	No	No			No	1	18.27		0
4328	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	0	4.4		No	No			Yes	1	0.92		0
4329	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2016	III	29	12.3		No	No	Signature.4	MUTYH	Yes	0	31.97		0
4330	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2017	IV	252	2.6	Stable	No	Yes or Unknown	Signature.1		No	1	19.61		0
4331	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	IV	41	14	Stable	No	No	Signature.4	MSH2	No	1	2.92		0
4332	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	267	5.3	Stable	No	Yes or Unknown			No	0	10.68		0
4333	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	34	3.5		No	No			No	0	25.49		0
4334	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	6.1	Stable	No	No		ARID1A	No	0	27.93		0
4335	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	21	7	Stable	No	No	Signature.1	ARID1A | BRIP1	No	0	30.95		0
4336	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	0	3.5	Stable	No	No			No	1	15.34		0
4337	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	1	0.9	Stable	No	No			No	0	23.13		0
4338	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	11	3.5		No	No		RAD51C	Yes	1	4.37		0
4339	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	IV	0	5.3		No	No	Signature.27		No	1	13.17		0
4340	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2016	III	246	0	Stable	No	No			No	0	17.02		0
4341	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	364	5.3	Stable	No	Yes or Unknown			No	0	25.56		0
4342	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2016	II	51	5.3		No	No		CHEK2	No	0	30.36		0
4343	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	57	1.8	Stable	No	No			Yes	0	29.01		0
4344	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	30	4.4	Stable	No	No			No	0	24.44		0
4345	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	257	5.3	Stable	No	Yes or Unknown			No	0	29.86		0
4346	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	II	0	3.5	Stable	No	Yes or Unknown			No	0	30.85		0
4347	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017		0	1.8		No	No			No	0	30.65		0
4348	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	3	2.6		No	Yes or Unknown			No	0	30		0
4349	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	I	28	33.4	Unstable	No	No	Signature.6	ARID1A | BRCA2 | CHEK2 | FANCC | MSH3	No	0	6.41		0
4350	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	30.98		0
4351	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2017		0	2.6		Yes or Unknown	Yes or Unknown			Yes	0	3.61		0
4352	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	245	3.5	Stable	No	Yes or Unknown			No	0	30.75		0
4353	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	54	2.6		No	No			Yes	0	27.2		0
4354	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	33	2.6	Stable	No	No			No	0	25.2		0
4355	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	III	699	1.8	Stable	No	No		FANCA	No	0	32.16		0
4356	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2017	III	111	20.2	Stable	No	No	Signature.7	MUTYH | PALB2	Yes	0	28.78		0
4357	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	19	3.5		No	Yes or Unknown			Yes	0	29.83		0
4358	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	2	0.9	Stable	No	No			No	0	12.65		0
4359	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	IV	586	4.4	Stable	No	Yes or Unknown			No	0	20.93		0
4360	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	182	2.6	Stable	No	Yes or Unknown			Yes	0	31.74		0
4361	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	6	6.1		No	No			No	1	18.07		0
4362	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		12	3.5		Yes or Unknown	Yes or Unknown			No	0	8.11		0
4363	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2016	III	104	1.8		No	No			No	0	31.97		0
4364	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	IV	20	2.6	Stable	No	No	Signature.29	MDC1	No	1	27.86		0
4365	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	2.6		No	Yes or Unknown			No	0	29.93		0
4366	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2016	II	42	25.5	Stable	No	No	Signature.13	ARID1A | ATR | BLM	Yes	0	30.26		0
4367	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	7.69		0
4368	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	26	7.9		No	No	Signature.4		No	0	4.83		0
4369	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	5.3	Stable	No	No	Signature.1	SLX4	No	0	29.47		0
4370	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	9	1.8	Stable	No	No		MUTYH	No	1	26.87		0
4371	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	59	1.8	Stable	No	No			No	0	30.62		0
4372	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	3.5		No	No			No	1	7.06		0
4373	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2016	I	31	6.1	Stable	No	No		ERCC4	Yes	0	28.32		0
4374	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	0	0		No	No			No	1	22.83		0
4375	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	28	7.9	Stable	No	No		ARID1A	No	0	25.26		0
4376	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		0	0.9		No	No			No	0	27.6		0
4377	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2016	II	20	1.8	Stable	No	No			No	0	31.74		0
4378	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	26	4.4		No	No			Yes	0	16.07		0
4379	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	22	3.5	Stable	No	No			Yes	0	30.13		0
4380	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	29	2.6		No	No			Yes	0	30		0
4381	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	31.08		0
4382	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	540	3.5	Stable	No	Yes or Unknown	Signature.13		No	1	21.36		0
4383	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	IV	33	4.4	Stable	No	No			No	1	17.51		0
4384	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	49	0.9	Stable	No	No			No	0	27.17		0
4385	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	30	1.8		No	No			No	0	30.59		0
4386	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	26	4.4	Stable	No	No			No	0	30.16		0
4387	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	14	1.8		No	Yes or Unknown			No	0	29.37		0
4388	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	41	9.7		No	No	Signature.2		No	0	26.87		0
4389	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	16	4.4	Stable	No	No			Yes	0	29.24		0
4390	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	2.6		No	No		BRCA1	No	0	27.07		0
4391	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	III	239	3.5	Stable	No	Yes or Unknown			No	0	29.9		0
4392	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	40	0.9	Stable	No	Yes or Unknown			No	0	27.3		0
4393	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	138	1.8	Stable	No	Yes or Unknown			No	0	8.94		0
4394	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	40	4.4		No	No		ATR	No	0	26.61		0
4395	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2017	II	321	7.9	Stable	No	Yes or Unknown	Signature.13	ARID1A | MSH6	No	0	30.82		0
4396	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	52	7.9	Stable	No	No	Signature.1		Yes	0	30.49		0
4397	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2017	I	49	4.4	Stable	No	No			No	0	27.17		0
4398	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	0	3.5	Stable	No	No		ARID1A | ATM	Yes	1	8.21		0
4399	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2016	IV	50	8.8	Stable	No	No	Signature.2	PMS1	Yes	1	30.59		0
4400	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	23	1.8		No	No			No	0	30.88		0
4401	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	III	0	5.3	Stable	No	No			Yes	0	30.62		0
4402	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	27.76		0
4403	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2016	IV	26	5.3	Stable	No	No		ARID1A	No	0	32.82		0
4404	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	91	3.5	Stable	No	No			No	0	29.83		0
4405	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	0	2.6	Stable	No	No		BRCA2	No	0	30.62		0
4406	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	0	30.09		0
4407	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	13	3.5		No	No		PALB2	Yes	1	8.94		0
4408	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	IV	5	2.6	Stable	No	No			No	1	11.01		0
4409	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	29	7.9	Stable	No	No		ATM	No	0	30.85		0
4410	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	3.5	Stable	No	Yes or Unknown			No	0	31.93		0
4411	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	IV	79	0	Stable	No	Yes or Unknown			No	0	32.23		0
4412	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	36	0.9	Stable	No	No			Yes	0	23.2		0
4413	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2016	IV	10	3.5		No	Yes or Unknown			No	0	30.32		0
4414	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	III	22	8.8	Stable	No	No	Signature.25	ATR | CHEK2	No	1	2.5		0
4415	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	I	692	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	29.73		0
4416	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	762	4.4	Stable	No	Yes or Unknown			No	0	27.56		0
4417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.3	MSH2	No	1	5.82		0
4418	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2016	I	107	32.5	Unstable	No	No	Signature.1	NBN | SLX4	No	0	31.74		0
4419	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	8	12.3	Stable	No	No	Signature.1	ATR	No	0	27.1		0
4420	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	4.4	Stable	No	No		ARID1A	Yes	0	25.17		0
4421	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	III	68	1.8	Stable	No	No			No	0	26.41		0
4422	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	130	7	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	7.66		0
4423	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	48	3.5	Stable	No	No	Signature.3		No	0	25.99		0
4424	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	20	6.1		No	No		ARID1A	Yes	1	3.02		0
4425	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0	Stable	No	No			No	0	28.29		0
4426	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	IV	45	7.9	Stable	No	No	Signature.1	ARID1A	Yes	1	2.56		0
4427	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	15	0.9		No	No			No	0	30.62		0
4428	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	378	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	24.71		0
4429	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			No	1	9.26		0
4430	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0	Stable	No	No			No	0	26.94		0
4431	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	III	38	41.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC2 | ERCC4 | MDC1 | MSH3	Yes	1	3.58		0
4432	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2016	I	23	0.9		No	No			No	0	29.7		0
4433	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	I	26	0.9	Stable	No	No			No	0	30.26		0
4434	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.5		No	1	28.25		0
4435	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	194	3.5	Stable	No	Yes or Unknown			No	0	30.39		0
4436	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	55	1.8	Stable	No	No	Signature.12		No	0	30.69		0
4437	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	IV	729	5.3	Stable	No	Yes or Unknown			No	0	31.74		0
4438	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2016	II	0	2.6	Stable	No	No			No	0	9.53		0
4439	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	1.8	Stable	No	No			No	0	24.87		0
4440	Non-ICI treated	Never received ICI	21 - 25	Female	NSCLC	2017	IV	191	8.8	Stable	No	Yes or Unknown	Signature.13	CHEK2 | TP53BP1	No	0	29.27		0
4441	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	24.87		0
4442	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	IV	0	14.9	Stable	No	No	Signature.4	XRCC2	Yes	1	9.92		0
4443	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	34	14.9		No	No	Signature.26		Yes	0	30.42		0
4444	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	36	2.6	Stable	No	No		MRE11A	No	0	29.47		0
4445	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	II	0	8.8	Stable	No	No	Signature.29	RAD50	No	0	7.16		0
4446	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	7	1.8	Stable	No	Yes or Unknown			No	0	29.86		0
4447	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	20	0.9		No	No			No	0	27.27		0
4448	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	27	4.4	Stable	No	No			Yes	0	27.3		0
4449	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	14.9	Stable	No	Yes or Unknown	Signature.6	ARID1A | MLH1	Yes	0	24.54		0
4450	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	I	64	0.9	Stable	No	No			No	0	3.02		0
4451	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	25	8.8	Stable	No	No		ARID1A	No	0	29.08		0
4452	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	20	4.4	Stable	No	No		MUTYH	No	0	30.52		0
4453	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	25	8.8	Stable	No	No	Signature.1		No	0	30.75		0
4454	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		0	1.8		Yes or Unknown	Yes or Unknown			Yes	0	18.07		0
4455	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	48	7	Stable	No	Yes or Unknown			No	0	30.13		0
4456	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	13	4.4	Stable	No	No		CHEK1	No	1	9.2		0
4457	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	0		No	No			No	0	29.67		0
4458	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	29	1.8	Stable	No	No			No	0	28.65		0
4459	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	IV	24	1.8	Stable	No	No			No	0	29.27		0
4460	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		4	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	10.18		0
4461	Non-ICI treated	Never received ICI	86 - 90	Female	Ovarian	2017	IV	125	4.4	Stable	No	Yes or Unknown			No	0	30.59		0
4462	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	39	3.5	Stable	No	No			No	0	28.39		0
4463	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	44	15.8	Unstable	No	No	Signature.6	ATM | MSH2	Yes	0	25.53		0
4464	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	0	0	Stable	No	No			No	0	30.98		0
4465	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		2	4.4	Stable	No	No			No	1	15.18		0
4466	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	9	4.4	Indeterminate	No	No			Yes	0	28.09		0
4467	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	22	2.6	Stable	No	Yes or Unknown			Yes	0	29.7		0
4468	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	0	0	Stable	No	No			No	0	28.42		0
4469	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	16	3.5	Stable	No	No			Yes	0	26.64		0
4470	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2016		319	2.6	Stable	No	Yes or Unknown			Yes	0	12.09		0
4471	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	IV	29	2.6	Stable	No	No		RAD50	No	1	10.25		0
4472	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	7.9	Stable	No	No			No	0	28.62		0
4473	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	5.3	Stable	No	No			No	1	25.89		0
4474	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	71	7	Stable	No	Yes or Unknown			No	1	12.81		0
4475	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	31	2.6	Stable	No	Yes or Unknown			No	0	29.5		0
4476	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	45	0	Stable	No	No			Yes	0	27.47		0
4477	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	4.4	Stable	No	No			Yes	0	6.47		0
4478	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	749	0.9	Stable	No	Yes or Unknown			Yes	0	28.42		0
4479	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		23	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	26.41		0
4480	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017		0	0		No	No			No	0	30.19		0
4481	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	5.3	Stable	No	Yes or Unknown		MSH6	No	0	25.99		0
4482	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	IV	98	0		No	Yes or Unknown			No	0	30.32		0
4483	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	0	30.13		0
4484	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	128	3.5	Stable	No	Yes or Unknown			No	0	30.19		0
4485	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	261	2.6	Stable	No	Yes or Unknown			No	0	28.75		0
4486	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	98	4.4	Stable	No	Yes or Unknown	Signature.3		No	1	17.97		0
4487	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	26	2.6	Stable	No	Yes or Unknown			No	0	24.97		0
4488	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	868	2.6	Stable	No	Yes or Unknown			No	0	31.05		0
4489	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2016	IV	0	0	Stable	No	Yes or Unknown			No	0	31.64		0
4490	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2016	IV	51	14.9	Stable	No	Yes or Unknown	Signature.2		No	1	20.3		0
4491	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	165	4.4	Stable	No	Yes or Unknown	Signature.10	NBN	No	1	11.4		0
4492	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	45	4.4	Stable	No	No	Signature.24	BRIP1	Yes	0	28.58		0
4493	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			Yes	0	24.71		0
4494	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	30.32		0
4495	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	IV	44	12.3	Stable	No	No	Signature.13	ARID1A | ATM | MSH2	No	0	4.9		0
4496	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	III	12	1.8	Stable	No	No			No	0	5.72		0
4497	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	IV	64	7		No	No	Signature.6		Yes	1	8.31		0
4498	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	90	3.5	Stable	No	Yes or Unknown		BRCA2	No	0	28.88		0
4499	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	283	0	Stable	No	Yes or Unknown			Yes	0	29.73		0
4500	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	0.9	Stable	No	No			Yes	0	24.64		0
4501	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown		PARP1	No	0	24.05		0
4502	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	3	8.8	Stable	No	No	Signature.13		Yes	0	29.21		0
4503	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	175	0	Stable	No	No			No	0	30.06		0
4504	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	26.48		0
4505	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	0	5.3	Stable	No	No	Signature.6		No	0	26.35		0
4506	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	15	4.4		No	No	Signature.26	BRCA2	Yes	0	29.73		0
4507	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	14	2.6	Stable	No	No		ATM	No	1	2.99		0
4508	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	24	6.1	Stable	No	No	Signature.2		No	0	25.59		0
4509	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	4.4		No	No		RAD50	No	1	20.6		0
4510	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	52	65.8	Stable	No	Yes or Unknown	Signature.2	ARID1A | ATM | ERCC2 | ERCC3 | ERCC4 | ERCC5 | FANCA | PMS2 | RAD50 | TP53BP1	No	0	29.24		0
4511	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	218	4.4	Stable	No	Yes or Unknown			No	1	27.6		0
4512	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	0	28.58		0
4513	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	0.9	Stable	No	Yes or Unknown			No	0	30.92		0
4514	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	7	Stable	No	No			No	0	17.91		0
4515	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	9	2.6	Stable	No	Yes or Unknown			No	0	30.09		0
4516	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	27	4.4	Stable	No	Yes or Unknown		MSH6	No	0	5.82		0
4517	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	29	0		No	No			No	0	29.93		0
4518	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	20	1.8	Stable	No	No			No	0	13.34		0
4519	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	33	0.9	Stable	No	Yes or Unknown			No	0	29.8		0
4520	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	19	0.9		No	No			Yes	0	26.18		0
4521	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		3	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	29.44		0
4522	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4		No	No	Signature.5	CHEK2	No	0	24.74		0
4523	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	4	7		No	No	Signature.4	BRIP1	Yes	0	1.77		0
4524	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	I	24	8.8	Stable	No	No	Signature.4	ATM | BRCA2	No	0	26.15		0
4525	Non-ICI treated	Never received ICI	81 - 85	Male	Sarcoma	2018	III	47	0	Stable	No	No			No	0	13.57		0
4526	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	65	4.4	Stable	No	Yes or Unknown			Yes	0	29.54		0
4527	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2017		0	0	Stable	No	No			No	0	27.79		0
4528	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	53	14	Stable	No	No	Signature.18		No	0	29.34		0
4529	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	12	5.3	Stable	No	No		ARID1A	No	0	28.55		0
4530	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		1	3.5	Stable	No	No		BRCA1	No	0	11.01		0
4531	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2016	I	100	0.9	Stable	No	No			No	0	27.63		0
4532	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	15.38		0
4533	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	0	0.9	Stable	No	No			No	0	28.25		0
4534	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	7.9	Stable	No	No	Signature.18	ARID1A	No	0	29.86		0
4535	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	28.58		0
4536	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	27.33		0
4537	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	11.4	Stable	No	No	Signature.4		No	0	25.03		0
4538	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	II	92	2.6	Stable	No	No			No	0	30.98		0
4539	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	440	2.6	Stable	No	Yes or Unknown			No	1	29.04		0
4540	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	0	13.2	Stable	No	No	Signature.1	ARID1A	Yes	0	29.57		0
4541	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	29	2.6	Stable	No	Yes or Unknown			Yes	0	7.66		0
4542	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			No	0	2.79		0
4543	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2016	IV	186	2.6	Stable	No	No	Signature.1		No	1	11.86		0
4544	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	21	3.5	Stable	No	No			No	0	21.98		0
4545	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	24	2.6	Stable	No	No			Yes	0	28.16		0
4546	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2017	III	0	0	Stable	No	No			No	0	29.47		0
4547	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	82	3.5	Stable	No	No			Yes	0	27.6		0
4548	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	50	0.9	Stable	No	Yes or Unknown			No	0	30.16		0
4549	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	24	13.2	Stable	No	No	Signature.4	ARID1A | ERCC5	No	0	30.23		0
4550	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	36	4.4	Stable	No	Yes or Unknown			No	1	22.31		0
4551	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	22	1.8	Stable	No	Yes or Unknown			Yes	0	28.98		0
4552	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	14	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	29.21		0
4553	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	33	5.3	Stable	No	No			No	0	17.84		0
4554	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	35	6.1	Stable	No	No			No	1	20.96		0
4555	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	2.6	Stable	No	No			No	0	25.99		0
4556	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	0	6.1	Stable	No	No		ARID1A	No	0	25.56		0
4557	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	22	35.1	Stable	No	No	Signature.6	ARID1A	No	0	20.34		0
4558	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	10	13.2		No	No	Signature.4		Yes	1	5.72		0
4559	Non-ICI treated	Never received ICI	76 - 80	Female	SCLC	2017	IV	21	7	Stable	No	No	Signature.29	BRCA2	Yes	1	20.9		0
4560	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	6	3.5	Stable	No	No			No	1	1.68		0
4561	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	8	4.4	Stable	No	No			No	1	7.62		0
4562	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	177	0.9	Stable	No	Yes or Unknown			No	0	19.84		0
4563	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	21	3.5	Stable	No	No			No	0	27.99		0
4564	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	27	5.3	Stable	No	No			No	0	26.05		0
4565	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	809	10.5	Stable	No	Yes or Unknown	Signature.1		No	0	30.16		0
4566	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	17	4.4	Stable	No	No			No	1	26.55		0
4567	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	577	1.8	Stable	No	Yes or Unknown	Signature.5		No	0	30.09		0
4568	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	360	5.3	Stable	No	No			No	0	30.03		0
4569	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	9.7	Stable	No	No	Signature.3	ATR	Yes	0	27.56		0
4570	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	14	7	Stable	No	No	Signature.19	TP53BP1	Yes	0	28.39		0
4571	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	IV	0	1.8	Stable	No	Yes or Unknown			No	0	29.9		0
4572	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	30.32		0
4573	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	III	27	0.9	Stable	No	Yes or Unknown			No	0	28.98		0
4574	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	23	0.9	Stable	No	No			No	0	23.89		0
4575	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	7	5.3	Stable	No	No		ARID1A | FANCC	Yes	1	3.71		0
4576	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	15	0.9	Stable	No	No			No	0	29.31		0
4577	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	0	3.5	Stable	No	No		BRCA1	No	0	29.8		0
4578	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	0	1.8	Stable	No	No			No	1	27.47		0
4579	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	28	0.9	Stable	No	Yes or Unknown			No	0	26.18		0
4580	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	21	2.6	Stable	No	No			No	0	27.66		0
4581	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		41	1.8	Stable	No	No			No	0	3.12		0
4582	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	1	6.1		No	No			No	1	18.96		0
4583	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	1	7.9	Stable	No	No	Signature.1		No	1	28.88		0
4584	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	IV	0	8.8	Stable	No	No	Signature.1		No	1	11.07		0
4585	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		6	0.9	Stable	Yes or Unknown	Yes or Unknown			Yes	0	3.55		0
4586	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	29.21		0
4587	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	2.6	Stable	No	No		MSH3	No	0	29.77		0
4588	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	23.46		0
4589	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	1	10.84		0
4590	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	26.61		0
4591	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	7	Stable	No	No		PMS2	No	1	1.18		0
4592	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	26	0.9	Stable	No	No			No	0	14.92		0
4593	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	9	6.1	Stable	No	No			No	1	20.34		0
4594	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	220	2.6	Stable	No	Yes or Unknown			No	0	29.37		0
4595	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	64	5.3	Stable	No	No			No	0	20.73		0
4596	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	27	6.1	Stable	No	No	Signature.1	ATM | ERCC2	Yes	1	2.17		0
4597	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	I	0	0	Stable	No	No			No	0	18.14		0
4598	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	286	3.5	Stable	No	Yes or Unknown			No	0	32.13		0
4599	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	28	4.4	Stable	No	No		ATM	Yes	0	28.48		0
4600	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	17	4.4	Stable	No	No		CHEK2	No	0	27.17		0
4601	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	0	5.3	Stable	No	Yes or Unknown			Yes	0	24.11		0
4602	Non-ICI treated	Never received ICI	26 - 30	Male	Head & Neck	2017	IV	0	8.8	Stable	No	No		ARID1A	Yes	0	30.03		0
4603	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	39	6.1	Stable	No	Yes or Unknown	Signature.2		Yes	0	27.14		0
4604	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	39	4.4	Stable	No	No			No	0	20.5		0
4605	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	II	7	9.7	Stable	No	No	Signature.1	FANCA	No	0	3.52		0
4606	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	18.53		0
4607	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	369	3.5	Stable	No	Yes or Unknown			No	1	23.16		0
4608	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	22	4.4	Stable	No	No			No	1	7.89		0
4609	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	409	10.5	Stable	No	Yes or Unknown	Signature.2	CHEK2	No	0	29.9		0
4610	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	24	9.7		No	No	Signature.24		Yes	1	2.27		0
4611	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	III	673	2.6	Stable	No	Yes or Unknown			No	0	29.24		0
4612	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	50	3.5	Stable	No	No			No	0	28.42		0
4613	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	26	7	Stable	No	No	Signature.29		No	0	4.34		0
4614	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	10.02		0
4615	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	37	2.6	Stable	No	Yes or Unknown		PALB2	No	0	23.85		0
4616	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	48	40.4	Stable	No	No	Signature.4	ATR | BRCA1	No	0	12.65		0
4617	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	26.51		0
4618	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	IV	0	1.8		No	Yes or Unknown			No	0	29.73		0
4619	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	17	1.8	Stable	No	No			No	0	28.68		0
4620	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	257	3.5	Stable	No	Yes or Unknown			No	1	19.71		0
4621	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	26.15		0
4622	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	29.34		0
4623	Non-ICI treated	Never received ICI	86 - 90	Female	Sarcoma	2017	III	42	0.9	Stable	No	Yes or Unknown			Yes	0	8.71		0
4624	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	16	2.6	Stable	No	No			No	0	29.47		0
4625	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2016		71	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	29.21		0
4626	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	28.29		0
4627	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	28	3.5	Stable	No	No		PALB2	No	0	26.12		0
4628	Non-ICI treated	Never received ICI	61 - 65	Female	Esophageal	2017	IV	0	6.1	Stable	No	No			No	1	14.95		0
4629	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	12.75		0
4630	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			Yes	0	29.37		0
4631	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	33	2.6	Stable	No	No			No	0	30.06		0
4632	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	0	4.4	Stable	No	No		ERCC5	Yes	0	28.22		0
4633	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		22	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	3.52		0
4634	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	27	4.4	Stable	No	No	Signature.1		No	1	14.62		0
4635	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	I	35	4.4	Stable	No	No	Signature.4		No	0	16.49		0
4636	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	1.8	Stable	No	Yes or Unknown			Yes	0	28.88		0
4637	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2016	IV	7	8.8	Stable	No	No	Signature.6		Yes	1	10.05		0
4638	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	28	1.8	Stable	No	No			Yes	0	2.89		0
4639	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	21	5.3	Stable	No	No			Yes	0	29.27		0
4640	Non-ICI treated	Never received ICI	36 - 40	Male	Sarcoma	2017		42	0.9	Stable	No	No			No	0	23.46		0
4641	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		2	4.4	Stable	No	No			Yes	1	6.11		0
4642	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	I	0	2.6	Stable	No	No		NBN	Yes	0	26.55		0
4643	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	33	2.6	Stable	No	No			Yes	0	29.17		0
4644	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2016	IV	442	9.7	Stable	No	Yes or Unknown	Signature.3		No	1	21.16		0
4645	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			No	0	29.4		0
4646	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	174	1.8	Stable	No	Yes or Unknown			No	0	29.83		0
4647	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	33	37.7	Unstable	No	No	Signature.1	ARID1A | ATM | MSH2 | MSH6	No	0	25.63		0
4648	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	II	14	57.9	Unstable	No	No	Signature.6	ARID1A | FANCA | MSH3 | XRCC2	Yes	0	27.6		0
4649	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	237	6.1	Stable	No	Yes or Unknown			No	1	9.26		0
4650	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	30.16		0
4651	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.18		No	0	29.63		0
4652	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	49	2.6	Stable	No	Yes or Unknown			Yes	0	25.4		0
4653	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	I	102	1.8	Stable	No	No			Yes	0	30.72		0
4654	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	13.47		0
4655	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	III	16	36	Unstable	No	No	Signature.6	ATM | BLM | CHEK2 | MDC1	No	0	24.57		0
4656	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	II	0	3.5	Stable	No	No		ATM	No	0	21.36		0
4657	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2016	III	62	1.8	Stable	No	No			No	1	15.44		0
4658	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	49	2.6	Stable	No	Yes or Unknown			No	0	30.09		0
4659	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	26	2.6	Stable	No	No			No	0	28.55		0
4660	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	36	115	Unstable	No	No	Signature.6	ATM | BRCA2 | BRIP1 | MDC1 | MLH1 | MSH2 | MSH3 | PALB2 | PMS1 | TP53BP1	No	0	26.22		0
4661	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	2	10.5	Stable	No	No	Signature.4	BRCA2 | MDC1	No	0	29.04		0
4662	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	III	0	15.8	Stable	No	No	Signature.4		No	1	24.84		0
4663	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	3.5	Stable	No	No		ATR	Yes	0	29.08		0
4664	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	35	13.2	Stable	No	No	Signature.2	RAD51	No	0	25.89		0
4665	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2016	IV	0	3.5	Stable	No	No			No	0	15.18		0
4666	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	35	3.5	Stable	No	No			Yes	0	24.08		0
4667	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		5	7	Stable	No	No			No	1	26.25		0
4668	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	12	2.6	Stable	No	No			Yes	1	20.83		0
4669	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	42	7	Stable	No	No			Yes	0	28.55		0
4670	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	146	1.8	Stable	No	No	Signature.5		No	0	27.47		0
4671	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	21	4.4	Stable	No	No		MSH2	No	0	29.24		0
4672	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	IV	28	33.4	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | PALB2	No	1	5.82		0
4673	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	54	2.6	Stable	No	Yes or Unknown			Yes	0	26.41		0
4674	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	29	0.9	Stable	No	No			No	0	24.08		0
4675	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	III	0	0.9	Stable	No	No			Yes	0	14.82		0
4676	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	29	6.1	Stable	No	No			No	0	27.4		0
4677	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	15.8	Indeterminate	No	No	Signature.13	ARID1A	No	1	5.68		0
4678	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	11	2.6	Stable	No	No			Yes	1	8.21		0
4679	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		9	0	Stable	No	No			No	0	21.45		0
4680	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	20	0.9	Stable	No	No			No	0	28.45		0
4681	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	1	20.76		0
4682	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	25.03		0
4683	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	19	3.5	Stable	No	No			No	0	28.81		0
4684	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2017	IV	196	18.4	Stable	No	Yes or Unknown	Signature.13	ATM | MDC1	No	0	29.54		0
4685	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	20	5.3	Stable	No	No		ATM | MSH6	No	0	29.17		0
4686	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	19	6.1	Stable	No	No			No	0	23.2		0
4687	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2017	I	7	2.6	Stable	No	No			Yes	1	7.69		0
4688	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	35	0.9	Stable	No	No			Yes	0	28.09		0
4689	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2017		14	0.9	Stable	No	No			Yes	0	28.35		0
4690	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2016	III	141	2.6	Stable	No	No			No	0	32		0
4691	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	6.1	Stable	No	No			Yes	0	29.01		0
4692	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2017	II	13	3.5	Stable	No	No			No	0	24.61		0
4693	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	14	4.4	Stable	No	No			No	0	21.32		0
4694	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	0.9	Stable	No	Yes or Unknown			No	0	28.88		0
4695	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	28.29		0
4696	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	9.7	Stable	No	Yes or Unknown	Signature.13	MDC1	No	0	27.14		0
4697	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	19	4.4	Stable	No	No			Yes	1	5.68		0
4698	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	29.47		0
4699	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017	IV	0	2.6	Stable	No	No			Yes	0	27.04		0
4700	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	143	0	Stable	No	Yes or Unknown	Signature.5		No	0	29.17		0
4701	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	4.4	Indeterminate	No	No	Signature.4		No	0	28.32		0
4702	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	154	0.9	Stable	No	Yes or Unknown			No	0	27.66		0
4703	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	0	0	Stable	No	No		MLH1	No	0	29.04		0
4704	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	21.39		0
4705	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	2.6	Stable	No	No		MSH2	No	0	23.85		0
4706	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	18	36.9	Unstable	No	No	Signature.6	ARID1A | NTHL1	Yes	0	20.9		0
4707	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	455	16.7	Stable	No	Yes or Unknown	Signature.13	ATR | BRCA2 | MRE11A | RAD50 | SLX4	Yes	0	20.47		0
4708	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	18	5.3	Stable	No	No			No	1	3.58		0
4709	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	31	1.8	Stable	No	Yes or Unknown			Yes	0	29.11		0
4710	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	632	3.5	Stable	No	Yes or Unknown			Yes	0	29.31		0
4711	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	29	3.5	Stable	No	No		BRCA1	No	0	25.82		0
4712	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	15	7	Stable	No	No	Signature.1		Yes	0	28.58		0
4713	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	518	4.4	Stable	No	Yes or Unknown	Signature.3	PARP1	No	0	29.17		0
4714	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2016	IV	176	6.1	Stable	No	No			No	0	33.12		0
4715	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2017	IV	0	4.4	Stable	No	No		ARID1A	No	0	10.35		0
4716	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	II	0	28.1	Stable	No	No	Signature.13	BRCA2 | CHEK2 | ERCC5 | RAD54L | SLX4	Yes	0	28.75		0
4717	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	54	3.5	Stable	No	No			Yes	0	28.52		0
4718	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	5	5.3	Stable	No	No			Yes	0	9.03		0
4719	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	8.77		0
4720	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	10	1.8	Stable	No	No			No	0	28.85		0
4721	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	23.33		0
4722	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	20	0.9	Stable	No	No			No	0	25.63		0
4723	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	0	29.67		0
4724	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	726	0.9	Stable	No	Yes or Unknown			No	0	29.21		0
4725	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	43	228.2	Stable	No	No	Signature.10	ARID1A | ATM | BRCA1 | BRCA2 | ERCC4 | ERCC5 | FANCC | MRE11A | MSH3 | MSH6 | PMS1 | PMS2 | RAD50 | SLX4 | TP53BP1	No	0	26.91		0
4726	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	0.9	Stable	No	No			Yes	0	25.07		0
4727	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	21	4.4	Stable	No	No			No	0	27.37		0
4728	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	20	7	Stable	No	No	Signature.13	BRCA2	No	0	29.14		0
4729	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	29	40.4	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA2 | ERCC3 | MLH1	No	0	20.53		0
4730	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	II	0	3.5	Stable	No	No	Signature.3	ATR	Yes	1	15.15		0
4731	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	9.7	Stable	No	No	Signature.17	ARID1A	No	1	13.11		0
4732	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	28	7	Stable	No	No			No	0	25.1		0
4733	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2016	IV	365	4.4	Stable	No	Yes or Unknown	Signature.3		No	0	31.34		0
4734	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	21	3.5	Stable	No	No			No	0	29.96		0
4735	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	28.39		0
4736	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	76	3.5	Stable	No	No			No	0	24.84		0
4737	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	28	2.6	Stable	No	No			Yes	0	27.4		0
4738	Non-ICI treated	Never received ICI	36 - 40	Female	Ovarian	2017	III	0	3.5	Stable	No	No			Yes	0	24.77		0
4739	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	175	0		No	Yes or Unknown			No	0	30.09		0
4740	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	56	4.4	Stable	No	No			No	0	30.09		0
4741	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No			No	1	15.8		0
4742	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	I	0	0	Stable	No	No	Signature.1		No	0	18.99		0
4743	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2016	IV	128	3.5	Stable	No	Yes or Unknown		ARID1A	No	1	10.18		0
4744	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	30	1.8	Stable	No	No			No	0	26.02		0
4745	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	5.3	Stable	No	No			No	1	17.12		0
4746	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	33	5.3	Stable	No	No	Signature.2	MSH6	Yes	0	28.09		0
4747	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	II	0	4.4	Stable	No	No			No	0	7.82		0
4748	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		6	6.1	Stable	Yes or Unknown	Yes or Unknown			No	0	10.61		0
4749	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	35	1.8	Stable	No	No		ATM	Yes	0	29.24		0
4750	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	429	4.4	Stable	No	No			No	0	14.72		0
4751	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	496	1.8	Stable	No	Yes or Unknown			No	1	20.04		0
4752	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	3.5	Stable	No	No			No	0	25.17		0
4753	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	1	25.13		0
4754	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	16	3.5	Stable	No	Yes or Unknown			No	0	29.7		0
4755	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	19	5.3	Stable	No	No	Signature.19	ARID1A	No	1	5.32		0
4756	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	23	1.8	Stable	No	No			No	0	25.63		0
4757	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	7.9	Stable	No	Yes or Unknown			No	0	28.55		0
4758	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	4.4	Indeterminate	No	No	Signature.3	RAD54L	No	1	11.93		0
4759	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	41	3.5	Stable	No	No		ARID1A	Yes	1	16.49		0
4760	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	I	48	0.9	Stable	No	No			No	0	30.09		0
4761	Non-ICI treated	Never received ICI	36 - 40	Male	Bladder	2017	I	0	4.4	Stable	No	No		BRCA2	No	0	28.98		0
4762	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	18	5.3	Stable	No	No			No	0	26.71		0
4763	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	28.85		0
4764	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	392	2.6	Stable	No	Yes or Unknown			No	1	26.09		0
4765	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	33	1.8	Stable	No	No			Yes	0	25.56		0
4766	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	31	3.5	Stable	No	No			No	0	27.2		0
4767	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.5		Yes	1	7.2		0
4768	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	286	8.8	Stable	No	No	Signature.1	BRCA2 | MSH3	Yes	0	29.17		0
4769	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	180	0	Stable	No	Yes or Unknown			No	0	29.86		0
4770	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	IV	12	0	Stable	No	No			Yes	0	3.22		0
4771	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		0	3.5	Stable	No	No			No	0	21.65		0
4772	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	16	7	Stable	No	No	Signature.24		No	1	14.19		0
4773	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2017	II	586	1.8	Stable	No	No			No	0	26.81		0
4774	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	II	8	2.6	Stable	No	No		PALB2	No	1	25.17		0
4775	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	145	0	Stable	No	No			No	1	24.11		0
4776	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	III	6	1.8	Stable	No	No			No	1	20.17		0
4777	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	0	7	Stable	No	Yes or Unknown	Signature.13		No	0	27.99		0
4778	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	8.25		0
4779	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	26.35		0
4780	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	0	6.1	Stable	No	No	Signature.5	RAD50	Yes	0	28.98		0
4781	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	7	2.6	Stable	No	No			No	0	29.17		0
4782	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	3.5	Stable	No	Yes or Unknown		BRCA2	No	0	28.55		0
4783	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	183	0		No	Yes or Unknown			No	0	28.45		0
4784	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	22	1.8	Stable	No	No			No	0	24.84		0
4785	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	1	5.3	Stable	No	No	Signature.6		No	0	29.27		0
4786	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	184	3.5	Stable	No	Yes or Unknown			No	0	26.15		0
4787	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	27.99		0
4788	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	0	6.93		0
4789	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	60	3.5	Stable	No	No		NBN	No	0	27.63		0
4790	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	19	7	Stable	No	No			Yes	0	24.97		0
4791	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	14	11.4	Stable	No	No	Signature.1	ARID1A | FANCC	No	1	17.41		0
4792	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	13	10.5	Stable	No	No	Signature.1		No	0	29.4		0
4793	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	18	32.5	Unstable	No	No	Signature.6	ARID1A | ATM | FANCA | MSH6 | MUTYH	No	0	26.68		0
4794	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	1	27.27		0
4795	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown		ATR	No	0	18.86		0
4796	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	46	1.8	Stable	No	No			No	0	23.85		0
4797	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	34	5.3	Stable	No	No			No	0	29.17		0
4798	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	106	7	Stable	No	Yes or Unknown	Signature.15		No	0	29.5		0
4799	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	0.9	Stable	No	No			No	0	26.25		0
4800	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	37	6.1	Stable	No	No	Signature.1		Yes	0	26.64		0
4801	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	22	7	Stable	No	No	Signature.1		Yes	0	26.02		0
4802	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	74	3.5	Stable	No	Yes or Unknown			No	1	6.11		0
4803	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	260	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	30.39		0
4804	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	6.7		0
4805	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	9	1.8	Stable	No	Yes or Unknown			No	0	29.67		0
4806	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	5.29		0
4807	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	3.5	Stable	No	No	Signature.2		No	0	27.96		0
4808	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	IV	42	36.9	Unstable	No	No	Signature.6	ARID1A | MSH6	No	0	28.71		0
4809	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2017	I	16	4.4	Stable	No	No			No	0	24.11		0
4810	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	24	8.8	Stable	No	No			Yes	0	8.28		0
4811	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		25	3.5	Stable	No	No			No	1	12.25		0
4812	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	224	10.5	Stable	No	No	Signature.2	ERCC4	Yes	0	30.16		0
4813	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No		BRCA1	No	1	25.63		0
4814	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	III	31	1.8	Stable	No	No			Yes	0	27.6		0
4815	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	27	1.8	Stable	No	No			No	0	25.76		0
4816	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	6	8.8	Stable	No	No	Signature.3	BRCA2	No	0	28.29		0
4817	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	27	0.9	Stable	No	No			No	0	25.2		0
4818	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	1.8	Stable	No	No			Yes	0	25.69		0
4819	Non-ICI treated	Never received ICI	56 - 60	Male	Cutaneous Melanoma 	2017	I	25	0.9	Stable	No	No			No	0	23.1		0
4820	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	419	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	26.97		0
4821	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	5.3	Stable	No	No		ATM	No	0	14.46		0
4822	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	27	4.4	Stable	No	No		ARID1A	Yes	0	28.71		0
4823	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	40	2.6	Stable	No	No		MSH3	Yes	0	22.51		0
4824	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	18	5.3	Stable	No	No			No	0	27.17		0
4825	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	26	3.5	Stable	No	No	Signature.20		No	0	28.65		0
4826	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	30	0.9	Stable	No	Yes or Unknown			No	0	28.85		0
4827	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2016	IV	0	4.4	Stable	No	No		ATR	No	0	31.93		0
4828	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	3.5	Stable	No	No		ARID1A	Yes	0	25.76		0
4829	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017		0	0.9	Stable	No	Yes or Unknown			No	0	28.65		0
4830	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	II	17	1.8	Stable	No	No			No	0	17.84		0
4831	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2016	IV	82	0.9	Stable	No	No			No	0	31.57		0
4832	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	26	7	Stable	No	Yes or Unknown	Signature.3	ERCC2	No	0	28.78		0
4833	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		5	2.6	Stable	No	No			No	1	27.4		0
4834	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2016	I	0	2.6	Stable	No	No		MSH2	No	0	33.97		0
4835	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	0	Stable	No	Yes or Unknown			No	0	29.11		0
4836	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2017	IV	19	0	Stable	No	No			No	1	10.48		0
4837	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	0.9	Stable	No	No		ATM | FANCA	No	0	29.08		0
4838	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	4.11		0
4839	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	III	179	3.5	Stable	No	Yes or Unknown			No	1	22.9		0
4840	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	3.5	Stable	No	No			No	0	28.16		0
4841	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	12	5.3	Stable	No	No		ATM	Yes	0	24.11		0
4842	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	264	5.3	Stable	No	Yes or Unknown			No	0	28.35		0
4843	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	IV	28	2.6	Stable	No	No			No	1	24.34		0
4844	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	44	5.3	Stable	No	No		ARID1A | CHEK2	No	1	17.64		0
4845	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		BRCA2	No	1	14.88		0
4846	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.6		No	0	30.39		0
4847	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	1	18.83		0
4848	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	III	109	3.5	Stable	No	No	Signature.1		No	0	29.8		0
4849	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	4.4	Stable	No	No	Signature.1		No	0	6.11		0
4850	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	34	0	Stable	No	Yes or Unknown			No	0	28.88		0
4851	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	0	0.9	Stable	No	No			No	0	26.22		0
4852	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	0	0		No	No			No	1	9.63		0
4853	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	44	23.7	Stable	No	No	Signature.6	SLX4	No	0	26.71		0
4854	Non-ICI treated	Never received ICI	31 - 35	Female	Gastric	2016	IV	112	2.6	Stable	No	No	Signature.1		No	0	9.03		0
4855	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		2	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	22.08		0
4856	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	0	3.5	Stable	No	No		ARID1A	No	0	25.92		0
4857	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	23.1		0
4858	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	154	0	Stable	No	Yes or Unknown			Yes	0	29.9		0
4859	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	1.8	Stable	No	No			Yes	0	26.91		0
4860	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	24	3.5	Stable	No	No	Signature.1		No	1	20.07		0
4861	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	27	4.4	Stable	No	No	Signature.1		Yes	0	26.48		0
4862	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	I	66	10.5		No	No	Signature.5	ATR	No	0	3.35		0
4863	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	27	4.4	Stable	No	No		ARID1A	Yes	0	28.65		0
4864	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	21.72		0
4865	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	29.11		0
4866	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	28	2.6	Stable	No	No			No	0	28.09		0
4867	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	64	7	Stable	No	No		PALB2	Yes	1	9.3		0
4868	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		2	4.4	Stable	No	No			No	1	7.89		0
4869	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	0	1.8	Stable	No	No			No	1	12.32		0
4870	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	25.99		0
4871	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2016		166	0	Stable	No	No			No	0	26.41		0
4872	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	III	0	14.9	Stable	No	No	Signature.3	ATM	Yes	0	26.15		0
4873	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	I	29	0	Stable	No	No			No	0	28.78		0
4874	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	6	9.7	Stable	No	No	Signature.22	ARID1A | BRIP1	No	1	6.47		0
4875	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	4.4	Stable	No	No			No	1	8.61		0
4876	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	12	1.8	Stable	No	No			No	0	25.1		0
4877	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	III	0	7.9	Stable	No	No	Signature.2	MRE11A	Yes	1	11.14		0
4878	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		95	2.6	Stable	No	No			Yes	0	27.1		0
4879	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	17	12.3	Stable	No	No	Signature.4	MDC1	Yes	1	1.74		0
4880	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	25	32.5	Unstable	No	No	Signature.6	ARID1A | PARP1	No	0	19.48		0
4881	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	III	0	2.6	Stable	No	No			Yes	0	2.14		0
4882	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	2.6	Stable	No	No		ARID1A	No	0	28.55		0
4883	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	IV	126	0	Stable	No	No			No	1	24.94		0
4884	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	III	143	1.8	Indeterminate	No	Yes or Unknown			No	0	28.85		0
4885	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	14.16		0
4886	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	22	4.4	Stable	No	Yes or Unknown			No	1	19.84		0
4887	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	3	2.6	Stable	No	No	Signature.26		Yes	1	6.28		0
4888	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	2.6	Stable	No	No		ERCC5	No	1	7.23		0
4889	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2017	I	0	29.8	Stable	No	No	Signature.2	ATM | ERCC2 | RAD50	Yes	0	26.18		0
4890	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	0.9	Stable	No	No			No	0	21.39		0
4891	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	0	4.4	Stable	No	No		BRCA1	No	0	27.76		0
4892	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	688	0.9	Stable	No	No			No	0	28.45		0
4893	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2017	IV	3	0	Stable	No	No			No	0	28.29		0
4894	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	0	0	Stable	No	No			No	0	23.59		0
4895	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	1	21.82		0
4896	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	II	337	2.6	Stable	No	No			No	0	28.35		0
4897	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	17	5.3	Stable	No	No	Signature.8	BRCA2 | NTHL1	Yes	0	28.45		0
4898	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	20	7	Stable	No	Yes or Unknown	Signature.1	RAD50	No	0	22.37		0
4899	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	715	8.8	Stable	No	No		MSH6	Yes	0	28.25		0
4900	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	III	168	19.3	Stable	No	No	Signature.4	ATM	No	0	23.1		0
4901	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2017	IV	0	7.9	Stable	No	No	Signature.13	ARID1A	No	0	27.83		0
4902	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	0	5.3	Stable	No	No			No	0	27.33		0
4903	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	5.3	Stable	No	Yes or Unknown			No	0	30.52		0
4904	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	20	5.3	Stable	No	No			No	1	16.72		0
4905	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	17	4.4	Stable	No	Yes or Unknown			No	0	28.02		0
4906	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	70	4.4	Stable	No	No		PALB2	Yes	0	25.2		0
4907	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2017	IV	0	11.4	Stable	No	No	Signature.29	ARID1A | FANCA	Yes	1	12.02		0
4908	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	II	720	0		No	Yes or Unknown			No	0	28.25		0
4909	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	86	0.9	Stable	No	No			Yes	0	28.62		0
4910	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	28	6.1	Stable	No	No			No	0	27.6		0
4911	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	21	0.9	Stable	No	No			Yes	0	28.48		0
4912	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	48	4.4	Stable	No	No			Yes	0	26.58		0
4913	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	29.7		0
4914	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	3	0.9	Stable	No	No			Yes	0	27.53		0
4915	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017		495	1.8	Stable	No	Yes or Unknown			No	0	30.03		0
4916	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	II	0	6.1	Stable	No	No		BRCA2	No	0	27.24		0
4917	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	27	2.6	Stable	No	Yes or Unknown			No	0	24.15		0
4918	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	38	0.9	Stable	No	Yes or Unknown			No	0	27.76		0
4919	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	4.4	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.18	ATR	No	0	14.16		0
4920	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2016	II	37	2.6	Stable	No	No		PMS2	No	0	34.04		0
4921	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	25	0.9	Stable	No	Yes or Unknown			No	0	26.91		0
4922	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	20	0.9	Stable	No	No			No	0	23.06		0
4923	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	0	20.6		0
4924	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	71	5.3	Stable	No	Yes or Unknown	Signature.3	BRIP1	No	0	29.86		0
4925	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	626	2.6	Stable	No	Yes or Unknown			No	0	29.11		0
4926	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2017	II	60	4.4	Stable	No	No			No	0	28.85		0
4927	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	478	6.1	Stable	No	Yes or Unknown	Signature.24		No	1	26.78		0
4928	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	708	12.3	Stable	No	Yes or Unknown	Signature.3	MDC1 | PARP1	No	1	23.69		0
4929	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	197	1.8	Stable	No	Yes or Unknown			No	1	15.61		0
4930	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	21.75		0
4931	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No	Signature.1		No	0	20.53		0
4932	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2017	III	17	3.5	Stable	No	No		FANCC	Yes	0	28.62		0
4933	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	20	0.9	Stable	No	No			No	0	28.25		0
4934	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	4.4	Stable	No	No			Yes	0	23.43		0
4935	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	202	0	Stable	No	Yes or Unknown			No	0	27.89		0
4936	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	18	0.9	Stable	No	No			No	0	27.43		0
4937	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	12.3	Stable	No	No	Signature.4		No	1	2.46		0
4938	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	28.09		0
4939	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	28	17.6	Indeterminate	No	No	Signature.5	ARID1A | BLM | PMS2 | SLX4	Yes	0	23.23		0
4940	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2016	IV	263	1.8	Stable	No	No			No	0	11.7		0
4941	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	28	0.9	Stable	No	No			Yes	0	25.95		0
4942	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	7	12.3	Stable	No	Yes or Unknown	Signature.4		No	0	27.1		0
4943	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	11	4.4	Stable	No	No		ATM	No	0	23		0
4944	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	III	0	2.6	Stable	No	No	Signature.5		No	0	28.68		0
4945	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	40	1.8	Stable	No	No		MUTYH	Yes	0	28.32		0
4946	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	8	5.3	Stable	No	Yes or Unknown			No	1	15.15		0
4947	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		Yes	0	26.91		0
4948	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	25	0		No	No		MUTYH	No	0	26.02		0
4949	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	IV	0	4.4	Stable	No	No	Signature.24		Yes	0	2.27		0
4950	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	26.45		0
4951	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	25	36.9	Unstable	No	Yes or Unknown	Signature.1	ARID1A | SLX4	No	0	28.39		0
4952	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	163	0	Stable	No	Yes or Unknown			Yes	0	26.81		0
4953	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	28.32		0
4954	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2016	IV	267	0.9	Stable	No	No	Signature.1		No	0	18.96		0
4955	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	6.1	Stable	No	No	Signature.8		No	0	12.91		0
4956	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2016	I	274	4.4	Stable	No	No			No	0	13.11		0
4957	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	93	0	Stable	No	No			No	0	27.4		0
4958	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	39	0		No	No			No	0	27.14		0
4959	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	22.24		0
4960	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	51	0.9	Stable	No	No			No	0	28.85		0
4961	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	31	7	Stable	No	No			No	0	2.99		0
4962	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		15	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	17.58		0
4963	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			Yes	0	28.06		0
4964	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	IV	24	0.9	Stable	No	Yes or Unknown			No	1	21.65		0
4965	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	69	4.4	Stable	No	No			No	0	28.42		0
4966	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	62	1.8	Stable	No	Yes or Unknown			No	0	27.63		0
4967	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	1	7.89		0
4968	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.29		No	1	15.74		0
4969	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	33	9.7	Stable	No	No	Signature.4	PMS1	No	0	25.3		0
4970	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	4.4	Stable	No	No			No	0	23.69		0
4971	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	20.2	Stable	No	No	Signature.4	BRCA1 | BRCA2 | MDC1	Yes	1	6.8		0
4972	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	31	0.9	Stable	No	No			No	0	27.83		0
4973	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	II	33	0	Stable	No	No			No	0	27.37		0
4974	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2017	IV	5	1.8	Stable	No	No		ARID1A	No	1	6.41		0
4975	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	34	0.9	Stable	No	No			No	0	28.39		0
4976	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	49	5.3	Indeterminate	No	Yes or Unknown			No	0	28.29		0
4977	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	13	1.8	Stable	No	No			No	0	27.6		0
4978	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	20	4.4	Stable	No	No			Yes	0	27.76		0
4979	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	317	6.1	Stable	No	No		ATM	No	0	25.4		0
4980	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	III	23	7.9	Stable	No	No	Signature.3		No	0	27.43		0
4981	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		0	5.3	Stable	No	No			Yes	0	26.48		0
4982	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	I	0	6.1	Stable	No	No			Yes	0	26.91		0
4983	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	32	7	Stable	No	No		ARID1A	No	0	25.56		0
4984	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	0	5.3	Stable	No	No			Yes	0	25.59		0
4985	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	4	6.1	Stable	No	No	Signature.2	ATM	No	0	27.99		0
4986	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	48	0	Stable	Yes or Unknown	Yes or Unknown			No	0	28.09		0
4987	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	1	21.52		0
4988	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	49	1.8	Stable	No	Yes or Unknown			No	0	28.19		0
4989	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	No	Signature.7		No	0	27.37		0
4990	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	0	0.9	Indeterminate	No	No			No	0	26.71		0
4991	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	II	4	7	Stable	No	No	Signature.13		No	0	25.63		0
4992	Non-ICI treated	Never received ICI	81 - 85	Male	Gastric	2017	IV	14	3.5	Stable	No	No	Signature.19		No	1	8.05		0
4993	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	37	2.6	Stable	No	No		FANCC	Yes	0	28.19		0
4994	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	4.4	Stable	No	No	Signature.24		No	0	0.92		0
4995	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		0	3.5	Stable	No	Yes or Unknown			No	0	27.53		0
4996	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	32	4.4	Stable	No	Yes or Unknown			No	0	27.7		0
4997	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	IV	8	1.8	Stable	No	No		ARID1A	No	1	7.16		0
4998	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	16	1.8	Stable	No	Yes or Unknown			No	0	26.87		0
4999	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	151	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	Yes	1	5.39		0
5000	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	21	0.9	Stable	No	No	Signature.3		No	0	26.38		0
5001	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	16	12.3	Stable	No	No	Signature.4		Yes	0	25.17		0
5002	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	110	2.6	Indeterminate	No	Yes or Unknown	Signature.5	BRCA2	Yes	1	4.7		0
5003	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	28.16		0
5004	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	35	3.5	Stable	No	Yes or Unknown			No	0	19.78		0
5005	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	54	0.9	Stable	No	No			No	0	26.68		0
5006	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	II	85	4.4	Stable	No	No			No	0	29.73		0
5007	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	38	54.4	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC2 | FANCA | MSH3 | RAD50	No	0	25.82		0
5008	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2016	IV	303	0	Stable	No	No			Yes	0	28.58		0
5009	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	36	1.8	Stable	No	No			No	0	23.62		0
5010	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2016	II	224	2.6	Stable	No	No			No	1	10.05		0
5011	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	III	57	21.1	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2	Yes	0	26.55		0
5012	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	91	1.8	Stable	No	No			No	0	28.68		0
5013	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	37	2.6	Stable	No	No			Yes	0	23.1		0
5014	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	5	1.8	Stable	No	No			No	0	28.52		0
5015	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	29	2.6	Stable	No	No			No	1	9.36		0
5016	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	86	374.8	Unstable	No	No	Signature.14	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | CHEK1 | CHEK2 | ERCC2 | ERCC3 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | PALB2 | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	25.95		0
5017	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	11.4	Stable	No	No	Signature.4	ARID1A | ATR	No	0	23.43		0
5018	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	9	6.1	Stable	No	No			No	1	21.65		0
5019	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	5	2.6	Stable	No	No			No	1	27.17		0
5020	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	0	5.3	Stable	No	No			No	0	24.87		0
5021	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	0	3.5	Stable	No	No			No	0	28.62		0
5022	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	35	4.4	Stable	No	No		ATM	No	0	27.17		0
5023	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	15	0.9	Stable	No	No	Signature.8		No	0	2.27		0
5024	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	109	4.4	Stable	No	No			No	0	12.62		0
5025	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2017	III	0	0.9	Stable	No	No		MUTYH	Yes	0	27.1		0
5026	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	25	0	Stable	No	No			Yes	0	26.28		0
5027	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	35	4.4	Stable	No	No	Signature.25	ERCC5	Yes	0	28.45		0
5028	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	4.4	Stable	No	No			No	1	10.22		0
5029	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	III	36	9.7	Stable	No	No		ARID1A | MUTYH	No	0	27.66		0
5030	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	29	5.3	Stable	No	No		ARID1A	No	0	5.95		0
5031	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	25.82		0
5032	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	22	1.8	Stable	No	Yes or Unknown			No	0	27.76		0
5033	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	36	10.5	Stable	No	No	Signature.13	ATR | RAD51	No	0	24.64		0
5034	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	38	6.1	Stable	No	No	Signature.1		Yes	0	26.55		0
5035	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	10	2.6	Stable	No	No	Signature.3	BRCA2	No	0	25.63		0
5036	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	64	2.6	Stable	No	No			No	0	28.62		0
5037	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	369	7.9	Stable	No	Yes or Unknown			No	0	26.84		0
5038	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	18	1.8	Stable	No	No			No	0	27.04		0
5039	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	39	1.8	Stable	No	No			No	0	27.99		0
5040	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	I	30	158	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | ERCC3 | ERCC5 | MSH2 | MSH3 | PMS2 | RAD50 | RAD51 | SLX4 | TP53BP1	No	0	21.75		0
5041	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	27.4		0
5042	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	0	0.9	Stable	No	No			No	0	26.45		0
5043	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	54	0	Stable	No	No			No	1	19.78		0
5044	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	125	2.6	Stable	No	Yes or Unknown			No	0	29.17		0
5045	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	I	367	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	28.02		0
5046	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	III	533	9.7	Stable	No	Yes or Unknown	Signature.30		No	0	23.46		0
5047	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	IV	65	12.3	Stable	No	No	Signature.2	ARID1A	No	0	28.78		0
5048	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	II	0	10.5	Stable	No	No	Signature.13		Yes	1	4.27		0
5049	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	26	2.6	Stable	No	No			Yes	1	10.74		0
5050	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	56	2.6	Stable	No	Yes or Unknown			No	0	28.02		0
5051	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	No			No	1	6.34		0
5052	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	0	4.4	Stable	No	No	Signature.13	ATR	No	0	26.09		0
5053	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	3	5.3	Stable	No	No		MUTYH	No	0	27.3		0
5054	Non-ICI treated	Never received ICI	10-Jun	Male	CNS	2017		0	1.8	Stable	No	No			No	0	3.91		0
5055	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	24.02		0
5056	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2017	IV	25	2.6	Stable	No	No			No	1	14.82		0
5057	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	22	14.9	Stable	No	No	Signature.24		Yes	0	23.85		0
5058	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	40	0.9	Stable	No	Yes or Unknown			Yes	0	27.1		0
5059	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2017	IV	16	3.5	Stable	No	No			No	1	7.62		0
5060	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	18	0.9	Stable	No	No		BLM	No	0	27.33		0
5061	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	21	130.8	Stable	No	No	Signature.10	ARID1A | ATM | ATR | CHEK1 | ERCC3 | ERCC5 | MSH2 | MSH3 | MUTYH | PALB2 | RAD54L | SLX4	No	0	26.87		0
5062	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	22	5.3	Stable	No	No			No	0	23		0
5063	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	12	8.8	Stable	No	No	Signature.4		Yes	1	2.1		0
5064	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	27	3.5	Stable	No	No			No	0	26.97		0
5065	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			No	1	13.24		0
5066	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	1	3.5	Stable	No	No			No	0	27.6		0
5067	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	12.42		0
5068	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	3.5	Stable	No	No			No	0	28.09		0
5069	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	IV	236	0	Stable	No	Yes or Unknown			No	1	14.52		0
5070	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	41	3.5	Stable	No	No	Signature.3		No	0	30.69		0
5071	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	13	1.8	Stable	No	No			Yes	0	4.86		0
5072	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	198	1.8	Stable	No	No		BRCA1	No	0	25.56		0
5073	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2016	IV	4	0	Stable	No	No			No	1	11.1		0
5074	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	37	0.9	Stable	No	No			No	0	20.3		0
5075	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	III	10	8.8	Stable	No	No			Yes	0	25.49		0
5076	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	30	2.6	Stable	No	No			Yes	1	8.54		0
5077	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No			No	1	4.86		0
5078	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	34	1.8	Stable	No	No			Yes	0	27.86		0
5079	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	II	22	45.6	Unstable	No	No	Signature.6	BLM | BRCA2 | PMS1	No	0	26.58		0
5080	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	9.53		0
5081	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	43	2.6	Stable	No	Yes or Unknown			No	0	27.2		0
5082	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	III	10	4.4	Stable	No	No		BRIP1	No	0	25.99		0
5083	Non-ICI treated	Never received ICI	51 - 55	Male	Breast	2017	II	665	2.6	Stable	No	Yes or Unknown	Signature.2	PARP1	No	0	27.66		0
5084	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	5.3	Stable	No	No		ARID1A	No	0	25.4		0
5085	Non-ICI treated	Never received ICI	91 - 95	Female	Endometrial	2017	III	0	1.8	Stable	No	No			No	1	18.96		0
5086	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	21	2.6	Stable	No	No			No	0	27.79		0
5087	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	IV	14	3.5	Stable	No	No			No	1	4.67		0
5088	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	7	2.6	Stable	No	Yes or Unknown			No	1	17.38		0
5089	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	39	1.8	Stable	No	No			No	0	24.48		0
5090	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	20	1.8	Stable	No	No			Yes	0	27.37		0
5091	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	28	2.6	Stable	No	No		CHEK2	Yes	0	26.41		0
5092	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	9	40.4	Stable	No	No	Signature.13	BRCA1 | BRCA2 | ERCC3 | MSH2	Yes	0	24.08		0
5093	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.19		No	1	15.05		0
5094	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		3	4.4	Stable	No	No			Yes	0	6.51		0
5095	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	82	2.6	Stable	No	No			Yes	0	28.52		0
5096	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	24	4.4	Stable	No	No	Signature.3		No	0	13.44		0
5097	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2016	IV	330	6.1	Stable	No	No	Signature.1		No	0	31.51		0
5098	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	13	20.2	Stable	No	No	Signature.4		No	0	24.77		0
5099	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	29	4.4	Stable	No	No			Yes	0	25.3		0
5100	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	14	6.1	Stable	No	No	Signature.1		No	0	27.2		0
5101	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	21.42		0
5102	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	III	12	14.9	Stable	No	No	Signature.5	MSH2	Yes	0	28.29		0
5103	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	507	1.8	Stable	No	Yes or Unknown			No	0	29.17		0
5104	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	36	5.3	Stable	No	No	Signature.24	RAD54L	Yes	0	26.12		0
5105	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	34	7.9	Stable	No	No	Signature.13	ATM	No	0	23.98		0
5106	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	47	3.5	Stable	No	No	Signature.6	ARID1A	No	0	27.89		0
5107	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	109	5.3	Stable	No	No		ATR	Yes	0	30.52		0
5108	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2016	III	579	3.5	Stable	No	Yes or Unknown			No	0	42.84		0
5109	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	13	1.8	Stable	No	No			No	0	28.48		0
5110	Non-ICI treated	Never received ICI	41 - 45	Male	Hepatobiliary	2017	IV	131	6.1	Stable	No	Yes or Unknown		ATM	No	0	26.15		0
5111	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		35	4.4	Stable	No	No			No	0	25.66		0
5112	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1	MSH3	No	1	9.66		0
5113	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	115	1.8	Stable	No	No		SLX4	No	0	21.42		0
5114	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	2.6	Stable	No	No	Signature.8		No	1	18.76		0
5115	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	14	6.1	Stable	No	Yes or Unknown	Signature.2	XRCC2	No	0	26.38		0
5116	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	I	0	6.1	Stable	No	No		ARID1A	Yes	0	25.99		0
5117	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	10	13.2	Stable	No	No	Signature.3	ARID1A | FANCA	No	1	6.44		0
5118	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	III	62	7.9	Stable	No	No	Signature.6		No	0	5.42		0
5119	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No		MSH6	No	0	24.8		0
5120	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	29	1.8	Stable	No	Yes or Unknown			No	0	26.64		0
5121	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	646	1.8	Stable	No	No			Yes	0	27.27		0
5122	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	224	1.8	Stable	No	Yes or Unknown			No	0	26.28		0
5123	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	26	2.6	Stable	No	No			No	0	24.05		0
5124	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	22	7	Stable	No	No			No	1	13.9		0
5125	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	41	2.6	Stable	No	No			Yes	0	24.38		0
5126	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	4	2.6	Stable	No	Yes or Unknown		ERCC5	No	0	7.95		0
5127	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2017	III	25	7.9	Stable	No	No	Signature.4	MRE11A | NBN	No	1	12.32		0
5128	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	IV	2	7	Stable	No	No	Signature.3	PARP1	No	1	17.41		0
5129	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	I	0	24.6	Indeterminate	No	No	Signature.1	BLM | MDC1 | SLX4	No	0	27.7		0
5130	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	III	0	9.7	Stable	No	No	Signature.13		No	1	8.9		0
5131	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		12	5.3	Stable	No	No		FANCC	Yes	0	4.63		0
5132	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	1	20.53		0
5133	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	III	0	72	Unstable	No	No	Signature.6	ARID1A | MDC1 | MRE11A | MSH3 | MSH6 | PMS1 | TP53BP1	Yes	0	26.84		0
5134	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	16	3.5	Stable	No	No		BRCA1	No	0	26.51		0
5135	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2017	IV	16	2.6	Stable	No	No			No	0	9.79		0
5136	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No		ARID1A	No	1	13.01		0
5137	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	22.8		0
5138	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	10.5	Stable	No	No	Signature.1		No	0	27.2		0
5139	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	2	4.4	Stable	No	No	Signature.12		No	0	26.05		0
5140	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	20	7.9	Stable	No	No		ARID1A | ERCC5	No	0	8.15		0
5141	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	39	7	Stable	No	No		ARID1A	No	0	27.3		0
5142	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	28.75		0
5143	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	306	7.9	Stable	No	Yes or Unknown	Signature.8	BRCA2	No	0	24.31		0
5144	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	0	4.4	Stable	No	No	Signature.1		Yes	1	16.59		0
5145	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	671	7	Stable	No	Yes or Unknown	Signature.3		No	0	27.79		0
5146	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	8.8	Stable	No	No	Signature.1		Yes	0	12.65		0
5147	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2016	II	0	2.6	Stable	No	No			No	0	33.54		0
5148	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	II	0	2.6	Stable	No	No			Yes	0	28.32		0
5149	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	34	9.7	Stable	No	No	Signature.1		Yes	0	22.9		0
5150	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No		TP53BP1	No	1	2.33		0
5151	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	II	446	5.3	Stable	No	Yes or Unknown			No	0	29.67		0
5152	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	53	7	Stable	No	No		ARID1A	No	1	16.1		0
5153	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	331	4.4	Stable	No	Yes or Unknown			No	1	23.13		0
5154	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017		59	0	Stable	No	No			No	0	15.47		0
5155	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	6.1	Stable	No	Yes or Unknown	Signature.3		No	0	25.99		0
5156	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	0	26.15		0
5157	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	6	9.7	Stable	No	Yes or Unknown	Signature.1	PALB2 | SLX4	No	0	27.27		0
5158	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	1	17.18		0
5159	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	325	7	Stable	No	Yes or Unknown	Signature.3	FANCA | RAD51C	No	0	30.03		0
5160	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	0	12.3	Stable	No	No	Signature.29		No	0	3.65		0
5161	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	III	108	0.9	Stable	No	Yes or Unknown			No	0	27.27		0
5162	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	17	4.4	Stable	No	No			Yes	0	27.04		0
5163	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	19	1.8	Stable	No	No			No	0	25.89		0
5164	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	23	8.8	Stable	No	No	Signature.29	ATR	No	0	22.67		0
5165	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	35	2.6	Stable	No	No			No	0	27.17		0
5166	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	4.4	Stable	No	No	Signature.19		No	0	4.8		0
5167	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	III	15	6.1	Stable	No	No			Yes	0	24.8		0
5168	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	109	0.9	Stable	No	Yes or Unknown			No	0	27.07		0
5169	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	III	29	0	Stable	No	No			Yes	0	26.87		0
5170	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	29	34.2	Unstable	No	No	Signature.15	ARID1A | PARP1 | PMS1	No	0	23.52		0
5171	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			Yes	0	26.45		0
5172	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	38	0.9	Stable	No	No			Yes	0	26.94		0
5173	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	39	2.6	Stable	No	No		CHEK2	No	0	27.07		0
5174	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	III	286	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	26.51		0
5175	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2016	II	224	0	Stable	No	No			No	0	23.23		0
5176	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	30	7	Stable	No	No		ARID1A	Yes	0	27.1		0
5177	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	25	4.4	Stable	No	No		ARID1A	No	0	24.77		0
5178	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	9	0	Stable	No	Yes or Unknown			No	0	27.3		0
5179	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	15	0	Stable	No	No			No	0	1.84		0
5180	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	33	0	Stable	No	No			No	0	26.18		0
5181	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	133	0.9	Stable	No	No			No	1	14.39		0
5182	Non-ICI treated	Never received ICI	10-Jun	Female	Cutaneous Melanoma 	2017	II	0	0	Stable	No	No			No	0	5.52		0
5183	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	41	4.4	Stable	No	No			No	1	23.2		0
5184	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	8	5.3	Stable	No	No	Signature.3		No	0	26.97		0
5185	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	2.56		0
5186	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	15	9.7	Indeterminate	No	No	Signature.13		No	1	7.29		0
5187	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	17	9.7	Stable	No	No	Signature.13	BLM | SLX4	No	0	26.12		0
5188	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	126	1.8	Stable	No	Yes or Unknown			Yes	0	28.78		0
5189	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	38	7	Stable	No	No	Signature.30	NTHL1	No	0	26.22		0
5190	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	3.5	Stable	No	No			No	0	28.19		0
5191	Non-ICI treated	Never received ICI	51 - 55	Male	Breast	2017	II	39	2.6	Stable	No	Yes or Unknown			No	0	27.1		0
5192	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		111	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.5		Yes	1	12.78		0
5193	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	7.9	Stable	No	Yes or Unknown			No	0	27.33		0
5194	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	379	2.6	Stable	No	No			Yes	0	27.14		0
5195	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	I	0	0.9	Stable	No	No			No	0	18.27		0
5196	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	III	52	2.6	Stable	No	No			Yes	0	5.59		0
5197	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	0	3.5	Stable	No	No			No	0	27.56		0
5198	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	27	86.9	Unstable	No	No	Signature.6	ATM | BLM | BRIP1 | CHEK2 | MSH3 | MSH6 | NBN | PALB2 | PMS2 | SLX4	No	0	26.12		0
5199	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	3	6.1	Stable	No	No		ATR	No	0	26.87		0
5200	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	14	Stable	No	No	Signature.4		No	1	5.16		0
5201	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	34	0.9	Stable	No	No		ATM | NBN	No	0	27.14		0
5202	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	15	0	Stable	No	No			No	0	3.12		0
5203	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			No	1	15.77		0
5204	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	6	5.3	Stable	No	No			Yes	1	2.92		0
5205	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	1	10.64		0
5206	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			Yes	0	5.36		0
5207	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	652	2.6	Stable	No	Yes or Unknown			No	0	29.44		0
5208	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	15	7.9	Stable	No	No	Signature.4	BRIP1	No	1	10.38		0
5209	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	21	0.9	Stable	No	No			Yes	0	26.64		0
5210	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	136	0.9	Stable	No	No			Yes	0	29.44		0
5211	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	35	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	0	25		0
5212	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	35	7	Stable	No	No		ARID1A	No	0	21.75		0
5213	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	IV	2	7	Stable	No	No	Signature.19		Yes	1	4.37		0
5214	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	37	2.6	Stable	No	No		RAD51C	Yes	0	26.22		0
5215	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	19	0.9	Stable	No	No			No	0	27.1		0
5216	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	77	0	Stable	No	Yes or Unknown			No	0	27.2		0
5217	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	16	3.5	Stable	No	No			No	0	4.9		0
5218	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	61	1.8	Stable	No	No			No	0	26.87		0
5219	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	48	2.6	Stable	No	No			No	0	26.58		0
5220	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	51	2.6	Stable	No	No			No	0	27.01		0
5221	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	33	7	Stable	No	No	Signature.1		No	0	25.53		0
5222	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	761	4.4	Stable	No	Yes or Unknown		ARID1A	Yes	0	26.91		0
5223	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	3.5	Indeterminate	No	No			No	0	26.32		0
5224	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	21	0	Stable	No	No			No	0	26.87		0
5225	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	III	30	8.8	Stable	No	No	Signature.1	ARID1A	Yes	0	27.01		0
5226	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	III	0	12.3	Indeterminate	No	No	Signature.24		Yes	0	27.01		0
5227	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	4.4	Stable	No	No			No	0	19.78		0
5228	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	I	0	1.8	Stable	No	No			No	0	23.98		0
5229	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	13	4.4	Stable	No	No			No	1	9.82		0
5230	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	58	7.9	Stable	No	No	Signature.4	ATM	No	0	27.83		0
5231	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	143	10.5	Stable	No	Yes or Unknown	Signature.24		No	0	26.12		0
5232	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	136	0.9	Stable	No	Yes or Unknown			No	1	22.37		0
5233	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	691	10.5	Stable	No	Yes or Unknown	Signature.1	MRE11A	Yes	0	30.39		0
5234	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	40	4.4	Stable	No	No			Yes	0	26.71		0
5235	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	45	3.5	Stable	No	No			Yes	0	15.93		0
5236	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	131	0	Stable	No	No			No	0	24.05		0
5237	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	26	3.5	Stable	No	No			Yes	0	26.68		0
5238	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	365	8.8	Stable	No	No	Signature.1	BLM | MSH2	No	0	14.13		0
5239	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	34	2.6	Stable	No	No			No	0	28.62		0
5240	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2018		0	0	Stable	No	No			No	0	13.54		0
5241	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	447	3.5	Stable	No	Yes or Unknown	Signature.3	CHEK1	No	1	18.3		0
5242	Non-ICI treated	Never received ICI	66 - 70	Male	Renal	2017	III	523	5.3	Stable	No	No			No	0	25.95		0
5243	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	7	0	Stable	No	Yes or Unknown			No	0	27.37		0
5244	Non-ICI treated	Never received ICI	86 - 90	Male	Cutaneous Melanoma 	2017	IV	20	38.6	Stable	No	No	Signature.7	ATR | BLM | ERCC4 | MRE11A | PARP1	No	1	1.18		0
5245	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	18	4.4	Stable	No	No			No	0	27.4		0
5246	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	13	0.9	Stable	No	No			No	1	14.06		0
5247	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	504	9.7	Stable	No	Yes or Unknown	Signature.1		No	0	26.58		0
5248	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	17	0.9	Stable	No	No			No	0	26.55		0
5249	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	11.73		0
5250	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	23	6.1	Stable	No	No			No	0	23.49		0
5251	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No			No	1	4.11		0
5252	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2017	IV	29	5.3	Stable	No	No			No	0	27.5		0
5253	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	29	1.8	Stable	No	Yes or Unknown		ATM	Yes	0	26.87		0
5254	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	27.07		0
5255	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		36	5.3	Stable	Yes or Unknown	Yes or Unknown			No	0	29.7		0
5256	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	13	2.6	Stable	No	No		ERCC4	Yes	0	23.95		0
5257	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	27.6		0
5258	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	18	1.8	Stable	No	No			Yes	0	25.3		0
5259	Non-ICI treated	Never received ICI	31 - 35	Male	Pancreatic	2017	IV	0	0	Stable	No	No			No	1	25.92		0
5260	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	II	0	2.6	Stable	No	No			Yes	0	26.64		0
5261	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	37.7	Stable	No	No	Signature.4	BRCA2 | ERCC2 | PARP1	No	0	21.78		0
5262	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2017	III	20	39.5	Stable	No	No	Signature.7	ERCC2 | MDC1	No	0	26.94		0
5263	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No	Signature.1		No	0	26.81		0
5264	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	45	4.4	Stable	No	Yes or Unknown			No	0	26.35		0
5265	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	47	2.6	Stable	No	No			Yes	0	27.63		0
5266	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	II	34	0	Stable	No	No			No	1	23.13		0
5267	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	0	2.6	Stable	No	No		BRCA1	No	0	27.1		0
5268	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	57	9.7	Stable	No	No	Signature.1		Yes	0	26.51		0
5269	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	27	13.2	Stable	No	No	Signature.1		No	0	26.68		0
5270	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	3.5	Stable	No	No			No	0	26.71		0
5271	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2017	I	26	0		No	No			No	0	21.26		0
5272	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	303	7	Stable	No	Yes or Unknown	Signature.1		No	0	26.22		0
5273	Non-ICI treated	Never received ICI	91 - 95	Female	CNS	2017		16	2.6	Stable	No	No			No	1	1.64		0
5274	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2017		0	0.9	Stable	No	No	Signature.5		No	0	24.25		0
5275	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	II	0	9.7	Stable	No	No	Signature.3		No	0	27.53		0
5276	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.4		Yes	1	7.13		0
5277	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	158	5.3	Stable	No	Yes or Unknown		ARID1A	No	1	9.95		0
5278	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	1	7.23		0
5279	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	34	0.9	Stable	No	No			No	0	16.99		0
5280	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2017	IV	19	3.5	Stable	No	No			Yes	0	24.18		0
5281	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	294	5.3	Stable	No	Yes or Unknown			No	1	14.98		0
5282	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	28	5.3	Stable	No	No			No	0	26.74		0
5283	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	9	0.9	Stable	No	Yes or Unknown			No	0	22.08		0
5284	Non-ICI treated	Never received ICI	61 - 65	Male	Breast	2017	I	32	2.6	Stable	No	No			Yes	0	12.98		0
5285	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	0	14.9	Stable	No	No	Signature.4		No	0	24.15		0
5286	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017		0	0	Stable	No	No			No	0	21.82		0
5287	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	1	6.97		0
5288	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	54	0.9	Stable	No	Yes or Unknown			No	0	26.91		0
5289	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	III	18	8.8	Stable	No	No	Signature.10	NTHL1	No	0	22.47		0
5290	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	254	7	Stable	No	Yes or Unknown	Signature.1		No	1	23.26		0
5291	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	ATR | MDC1 | PMS2 | XRCC2	Yes	0	25.2		0
5292	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	6	6.1	Stable	No	No		BLM	No	0	26.45		0
5293	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	1	14.36		0
5294	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	20	2.6	Stable	No	No			No	0	24.38		0
5295	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2016	II	334	4.4	Stable	No	No			No	1	26.74		0
5296	Non-ICI treated	Never received ICI	36 - 40	Female	Renal	2017	I	26	3.5	Stable	No	No			No	0	24.97		0
5297	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	20	1.8	Stable	No	Yes or Unknown			Yes	0	23.16		0
5298	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	1	1.48		0
5299	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	21	1.8	Stable	No	No			Yes	0	25.82		0
5300	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	36	6.1	Stable	No	No		ARID1A	No	0	4.37		0
5301	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	0	8.8	Stable	No	No	Signature.3		No	0	25.49		0
5302	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	I	274	4.4	Stable	No	No		MSH3 | MUTYH	No	0	12.25		0
5303	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	0	1.8	Stable	No	No	Signature.1		No	0	26.74		0
5304	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			No	0	26.71		0
5305	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	25.53		0
5306	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	743	2.6	Stable	No	Yes or Unknown			Yes	0	25.1		0
5307	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	47	7	Stable	No	No	Signature.4		No	0	22.31		0
5308	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	82	1.8	Stable	No	No			No	0	28.98		0
5309	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	204	0.9	Stable	No	No			No	0	8.38		0
5310	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	10	2.6	Stable	No	No			No	1	15.08		0
5311	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	1	0.9	Stable	No	Yes or Unknown		MUTYH	No	1	20.7		0
5312	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	624	7	Stable	No	Yes or Unknown	Signature.6		No	0	26.97		0
5313	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	0	4.4	Stable	No	Yes or Unknown			No	1	19.65		0
5314	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		18	3.5	Stable	No	No		BLM	Yes	1	16.33		0
5315	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	23	1.8	Stable	No	No			No	0	14.78		0
5316	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	18	7	Indeterminate	No	No	Signature.7		No	1	4.27		0
5317	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	No	Signature.1		No	1	4.63		0
5318	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	783	2.6	Stable	No	Yes or Unknown			No	0	27.7		0
5319	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	31	3.5	Stable	No	No			No	0	26.09		0
5320	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	25	1.8	Stable	No	No			No	0	26.55		0
5321	Non-ICI treated	Never received ICI	21 - 25	Female	CNS	2017		46	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	25.76		0
5322	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	0	29	Unstable	No	Yes or Unknown	Signature.6	ATM | MSH2 | MSH6 | SLX4 | TP53BP1	No	0	27.01		0
5323	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	15	5.3	Stable	No	No	Signature.1	ARID1A	Yes	0	23.39		0
5324	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	31	7	Stable	No	No		FANCA	No	0	25.72		0
5325	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	32	2.6	Stable	No	No			No	0	24.21		0
5326	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	43	0	Stable	No	No			No	0	20.21		0
5327	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	III	241	7	Stable	No	Yes or Unknown			No	0	25.59		0
5328	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	15	4.4	Stable	No	No			Yes	0	5.68		0
5329	Non-ICI treated	Never received ICI	76 - 80	Female	Bladder	2017	III	32	8.8	Stable	No	No	Signature.4	FANCA | PMS1	No	1	17.02		0
5330	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	28	2.6	Stable	No	No			No	0	26.48		0
5331	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	12	7	Indeterminate	No	No	Signature.15		No	0	17.12		0
5332	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017		259	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	27.07		0
5333	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	35	0	Stable	No	No			Yes	1	3.42		0
5334	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	67	0	Stable	No	Yes or Unknown		BRCA2	No	0	24.11		0
5335	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	III	0	2.6	Stable	No	No		BRCA2	No	0	25.53		0
5336	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	10	49.2	Unstable	No	No	Signature.1	ARID1A | ATR | BRCA2 | MSH6 | RAD54L | TP53BP1	No	0	4.27		0
5337	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		0	4.4	Stable	No	No			Yes	1	6.6		0
5338	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	7	5.3	Stable	No	No	Signature.1	ARID1A	No	1	5.65		0
5339	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	266	0		No	Yes or Unknown			No	0	24.8		0
5340	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	III	19	26.3	Unstable	No	No	Signature.1	ARID1A | BLM	No	0	26.35		0
5341	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			No	1	18.5		0
5342	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	10	14	Stable	No	No	Signature.4	ERCC4	No	1	4.57		0
5343	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	33	0.9	Stable	No	No			No	0	24.54		0
5344	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	0.9	Stable	No	No			No	0	21.88		0
5345	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2017		169	1.8	Stable	No	No			No	0	28.81		0
5346	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2017	IV	218	0	Stable	No	Yes or Unknown			Yes	0	24.44		0
5347	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	68	0		No	No		BRCA1	No	0	25.3		0
5348	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	50	3.5	Stable	No	No			No	0	25.89		0
5349	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	38	7	Stable	No	Yes or Unknown		ARID1A	No	0	26.12		0
5350	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	145	1.8	Stable	No	No		ARID1A	No	1	14.03		0
5351	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	32	0.9	Stable	No	No			No	0	23		0
5352	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		ATM	No	1	16.89		0
5353	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	13	8.8	Stable	No	Yes or Unknown		BRCA2	No	0	22.08		0
5354	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	1	19.45		0
5355	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	0	5.3	Stable	No	No			No	0	26.15		0
5356	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	II	24	0.9	Stable	No	No			No	0	26.45		0
5357	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	289	1.8	Stable	No	Yes or Unknown			Yes	0	27.2		0
5358	Non-ICI treated	Never received ICI	46 - 50	Male	Renal	2017	I	0	0	Stable	No	No			No	0	19.94		0
5359	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	509	4.4	Stable	No	No		ARID1A | FANCA	No	1	23.82		0
5360	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2017	IV	308	12.3	Stable	No	No	Signature.7		No	0	10.12		0
5361	Non-ICI treated	Never received ICI	46 - 50	Female	Cutaneous Melanoma 	2017	I	0	0.9	Stable	No	No			No	0	26.41		0
5362	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	12	0.9	Stable	No	No			No	1	17.08		0
5363	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	504	1.8	Stable	No	Yes or Unknown			Yes	1	24.51		0
5364	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	40	2.6	Stable	No	Yes or Unknown			No	0	25.66		0
5365	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	16	0	Stable	No	No			No	0	18.73		0
5366	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	IV	6	4.4	Stable	No	No	Signature.4		Yes	1	11.04		0
5367	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	39	1.8	Stable	No	No			No	0	23.16		0
5368	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	0	0.9	Stable	No	No			No	1	22.21		0
5369	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2017		14	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	15.05		0
5370	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	373	8.8	Stable	No	Yes or Unknown	Signature.10		No	0	26.35		0
5371	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	739	1.8	Stable	No	Yes or Unknown			No	0	26.58		0
5372	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	9.26		0
5373	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	25.92		0
5374	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	9	3.5	Stable	No	No	Signature.3	ATM	No	1	18.33		0
5375	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	26.18		0
5376	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	73	3.5	Stable	No	No			No	0	10.45		0
5377	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	47	1.8	Stable	No	No			No	0	23.92		0
5378	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	0	9.7	Stable	No	No	Signature.5	ARID1A | FANCA	Yes	0	26.41		0
5379	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	II	140	1.8	Stable	No	Yes or Unknown			No	0	23.23		0
5380	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	III	28	0.9	Stable	No	Yes or Unknown			Yes	0	25.66		0
5381	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	0	0.9	Stable	No	No			Yes	0	21.36		0
5382	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	86	1.8	Stable	No	No			No	0	7.13		0
5383	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	49	0.9	Stable	No	No			No	0	21.95		0
5384	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	20	0.9	Stable	No	Yes or Unknown			No	0	25.99		0
5385	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	142	6.1	Stable	No	No			No	0	25.07		0
5386	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		ARID1A	No	1	9.86		0
5387	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	60	23.7	Stable	No	Yes or Unknown	Signature.4		No	1	10.58		0
5388	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	I	187	0	Stable	No	Yes or Unknown	Signature.16		Yes	0	24.97		0
5389	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	77	3.5	Stable	No	No			No	1	19.91		0
5390	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	II	28	4.4	Stable	No	No			No	0	26.02		0
5391	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2016	II	254	31.6	Stable	No	No	Signature.4	ARID1A | FANCA | NBN	No	0	32.82		0
5392	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	43	2.6	Stable	No	Yes or Unknown		BLM	Yes	1	14		0
5393	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	24	3.5	Stable	No	No	Signature.1		No	0	25.86		0
5394	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	12	5.3	Stable	No	No			No	1	21.62		0
5395	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	46	0.9	Stable	No	No			Yes	0	23.98		0
5396	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	4.4	Stable	No	No	Signature.3	BRCA2	No	0	25.63		0
5397	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	3.5	Stable	No	No			No	0	25.86		0
5398	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	34	7.9	Stable	No	No	Signature.4	BRCA2	No	0	25.69		0
5399	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	28	2.6	Stable	No	No			Yes	0	25.79		0
5400	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2017		22	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	8.71		0
5401	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	9	7	Stable	No	No	Signature.1		No	0	25.13		0
5402	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2017	III	0	4.4	Stable	No	No	Signature.5		No	0	23.36		0
5403	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	I	656	2.6	Stable	No	No			No	0	25.3		0
5404	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	38	4.4	Stable	No	Yes or Unknown	Signature.13	NBN	No	0	24.15		0
5405	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	45	7	Stable	No	Yes or Unknown			Yes	0	24.11		0
5406	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	91	1.8	Stable	No	No			Yes	0	25.86		0
5407	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	III	139	0	Stable	No	No			No	0	22.54		0
5408	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	25	4.4	Stable	No	No			Yes	0	25.82		0
5409	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	24.08		0
5410	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	42	27.2	Unstable	No	No	Signature.6	ARID1A | MRE11A	No	0	25.59		0
5411	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	IV	0	0.9	Stable	No	No		ARID1A	No	0	25.36		0
5412	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	10	5.3	Stable	No	No			No	1	13.14		0
5413	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	0	0.9	Stable	No	No			Yes	0	25.13		0
5414	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	167	1.8	Stable	No	Yes or Unknown			No	0	25.59		0
5415	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	203	4.4	Stable	No	Yes or Unknown	Signature.8	SLX4	No	0	25.99		0
5416	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	6	3.5	Stable	No	Yes or Unknown		MDC1	No	1	18.04		0
5417	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	123	14	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	15.77		0
5418	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	5.3	Stable	No	No		ATM	No	1	6.67		0
5419	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	28	4.4	Stable	No	No		ATR	Yes	0	23.69		0
5420	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2017		72	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	24.67		0
5421	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1	ATM	No	0	24.9		0
5422	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	III	41	1.8	Stable	No	No			Yes	0	10.74		0
5423	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	35	10.5	Stable	No	Yes or Unknown		BRCA2	No	0	23.85		0
5424	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	0	4.4	Stable	No	No		MSH6	No	0	25.23		0
5425	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	200	0	Stable	No	Yes or Unknown		ATM	No	0	25.69		0
5426	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	25.79		0
5427	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	308	4.4	Stable	No	Yes or Unknown			No	0	25.2		0
5428	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	26	1.8	Stable	No	Yes or Unknown			Yes	0	4.11		0
5429	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	192	0.9	Stable	No	Yes or Unknown			No	0	26.09		0
5430	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	II	20	0.9	Stable	No	No			No	0	26.28		0
5431	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	52	2.6	Stable	No	No			No	0	25.26		0
5432	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	12	2.6	Stable	No	No			Yes	1	7.06		0
5433	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	16	7	Stable	No	No		BLM	Yes	0	24.38		0
5434	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	34	4.4	Stable	No	No			Yes	0	25.82		0
5435	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017		0	0	Stable	No	No			No	0	24.61		0
5436	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	5.3	Stable	No	No			No	0	25.1		0
5437	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	22	1.8	Stable	No	No			Yes	0	20.8		0
5438	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	III	0	0.9	Stable	No	No			Yes	0	20.11		0
5439	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	23	2.6	Stable	No	No			No	0	25.86		0
5440	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	514	0	Indeterminate	No	Yes or Unknown	Signature.5		No	0	24.94		0
5441	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	14	2.6	Stable	No	No			No	0	25.69		0
5442	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		4	4.4	Stable	No	No	Signature.1		No	1	16.99		0
5443	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	71	32.5	Stable	No	No	Signature.4	BRCA1 | ERCC5 | NTHL1	No	0	23.52		0
5444	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	310	3.5	Stable	No	Yes or Unknown			No	0	25.56		0
5445	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	2.6	Stable	No	Yes or Unknown			No	0	19.91		0
5446	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No		ARID1A	Yes	0	25.82		0
5447	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	0	1.8	Stable	No	No			No	0	25.03		0
5448	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	64	0	Stable	No	No			Yes	0	24.84		0
5449	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	1.8	Stable	No	Yes or Unknown			No	0	26.15		0
5450	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2017	III	0	7	Stable	No	No	Signature.13	TP53BP1	No	1	8.77		0
5451	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	21	0.9	Stable	No	No			Yes	0	24.64		0
5452	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	III	0	3.5	Stable	No	No		ERCC2	No	0	25.3		0
5453	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	5	4.4	Stable	No	Yes or Unknown			Yes	0	26.15		0
5454	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	29	4.4	Stable	No	No	Signature.6		Yes	0	22.51		0
5455	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	47	6.1	Stable	No	No		PALB2	No	1	10.97		0
5456	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	155	3.5	Stable	No	Yes or Unknown	Signature.1		Yes	0	20.83		0
5457	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	21	2.6	Indeterminate	No	No			No	0	21.52		0
5458	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	0	2.6	Stable	No	No			Yes	1	12.45		0
5459	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	11	2.6	Stable	No	No			No	1	15.51		0
5460	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	565	5.3	Stable	No	Yes or Unknown	Signature.24		No	0	26.55		0
5461	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	118	13.2	Stable	No	No	Signature.1	RAD50	No	0	24.34		0
5462	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	0	16.7	Stable	No	No	Signature.1		No	0	25.53		0
5463	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	27	2.6	Stable	No	No			No	0	25.92		0
5464	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	22	3.5	Stable	No	Yes or Unknown			No	0	25.76		0
5465	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	28	2.6	Stable	No	No			No	0	25.53		0
5466	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	13.2	Stable	No	No	Signature.13	MSH6	No	0	25.76		0
5467	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	152	0		No	Yes or Unknown			Yes	0	25.3		0
5468	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	IV	15	10.5	Stable	No	No		ERCC2	No	1	4.11		0
5469	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	45	1.8	Stable	No	No			No	1	6.97		0
5470	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017		53	1.8	Stable	No	Yes or Unknown			Yes	1	14.65		0
5471	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	11	6.1	Stable	No	No		ATM | BRCA2	Yes	0	26.12		0
5472	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	4.4	Stable	No	No			Yes	0	25.36		0
5473	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	III	75	4.4	Stable	No	Yes or Unknown	Signature.5		Yes	0	25.76		0
5474	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	79	2.6	Stable	No	No			No	0	15.74		0
5475	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	0	0	Stable	No	No			No	0	24.77		0
5476	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	23.29		0
5477	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	19	10.5	Stable	No	No	Signature.1	ERCC2 | SLX4 | TP53BP1	Yes	1	8.02		0
5478	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	I	0	9.7	Stable	No	No		ARID1A | ATM | ERCC3	No	1	10.12		0
5479	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		5	3.5	Stable	Yes or Unknown	Yes or Unknown		MSH2	No	1	17.05		0
5480	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	14	3.5	Stable	No	No	Signature.2		Yes	0	25.03		0
5481	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	73	0.9	Stable	No	No			Yes	0	24.28		0
5482	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	II	0	32.5	Stable	No	No	Signature.2	ARID1A | ERCC2 | FANCA | RAD50	No	0	25.99		0
5483	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	34	0	Stable	No	Yes or Unknown			No	0	22.05		0
5484	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	I	0	3.5	Stable	No	No			No	0	25		0
5485	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	100	3.5	Stable	No	Yes or Unknown		MUTYH	No	0	26.71		0
5486	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	III	0	3.5	Indeterminate	No	No			No	0	25.79		0
5487	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	38	5.3	Stable	No	No	Signature.1		Yes	0	25.76		0
5488	Non-ICI treated	Never received ICI	66 - 70	Male	Cutaneous Melanoma 	2017	II	34	12.3	Stable	No	No	Signature.7	ERCC3 | MRE11A	No	0	25.76		0
5489	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	9	3.5	Stable	No	No			No	1	8.61		0
5490	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	IV	0	2.6	Stable	No	No			Yes	0	22.93		0
5491	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	24	6.1	Stable	No	No	Signature.6		Yes	0	21.75		0
5492	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	86	0.9	Stable	No	No			No	0	23.98		0
5493	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	54	2.6	Stable	No	No			No	0	23.79		0
5494	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	2.6	Stable	No	No			No	0	24.94		0
5495	Non-ICI treated	Never received ICI	66 - 70	Female	Renal	2017	III	9	0.9	Stable	No	No		ERCC3	No	0	19.02		0
5496	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	III	14	3.5	Stable	No	No			No	0	25.82		0
5497	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	69.3	Unstable	No	No	Signature.1	ERCC3 | MSH3 | SLX4 | TP53BP1	No	0	25.23		0
5498	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	24	8.8	Stable	No	No	Signature.1	RAD51	No	0	23.13		0
5499	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	II	23	81.6	Unstable	No	No	Signature.6	ARID1A | BRCA1 | BRCA2 | ERCC5 | MSH3	Yes	0	24.38		0
5500	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	33	4.4	Stable	No	Yes or Unknown			No	0	25		0
5501	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	II	86	0		No	No			No	0	25.33		0
5502	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	54	12.3	Stable	No	Yes or Unknown	Signature.24	ARID1A | PALB2	No	0	25.26		0
5503	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	7	6.1	Stable	No	Yes or Unknown	Signature.3	MDC1	No	0	25.63		0
5504	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	16	5.3	Stable	No	No	Signature.15	ATM	Yes	0	25.13		0
5505	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	41	13.2	Stable	No	No	Signature.4	ERCC2 | NBN	No	0	24.21		0
5506	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2017		80	5.3	Stable	No	No			No	0	19.42		0
5507	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	152	6.1	Stable	No	Yes or Unknown	Signature.20		No	1	12.75		0
5508	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		31	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	16.39		0
5509	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2017	IV	4	7	Stable	No	No	Signature.1		Yes	1	0.79		0
5510	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1		No	1	16.99		0
5511	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	6.34		0
5512	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	0	1.8	Stable	No	No			Yes	0	23.89		0
5513	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	48	1.8	Stable	No	Yes or Unknown			No	0	25.53		0
5514	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	III	2	4.4	Stable	No	No			No	0	25.76		0
5515	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	18	5.3	Stable	No	No			No	1	10.05		0
5516	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	214	6.1	Stable	No	Yes or Unknown	Signature.4		No	0	24.38		0
5517	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	24	3.5	Stable	No	No			Yes	0	25.3		0
5518	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	39	6.1	Stable	No	No			No	0	24.02		0
5519	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No			No	1	15.38		0
5520	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	4.4	Stable	No	No			Yes	0	26.71		0
5521	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No			Yes	0	24.84		0
5522	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	0	6.1	Stable	No	No	Signature.1		Yes	1	20.37		0
5523	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	II	311	5.3	Stable	No	No		ARID1A	No	1	26.15		0
5524	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	146	2.6		No	Yes or Unknown	Signature.5		No	0	25.76		0
5525	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	16	3.5	Stable	No	No			Yes	0	23.92		0
5526	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	223	0		No	Yes or Unknown			Yes	0	24.44		0
5527	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	84	0	Stable	No	No			No	0	24.38		0
5528	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	13	0.9	Stable	No	No			No	0	25.33		0
5529	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	36	5.3	Stable	No	No	Signature.29	MRE11A	Yes	0	24.31		0
5530	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	I	45	38.6	Unstable	No	No	Signature.1	CHEK2 | FANCC | NBN	No	0	22.37		0
5531	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	1.8	Stable	No	No			Yes	0	24.21		0
5532	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	174	1.8	Stable	No	Yes or Unknown			Yes	0	25.53		0
5533	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		17	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.91		0
5534	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	25.72		0
5535	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	II	0	2.6	Stable	No	No		BRCA1	Yes	0	22.97		0
5536	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		4	3.5	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	1	13.54		0
5537	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	3.5	Stable	No	No			Yes	0	23.46		0
5538	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	235	1.8	Stable	No	Yes or Unknown	Signature.13		No	1	14.62		0
5539	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	36	3.5	Stable	No	Yes or Unknown			No	0	23.69		0
5540	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	159	1.8	Stable	No	No			Yes	1	22.6		0
5541	Non-ICI treated	Never received ICI	21 - 25	Female	Ovarian	2017	III	4	0	Stable	No	No			Yes	0	23.59		0
5542	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	II	41	53.5	Unstable	No	No	Signature.6	BLM | BRCA1 | CHEK1 | ERCC5 | MSH3 | RAD50	No	0	24.08		0
5543	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	69	2.6	Stable	No	Yes or Unknown			Yes	0	23.26		0
5544	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	18	1.8	Stable	No	No	Signature.16		No	0	23.2		0
5545	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	III	158	3.5	Stable	No	No			No	0	19.94		0
5546	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	I	0	0	Stable	No	No			No	0	19.06		0
5547	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	5	1.8	Stable	No	No			No	0	23.2		0
5548	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.2	FANCA	Yes	0	22.11		0
5549	Non-ICI treated	Never received ICI	76 - 80	Female	Cutaneous Melanoma 	2017	IV	0	3.5	Stable	No	No	Signature.7		No	0	12.25		0
5550	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	9	2.6	Stable	No	No			Yes	1	3.06		0
5551	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	10.5	Stable	No	No	Signature.24		No	1	1.71		0
5552	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	62	1.8	Stable	No	No			No	0	24.64		0
5553	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	20	1.8	Stable	No	No			No	0	19.32		0
5554	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	0	12.3	Stable	No	Yes or Unknown	Signature.4		No	1	4.57		0
5555	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	48	3.5	Stable	No	No			Yes	0	14.75		0
5556	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.2	ARID1A	No	0	24.77		0
5557	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	11	0	Stable	No	No			No	0	24.74		0
5558	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	5.3	Stable	No	No			Yes	0	9.03		0
5559	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	IV	0	2.6	Stable	No	No			No	1	9.1		0
5560	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	76	3.5	Stable	No	No			No	0	5.75		0
5561	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	48	4.4	Stable	No	No			No	0	26.22		0
5562	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	337	0.9	Stable	No	Yes or Unknown			No	1	24.44		0
5563	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	3.5	Stable	No	No			No	0	15.41		0
5564	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	I	31	3.5	Stable	No	No			Yes	0	24.31		0
5565	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	30	2.6	Stable	No	Yes or Unknown			Yes	0	22.74		0
5566	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	IV	0	2.6	Stable	No	No			No	0	22.28		0
5567	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	26	2.6	Stable	No	Yes or Unknown			Yes	0	25.2		0
5568	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	0	4.4	Stable	No	No			Yes	1	0.85		0
5569	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	6.1	Stable	No	No	Signature.13	ATR | BRCA1 | CHEK1	No	0	24.38		0
5570	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	43	0		No	No			No	1	7.98		0
5571	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	III	87	2.6	Stable	No	Yes or Unknown			No	0	22.47		0
5572	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	5.3	Stable	No	No		ARID1A	No	0	6.97		0
5573	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	0	5.3	Stable	No	No		ARID1A	Yes	0	22.34		0
5574	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	7.9	Stable	No	No	Signature.4	CHEK2	No	0	9.72		0
5575	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	25	7	Stable	No	Yes or Unknown	Signature.1		No	0	25.13		0
5576	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	30	3.5	Stable	No	No			No	1	23.75		0
5577	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	37	8.8	Stable	No	No	Signature.1		No	0	25.13		0
5578	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	0	3.5	Stable	No	Yes or Unknown		NBN	No	0	24.74		0
5579	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	8	0	Stable	No	No			No	0	25.76		0
5580	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		5	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	24.77		0
5581	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	103	3.5	Stable	No	No			No	0	24.21		0
5582	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	26	4.4	Stable	No	Yes or Unknown			Yes	0	23.98		0
5583	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	I	0	0.9	Stable	No	No			No	0	18.66		0
5584	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	50	5.3	Stable	No	Yes or Unknown	Signature.30		No	1	13.5		0
5585	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	37	5.3	Stable	No	No	Signature.13		No	1	18.63		0
5586	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	56	0.9	Stable	No	No			No	0	22.57		0
5587	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	7	7	Stable	No	No	Signature.3		No	0	23.13		0
5588	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	37	5.3	Stable	No	No			Yes	0	22.97		0
5589	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	III	32	2.6	Stable	No	No			Yes	0	5.22		0
5590	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	5	6.1	Stable	No	No	Signature.12		Yes	1	4.86		0
5591	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	42	0.9	Stable	No	No			Yes	0	24.15		0
5592	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	30	9.7	Stable	No	No	Signature.1		No	0	26.74		0
5593	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	2.6	Stable	No	No			No	0	23.98		0
5594	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	II	22	2.6	Indeterminate	No	No	Signature.1		No	0	24.84		0
5595	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	74	4.4	Stable	No	No		ATM	No	0	20.73		0
5596	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		BRCA2	No	1	6.57		0
5597	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	II	126	0.9	Stable	No	No			No	0	25.79		0
5598	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	15	3.5	Stable	No	No	Signature.3		No	0	22.54		0
5599	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	0	1.8	Stable	No	No			No	0	23.23		0
5600	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown			Yes	0	1.61		0
5601	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	III	25	2.6	Stable	No	No			No	0	19.58		0
5602	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	3.5	Stable	No	No	Signature.11		No	0	25.13		0
5603	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	7	Stable	No	No	Signature.18		No	0	21.95		0
5604	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		92	0.9	Stable	No	No			Yes	0	16.46		0
5605	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	27	6.1	Stable	No	No	Signature.4		No	0	13.67		0
5606	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	24.25		0
5607	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		187	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	23.72		0
5608	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	IV	0	0.9	Indeterminate	No	No	Signature.5		No	0	23.69		0
5609	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	16	4.4	Stable	No	Yes or Unknown			No	0	22.8		0
5610	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	III	207	27.2	Stable	No	Yes or Unknown	Signature.4	BRCA1	Yes	0	23.1		0
5611	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	0	0	Stable	No	No			No	0	24.15		0
5612	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	IV	0	6.1	Stable	No	No	Signature.13		Yes	0	15.21		0
5613	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	II	0	2.6	Stable	No	No			No	1	6.18		0
5614	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	7	1.8	Stable	No	No		RAD50	No	0	25.26		0
5615	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	IV	27	5.3	Stable	No	No	Signature.1		Yes	1	5.72		0
5616	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	IV	0	7	Stable	No	No	Signature.1		Yes	1	5.42		0
5617	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	3	4.4	Stable	No	Yes or Unknown			No	0	24.57		0
5618	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	3	0		No	Yes or Unknown			No	1	11.79		0
5619	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	106	1.8	Stable	No	Yes or Unknown			No	0	25.72		0
5620	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	22	74.6	Stable	No	No	Signature.10	ATM | BRCA2 | MSH3 | MSH6	Yes	0	23.36		0
5621	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	0	5.3	Stable	No	Yes or Unknown			Yes	0	28.25		0
5622	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	0	Stable	No	Yes or Unknown			No	0	23.26		0
5623	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	34	4.4	Stable	No	No			No	0	24.44		0
5624	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	0	5.3	Stable	No	No			No	0	23.72		0
5625	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	231	7.9	Stable	No	Yes or Unknown			No	1	8.18		0
5626	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	35	2.6	Stable	No	No			No	0	23.62		0
5627	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	5	10.5	Stable	No	No	Signature.13	MSH6	No	1	19.06		0
5628	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2017		46	0.9	Stable	No	Yes or Unknown			No	0	23.85		0
5629	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	35	0.9	Stable	No	No		ERCC5	No	0	12.45		0
5630	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	0	4.4	Stable	No	No			Yes	0	19.52		0
5631	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	39	4.4	Stable	No	Yes or Unknown			No	0	24.28		0
5632	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2017	III	13	31.6	Stable	No	No	Signature.7	BRIP1 | RAD50	No	0	22.97		0
5633	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	III	562	29	Stable	No	Yes or Unknown	Signature.7	BLM | MLH1 | MSH6 | SLX4	No	0	25.07		0
5634	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	442	6.1	Stable	No	Yes or Unknown		ATM	No	0	23.98		0
5635	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	II	8	7.9	Stable	No	No	Signature.1	ARID1A	No	0	24.84		0
5636	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	14	2.6	Stable	No	No			Yes	0	24.11		0
5637	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	12	2.6	Stable	No	No			No	0	13.31		0
5638	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	III	28	10.5	Stable	No	No	Signature.2	PALB2	No	0	24.71		0
5639	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	148	4.4	Stable	No	Yes or Unknown	Signature.9		Yes	0	23.43		0
5640	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	III	18	5.3	Stable	No	No			No	1	18.4		0
5641	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	III	0	0.9	Stable	No	No		BRCA2	Yes	0	7.39		0
5642	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	55	4.4	Stable	No	No			Yes	0	24.38		0
5643	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	211	0	Stable	No	No			No	1	24.21		0
5644	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		2	8.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	23.2		0
5645	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	15	3.5	Stable	No	No			No	0	24.38		0
5646	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	60	0.9	Stable	No	No			No	0	14.26		0
5647	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	32	3.5	Stable	No	No		BRCA2	No	0	25.56		0
5648	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	7	1.8	Stable	No	No			No	0	22.97		0
5649	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	23	4.4	Stable	No	Yes or Unknown			No	0	26.94		0
5650	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	19	111.5	Unstable	No	No	Signature.6	ARID1A | BRCA1 | BRCA2 | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | RAD50 | SLX4	No	0	21.85		0
5651	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No		PMS2	No	0	24.38		0
5652	Non-ICI treated	Never received ICI	21 - 25	Male	Pancreatic	2017	II	0	1.8	Stable	No	No		ATM | RAD51C	Yes	0	24.28		0
5653	Non-ICI treated	Never received ICI	71 - 75	Female	Bladder	2017	II	151	17.6	Stable	No	Yes or Unknown	Signature.13	ARID1A	Yes	0	24.38		0
5654	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2017	IV	0	0	Stable	No	Yes or Unknown			No	1	10.18		0
5655	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	14	6.1	Stable	No	No		ATM	No	0	23.98		0
5656	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	0.9		No	No	Signature.1		No	1	2.92		0
5657	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2017	II	217	6.1	Stable	No	Yes or Unknown	Signature.30	FANCC | SLX4	No	0	24.77		0
5658	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	32	3.5	Stable	No	No			No	0	24.8		0
5659	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	17	0	Stable	No	No			No	0	20.6		0
5660	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	213	0.9	Stable	No	Yes or Unknown			No	1	11.76		0
5661	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	33	3.5	Stable	No	No		ERCC4	No	0	20.14		0
5662	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	41	5.3	Stable	No	No			No	0	11.3		0
5663	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	54	3.5	Stable	No	No			Yes	0	23.85		0
5664	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	6	12.3	Stable	No	No	Signature.1		No	0	24.8		0
5665	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	21	5.3	Stable	No	No			No	0	2.56		0
5666	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	35	4.4	Stable	No	No			No	0	19.35		0
5667	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	7	0	Stable	No	No			No	0	11.14		0
5668	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	19	9.7	Stable	No	No	Signature.6		No	1	6.24		0
5669	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	13	3.5	Stable	No	Yes or Unknown		ATM	No	1	7.36		0
5670	Non-ICI treated	Never received ICI	81 - 85	Male	Cutaneous Melanoma 	2017	III	0	21.1	Stable	No	No	Signature.7		No	0	22.57		0
5671	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	178	1.8	Stable	No	No			No	1	11.56		0
5672	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	49	1.8	Stable	No	No		BRCA2	No	0	21.32		0
5673	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	3.5	Stable	No	No	Signature.20		No	0	18.76		0
5674	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	163	1.8	Stable	No	Yes or Unknown			No	0	24.57		0
5675	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	3.5	Stable	No	No		CHEK2	Yes	0	21.85		0
5676	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	56	1.8	Stable	No	No			Yes	0	21.36		0
5677	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	104	0.9	Stable	No	No			No	0	27.3		0
5678	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	16	0.9	Stable	No	No			Yes	0	22.77		0
5679	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	8	4.4	Stable	No	No	Signature.5	ARID1A	No	1	16.76		0
5680	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	18	7.9	Stable	No	No	Signature.4		No	0	3.32		0
5681	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	21	1.8	Stable	No	No			Yes	0	19.58		0
5682	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	1	11.3		0
5683	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	33	2.6	Stable	No	No			Yes	0	23.13		0
5684	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	0	13.2	Stable	No	No	Signature.4	ARID1A	Yes	1	4.11		0
5685	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	160	5.3	Stable	No	No			No	0	7.89		0
5686	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	87	3.5	Stable	No	No			Yes	0	26.55		0
5687	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	18	2.6	Stable	No	No			Yes	1	5.32		0
5688	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	16	2.6	Stable	No	No			No	1	20.44		0
5689	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	II	123	19.3	Stable	No	Yes or Unknown	Signature.4	ERCC5	Yes	0	22.47		0
5690	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	31	1.8	Stable	No	No			No	1	15.28		0
5691	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	44	7	Stable	No	No	Signature.4	MDC1	No	1	10.68		0
5692	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	10	7.9	Stable	No	No	Signature.26	BLM | CHEK2	Yes	1	4.37		0
5693	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	46	1.8	Stable	No	No			No	0	24.02		0
5694	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	30	2.6	Stable	No	Yes or Unknown			No	0	23.03		0
5695	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	0	6.1	Stable	No	No	Signature.13	BRCA2	No	0	24.18		0
5696	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	III	2	4.4	Stable	No	No			No	0	24.87		0
5697	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	29	7	Stable	No	No	Signature.2	MUTYH	No	0	22.97		0
5698	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	48	0.9	Stable	No	No			No	0	24.11		0
5699	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	3.5	Stable	No	No			No	0	22.05		0
5700	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	2.6	Stable	No	No			No	0	23.59		0
5701	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	4.4	Stable	No	No			Yes	1	7.06		0
5702	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	IV	25	4.4	Stable	No	No	Signature.10	ARID1A | ATM	No	1	13.17		0
5703	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	57	3.5	Stable	No	No			No	0	23.75		0
5704	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	0	0.9	Stable	No	No			No	0	23.29		0
5705	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	32	5.3	Stable	No	No			No	0	24.08		0
5706	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	23.52		0
5707	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	23.98		0
5708	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	29	7.9	Stable	No	No	Signature.1		No	1	17.35		0
5709	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		16	2.6	Stable	No	No			No	0	23.39		0
5710	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	148	0.9	Stable	No	Yes or Unknown			Yes	0	24.08		0
5711	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	0.9	Stable	No	No		TP53BP1	No	0	24.54		0
5712	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	51	4.4	Stable	No	No			Yes	0	21.88		0
5713	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	218	2.6	Stable	No	Yes or Unknown		ATM	No	1	23.26		0
5714	Non-ICI treated	Never received ICI	36 - 40	Female	Cutaneous Melanoma 	2017	III	0	6.1	Stable	No	No	Signature.7		No	0	18.63		0
5715	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	II	10	1.8	Stable	No	No			No	0	23.26		0
5716	Non-ICI treated	Never received ICI	26 - 30	Male	Head & Neck	2017	II	400	0.9	Stable	No	Yes or Unknown			Yes	0	24.41		0
5717	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	201	1.8	Stable	No	No			No	0	24.87		0
5718	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	IV	16	1.8	Stable	No	No	Signature.5		No	1	7.2		0
5719	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	1	13.83		0
5720	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	19	2.6	Stable	No	No			No	0	24.34		0
5721	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	22	0	Stable	No	No			No	0	21.22		0
5722	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	36	2.6	Stable	No	No			No	1	21.29		0
5723	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	125	0		No	No			No	0	4.76		0
5724	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	24	3.5	Stable	No	No	Signature.19		No	0	6.74		0
5725	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	132	4.4	Stable	No	Yes or Unknown		SLX4	No	1	22.28		0
5726	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	III	122	8.8	Stable	No	No	Signature.4	ATR | SLX4	No	0	6.24		0
5727	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	22	1.8	Stable	No	No			No	0	22.14		0
5728	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	II	13	4.4	Stable	No	No			Yes	0	24.38		0
5729	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	34	7	Stable	No	No	Signature.9		No	0	25		0
5730	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2017	IV	6	2.6	Stable	No	Yes or Unknown	Signature.9		No	1	6.34		0
5731	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	0	2.6	Stable	No	No			No	0	21.98		0
5732	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	8	3.5	Stable	No	No			Yes	0	24.38		0
5733	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	264	7	Stable	No	Yes or Unknown	Signature.1		No	1	17.31		0
5734	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	28	0.9	Stable	No	No			Yes	0	23.56		0
5735	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2017	III	16	3.5	Stable	No	No		BRCA2	No	1	9.92		0
5736	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	III	44	8.8	Stable	No	No	Signature.4		Yes	0	21.68		0
5737	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	III	0	12.3	Stable	No	No	Signature.7	BRCA2 | MDC1	No	0	24.08		0
5738	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	29	36.9	Stable	No	No	Signature.4	ATR | MDC1 | MSH6	No	0	19.98		0
5739	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	III	98	1.8	Stable	No	No			No	0	18.86		0
5740	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	142	2.6	Stable	No	Yes or Unknown			No	0	24.84		0
5741	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	30	4.4	Stable	No	No		MRE11A	No	0	23.16		0
5742	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	0	14	Stable	No	No	Signature.1	ARID1A | RAD54L	No	1	11.6		0
5743	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	23	0.9	Stable	No	No			No	0	23.39		0
5744	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	0	7	Stable	No	No	Signature.26		No	1	11.17		0
5745	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	II	0	2.6	Stable	No	No			Yes	0	23.59		0
5746	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.62		0
5747	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	14	Stable	No	No	Signature.20	ARID1A	No	0	18.1		0
5748	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	0	2.6	Stable	No	No			No	0	19.12		0
5749	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	1.8	Stable	No	No			Yes	0	23.92		0
5750	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	7.9	Stable	No	No			No	0	24.9		0
5751	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	16	3.5	Stable	No	No		ARID1A	Yes	0	20.14		0
5752	Non-ICI treated	Never received ICI	51 - 55	Male	Renal	2017	I	8	1.8	Stable	No	No			No	0	23.52		0
5753	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	58	3.5	Stable	No	No		BRCA1	Yes	0	23		0
5754	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	II	8	10.5	Stable	No	No	Signature.3		Yes	0	7		0
5755	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	III	0	22.8	Stable	No	No	Signature.7	BRIP1 | MLH1	No	0	20.83		0
5756	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	15	1.8	Stable	No	Yes or Unknown			No	0	18.5		0
5757	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	40	8.8	Stable	No	No	Signature.1		No	0	24.08		0
5758	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No			No	0	18.27		0
5759	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	0	Stable	No	No		BRCA2	Yes	1	8.71		0
5760	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	12.3	Stable	No	No	Signature.1	PARP1	No	1	20.99		0
5761	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2017	IV	7	4.4	Stable	No	No	Signature.1		No	0	20.01		0
5762	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	0	26.3	Unstable	No	No	Signature.6	ARID1A | FANCA | MLH1 | PMS1	No	1	2.92		0
5763	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	III	27	0.9	Stable	No	No			No	1	12.02		0
5764	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No		MUTYH	Yes	0	17.81		0
5765	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	13	2.6	Stable	No	No			No	1	13.47		0
5766	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	147	5.3	Stable	No	Yes or Unknown		BRCA1 | ERCC2	No	0	23.95		0
5767	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		14	2.6	Stable	No	No		BRCA1	No	1	7.06		0
5768	Non-ICI treated	Never received ICI	26 - 30	Male	Renal	2017	III	0	3.5	Stable	No	No			No	0	2.73		0
5769	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	55	0.9	Stable	No	No			Yes	0	21.65		0
5770	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	23	0.9	Stable	No	Yes or Unknown			Yes	0	23.52		0
5771	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	III	52	3.5	Stable	No	No		MRE11A	No	0	23.49		0
5772	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.13		0
5773	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	PMS2	No	0	23.39		0
5774	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	91	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	5.19		0
5775	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2017	III	33	4.4	Stable	No	No		ATM	No	1	15.34		0
5776	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	30	0		No	No			Yes	0	18.6		0
5777	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	33	4.4	Stable	No	No			No	0	24.08		0
5778	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	40	6.1	Stable	No	Yes or Unknown			Yes	0	23.75		0
5779	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	25.76		0
5780	Non-ICI treated	Never received ICI	21 - 25	Female	Ovarian	2017	I	0	3.5	Stable	No	No			No	0	22.24		0
5781	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	35	1.8	Stable	No	No		TP53BP1	Yes	0	21.62		0
5782	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2017	III	0	7.9	Stable	No	No	Signature.19		Yes	0	23.66		0
5783	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	78	1.8	Stable	No	No			No	0	24.34		0
5784	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	1	4.96		0
5785	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	III	617	5.3	Stable	No	Yes or Unknown	Signature.30		Yes	0	23.56		0
5786	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	78	14.9	Stable	No	No	Signature.1	RAD54L	No	0	3.94		0
5787	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	393	3.5	Stable	No	Yes or Unknown			No	0	24.64		0
5788	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	427	3.5	Stable	No	Yes or Unknown		SLX4	No	0	24.15		0
5789	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	6	1.8	Stable	No	No			No	0	24.11		0
5790	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	III	13	5.3	Stable	No	No			No	0	24.71		0
5791	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	19	4.4	Stable	No	No			Yes	1	8.15		0
5792	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	0	7	Stable	No	No	Signature.13		Yes	0	22.83		0
5793	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2017	IV	26	56.2	Stable	No	No	Signature.4	ARID1A | ATR | BRCA2 | FANCA | MSH3	Yes	0	5.52		0
5794	Non-ICI treated	Never received ICI	46 - 50	Male	Breast	2017	II	32	0	Stable	No	No			No	0	27.3		0
5795	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	I	117	5.3	Stable	No	No			No	0	24.64		0
5796	Non-ICI treated	Never received ICI	31 - 35	Male	Hepatobiliary	2017	IV	6	2.6	Stable	No	No		ARID1A	No	1	12.39		0
5797	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	7	Stable	No	No	Signature.24		Yes	0	26.64		0
5798	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	189	0.9	Stable	No	Yes or Unknown			No	1	15.28		0
5799	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	35	2.6	Stable	No	No			Yes	0	23.39		0
5800	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	II	146	0.9	Stable	No	Yes or Unknown			No	0	23.92		0
5801	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	18	7.9	Stable	No	No	Signature.1	MUTYH	No	0	25		0
5802	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	2.6	Stable	No	No		ATM	No	0	13.24		0
5803	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.30		Yes	0	3.09		0
5804	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	I	8	3.5	Stable	No	No			Yes	0	23.75		0
5805	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	0	Stable	No	No			Yes	0	24.15		0
5806	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			Yes	0	23.59		0
5807	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	38	3.5	Stable	No	No			No	0	21.03		0
5808	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	6	6.1	Stable	No	No	Signature.3		Yes	1	15.11		0
5809	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	I	0	5.3	Stable	No	Yes or Unknown			Yes	0	18.83		0
5810	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	9	0.9	Stable	No	No			Yes	0	24.02		0
5811	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	19.02		0
5812	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	I	0	1.8	Stable	No	Yes or Unknown			Yes	0	6.74		0
5813	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	15	7	Stable	No	Yes or Unknown	Signature.3	ATM | BRCA2 | MDC1	Yes	0	23.92		0
5814	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	III	0	15.8	Stable	No	No	Signature.4		Yes	0	19.52		0
5815	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	6	7	Stable	No	No	Signature.29		No	0	17.48		0
5816	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	30	2.6	Stable	No	No		FANCA	No	1	7.23		0
5817	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	6	7	Stable	No	No			Yes	0	22.47		0
5818	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	32	3.5	Stable	No	No			Yes	0	20.76		0
5819	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2017	II	0	2.6	Stable	No	No			Yes	1	13.54		0
5820	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	16	0.9	Stable	No	No			No	0	26.64		0
5821	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	30	140.4	Stable	No	No	Signature.10	ARID1A | ATM | BRCA1 | BRCA2 | ERCC3 | ERCC5 | MRE11A | RAD51C | SLX4	No	0	24.18		0
5822	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	23	1.8	Stable	No	Yes or Unknown			No	0	23.43		0
5823	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	11	3.5	Stable	No	No			No	1	16.82		0
5824	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	8	1.8	Stable	No	No			No	0	21.98		0
5825	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	147	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	23.33		0
5826	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	29	3.5	Stable	No	No			No	0	23.49		0
5827	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	28	4.4	Stable	No	Yes or Unknown		ARID1A | RAD52	No	1	16.56		0
5828	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	35	7.9	Stable	No	No	Signature.16		No	1	4.14		0
5829	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	0.9	Stable	No	No			Yes	0	19.75		0
5830	Non-ICI treated	Never received ICI	36 - 40	Male	Prostatic	2017	IV	64	1.8	Stable	No	Yes or Unknown			No	1	16		0
5831	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	7	5.3	Stable	No	No			No	1	9.33		0
5832	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	214	5.3	Stable	No	Yes or Unknown			No	0	21.55		0
5833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	0	0		No	No			No	0	19.38		0
5834	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	147	4.4	Stable	No	Yes or Unknown			No	0	24.15		0
5835	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	25	0	Stable	No	No			No	0	21.95		0
5836	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	0	7	Stable	No	No	Signature.1		No	1	21.26		0
5837	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	III	32	7.9	Stable	No	No	Signature.4	ATM | PALB2	Yes	0	20.27		0
5838	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2017	I	0	3.5	Stable	No	No		ATM	No	0	19.32		0
5839	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		9	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.29		0
5840	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	III	0	3.5	Stable	No	No			No	1	23.13		0
5841	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	23.62		0
5842	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	25	27.2	Stable	No	Yes or Unknown	Signature.4	ARID1A	Yes	0	24.02		0
5843	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	0		No	No			Yes	0	3.32		0
5844	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	55	4.4	Stable	No	No			Yes	0	23.92		0
5845	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	39	1.8	Stable	No	No		BLM	No	0	18.99		0
5846	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	23.92		0
5847	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	0		No	No			No	1	6.47		0
5848	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	23	4.4	Stable	No	No			Yes	1	4.17		0
5849	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	4	2.6	Stable	No	No		ATM	Yes	0	23.89		0
5850	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	III	27	0		No	No			Yes	0	23.62		0
5851	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		112	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	11.56		0
5852	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	23	6.1	Stable	No	No			No	0	19.55		0
5853	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	9.7	Stable	No	No	Signature.3	BRCA2 | MSH6	No	0	23.66		0
5854	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	0	1.8	Stable	No	Yes or Unknown	Signature.1		No	0	25.95		0
5855	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	12	4.4	Stable	No	No	Signature.3		Yes	0	22.24		0
5856	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	17.97		0
5857	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	34	3.5	Stable	No	No	Signature.1		No	0	23.92		0
5858	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	0	0.62		0
5859	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	10	4.4	Stable	No	No		ERCC3	No	0	23.85		0
5860	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	10.5	Stable	No	No	Signature.5		No	0	16.79		0
5861	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	24.21		0
5862	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2017	IV	194	3.5	Stable	No	Yes or Unknown		MSH3	Yes	0	14.88		0
5863	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	0	9.7	Stable	No	No		ATR	No	0	24.15		0
5864	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	III	19	6.1	Stable	No	No	Signature.1		Yes	0	22.9		0
5865	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	0	3.5	Stable	No	No		ATR	No	0	22.41		0
5866	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	166	6.1	Stable	No	Yes or Unknown			No	0	23.23		0
5867	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	2	7.9	Stable	No	No			No	1	19.45		0
5868	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	II	32	3.5	Stable	No	No			Yes	1	20.57		0
5869	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	24.15		0
5870	Non-ICI treated	Never received ICI	81 - 85	Male	Cutaneous Melanoma 	2017	II	34	5.3	Stable	No	No	Signature.19		No	0	20.63		0
5871	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	0	7	Stable	No	Yes or Unknown			No	1	7.29		0
5872	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	IV	16	43.9	Unstable	No	No	Signature.6	ARID1A | ATM | CHEK1 | MSH3	Yes	1	6.18		0
5873	Non-ICI treated	Never received ICI	36 - 40	Male	Gastric	2017	IV	20	2.6	Stable	No	No			No	0	6.57		0
5874	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	0	6.1	Stable	No	No	Signature.1		No	0	23.79		0
5875	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	28	2.6	Stable	No	No		ARID1A	No	0	12.12		0
5876	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	29	2.6	Stable	No	No			Yes	0	21.59		0
5877	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	30	87.8	Unstable	No	No	Signature.6	BRCA1 | BRCA2 | MDC1 | MSH3 | RAD51	No	0	17.05		0
5878	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	II	385	14	Stable	No	Yes or Unknown	Signature.24	ATM	No	0	14.49		0
5879	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	0	3.5	Stable	No	No			Yes	0	21.82		0
5880	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	III	0	8.8	Stable	No	No	Signature.5	ERCC2	Yes	0	20.93		0
5881	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	163	2.6	Stable	No	Yes or Unknown			No	1	10.87		0
5882	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	9	5.3	Stable	No	No		ATM	No	1	19.12		0
5883	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	56	2.6	Stable	No	Yes or Unknown			No	0	23.26		0
5884	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	22	0.9	Stable	No	No			No	0	22.37		0
5885	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	22.97		0
5886	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	15	4.4	Stable	No	Yes or Unknown			Yes	0	17.31		0
5887	Non-ICI treated	Never received ICI	86 - 90	Male	Pancreatic	2017	II	2	0.9	Stable	No	No			No	1	13.83		0
5888	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	0	5.3	Stable	No	Yes or Unknown		MSH6	Yes	1	4.21		0
5889	Non-ICI treated	Never received ICI	51 - 55	Male	Bladder	2017		0	15.8	Stable	No	No	Signature.2	ERCC4	No	0	17.05		0
5890	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	10	8.8	Stable	No	No	Signature.1	ARID1A | ATM	No	1	18.3		0
5891	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	0	8.8	Stable	No	No		ARID1A	Yes	1	3.75		0
5892	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	III	0	5.3	Stable	No	No			Yes	0	5.26		0
5893	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	II	39	2.6	Stable	No	No			No	0	20.47		0
5894	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	44	1.8	Stable	No	No			No	0	23.03		0
5895	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	21	0.9	Stable	No	No			No	0	22.14		0
5896	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		41	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	21.16		0
5897	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2017	III	0	0.9	Stable	No	No			No	0	22.08		0
5898	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	36	14.9	Stable	No	No	Signature.13	NTHL1	Yes	0	23.66		0
5899	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	III	0	3.5	Stable	No	No			Yes	0	24.11		0
5900	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	27	4.4	Stable	No	No			Yes	0	22.74		0
5901	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	I	88	0.9	Stable	No	No			No	0	9.63		0
5902	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	I	0	1.8	Stable	No	No			No	0	16.13		0
5903	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2017		16	0	Stable	No	No			No	0	20.47		0
5904	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	0	Stable	No	Yes or Unknown			No	0	19.91		0
5905	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	13.2	Stable	No	No	Signature.1		No	0	23.92		0
5906	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	85	3.5	Stable	No	No			Yes	0	19.61		0
5907	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	89	1.8	Stable	No	No			No	1	17.97		0
5908	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	15.8	Stable	No	No	Signature.4		No	0	16.62		0
5909	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	43	3.5	Stable	No	No			Yes	0	23.59		0
5910	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	III	1	1.8	Stable	No	No			Yes	0	24.18		0
5911	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No	Signature.26		No	1	19.81		0
5912	Non-ICI treated	Never received ICI	26 - 30	Male	Gastric	2017	IV	0	2.6	Stable	No	No			No	1	10.94		0
5913	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	0	26.78		0
5914	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2017	IV	0	16.7	Stable	No	No	Signature.17		No	0	9.07		0
5915	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	0	6.1	Stable	No	No			No	0	23.52		0
5916	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	21	3.5	Stable	No	No		ATM	No	1	12.45		0
5917	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	0.9	Stable	No	Yes or Unknown			No	0	24.02		0
5918	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	752	3.5	Stable	No	Yes or Unknown		RAD51C	No	0	23.49		0
5919	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	28	2.6	Stable	No	No			No	0	23.52		0
5920	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	47	4.4	Stable	No	No		ATM	No	1	21.13		0
5921	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	5	7.9	Stable	No	No			Yes	0	11.01		0
5922	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2017	III	0	7	Stable	No	No	Signature.7		No	0	17.41		0
5923	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	III	21	0	Stable	No	Yes or Unknown			No	1	10.68		0
5924	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	44	2.6	Stable	No	No			Yes	0	17.94		0
5925	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	III	0	1.8	Stable	No	No	Signature.1		Yes	1	7		0
5926	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017		253	1.8	Stable	No	No			Yes	0	16.07		0
5927	Non-ICI treated	Never received ICI	51 - 55	Female	Renal	2017	I	16	1.8	Stable	No	No			No	0	20.63		0
5928	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		13	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.25	TP53BP1	Yes	0	15.67		0
5929	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	0	11.4	Stable	No	No	Signature.1	ATM	Yes	1	4.01		0
5930	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	5	5.3	Stable	No	No		FANCA	No	0	25.3		0
5931	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	II	21	1.8	Stable	No	No			Yes	0	22.77		0
5932	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	40	4.4	Stable	No	No			No	0	13.11		0
5933	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	20.96		0
5934	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	1.8	Stable	No	No			No	0	17.61		0
5935	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		25	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	RAD51C	No	1	2.53		0
5936	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	34	2.6	Stable	No	No			No	0	22.28		0
5937	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	6.1	Stable	No	No	Signature.1		No	0	24.44		0
5938	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	35	2.6	Stable	No	Yes or Unknown			No	0	23.49		0
5939	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	28	3.5	Stable	No	No		FANCA	Yes	0	23.43		0
5940	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	18.4	Stable	No	No	Signature.4	ARID1A	No	0	20.67		0
5941	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	76	0.9	Stable	No	Yes or Unknown			Yes	0	24.05		0
5942	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	30	1.8	Stable	No	No			Yes	0	21.13		0
5943	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2017	I	0	3.5	Stable	No	No			No	0	13.04		0
5944	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			Yes	0	20.67		0
5945	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	III	67	4.4	Stable	No	No		MSH2	No	0	24.57		0
5946	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	9	1.8	Stable	No	No			No	0	21.68		0
5947	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	1	10.5	Stable	No	No	Signature.1		No	0	13.14		0
5948	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	II	6	74.6	Unstable	No	No	Signature.6	ARID1A | ATM | BRCA2 | ERCC3 | ERCC5 | MRE11A | MSH3 | MSH6 | RAD52 | TP53BP1 | XRCC2	No	0	21.09		0
5949	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	7	0.9	Stable	No	No			No	1	5.03		0
5950	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	IV	0	7	Stable	No	No		ARID1A | BRCA2	Yes	1	2.96		0
5951	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	III	59	12.3	Stable	No	No	Signature.4	NBN	No	0	9.03		0
5952	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		0	1.8	Stable	No	No			No	0	1.15		0
5953	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	II	156	2.6	Stable	No	No			No	0	8.48		0
5954	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	4.4	Stable	No	No			No	1	15.77		0
5955	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.1	BLM	No	0	23.13		0
5956	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	49	1.8	Stable	No	No			No	0	23.62		0
5957	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2017	III	10	0.9	Stable	No	No			Yes	0	21.62		0
5958	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	III	33	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	23.03		0
5959	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	8	8.8	Stable	No	No	Signature.1	ARID1A	Yes	1	13.17		0
5960	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	15	9.7	Stable	No	No	Signature.3	BRCA1	Yes	0	5.95		0
5961	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	22.51		0
5962	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	45	1.8	Stable	No	No			No	0	19.61		0
5963	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	IV	68	4.4	Stable	No	Yes or Unknown			Yes	0	14.88		0
5964	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		18	6.1	Stable	No	No	Signature.1		No	0	1.35		0
5965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	175	2.6	Stable	No	Yes or Unknown			No	0	8.8		0
5966	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2017	IV	0	5.3	Stable	No	Yes or Unknown	Signature.18	MUTYH | PALB2	No	0	23.69		0
5967	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	6.1	Stable	No	No		BRIP1	No	0	16.36		0
5968	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	17	0.9	Stable	No	No			Yes	0	19.42		0
5969	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	III	15	14.9	Stable	No	No	Signature.13		No	0	20.47		0
5970	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	0	16.39		0
5971	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	3.5	Stable	No	No	Signature.4		Yes	1	12.06		0
5972	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	0	11.4	Indeterminate	No	No	Signature.3		No	0	22.74		0
5973	Non-ICI treated	Never received ICI	41 - 45	Male	Pancreatic	2017	III	622	0.9	Stable	No	Yes or Unknown			No	0	23.29		0
5974	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2017	IV	14	4.4	Stable	No	No			No	1	12.02		0
5975	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2017	IV	0	5.3	Stable	No	No			No	0	21.19		0
5976	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	II	0	0.9	Stable	No	Yes or Unknown			Yes	0	20.9		0
5977	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	26	2.6	Stable	No	Yes or Unknown			Yes	0	23.26		0
5978	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	3	4.4	Stable	No	No			Yes	1	3.45		0
5979	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	0.9	Stable	No	No			No	0	22.64		0
5980	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	26	2.6	Stable	No	Yes or Unknown			Yes	0	20.9		0
5981	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	III	55	64.1	Unstable	No	No	Signature.6	ARID1A | MSH3 | MSH6 | PMS2	Yes	0	20.53		0
5982	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		232	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	8.31		0
5983	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2017	IV	47	0	Stable	No	No			No	0	21.19		0
5984	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	21	2.6	Stable	No	No			No	0	22.18		0
5985	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	21	2.6	Stable	No	No		BLM	No	0	23.52		0
5986	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	256	4.4		No	Yes or Unknown		BRCA1	No	0	23.43		0
5987	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	173	1.8	Stable	No	Yes or Unknown		BRCA1	No	0	19.88		0
5988	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	41	1.8	Stable	No	No	Signature.1		Yes	0	20.37		0
5989	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017		1	0	Stable	Yes or Unknown	Yes or Unknown			No	0	22.93		0
5990	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	III	502	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	23.1		0
5991	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	42	2.6	Stable	No	Yes or Unknown			No	0	21.13		0
5992	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	34	0	Stable	No	No			Yes	0	22.28		0
5993	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	II	69	2.6	Stable	No	No		ARID1A	Yes	0	23.26		0
5994	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	4.4	Stable	No	No		BLM | BRCA2	Yes	0	21.78		0
5995	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	43	3.5	Stable	No	Yes or Unknown			No	0	23.43		0
5996	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	No		ATM	Yes	0	22.57		0
5997	Non-ICI treated	Never received ICI	41 - 45	Male	Head & Neck	2017	IV	44	0		No	No			No	0	22.41		0
5998	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	0	4.4	Indeterminate	No	No	Signature.30		No	1	6.97		0
5999	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	25	3.5	Stable	No	No		ARID1A	Yes	1	6.18		0
6000	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	1	7.36		0
6001	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	I	0	3.5	Stable	No	No			No	0	7.36		0
6002	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	17	0.9	Stable	No	No			No	0	22.83		0
6003	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	0	1.8	Stable	No	No	Signature.1	NBN	No	1	11.24		0
6004	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	43	3.5	Stable	No	Yes or Unknown			No	0	15.21		0
6005	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	2	8.8	Stable	No	No			Yes	0	24.25		0
6006	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	192	0	Stable	No	Yes or Unknown			No	1	22.01		0
6007	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	13	6.1	Stable	No	No	Signature.1		No	1	15.77		0
6008	Non-ICI treated	Never received ICI	81 - 85	Female	Esophageal	2017	IV	0	6.1	Stable	No	Yes or Unknown		ATR	No	1	20.76		0
6009	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	24	5.3	Stable	No	No	Signature.4	ATM | MRE11A	No	0	22.11		0
6010	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	202	5.3	Stable	No	Yes or Unknown			No	1	14.36		0
6011	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	148	7	Stable	No	No	Signature.1		No	0	14.78		0
6012	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	III	28	38.6	Stable	No	No	Signature.22	ARID1A | ATM | MDC1 | MSH3	No	0	20.47		0
6013	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No		MDC1	Yes	1	4.07		0
6014	Non-ICI treated	Never received ICI	76 - 80	Female	Gastric	2017	IV	21	4.4	Stable	No	No	Signature.1		No	0	22.9		0
6015	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	625	15.8	Stable	No	Yes or Unknown	Signature.1	BRIP1	No	0	25.1		0
6016	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	II	0	3.5	Stable	No	No	Signature.1		No	0	22.74		0
6017	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No		PALB2	No	1	11.79		0
6018	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	51	2.6	Stable	No	No		ARID1A	Yes	0	19.35		0
6019	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	I	242	4.4	Stable	No	Yes or Unknown			No	0	25.66		0
6020	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	1.8	Indeterminate	No	No			No	1	15.47		0
6021	Non-ICI treated	Never received ICI	26 - 30	Female	Renal	2017	I	55	2.6	Stable	No	No			No	0	21.03		0
6022	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	14	4.4	Stable	No	No		CHEK2	Yes	1	5.62		0
6023	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	II	564	1.8	Stable	No	Yes or Unknown			No	0	22.77		0
6024	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	29	2.6	Stable	No	No			No	0	22.7		0
6025	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	433	27.2	Unstable	No	Yes or Unknown	Signature.12	ARID1A | ERCC5	Yes	0	21.72		0
6026	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No			Yes	1	12.45		0
6027	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	III	24	1.8	Stable	No	No			Yes	0	20.57		0
6028	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	4	7.9	Stable	No	No		BRCA2	No	0	22.87		0
6029	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	12	0	Stable	No	No		ATM	No	1	11.96		0
6030	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	20	4.4	Stable	No	No			No	1	3.52		0
6031	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	104	5.3	Stable	No	No	Signature.4		No	0	14.19		0
6032	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	119	2.6	Stable	No	Yes or Unknown			No	0	23		0
6033	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	52	3.5	Stable	No	No		MDC1	No	0	22.57		0
6034	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	70	6.1	Stable	No	No			Yes	0	22.34		0
6035	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	50	18.4	Stable	No	No	Signature.4	MDC1	No	0	21.26		0
6036	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	6	3.5	Stable	No	No			No	0	22.64		0
6037	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	22	6.1	Stable	No	No			No	0	22.83		0
6038	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	0	7.9	Stable	No	No	Signature.1	MLH1	Yes	0	7.52		0
6039	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	42	5.3	Stable	No	No			No	0	17.18		0
6040	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	21	4.4	Stable	No	No	Signature.6		No	0	22.77		0
6041	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	II	7	7.9	Stable	No	No	Signature.1		No	0	20.44		0
6042	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	171	0.9	Stable	No	Yes or Unknown			No	0	23.13		0
6043	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1	ARID1A	No	0	23.89		0
6044	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	0	9.7	Stable	No	No		BRCA2	No	0	22.97		0
6045	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	II	119	2.6	Stable	No	No		ARID1A	No	0	25.46		0
6046	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	22	2.6	Stable	No	No	Signature.5		No	0	17.94		0
6047	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	20	7	Stable	No	No			Yes	1	14.23		0
6048	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	22.44		0
6049	Non-ICI treated	Never received ICI	10-Jun	Female	Renal	2017	IV	0	2.6	Stable	No	No			No	1	13.86		0
6050	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	0	3.5	Stable	No	No		ARID1A	No	1	14.55		0
6051	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	3	5.3	Stable	No	No			No	1	4.5		0
6052	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	112	0	Stable	No	No			No	0	3.68		0
6053	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	0	7.9	Stable	No	No	Signature.1	ATR	Yes	0	10.48		0
6054	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	16	0.9	Stable	No	No			No	0	14.03		0
6055	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	197	0.9	Stable	No	Yes or Unknown			No	0	19.55		0
6056	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	IV	0	2.6	Stable	No	No		ATM	No	0	3.81		0
6057	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	III	126	7	Stable	No	No	Signature.24		No	1	7.62		0
6058	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2017	III	0	2.6	Stable	No	Yes or Unknown			Yes	0	20.01		0
6059	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	2.6	Stable	No	No			No	0	19.55		0
6060	Non-ICI treated	Never received ICI	16 - 20	Male	Colorectal	2017	III	0	58.8	Unstable	No	No	Signature.6	ARID1A | ERCC4 | MLH1 | MSH3	Yes	0	19.91		0
6061	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	16.72		0
6062	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	34	8.8	Stable	No	No	Signature.1	ATR	No	1	20.6		0
6063	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	11	7	Stable	No	No			No	0	23.1		0
6064	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	215	0	Stable	No	Yes or Unknown			No	0	22.57		0
6065	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	1	3.5	Stable	No	No			Yes	0	23.06		0
6066	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	III	26	25.5	Stable	No	No	Signature.6	BRCA1 | MDC1	No	0	22.47		0
6067	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	III	37	0.9	Stable	No	No			Yes	0	23.2		0
6068	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	20	0	Stable	No	No			No	0	17.94		0
6069	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	I	52	5.3	Stable	No	No	Signature.9	ERCC5	No	0	23.39		0
6070	Non-ICI treated	Never received ICI	81 - 85	Male	Hepatobiliary	2017	II	24	2.6	Stable	No	No			No	0	18.83		0
6071	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No	Signature.1		Yes	1	5.13		0
6072	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	0	1.8	Stable	No	No			Yes	0	22.8		0
6073	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	5.3	Stable	No	No	Signature.1		No	0	22.97		0
6074	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	II	22	0.9	Stable	No	No			No	0	21.16		0
6075	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	III	186	9.7	Stable	No	Yes or Unknown	Signature.4	ERCC5	No	0	23.69		0
6076	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	III	142	0	Stable	No	No			No	0	4.96		0
6077	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	I	33	62.3	Unstable	No	No	Signature.6	ARID1A | ERCC2 | MSH3 | MSH6	No	0	23.26		0
6078	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	35	4.4	Stable	No	No		ATM	Yes	0	6.37		0
6079	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2017	IV	30	4.4	Stable	No	Yes or Unknown	Signature.1		No	0	22.9		0
6080	Non-ICI treated	Never received ICI	26 - 30	Female	Hepatobiliary	2017		14	0	Stable	No	No			No	0	20.01		0
6081	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	0	0		No	No			No	0	20.99		0
6082	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		68	0	Stable	No	No			No	0	17.94		0
6083	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	0	28.1	Stable	No	No	Signature.4	ATR	No	1	6.64		0
6084	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	20	6.1	Stable	No	No		NBN	No	1	10.87		0
6085	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	21	5.3	Stable	No	No		MSH3	No	0	22.9		0
6086	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	22	40.4	Unstable	No	No	Signature.6	ATM | ERCC3 | MSH2 | PARP1 | PMS1	No	0	22.44		0
6087	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	III	0	0.9	Stable	No	No			Yes	0	22.28		0
6088	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	III	8	5.3	Stable	No	Yes or Unknown		ARID1A	Yes	0	17.02		0
6089	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	IV	0	4.4	Stable	No	No			No	0	23.39		0
6090	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	40	5.3	Stable	No	No	Signature.5		No	0	5.26		0
6091	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	19	1.8	Stable	No	No			No	0	18.63		0
6092	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	4	4.4	Stable	No	No	Signature.6		No	0	22.05		0
6093	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	44	9.7	Stable	No	No	Signature.13		Yes	0	20.93		0
6094	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	IV	23	5.3	Stable	No	No		BRCA2	No	0	22.51		0
6095	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	232	1.8	Stable	No	Yes or Unknown			No	1	9.59		0
6096	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	0	2.6	Stable	No	Yes or Unknown	Signature.7		No	0	23		0
6097	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	0	23.26		0
6098	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2017	IV	35	2.6	Stable	No	No			Yes	0	21.85		0
6099	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	2.6	Stable	No	No		BRCA2	Yes	1	3.48		0
6100	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	0	4.4	Stable	No	No	Signature.3		No	0	22.67		0
6101	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	6.1	Stable	No	No			Yes	1	6.47		0
6102	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	42	3.5	Stable	No	Yes or Unknown			No	0	18.89		0
6103	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	III	0	5.3	Stable	No	No			No	0	17.68		0
6104	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	30	4.4	Stable	No	Yes or Unknown			Yes	0	2.56		0
6105	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	144	6.1	Stable	No	Yes or Unknown			Yes	0	17.22		0
6106	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.4	BRCA2	No	0	20.07		0
6107	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	128	3.5	Stable	No	Yes or Unknown		PMS2	No	0	22.77		0
6108	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	280	14	Stable	No	Yes or Unknown	Signature.2	BRCA1	No	0	10.41		0
6109	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	237	0.9	Stable	No	Yes or Unknown			No	0	22.97		0
6110	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	46	3.5	Stable	No	No	Signature.29		No	0	20.44		0
6111	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	11	2.6	Stable	No	No		ATM | MSH3	No	1	18.1		0
6112	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2017	IV	1	4.4	Stable	No	No		PMS1	No	0	22.83		0
6113	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	1	4.4	Stable	No	No			No	0	23.1		0
6114	Non-ICI treated	Never received ICI	36 - 40	Male	Hepatobiliary	2017	IV	10	0.9	Stable	No	No			No	1	17.31		0
6115	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	63	2.6	Stable	No	No			No	0	23.16		0
6116	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	6	6.1	Stable	No	No	Signature.1		No	1	7.98		0
6117	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	50	10.5	Stable	No	No	Signature.13	ATR	No	0	20.86		0
6118	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	21	1.8	Stable	No	No		ATM	No	1	8.97		0
6119	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2017	I	62	0	Stable	No	No			No	0	4.93		0
6120	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	0	23.03		0
6121	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	102	1.8	Stable	No	Yes or Unknown			No	1	13.67		0
6122	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017	IV	30	1.8	Stable	No	No			No	0	22.54		0
6123	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	9	24.6	Unstable	No	No	Signature.6	ARID1A | MLH1	No	0	22.83		0
6124	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	3	3.5	Stable	No	No			No	0	13.37		0
6125	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	22.51		0
6126	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	1.8	Stable	No	No			No	0	21.65		0
6127	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	17	1.8	Stable	No	Yes or Unknown			Yes	0	22.41		0
6128	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	I	28	1.8	Stable	No	No		RAD52	No	0	21.32		0
6129	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	5.3	Stable	No	No		ARID1A | BRIP1 | MSH2	No	0	17.12		0
6130	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	8	3.5	Stable	No	No			No	0	20.53		0
6131	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	13	8.8	Stable	No	No		CHEK2	No	0	22.77		0
6132	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	II	266	1.8	Stable	No	Yes or Unknown			Yes	0	22.37		0
6133	Non-ICI treated	Never received ICI	21 - 25	Male	Pancreatic	2017	I	52	1.8	Stable	No	No		BRCA2	No	0	22.64		0
6134	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	134	3.5	Stable	No	Yes or Unknown		NBN	No	1	10.84		0
6135	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	34	5.3	Stable	No	Yes or Unknown	Signature.3		No	1	2.92		0
6136	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	268	6.1	Stable	No	No		PALB2 | PMS2	No	0	22.18		0
6137	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	22.08		0
6138	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	I	34	2.6	Stable	No	No			No	0	21.85		0
6139	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	85	0.9	Stable	No	No			Yes	0	20.3		0
6140	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	21	37.7	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC3 | MSH2 | NTHL1 | TP53BP1	No	0	20.73		0
6141	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	0	9.7	Stable	No	No	Signature.4		Yes	1	6.41		0
6142	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2017	IV	21	4.4	Stable	No	No	Signature.1	MSH6	Yes	0	4.17		0
6143	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	IV	0	2.6	Stable	No	No		RAD50	Yes	0	22.37		0
6144	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	I	0	0.9	Stable	No	No			No	0	21.42		0
6145	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	1	4.4	Stable	No	No			No	1	16.46		0
6146	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	181	1.8	Stable	No	Yes or Unknown			Yes	0	18.23		0
6147	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	0	12.3	Stable	No	No	Signature.3	RAD50	No	1	16.76		0
6148	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	IV	14	7	Stable	No	No	Signature.8	ARID1A | ATM | CHEK2	No	1	8.61		0
6149	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2017		19	0.9	Stable	No	No	Signature.5		Yes	1	2.17		0
6150	Non-ICI treated	Never received ICI	41 - 45	Female	Ovarian	2017	IV	0	4.4	Stable	No	No	Signature.3		No	0	24.02		0
6151	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	0	3.5	Stable	No	No			No	0	20.99		0
6152	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	II	0	5.3	Stable	No	No			No	0	25.2		0
6153	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	100	0	Stable	No	No			No	0	20.57		0
6154	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	19	0.9	Stable	No	Yes or Unknown			Yes	0	19.29		0
6155	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2017	III	0	0	Stable	No	No			No	0	21.03		0
6156	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	38	0	Stable	No	No			No	0	21.98		0
6157	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	6.1	Stable	No	No			Yes	0	4.24		0
6158	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	II	41	2.6	Stable	No	No			No	1	17.25		0
6159	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	6.41		0
6160	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	34	25.5	Unstable	No	No	Signature.6	FANCA	No	0	21.55		0
6161	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2017	III	14	6.1	Stable	No	No	Signature.2		No	0	20.6		0
6162	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2017		48	0.9	Stable	No	Yes or Unknown			Yes	0	18.86		0
6163	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017	I	12	9.7	Stable	No	No	Signature.1	ARID1A | BRCA2	Yes	0	21.39		0
6164	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	244	4.4	Stable	No	Yes or Unknown	Signature.17		No	0	24.25		0
6165	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	I	154	7	Stable	No	Yes or Unknown	Signature.1		Yes	0	14.46		0
6166	Non-ICI treated	Never received ICI	81 - 85	Female	CNS	2017		0	2.6	Stable	No	No			No	0	8.87		0
6167	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	1.8	Stable	No	No			No	0	21.16		0
6168	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	121	1.8	Stable	No	Yes or Unknown			No	1	18.04		0
6169	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	370	36	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA1 | ERCC4 | ERCC5 | MLH1 | MUTYH	No	1	18.69		0
6170	Non-ICI treated	Never received ICI	26 - 30	Female	Ovarian	2017	II	391	1.8	Stable	No	Yes or Unknown			No	0	20.86		0
6171	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	0	1.8	Stable	No	No			Yes	0	12.45		0
6172	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	18	2.6	Stable	No	No			Yes	0	22.28		0
6173	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	21	0.9	Stable	No	Yes or Unknown		ATM	Yes	0	20.47		0
6174	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1		No	0	23.13		0
6175	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	12.39		0
6176	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	28	1.8	Stable	No	No			Yes	0	19.91		0
6177	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	49	0.9	Stable	No	No		BRCA2	No	0	20.04		0
6178	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	IV	7	2.6	Stable	No	No		ARID1A	No	0	22.11		0
6179	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	0	4.4	Indeterminate	No	No	Signature.5		No	0	22.34		0
6180	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	IV	112	0		No	Yes or Unknown		NTHL1	No	0	22.54		0
6181	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	25	2.6	Stable	No	No			No	0	22.14		0
6182	Non-ICI treated	Never received ICI	76 - 80	Female	Hepatobiliary	2017	IV	48	1.8	Stable	No	No			Yes	0	22.44		0
6183	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	24	5.3	Stable	No	No			No	0	21.85		0
6184	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	III	0	3.5	Stable	No	No		ARID1A | TP53BP1	No	1	18.66		0
6185	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	I	225	0.9	Stable	No	No			No	0	22.31		0
6186	Non-ICI treated	Never received ICI	51 - 55	Male	SCLC	2017	IV	0	13.2	Stable	No	No	Signature.4	BLM | NBN	Yes	0	18.14		0
6187	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	III	611	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	22.28		0
6188	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	5.3	Stable	No	No		BRCA2	No	0	23.23		0
6189	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2017		4	1.8	Stable	No	No			No	0	20.9		0
6190	Non-ICI treated	Never received ICI	41 - 45	Female	Endometrial	2017	III	28	7.9	Stable	No	No	Signature.3		No	0	22.14		0
6191	Non-ICI treated	Never received ICI	76 - 80	Male	SCLC	2017	IV	11	7.9	Stable	No	No	Signature.13		Yes	1	1.77		0
6192	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	1	4.4	Stable	No	No			No	0	19.29		0
6193	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0	Stable	No	No			Yes	1	16.69		0
6194	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	0	6.1	Stable	No	No			No	1	20.34		0
6195	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	45	25.5	Unstable	No	No	Signature.6	ARID1A	No	0	17.51		0
6196	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	2.6	Stable	No	No			No	0	19.12		0
6197	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	0	0	Stable	No	No			No	0	12.85		0
6198	Non-ICI treated	Never received ICI	41 - 45	Female	CNS	2017		7	8.8	Stable	No	No			No	0	21.49		0
6199	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	33	31.6	Unstable	No	No	Signature.6	ATR | FANCA | MSH6 | NTHL1	No	0	12.16		0
6200	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	13	6.1	Stable	No	No	Signature.2	FANCA	No	0	22.01		0
6201	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2017	I	36	1.8	Stable	No	No		BLM	No	0	20.21		0
6202	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017	IV	0	2.6	Stable	No	Yes or Unknown	Signature.5		No	1	17.51		0
6203	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	IV	153	3.5	Stable	No	No			No	1	24.31		0
6204	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2017	I	89	4.4	Stable	No	No	Signature.5		No	0	19.32		0
6205	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	18.23		0
6206	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	7	Stable	No	No	Signature.1		No	0	22.01		0
6207	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	29	3.5	Stable	No	No			No	0	19.35		0
6208	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			Yes	1	15.51		0
6209	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	22	2.6	Stable	No	No			No	1	11.17		0
6210	Non-ICI treated	Never received ICI	81 - 85	Male	SCLC	2017	IV	2	11.4	Stable	No	No	Signature.4		No	1	1.68		0
6211	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	18	2.6	Stable	No	No			No	0	21.68		0
6212	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	202	1.8	Stable	No	Yes or Unknown			No	0	21.95		0
6213	Non-ICI treated	Never received ICI	16 - 20	Male	Bladder	2017		0	0	Stable	No	No			No	0	22.24		0
6214	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	381	7	Stable	No	Yes or Unknown	Signature.1		No	0	20.07		0
6215	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017		0	1.8	Stable	No	No			No	0	18.99		0
6216	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	42	2.6	Stable	No	No			No	0	21.95		0
6217	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	645	8.8	Indeterminate	No	Yes or Unknown	Signature.1	MSH3	Yes	0	21.62		0
6218	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	2.6	Stable	No	No			Yes	0	20.17		0
6219	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	III	0	7	Stable	No	No		ATM | BRIP1	Yes	0	21.52		0
6220	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	13	2.6	Stable	No	No			No	0	20.01		0
6221	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	28	4.4	Stable	No	No			No	0	20.37		0
6222	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	IV	0	0	Stable	No	No			No	1	6.8		0
6223	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	575	1.8	Stable	No	Yes or Unknown			No	0	22.54		0
6224	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	I	0	4.4	Stable	No	No	Signature.1	BRCA2	No	0	17.94		0
6225	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	27	6.1	Stable	No	Yes or Unknown		BRCA2	No	0	20.7		0
6226	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2017	IV	263	0.9	Stable	No	No			No	0	16.2		0
6227	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	0.9	Stable	No	No			No	0	6.37		0
6228	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	8	4.4	Stable	No	No	Signature.1		No	0	18.86		0
6229	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	31	3.5	Stable	No	No		ARID1A	Yes	0	13.93		0
6230	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	IV	0	9.7	Stable	No	No	Signature.1		No	0	25.49		0
6231	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	IV	128	0	Stable	No	No			No	0	23.13		0
6232	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	43	41.3	Unstable	No	No	Signature.6	ATR | MDC1 | RAD54L | SLX4	No	0	5.88		0
6233	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	0	6.1	Stable	No	No			No	0	22.05		0
6234	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	54	0.9	Stable	No	No			No	0	20.17		0
6235	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	29	2.6	Stable	No	Yes or Unknown		SLX4	No	0	21.98		0
6236	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	14	0.9	Stable	No	No			Yes	1	4.53		0
6237	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	23	3.5	Stable	No	No			No	0	21.72		0
6238	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	70	1.8	Stable	No	Yes or Unknown			No	0	24.67		0
6239	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		2	2.6	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	1	11.33		0
6240	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	IV	27	0	Stable	Yes or Unknown	Yes or Unknown			No	0	21.85		0
6241	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	4	2.6	Stable	No	Yes or Unknown			Yes	0	22.08		0
6242	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	I	46	22.8	Indeterminate	No	No	Signature.6	ARID1A	No	0	17.81		0
6243	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	7	6.1	Indeterminate	No	No		ARID1A	No	1	3.52		0
6244	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	20	2.6	Stable	No	No			No	0	21.39		0
6245	Non-ICI treated	Never received ICI	66 - 70	Female	Bladder	2017	III	0	34.2	Unstable	No	No	Signature.6	ARID1A | MLH1 | PALB2	Yes	0	19.42		0
6246	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	IV	0	5.3	Stable	No	No	Signature.4		Yes	0	1.74		0
6247	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	65	3.5	Stable	No	No			No	0	21.98		0
6248	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	13	6.1	Stable	No	No	Signature.15		No	0	5.62		0
6249	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017		30	6.1	Stable	No	No	Signature.24	ERCC2	Yes	0	22.08		0
6250	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	0	3.5	Stable	No	No	Signature.3	BRCA2	No	1	1.51		0
6251	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	I	391	44.8	Unstable	No	No	Signature.6	ATM | CHEK1	No	0	20.04		0
6252	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	II	28	69.3	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | RAD51	No	0	20.93		0
6253	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	II	58	2.6	Stable	No	No		ATM	Yes	0	20.93		0
6254	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	69	0.9	Stable	No	Yes or Unknown			No	0	22.31		0
6255	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	188	2.6	Stable	No	Yes or Unknown		ATR	No	1	13.27		0
6256	Non-ICI treated	Never received ICI	56 - 60	Male	Renal	2017	I	0	2.6	Stable	No	No			No	0	19.52		0
6257	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2017	IV	11	1.8	Stable	No	No			No	1	14.36		0
6258	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	II	186	7.9	Stable	No	Yes or Unknown	Signature.1	NTHL1	Yes	0	21.03		0
6259	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2016	II	690	5.3	Stable	No	No	Signature.8	SLX4	No	0	26.35		0
6260	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	59	10.5	Stable	No	No	Signature.4		No	0	20.47		0
6261	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	1.8	Stable	No	No			No	0	21.91		0
6262	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	47	0	Stable	No	No			No	1	9.53		0
6263	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	35	3.5	Stable	No	No	Signature.9		Yes	0	21.88		0
6264	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	32	7.9	Stable	No	No	Signature.1		Yes	0	22.01		0
6265	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	470	6.1	Stable	No	Yes or Unknown		NBN	No	0	21.72		0
6266	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	0	1.8	Stable	No	No			Yes	0	19.65		0
6267	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	III	33	4.4	Stable	No	Yes or Unknown	Signature.19		No	0	21.39		0
6268	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	IV	43	0.9	Stable	No	No			Yes	0	22.8		0
6269	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	28	9.7	Stable	No	No	Signature.4		No	0	17.74		0
6270	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		1	3.5	Stable	No	No	Signature.2		Yes	0	21.22		0
6271	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2017		11	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	20.17		0
6272	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	22	2.6	Stable	No	No			No	0	21.59		0
6273	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	11	6.1	Stable	No	No		ARID1A | FANCC	No	1	11.47		0
6274	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	II	63	15.8	Stable	No	No	Signature.26	ERCC2	No	0	22.14		0
6275	Non-ICI treated	Never received ICI	61 - 65	Female	Cutaneous Melanoma 	2018	I	71	0	Stable	No	No			No	0	14.72		0
6276	Non-ICI treated	Never received ICI	86 - 90	Female	Endometrial	2017	I	42	3.5	Stable	No	No		ARID1A	No	0	19.32		0
6277	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	33	7	Stable	No	No	Signature.5	ARID1A	No	0	18.73		0
6278	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	I	20	44.8	Unstable	No	No	Signature.6	BRCA2 | MLH1 | NBN | PMS2	No	0	19.75		0
6279	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	I	106	4.4	Stable	No	No	Signature.5		No	0	12.19		0
6280	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	III	0	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	18.76		0
6281	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2017	IV	2	2.6	Stable	No	Yes or Unknown	Signature.19	BRIP1	No	0	21.26		0
6282	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	21.22		0
6283	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2017	I	14	0.9	Stable	No	No			No	0	21.36		0
6284	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2017	I	20	2.6	Stable	No	No			No	0	21.82		0
6285	Non-ICI treated	Never received ICI	71 - 75	Male	Renal	2017	IV	15	5.3	Stable	No	No		ERCC5	No	1	9.03		0
6286	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			Yes	0	19.91		0
6287	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	IV	37	6.1	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	20.76		0
6288	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	4	6.1	Stable	No	No			No	0	20.96		0
6289	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	25	5.3	Stable	No	No			No	0	16.99		0
6290	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2017	IV	34	9.7	Stable	No	No	Signature.1		Yes	1	2.56		0
6291	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2017		0	5.3	Stable	No	No	Signature.19		Yes	1	10.41		0
6292	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2017	IV	10	5.3	Stable	No	Yes or Unknown			No	1	13.54		0
6293	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	17	0.9	Stable	No	No			Yes	0	20.83		0
6294	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	III	75	0		No	No			No	0	21.49		0
6295	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2017	IV	10	0.9	Stable	No	No			No	1	14.26		0
6296	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2017	IV	6	7.9	Stable	No	No		ERCC5 | MSH6	Yes	0	21.88		0
6297	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	2	0	Stable	No	No			Yes	0	21.29		0
6298	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2017	IV	0	1.8	Stable	No	No			Yes	0	8.28		0
6299	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	II	374	3.5	Stable	No	Yes or Unknown			No	0	22.97		0
6300	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	II	26	2.6	Stable	No	No			No	0	19.29		0
6301	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	15	1.8	Stable	No	No			Yes	1	1.51		0
6302	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	33	3.5	Stable	No	Yes or Unknown			No	0	20.93		0
6303	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	17	2.6	Stable	No	Yes or Unknown			No	0	20.21		0
6304	Non-ICI treated	Never received ICI	21 - 25	Female	Sarcoma	2017	III	106	0	Stable	No	Yes or Unknown			No	0	21.91		0
6305	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	159	7.9	Stable	No	Yes or Unknown		ATR	No	1	18.4		0
6306	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	IV	0	0	Stable	No	No			No	0	22.57		0
6307	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2017	IV	49	2.6	Stable	No	Yes or Unknown			No	0	21.82		0
6308	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	III	136	7.9	Stable	No	Yes or Unknown	Signature.3		No	1	14.39		0
6309	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2017	II	0	1.8	Stable	No	No			Yes	0	23.23		0
6310	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2017	II	0	104.4	Stable	No	No	Signature.7	ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC2 | MSH2 | MSH3 | PARP1 | SLX4 | TP53BP1	No	0	18.63		0
6311	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	14	0.9	Stable	No	No			Yes	0	21.19		0
6312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	167	1.8	Stable	No	Yes or Unknown		FANCC	No	0	20.83		0
6313	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	0	4.04		0
6314	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	89	0.9	Stable	No	No			Yes	0	21.65		0
6315	Non-ICI treated	Never received ICI	10-Jun	Female	CNS	2017		272	0	Stable	No	Yes or Unknown			No	1	21.55		0
6316	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	289	4.4	Stable	No	No	Signature.19		No	0	22.24		0
6317	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	IV	113	0	Stable	No	Yes or Unknown		CHEK2	Yes	0	23.2		0
6318	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2017	I	245	10.5	Stable	No	No	Signature.2	MDC1 | RAD54L	No	1	13.31		0
6319	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	23	1.8	Stable	No	No		BLM	No	0	20.99		0
6320	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	29	0.9	Stable	No	No			No	0	13.31		0
6321	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017		23	1.8	Stable	No	No			No	0	11.37		0
6322	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2017	IV	7	3.5	Stable	No	No		ATM	No	1	14.13		0
6323	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	4	1.8	Stable	No	No			No	1	15.15		0
6324	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	35	3.5	Stable	No	No	Signature.5	MUTYH	No	1	19.88		0
6325	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	66	5.3	Stable	No	No			Yes	0	14.19		0
6326	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	IV	387	5.3	Stable	No	Yes or Unknown	Signature.24	ARID1A	No	0	20.67		0
6327	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	34	1.8	Stable	No	No			No	0	18.37		0
6328	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2017		0	3.5	Stable	No	No			Yes	1	8.38		0
6329	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	158	1.8	Stable	No	No			No	0	17.28		0
6330	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	26	0.9	Stable	No	No			No	0	21.09		0
6331	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	27	4.4	Stable	No	No			Yes	0	19.38		0
6332	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	66	5.3	Stable	No	No			No	0	22.11		0
6333	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2017	II	36	50	Unstable	No	No	Signature.6	ATM | BRCA2 | ERCC4 | MUTYH	No	0	13.54		0
6334	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	11	4.4	Stable	No	No		BRIP1	Yes	0	20.63		0
6335	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2017	IV	1	0	Stable	No	No			Yes	1	19.45		0
6336	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	I	28	1.8	Stable	No	No			No	0	19.58		0
6337	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	25	1.8	Stable	No	No			No	0	13.7		0
6338	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	II	20	7	Stable	No	No			No	0	10.25		0
6339	Non-ICI treated	Never received ICI	41 - 45	Female	Esophageal	2017	III	0	7.9	Stable	No	No			No	0	22.05		0
6340	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	7	7.9	Stable	No	Yes or Unknown		ARID1A | FANCC	Yes	1	2.43		0
6341	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	20	2.6	Stable	No	No			No	0	18.33		0
6342	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	IV	0	0.9	Stable	No	No			No	1	5.82		0
6343	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	IV	6	1.8	Stable	No	No		ATM	Yes	0	4.34		0
6344	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	131	7.9		No	No	Signature.1	MDC1	No	1	14.03		0
6345	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	11	7.9	Stable	No	No			No	1	16.16		0
6346	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	82	0.9	Stable	No	Yes or Unknown			Yes	0	20.6		0
6347	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	Yes	0	21.59		0
6348	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2017		7	1.8	Stable	No	Yes or Unknown			No	0	20.8		0
6349	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	23	44.8	Unstable	No	No	Signature.1	ARID1A | ATM | BLM | BRIP1 | MRE11A | MSH6 | NTHL1	Yes	0	11.17		0
6350	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	37	86.9	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | MLH1 | PMS2 | RAD51C | SLX4	Yes	0	16.59		0
6351	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	II	0	0.9	Stable	No	Yes or Unknown		BRCA2	Yes	0	19.32		0
6352	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2017	II	52	6.1	Stable	No	No	Signature.5	ARID1A	No	0	3.45		0
6353	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	44	17.6	Stable	No	No	Signature.4		No	0	20.53		0
6354	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	IV	0	0.9	Stable	No	No			No	1	18.46		0
6355	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	14	6.1	Stable	No	No			No	0	20.7		0
6356	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	III	19	3.5	Stable	No	No			Yes	1	6.24		0
6357	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	0	7	Stable	No	No	Signature.14		No	0	20.53		0
6358	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	219	2.6	Stable	No	Yes or Unknown			No	0	22.11		0
6359	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	I	565	0.9	Stable	No	No	Signature.5		No	0	20.5		0
6360	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	0	4.4	Stable	No	No		ERCC5	No	0	20.93		0
6361	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	II	0	2.6	Stable	No	No			Yes	0	19.68		0
6362	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2017	IV	127	3.5	Stable	No	No			No	0	24.15		0
6363	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2017	III	0	0		No	No			No	1	15.28		0
6364	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2017	III	0	9.7	Stable	No	No	Signature.4	MRE11A | MSH3	Yes	0	4.96		0
6365	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	3.5	Stable	No	No			No	0	17.28		0
6366	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	31	2.6	Stable	No	Yes or Unknown		CHEK2	Yes	0	18.73		0
6367	Non-ICI treated	Never received ICI	76 - 80	Male	Sarcoma	2017		115	1.8	Stable	No	No		BRCA2	No	0	21.52		0
6368	Non-ICI treated	Never received ICI	81 - 85	Female	Breast	2017	II	390	6.1	Stable	No	Yes or Unknown	Signature.13	MSH2	No	0	22.97		0
6369	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	16	2.6	Stable	No	Yes or Unknown			No	0	15.9		0
6370	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017		83	0.9	Stable	No	No			No	0	20.11		0
6371	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	IV	1	2.6	Stable	No	No			No	0	19.42		0
6372	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	19	3.5	Stable	No	No			No	0	20.9		0
6373	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	144	1.8	Stable	No	No			Yes	0	23		0
6374	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	0	4.4	Stable	No	No	Signature.1		No	0	21.52		0
6375	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	I	121	0.9	Stable	No	No	Signature.5		No	0	19.32		0
6376	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	81	9.7	Stable	No	No	Signature.4		No	0	15.77		0
6377	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	26	2.6	Stable	No	No			No	1	8.44		0
6378	Non-ICI treated	Never received ICI	81 - 85	Female	Hepatobiliary	2017	IV	34	2.6	Stable	No	No			No	0	14.29		0
6379	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	III	158	14.9	Stable	No	Yes or Unknown	Signature.4	BRCA2 | ERCC5 | MDC1	Yes	1	11.37		0
6380	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	66.7	Indeterminate	No	No	Signature.21	ARID1A | ATM | ATR | BRCA2 | CHEK2 | MSH2 | RAD54L | TP53BP1	No	0	20.21		0
6381	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	166	8.8	Stable	No	Yes or Unknown	Signature.24	ARID1A | BRCA1	No	1	8.67		0
6382	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	IV	11	1.8	Stable	No	No	Signature.3		No	0	21.06		0
6383	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	25	1.8	Stable	No	No			Yes	0	20.24		0
6384	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	6.1	Stable	No	Yes or Unknown		BRCA1	No	0	21.36		0
6385	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	15	2.6	Stable	No	No			No	0	14.88		0
6386	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	0	2.6	Stable	No	No			No	0	12.45		0
6387	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	0	1.8	Stable	No	No			Yes	0	11.7		0
6388	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2017	IV	10	7	Stable	No	No	Signature.13	ARID1A | ATM	Yes	1	6.74		0
6389	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	I	42	3.5	Stable	No	No			Yes	0	18.89		0
6390	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	II	59	1.8	Stable	No	No			No	0	22.05		0
6391	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	26	47.4	Stable	No	Yes or Unknown	Signature.4	ATM | BLM | FANCC	Yes	0	6.01		0
6392	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	154	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	19.32		0
6393	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	33	1.8	Stable	No	No			No	0	19.98		0
6394	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	21	11.4	Stable	No	No	Signature.24		No	0	19.15		0
6395	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	271	7	Stable	No	Yes or Unknown			No	0	20.9		0
6396	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	IV	27	3.5	Stable	No	No			No	0	21.39		0
6397	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	24	7.9	Stable	No	No	Signature.6		No	0	20.73		0
6398	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	31	0.9	Stable	No	No			No	0	19.78		0
6399	Non-ICI treated	Never received ICI	16 - 20	Female	Breast	2017	IV	11	0	Stable	No	Yes or Unknown			Yes	0	20.37		0
6400	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	4.4	Indeterminate	No	Yes or Unknown			No	0	19.15		0
6401	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	IV	34	0		No	No			No	0	21.13		0
6402	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	286	9.7	Stable	No	Yes or Unknown	Signature.1		No	0	25.07		0
6403	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	I	0	1.8	Stable	No	No			No	0	20.86		0
6404	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	221	3.5	Stable	No	Yes or Unknown			No	0	21.98		0
6405	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	III	35	8.8	Stable	No	No		ARID1A	No	0	20.99		0
6406	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	35	2.6	Stable	No	Yes or Unknown	Signature.19	TP53BP1	Yes	0	18.53		0
6407	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2017		0	1.8	Stable	No	No		ATM	No	0	3.75		0
6408	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	II	63	1.8	Stable	No	No			No	0	20.67		0
6409	Non-ICI treated	Never received ICI	86 - 90	Female	NSCLC	2017	I	92	0.9	Stable	No	No			No	0	21.45		0
6410	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	19.48		0
6411	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2017		0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	20.76		0
6412	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	33	65	Unstable	No	No	Signature.6	ARID1A | BRCA2 | CHEK1 | CHEK2 | FANCC | MSH6 | MUTYH | NTHL1 | SLX4	No	0	2.07		0
6413	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	0.9	Stable	No	No			No	0	19.29		0
6414	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2017	I	81	5.3	Stable	No	No	Signature.1		No	0	19.42		0
6415	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2017	IV	24	6.1	Stable	No	No			No	1	18.53		0
6416	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	I	72	1.8	Stable	No	No			Yes	0	18.99		0
6417	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	I	16	53.5	Stable	No	No	Signature.4	ARID1A | ATR | BRCA1	Yes	0	20.24		0
6418	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	0	0.9	Stable	No	No			No	0	20.99		0
6419	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	155	4.4	Stable	No	No			No	0	19.91		0
6420	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	28	0.9	Stable	No	No			Yes	0	20.93		0
6421	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	II	13	4.4	Stable	No	No			Yes	0	17.22		0
6422	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	0	10.5	Stable	No	No	Signature.18		No	0	4.14		0
6423	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2017	IV	0	0	Stable	No	No			Yes	1	18.73		0
6424	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	II	24	1.8	Stable	No	No			Yes	0	20.86		0
6425	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2017	II	98	2.6	Stable	No	No			No	1	16.03		0
6426	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	95	2.6	Stable	No	No			No	0	24.31		0
6427	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	442	7.9		No	Yes or Unknown	Signature.5	ATM | ATR | MSH3	No	0	20.96		0
6428	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	III	36	6.1	Stable	No	No		MSH2	Yes	0	19.68		0
6429	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2017	III	0	7.9	Stable	No	No	Signature.4	PMS1	Yes	1	5.22		0
6430	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	177	7	Stable	No	No	Signature.5		No	0	18.4		0
6431	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No		FANCA	No	0	15.01		0
6432	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	16	0.9	Stable	No	No			Yes	0	19.94		0
6433	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	41	2.6	Stable	No	Yes or Unknown			No	0	18.07		0
6434	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	0	3.5	Stable	No	No			No	0	20.73		0
6435	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	33	7.9	Stable	No	No	Signature.1		No	0	21.13		0
6436	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2017	III	0	14	Stable	No	No	Signature.5		Yes	0	20.47		0
6437	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	42	4.4	Stable	No	No		MDC1	Yes	0	20.96		0
6438	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	10.5	Stable	No	No	Signature.13	BRCA1	Yes	0	15.7		0
6439	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		63	2.6	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	18.73		0
6440	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2017		0	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	17.77		0
6441	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	I	11	4.4	Stable	No	No			Yes	0	20.47		0
6442	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	I	35	60.6	Unstable	No	No	Signature.6	ARID1A | ATR | BLM | BRCA2 | XRCC2	No	0	21.09		0
6443	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	I	10	1.8	Stable	No	Yes or Unknown			No	0	18.69		0
6444	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	0	19.75		0
6445	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	27	0.9	Stable	No	No			No	0	19.48		0
6446	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	II	161	1.8	Stable	No	Yes or Unknown			No	0	20.44		0
6447	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	I	27	0	Stable	No	No			No	0	10.02		0
6448	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	I	0	4.4	Stable	No	No			No	0	20.73		0
6449	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2017	III	34	1.8	Stable	No	No			Yes	0	5.52		0
6450	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	136	4.4	Stable	No	Yes or Unknown			No	1	12.75		0
6451	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2017	I	61	1.8	Stable	No	No			No	0	20.67		0
6452	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.13		Yes	1	1.28		0
6453	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	75	4.4	Stable	No	No			No	0	19.42		0
6454	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	239	5.3	Stable	No	Yes or Unknown			No	0	20.44		0
6455	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	I	0	2.6	Stable	No	No			No	0	19.25		0
6456	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2017	III	0	8.8	Stable	No	No	Signature.8	PALB2	Yes	0	20.17		0
6457	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	I	0	55.3	Stable	No	No	Signature.4	ATM	Yes	0	16.56		0
6458	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	51	0	Stable	No	No			Yes	0	18.2		0
6459	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2017	II	361	10.5	Stable	No	No	Signature.2		No	0	25.82		0
6460	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			Yes	0	2.4		0
6461	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2017	III	37	39.5	Unstable	No	No	Signature.1	ARID1A | BRIP1 | CHEK1 | ERCC2 | MLH1	No	0	18.1		0
6462	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	8	0.9	Stable	No	No			Yes	0	20.14		0
6463	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	II	0	1.8	Stable	No	No			No	0	20.01		0
6464	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	I	36	3.5	Stable	No	No			No	0	20.8		0
6465	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	15	8.8	Stable	No	No	Signature.1	ATM	No	0	20.7		0
6466	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	35	79.9	Unstable	No	No	Signature.1	ARID1A | CHEK2 | MSH2 | MUTYH	No	0	20.6		0
6467	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	40	8.8	Stable	No	No	Signature.4		No	0	17.51		0
6468	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	7	4.4	Stable	No	Yes or Unknown			No	0	20.9		0
6469	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	0	0	Stable	No	Yes or Unknown			No	0	20.01		0
6470	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	II	28	6.1	Stable	No	No	Signature.1		No	0	20.6		0
6471	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	30	11.4	Stable	No	No	Signature.4	ATM	No	0	18.92		0
6472	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2017	II	42	2.6	Stable	No	Yes or Unknown			Yes	0	20.47		0
6473	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	34	0	Stable	No	Yes or Unknown			Yes	0	13.8		0
6474	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	2	3.5	Stable	No	Yes or Unknown			No	0	20.86		0
6475	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	20.96		0
6476	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	II	6	8.8	Stable	No	No	Signature.4	TP53BP1	Yes	0	19.98		0
6477	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	I	21	182.6	Stable	No	No	Signature.10	ARID1A | ATR | ERCC5 | MDC1 | MRE11A | MSH2 | PMS2 | RAD50 | RAD51C | RAD54L | SLX4	No	0	18.92		0
6478	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2017	IV	39	1.8	Stable	No	Yes or Unknown			No	0	19.61		0
6479	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2016		10	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	29.24		0
6480	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	41	5.3	Stable	No	No			Yes	0	17.68		0
6481	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	I	162	21.9	Stable	No	No	Signature.4	ARID1A	No	0	17.81		0
6482	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	III	0	1.8	Stable	No	Yes or Unknown			Yes	0	19.94		0
6483	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	III	182	0		No	Yes or Unknown			No	0	20.53		0
6484	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	IV	17	3.5	Stable	No	No			Yes	0	20.47		0
6485	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	280	7.9	Stable	No	Yes or Unknown	Signature.2	ARID1A	No	0	19.91		0
6486	Non-ICI treated	Never received ICI	36 - 40	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No		MSH3	Yes	1	11.73		0
6487	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2017		0	5.3	Stable	No	No		ATR	Yes	0	19.29		0
6488	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	III	218	0	Stable	No	No			Yes	1	9.26		0
6489	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	II	482	0	Stable	No	Yes or Unknown			No	0	20.47		0
6490	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	24	10.5	Stable	No	Yes or Unknown	Signature.2	ATM | CHEK1	No	0	19.75		0
6491	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	4.4	Stable	No	No			No	0	17.58		0
6492	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	II	0	0.9	Stable	No	No			No	0	19.19		0
6493	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	17	5.3	Stable	No	No	Signature.5		No	0	16.2		0
6494	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	78	4.4	Stable	No	No			No	0	18.17		0
6495	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	19	5.3	Stable	No	No	Signature.1		Yes	0	12.22		0
6496	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2017	III	181	0	Stable	No	No			Yes	0	23.2		0
6497	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	7	2.6	Stable	No	No	Signature.5		No	0	20.01		0
6498	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2017	IV	0	4.4	Stable	No	No		BRCA1 | ERCC3 | FANCC	No	0	19.58		0
6499	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	11	2.6	Stable	No	Yes or Unknown			No	0	21.29		0
6500	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	111	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	8.51		0
6501	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2017	IV	12	1.8	Stable	No	No		ARID1A	No	1	10.55		0
6502	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		15	5.3	Stable	No	No		CHEK2	Yes	0	19.09		0
6503	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2017	IV	64	2.6	Stable	No	Yes or Unknown			No	0	20.96		0
6504	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	2.6	Stable	No	No			Yes	0	18.86		0
6505	Non-ICI treated	Never received ICI	31 - 35	Female	Ovarian	2017	III	0	2.6	Stable	No	No			Yes	0	20.5		0
6506	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2017		192	0	Stable	No	No			No	0	16.1		0
6507	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		3	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	14.95		0
6508	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	II	0	7		No	No	Signature.5	BRCA1	No	0	19.75		0
6509	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	IV	333	0.9	Stable	No	Yes or Unknown			No	0	21.32		0
6510	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	0	8.8	Stable	No	Yes or Unknown	Signature.4	BRCA2	No	1	17.12		0
6511	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	21	2.6	Stable	No	No			No	0	18.46		0
6512	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	I	379	0	Stable	No	Yes or Unknown			No	0	20.53		0
6513	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	IV	14	2.6	Stable	No	No	Signature.14		No	0	20.44		0
6514	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	III	66	0.9	Stable	No	No			No	0	8.54		0
6515	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	138	2.6	Stable	No	No			No	1	10.84		0
6516	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	38	3.5	Stable	No	No			No	0	14.85		0
6517	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	65	0.9	Stable	No	No			No	0	16.62		0
6518	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2017	II	127	4.4	Stable	No	Yes or Unknown		PMS1	Yes	0	18.23		0
6519	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2017	IV	6	2.6	Stable	No	No			No	1	11.89		0
6520	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	116	1.8	Stable	No	Yes or Unknown			No	0	20.7		0
6521	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	49	0.9	Stable	No	No			Yes	0	19.75		0
6522	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2017	I	38	7.9	Stable	No	Yes or Unknown			Yes	0	18.63		0
6523	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2017	III	39	7	Stable	No	No	Signature.8		No	0	18.5		0
6524	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	9	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	11.24		0
6525	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	II	0	0.9	Stable	No	No			No	0	18		0
6526	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	93	1.8	Stable	No	Yes or Unknown			No	0	19.61		0
6527	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	3.5	Stable	No	No		ARID1A | ATM	No	0	18.46		0
6528	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2017	III	11	5.3	Stable	No	No			No	0	20.24		0
6529	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2017	IV	6	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA1	No	0	20.01		0
6530	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	II	0	10.5	Stable	No	No	Signature.1		Yes	0	12.45		0
6531	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	II	20	7	Stable	No	No	Signature.1		No	0	19.75		0
6532	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	II	0	3.5	Stable	No	No	Signature.1		No	0	20.63		0
6533	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	II	1	0	Stable	No	No			No	0	17.71		0
6534	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2017		4	0.9	Stable	No	No			Yes	0	17.25		0
6535	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	0	0.9	Stable	No	Yes or Unknown			No	0	13.08		0
6536	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2017	II	21	4.4	Stable	No	No			No	0	19.75		0
6537	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	92	7	Stable	No	No		BRIP1 | PARP1	No	0	14.62		0
6538	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No		BRCA2	No	1	8.74		0
6539	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	16	2.6	Stable	No	No			No	0	19.12		0
6540	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	8.11		0
6541	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	22.8	Indeterminate	No	Yes or Unknown	Signature.6	ATM | ERCC3	No	0	18.37		0
6542	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	20	1.8	Stable	No	No			Yes	0	20.17		0
6543	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	III	0	31.6	Stable	No	No	Signature.4	BRCA1 | PARP1 | SLX4	No	0	19.42		0
6544	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2017		5	7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MSH6	No	1	13.24		0
6545	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	I	0	0		No	No			Yes	0	20.73		0
6546	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	66	9.7	Stable	No	No	Signature.3		No	0	18.53		0
6547	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	62	0	Stable	No	No			Yes	0	20.04		0
6548	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2017	III	14	0.9	Stable	No	No			Yes	0	8.87		0
6549	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017		63	1.8	Stable	No	No			No	0	16.85		0
6550	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	I	20	7	Stable	No	No			No	0	18.4		0
6551	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	I	53	1.8	Stable	No	No			Yes	0	20.4		0
6552	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2017	III	0	7.9	Stable	No	No	Signature.7	RAD50	No	0	20.63		0
6553	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	17	1.8	Stable	No	No			No	0	19.94		0
6554	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2017		6	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.8		Yes	1	13.37		0
6555	Non-ICI treated	Never received ICI	26 - 30	Male	Sarcoma	2017	IV	65	3.5	Stable	No	Yes or Unknown			No	0	20.07		0
6556	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	II	36	1.8	Stable	No	No			No	0	19.22		0
6557	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	0	0.9	Stable	No	No			No	0	14.46		0
6558	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	II	0	7.9	Stable	No	No	Signature.24		No	1	13.93		0
6559	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.15		No	0	21.65		0
6560	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	19.3	Stable	No	No	Signature.1	ERCC3	No	0	14.88		0
6561	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	3.5	Stable	No	No			Yes	0	1.38		0
6562	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	91	0.9	Stable	No	Yes or Unknown			No	0	19.91		0
6563	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	91	3.5	Stable	No	Yes or Unknown		PMS2	No	1	13.01		0
6564	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	I	20	0	Stable	No	No			No	0	19.68		0
6565	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2017	IV	0	5.3	Stable	No	No			No	1	11.99		0
6566	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	421	5.3	Stable	No	No			Yes	0	19.88		0
6567	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	I	35	7	Stable	No	No	Signature.3	BRCA1 | BRIP1	Yes	0	20.01		0
6568	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	9.53		0
6569	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	0	1.8	Stable	No	No			No	0	20.37		0
6570	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	II	25	13.2	Stable	No	Yes or Unknown	Signature.4		No	1	4.99		0
6571	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	141	0.9	Stable	No	Yes or Unknown			No	1	10.15		0
6572	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2017	III	170	26.3	Stable	No	Yes or Unknown	Signature.2	ATM | MSH6	Yes	0	21.55		0
6573	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	II	62	2.6	Indeterminate	No	Yes or Unknown			No	0	19.75		0
6574	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	25	0		No	No			No	0	20.04		0
6575	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	IV	0	3.5	Stable	No	No		ARID1A	Yes	0	20.34		0
6576	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2017		0	4.4	Stable	No	No		ARID1A	Yes	1	7.13		0
6577	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2017	II	18	5.3	Stable	No	No			No	0	19.78		0
6578	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		17	0.9	Stable	No	No			No	0	2.3		0
6579	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	II	5	5.3	Stable	No	No		RAD50	No	0	18.4		0
6580	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	0	2.6	Stable	No	No			No	0	20.24		0
6581	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	IV	0	3.5	Stable	No	No			Yes	0	19.06		0
6582	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2017	III	27	11.4	Stable	No	No		ARID1A | ATM	Yes	0	17.68		0
6583	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	71	15.8	Stable	No	No	Signature.4	FANCA	No	0	17.35		0
6584	Non-ICI treated	Never received ICI	91 - 95	Male	NSCLC	2017	IV	10	21.1	Stable	No	No	Signature.3	SLX4	No	1	12.81		0
6585	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2017	I	0	222.1	Stable	No	Yes or Unknown	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC5 | FANCC | MLH1 | MRE11A | MSH2 | MSH3 | MSH6 | PMS2 | RAD50 | TP53BP1	No	0	18.79		0
6586	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2017	II	42	1.8	Stable	No	No			No	0	18.23		0
6587	Non-ICI treated	Never received ICI	81 - 85	Male	Pancreatic	2017	IV	0	46.5	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA2 | ERCC4 | MSH2 | PMS1	No	1	4.27		0
6588	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	22	2.6	Stable	No	Yes or Unknown			No	0	18.86		0
6589	Non-ICI treated	Never received ICI	51 - 55	Male	Head & Neck	2017	IV	33	6.1	Stable	No	No			No	0	18		0
6590	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	II	22	7.9	Stable	No	No	Signature.1		Yes	0	18.37		0
6591	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		61	0	Stable	No	No			No	0	18.37		0
6592	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	III	19	17.6	Indeterminate	No	No	Signature.4	NBN	Yes	0	17.45		0
6593	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2017	II	19	0		No	No			No	1	10.25		0
6594	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2017	IV	314	7	Stable	No	Yes or Unknown	Signature.26	SLX4	No	1	13.6		0
6595	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2017	I	37	1.8	Stable	No	No			No	0	18.99		0
6596	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	26	3.5	Stable	No	No			No	0	17.97		0
6597	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2017	IV	6	11.4	Stable	No	No	Signature.13		Yes	0	18.07		0
6598	Non-ICI treated	Never received ICI	21 - 25	Female	Gastric	2017	IV	10	1.8	Stable	No	No			No	0	15.74		0
6599	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	3.5	Stable	No	Yes or Unknown			No	0	20.7		0
6600	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	III	294	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	19.29		0
6601	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	II	13	1.8	Stable	No	No			Yes	0	8.51		0
6602	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	I	7	7.9	Stable	No	No	Signature.4	ATM	Yes	0	16.26		0
6603	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	1	10.68		0
6604	Non-ICI treated	Never received ICI	36 - 40	Male	Cutaneous Melanoma 	2017	III	0	7.9	Stable	No	No	Signature.7		No	0	17.48		0
6605	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	III	7	5.3	Stable	No	No	Signature.29		No	0	19.25		0
6606	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2017	IV	0	0.9	Stable	No	No			No	1	12.06		0
6607	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	II	0	0.9	Stable	No	Yes or Unknown			No	0	19.58		0
6608	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2017	II	223	1.8	Stable	No	Yes or Unknown		ATM	No	0	20.44		0
6609	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2017	IV	24	8.8	Stable	No	Yes or Unknown	Signature.3	RAD50	No	0	15.54		0
6610	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	24	4.4	Stable	No	No	Signature.24	CHEK2 | ERCC3	Yes	1	6.37		0
6611	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	19.42		0
6612	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2017	IV	50	0	Stable	No	No			No	0	19.75		0
6613	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2017	II	0	4.4	Stable	No	No			No	0	19.65		0
6614	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	22	7	Stable	No	No	Signature.24		Yes	1	1.68		0
6615	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	15	3.5	Stable	No	No			No	1	12.29		0
6616	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	II	0	9.7	Stable	No	No	Signature.4	BLM | ERCC2	Yes	0	16.79		0
6617	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	0	6.1	Stable	No	No	Signature.13		No	0	19.45		0
6618	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	17	1.8	Stable	No	No			No	0	19.12		0
6619	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2017	IV	0	0.9	Stable	No	Yes or Unknown		TP53BP1	No	1	12.88		0
6620	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	IV	27	5.3	Stable	No	No			No	0	21.19		0
6621	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2017	IV	23	3.5	Stable	No	No			No	0	19.78		0
6622	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2017	II	27	2.6	Stable	No	No			No	0	19.81		0
6623	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	III	2	3.5	Stable	No	No		ARID1A	No	0	18.4		0
6624	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	III	10	5.3	Stable	No	No	Signature.1		Yes	0	17.77		0
6625	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	IV	3	6.1	Stable	No	No			No	0	19.32		0
6626	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	41	9.7	Stable	No	No	Signature.3	ARID1A | BRCA1 | BRCA2 | MUTYH	No	1	13.63		0
6627	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2017	I	55	0		No	No			No	0	15.31		0
6628	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2017	II	75	7	Stable	No	No	Signature.5		Yes	0	13.77		0
6629	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2017	IV	31	2.6	Stable	No	No			No	0	5.82		0
6630	Non-ICI treated	Never received ICI	21 - 25	Male	CNS	2017		0	0		No	No			Yes	0	15.7		0
6631	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2017	I	39	3.5	Stable	No	No	Signature.4	XRCC2	No	0	19.12		0
6632	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2017	III	0	1.8	Stable	No	No			No	0	21.42		0
6633	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017		0	7.9	Stable	No	No	Signature.1	ARID1A	No	0	14.98		0
6634	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	II	27	5.3	Stable	No	No			No	0	13.96		0
6635	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2017	IV	19	3.5	Stable	No	No			No	0	20.3		0
6636	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	0	6.1	Stable	No	No			No	1	5.65		0
6637	Non-ICI treated	Never received ICI	66 - 70	Male	Breast	2017	II	512	3.5	Stable	No	Yes or Unknown	Signature.1		No	0	19.75		0
6638	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	70	2.6		No	Yes or Unknown	Signature.1	BRCA2	Yes	0	18.6		0
6639	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2017		148	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	19.45		0
6640	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	37	3.5	Stable	No	Yes or Unknown		PALB2 | XRCC2	No	0	17.94		0
6641	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	0	2.6	Stable	No	No		FANCC	No	0	5.03		0
6642	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	I	34	0.9	Stable	No	No			Yes	0	14.95		0
6643	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	9	3.5	Stable	No	No			Yes	0	18.86		0
6644	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	126	1.8	Indeterminate	No	Yes or Unknown		PMS2	No	0	17.38		0
6645	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2017	IV	6	6.1	Stable	No	No		SLX4	No	0	19.71		0
6646	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	I	70	0.9	Stable	No	No			No	0	20.4		0
6647	Non-ICI treated	Never received ICI	51 - 55	Female	Gastric	2017	IV	20	1.8	Stable	No	No			Yes	1	14.62		0
6648	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	IV	1	15.8	Stable	No	No	Signature.1	MSH6	No	1	4.53		0
6649	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	35	7.9	Stable	No	No	Signature.1	BLM	No	0	20.3		0
6650	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	65	0		No	No			No	1	11.27		0
6651	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	IV	161	7	Stable	No	Yes or Unknown	Signature.15		No	0	19.35		0
6652	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	23	8.8	Stable	No	No	Signature.4		Yes	0	19.71		0
6653	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2017	II	86	0	Stable	No	No			No	0	19.12		0
6654	Non-ICI treated	Never received ICI	41 - 45	Male	Renal	2017	IV	29	1.8	Stable	No	No			No	1	15.21		0
6655	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2017	I	35	8.8	Stable	No	Yes or Unknown	Signature.24	ARID1A | ATR | TP53BP1	Yes	1	4.4		0
6656	Non-ICI treated	Never received ICI	61 - 65	Female	Bladder	2017	IV	151	7.9	Stable	No	No		ARID1A	No	0	5.32		0
6657	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2017	IV	0	7.9	Stable	No	No	Signature.13	ARID1A	Yes	1	5.22		0
6658	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	III	29	2.6	Stable	No	No			No	0	16.82		0
6659	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018		3	3.5	Stable	No	No			Yes	0	17.77		0
6660	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2017	IV	27	0	Stable	No	Yes or Unknown			Yes	0	19.81		0
6661	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2017	IV	14	2.6	Stable	No	Yes or Unknown			No	1	16.79		0
6662	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	I	36	6.1	Stable	No	No			No	0	13.8		0
6663	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2017	III	51	3.5	Stable	No	No			No	0	20.86		0
6664	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2017	III	8	2.6	Stable	No	No			No	1	13.34		0
6665	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	III	0	5.3	Stable	No	No			Yes	0	19.38		0
6666	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2017	IV	27	2.6	Stable	No	No			No	0	19.38		0
6667	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2017	II	25	4.4	Stable	No	No			No	0	13.73		0
6668	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.13		Yes	1	11.07		0
6669	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2017	I	510	18.4	Stable	No	No	Signature.7	ARID1A | PALB2	No	1	17.51		0
6670	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	I	605	7	Stable	No	Yes or Unknown	Signature.17		Yes	0	20.76		0
6671	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.6		Yes	0	16.82		0
6672	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2017	III	0	9.7	Stable	No	No	Signature.5		Yes	0	18.92		0
6673	Non-ICI treated	Never received ICI	76 - 80	Male	CNS	2017		15	5.3	Stable	No	No	Signature.3		No	1	4.27		0
6674	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	0.9	Stable	No	No		MUTYH	No	0	20.57		0
6675	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	II	41	0.9	Stable	No	No			No	0	19.09		0
6676	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2017	I	26	5.3	Stable	No	Yes or Unknown			No	0	19.94		0
6677	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2017	I	0	3.5	Stable	No	No	Signature.13	ARID1A | PARP1	No	0	19.55		0
6678	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	19.06		0
6679	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	IV	27	5.3	Stable	No	Yes or Unknown	Signature.1		Yes	0	15.67		0
6680	Non-ICI treated	Never received ICI	71 - 75	Male	Sarcoma	2017	IV	41	1.8	Stable	No	No			No	0	19.55		0
6681	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	485	10.5	Stable	No	Yes or Unknown	Signature.2		No	0	17.74		0
6682	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	III	0	0.9	Stable	No	Yes or Unknown			No	0	18.4		0
6683	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	236	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	19.75		0
6684	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	III	27	3.5	Stable	No	No		ARID1A | FANCA	No	0	19.75		0
6685	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2017	IV	191	2.6	Stable	No	Yes or Unknown			No	0	20.73		0
6686	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2017	II	37	7	Stable	No	No			Yes	0	21.88		0
6687	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2017	IV	18	3.5	Stable	No	No	Signature.5		Yes	0	17.81		0
6688	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2017	IV	162	0	Stable	No	No			No	0	22.54		0
6689	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	III	8	13.2	Stable	No	No	Signature.24		No	0	18.69		0
6690	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2017	III	56	9.7	Stable	No	No	Signature.16	PARP1	Yes	0	17.25		0
6691	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	6	0.9	Stable	No	No			No	1	2.89		0
6692	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	459	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	19.09		0
6693	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	5	6.1	Stable	No	No	Signature.6		No	1	11.7		0
6694	Non-ICI treated	Never received ICI	91 - 95	Female	Colorectal	2018	II	24	45.6	Unstable	No	No	Signature.1	ATR | ERCC5 | MSH3 | MSH6 | NTHL1 | SLX4	No	0	17.68		0
6695	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2017	IV	200	0	Stable	No	No			No	0	21.88		0
6696	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2017	I	29	0.9	Stable	No	No			No	0	14.09		0
6697	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	444	4.4	Stable	No	Yes or Unknown			No	0	19.68		0
6698	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	13.73		0
6699	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	IV	45	3.5	Stable	No	No			No	1	11.53		0
6700	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2017	IV	3	3.5	Stable	No	No			No	0	20.04		0
6701	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2017	IV	1	4.4	Stable	No	No			Yes	1	6.77		0
6702	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	0	2.6	Stable	No	No			No	1	8.25		0
6703	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2017	IV	15	4.4	Stable	No	No	Signature.6		No	0	21.06		0
6704	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	III	11	3.5	Stable	No	No			Yes	0	18		0
6705	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	37	6.1	Stable	No	No		ATM	Yes	0	20.27		0
6706	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2017	IV	452	0.9	Stable	No	Yes or Unknown			No	0	19.98		0
6707	Non-ICI treated	Never received ICI	31 - 35	Male	Head & Neck	2018	III	29	1.8	Stable	No	No			Yes	0	18.14		0
6708	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	17	2.6	Stable	No	No	Signature.1		No	0	12.78		0
6709	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2017	IV	50	6.1	Stable	No	No	Signature.3	BRCA2	No	0	19.45		0
6710	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2017	IV	0	2.6	Stable	No	Yes or Unknown			Yes	0	19.12		0
6711	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2017	IV	62	3.5	Stable	No	Yes or Unknown			Yes	0	19.94		0
6712	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	22	1.8	Stable	No	No	Signature.25		No	0	18.99		0
6713	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	III	80	0	Stable	No	Yes or Unknown			No	0	18.53		0
6714	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	I	147	1.8	Stable	No	Yes or Unknown		MUTYH	Yes	0	15.21		0
6715	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2017		103	9.7	Stable	No	No	Signature.12	BRCA1 | BRIP1 | CHEK2	Yes	0	20.86		0
6716	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		3	6.1	Stable	No	No			No	1	17.61		0
6717	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	14	6.1	Stable	No	No	Signature.4		No	0	16.23		0
6718	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		24	0	Stable	No	No			No	0	19.35		0
6719	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2017	III	53	1.8	Stable	No	No			No	0	18.33		0
6720	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	27	7.9	Stable	No	No		MSH6	No	0	19.09		0
6721	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	54	2.6	Stable	No	No			No	0	19.06		0
6722	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2017	IV	44	0.9	Stable	No	No			No	1	15.74		0
6723	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	7	0.9	Stable	No	No			Yes	0	16.79		0
6724	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2017	IV	537	1.8	Stable	No	Yes or Unknown			No	0	19.81		0
6725	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	III	2	2.6	Stable	No	No			Yes	1	18.76		0
6726	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	III	10	3.5	Stable	No	No			No	1	17.05		0
6727	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	I	16	2.6	Stable	No	No			Yes	0	18.27		0
6728	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2017	II	91	4.4	Stable	No	No			Yes	0	16.79		0
6729	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	11	4.4	Stable	No	No			No	0	16.3		0
6730	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	26	8.8	Stable	No	No	Signature.4		No	0	14.88		0
6731	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2017	IV	0	3.5	Stable	No	No			Yes	1	3.02		0
6732	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2017	IV	7	7	Stable	No	No	Signature.2		Yes	0	19.52		0
6733	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2017	III	23	2.6	Stable	No	Yes or Unknown			No	0	19.38		0
6734	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	0	19.29		0
6735	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2017	II	232	14.9	Stable	No	Yes or Unknown	Signature.13	MSH3	No	1	9.46		0
6736	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	51	1.8	Stable	No	No	Signature.1		Yes	0	20.04		0
6737	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2018		0	6.1	Stable	No	No	Signature.17	MSH3	Yes	0	17.51		0
6738	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	I	11	7	Stable	No	No		ARID1A	No	0	18.92		0
6739	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	10	3.5	Stable	No	Yes or Unknown		BLM	No	1	18.33		0
6740	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	8.8	Stable	No	No	Signature.2	MLH1	No	0	17.84		0
6741	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	50	1.8	Stable	No	Yes or Unknown			No	0	19.19		0
6742	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	I	0	3.5	Stable	No	No	Signature.5		Yes	0	13.6		0
6743	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	0	Stable	No	No			Yes	0	18.14		0
6744	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	0	16.26		0
6745	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	6	3.5	Stable	No	No			No	0	18.1		0
6746	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2017	IV	44	6.1	Stable	No	No	Signature.4	ARID1A	Yes	1	3.75		0
6747	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2017	III	0	8.8	Stable	No	No	Signature.1		Yes	0	19.32		0
6748	Non-ICI treated	Never received ICI	31 - 35	Female	CNS	2018		14	3.5	Stable	No	No			Yes	0	18.17		0
6749	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2017		36	0.9	Stable	No	No			No	0	19.55		0
6750	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		61	0.9	Stable	No	No			No	0	18.07		0
6751	Non-ICI treated	Never received ICI	81 - 85	Male	Esophageal	2017	IV	0	3.5	Stable	No	No	Signature.1		Yes	1	9.2		0
6752	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	22	2.6	Stable	No	No		ARID1A	No	1	7.33		0
6753	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	IV	6	3.5	Stable	No	No			No	0	3.98		0
6754	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018		0	1.8	Stable	No	No			No	0	17.94		0
6755	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	12.3	Stable	No	No	Signature.3	ATM	No	0	18.56		0
6756	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2017	II	0	11.4	Stable	No	No	Signature.4	ARID1A | ERCC5	No	0	17.94		0
6757	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	63	2.6	Stable	No	No			No	0	16.23		0
6758	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	18.99		0
6759	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1	TP53BP1	No	0	19.02		0
6760	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	5.3		No	No	Signature.5	ATR | MLH1	No	1	11.17		0
6761	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	IV	31	0	Stable	No	Yes or Unknown			No	1	18.46		0
6762	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	364	8.8	Stable	No	Yes or Unknown	Signature.2		No	0	18.83		0
6763	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2017	I	158	12.3	Stable	No	No	Signature.4		Yes	0	13.24		0
6764	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2018	III	0	11.4	Stable	No	No	Signature.30	CHEK2 | ERCC2	Yes	0	17.31		0
6765	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	3	3.5	Stable	No	No			Yes	1	1.91		0
6766	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	13	7	Stable	No	No	Signature.1		Yes	0	18.6		0
6767	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	IV	16	2.6	Stable	No	No		ARID1A	No	1	9.1		0
6768	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	81	2.6	Stable	No	No		ERCC2	Yes	0	13.9		0
6769	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	18	6.1	Stable	No	No	Signature.1	ARID1A	No	0	9.72		0
6770	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	0	1.8	Stable	No	No	Signature.21		No	0	17.97		0
6771	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	IV	14	3.5	Stable	No	No			No	0	18.89		0
6772	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	5.3	Stable	No	Yes or Unknown		MSH2	No	0	21.06		0
6773	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2017	II	30	0	Stable	No	No			No	0	25.33		0
6774	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2017	IV	42	1.8	Stable	No	No			No	0	17.58		0
6775	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2017	III	38	5.3	Stable	No	No		ARID1A	No	0	19.38		0
6776	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	0	6.1	Stable	No	No		BRCA1	No	0	14.65		0
6777	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018	II	120	0.9	Stable	No	Yes or Unknown			No	0	18.6		0
6778	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2017	IV	127	1.8	Stable	No	No			No	0	12.68		0
6779	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	20	3.5		No	No	Signature.5		No	0	14.72		0
6780	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	8	1.8	Stable	No	No			No	0	19.19		0
6781	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	0	104.4	Unstable	No	No	Signature.6	ARID1A | ATM | BRCA1 | BRCA2 | ERCC4 | MLH1 | MSH3 | MUTYH | PMS1 | RAD54L | SLX4 | XRCC2	Yes	0	17.74		0
6782	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	I	65	17.6	Stable	No	No	Signature.4	ERCC3 | FANCC	No	0	14.49		0
6783	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	39	10.5	Stable	No	No	Signature.4	ARID1A	No	0	18.73		0
6784	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	36	3.5	Stable	No	No			Yes	0	16.85		0
6785	Non-ICI treated	Never received ICI	31 - 35	Male	Renal	2018	III	0	2.6	Stable	No	No	Signature.3	MUTYH	No	0	14.13		0
6786	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018		73	3.5	Stable	No	Yes or Unknown			No	0	19.25		0
6787	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		1	2.6	Stable	No	No			No	0	18.79		0
6788	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2018	IV	2	1.8	Stable	No	No			Yes	1	0.85		0
6789	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	9	4.4	Stable	No	No			Yes	1	2.79		0
6790	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2018	IV	379	3.5	Stable	No	Yes or Unknown			Yes	0	17.71		0
6791	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	IV	0	1.8	Stable	No	No			No	0	18.69		0
6792	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	I	74	3.5	Stable	No	No			No	0	18.04		0
6793	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2018	II	358	39.5	Stable	No	Yes or Unknown	Signature.2	ERCC4 | MSH6	Yes	0	17.87		0
6794	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	IV	0	1.8	Stable	No	No			No	0	17.97		0
6795	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	III	20	9.7	Stable	No	No	Signature.7		No	0	15.57		0
6796	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2018		0	0	Stable	No	No			No	0	12.45		0
6797	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	30	3.5	Stable	No	Yes or Unknown			No	1	13.44		0
6798	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	12	3.5	Stable	No	Yes or Unknown	Signature.30		Yes	1	13.86		0
6799	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	19.19		0
6800	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	IV	2	2.6	Indeterminate	No	No		FANCA	No	1	3.25		0
6801	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	3.5	Stable	No	No			Yes	0	18.27		0
6802	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	I	29	15.8	Unstable	No	No	Signature.1	ARID1A	No	0	18		0
6803	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2018	IV	34	7	Stable	No	No	Signature.4		Yes	1	2.83		0
6804	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018		0	1.8	Stable	No	No			Yes	0	16.62		0
6805	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	23	113.2	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | ERCC5 | FANCC | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | PARP1 | PMS1 | PMS2 | TP53BP1	No	0	9.1		0
6806	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2018	IV	6	1.8	Stable	No	Yes or Unknown			No	1	9.46		0
6807	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	26	7	Stable	No	No	Signature.8		No	0	13.54		0
6808	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	18	2.6	Stable	No	No			No	0	14.69		0
6809	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	48	0.9	Stable	No	No			Yes	0	16.49		0
6810	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	6.1	Stable	No	No			No	1	17.58		0
6811	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	171	0.9	Stable	No	No			No	0	12.88		0
6812	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	43	1.8	Stable	No	No			Yes	0	17.97		0
6813	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	18	2.6	Stable	No	Yes or Unknown			No	1	13.01		0
6814	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	0	2.6	Stable	No	No		ATM	No	0	18.3		0
6815	Non-ICI treated	Never received ICI	36 - 40	Male	Head & Neck	2018	III	496	1.8	Stable	No	Yes or Unknown			No	0	18.66		0
6816	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	5	7.9		No	No		ARID1A	No	1	10.68		0
6817	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2017	IV	66	0		No	No			Yes	1	6.9		0
6818	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2017	IV	198	1.8	Stable	No	No			No	0	22.14		0
6819	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	115	0.9	Stable	No	No			No	0	17.94		0
6820	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	48	4.4	Stable	No	No		ARID1A	No	0	17.38		0
6821	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	II	0	1.8	Stable	No	Yes or Unknown		MDC1	No	0	18.37		0
6822	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	314	1.8	Stable	No	Yes or Unknown			Yes	0	17.38		0
6823	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018		24	1.8	Stable	No	No			No	1	10.12		0
6824	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	70	4.4	Stable	No	No			No	0	15.74		0
6825	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	IV	40	1.8	Stable	No	No		ARID1A	No	0	18.69		0
6826	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	394	7	Stable	No	No	Signature.1	BRCA2	No	0	17.35		0
6827	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	15	5.3	Stable	No	No	Signature.3	PMS1	No	1	11.33		0
6828	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	21	7	Stable	No	No	Signature.1		Yes	0	17.68		0
6829	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	0	18.27		0
6830	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	38	4.4	Stable	No	No			No	0	17.87		0
6831	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	39	4.4	Stable	No	No			Yes	0	8.77		0
6832	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	81	0.9	Stable	No	No			Yes	0	17.08		0
6833	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	6	8.8	Stable	No	No	Signature.1		No	0	18.56		0
6834	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	60	1.8	Stable	No	Yes or Unknown			Yes	0	17.94		0
6835	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	18.69		0
6836	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2017	IV	266	2.6	Stable	No	Yes or Unknown			No	0	19.94		0
6837	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	17.94		0
6838	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	I	2	1.8	Stable	No	No			Yes	1	4.07		0
6839	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	4	5.3	Stable	No	No			No	1	3.19		0
6840	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	27	2.6	Stable	No	No			Yes	0	15.24		0
6841	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	16	2.6	Stable	No	Yes or Unknown			No	0	18.43		0
6842	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	III	156	4.4	Stable	No	No			No	0	17.31		0
6843	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2017	IV	83	0.9	Stable	No	Yes or Unknown			Yes	0	19.52		0
6844	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	2.6	Stable	No	No			No	0	18.3		0
6845	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018		0	4.4	Stable	No	No	Signature.4		No	0	12.78		0
6846	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2018	IV	31	6.1	Stable	No	No	Signature.2	BRCA2 | RAD51	No	1	7.52		0
6847	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2017	IV	134	1.8	Stable	No	Yes or Unknown			No	0	17.94		0
6848	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	III	8	2.6	Stable	No	No			No	0	19.12		0
6849	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	78	7	Stable	No	No			No	0	18.76		0
6850	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2017	III	120	1.8	Stable	No	Yes or Unknown			Yes	0	18.14		0
6851	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	16	1.8	Stable	No	No			Yes	1	8.38		0
6852	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	45	3.5	Stable	No	Yes or Unknown			No	0	18.66		0
6853	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	18.23		0
6854	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1		No	0	18.6		0
6855	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	21	9.7	Stable	No	No	Signature.4		No	0	12.91		0
6856	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	27	2.6	Stable	No	Yes or Unknown			Yes	0	13.83		0
6857	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	54	1.8	Stable	No	No		FANCA	No	0	10.71		0
6858	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	456	1.8	Stable	No	Yes or Unknown			Yes	0	17.81		0
6859	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	52	10.5	Stable	No	No	Signature.29	ERCC5	No	0	14.29		0
6860	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	27	7.9	Stable	No	No	Signature.4	MUTYH	Yes	0	14.32		0
6861	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	28	2.6	Stable	No	No		ARID1A	No	0	18.17		0
6862	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	451	2.6	Stable	No	Yes or Unknown			No	0	17.08		0
6863	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	27	5.3	Stable	No	No	Signature.2	NBN	No	0	18.07		0
6864	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	I	51	2.6	Stable	No	No			No	0	17.61		0
6865	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	5	7	Stable	No	No	Signature.1		Yes	0	18.53		0
6866	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	58	5.3	Stable	No	No	Signature.24		No	0	17.74		0
6867	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	7	6.1	Stable	No	No			Yes	1	12.48		0
6868	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2017	IV	207	0		No	Yes or Unknown			No	0	19.32		0
6869	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	32	21.1	Stable	No	No	Signature.13		No	0	13.11		0
6870	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	45	3.5	Stable	No	No			Yes	0	13.77		0
6871	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2017	IV	0	1.8	Stable	No	No			No	1	8.77		0
6872	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2017	IV	0	3.5	Stable	No	No			No	0	19.25		0
6873	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	III	43	5.3	Stable	No	No			No	0	16.3		0
6874	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	46	3.5	Stable	No	No			No	0	17.25		0
6875	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	12	4.4	Stable	No	No			No	1	7.82		0
6876	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	12	34.2	Stable	No	No	Signature.1	MRE11A | RAD54L | SLX4	Yes	1	9.49		0
6877	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	44	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	18.73		0
6878	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	I	28	30.7	Unstable	No	No	Signature.1	ARID1A | RAD54L	No	0	17.25		0
6879	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	III	12	6.1	Stable	No	No		BRCA2	Yes	0	12.88		0
6880	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	42	1.8	Stable	No	No			No	0	17.38		0
6881	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	32	1.8	Stable	No	No			No	0	17.74		0
6882	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	16.79		0
6883	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	114	6.1	Stable	No	Yes or Unknown	Signature.30	BRCA2 | MLH1	No	0	17.05		0
6884	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	9	5.3	Stable	No	Yes or Unknown			No	1	12.48		0
6885	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	7	4.4	Stable	No	No	Signature.9		No	1	14.82		0
6886	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	4	7.9	Stable	No	No			No	0	17.28		0
6887	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2017	IV	161	6.1	Stable	No	No			Yes	1	11.96		0
6888	Non-ICI treated	Never received ICI	61 - 65	Male	Bladder	2018		30	33.4	Stable	No	No	Signature.1	MSH6	No	0	17.18		0
6889	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	76	19.3	Stable	No	No	Signature.2	ARID1A | BRCA1 | BRIP1	Yes	0	18.89		0
6890	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2017	III	71	79.9	Unstable	No	No	Signature.6	ATM | ATR | CHEK1 | ERCC2 | MSH3 | PALB2 | PARP1 | PMS1 | RAD50	Yes	0	20.6		0
6891	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	IV	2	6.1	Stable	No	Yes or Unknown			No	1	11.79		0
6892	Non-ICI treated	Never received ICI	46 - 50	Male	Hepatobiliary	2018	IV	0	6.1	Stable	No	No	Signature.1		No	1	8.77		0
6893	Non-ICI treated	Never received ICI	56 - 60	Male	SCLC	2018	II	9	7	Indeterminate	No	No	Signature.4	ERCC2 | FANCA | MSH6	Yes	0	15.61		0
6894	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	2	8.8	Stable	No	No	Signature.1	ATR | BRIP1	Yes	0	18.4		0
6895	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	27	361.6	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA2 | BRIP1 | CHEK1 | ERCC3 | ERCC5 | FANCA | MDC1 | MUTYH | NBN | RAD50 | RAD54L | SLX4 | TP53BP1	Yes	0	17.02		0
6896	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	III	27	1.8	Stable	No	No			No	0	16.36		0
6897	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	49	1.8	Stable	No	No			No	0	14.55		0
6898	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	0	0.9		No	No	Signature.5		No	0	13.04		0
6899	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	63	2.6	Stable	No	No			No	0	18		0
6900	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	III	21	7	Stable	No	No		TP53BP1	Yes	0	18.23		0
6901	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	21	0	Stable	No	No			Yes	0	17.51		0
6902	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	357	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	17.87		0
6903	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1	PMS2	Yes	1	1.77		0
6904	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	24	12.3	Stable	No	No	Signature.1	ATM	No	0	17.77		0
6905	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	0	0	Stable	No	No			No	0	10.61		0
6906	Non-ICI treated	Never received ICI	21 - 25	Female	Hepatobiliary	2018	IV	7	2.6	Stable	No	No			No	1	7.79		0
6907	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	5	4.4	Stable	No	No			Yes	0	2		0
6908	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	2	5.3	Stable	No	No	Signature.1	ATM	Yes	1	9.46		0
6909	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	11	5.3	Stable	No	No	Signature.6	ATM	Yes	0	17.64		0
6910	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	57	7	Stable	No	Yes or Unknown			No	0	19.06		0
6911	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	41	1.8	Stable	No	No			No	0	15.84		0
6912	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	94	272.1	Stable	No	Yes or Unknown	Signature.10	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC2 | ERCC4 | ERCC5 | FANCA | MDC1 | MLH1 | MSH3 | MSH6 | NBN | PALB2 | PMS1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1	No	0	19.25		0
6913	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	215	7.9	Stable	No	No	Signature.1		No	0	21.06		0
6914	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	47	4.4	Stable	No	No	Signature.1		No	0	18.89		0
6915	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	9	10.5	Stable	No	No	Signature.1	BLM	No	1	11.1		0
6916	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	2.6	Stable	No	Yes or Unknown		FANCC	No	0	18.6		0
6917	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	126	5.3	Stable	No	No		ATM | CHEK2	Yes	0	17.45		0
6918	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	37	4.4	Stable	No	No	Signature.24		No	0	10.78		0
6919	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	IV	11	1.8	Stable	No	No			No	0	3.81		0
6920	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	17.41		0
6921	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	37	31.6	Indeterminate	No	No	Signature.6	ARID1A | FANCC | MRE11A | MSH2	Yes	0	15.18		0
6922	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	64	2.6	Stable	No	No			No	0	17.77		0
6923	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	316	0.9	Stable	No	Yes or Unknown			No	1	14.98		0
6924	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	59	4.4	Stable	No	Yes or Unknown	Signature.13		No	0	17.51		0
6925	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2017	IV	203	5.3	Stable	No	No			Yes	0	21.55		0
6926	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	II	15	0	Stable	No	No		BRCA2	Yes	0	17.84		0
6927	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	IV	156	3.5	Stable	No	Yes or Unknown			No	0	18.17		0
6928	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	47	9.7	Stable	No	No	Signature.4	MRE11A	No	0	17.02		0
6929	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	37	3.5	Stable	No	Yes or Unknown			No	0	17.74		0
6930	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	I	19	4.4	Stable	No	No		ARID1A	Yes	0	16.03		0
6931	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	I	0	17.6	Stable	No	No	Signature.4	MUTYH	No	0	15.18		0
6932	Non-ICI treated	Never received ICI	51 - 55	Female	Head & Neck	2018	IV	4	2.6	Stable	No	No			Yes	1	3.38		0
6933	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	2.6	Stable	No	No			Yes	1	6.14		0
6934	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	III	7	2.6	Stable	No	Yes or Unknown			No	1	16.76		0
6935	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	138	6.1	Stable	No	Yes or Unknown	Signature.4		Yes	0	13.11		0
6936	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2018		0	8.8	Stable	No	No	Signature.19	ERCC2	Yes	0	16.07		0
6937	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	43	4.4	Stable	No	No		ATM	No	0	17.61		0
6938	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	98	3.5	Stable	No	Yes or Unknown			No	0	17.91		0
6939	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	No			No	0	17.18		0
6940	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	75	1.8	Stable	No	No			No	0	17.31		0
6941	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	3.5	Stable	No	No			No	0	16.59		0
6942	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	74	1.8	Stable	No	No			No	0	18.07		0
6943	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	IV	100	0.9	Stable	No	No			No	1	11.4		0
6944	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2018		11	0.9	Stable	No	No			No	1	17.18		0
6945	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		2	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MUTYH	Yes	1	5.88		0
6946	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	II	61	13.2	Stable	No	No	Signature.1		No	0	14.46		0
6947	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	26	6.1	Stable	No	No			Yes	0	14.88		0
6948	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	31	5.3	Stable	No	No	Signature.4		Yes	0	16.2		0
6949	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	31	1.8	Stable	No	No			Yes	0	8.61		0
6950	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2018	IV	0	6.1	Stable	No	No		ARID1A	No	1	4.01		0
6951	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	II	15	3.5	Stable	No	No			No	0	17.02		0
6952	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	98	0	Stable	No	No			No	0	17.22		0
6953	Non-ICI treated	Never received ICI	26 - 30	Male	CNS	2018		10	19.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	MRE11A | MSH6	No	0	17.28		0
6954	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	0	21.1	Stable	No	Yes or Unknown	Signature.4	ARID1A | ERCC5 | TP53BP1	Yes	0	16.99		0
6955	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2017	IV	210	7	Stable	No	No	Signature.8		No	0	19.61		0
6956	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	1.8	Stable	No	No			No	1	1.97		0
6957	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	16.79		0
6958	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		120	0	Stable	No	No			No	0	18.4		0
6959	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	14	0.9	Stable	No	Yes or Unknown			No	0	17.45		0
6960	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	7	36.9	Unstable	No	No	Signature.12	ARID1A | ATR | MSH6 | PMS2	Yes	0	11.1		0
6961	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	III	19	0.9	Stable	No	No			No	1	11.76		0
6962	Non-ICI treated	Never received ICI	26 - 30	Female	Endometrial	2018	I	28	4.4	Stable	No	No		ARID1A	No	0	14		0
6963	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	17	218.6	Unstable	No	No	Signature.15	ARID1A | ATM | BLM | BRCA1 | BRIP1 | ERCC2 | ERCC3 | ERCC4 | FANCC | MDC1 | MSH2 | MSH6 | MUTYH | NBN | PALB2 | PARP1 | PMS2 | RAD50 | RAD54L | SLX4 | TP53BP1 | XRCC2	No	0	12.58		0
6964	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	4.4	Stable	No	No		PMS2	No	0	17.18		0
6965	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	III	162	0.9	Stable	No	No			Yes	0	17.71		0
6966	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	1	2.33		0
6967	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	7	Stable	No	No	Signature.17		No	1	16.92		0
6968	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	3.5	Stable	No	No			No	0	13.27		0
6969	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	II	0	5.3	Stable	No	No	Signature.3	MDC1	No	0	12.48		0
6970	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	22	2.6	Stable	No	No		MSH2	No	0	15.31		0
6971	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	II	24	59.7	Unstable	No	No	Signature.1	ARID1A | ERCC5 | MDC1 | MSH3 | MSH6 | NTHL1 | SLX4	No	0	14.32		0
6972	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	4.4	Stable	No	No			No	0	18.14		0
6973	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	41	5.3	Stable	No	No		NBN	Yes	1	4.37		0
6974	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	127	0.9	Stable	No	No			No	0	13.31		0
6975	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	19	4.4	Stable	No	No			No	0	17.61		0
6976	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	46	0	Stable	No	No		BRIP1	No	0	16.95		0
6977	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2018	III	1	11.4	Stable	No	No	Signature.4	ARID1A | MSH3	Yes	0	17.31		0
6978	Non-ICI treated	Never received ICI	16 - 20	Female	Colorectal	2018	III	7	0.9	Stable	No	No			No	0	17.45		0
6979	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1	RAD50	No	0	17.15		0
6980	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	II	12	2.6	Stable	No	No			No	0	17.18		0
6981	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	11	7.9	Stable	No	No	Signature.8	MRE11A	No	0	16.76		0
6982	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	77	2.6	Stable	No	No			No	0	14.78		0
6983	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		No	0	16.82		0
6984	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	98	2.6	Stable	No	Yes or Unknown			No	0	11.1		0
6985	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	49	1.8	Stable	No	No			No	0	17.74		0
6986	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2018	III	0	7	Stable	No	No	Signature.1		Yes	0	17.05		0
6987	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	II	9	2.6	Stable	No	No		ARID1A	No	1	7.52		0
6988	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	3	7	Stable	No	No			No	0	17.22		0
6989	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	35	16.7	Stable	No	Yes or Unknown	Signature.13	CHEK2	No	0	17.35		0
6990	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	6	7.9	Stable	No	No	Signature.1		Yes	0	17.54		0
6991	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	0.9	Stable	No	No			Yes	0	17.74		0
6992	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	25	2.6	Stable	No	No			No	0	12.68		0
6993	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	175	0.9	Stable	No	No			No	0	18.83		0
6994	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	0	3.5	Stable	No	No	Signature.3		No	0	17.05		0
6995	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	75	8.8	Stable	No	Yes or Unknown	Signature.13		No	0	18.83		0
6996	Non-ICI treated	Never received ICI	41 - 45	Female	Pancreatic	2018	III	192	0.9	Stable	No	Yes or Unknown		CHEK2	No	0	16		0
6997	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	II	16	4.4	Stable	No	No			Yes	0	6.97		0
6998	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2018	IV	16	6.1	Stable	No	No	Signature.7		Yes	0	17.94		0
6999	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	II	14	4.4	Stable	No	No			No	0	15.9		0
7000	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	22	1.8	Stable	No	Yes or Unknown			Yes	0	14.36		0
7001	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	79	0.9	Stable	No	No			Yes	0	17.77		0
7002	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2018		0	3.5	Stable	No	No			Yes	0	16.99		0
7003	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2017	III	0	0.9	Stable	No	No			No	0	20.44		0
7004	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	1.8	Stable	No	No			No	0	13.5		0
7005	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	5.3	Stable	No	No		ARID1A	No	1	11.47		0
7006	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	38	1.8	Stable	No	No		ARID1A	Yes	0	14		0
7007	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	17.35		0
7008	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	III	53	14.9	Indeterminate	No	No	Signature.1	ARID1A	Yes	0	17.97		0
7009	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	9	2.6	Stable	No	No	Signature.1	BRIP1	Yes	0	17.25		0
7010	Non-ICI treated	Never received ICI	16 - 20	Female	Head & Neck	2018		0	0.9	Stable	No	No			No	0	17.12		0
7011	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	6	10.5	Stable	No	No	Signature.4		Yes	0	16.95		0
7012	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2017	I	67	6.1	Stable	No	No		ARID1A | ATM	No	0	20.57		0
7013	Non-ICI treated	Never received ICI	46 - 50	Male	Gastric	2018	III	0	0	Stable	No	No			Yes	0	12.25		0
7014	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	104	67.6	Stable	No	No	Signature.4	ATR | ERCC2 | FANCA | PMS1 | RAD51C	No	0	9.99		0
7015	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ERCC3 | PMS2	Yes	0	20.47		0
7016	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	0	17.41		0
7017	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	III	40	1.8	Stable	No	No			No	1	10.41		0
7018	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	20	1.8	Stable	No	Yes or Unknown			No	0	15.44		0
7019	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		19	10.5	Stable	No	No			No	0	17.48		0
7020	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	IV	0	6.1	Stable	No	No		ARID1A	No	1	6.18		0
7021	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	177	1.8	Stable	No	Yes or Unknown			No	1	15.08		0
7022	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	330	5.3	Stable	No	Yes or Unknown	Signature.3	BRCA1 | TP53BP1	No	0	16.92		0
7023	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	0	4.4	Stable	No	No			No	0	14.36		0
7024	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			Yes	0	14.95		0
7025	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	7.85		0
7026	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	I	50	1.8	Stable	No	No			No	0	14.55		0
7027	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	IV	25	14	Stable	No	No	Signature.4	BLM | BRIP1 | ERCC4	No	0	17.61		0
7028	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2017	I	146	1.8	Stable	No	No			No	1	11.93		0
7029	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	53	4.4	Stable	No	No			Yes	0	15.34		0
7030	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	15	4.4	Stable	No	No			Yes	0	16.69		0
7031	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	62	1.8	Stable	No	No			Yes	0	11.79		0
7032	Non-ICI treated	Never received ICI	86 - 90	Female	Pancreatic	2018	IV	0	5.3	Stable	No	No		ARID1A	Yes	0	17.71		0
7033	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	40	8.8	Stable	No	No	Signature.8	ARID1A	Yes	0	10.45		0
7034	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	69	0	Stable	No	No			Yes	0	14.46		0
7035	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	IV	7	2.6	Stable	No	No			No	0	17.81		0
7036	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		147	0	Stable	No	No			No	0	11.86		0
7037	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	67	6.1	Stable	No	No	Signature.3	ERCC2	Yes	0	16.43		0
7038	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	174	3.5	Stable	No	Yes or Unknown			No	0	17.25		0
7039	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	56	2.6	Stable	No	No			Yes	0	16		0
7040	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	0.9	Stable	No	No			No	0	14.82		0
7041	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	224	6.1	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	16.62		0
7042	Non-ICI treated	Never received ICI	46 - 50	Female	Renal	2018	I	0	4.4	Stable	No	No			No	0	11.63		0
7043	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2017	IV	102	0	Stable	No	No			No	0	19.75		0
7044	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	44	1.8	Stable	No	No			No	0	17.25		0
7045	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2018	IV	0	4.4	Stable	No	No	Signature.5	ARID1A | ATM	Yes	0	17.15		0
7046	Non-ICI treated	Never received ICI	31 - 35	Female	Pancreatic	2018	II	34	1.8	Stable	No	No		NBN	No	0	13.77		0
7047	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	199	1.8	Stable	No	Yes or Unknown			No	0	17.18		0
7048	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	20	14.9	Stable	No	No	Signature.13	ARID1A | MSH2	No	0	17.12		0
7049	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	II	15	6.1	Stable	No	No	Signature.3		Yes	0	16.33		0
7050	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2018	III	216	7.9	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	10.38		0
7051	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	IV	458	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	17.08		0
7052	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	27	3.5	Stable	No	No			No	0	16.95		0
7053	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	21	5.3	Stable	No	No			No	0	13.01		0
7054	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2017	IV	96	6.1	Stable	No	No	Signature.30	BRCA2	Yes	0	11.04		0
7055	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	24	4.4	Indeterminate	No	No	Signature.13		No	0	17.02		0
7056	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	III	0	4.4	Stable	No	No			No	0	17.25		0
7057	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	II	58	9.7	Stable	No	No	Signature.1	ERCC2	Yes	0	17.81		0
7058	Non-ICI treated	Never received ICI	56 - 60	Male	Gastric	2018	III	0	3.5	Stable	No	No	Signature.8		No	0	16.33		0
7059	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2017	I	133	2.6	Stable	No	No		MUTYH	No	0	20.9		0
7060	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	I	36	3.5	Stable	No	No			Yes	0	17.02		0
7061	Non-ICI treated	Never received ICI	91 - 95	Female	Hepatobiliary	2018	III	28	4.4	Stable	No	Yes or Unknown			Yes	0	15.61		0
7062	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	II	47	11.4	Stable	No	No	Signature.4	BRCA2	Yes	0	14.62		0
7063	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	34	0.9	Stable	No	No			No	0	13.93		0
7064	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	16.59		0
7065	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	III	298	4.4	Stable	No	Yes or Unknown	Signature.5	BRCA1 | BRIP1	Yes	0	17.68		0
7066	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018		27	2.6	Stable	No	No			No	0	8.9		0
7067	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	15.77		0
7068	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	0	6.1	Stable	No	No			Yes	0	16.2		0
7069	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	4.24		0
7070	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	13.27		0
7071	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	20	3.5	Stable	No	No		ERCC2 | ERCC4	No	0	16.53		0
7072	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	31	0.9	Stable	No	No			No	0	16.53		0
7073	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	7.9	Stable	No	No			No	0	17.08		0
7074	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	116	6.1	Stable	No	Yes or Unknown			No	0	17.64		0
7075	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2018	II	15	0	Stable	No	No			No	0	16.69		0
7076	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	III	34	9.7	Stable	No	Yes or Unknown			No	0	15.84		0
7077	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	49	0.9	Stable	No	No			No	0	13.77		0
7078	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	14	3.5	Stable	No	No			Yes	0	17.22		0
7079	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	3	58.8	Unstable	No	No	Signature.6	ARID1A | MLH1 | MSH3 | MUTYH	Yes	0	15.97		0
7080	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	26	3.5	Stable	No	No			Yes	0	16.92		0
7081	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	312	0.9	Stable	No	Yes or Unknown			No	0	17.18		0
7082	Non-ICI treated	Never received ICI	66 - 70	Female	Cutaneous Melanoma 	2018	III	27	0.9	Stable	No	Yes or Unknown			No	0	16.26		0
7083	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	1	7.9	Stable	No	No	Signature.30		No	0	4.63		0
7084	Non-ICI treated	Never received ICI	81 - 85	Male	Prostatic	2018	IV	43	1.8	Stable	No	No			No	0	14.65		0
7085	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	0	31.6		No	No	Signature.4	ATM | FANCC	Yes	0	15.74		0
7086	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	33	5.3	Stable	No	No			No	0	18.37		0
7087	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	IV	31	1.8	Stable	No	No			Yes	0	16.66		0
7088	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	39	1.8	Stable	No	No			No	0	15.31		0
7089	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	30	1.8	Stable	No	No			No	0	13.9		0
7090	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	13	6.1	Stable	No	No	Signature.3		Yes	0	16.53		0
7091	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2018	IV	28	0	Stable	No	No			No	0	16.26		0
7092	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	72	1.8	Stable	No	Yes or Unknown			No	0	17.05		0
7093	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	46	302.8	Indeterminate	No	No	Signature.12	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH2 | NTHL1 | PARP1 | PMS1 | RAD54L | SLX4 | XRCC2	No	0	11.96		0
7094	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	III	0	0.9	Stable	No	No			Yes	0	17.48		0
7095	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	68	1.8	Stable	No	No		ARID1A	No	0	14.52		0
7096	Non-ICI treated	Never received ICI	46 - 50	Male	Cutaneous Melanoma 	2018	III	68	2.6	Stable	No	No			Yes	0	14.16		0
7097	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	27	0.9	Stable	No	No			Yes	0	16.89		0
7098	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018	I	13	3.5	Stable	No	No			No	0	14.26		0
7099	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	0	9.7	Stable	No	No	Signature.1		Yes	0	16.79		0
7100	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	IV	7	1.8	Stable	No	No			No	0	16.72		0
7101	Non-ICI treated	Never received ICI	71 - 75	Male	Hepatobiliary	2018	III	12	3.5	Stable	No	No	Signature.13	ATM	Yes	0	17.12		0
7102	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	1.8	Stable	No	No		BRIP1	No	0	16.53		0
7103	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	27	2.6	Stable	No	Yes or Unknown			No	0	15.77		0
7104	Non-ICI treated	Never received ICI	61 - 65	Male	Esophageal	2018	IV	20	2.6	Stable	No	No			Yes	0	2.1		0
7105	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	22	6.1	Stable	No	No	Signature.1		No	1	9.1		0
7106	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2018		8	1.8	Stable	No	No	Signature.19		No	0	2.27		0
7107	Non-ICI treated	Never received ICI	81 - 85	Male	Esophageal	2018	I	16	2.6	Stable	No	No	Signature.17		No	0	15.64		0
7108	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	7	2.6	Stable	No	No			No	0	16.53		0
7109	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	16	5.3	Stable	No	Yes or Unknown		FANCA	No	1	16.2		0
7110	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2017	II	179	0.9	Stable	No	No			Yes	0	19.25		0
7111	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	9.7	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	0	16.66		0
7112	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	11	7	Stable	No	No	Signature.12	SLX4	No	0	16.79		0
7113	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	0	16.59		0
7114	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		21	0.9	Stable	No	No			No	0	15.44		0
7115	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	18	2.6	Stable	No	No			No	1	14.52		0
7116	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	II	64	4.4	Stable	No	No			Yes	0	16.99		0
7117	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	0	1.8	Stable	No	No			No	0	15.57		0
7118	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	57	1.8	Stable	No	No			No	0	15.47		0
7119	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	IV	20	4.4	Stable	No	No			No	0	16.82		0
7120	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	6.1	Stable	No	No			No	0	15.9		0
7121	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	37	6.1	Stable	No	No	Signature.1		No	1	16		0
7122	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	0	8.8	Stable	No	No	Signature.4		Yes	0	13.8		0
7123	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	7	3.5	Stable	No	No			No	0	16.62		0
7124	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	6	5.3	Stable	No	No	Signature.2		No	0	14.69		0
7125	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	0	5.3	Stable	No	No	Signature.2	FANCA	No	0	14.55		0
7126	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	0	0	Stable	No	Yes or Unknown			No	0	18.17		0
7127	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018	IV	45	0	Stable	No	No			No	0	16.3		0
7128	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	17	3.5	Stable	No	No			No	0	16.69		0
7129	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	14	0.9	Stable	No	No			No	1	14.42		0
7130	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2018	IV	127	1.8	Stable	No	Yes or Unknown			No	1	11.7		0
7131	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	22	6.1	Stable	No	No	Signature.1	ATM	No	1	14.75		0
7132	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.13		Yes	0	16.43		0
7133	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	II	209	4.4	Stable	No	Yes or Unknown			No	0	10.32		0
7134	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	I	0	7.9	Stable	No	No			No	0	16.16		0
7135	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	29	0	Stable	No	No			Yes	0	16.26		0
7136	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	29	1.8	Stable	No	No			No	0	16.89		0
7137	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018		0	0.9	Stable	No	No			No	1	4.67		0
7138	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		1	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	14.46		0
7139	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	9.7	Stable	No	Yes or Unknown	Signature.6		No	0	17.25		0
7140	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	II	0	93	Stable	No	No	Signature.7	ARID1A | ATR | MDC1 | MRE11A | SLX4	No	0	16.59		0
7141	Non-ICI treated	Never received ICI	56 - 60	Female	CNS	2018		1	4.4	Stable	Yes or Unknown	Yes or Unknown		ATR	No	0	16.69		0
7142	Non-ICI treated	Never received ICI	21 - 25	Male	Sarcoma	2018		0	0	Stable	No	No			No	0	9.49		0
7143	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	16	4.4	Stable	No	No		ERCC2	Yes	1	3.58		0
7144	Non-ICI treated	Never received ICI	76 - 80	Male	Gastric	2018	I	77	1.8	Stable	No	No		BLM	No	0	12.65		0
7145	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018		0	1.8	Stable	No	No			No	1	0.26		0
7146	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	III	6	2.6	Stable	No	No		MUTYH	No	0	14.46		0
7147	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	0	7	Stable	No	No	Signature.1		No	0	16.07		0
7148	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	II	0	0.9	Stable	No	No			Yes	0	14.49		0
7149	Non-ICI treated	Never received ICI	86 - 90	Male	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.5	ERCC5	No	1	1.71		0
7150	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	29	2.6	Stable	No	No			Yes	0	16.13		0
7151	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	6	1.8	Stable	No	Yes or Unknown		BRIP1	No	0	15.9		0
7152	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	III	23	1.8	Stable	No	No			No	1	10.09		0
7153	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	0	4.4	Stable	No	No			No	0	15.47		0
7154	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	39	1.8	Stable	No	No			No	0	15.44		0
7155	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	2	7.9	Stable	No	No	Signature.1	ARID1A | MDC1	Yes	1	6.41		0
7156	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	I	4	5.3	Stable	No	No			No	0	15.21		0
7157	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	126	3.5	Stable	No	Yes or Unknown		BRCA2 | CHEK2	No	1	11.73		0
7158	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	11	4.4	Stable	No	No			No	1	10.94		0
7159	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	III	0	3.5	Stable	No	No			No	0	13.37		0
7160	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	21	2.6	Stable	No	No	Signature.5		No	0	16.89		0
7161	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	49	4.4	Stable	No	No	Signature.6		Yes	0	16.99		0
7162	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	IV	20	3.5	Stable	No	No	Signature.1		No	1	12.62		0
7163	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	II	0	1.8	Stable	No	No			Yes	0	13.7		0
7164	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		0	1.8	Stable	No	No			Yes	1	8.87		0
7165	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	77	3.5	Stable	No	No		NBN	Yes	0	17.38		0
7166	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	38	21.1	Stable	No	No	Signature.4	ATR	Yes	0	13.17		0
7167	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		39	0	Stable	No	No			No	0	16.33		0
7168	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	218	0		No	Yes or Unknown			No	0	16.23		0
7169	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	III	13	7.9	Stable	No	No	Signature.20	BRCA2 | MSH6	No	0	16		0
7170	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	21	0.9	Stable	No	No			No	0	16.03		0
7171	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	58	1.8	Stable	No	Yes or Unknown			No	0	15.61		0
7172	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	1	5.68		0
7173	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	27	1.8	Stable	No	No			No	0	12.68		0
7174	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	III	0	14	Stable	No	No	Signature.9	ATM	No	0	16.33		0
7175	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	22	0.9	Stable	No	No			Yes	0	15.64		0
7176	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	106	7.9	Stable	No	Yes or Unknown	Signature.13		No	1	9.99		0
7177	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	5.3	Stable	No	Yes or Unknown			Yes	0	14.26		0
7178	Non-ICI treated	Never received ICI	46 - 50	Female	Endometrial	2018	II	13	228.2	Stable	No	No	Signature.9	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | ERCC4 | ERCC5 | FANCA | MDC1 | MLH1 | MSH2 | MSH6 | NBN | PALB2 | PMS1 | RAD50 | RAD54L | TP53BP1 | XRCC2	Yes	0	14.16		0
7179	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2018	II	94	9.7	Stable	No	Yes or Unknown	Signature.17		Yes	0	16.03		0
7180	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2017	I	279	0.9	Stable	No	Yes or Unknown			Yes	0	12.81		0
7181	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	68	4.4	Stable	No	No			Yes	0	16.39		0
7182	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	28	2.6	Stable	No	No		MSH6	No	0	13.93		0
7183	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	16		0
7184	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	4.4	Stable	No	No	Signature.1	ATM	No	0	16.16		0
7185	Non-ICI treated	Never received ICI	61 - 65	Male	Renal	2018	IV	19	7	Stable	No	No			Yes	1	1.77		0
7186	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	II	27	20.2	Stable	No	No	Signature.4	SLX4	No	0	9.56		0
7187	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	Yes or Unknown	Signature.1		No	0	16.69		0
7188	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	27	1.8	Stable	No	No			No	0	17.41		0
7189	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	2.6	Stable	No	No		ATM	No	0	18.17		0
7190	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	24	5.3	Stable	No	No	Signature.1	FANCC | MUTYH | SLX4	Yes	0	12.42		0
7191	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	138	2.6	Stable	No	No			No	0	17.97		0
7192	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	27	3.5	Stable	No	No			No	0	14.13		0
7193	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	III	66	3.5	Stable	No	No		NBN	Yes	0	15.61		0
7194	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	11	10.5	Stable	No	No	Signature.1	TP53BP1	No	0	14.36		0
7195	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	309	4.4	Stable	No	No			No	0	23.95		0
7196	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	35	3.5	Stable	No	No			No	0	13.54		0
7197	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	34	2.6	Stable	No	Yes or Unknown			No	0	16.3		0
7198	Non-ICI treated	Never received ICI	71 - 75	Female	Ovarian	2018	IV	134	1.8	Stable	No	Yes or Unknown			No	0	16.16		0
7199	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	II	300	0	Stable	No	No			No	0	15.84		0
7200	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	52	6.1	Stable	No	No			No	0	14.95		0
7201	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	I	35	3.5	Stable	No	No			No	0	8.11		0
7202	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	225	8.8	Stable	No	No	Signature.1		No	0	14.13		0
7203	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	III	31	2.6	Stable	No	No			No	0	13.77		0
7204	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	15.41		0
7205	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	11	6.1	Stable	No	No			Yes	1	0.89		0
7206	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2017	I	362	7	Stable	No	No	Signature.1		No	0	21.39		0
7207	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	92	4.4	Stable	No	No		ATM	No	0	16.3		0
7208	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	II	15	0	Stable	No	No			Yes	0	15.51		0
7209	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	5.3	Stable	No	No			No	0	15.15		0
7210	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	211	2.6	Stable	No	Yes or Unknown		SLX4	No	0	16.2		0
7211	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	II	59	42.1	Unstable	No	No	Signature.26	ARID1A | ATR | BRIP1 | MDC1 | MRE11A | NTHL1 | PALB2 | PMS2 | TP53BP1	No	0	15.08		0
7212	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	3	1.8	Stable	No	Yes or Unknown			No	0	17.94		0
7213	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	I	51	7	Stable	No	No			No	0	13.83		0
7214	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	I	60	3.5	Stable	No	No	Signature.4		No	0	10.58		0
7215	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	0	0.9	Stable	No	No			No	0	8.34		0
7216	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	25	0.9	Stable	No	No			Yes	0	13.83		0
7217	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	II	8	5.3	Stable	No	No	Signature.1		Yes	0	15.64		0
7218	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	4.4	Stable	No	No			No	0	15.01		0
7219	Non-ICI treated	Never received ICI	31 - 35	Male	Gastric	2018	IV	13	2.6	Stable	No	No			No	1	9.89		0
7220	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	52	3.5	Stable	No	Yes or Unknown			Yes	0	15.47		0
7221	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	16.82		0
7222	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.1		No	0	16.3		0
7223	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1		Yes	0	16.76		0
7224	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	37	3.5	Stable	No	Yes or Unknown		ARID1A	No	0	15.18		0
7225	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2017	IV	186	2.6	Stable	No	No		ARID1A	No	0	20.53		0
7226	Non-ICI treated	Never received ICI	36 - 40	Male	CNS	2017		7	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	23.79		0
7227	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	I	21	4.4	Stable	No	No			No	1	12.71		0
7228	Non-ICI treated	Never received ICI	31 - 35	Female	Cutaneous Melanoma 	2018	III	39	18.4	Stable	No	No	Signature.7	ARID1A	No	0	13.7		0
7229	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	53	6.1	Stable	No	No			Yes	1	4.93		0
7230	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018	IV	0	0.9	Stable	No	No			No	0	15.87		0
7231	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	IV	6	7	Stable	No	No	Signature.4		Yes	1	10.25		0
7232	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	I	16	0.9	Stable	No	No			No	0	13.57		0
7233	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	21	5.3	Stable	No	No		ARID1A	Yes	0	13.14		0
7234	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2018	IV	26	4.4	Stable	No	Yes or Unknown			No	1	13.04		0
7235	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	36	40.4	Unstable	No	No	Signature.6	ARID1A | ATM | BLM | MRE11A | SLX4	No	0	14.03		0
7236	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	7	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	15.67		0
7237	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	43	2.6	Stable	No	Yes or Unknown			No	0	16.43		0
7238	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	21	6.1	Stable	No	No			No	0	15.9		0
7239	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	0	1.8	Stable	No	No			No	0	12.94		0
7240	Non-ICI treated	Never received ICI	41 - 45	Male	Esophageal	2018	I	8	2.6	Stable	No	No			No	0	13.37		0
7241	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	III	0	4.4	Stable	No	No			No	0	16.49		0
7242	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	III	0	60.6	Unstable	No	Yes or Unknown	Signature.1	ERCC2 | MSH2 | SLX4 | XRCC2	Yes	0	13.14		0
7243	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	I	0	0.9	Stable	No	No			Yes	0	14.72		0
7244	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	19	32.5	Stable	No	No	Signature.2	MDC1	Yes	0	13.5		0
7245	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	422	2.6	Stable	No	Yes or Unknown			No	0	18.69		0
7246	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	3	8.8	Stable	No	No			Yes	0	15.74		0
7247	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	3	8.8	Stable	No	No		BRCA1	No	0	11.3		0
7248	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	47	34.2	Stable	No	Yes or Unknown	Signature.6	ARID1A | BRCA2 | ERCC2 | MLH1 | MSH6	Yes	0	18.07		0
7249	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	III	22	94.8	Unstable	No	Yes or Unknown	Signature.6	ATM | ATR | BLM | BRCA1 | ERCC4 | FANCC | MRE11A | MSH3 | MSH6 | PALB2 | SLX4 | TP53BP1	Yes	0	13.37		0
7250	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.1	ATM	No	0	19.32		0
7251	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		0	0.9	Stable	No	No			Yes	0	13.7		0
7252	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2018	I	56	0	Stable	No	No			No	0	15.77		0
7253	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	22	0.9	Stable	No	Yes or Unknown			Yes	1	4.11		0
7254	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		No	0	16.2		0
7255	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	II	0	1.8	Stable	No	No			Yes	0	14.52		0
7256	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	41	5.3	Stable	No	Yes or Unknown		ATM | ATR	No	0	16.39		0
7257	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	II	30	19.3	Stable	No	No	Signature.2	ARID1A | ATR | FANCA | MSH6	Yes	0	15.38		0
7258	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	11.4	Stable	No	No	Signature.4	BRCA2 | MRE11A | SLX4	Yes	0	7.43		0
7259	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2017	IV	312	5.3	Stable	No	No			No	0	22.7		0
7260	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	0	15.84		0
7261	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	51	38.6	Unstable	No	No	Signature.6	ARID1A | MLH1 | PMS2 | SLX4	No	0	16.23		0
7262	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		4	4.4	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.35		0
7263	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		6	0	Stable	No	No			No	0	14.88		0
7264	Non-ICI treated	Never received ICI	76 - 80	Male	Bladder	2018	I	61	9.7	Stable	No	No	Signature.5	RAD51C | TP53BP1	No	0	15.51		0
7265	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	15.08		0
7266	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	77	5.3	Stable	No	No			No	0	16.33		0
7267	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	53	4.4	Stable	No	No			No	0	17.97		0
7268	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	46	9.7	Stable	No	No	Signature.1		No	0	15.9		0
7269	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	13	4.4	Stable	No	No	Signature.1	BRCA1	No	0	16.1		0
7270	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	5.3	Stable	No	No			Yes	0	15.47		0
7271	Non-ICI treated	Never received ICI	56 - 60	Female	Cutaneous Melanoma 	2018	III	42	2.6	Stable	No	No			Yes	0	14.49		0
7272	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	0	42.1	Indeterminate	No	No	Signature.1	ARID1A | ERCC2 | ERCC5 | MSH6	No	0	11.53		0
7273	Non-ICI treated	Never received ICI	41 - 45	Female	Esophageal	2018	III	0	1.8	Stable	No	No			No	0	15.11		0
7274	Non-ICI treated	Never received ICI	81 - 85	Female	Sarcoma	2018	III	0	0.9	Stable	No	No			No	0	14.26		0
7275	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	0	1.8	Stable	No	No		MDC1	Yes	0	15.87		0
7276	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	I	20	0.9	Stable	No	No			No	0	13.31		0
7277	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	2	3.5	Stable	No	No		ARID1A	No	1	9.59		0
7278	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	0	5.3	Stable	No	No		CHEK2	No	0	15.84		0
7279	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018		36	3.5	Stable	No	No	Signature.2		No	0	15.34		0
7280	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	IV	62	6.1	Stable	No	Yes or Unknown	Signature.16	RAD50	No	0	14.13		0
7281	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	14	0.9	Stable	No	No			Yes	0	11.79		0
7282	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	14	4.4	Stable	No	No	Signature.4	ATM | TP53BP1	No	1	1.58		0
7283	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	180	2.6	Stable	No	Yes or Unknown			Yes	0	12.29		0
7284	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	31	3.5	Stable	No	Yes or Unknown			Yes	0	11.83		0
7285	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	36	4.4	Stable	No	No			No	0	15.18		0
7286	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.29		No	0	15.51		0
7287	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	18	3.5	Stable	No	No	Signature.4		No	0	11.37		0
7288	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	0.9	Stable	No	No	Signature.13		No	0	14.59		0
7289	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	56	3.5	Stable	No	Yes or Unknown			Yes	0	15.64		0
7290	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	15.15		0
7291	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	138	4.4	Stable	No	Yes or Unknown			No	0	7.16		0
7292	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	20	6.1	Stable	No	No			No	0	15.61		0
7293	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	8	4.4	Stable	No	No			No	0	15.41		0
7294	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	II	22	5.3	Stable	No	No		BRCA1	Yes	0	15.11		0
7295	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	6.1	Stable	No	No			Yes	0	14.36		0
7296	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	IV	78	2.6	Stable	No	No			No	0	15.34		0
7297	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	0	14	Stable	No	No	Signature.3	ARID1A | ERCC5 | PMS1	No	0	12.68		0
7298	Non-ICI treated	Never received ICI	31 - 35	Male	CNS	2018		54	2.6	Stable	No	No			No	0	13.83		0
7299	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	IV	25	6.1	Stable	No	No	Signature.1	ARID1A	No	0	15.87		0
7300	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	7	Stable	No	No	Signature.13	ATM | BRCA1 | MLH1 | PALB2	No	0	15.18		0
7301	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	0	Stable	No	No			No	0	15.9		0
7302	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	77	7	Stable	No	Yes or Unknown	Signature.13		No	0	14.59		0
7303	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	21	4.4	Stable	No	No		BLM	Yes	0	13.31		0
7304	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	IV	1	11.4	Stable	No	No	Signature.2		Yes	0	6.44		0
7305	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	II	10	14.9	Stable	No	No	Signature.18	MUTYH	No	0	12.22		0
7306	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	33	4.4	Stable	No	No	Signature.4	BRCA2	No	0	4.7		0
7307	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	36	1.8	Stable	No	Yes or Unknown			No	1	8.38		0
7308	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	0	10.5	Stable	No	No	Signature.1	ARID1A	No	0	14.75		0
7309	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	4	3.5	Stable	No	Yes or Unknown		FANCC	Yes	0	15.11		0
7310	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	III	17	12.3	Stable	No	No	Signature.1	ARID1A	No	0	15.28		0
7311	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	32	2.6	Stable	No	No			Yes	0	13.67		0
7312	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	271	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	17.84		0
7313	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	23	4.4	Stable	No	No	Signature.25	ATR	No	0	14.59		0
7314	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	II	11	3.5	Stable	No	No			Yes	0	15.38		0
7315	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2018	IV	156	0.9	Stable	No	No			No	0	6.47		0
7316	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	14.62		0
7317	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	12.22		0
7318	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	15.15		0
7319	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	III	111	0	Stable	No	Yes or Unknown			No	0	11.93		0
7320	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	15	3.5	Stable	No	No			Yes	0	14.92		0
7321	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	36	6.1	Stable	No	No	Signature.1		No	0	15.97		0
7322	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	III	18	1.8	Stable	No	No	Signature.13		No	0	12.19		0
7323	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	0	2.6	Stable	No	No			No	1	15.38		0
7324	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	13.57		0
7325	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	14	5.3	Stable	No	No	Signature.1		Yes	1	4.86		0
7326	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	4.24		0
7327	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	III	0	5.3	Stable	No	No			Yes	0	14.03		0
7328	Non-ICI treated	Never received ICI	51 - 55	Male	Gastric	2018	I	17	6.1	Stable	No	No			No	0	13.11		0
7329	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	IV	90	3.5	Stable	No	Yes or Unknown			Yes	0	15.41		0
7330	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	151	2.6	Stable	No	No			No	0	14.95		0
7331	Non-ICI treated	Never received ICI	41 - 45	Male	Sarcoma	2018	IV	2	1.8	Stable	No	No			No	0	13.57		0
7332	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	147	0.9	Stable	No	Yes or Unknown			No	0	13.57		0
7333	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	53	0.9	Stable	No	No			Yes	0	14.29		0
7334	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	II	35	5.3	Stable	No	No			Yes	0	10.35		0
7335	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2018	IV	36	1.8	Stable	No	No		ERCC5	Yes	0	10.38		0
7336	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	31	7	Stable	No	No	Signature.5	BRCA2	Yes	0	7.29		0
7337	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	IV	0	1.8	Stable	No	No			Yes	1	2.53		0
7338	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	30	6.1	Stable	No	No			No	0	13.37		0
7339	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	20	0	Stable	No	No			No	0	13.63		0
7340	Non-ICI treated	Never received ICI	91 - 95	Female	Breast	2018	IV	0	4.4	Stable	No	No			No	0	14.29		0
7341	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	18	5.3	Stable	No	No			No	0	16.56		0
7342	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	14.03		0
7343	Non-ICI treated	Never received ICI	76 - 80	Female	Esophageal	2018	III	117	7	Stable	No	No	Signature.17	MDC1	No	0	10.55		0
7344	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	41	1.8	Stable	No	No		MSH3	No	0	12.29		0
7345	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	17	3.5	Stable	No	No	Signature.1		Yes	0	15.18		0
7346	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	16	7.9	Stable	No	No	Signature.24	ATM | MRE11A	No	0	13.8		0
7347	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	III	0	1.8	Stable	No	Yes or Unknown			No	0	14.62		0
7348	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018		0	4.4	Stable	No	No	Signature.2		No	0	15.74		0
7349	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	15.77		0
7350	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	15.87		0
7351	Non-ICI treated	Never received ICI	46 - 50	Female	Bladder	2017	II	0	4.4	Stable	No	No			No	0	14.52		0
7352	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2018	IV	0	6.1	Stable	No	No			Yes	0	16.53		0
7353	Non-ICI treated	Never received ICI	61 - 65	Female	Sarcoma	2018	I	19	1.8	Stable	No	Yes or Unknown		ATM	Yes	0	13.63		0
7354	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	15.87		0
7355	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	III	2	1.8	Stable	No	No	Signature.1	MSH3	No	0	11.07		0
7356	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	0	8.8	Stable	No	No	Signature.1		Yes	0	12.85		0
7357	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	2	7	Stable	No	No			Yes	0	14.82		0
7358	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	III	34	66.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | CHEK2 | ERCC2 | MDC1 | MLH1 | MSH3	Yes	0	10.05		0
7359	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	148	1.8	Stable	No	No			Yes	0	15.41		0
7360	Non-ICI treated	Never received ICI	56 - 60	Female	Bladder	2018	I	315	8.8	Stable	No	Yes or Unknown	Signature.2		Yes	0	18.3		0
7361	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	28	3.5	Stable	No	No	Signature.1		No	0	15.21		0
7362	Non-ICI treated	Never received ICI	76 - 80	Female	Cutaneous Melanoma 	2018	III	27	5.3	Stable	No	No	Signature.7		No	0	14.19		0
7363	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	1	11.47		0
7364	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	27	4.4	Stable	No	No			Yes	0	14.69		0
7365	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	52	6.1	Stable	No	No		ARID1A	No	0	15.74		0
7366	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	22	26.3	Unstable	No	No	Signature.6	ARID1A | ATR	No	0	11.56		0
7367	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	25	14	Stable	No	No	Signature.1		No	0	15.51		0
7368	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	52	12.3	Stable	No	No	Signature.1		No	0	14.06		0
7369	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		38	4.4	Stable	No	No	Signature.1		No	0	13.83		0
7370	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	No			Yes	0	15.7		0
7371	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1		No	0	15.87		0
7372	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	1.8	Stable	No	No			No	0	14.42		0
7373	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		10	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	15.15		0
7374	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	2.6	Stable	No	Yes or Unknown			No	0	14.06		0
7375	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	62	8.8	Stable	No	No	Signature.4		Yes	0	13.37		0
7376	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	I	82	2.6	Stable	No	No		ARID1A	No	0	15.38		0
7377	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	35	2.6	Stable	No	No			No	0	14.49		0
7378	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	72	2.6	Stable	No	No			Yes	0	14.06		0
7379	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2018	III	139	16.7	Stable	No	Yes or Unknown	Signature.4	CHEK2 | PMS2 | TP53BP1	No	0	14.88		0
7380	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	153	7.9	Stable	No	Yes or Unknown	Signature.6		No	0	18.66		0
7381	Non-ICI treated	Never received ICI	76 - 80	Female	Sarcoma	2018		0	7	Stable	No	No	Signature.7	ATM | MDC1	No	0	9.63		0
7382	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	19	7.9	Stable	No	No	Signature.1	ATM	No	0	8.97		0
7383	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	48	2.6	Stable	No	No		ARID1A	No	0	14.98		0
7384	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	85	1.8	Stable	No	No			No	0	16.53		0
7385	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	0	3.5	Stable	No	No		SLX4	Yes	0	14		0
7386	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	3	5.3	Stable	No	No		BRCA2	No	0	14.59		0
7387	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	110	2.6	Stable	No	No		ATM	No	0	10.71		0
7388	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	42	0.9	Stable	No	No		FANCA	No	0	10.35		0
7389	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	33	1.8	Stable	No	No		BRCA2	No	0	15.31		0
7390	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	42	9.7	Stable	No	Yes or Unknown	Signature.13	ATR | BRCA2 | RAD51	No	0	14.06		0
7391	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	15.77		0
7392	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	27	7.9	Stable	No	No	Signature.6	ATM	Yes	0	14.42		0
7393	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	23	3.5	Stable	No	No			Yes	0	14.03		0
7394	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	0	Stable	No	No			No	0	15.28		0
7395	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	I	44	2.6	Stable	No	No			No	0	12.65		0
7396	Non-ICI treated	Never received ICI	41 - 45	Male	Gastric	2018	IV	4	3.5	Stable	No	No			Yes	1	5.39		0
7397	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	2	5.3	Stable	No	No	Signature.1		Yes	0	8.11		0
7398	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	24	5.3	Stable	No	Yes or Unknown	Signature.13		Yes	0	13.37		0
7399	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	II	55	0.9	Stable	No	No			Yes	0	9.63		0
7400	Non-ICI treated	Never received ICI	71 - 75	Male	Bladder	2018	II	0	15.8	Stable	No	No	Signature.13	ARID1A	Yes	0	13.8		0
7401	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	61	7.9	Stable	No	No	Signature.1		No	0	13.11		0
7402	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	212	1.8	Stable	No	Yes or Unknown			No	0	14.39		0
7403	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	11	6.1	Stable	No	No	Signature.4	BLM	No	0	13.11		0
7404	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	0	1.8	Stable	No	Yes or Unknown			No	0	14.03		0
7405	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	2	2.6	Stable	No	No			Yes	0	14.72		0
7406	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	8	14	Stable	No	No	Signature.15	ATM	No	0	14.72		0
7407	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	II	0	11.4	Stable	No	No	Signature.4		Yes	0	10.74		0
7408	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	76.4	Unstable	No	No	Signature.6	BRIP1 | ERCC4 | FANCA | PMS2	No	0	15.7		0
7409	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	15.34		0
7410	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	22	0.9	Stable	No	No			No	0	14.52		0
7411	Non-ICI treated	Never received ICI	51 - 55	Male	Esophageal	2017	II	187	1.8	Stable	No	No			No	0	17.58		0
7412	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	12	3.5	Stable	No	Yes or Unknown			Yes	0	14		0
7413	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	3.5	Stable	No	No			No	0	14.72		0
7414	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	III	174	1.8	Stable	No	Yes or Unknown			No	0	14.69		0
7415	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	III	33	1.8	Stable	No	No			Yes	0	15.38		0
7416	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	149	3.5	Stable	No	Yes or Unknown			Yes	0	7		0
7417	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	47	3.5	Stable	No	No	Signature.8		No	0	2.3		0
7418	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2018	II	21	2.6	Stable	No	No		ARID1A	Yes	0	13.11		0
7419	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	15.15		0
7420	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	16	3.5	Stable	No	No			Yes	0	15.67		0
7421	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	II	46	2.6	Stable	No	No			No	0	14.19		0
7422	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	2.6	Stable	No	No			No	0	15.51		0
7423	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	24	5.3	Stable	No	No			No	0	11.27		0
7424	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2018	II	32	42.1	Unstable	No	No	Signature.15	ARID1A | BRCA2 | BRIP1 | CHEK2 | FANCA | MRE11A | NTHL1 | SLX4	Yes	0	14.16		0
7425	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	0	Stable	No	No			Yes	0	11.93		0
7426	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	0	11.4	Stable	No	No	Signature.1	ATM	Yes	0	13.4		0
7427	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	I	245	0	Stable	No	Yes or Unknown			No	0	14.72		0
7428	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	0	3.5		No	No			No	0	11.3		0
7429	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	327	2.6	Stable	No	Yes or Unknown			No	0	14.49		0
7430	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	182	2.6	Stable	No	No			No	0	18.17		0
7431	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	0	15.8	Stable	No	No	Signature.4	BLM | ERCC3	No	0	13.01		0
7432	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	II	250	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	13.31		0
7433	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	6.1	Stable	No	No		PMS2	No	0	15.18		0
7434	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	57	6.1	Stable	No	No	Signature.4	NBN	Yes	0	13.9		0
7435	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	II	25	6.1	Stable	No	No			No	0	12.98		0
7436	Non-ICI treated	Never received ICI	36 - 40	Female	Endometrial	2018	I	74	7.9	Stable	No	Yes or Unknown		ARID1A	Yes	0	11.99		0
7437	Non-ICI treated	Never received ICI	71 - 75	Female	Gastric	2018	IV	20	1.8	Stable	No	No		BLM	No	0	14.59		0
7438	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018	III	1	4.4	Stable	No	No			No	0	13.73		0
7439	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	II	170	5.3	Stable	No	Yes or Unknown		PMS2 | SLX4	No	0	14.42		0
7440	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	I	22	6.1	Stable	No	No	Signature.3	ERCC5	No	0	14.52		0
7441	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	27	5.3	Stable	No	No			Yes	0	14.88		0
7442	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	3	1.8	Stable	No	No			No	1	6.6		0
7443	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	43	10.5		No	No	Signature.3	BRCA1	No	0	14.26		0
7444	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	9	1.8	Stable	No	No		ARID1A	No	0	15.61		0
7445	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	32	1.8	Stable	No	No			No	0	10.68		0
7446	Non-ICI treated	Never received ICI	76 - 80	Female	Endometrial	2018	IV	43	3.5	Stable	No	No			No	1	13.77		0
7447	Non-ICI treated	Never received ICI	66 - 70	Male	CNS	2018		20	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	14.75		0
7448	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		0	7	Stable	No	No			Yes	1	12.55		0
7449	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	0	28.1		No	No	Signature.5	BRCA1 | BRCA2 | FANCA | RAD54L | TP53BP1	No	0	4.47		0
7450	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	9	1.8	Stable	No	No			Yes	0	11.93		0
7451	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	2	3.5	Stable	No	No			No	0	15.21		0
7452	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	I	449	0	Stable	No	Yes or Unknown			No	0	18.14		0
7453	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	II	16	7	Stable	No	No	Signature.4		Yes	1	9.89		0
7454	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		0	0.9	Stable	No	No			No	0	14.69		0
7455	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	33	13.2	Stable	No	No	Signature.24	BRCA1 | MLH1	Yes	0	9.66		0
7456	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	55	8.8	Stable	No	No			No	0	13.11		0
7457	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	23	0.9	Stable	No	No			No	0	14.92		0
7458	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	I	5	8.8	Stable	No	No	Signature.1		Yes	0	12.42		0
7459	Non-ICI treated	Never received ICI	56 - 60	Female	Hepatobiliary	2018	III	22	6.1	Stable	No	No			Yes	0	14.49		0
7460	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	1.8	Stable	No	No		ATM	No	0	14.03		0
7461	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	103	25.5	Stable	No	Yes or Unknown	Signature.4		Yes	0	13.14		0
7462	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018	III	4	0.9	Stable	No	No			Yes	0	13.8		0
7463	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	15	8.8	Stable	No	No	Signature.1		No	0	13.93		0
7464	Non-ICI treated	Never received ICI	41 - 45	Female	Head & Neck	2018	II	0	1.8	Stable	No	No			Yes	0	13.83		0
7465	Non-ICI treated	Never received ICI	86 - 90	Female	Bladder	2018	IV	0	5.3	Stable	No	No	Signature.2	ATM | BRCA1	Yes	1	4.07		0
7466	Non-ICI treated	Never received ICI	41 - 45	Female	Gastric	2018	II	26	8.8	Stable	No	No			No	0	14.03		0
7467	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	21	0	Stable	No	No			No	0	12.19		0
7468	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	I	292	2.6	Stable	No	Yes or Unknown			No	0	16.76		0
7469	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	II	0	0	Stable	No	No			No	0	15.67		0
7470	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	III	54	5.3	Stable	No	No			Yes	0	14.65		0
7471	Non-ICI treated	Never received ICI	41 - 45	Male	Bladder	2018		3	10.5	Stable	No	No	Signature.13	RAD50	No	0	8.38		0
7472	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	0	3.5	Stable	No	No		ARID1A | ATM	Yes	0	12.42		0
7473	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	21	7.9	Stable	No	No	Signature.4	RAD50	No	0	12.45		0
7474	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	6.14		0
7475	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		5	5.3	Stable	No	No	Signature.23	ATM | CHEK2	No	0	11.53		0
7476	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	23	0.9	Stable	No	No			Yes	0	14.32		0
7477	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2018	IV	3	5.3	Stable	No	No			Yes	0	5.16		0
7478	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	I	21	3.5	Stable	No	No			No	0	13.96		0
7479	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	II	17	2.6	Stable	No	No			Yes	0	13.8		0
7480	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	275	6.1	Stable	No	Yes or Unknown	Signature.1		No	0	14.62		0
7481	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	IV	0	5.3	Stable	No	No	Signature.26		No	0	2.1		0
7482	Non-ICI treated	Never received ICI	21 - 25	Male	Head & Neck	2018	IV	36	6.1	Stable	No	No			Yes	0	13.57		0
7483	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	10	10.5	Stable	No	No	Signature.3	BRCA2 | CHEK2 | ERCC4	Yes	0	12.71		0
7484	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	10	22.8	Stable	No	No	Signature.4	ATM | BRIP1 | ERCC4	No	1	1.54		0
7485	Non-ICI treated	Never received ICI	51 - 55	Female	CNS	2018		0	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	13.14		0
7486	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	III	0	1.8	Stable	No	No			Yes	0	13.73		0
7487	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	5	6.1	Stable	No	No			No	0	17.51		0
7488	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	70	0.9	Stable	No	No			No	0	14.46		0
7489	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	31	3.5	Stable	No	No			Yes	0	12.62		0
7490	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	9.76		0
7491	Non-ICI treated	Never received ICI	71 - 75	Female	Sarcoma	2018	IV	0	1.8	Stable	No	Yes or Unknown			Yes	1	6.93		0
7492	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	IV	5	7.9	Stable	No	No		ARID1A	Yes	0	13.77		0
7493	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	0	22.8	Stable	No	No	Signature.4	CHEK1 | MRE11A | PALB2 | TP53BP1	Yes	0	13.24		0
7494	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	32	10.5	Indeterminate	No	No	Signature.3	FANCC	No	0	14		0
7495	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	45	0.9	Stable	No	Yes or Unknown			No	0	13.37		0
7496	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2018	IV	200	3.5	Stable	No	No			Yes	1	13.44		0
7497	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	21	8.8	Stable	No	No	Signature.1	ARID1A	No	0	14.06		0
7498	Non-ICI treated	Never received ICI	26 - 30	Female	Colorectal	2018	IV	19	2.6	Stable	No	No			No	0	15.31		0
7499	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	II	56	1.8	Stable	No	No			No	0	6.47		0
7500	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	9	3.5	Stable	No	No		ATM	Yes	0	14.55		0
7501	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	13.04		0
7502	Non-ICI treated	Never received ICI	36 - 40	Male	Bladder	2018	II	17	7.9	Stable	No	No	Signature.13	BRIP1	Yes	0	13.6		0
7503	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	42	10.5	Stable	No	No	Signature.1		Yes	0	12.91		0
7504	Non-ICI treated	Never received ICI	0 - 5	Male	Hepatobiliary	2018		1	1.8	Stable	No	No			Yes	0	13.27		0
7505	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	70	0		No	No			Yes	0	15.97		0
7506	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	8.8	Stable	No	No	Signature.13		No	1	6.74		0
7507	Non-ICI treated	Never received ICI	91 - 95	Male	Gastric	2018	III	0	0	Stable	No	Yes or Unknown			No	0	13.4		0
7508	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	0	1.8	Stable	No	No			Yes	0	12.78		0
7509	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	59	3.5	Stable	No	No		BRCA2	No	0	15.08		0
7510	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	IV	2	4.4	Stable	No	No			No	0	14.49		0
7511	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	37	0.9	Stable	No	Yes or Unknown			No	0	15.38		0
7512	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	0	0.9	Stable	No	No			No	0	14.09		0
7513	Non-ICI treated	Never received ICI	71 - 75	Female	Hepatobiliary	2018	IV	27	3.5	Stable	No	No		ARID1A	No	0	4.5		0
7514	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	31	5.3	Stable	No	No		ARID1A	Yes	0	14.42		0
7515	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		2	2.6	Stable	Yes or Unknown	Yes or Unknown		FANCA	No	0	17.12		0
7516	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	I	0	4.4	Stable	No	No			No	0	9.23		0
7517	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	5	6.1	Stable	No	No	Signature.6	FANCA	No	1	12.32		0
7518	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	48	9.7	Stable	No	No	Signature.1	TP53BP1	No	0	14.23		0
7519	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2018		14	0	Stable	No	No			No	0	12.45		0
7520	Non-ICI treated	Never received ICI	36 - 40	Female	NSCLC	2018	IV	0	4.4	Stable	No	No			Yes	0	12.65		0
7521	Non-ICI treated	Never received ICI	66 - 70	Male	Gastric	2018	III	161	0	Stable	No	No			No	0	6.08		0
7522	Non-ICI treated	Never received ICI	76 - 80	Male	Hepatobiliary	2018	IV	0	4.4	Stable	No	No		MSH2	Yes	1	5.59		0
7523	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	130	3.5	Stable	No	No			No	0	16.95		0
7524	Non-ICI treated	Never received ICI	21 - 25	Female	Hepatobiliary	2018	IV	20	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	10.55		0
7525	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	5.3	Stable	No	No		BRCA1	No	0	13.77		0
7526	Non-ICI treated	Never received ICI	46 - 50	Male	CNS	2018		0	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.38		0
7527	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	15	12.3	Stable	No	No	Signature.30	BRCA2	Yes	0	12.88		0
7528	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	9	3.5	Stable	No	Yes or Unknown			Yes	0	13.24		0
7529	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	III	2	5.3	Stable	No	No	Signature.1		No	0	12.94		0
7530	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	3.5	Stable	No	No			No	0	11.99		0
7531	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	III	0	2.6	Stable	No	No			No	0	13.21		0
7532	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	II	14	1.8	Stable	No	No			No	0	14.16		0
7533	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	0	9.7	Stable	No	No	Signature.1	ATR	No	0	15.15		0
7534	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	57	0.9	Stable	No	No			No	0	12.94		0
7535	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	12	78.1	Unstable	No	No	Signature.6	BLM | MLH1 | MSH3 | SLX4	Yes	0	4.4		0
7536	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018		0	0	Stable	No	No			Yes	0	13.37		0
7537	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	0	7	Stable	No	No		ATM	Yes	0	12.39		0
7538	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	III	22	7.9	Stable	No	No		ARID1A	No	0	14.49		0
7539	Non-ICI treated	Never received ICI	26 - 30	Female	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown			Yes	0	12.52		0
7540	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	182.6	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA2 | BRIP1 | CHEK1 | ERCC5 | MDC1 | MSH6 | PMS1 | PMS2 | RAD50 | RAD51C | TP53BP1 | XRCC2	No	0	12.22		0
7541	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			No	0	13.77		0
7542	Non-ICI treated	Never received ICI	56 - 60	Male	Head & Neck	2018	IV	86	6.1	Stable	No	No			Yes	0	13.5		0
7543	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018	I	0	0	Stable	No	No			No	0	12.71		0
7544	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	2.6	Stable	No	No		PALB2	No	0	14.39		0
7545	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			Yes	0	13.14		0
7546	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	83	8.8	Stable	No	No	Signature.10		No	1	4.3		0
7547	Non-ICI treated	Never received ICI	71 - 75	Male	Esophageal	2018		141	8.8	Stable	No	No	Signature.15	ARID1A	No	0	12.65		0
7548	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	I	182	11.4	Stable	No	Yes or Unknown	Signature.2		Yes	0	13.27		0
7549	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	91	1.8	Stable	No	Yes or Unknown			Yes	0	13.34		0
7550	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	I	0	5.3	Stable	No	No			No	0	13.17		0
7551	Non-ICI treated	Never received ICI	36 - 40	Female	CNS	2018		37	0	Stable	No	No			No	0	13.14		0
7552	Non-ICI treated	Never received ICI	46 - 50	Female	Ovarian	2018	IV	109	2.6	Stable	No	Yes or Unknown		BRCA1	No	0	14.03		0
7553	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018		0	0	Stable	No	No			No	0	13.14		0
7554	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	7	6.1	Stable	No	Yes or Unknown	Signature.1	BRCA2	No	0	14.23		0
7555	Non-ICI treated	Never received ICI	26 - 30	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			No	0	13.63		0
7556	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	38	8.8	Stable	No	No	Signature.2		Yes	0	13.21		0
7557	Non-ICI treated	Never received ICI	21 - 25	Male	Esophageal	2018	IV	29	0.9	Stable	No	No			No	0	13.14		0
7558	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	1	11.63		0
7559	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	153	1.8	Stable	No	Yes or Unknown			No	0	13.11		0
7560	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	0.9	Stable	No	Yes or Unknown			No	0	14.19		0
7561	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	59	1.8	Stable	No	No			No	0	8.84		0
7562	Non-ICI treated	Never received ICI	31 - 35	Female	Sarcoma	2018	III	149	0.9	Stable	No	Yes or Unknown			No	0	13.47		0
7563	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	71	2.6	Stable	No	No			No	0	15.01		0
7564	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	I	20	1.8	Stable	No	No			No	0	12.48		0
7565	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	204	0	Stable	No	Yes or Unknown			Yes	0	10.81		0
7566	Non-ICI treated	Never received ICI	66 - 70	Male	SCLC	2018	II	36	10.5	Stable	No	No	Signature.4		Yes	0	13.96		0
7567	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	37	2.6	Stable	No	No			Yes	0	14.42		0
7568	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	III	0	2.6	Stable	No	No	Signature.26	ERCC3	No	0	11.89		0
7569	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	8	8.8	Stable	No	No	Signature.1		No	0	13.4		0
7570	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	28	7.9	Stable	No	No	Signature.1	ATM	No	0	13.08		0
7571	Non-ICI treated	Never received ICI	46 - 50	Female	CNS	2018		6	1.8	Stable	No	No			No	0	7.69		0
7572	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			Yes	0	11.99		0
7573	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	13.73		0
7574	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	40	0.9	Stable	No	No			Yes	0	13.6		0
7575	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	III	30	7	Stable	No	No	Signature.7	MDC1	Yes	0	14.23		0
7576	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	IV	28	2.6	Stable	No	No		ERCC5	No	0	13.67		0
7577	Non-ICI treated	Never received ICI	51 - 55	Male	Cutaneous Melanoma 	2018	IV	0	52.7	Stable	No	No	Signature.7	BRCA2 | BRIP1 | MSH6 | PALB2	No	0	11.43		0
7578	Non-ICI treated	Never received ICI	71 - 75	Male	Gastric	2018	I	100	59.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | MRE11A | MSH2 | MSH3 | NBN | RAD50	Yes	0	13.8		0
7579	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	58	4.4	Stable	No	No			Yes	0	12.02		0
7580	Non-ICI treated	Never received ICI	71 - 75	Female	Renal	2018	I	0	5.3	Stable	No	No		RAD50 | RAD51C	No	0	11.93		0
7581	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	I	103	0.9	Stable	No	No			No	0	6.93		0
7582	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	0	3.5	Stable	No	No			Yes	1	11.01		0
7583	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	24	7	Stable	No	No	Signature.1		Yes	0	13.9		0
7584	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	72	0.9	Stable	No	No			No	0	9.23		0
7585	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	177	16.7	Stable	No	No	Signature.4	ARID1A	No	0	8.02		0
7586	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	97	6.1	Stable	No	No			No	0	13.34		0
7587	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	III	0	5.3	Stable	No	No	Signature.4		Yes	0	11.89		0
7588	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	48	6.1	Stable	No	No			No	0	14.03		0
7589	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	0	11.4	Stable	No	No	Signature.1	ARID1A	No	0	13.83		0
7590	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	33	5.3	Stable	No	No			Yes	0	10.97		0
7591	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	0	2.6	Stable	No	No			No	1	13.01		0
7592	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1	SLX4	No	1	2.33		0
7593	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2018	III	0	2.6	Stable	No	No			No	1	10.91		0
7594	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	12	5.3	Stable	No	No	Signature.16		No	0	12.71		0
7595	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	III	27	31.6	Unstable	No	No	Signature.20	ARID1A | BLM | ERCC3 | ERCC5 | MRE11A | MSH3 | MSH6	No	0	13.8		0
7596	Non-ICI treated	Never received ICI	81 - 85	Female	NSCLC	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	12.29		0
7597	Non-ICI treated	Never received ICI	31 - 35	Female	NSCLC	2018	III	142	0	Stable	No	Yes or Unknown			No	0	13.14		0
7598	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	26	4.4	Stable	No	No	Signature.1	ERCC5	No	0	13.37		0
7599	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	28	3.5	Stable	No	No		ATM	No	0	14.06		0
7600	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	90	6.1	Stable	No	No			Yes	0	12.65		0
7601	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		0	3.5	Stable	No	No	Signature.26		Yes	0	13.54		0
7602	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	19	0.9	Stable	No	No			No	0	11.17		0
7603	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2018	I	0	4.4	Stable	No	No	Signature.6	BRCA2 | FANCA	Yes	0	14.85		0
7604	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	III	15	5.3	Stable	No	No	Signature.1		Yes	0	4.67		0
7605	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	IV	14	3.5	Stable	No	No			No	1	6.64		0
7606	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2018	III	223	0	Stable	No	Yes or Unknown			No	0	12.12		0
7607	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	II	155	0	Stable	No	Yes or Unknown			No	0	13.86		0
7608	Non-ICI treated	Never received ICI	41 - 45	Male	CNS	2018		9	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	13.54		0
7609	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	125	1.8	Stable	No	No			Yes	0	15.05		0
7610	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	1	12.75		0
7611	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	14.65		0
7612	Non-ICI treated	Never received ICI	56 - 60	Male	Esophageal	2018	IV	0	6.1	Stable	No	No	Signature.3		No	1	11.76		0
7613	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	0.9	Stable	No	No			No	0	12.85		0
7614	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	92	0	Stable	No	Yes or Unknown		MRE11A	No	0	15.01		0
7615	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	0	2.6	Stable	No	No			No	0	12.94		0
7616	Non-ICI treated	Never received ICI	91 - 95	Female	Breast	2018	II	0	0.9	Stable	No	No			Yes	0	11.1		0
7617	Non-ICI treated	Never received ICI	51 - 55	Female	Hepatobiliary	2018	III	0	5.3	Stable	No	No			No	1	7.16		0
7618	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	17	3.5	Stable	No	No			Yes	0	13.37		0
7619	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	III	0	1.8	Stable	No	No			Yes	0	14.03		0
7620	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	34	4.4	Stable	No	Yes or Unknown			Yes	0	14.13		0
7621	Non-ICI treated	Never received ICI	66 - 70	Female	Gastric	2018	IV	196	3.5	Stable	No	Yes or Unknown			No	1	13.31		0
7622	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	II	32	11.4	Stable	No	No	Signature.24		Yes	0	9.63		0
7623	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	Yes or Unknown	Signature.2		No	0	14.42		0
7624	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	III	172	0		No	Yes or Unknown			Yes	0	12.29		0
7625	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	III	20	1.8	Stable	No	No		MSH3	No	0	12.91		0
7626	Non-ICI treated	Never received ICI	0 - 5	Male	CNS	2018		3	0.9	Indeterminate	No	No			No	0	13.73		0
7627	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	4.4	Stable	No	No	Signature.3		No	0	13.11		0
7628	Non-ICI treated	Never received ICI	56 - 60	Female	Pancreatic	2018	IV	19	4.4	Stable	No	No			Yes	0	14		0
7629	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	No			No	0	9.69		0
7630	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	I	273	1.8	Stable	No	No			Yes	0	14.03		0
7631	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	233	0	Stable	No	Yes or Unknown			Yes	0	14.03		0
7632	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	223	0	Stable	No	No			No	0	12.71		0
7633	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	I	20	5.3	Stable	No	No	Signature.24		No	0	13.57		0
7634	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	No			Yes	0	13.73		0
7635	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	56	1.8	Stable	No	No		NTHL1	No	0	13.93		0
7636	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	1	1.91		0
7637	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	32	1.8	Stable	No	No			No	0	13.14		0
7638	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	0.9	Stable	No	No		PMS1	No	0	9.69		0
7639	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	1.8	Stable	No	No			No	0	12.42		0
7640	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	3.5	Stable	No	No			Yes	1	4.11		0
7641	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	5.3	Stable	No	No			No	0	13.7		0
7642	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	III	18	2.6	Stable	No	No			Yes	0	8.31		0
7643	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	0	3.5	Stable	No	No			No	0	14.03		0
7644	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	112	1.8	Stable	No	Yes or Unknown			No	0	13.54		0
7645	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	0	4.4	Stable	No	No	Signature.5		Yes	0	5.22		0
7646	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	0	5.3	Stable	No	No			Yes	0	5.29		0
7647	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.1		Yes	0	13.14		0
7648	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	27	11.4	Stable	No	Yes or Unknown	Signature.4		No	1	5.55		0
7649	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.14		No	0	13.86		0
7650	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	III	111	20.2	Stable	No	No	Signature.2	PMS2	No	0	14.52		0
7651	Non-ICI treated	Never received ICI	66 - 70	Female	SCLC	2018	III	0	8.8	Stable	No	No	Signature.16		Yes	0	11.07		0
7652	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	0	3.5	Stable	No	No			Yes	0	13.17		0
7653	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	3	3.5	Stable	No	No		SLX4	Yes	1	2.14		0
7654	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	3	8.8	Stable	No	No	Signature.17	MDC1	Yes	0	7.92		0
7655	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	35	1.8	Stable	No	Yes or Unknown		MUTYH	No	0	13.57		0
7656	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	48	5.3	Stable	No	No			No	0	11.73		0
7657	Non-ICI treated	Never received ICI	76 - 80	Female	CNS	2018		0	6.1	Stable	No	No			Yes	1	12.32		0
7658	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	6	3.5	Stable	No	No			Yes	0	13.54		0
7659	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		108	1.8	Stable	No	No			No	0	14.39		0
7660	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	3	0.9	Stable	No	Yes or Unknown		ERCC2	No	0	11.07		0
7661	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	II	2	2.6	Stable	No	No		ARID1A	No	1	5.42		0
7662	Non-ICI treated	Never received ICI	71 - 75	Female	SCLC	2018	IV	19	7	Stable	No	No	Signature.4		No	0	9.92		0
7663	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	II	58	8.8	Stable	No	No	Signature.4	MSH2	Yes	0	9.95		0
7664	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	1	2.33		0
7665	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	16	6.1	Stable	No	No	Signature.13		Yes	0	12.48		0
7666	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	1.8	Stable	No	Yes or Unknown			No	0	15.84		0
7667	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	17	2.6	Stable	No	No	Signature.1		Yes	0	12.19		0
7668	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	0	5.3	Stable	No	No	Signature.28		No	0	12.62		0
7669	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	12.75		0
7670	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	II	0	1.8	Stable	No	Yes or Unknown			No	0	13.4		0
7671	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	III	48	3.5	Indeterminate	No	No			No	0	14.26		0
7672	Non-ICI treated	Never received ICI	31 - 35	Female	Endometrial	2018	I	303	5.3	Stable	No	No			No	0	11.24		0
7673	Non-ICI treated	Never received ICI	81 - 85	Female	Endometrial	2018	I	49	0		No	No			No	1	4.37		0
7674	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	0	3.5	Stable	No	No			No	0	12.29		0
7675	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	IV	0	7	Stable	No	No	Signature.1	FANCA	No	0	13.77		0
7676	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	85	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	7.85		0
7677	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	0	0	Stable	No	No			No	0	12.22		0
7678	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	49	4.4	Stable	No	Yes or Unknown	Signature.3	BRCA2 | CHEK2	No	0	11.76		0
7679	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	II	31	5.3	Stable	No	No			No	0	13.63		0
7680	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		1	3.5	Stable	No	No			No	0	11.1		0
7681	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	7	4.4	Stable	No	No			No	0	13.08		0
7682	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	III	27	6.1	Stable	No	No	Signature.2		No	0	15.7		0
7683	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018		0	0		No	No			No	0	12.71		0
7684	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018	III	11	1.8	Stable	No	No			No	0	13.11		0
7685	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	16	2.6	Stable	No	No		BRCA2	Yes	0	13.21		0
7686	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	5.3	Stable	No	Yes or Unknown		SLX4	No	0	11.76		0
7687	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	IV	0	7.9	Stable	No	No	Signature.1		Yes	1	10.55		0
7688	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	I	47	4.4	Stable	No	No			No	0	2.66		0
7689	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	II	14	2.6	Stable	No	No			No	0	2.27		0
7690	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	95	1.8	Stable	No	No			No	0	12.65		0
7691	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	8	7	Stable	No	No		ATM	No	0	12.65		0
7692	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	15	0	Stable	No	No			No	0	12.25		0
7693	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	0	5.3	Stable	No	No			No	0	13.31		0
7694	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	IV	0	3.5	Stable	No	No			No	0	1.97		0
7695	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	0	5.3	Stable	No	No			No	1	3.81		0
7696	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	0	7	Stable	No	Yes or Unknown		MSH6	Yes	0	14.03		0
7697	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	0.9	Stable	No	No			No	0	13.77		0
7698	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	337	1.8	Stable	No	Yes or Unknown			Yes	0	13.44		0
7699	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	20	3.5	Stable	No	No			Yes	1	12.88		0
7700	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	0	1.8	Stable	No	No			Yes	0	11.86		0
7701	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	III	20	9.7	Stable	No	No	Signature.4		Yes	0	11.99		0
7702	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	166	1.8	Stable	No	Yes or Unknown			No	0	13.08		0
7703	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	4	0	Stable	No	Yes or Unknown			No	0	14.26		0
7704	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	0	7.9	Stable	No	Yes or Unknown	Signature.13	BRCA2 | PMS2	No	1	13.8		0
7705	Non-ICI treated	Never received ICI	71 - 75	Male	SCLC	2018	IV	2	7.9	Stable	No	No	Signature.4		Yes	0	11.89		0
7706	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	I	46	60.6	Stable	No	No	Signature.4	ARID1A | ATM | ATR | BRCA1 | MDC1 | MLH1 | PARP1	Yes	0	10.51		0
7707	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	18	5.3	Stable	No	No			Yes	0	12.19		0
7708	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	0	7	Stable	No	No		MRE11A	No	0	13.14		0
7709	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		15	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	13.08		0
7710	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	I	28	0	Stable	No	No			No	0	7.79		0
7711	Non-ICI treated	Never received ICI	56 - 60	Male	Bladder	2018	II	232	7	Stable	No	Yes or Unknown	Signature.10		Yes	0	13.54		0
7712	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	16	9.7	Stable	No	No	Signature.1	ARID1A	No	1	9.63		0
7713	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	46	4.4	Stable	No	No			No	0	12.58		0
7714	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	II	17	20.2	Stable	No	No	Signature.4	ERCC5	Yes	0	9.03		0
7715	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	66	3.5	Stable	No	No			No	0	14.72		0
7716	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		47	0.9	Stable	No	No			No	0	2.04		0
7717	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	8	6.1	Stable	No	No			No	1	8.97		0
7718	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	I	11	0	Stable	No	No			No	0	6.41		0
7719	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	23	18.4	Stable	No	No	Signature.2		No	0	11.6		0
7720	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	IV	0	1.8	Stable	No	No			Yes	0	12.91		0
7721	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	2.6	Stable	No	No		ATM	No	0	14.32		0
7722	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	23	5.3	Stable	No	No			No	0	12.94		0
7723	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	III	14	5.3	Stable	No	No	Signature.1	MSH3	Yes	0	12.09		0
7724	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	IV	13	4.4	Stable	No	No		RAD50	Yes	0	12.65		0
7725	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	60	0.9	Stable	No	No			No	0	13.5		0
7726	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	42	0.9	Stable	No	Yes or Unknown			No	0	12.48		0
7727	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	44	1.8	Stable	No	Yes or Unknown		ATM	No	0	13.8		0
7728	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	108	10.5	Stable	No	No	Signature.5		Yes	1	7.69		0
7729	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	43	3.5	Stable	No	No			Yes	0	13.34		0
7730	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	6	5.3	Stable	No	Yes or Unknown		ERCC3	Yes	0	4.73		0
7731	Non-ICI treated	Never received ICI	61 - 65	Male	Sarcoma	2018	I	6	2.6	Stable	No	No			No	0	10.61		0
7732	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	IV	13	4.4	Stable	No	No	Signature.2	RAD52	Yes	1	2.6		0
7733	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	III	0	6.1	Stable	No	No		ARID1A	Yes	0	11.96		0
7734	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	IV	46	0.9	Stable	No	No			Yes	1	9.3		0
7735	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	II	39	3.5	Stable	No	No			Yes	0	11.47		0
7736	Non-ICI treated	Never received ICI	31 - 35	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	13.9		0
7737	Non-ICI treated	Never received ICI	81 - 85	Male	Colorectal	2018	IV	8	2.6	Stable	No	No			No	0	12.88		0
7738	Non-ICI treated	Never received ICI	51 - 55	Female	Ovarian	2018	III	16	6.1	Stable	No	No			Yes	0	12.98		0
7739	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	21	1.8	Indeterminate	No	Yes or Unknown			No	0	13.77		0
7740	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	0	10.5	Stable	No	No	Signature.1	MSH2 | MUTYH	No	1	11.1		0
7741	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	74	2.6	Stable	No	No			No	0	11.53		0
7742	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	0	2.6	Stable	No	No			No	0	13.44		0
7743	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	267	0.9	Stable	No	Yes or Unknown			No	0	13.77		0
7744	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	43	2.6	Stable	No	No			Yes	0	11.33		0
7745	Non-ICI treated	Never received ICI	71 - 75	Male	Head & Neck	2018	I	38	20.2	Stable	No	No	Signature.2	ATM | ATR | BRCA1	No	0	9		0
7746	Non-ICI treated	Never received ICI	51 - 55	Male	Hepatobiliary	2018	IV	140	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	12.55		0
7747	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	0	6.1	Stable	No	No		CHEK2	No	0	13.5		0
7748	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	I	90	0	Stable	No	Yes or Unknown			Yes	0	9.92		0
7749	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	27	0	Stable	No	Yes or Unknown			No	0	12.81		0
7750	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	IV	0	9.7	Stable	No	No	Signature.1		No	0	13.01		0
7751	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	3	14	Stable	No	No	Signature.13	MLH1 | RAD50	No	1	2.89		0
7752	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	179	1.8	Stable	No	Yes or Unknown		ARID1A	No	0	11.86		0
7753	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	0	2.6	Stable	No	No		ARID1A | ATM	No	0	10.97		0
7754	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	27	1.8	Stable	No	No			No	0	12.45		0
7755	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		45	0		No	No			No	0	12.39		0
7756	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	28	2.6	Stable	No	No			Yes	0	12.78		0
7757	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	I	29	1.8	Stable	No	No			No	0	11.5		0
7758	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	12.45		0
7759	Non-ICI treated	Never received ICI	46 - 50	Female	Gastric	2018	III	0	4.4	Stable	No	No		ARID1A	Yes	0	13.37		0
7760	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2017	III	244	4.4	Stable	No	Yes or Unknown			No	0	21.36		0
7761	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		25	4.4		No	No	Signature.1		No	0	9.76		0
7762	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	I	0	25.5	Stable	No	No	Signature.4	BRIP1	No	0	11.99		0
7763	Non-ICI treated	Never received ICI	0 - 5	Male	Renal	2018		5	0.9	Stable	No	No			No	0	12.39		0
7764	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	IV	0	3.5	Stable	No	No			Yes	0	10.84		0
7765	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	161	4.4	Stable	No	Yes or Unknown			No	0	14.23		0
7766	Non-ICI treated	Never received ICI	61 - 65	Female	SCLC	2018	I	0	15.8	Stable	No	No	Signature.4	ARID1A | ATR | PALB2	Yes	0	13.63		0
7767	Non-ICI treated	Never received ICI	61 - 65	Male	CNS	2018		3	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	11.63		0
7768	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	287	0.9	Stable	No	Yes or Unknown			No	0	12.68		0
7769	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	IV	29	1.8	Stable	No	No			No	0	13.04		0
7770	Non-ICI treated	Never received ICI	81 - 85	Female	Pancreatic	2018	I	0	3.5	Stable	No	No			No	1	7.03		0
7771	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	260	4.4	Stable	No	Yes or Unknown			No	0	13.9		0
7772	Non-ICI treated	Never received ICI	46 - 50	Female	Pancreatic	2018	IV	17	5.3	Stable	No	No			Yes	1	2.99		0
7773	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	13	1.8	Stable	No	No		ATM	No	0	11.96		0
7774	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	103	4.4	Stable	No	Yes or Unknown			Yes	0	12.65		0
7775	Non-ICI treated	Never received ICI	66 - 70	Male	Bladder	2018	III	187	3.5	Stable	No	No			No	0	10.78		0
7776	Non-ICI treated	Never received ICI	71 - 75	Male	Cutaneous Melanoma 	2018	III	19	5.3	Stable	No	No	Signature.7		No	0	10.97		0
7777	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	I	42	1.8	Stable	No	No			No	0	13.21		0
7778	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	33	7	Stable	No	Yes or Unknown	Signature.1		No	0	13.21		0
7779	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	IV	0	11.4	Stable	No	No	Signature.1	ERCC2	Yes	0	12.42		0
7780	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	2.6	Stable	No	No			Yes	0	11.3		0
7781	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	0	3.5	Stable	No	No			No	0	12.42		0
7782	Non-ICI treated	Never received ICI	51 - 55	Female	Endometrial	2018	I	13	66.7	Stable	No	No	Signature.10	ATM | ATR | BRCA2 | ERCC5 | MSH2 | NBN | RAD54L	No	0	2.53		0
7783	Non-ICI treated	Never received ICI	66 - 70	Male	Esophageal	2018	III	177	14.9		No	Yes or Unknown	Signature.3	BRIP1	Yes	1	7.29		0
7784	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown			No	0	13.17		0
7785	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	9	5.3	Stable	No	No			No	0	9.95		0
7786	Non-ICI treated	Never received ICI	61 - 65	Female	Pancreatic	2018	I	141	0	Stable	No	Yes or Unknown			No	0	10.68		0
7787	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	50	2.6	Stable	No	No		CHEK1	No	0	8.84		0
7788	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	14	2.6	Stable	No	Yes or Unknown			No	0	9.59		0
7789	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	51	2.6	Stable	No	No			No	0	8.15		0
7790	Non-ICI treated	Never received ICI	46 - 50	Male	NSCLC	2018	II	26	1.8	Stable	No	No			No	0	5.88		0
7791	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		0	0	Stable	No	No			No	0	7.49		0
7792	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	I	31	8.8	Stable	No	No	Signature.1		No	0	11.07		0
7793	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	0	4.4	Stable	No	No			No	0	11.14		0
7794	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	II	0	10.5	Stable	No	No	Signature.2		No	0	12.32		0
7795	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	13	35.1	Unstable	No	No	Signature.6	ARID1A	Yes	0	9.89		0
7796	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	120	4.4	Stable	No	No			No	0	13.31		0
7797	Non-ICI treated	Never received ICI	56 - 60	Male	Sarcoma	2018		2	2.6	Stable	No	No			No	0	12.29		0
7798	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	141	16.7	Stable	No	Yes or Unknown	Signature.29	MSH3	No	1	10.09		0
7799	Non-ICI treated	Never received ICI	31 - 35	Male	Sarcoma	2018	III	24	2.6	Stable	No	No			No	0	12.42		0
7800	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	59	2.6	Stable	No	No			No	0	12.81		0
7801	Non-ICI treated	Never received ICI	46 - 50	Female	Sarcoma	2018	II	35	1.8	Stable	No	No			Yes	0	10.68		0
7802	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	313	4.4	Stable	No	Yes or Unknown			No	0	12.42		0
7803	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	I	57	1.8	Stable	No	No			No	0	5.85		0
7804	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	III	6	9.7	Stable	No	No	Signature.1		No	0	12.42		0
7805	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	2.6	Stable	No	No			No	0	12.75		0
7806	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	33	7.9	Stable	No	No	Signature.1		No	1	12.12		0
7807	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			Yes	0	2.86		0
7808	Non-ICI treated	Never received ICI	76 - 80	Male	NSCLC	2018	III	161	0		No	Yes or Unknown			Yes	0	9.99		0
7809	Non-ICI treated	Never received ICI	61 - 65	Male	Gastric	2018	II	36	6.1	Stable	No	No	Signature.1	ARID1A | ATM | MLH1	Yes	0	11.47		0
7810	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	IV	7	5.3	Stable	No	No	Signature.13	MSH3 | MUTYH	No	1	8.74		0
7811	Non-ICI treated	Never received ICI	66 - 70	Female	Ovarian	2018	IV	133	3.5	Stable	No	Yes or Unknown	Signature.3		Yes	0	12.35		0
7812	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	83	6.1	Stable	No	No			No	0	14.29		0
7813	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	5	0.9	Stable	No	No			No	0	6.18		0
7814	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018		2	0	Stable	No	Yes or Unknown			No	0	12.58		0
7815	Non-ICI treated	Never received ICI	46 - 50	Male	Sarcoma	2018	III	0	0		No	No			Yes	0	10.78		0
7816	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	65	1.8	Stable	No	No			No	0	12.35		0
7817	Non-ICI treated	Never received ICI	86 - 90	Female	Colorectal	2018	I	29	58.8	Unstable	No	No	Signature.6	ARID1A | ATR | MRE11A | MSH3 | RAD50 | SLX4	No	0	6.67		0
7818	Non-ICI treated	Never received ICI	76 - 80	Female	NSCLC	2018	IV	0	28.1	Stable	No	No	Signature.4	MSH6	No	1	10.09		0
7819	Non-ICI treated	Never received ICI	36 - 40	Female	Pancreatic	2018	IV	9	2.6	Stable	No	No			No	0	11.6		0
7820	Non-ICI treated	Never received ICI	61 - 65	Female	Ovarian	2018	I	0	0.9	Stable	No	No			Yes	0	14.72		0
7821	Non-ICI treated	Never received ICI	56 - 60	Male	Pancreatic	2018	IV	59	2.6	Stable	No	No			No	1	8.87		0
7822	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	0	2.6	Stable	No	No			No	1	9.56		0
7823	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	15	4.4	Stable	No	No	Signature.14		Yes	0	9.56		0
7824	Non-ICI treated	Never received ICI	51 - 55	Female	NSCLC	2018	III	0	11.4	Stable	No	No	Signature.24		Yes	1	4.37		0
7825	Non-ICI treated	Never received ICI	21 - 25	Female	Breast	2018	III	0	5.3	Stable	No	Yes or Unknown	Signature.3	PARP1	No	1	9.43		0
7826	Non-ICI treated	Never received ICI	31 - 35	Female	Renal	2018		0	0.9	Stable	No	No			Yes	0	16.33		0
7827	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	5.3	Stable	No	Yes or Unknown			Yes	1	13.4		0
7828	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	IV	49	0	Stable	No	No			No	0	10.81		0
7829	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	0	0.9	Stable	No	Yes or Unknown			No	0	9.53		0
7830	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	10.64		0
7831	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2018	IV	0	3.5	Stable	No	No		ERCC3	Yes	0	12.45		0
7832	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	42	3.5	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	5.49		0
7833	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	II	65	1.8	Stable	No	No			No	0	10.12		0
7834	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	IV	6	2.6	Stable	No	No			No	0	12.91		0
7835	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	249	0.9	Stable	No	Yes or Unknown			No	0	12.02		0
7836	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	0	2.6	Stable	No	Yes or Unknown			Yes	0	18.83		0
7837	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	53	0.9	Stable	No	Yes or Unknown		MUTYH	No	0	12.32		0
7838	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	30	3.5	Stable	No	No			No	0	12.48		0
7839	Non-ICI treated	Never received ICI	66 - 70	Male	Pancreatic	2018	IV	14	3.5	Stable	No	No			Yes	1	1.45		0
7840	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	III	43	5.3	Stable	No	Yes or Unknown		PARP1	Yes	0	3.58		0
7841	Non-ICI treated	Never received ICI	66 - 70	Male	Hepatobiliary	2018	I	27	4.4	Stable	No	Yes or Unknown			No	0	11.07		0
7842	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	25	256.3	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC3 | ERCC4 | ERCC5 | MSH2 | MSH6 | MUTYH | RAD50 | RAD54L | TP53BP1 | XRCC2	No	0	10.45		0
7843	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2018	I	38	7	Stable	No	No	Signature.1	MLH1	No	0	10.25		0
7844	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	27	1.8	Stable	No	No			No	0	12.52		0
7845	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	24	7.9	Stable	No	No	Signature.1	BRCA2	Yes	1	5.98		0
7846	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	IV	0	6.1	Stable	No	No			No	0	12.19		0
7847	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	0	1.8	Stable	No	No	Signature.20		Yes	0	11.53		0
7848	Non-ICI treated	Never received ICI	86 - 90	Female	Cutaneous Melanoma 	2018	IV	65	12.3	Stable	No	No	Signature.7	MSH3	Yes	0	12.42		0
7849	Non-ICI treated	Never received ICI	56 - 60	Female	Ovarian	2018	IV	93	2.6	Stable	No	Yes or Unknown		FANCC	Yes	0	11.4		0
7850	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	223	0		No	Yes or Unknown			No	0	13.11		0
7851	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	III	49	7.9	Stable	No	No		ARID1A	No	0	10.05		0
7852	Non-ICI treated	Never received ICI	51 - 55	Female	Esophageal	2018	III	0	8.8	Stable	No	No	Signature.17		No	1	8.08		0
7853	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	1	1.8	Stable	No	No			No	0	12.29		0
7854	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	0	1.8	Stable	No	No			No	0	14.72		0
7855	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	0	4.4	Stable	No	No			No	0	10.05		0
7856	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	0.9	Stable	No	No			No	0	11.63		0
7857	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	49	0	Stable	No	No			No	0	9.33		0
7858	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	0	3.5	Stable	No	No			No	0	12.19		0
7859	Non-ICI treated	Never received ICI	41 - 45	Male	NSCLC	2018	IV	11	7	Stable	No	No			No	0	12.29		0
7860	Non-ICI treated	Never received ICI	71 - 75	Female	Cutaneous Melanoma 	2018	III	20	21.1	Stable	No	No	Signature.7	BLM	No	0	10.28		0
7861	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	74	0.9	Stable	No	No			No	0	11.93		0
7862	Non-ICI treated	Never received ICI	66 - 70	Female	Head & Neck	2018	IV	37	13.2	Stable	No	Yes or Unknown	Signature.4	MSH3	Yes	1	3.29		0
7863	Non-ICI treated	Never received ICI	71 - 75	Male	CNS	2018		0	4.4	Stable	No	No			Yes	0	11.04		0
7864	Non-ICI treated	Never received ICI	61 - 65	Female	Endometrial	2018	I	30	0.9	Stable	No	No			Yes	0	12.32		0
7865	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	0.9	Stable	No	No			No	0	13.44		0
7866	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	18	6.1	Stable	No	No			No	0	12.09		0
7867	Non-ICI treated	Never received ICI	71 - 75	Female	Pancreatic	2018	IV	7	5.3	Stable	No	No			Yes	1	9.43		0
7868	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	28	7	Stable	No	No			No	0	10.12		0
7869	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	III	97	0	Stable	No	No			No	0	11.89		0
7870	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	1.8	Stable	No	No			No	0	12.88		0
7871	Non-ICI treated	Never received ICI	56 - 60	Male	CNS	2018		0	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.3		Yes	0	12.35		0
7872	Non-ICI treated	Never received ICI	46 - 50	Male	Esophageal	2018	IV	51	4.4	Stable	No	No	Signature.13	BRCA1 | MSH6 | MUTYH	No	0	13.14		0
7873	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	IV	89	60.6	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | MLH1 | MRE11A | MSH2 | MSH3 | MSH6 | SLX4	Yes	1	3.94		0
7874	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	8	0.9	Stable	No	Yes or Unknown			No	0	11.99		0
7875	Non-ICI treated	Never received ICI	51 - 55	Male	CNS	2018		0	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	10.25		0
7876	Non-ICI treated	Never received ICI	81 - 85	Male	Sarcoma	2018		70	7	Stable	No	No	Signature.11		No	0	13.37		0
7877	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	5.3	Stable	No	Yes or Unknown		SLX4	No	1	5.49		0
7878	Non-ICI treated	Never received ICI	61 - 65	Male	NSCLC	2018	IV	57	14	Stable	No	No	Signature.13	PARP1	Yes	0	13.37		0
7879	Non-ICI treated	Never received ICI	76 - 80	Female	Ovarian	2018	IV	33	3.5	Stable	No	No			No	0	12.29		0
7880	Non-ICI treated	Never received ICI	51 - 55	Female	Cutaneous Melanoma 	2018	III	26	0.9	Stable	No	No			Yes	0	11.89		0
7881	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	217	6.1	Stable	No	Yes or Unknown	Signature.3		Yes	0	12.29		0
7882	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	17	12.3	Stable	No	No	Signature.3	ARID1A | BRCA2	No	0	2.3		0
7883	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	47	0	Stable	No	No			No	0	10.28		0
7884	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	57	10.5	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	0	11.76		0
7885	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	29	6.1	Stable	No	No			Yes	0	11.66		0
7886	Non-ICI treated	Never received ICI	81 - 85	Male	Gastric	2018	II	13	4.4	Stable	No	No	Signature.15		Yes	0	11.47		0
7887	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	I	13	14	Stable	No	No	Signature.4	ARID1A	No	0	9.56		0
7888	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	IV	0	4.4	Stable	No	Yes or Unknown			No	0	8.77		0
7889	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	8	3.5	Stable	No	No			No	0	2.53		0
7890	Non-ICI treated	Never received ICI	0 - 5	Female	Sarcoma	2018		83	0.9	Stable	No	No			Yes	0	5.98		0
7891	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	1.8	Stable	No	No			Yes	0	13.21		0
7892	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	18	10.5	Stable	No	No	Signature.1	CHEK2	No	0	11.93		0
7893	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	0	3.5	Stable	No	No		SLX4	No	0	11.96		0
7894	Non-ICI treated	Never received ICI	71 - 75	Male	Pancreatic	2018	III	269	1.8	Stable	No	Yes or Unknown			No	0	9.2		0
7895	Non-ICI treated	Never received ICI	76 - 80	Male	Cutaneous Melanoma 	2018	III	35	11.4	Stable	No	No	Signature.7		Yes	0	11.76		0
7896	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	0	8.8	Stable	No	No	Signature.1	BRIP1 | RAD51C	Yes	0	11.96		0
7897	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	III	0	4.4	Stable	No	Yes or Unknown			No	0	18.23		0
7898	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	I	18	7	Stable	No	Yes or Unknown			Yes	0	11.14		0
7899	Non-ICI treated	Never received ICI	51 - 55	Male	Sarcoma	2018	II	24	5.3	Stable	No	No			Yes	0	11.53		0
7900	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	25	2.6	Stable	No	No			No	0	11.86		0
7901	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	I	44	7	Stable	No	No		ARID1A	No	0	7.82		0
7902	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	III	12	3.5	Stable	No	Yes or Unknown			No	1	10.74		0
7903	Non-ICI treated	Never received ICI	56 - 60	Female	Gastric	2018	II	33	47.4	Unstable	No	No	Signature.6	ARID1A | ERCC2 | MLH1 | MSH2	No	0	9.23		0
7904	Non-ICI treated	Never received ICI	61 - 65	Female	Gastric	2018	IV	0	2.6	Stable	No	No			No	0	10.58		0
7905	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	I	53	1.8	Stable	No	No			No	0	14.95		0
7906	Non-ICI treated	Never received ICI	56 - 60	Female	NSCLC	2018	III	0	13.2		No	No	Signature.5	BRCA1	Yes	0	7.33		0
7907	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	II	0	4.4	Stable	No	No			Yes	1	5.42		0
7908	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	19	3.5	Stable	No	No	Signature.1		No	0	12.85		0
7909	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	IV	0	1.8	Stable	No	No			No	0	12.09		0
7910	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	13	3.5	Stable	No	No			No	0	11.27		0
7911	Non-ICI treated	Never received ICI	61 - 65	Female	CNS	2018		2	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	11.79		0
7912	Non-ICI treated	Never received ICI	56 - 60	Female	Sarcoma	2018	I	0	0.9	Stable	No	No			Yes	0	8.15		0
7913	Non-ICI treated	Never received ICI	41 - 45	Female	NSCLC	2018	IV	20	4.4	Stable	No	No		ERCC4	Yes	0	10.25		0
7914	Non-ICI treated	Never received ICI	0 - 5	Female	CNS	2018		1	3.5	Indeterminate	No	No			Yes	1	6.05		0
7915	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	II	7	5.3	Stable	No	No	Signature.15		No	0	11.73		0
7916	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	II	7	9.7	Stable	No	No			No	0	5.91		0
7917	Non-ICI treated	Never received ICI	61 - 65	Male	Pancreatic	2018	IV	19	5.3	Stable	No	No			No	1	9.86		0
7918	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	36	0.9	Stable	No	No			No	0	11.96		0
7919	Non-ICI treated	Never received ICI	71 - 75	Male	NSCLC	2018	IV	1	2.6	Stable	No	No			No	1	11.43		0
7920	Non-ICI treated	Never received ICI	61 - 65	Male	Head & Neck	2018	IV	120	20.2	Stable	No	No	Signature.4		Yes	0	9.46		0
7921	Non-ICI treated	Never received ICI	46 - 50	Female	NSCLC	2018	I	115	0.9	Stable	No	Yes or Unknown			Yes	0	10.87		0
7922	Non-ICI treated	Never received ICI	51 - 55	Female	Sarcoma	2018	IV	153	0.9	Stable	No	No			Yes	0	15.34		0
7923	Non-ICI treated	Never received ICI	76 - 80	Male	Esophageal	2018	IV	0	5.3	Stable	No	No	Signature.6		Yes	0	0.99		0
7924	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	18	1.8	Stable	No	No			Yes	0	5.19		0
7925	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	IV	0	0.9	Stable	No	No			No	0	10.22		0
7926	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	0.9	Stable	No	Yes or Unknown			No	0	6.37		0
7927	Non-ICI treated	Never received ICI	66 - 70	Female	Sarcoma	2018	III	79	6.1	Stable	No	No		ATR	No	0	3.48		0
7928	Non-ICI treated	Never received ICI	61 - 65	Female	NSCLC	2018	IV	28	6.1	Stable	No	No			No	1	2.2		0
7929	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	34	1.8	Stable	No	No		BRCA2	No	0	12.22		0
7930	Non-ICI treated	Never received ICI	56 - 60	Male	NSCLC	2018	IV	16	68.5		No	No	Signature.15	ARID1A | BRCA2 | ERCC5 | MLH1 | MSH3	Yes	0	11.5		0
7931	Non-ICI treated	Never received ICI	46 - 50	Male	Pancreatic	2018	III	0	3.5	Stable	No	No			No	0	11.73		0
7932	Non-ICI treated	Never received ICI	61 - 65	Male	Hepatobiliary	2018	II	0	15.8	Stable	No	No	Signature.2		Yes	0	8.51		0
7933	Non-ICI treated	Never received ICI	21 - 25	Female	Pancreatic	2018	IV	17	7.9	Stable	No	No	Signature.3	ARID1A	No	1	3.45		0
7934	Non-ICI treated	Never received ICI	66 - 70	Male	Sarcoma	2018	III	22	0	Stable	No	No			No	0	11.93		0
7935	Non-ICI treated	Never received ICI	81 - 85	Male	NSCLC	2018	I	0	10.5		No	No	Signature.1	PALB2 | RAD54L	No	0	9.53		0
7936	Non-ICI treated	Never received ICI	86 - 90	Male	Prostatic	2018	IV	23	0.9	Stable	No	Yes or Unknown			No	0	10.58		0
7937	Non-ICI treated	Never received ICI	66 - 70	Female	Endometrial	2018	IV	0	5.3	Stable	No	No		BLM	Yes	0	9.69		0
7938	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	0	1.8	Stable	No	No			No	0	10.55		0
7939	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	0.9	Stable	No	Yes or Unknown	Signature.5		No	0	11.1		0
7940	Non-ICI treated	Never received ICI	56 - 60	Male	Hepatobiliary	2018	III	25	1.8	Stable	No	No			Yes	0	11.63		0
7941	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	62	56.2	Unstable	No	Yes or Unknown	Signature.1	ARID1A | MSH2 | MSH6 | PARP1 | PMS1	Yes	0	3.68		0
7942	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	0	7	Stable	No	No	Signature.4	PARP1	Yes	0	9.2		0
7943	Non-ICI treated	Never received ICI	41 - 45	Female	Sarcoma	2018	IV	21	2.6	Stable	No	No			No	0	10.74		0
7944	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	158	4.4	Stable	No	No		ARID1A	Yes	0	13.57		0
7945	Non-ICI treated	Never received ICI	66 - 70	Female	CNS	2018		47	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	14.13		0
7946	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	3.5	Stable	No	No	Signature.8		No	0	12.19		0
7947	Non-ICI treated	Never received ICI	76 - 80	Male	Pancreatic	2018	III	0	6.1	Stable	No	Yes or Unknown			No	0	8.25		0
7948	Non-ICI treated	Never received ICI	66 - 70	Female	Hepatobiliary	2018	IV	0	2.6	Stable	No	No		ATM	No	0	10.84		0
7949	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	III	180	3.5	Stable	No	Yes or Unknown			Yes	0	11.86		0
7950	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	39	1.8	Stable	No	No			No	0	7.43		0
7951	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	24	0.9	Stable	No	No			Yes	0	8.97		0
7952	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	95	4.4	Stable	No	No		ATM	No	0	12.16		0
7953	Non-ICI treated	Never received ICI	61 - 65	Female	Hepatobiliary	2018	III	134	3.5	Stable	No	No		ARID1A	No	0	11.53		0
7954	Non-ICI treated	Never received ICI	51 - 55	Male	NSCLC	2018	IV	233	14	Stable	No	Yes or Unknown	Signature.2	ERCC3 | FANCC | TP53BP1	No	0	12.02		0
7955	Non-ICI treated	Never received ICI	51 - 55	Female	Pancreatic	2018	II	159	4.4	Stable	No	Yes or Unknown		BRCA2	No	0	11.37		0
7956	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	55	7	Stable	No	No	Signature.9	ATM | BRCA2	Yes	0	9.66		0
7957	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	11	2.6	Stable	No	No			No	0	11.17		0
7958	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	III	181	0		No	Yes or Unknown			No	0	11.86		0
7959	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	29	4.4	Stable	No	No			Yes	0	11.37		0
7960	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	29	20.2	Unstable	No	No	Signature.6	BRCA2 | MLH1	No	0	11.04		0
7961	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	46	0.9	Stable	No	Yes or Unknown		ATM	Yes	0	10.55		0
7962	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	III	0	3.5	Stable	No	No			No	0	11.47		0
7963	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	0	5.3	Stable	No	No	Signature.1		Yes	0	11.47		0
7964	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	7	Stable	No	No		ATM	No	0	11.4		0
7965	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	119	0.9	Stable	No	Yes or Unknown			No	0	11.4		0
7966	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	5.3	Stable	No	No		BRCA2	No	0	11.7		0
7967	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	128	4.4	Stable	No	No	Signature.3		No	0	14.82		0
7968	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	9	6.1	Stable	No	No		MDC1	No	0	11.3		0
7969	Non-ICI treated	Never received ICI	66 - 70	Female	Breast	2018	IV	44	1.8	Stable	No	Yes or Unknown			Yes	0	11.5		0
7970	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	4	3.5	Stable	No	No			No	0	10.51		0
7971	Non-ICI treated	Never received ICI	46 - 50	Male	Head & Neck	2018	II	35	0.9	Stable	No	No			Yes	0	9.46		0
7972	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	I	24	6.1	Stable	No	No			No	0	6.64		0
7973	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	5.3	Stable	No	No			Yes	0	11.07		0
7974	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	31	0	Stable	No	No			Yes	0	8.74		0
7975	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	0	2.6	Stable	No	No			Yes	0	10.78		0
7976	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	2.6	Stable	No	No			No	0	11.4		0
7977	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	4.4	Stable	No	No		SLX4	No	0	11.5		0
7978	Non-ICI treated	Never received ICI	66 - 70	Male	NSCLC	2018	IV	34	4.4	Stable	No	No			Yes	0	12.58		0
7979	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	41	41.3	Unstable	No	No	Signature.1	ATM | ERCC5 | MDC1 | MRE11A | MSH2 | MUTYH	No	0	8.97		0
7980	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		0	4.4	Stable	No	No			Yes	0	11.27		0
7981	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	0	Stable	No	No			No	0	11.3		0
7982	Non-ICI treated	Never received ICI	71 - 75	Female	Endometrial	2018	IV	231	3.5	Stable	No	Yes or Unknown			Yes	0	11.6		0
7983	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	2	5.3	Stable	No	No		MDC1	No	0	11.33		0
7984	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	54	5.3	Stable	No	No			Yes	0	10.61		0
7985	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	IV	43	2.6	Stable	No	No			No	1	7.43		0
7986	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	0	2.6	Stable	No	No			Yes	0	12.48		0
7987	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	1	8.8	Stable	No	No	Signature.24	BRCA1 | MSH2	No	0	11.6		0
7988	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	19	6.1	Stable	No	No			No	0	10.74		0
7989	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	25	0.9	Stable	No	No			No	0	11.14		0
7990	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	2.6	Stable	No	No		SLX4	No	0	10.15		0
7991	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	27	4.4	Stable	No	No			No	0	2.53		0
7992	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	28	0.9	Stable	No	Yes or Unknown			No	0	13.21		0
7993	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	32	0.9	Stable	No	No			No	0	11.27		0
7994	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2018	III	56	1.8	Stable	No	No		ATM	Yes	0	11.76		0
7995	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	29	4.4	Stable	No	No			No	0	6.24		0
7996	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	7.9	Stable	No	No	Signature.1		Yes	0	11.27		0
7997	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	0	4.4	Stable	No	No	Signature.3		No	0	6.21		0
7998	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	IV	7	4.4	Stable	No	No	Signature.3	BRCA1	No	0	11.47		0
7999	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	2.6	Stable	No	No		ARID1A	No	0	8.41		0
8000	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	III	0	3.5	Stable	No	No			No	0	8.28		0
8001	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	II	1	7.9	Stable	No	No			No	0	9.46		0
8002	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	II	2	65	Unstable	No	No	Signature.6	ARID1A | ATR | BRCA1 | BRCA2 | MDC1 | MSH3 | MSH6 | NBN | SLX4 | TP53BP1	Yes	0	10.81		0
8003	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	0	0.9	Stable	No	Yes or Unknown			Yes	0	10.97		0
8004	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	11.01		0
8005	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	3.5	Stable	No	No	Signature.3		No	0	11.14		0
8006	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	II	0	11.4	Stable	No	No	Signature.1	ATM | PMS2	Yes	0	10.15		0
8007	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		ERCC2 | ERCC5	Yes	0	11.86		0
8008	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	II	31	7.9	Stable	No	No	Signature.1	MSH2	No	0	10.64		0
8009	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	43	0.9	Stable	No	No			No	0	5.65		0
8010	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	3.5	Stable	No	No			No	0	10.55		0
8011	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	80	3.5	Stable	No	No	Signature.8		Yes	0	13.21		0
8012	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	11	6.1	Stable	No	Yes or Unknown			No	0	10.78		0
8013	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018	III	0	0	Stable	No	No			No	0	10.58		0
8014	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	232	7.9	Stable	No	Yes or Unknown			No	0	9.72		0
8015	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	16	5.3	Stable	No	No	Signature.1		Yes	0	9.86		0
8016	Non-ICI treated	Never received ICI	21 - 25	Female	Colorectal	2018	I	0	2.6	Stable	No	No			No	0	8.51		0
8017	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	IV	0	0	Stable	No	No			No	1	8.97		0
8018	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	37	5.3	Stable	No	Yes or Unknown	Signature.20		No	0	9.69		0
8019	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	I	38	2.6	Stable	No	No			Yes	0	10.22		0
8020	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	23	5.3	Stable	No	Yes or Unknown	Signature.1		No	0	10.58		0
8021	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	7.9	Stable	No	No		MSH3	No	0	13.9		0
8022	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	22	3.5	Stable	No	No			Yes	0	10.84		0
8023	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	26	0	Stable	No	No			No	0	9.23		0
8024	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	III	61	0.9	Stable	No	No			No	0	11.89		0
8025	Non-ICI treated	Never received ICI	26 - 30	Male	Colorectal	2018	III	9	123.8	Stable	No	No	Signature.10	ATM | ATR | BRCA1 | BRCA2 | MRE11A | MSH6 | RAD50 | SLX4	Yes	0	10.12		0
8026	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	IV	33	2.6	Stable	No	No		MRE11A	No	0	10.78		0
8027	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	2	6.1	Stable	No	No			No	0	11.07		0
8028	Non-ICI treated	Never received ICI	86 - 90	Female	Hepatobiliary	2018	IV	36	1.8	Stable	No	No			No	0	1.51		0
8029	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	175	1.8	Stable	No	Yes or Unknown			No	0	9.72		0
8030	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	0	1.8	Stable	No	Yes or Unknown		RAD51	No	0	10.71		0
8031	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	14	3.5	Stable	No	No			No	0	9.72		0
8032	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	35	5.3	Stable	No	No			No	0	10.68		0
8033	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	II	22	2.6	Stable	No	No			Yes	0	7.85		0
8034	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	25	9.7	Stable	No	No	Signature.6		Yes	0	10.45		0
8035	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		ATM	No	0	10.48		0
8036	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	10	70.2	Unstable	No	No	Signature.6	ATM | BLM | BRCA1 | FANCA | MSH6 | SLX4	No	0	5.16		0
8037	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	43	1.8	Stable	No	Yes or Unknown			No	0	11.53		0
8038	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	I	32	2.6	Stable	No	No			No	0	7.59		0
8039	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	170	7.9	Stable	No	Yes or Unknown	Signature.1		No	0	9.72		0
8040	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	19	73.7	Unstable	No	No	Signature.6	ARID1A | CHEK1 | ERCC5 | MRE11A | MSH2 | MSH3 | MSH6 | RAD51C	No	0	10.41		0
8041	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	18	6.1	Stable	No	No	Signature.10		Yes	1	3.06		0
8042	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.17	ATM | PALB2	No	1	4.7		0
8043	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	1.8	Stable	No	No			No	0	10.48		0
8044	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	14	6.1	Stable	No	No			Yes	0	10.61		0
8045	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	2.6	Stable	No	No			No	0	9.89		0
8046	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	I	91	3.5	Stable	No	No			Yes	0	10.81		0
8047	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	I	27	28.1	Unstable	No	No	Signature.6	BLM | BRCA2 | MLH1	No	0	7.72		0
8048	Non-ICI treated	Never received ICI	46 - 50	Male	Prostatic	2018	IV	0	4.4	Stable	No	Yes or Unknown			No	0	10.45		0
8049	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	I	26	49.2	Unstable	No	No	Signature.6	ARID1A | ATM | CHEK2 | MSH3 | RAD50	No	0	6.37		0
8050	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	9.7	Stable	No	No			No	0	10.55		0
8051	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	10.41		0
8052	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	50	52.7	Unstable	No	No	Signature.6	ATM | BRCA2 | MRE11A | MSH3 | MSH6 | XRCC2	Yes	0	9.59		0
8053	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	III	18	4.4	Stable	No	No		ATM | CHEK2	Yes	0	7.16		0
8054	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	63	2.6	Stable	No	No			No	0	9.89		0
8055	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	28	10.5	Stable	No	No	Signature.1		Yes	0	9.17		0
8056	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	II	0	2.6	Stable	No	Yes or Unknown			No	0	9.76		0
8057	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	3.5	Stable	No	No		PALB2	No	0	9.66		0
8058	Non-ICI treated	Never received ICI	0 - 5	Male	Sarcoma	2018		11	0	Stable	No	No			No	0	10.35		0
8059	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	III	0	0.9	Stable	No	No			No	0	9.89		0
8060	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	II	0	2.6	Stable	No	No		FANCC	No	0	10.09		0
8061	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	0	5.3	Stable	No	No	Signature.1		No	0	10.61		0
8062	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	15	5.3	Stable	No	No			No	0	9.95		0
8063	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	37	2.6	Stable	No	No		MSH2	Yes	0	8.71		0
8064	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown		ATM | BRCA2	No	0	8.77		0
8065	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018		0	0.9	Stable	No	No			No	0	10.12		0
8066	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	13	7	Stable	No	No	Signature.13	ATM	No	0	9.4		0
8067	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	37	6.1	Stable	No	No			Yes	0	11.76		0
8068	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	6	2.6	Stable	No	Yes or Unknown			No	0	9.69		0
8069	Non-ICI treated	Never received ICI	71 - 75	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	1	10.18		0
8070	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	III	0	2.6	Stable	No	No			Yes	0	7		0
8071	Non-ICI treated	Never received ICI	56 - 60	Female	Endometrial	2018	I	51	8.8	Stable	No	No		ARID1A	No	0	5.98		0
8072	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	0.9	Stable	No	Yes or Unknown			Yes	0	16.56		0
8073	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	21	4.4	Stable	No	No		NTHL1	No	0	8.94		0
8074	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	0	4.4	Stable	No	No			Yes	0	8.41		0
8075	Non-ICI treated	Never received ICI	21 - 25	Male	Colorectal	2018	IV	174	5.3	Stable	No	No	Signature.1		No	0	6.14		0
8076	Non-ICI treated	Never received ICI	10-Jun	Male	Sarcoma	2018	II	0	0	Stable	No	No			No	0	9.53		0
8077	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	III	68	0.9	Stable	No	Yes or Unknown			Yes	0	9.3		0
8078	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	85	0	Stable	No	No			No	0	5.06		0
8079	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	IV	34	6.1	Stable	No	No			No	1	15.38		0
8080	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	3	6.1	Stable	No	No			No	0	10.68		0
8081	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018		44	1.8	Stable	No	Yes or Unknown			No	0	8.77		0
8082	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	IV	3	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	9.63		0
8083	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	IV	21	0.9	Stable	No	Yes or Unknown	Signature.5		No	0	12.42		0
8084	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	II	34	4.4	Stable	No	No	Signature.5		Yes	0	8.77		0
8085	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	49	3.5	Stable	No	No			Yes	0	11.27		0
8086	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	III	41	7	Stable	No	No	Signature.8	ARID1A	No	0	9.07		0
8087	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	9.23		0
8088	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	0	0.9	Stable	No	No			No	0	9.03		0
8089	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	20	7.9	Stable	No	No	Signature.29	ATM	No	0	7.36		0
8090	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	I	0	3.5	Stable	No	Yes or Unknown			No	0	10.41		0
8091	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	III	52	8.8	Stable	No	No	Signature.1	BRIP1	No	0	3.78		0
8092	Non-ICI treated	Never received ICI	76 - 80	Female	Pancreatic	2018	I	7	2.6	Stable	No	No			Yes	0	9.36		0
8093	Non-ICI treated	Never received ICI	16 - 20	Male	CNS	2018		36	6.1	Stable	No	Yes or Unknown			No	0	8.84		0
8094	Non-ICI treated	Never received ICI	86 - 90	Male	Colorectal	2018	IV	63	7	Stable	No	Yes or Unknown	Signature.1		No	1	6.44		0
8095	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	II	112	2.6	Stable	No	No			No	0	10.32		0
8096	Non-ICI treated	Never received ICI	51 - 55	Female	Breast	2018	IV	49	4.4	Stable	No	Yes or Unknown			No	0	9.82		0
8097	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	1.8	Stable	No	No			Yes	0	9.3		0
8098	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0		No	No			No	0	9.86		0
8099	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	3	2.6	Stable	No	Yes or Unknown			No	0	7.66		0
8100	Non-ICI treated	Never received ICI	66 - 70	Male	Prostatic	2018	I	0	3.5	Stable	No	No			No	0	10.38		0
8101	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	0	3.5	Stable	No	No			Yes	0	8.34		0
8102	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	I	49	0.9	Stable	No	No			Yes	0	8.34		0
8103	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	0	2.6	Stable	No	No			No	0	9.69		0
8104	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	I	0	1.8	Stable	No	No			No	0	8.97		0
8105	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	IV	0	0	Stable	No	No			No	0	9		0
8106	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	I	35	24.6	Stable	No	No	Signature.4		No	0	8.34		0
8107	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2016	II	930	0	Stable	No	No			Yes	1	36.07		0
8108	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	36	0.9	Stable	No	Yes or Unknown			No	0	8.87		0
8109	Non-ICI treated	Never received ICI	41 - 45	Male	Prostatic	2018	III	0	3.5	Stable	No	No		ARID1A	No	0	9.49		0
8110	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	10	14	Stable	No	No	Signature.10	MSH2	Yes	0	8.64		0
8111	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	22	7	Stable	No	No	Signature.13		Yes	0	8.8		0
8112	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	III	89	34.2	Unstable	No	Yes or Unknown	Signature.6	BRCA2 | ERCC3 | MSH2	Yes	0	8.9		0
8113	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	I	21	7.9	Stable	No	No	Signature.1	BRCA2	No	0	7.62		0
8114	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	III	40	7	Stable	No	No			Yes	0	9.17		0
8115	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			No	0	10.64		0
8116	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	II	10	3.5	Stable	No	No	Signature.1	ERCC3	Yes	0	8.11		0
8117	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	7	Stable	No	No			Yes	0	9.2		0
8118	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	IV	0	2.6	Stable	No	Yes or Unknown		BRCA2	No	0	8.67		0
8119	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	1	5.3	Stable	No	No			No	0	8.71		0
8120	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	4.4	Stable	No	No			No	0	7.75		0
8121	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	IV	4	9.7	Stable	No	No	Signature.1		Yes	0	8.71		0
8122	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	IV	17	0	Stable	No	No			No	0	8.74		0
8123	Non-ICI treated	Never received ICI	0 - 5	Female	Renal	2018		77	1.8	Stable	No	Yes or Unknown			No	0	8.8		0
8124	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	3.5	Stable	No	No			Yes	0	10.25		0
8125	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	IV	17	3.5	Stable	No	No	Signature.1		No	0	7.39		0
8126	Non-ICI treated	Never received ICI	16 - 20	Male	Sarcoma	2018		35	1.8	Stable	No	Yes or Unknown			Yes	0	8.97		0
8127	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	29	2.6	Stable	No	No		MRE11A	Yes	0	7.36		0
8128	Non-ICI treated	Never received ICI	66 - 70	Female	Pancreatic	2018	III	0	3.5	Stable	No	No		MUTYH	Yes	0	9.36		0
8129	Non-ICI treated	Never received ICI	76 - 80	Male	Prostatic	2018	IV	0	0	Stable	No	No			Yes	0	6.54		0
8130	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	100	0	Stable	No	No			No	0	9.13		0
8131	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	47	4.4	Stable	No	No			Yes	0	3.84		0
8132	Non-ICI treated	Never received ICI	71 - 75	Female	CNS	2018		0	2.6	Stable	No	No	Signature.19		No	0	8.31		0
8133	Non-ICI treated	Never received ICI	61 - 65	Male	Prostatic	2018	IV	219	3.5	Stable	No	Yes or Unknown		MSH3 | TP53BP1	No	0	9		0
8134	Non-ICI treated	Never received ICI	41 - 45	Female	Breast	2018	II	0	3.5	Stable	No	Yes or Unknown			No	0	8.28		0
8135	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	III	0	1.8	Stable	No	No			No	0	9.43		0
8136	Non-ICI treated	Never received ICI	36 - 40	Female	Colorectal	2018	IV	1	6.1	Stable	No	No			Yes	0	8.84		0
8137	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	II	95	2.6	Stable	No	No			No	0	8.71		0
8138	Non-ICI treated	Never received ICI	26 - 30	Female	Breast	2018	IV	40	4.4	Stable	No	No			No	0	9.2		0
8139	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	II	0	10.5	Stable	No	No	Signature.13	TP53BP1	No	0	8.64		0
8140	Non-ICI treated	Never received ICI	76 - 80	Female	Colorectal	2018	III	56	54.4	Unstable	No	No	Signature.6	ARID1A | ERCC5 | MRE11A | PARP1 | RAD50 | SLX4	No	0	8.11		0
8141	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	70	0		No	No			No	0	8.71		0
8142	Non-ICI treated	Never received ICI	51 - 55	Male	Prostatic	2018	I	191	0.9	Stable	No	No			No	0	10.28		0
8143	Non-ICI treated	Never received ICI	76 - 80	Female	Breast	2018	I	35	5.3	Stable	No	No		ATR	Yes	0	7.29		0
8144	Non-ICI treated	Never received ICI	56 - 60	Female	Colorectal	2018	IV	51	4.4	Stable	No	No	Signature.1		No	0	9.63		0
8145	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	6	10.5	Stable	No	No	Signature.29		No	0	8.54		0
8146	Non-ICI treated	Never received ICI	56 - 60	Male	Prostatic	2018	IV	0	3.5	Stable	No	Yes or Unknown			No	0	7.16		0
8147	Non-ICI treated	Never received ICI	61 - 65	Female	Colorectal	2018	IV	0	6.1	Stable	No	No	Signature.1	ARID1A | SLX4	Yes	1	2.43		0
8148	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.1	ATM | BRIP1	Yes	0	8.18		0
8149	Non-ICI treated	Never received ICI	15-Nov	Female	Renal	2018		36	1.8	Stable	No	Yes or Unknown			No	0	8.05		0
8150	Non-ICI treated	Never received ICI	31 - 35	Female	Breast	2018	IV	0	2.6	Stable	No	No			No	0	12.42		0
8151	Non-ICI treated	Never received ICI	76 - 80	Male	Colorectal	2018	IV	22	7	Stable	No	Yes or Unknown	Signature.8		No	0	8.54		0
8152	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	II	15	5.3	Stable	No	No	Signature.1		No	0	8.28		0
8153	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	IV	11	1.8	Stable	No	No	Signature.13		No	0	10.35		0
8154	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	0	8.8	Stable	No	No	Signature.5	BRCA1	Yes	0	8.34		0
8155	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	IV	4	4.4	Stable	No	No		ARID1A	No	0	8.25		0
8156	Non-ICI treated	Never received ICI	81 - 85	Female	Colorectal	2018	I	49	67.6	Unstable	No	No	Signature.6	ARID1A | BLM | MSH3 | MUTYH | NBN | NTHL1 | TP53BP1	No	0	5.42		0
8157	Non-ICI treated	Never received ICI	46 - 50	Female	Hepatobiliary	2018	IV	212	4.4	Stable	No	Yes or Unknown			Yes	0	8.9		0
8158	Non-ICI treated	Never received ICI	41 - 45	Female	Colorectal	2018	II	15	5.3	Stable	No	No	Signature.29		No	0	7.66		0
8159	Non-ICI treated	Never received ICI	66 - 70	Male	Colorectal	2018	I	45	53.5	Unstable	No	No	Signature.6	ATM | ATR | BRCA1 | BRCA2 | BRIP1 | PARP1 | TP53BP1	No	0	5.32		0
8160	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	III	19	102.7	Unstable	No	No	Signature.6	ARID1A | BLM | FANCA | MSH3 | MSH6 | SLX4 | TP53BP1	No	0	7.06		0
8161	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	2	5.3	Stable	No	No			No	0	7.89		0
8162	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	26	2.6	Stable	No	No	Signature.1		Yes	0	8.02		0
8163	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	II	0	0.9	Stable	No	No			No	0	7.85		0
8164	Non-ICI treated	Never received ICI	15-Nov	Male	Sarcoma	2018	IV	0	0.9	Stable	No	No			No	0	8.28		0
8165	Non-ICI treated	Never received ICI	31 - 35	Male	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1		Yes	0	5.09		0
8166	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	0	10.5	Stable	No	No	Signature.1		No	0	8.11		0
8167	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	II	10	97.4	Stable	No	No	Signature.10	BRCA1 | BRCA2 | BRIP1 | FANCA | MSH6 | PMS1 | TP53BP1	Yes	0	7.16		0
8168	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	21	3.5	Stable	No	No		ATM	No	0	9.1		0
8169	Non-ICI treated	Never received ICI	61 - 65	Female	Breast	2018	I	34	0	Stable	No	No			Yes	0	8.21		0
8170	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	II	5	5.3	Stable	No	No			Yes	0	6.21		0
8171	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	21	36	Unstable	No	No	Signature.6	ARID1A | BLM | ERCC2 | PALB2	No	0	7.85		0
8172	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	III	28	11.4	Stable	No	No	Signature.1		Yes	0	7.62		0
8173	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	I	23	86	Unstable	No	No	Signature.6	ARID1A | BRIP1 | CHEK2 | ERCC2 | ERCC4 | MLH1 | MSH6 | RAD50 | TP53BP1	No	0	4.57		0
8174	Non-ICI treated	Never received ICI	81 - 85	Female	Ovarian	2018	IV	6	1.8	Stable	No	No			No	0	7.79		0
8175	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	28	4.4	Stable	No	No		BRCA2	No	0	8.02		0
8176	Non-ICI treated	Never received ICI	56 - 60	Male	Colorectal	2018	IV	20	4.4	Stable	No	No			Yes	0	7.52		0
8177	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	IV	82	2.6	Stable	No	Yes or Unknown			No	0	9.23		0
8178	Non-ICI treated	Never received ICI	16 - 20	Female	Sarcoma	2018	IV	6	0	Stable	No	Yes or Unknown			No	0	7.85		0
8179	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	42	3.5	Stable	No	Yes or Unknown			No	0	7.79		0
8180	Non-ICI treated	Never received ICI	71 - 75	Female	NSCLC	2018	III	154	0.9	Stable	No	Yes or Unknown			Yes	0	7.89		0
8181	Non-ICI treated	Never received ICI	61 - 65	Male	Colorectal	2018	III	26	61.4	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA1 | BRCA2 | ERCC4 | MSH3 | MSH6 | PARP1 | RAD51C | RAD54L	Yes	0	8.21		0
8182	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		7	2.6	Stable	No	No			No	0	7.69		0
8183	Non-ICI treated	Never received ICI	71 - 75	Female	Colorectal	2018	II	70	49.2	Unstable	No	No	Signature.6	ARID1A | BLM | MDC1 | MRE11A | MSH3	No	0	7.92		0
8184	Non-ICI treated	Never received ICI	41 - 45	Male	Colorectal	2018	I	45	103.6	Unstable	No	No	Signature.1	ARID1A | ATM | ATR | ERCC3 | MDC1 | MLH1 | MRE11A | MSH3 | MSH6 | NBN | PALB2 | RAD50 | RAD54L	No	0	7		0
8185	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	III	23	7	Stable	No	No			Yes	0	5.26		0
8186	Non-ICI treated	Never received ICI	56 - 60	Female	Breast	2018	I	35	3.5	Stable	No	No			No	0	5.06		0
8187	Non-ICI treated	Never received ICI	81 - 85	Male	Bladder	2018	IV	0	13.2	Stable	No	No	Signature.2	ARID1A	No	0	8.97		0
8188	Non-ICI treated	Never received ICI	66 - 70	Female	NSCLC	2018	III	41	13.2	Stable	No	Yes or Unknown	Signature.4		No	0	7.98		0
8189	Non-ICI treated	Never received ICI	51 - 55	Male	Colorectal	2018	IV	0	6.1	Stable	No	No		RAD50	No	0	7.59		0
8190	Non-ICI treated	Never received ICI	16 - 20	Female	Cutaneous Melanoma 	2018	III	38	0.9	Stable	No	No			Yes	0	4.5		0
8191	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	IV	22	6.1	Stable	No	No			No	0	8.08		0
8192	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	I	54	69.3	Unstable	No	No	Signature.6	ARID1A | BRCA2 | BRIP1 | MLH1 | MSH3 | MSH6 | PMS1 | RAD51 | TP53BP1	No	0	3.38		0
8193	Non-ICI treated	Never received ICI	36 - 40	Female	Breast	2018	IV	0	3.5	Stable	No	No			No	0	7.43		0
8194	Non-ICI treated	Never received ICI	15-Nov	Female	CNS	2018		3	4.4	Stable	No	No			No	0	5.22		0
8195	Non-ICI treated	Never received ICI	71 - 75	Female	Breast	2018	I	41	4.4	Stable	No	No			Yes	0	7.69		0
8196	Non-ICI treated	Never received ICI	71 - 75	Male	Colorectal	2018	III	59	8.8	Stable	No	No	Signature.1		Yes	0	7.89		0
8197	Non-ICI treated	Never received ICI	15-Nov	Female	Sarcoma	2018	II	0	0.9	Stable	No	No			No	0	8.31		0
8198	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	III	0	6.1	Stable	No	No			No	1	7.13		0
8199	Non-ICI treated	Never received ICI	66 - 70	Female	Colorectal	2018	IV	41	12.3	Stable	No	No	Signature.1		No	0	7.72		0
8200	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	IV	0	9.7	Stable	No	No	Signature.1	ERCC3 | RAD51C	No	0	7.82		0
8201	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	II	41	6.1	Stable	No	No	Signature.1		Yes	0	7.29		0
8202	Non-ICI treated	Never received ICI	46 - 50	Female	Breast	2018	IV	54	1.8	Stable	No	No			Yes	0	7.56		0
8203	Non-ICI treated	Never received ICI	36 - 40	Male	Colorectal	2018	II	1	6.1	Stable	No	No	Signature.13	PMS1	Yes	0	7.59		0
8204	Non-ICI treated	Never received ICI	51 - 55	Male	Pancreatic	2018	IV	182	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	7.36		0
8205	Non-ICI treated	Never received ICI	46 - 50	Female	Colorectal	2018	IV	11	0	Stable	No	No			No	1	9.36		0
8206	Non-ICI treated	Never received ICI	46 - 50	Male	Colorectal	2018	III	0	50.9	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA1 | ERCC4 | FANCA | MSH3 | RAD50	Yes	0	8.77		0
8207	Non-ICI treated	Never received ICI	31 - 35	Female	Colorectal	2018	III	78	4.4	Stable	No	No			Yes	0	7.89		0
8208	Non-ICI treated	Never received ICI	51 - 55	Female	Colorectal	2018	IV	203	6.1	Stable	No	No	Signature.1		No	0	8.71		0
8209	Non-ICI treated	Never received ICI	36 - 40	Female	Sarcoma	2017	III	34	3.5	Stable	No	No			No	0	26.87		0
8210	Non-ICI treated	Never received ICI	26 - 30	Female	Sarcoma	2015	I	366	2.6		No	No			No	1	32.16		0
8211	Non-ICI treated	Never received ICI	10-Jun	Female	Sarcoma	2018		0	0.9	Stable	No	No			No	0	15.41		0
8212	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2015		4	2	Stable	Yes or Unknown	Yes or Unknown			No	1	20.96	1.02	1
8213	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	0	4.9		No	No	Signature.1		No	1	20.9	15.28	1
8214	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	21	32.5	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH6 | PMS2	No	0	19.91	5.55	1
8215	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2018	IV	9	19.3	Stable	No	No	Signature.4	ATM | NBN	No	0	9.82	1.41	1
8216	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	85	1	Stable	No	No			No	0	52.11	3.48	1
8217	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4		No	0	10.55	2.66	1
8218	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	447	6.1		No	Yes or Unknown			No	1	21.39	15.34	1
8219	ICI-treated	ICI as first line	51 - 55	Male	Gastric	2017	IV	0	0	Stable	No	Yes or Unknown			No	1	19.61	0.79	1
8220	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	8.25	6.6	1
8221	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2015	IV	0	2	Indeterminate	No	Yes or Unknown			No	1	16.33	14	1
8222	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2016	IV	264	4.4	Stable	Yes or Unknown	Yes or Unknown		TP53BP1	No	1	11.99	8.87	1
8223	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	III	34	41.3	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.6	MSH6 | SLX4 | TP53BP1	No	1	24.61	17.48	1
8224	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2016	IV	30	6.1		No	No			No	1	10.32	6.51	1
8225	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016	IV	73	8.8		No	No	Signature.13		Yes	1	7.03	4.67	1
8226	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	0	3.5	Stable	No	No	Signature.4		No	0	11.63	9.63	1
8227	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016	IV	237	5.3	Stable	No	Yes or Unknown			No	1	26.38	8.15	1
8228	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	431	7		No	Yes or Unknown	Signature.24		No	1	30.03	20.7	1
8229	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	64	19.7	Stable	No	Yes or Unknown	Signature.29	ARID1A | BRCA2	No	0	51.78	5.82	1
8230	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	I	696	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BLM | BRIP1	No	1	35.52	28.75	1
8231	ICI-treated	ICI as first line	91 - 95	Female	Endometrial	2016	I	9	32.5	Unstable	No	No	Signature.1	ARID1A | ATM | NBN	No	0	30.69	17.25	1
8232	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	20	14	Stable	No	No	Signature.2	ATM | ERCC3 | ERCC4	No	1	6.77	1.25	1
8233	ICI-treated	ICI as subsequent line	76 - 80	Female	SCLC	2017	IV	11	15.8	Indeterminate	No	No	Signature.4	ATR | RAD52	No	0	21.06	5.88	1
8234	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2016		0	36.9	Unstable	No	No	Signature.1	ARID1A | ERCC2 | MSH3 | TP53BP1	No	0	31.01	21.78	1
8235	ICI-treated	ICI as subsequent line	46 - 50	Female	Bladder	2015	IV	0	1		No	No	Signature.30		No	1	12.35	9.43	1
8236	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	I	626	0.9	Stable	No	Yes or Unknown			No	0	40.71	21.62	1
8237	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	II	275	6.1		No	Yes or Unknown	Signature.24	XRCC2	No	1	16.69	14.75	1
8238	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	0	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.24	MRE11A	No	0	17.77	8.48	1
8239	ICI-treated	ICI as subsequent line	76 - 80	Female	Esophageal	2016	IV	62	24.6	Unstable	No	Yes or Unknown	Signature.1	ERCC2 | FANCA | PMS1	No	1	20.24	12.35	1
8240	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2017	I	6	43	Stable	No	No	Signature.7	MSH3 | XRCC2	No	0	23.72	1.22	1
8241	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.3		No	1	7.03	1.02	1
8242	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2018	IV	17	3.5	Stable	No	Yes or Unknown			No	0	17.41	8.71	1
8243	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	19	3.5	Stable	No	No			No	1	9.69	5.19	1
8244	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	14	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.19	BRCA2	No	0	32.46	20.17	1
8245	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2018	IV	0	3.5	Stable	No	No	Signature.2		No	0	12.81	1.51	1
8246	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	0	9.7	Stable	No	No	Signature.4	ATR	No	0	26.22	1.12	1
8247	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	24	7		No	No			No	1	14.88	0.99	1
8248	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2015	IV	250	12.8	Stable	No	No	Signature.30	ATM	No	0	49.02	8.28	1
8249	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2015		24	3.9	Stable	Yes or Unknown	Yes or Unknown		NBN | RAD50	No	1	31.01	27.24	1
8250	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	1	15.84	2	1
8251	ICI-treated	ICI as first line	86 - 90	Female	NSCLC	2016	III	39	3.5		No	No			No	1	29.27	3.78	1
8252	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	2	50.9	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MDC1 | MRE11A | MSH6	No	0	30.49	12.06	1
8253	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	32	0	Stable	No	No			No	1	26.45	12.62	1
8254	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	1	20.67	18.5	1
8255	ICI-treated	ICI as first line	81 - 85	Male	Sarcoma	2018	IV	45	8.8	Indeterminate	No	No	Signature.4	PARP1	Yes	1	2.6	2.27	1
8256	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	14	3.5	Stable	No	Yes or Unknown	Signature.19		No	1	20.34	1.74	1
8257	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016		34	7.9	Stable	No	No	Signature.7	ATM	No	0	35.68	2.04	1
8258	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	III	0	2	Stable	No	No	Signature.26		No	1	7.36	4.67	1
8259	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	III	16	3.9	Stable	No	Yes or Unknown			No	1	11.17	6.54	1
8260	ICI-treated	ICI as subsequent line	46 - 50	Male	Pancreatic	2017	II	515	3.5	Stable	No	Yes or Unknown			No	1	23.75	20.86	1
8261	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2015	IV	815	17.6	Stable	No	Yes or Unknown	Signature.1		No	0	39.36	28.81	1
8262	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	IV	0	5.3	Stable	No	No	Signature.6		No	1	5.72	5.59	1
8263	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	34	7.9	Stable	No	No	Signature.24		No	1	30.39	14.26	1
8264	ICI-treated	ICI as subsequent line	56 - 60	Female	Gastric	2017	II	242	5.3	Stable	Yes or Unknown	Yes or Unknown		BRCA2 | PALB2	No	1	11.3	10.35	1
8265	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	II	29	2	Stable	No	No			No	0	41.72	32.26	1
8266	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2016	IV	251	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	0	36.93	8.54	1
8267	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	0	12.8	Stable	No	No	Signature.24		Yes	1	2.23	1.38	1
8268	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2015	I	309	2		No	No		ATM	Yes	0	44.94	26.48	1
8269	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	36	2.6		No	No			No	0	29.17	8.25	1
8270	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2015	IV	4	1.8		No	No	Signature.24		No	1	31.57	24.51	1
8271	ICI-treated	ICI as subsequent line	71 - 75	Male	Cutaneous Melanoma 	2015	III	365	1.8		No	Yes or Unknown			No	0	46.78	14.59	1
8272	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	III	5	9.7	Stable	No	No	Signature.4	BRCA1 | PMS1	No	1	13.4	13.01	1
8273	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2017	I	30	29.8	Unstable	No	No	Signature.6	ARID1A | TP53BP1	No	1	25.1	13.83	1
8274	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2016	III	16	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ERCC2	Yes	0	34.5	8.11	1
8275	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	0	4.4	Stable	No	No			No	1	20.24	11.99	1
8276	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2015	III	0	0	Stable	No	No			No	0	50.14	27.37	1
8277	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2017	III	238	4.4	Stable	No	Yes or Unknown			No	1	21.13	16.92	1
8278	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	0	36		No	Yes or Unknown	Signature.7	BRCA2 | FANCA | NBN	No	0	38.11	1.05	1
8279	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	II	56	6.1	Stable	No	No	Signature.25	ARID1A	No	0	20.37	16.03	1
8280	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	8.9		No	No	Signature.4		No	0	14.65	5.55	1
8281	ICI-treated	ICI as first line	86 - 90	Male	Bladder	2017	IV	46	4.4	Indeterminate	No	No	Signature.25		No	1	13.96	1.84	1
8282	ICI-treated	ICI as first line	61 - 65	Female	CNS	2015		2	3	Stable	No	No			Yes	1	21.16	0.95	1
8283	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	IV	0	36		No	No	Signature.7	BRIP1 | ERCC2 | ERCC5 | FANCA | PARP1	No	0	5.22	1.81	1
8284	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2015	I	1052	11.4	Stable	No	No	Signature.4	ATM	Yes	1	41.33	34.73	1
8285	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2015	II	18	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	27.79	23.16	1
8286	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2017	IV	26	1.8	Stable	No	No			Yes	0	24.15	1.87	1
8287	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	1035	3.5	Stable	No	Yes or Unknown	Signature.17		No	0	47.21	27.66	1
8288	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	I	1270	4.4	Stable	No	No			No	0	53.85	45.57	1
8289	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	II	0	10.5	Stable	No	No	Signature.4	RAD50	No	1	15.15	7.36	1
8290	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2015	IV	18	3.9	Stable	No	Yes or Unknown			No	0	50.92	25.82	1
8291	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	III	0	8.9	Stable	No	No			Yes	0	53.16	7.62	1
8292	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2015	II	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	25.17	11.96	1
8293	ICI-treated	ICI as subsequent line	36 - 40	Male	Pancreatic	2015	III	379	3	Stable	No	Yes or Unknown			No	1	33.08	18.92	1
8294	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	I	518	9.7		No	No	Signature.13	ARID1A | CHEK2	No	1	37.26	25.2	1
8295	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	41	30.5	Stable	No	Yes or Unknown	Signature.4	ATR | BRCA2	No	0	53.78	16.07	1
8296	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	325	7		No	Yes or Unknown	Signature.2		No	1	31.8	21.75	1
8297	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	499	39.4	Stable	No	Yes or Unknown	Signature.4	ATM | BRCA1 | FANCA | MUTYH	No	1	29.08	8.15	1
8298	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	0	49.2	Stable	No	No	Signature.7	ARID1A | BRIP1 | PMS1	Yes	0	53.22	0.79	1
8299	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	II	22	5.9	Stable	No	Yes or Unknown	Signature.13		No	0	53.19	34.92	1
8300	ICI-treated	ICI as subsequent line	41 - 45	Male	Hepatobiliary	2015	II	89	4.9	Stable	No	Yes or Unknown			No	1	23.98	23.66	1
8301	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	I	409	2.6	Stable	No	Yes or Unknown			No	0	53.72	33.41	1
8302	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		43	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	43.53	39.36	1
8303	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	179	3	Stable	No	Yes or Unknown			No	1	8.31	8.28	1
8304	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	1003	9.7	Stable	No	Yes or Unknown	Signature.4		No	1	40.02	27.89	1
8305	ICI-treated	ICI as subsequent line	16 - 20	Female	CNS	2015		3	7.9	Stable	No	No			No	1	24.31	22.77	1
8306	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	926	4.4	Stable	No	Yes or Unknown			No	1	37.22	1.48	1
8307	ICI-treated	ICI as first line	41 - 45	Female	Renal	2015	IV	0	6.9	Stable	No	No	Signature.18	ARID1A | MLH1 | MUTYH	Yes	0	52.07	1.71	1
8308	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	29	3	Stable	No	Yes or Unknown			No	1	26.97	19.35	1
8309	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	31	1	Stable	No	No			No	1	26.68	23.33	1
8310	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	5.9	Stable	No	No			No	0	52.7	2.46	1
8311	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	IV	20	102.3	Indeterminate	No	Yes or Unknown	Signature.7	ARID1A | BRCA2 | MLH1 | MSH2	No	1	30.23	2.76	1
8312	ICI-treated	ICI as subsequent line	76 - 80	Female	Head & Neck	2015	IV	242	3.9	Stable	No	Yes or Unknown	Signature.1		No	1	12.02	10.48	1
8313	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	277	4.9	Stable	No	Yes or Unknown			No	1	40.41	8.94	1
8314	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	III	27	4.9	Stable	No	Yes or Unknown			No	0	52.14	21.65	1
8315	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2015	II	48	3	Stable	No	No			No	0	48.92	41.79	1
8316	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	45	3	Stable	No	No			No	0	12.65	1.94	1
8317	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	IV	0	10.8	Stable	No	No	Signature.7		No	1	4.21	0.95	1
8318	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2015	IV	50	4.9	Stable	No	No	Signature.4	MUTYH	No	1	30.03	2.07	1
8319	ICI-treated	ICI as first line	21 - 25	Male	Cutaneous Melanoma 	2015	III	20	9.8	Stable	No	No	Signature.7	ERCC3 | MSH6	Yes	0	51.06	1.15	1
8320	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	0	13.8	Stable	No	No	Signature.4	BRCA1	No	1	11.01	7.33	1
8321	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	II	929	7	Stable	No	Yes or Unknown	Signature.1	FANCA	No	0	52.76	33.97	1
8322	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2015	IV	55	0	Stable	No	Yes or Unknown			No	1	17.91	6.57	1
8323	ICI-treated	ICI as subsequent line	10-Jun	Male	CNS	2015		12	0	Stable	Yes or Unknown	Yes or Unknown			No	1	31.8	28.55	1
8324	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2015	IV	26	4.9	Stable	No	No			No	1	46.32	21.42	1
8325	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2015	I	807	14.9	Stable	No	No	Signature.7	BRCA2	Yes	0	52.6	27.6	1
8326	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2015	I	1126	13.2	Stable	No	No	Signature.7	TP53BP1	No	1	50.46	37.65	1
8327	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	381	10.8	Stable	No	Yes or Unknown	Signature.4	BRCA2 | PMS1	No	1	22.28	12.75	1
8328	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	343	8.9	Stable	No	Yes or Unknown	Signature.29		No	1	14.13	13.11	1
8329	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	10.32	8.77	1
8330	ICI-treated	ICI as first line	81 - 85	Female	Cutaneous Melanoma 	2015	IV	25	39.4	Stable	No	No	Signature.7	ERCC4 | MLH1	Yes	1	12.16	1.61	1
8331	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2015	IV	653	0		No	Yes or Unknown	Signature.5		No	1	31.47	28.32	1
8332	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	346	8.9	Indeterminate	No	Yes or Unknown	Signature.3	NBN	No	1	13.7	12.06	1
8333	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	17	3	Stable	No	No		ATM	No	0	20.7	7.23	1
8334	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	IV	700	1.8	Stable	No	Yes or Unknown			No	1	33.12	23.43	1
8335	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	I	13	6.9	Stable	No	No	Signature.4	ATM	No	0	49.91	22.51	1
8336	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2015	IV	211	6.9	Stable	No	Yes or Unknown	Signature.1		No	1	23	19.12	1
8337	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	0	1	Stable	No	No			No	0	30.46	1.91	1
8338	ICI-treated	ICI - unknown sequence	51 - 55	Male	Prostatic	2015	IV	28	43.3	Unstable	No	Yes or Unknown	Signature.6	ARID1A | CHEK2 | MLH1 | PMS1 | PMS2 | RAD50	No	1	23.49	17.41	1
8339	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	III	28	2	Stable	No	Yes or Unknown	Signature.9		No	1	36.3	31.18	1
8340	ICI-treated	ICI as subsequent line	56 - 60	Female	Esophageal	2015	IV	102	6.9	Stable	No	Yes or Unknown	Signature.2		No	1	13.01	10.25	1
8341	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	0	59	Stable	No	No	Signature.4	ATR | BRCA1 | ERCC3 | FANCA | RAD50	No	0	51.52	18.4	1
8342	ICI-treated	ICI as subsequent line	56 - 60	Female	Colorectal	2015	III	585	4.4	Stable	No	Yes or Unknown		ATM	No	1	44.48	24.28	1
8343	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	14	12.8	Stable	No	No	Signature.13	ATM	No	0	52.27	40.38	1
8344	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	194	3.9	Stable	No	Yes or Unknown			No	1	9.53	7.79	1
8345	ICI-treated	ICI as subsequent line	46 - 50	Female	Endometrial	2015	IV	63	3	Stable	No	No	Signature.26		No	1	41.23	28.91	1
8346	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	154	6.9	Stable	No	Yes or Unknown	Signature.4		No	1	19.15	5.49	1
8347	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	50	9.8	Stable	No	Yes or Unknown	Signature.29	ERCC5	No	1	8.21	6.47	1
8348	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	IV	162	14.8	Stable	No	Yes or Unknown	Signature.4		No	1	39.92	28.39	1
8349	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	III	0	1	Stable	Yes or Unknown	Yes or Unknown		ATM	No	1	21.75	10.45	1
8350	ICI-treated	ICI as subsequent line	41 - 45	Male	Esophageal	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.2		No	1	38.51	27.6	1
8351	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	III	104	8.8		No	Yes or Unknown	Signature.1	ARID1A	No	1	28.29	12.58	1
8352	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	48	4.4		No	No	Signature.4		No	0	52.8	6.21	1
8353	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	18	5.9	Stable	No	No		ARID1A | ATM	No	1	29.31	5.52	1
8354	ICI-treated	ICI as subsequent line	26 - 30	Male	Sarcoma	2015	I	980	0.9	Stable	No	Yes or Unknown			No	1	47.7	41.86	1
8355	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2015	IV	0	3.5		No	No		BRCA2 | RAD50	No	1	36.04	12.52	1
8356	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	I	6	4.4	Stable	No	No	Signature.4		No	0	51.15	41.17	1
8357	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	IV	43	3	Stable	Yes or Unknown	Yes or Unknown		BRIP1	No	0	52.93	34.46	1
8358	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	20	3	Stable	No	Yes or Unknown		ARID1A	No	1	41.43	2.04	1
8359	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	0	51.2	Stable	No	No	Signature.7	MSH2	Yes	0	52.57	42.28	1
8360	ICI-treated	ICI as first line	51 - 55	Male	Sarcoma	2015		19	7		No	Yes or Unknown	Signature.1	BRCA2 | MSH2 | RAD54L	No	0	51.02	30.88	1
8361	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	32	11.8	Stable	No	Yes or Unknown	Signature.4	NBN	No	1	35.55	14.88	1
8362	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	34	3.9	Stable	No	No			No	1	42.09	31.54	1
8363	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	0	Stable	No	No			No	0	51.25	5.36	1
8364	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	IV	1	2	Indeterminate	No	No		BRCA1	No	0	51.32	33.81	1
8365	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	12	4.9	Stable	No	No			No	0	9.33	9.33	1
8366	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2015	IV	36	3.9	Stable	No	Yes or Unknown			No	0	21.78	21.78	1
8367	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2015	IV	0	8.9	Stable	No	Yes or Unknown	Signature.4	ATM | BRCA2 | ERCC2	No	1	13.8	5.85	1
8368	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	22	7.9		No	No	Signature.4	MSH2	No	0	52.5	16.39	1
8369	ICI-treated	ICI as first line	71 - 75	Male	Renal	2015	IV	51	9.8	Stable	No	No	Signature.3	ERCC5	Yes	0	51.12	2.53	1
8370	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	28.85	20.53	1
8371	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	IV	21	36.4	Stable	No	No	Signature.7	PALB2	Yes	0	50.2	1.68	1
8372	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	IV	76	4.4	Stable	No	No		ARID1A	No	1	33.45	22.37	1
8373	ICI-treated	ICI as subsequent line	31 - 35	Female	Gastric	2015	IV	1135	4.4	Stable	No	Yes or Unknown			No	1	44.88	42.45	1
8374	ICI-treated	ICI as subsequent line	76 - 80	Male	Cutaneous Melanoma 	2015	I	1126	12.3	Stable	No	No	Signature.7		No	0	50.99	15.05	1
8375	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	BRIP1	No	1	14.42	1.48	1
8376	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	378	9.8	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	19.61	15.41	1
8377	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	20	12.8	Stable	No	No	Signature.18	BRCA1 | MLH1 | MSH2	No	1	13.8	7.75	1
8378	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	966	1.8	Stable	No	No			No	0	51.32	34.3	1
8379	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	42	1	Stable	No	Yes or Unknown			No	1	27.27	18.46	1
8380	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2015		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	23.52	7.82	1
8381	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	146	2	Stable	No	Yes or Unknown			No	0	49.87	5.68	1
8382	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	IV	0	3.5		No	No			No	0	50.5	32.2	1
8383	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2015		31	2	Stable	Yes or Unknown	Yes or Unknown			No	1	13.86	8.8	1
8384	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	IV	0	27.5	Stable	No	No	Signature.7	BRCA2 | ERCC2 | FANCA | RAD51C	No	1	37.95	6.41	1
8385	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2015	IV	22	3.9	Stable	No	No			No	0	39.13	33.87	1
8386	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	IV	23	4.9	Stable	No	No	Signature.4		No	1	8.94	6.9	1
8387	ICI-treated	ICI as first line	71 - 75	Female	Sarcoma	2015	III	35	1.8	Stable	No	No		ERCC5 | TP53BP1	Yes	0	50.63	39.36	1
8388	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	IV	0	6.9	Stable	No	No	Signature.6		No	1	48.26	32.62	1
8389	ICI-treated	ICI as first line	61 - 65	Male	Esophageal	2015	II	456	8.8		No	No	Signature.17		Yes	1	21.19	15.11	1
8390	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	1319	9.7	Stable	No	Yes or Unknown	Signature.4	ATM	No	0	51.02	18.4	1
8391	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	IV	0	6.1	Stable	No	No		BRCA2 | SLX4	No	1	32.07	19.94	1
8392	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	286	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA1 | MSH6	No	1	17.35	12.42	1
8393	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2015	IV	1217	12.3	Stable	No	Yes or Unknown	Signature.13		No	0	50.69	40.44	1
8394	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	0	12.8	Stable	No	No	Signature.4		No	1	13.7	11.56	1
8395	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	II	42	2	Stable	No	No			Yes	0	51.19	31.41	1
8396	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	IV	1085	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.19		No	0	50.37	35.68	1
8397	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	III	25	7.9	Stable	No	No			No	1	44.35	25.82	1
8398	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	463	14.8	Indeterminate	No	Yes or Unknown	Signature.4		No	1	20.57	19.38	1
8399	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	III	252	7.9	Stable	No	Yes or Unknown	Signature.3		No	0	50.27	13.86	1
8400	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	III	182	4.9	Stable	No	No	Signature.7		Yes	0	51.98	6.44	1
8401	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	6	2	Stable	No	No			No	1	40.97	18.86	1
8402	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	72	17.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	0	20.53	2.4	1
8403	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	638	3.5		No	Yes or Unknown			No	1	28.85	23.29	1
8404	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	III	506	1.8		No	No			Yes	0	47.8	19.78	1
8405	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2015	IV	466	5.9		No	Yes or Unknown	Signature.11	PARP1	No	1	29.34	26.48	1
8406	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2015		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	13.4	0.89	1
8407	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	30	3.9	Stable	No	Yes or Unknown			No	1	22.18	2.07	1
8408	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	IV	159	27.5	Stable	No	Yes or Unknown	Signature.13	ATM | ATR | ERCC5 | MSH6 | PARP1	No	1	38.93	13.96	1
8409	ICI-treated	ICI as subsequent line	21 - 25	Male	Sarcoma	2015	IV	143	1	Stable	Yes or Unknown	Yes or Unknown			No	0	50.04	33.61	1
8410	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	89	6.9	Stable	No	Yes or Unknown			No	1	29.7	9.13	1
8411	ICI-treated	ICI as subsequent line	36 - 40	Male	Hepatobiliary	2015	IV	0	9.8	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	37.85	32.79	1
8412	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	70	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	12.45	8.74	1
8413	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2015	IV	558	4.4		No	Yes or Unknown			No	1	36.9	35.38	1
8414	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	15	4.9	Stable	No	Yes or Unknown	Signature.1	PMS1	No	1	35.84	32.36	1
8415	ICI-treated	ICI as subsequent line	21 - 25	Male	Colorectal	2015	IV	7	3.9	Stable	No	No			No	1	45.7	41.56	1
8416	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2015	IV	0	6.9	Stable	No	Yes or Unknown	Signature.17		No	1	41	34.79	1
8417	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	0	48.76	7.98	1
8418	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	191	6.9	Stable	No	Yes or Unknown	Signature.24		No	1	9.03	5.82	1
8419	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	II	0	2	Stable	No	Yes or Unknown			No	1	42.28	5.32	1
8420	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2015	IV	0	3.9	Stable	No	No		ARID1A	No	1	39	36.24	1
8421	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	154	2	Stable	No	Yes or Unknown			No	1	9.4	7.79	1
8422	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	84	3	Stable	No	Yes or Unknown			No	1	25.76	18.66	1
8423	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2015	IV	268	3	Stable	No	Yes or Unknown			No	1	15.74	9.43	1
8424	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	IV	0	7.9	Stable	No	No			No	1	10.91	9.03	1
8425	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	0	7.9	Stable	No	No	Signature.4	FANCC	No	1	29.9	13.21	1
8426	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	29.73	0.92	1
8427	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2015	III	711	7		No	No	Signature.7		No	0	49.77	24.08	1
8428	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	II	349	1	Indeterminate	No	No			No	1	30	25.23	1
8429	ICI-treated	ICI as subsequent line	36 - 40	Male	Esophageal	2015	III	15	3	Stable	No	Yes or Unknown			No	1	21.75	21.16	1
8430	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2015	III	83	1	Stable	No	Yes or Unknown			No	1	35.09	25.1	1
8431	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	0	5.9	Stable	No	No		ATM	No	1	14.52	9.13	1
8432	ICI-treated	ICI as subsequent line	10-Jun	Female	Sarcoma	2015	III	0	0	Stable	No	No			No	1	41	40.51	1
8433	ICI-treated	ICI - unknown sequence	26 - 30	Male	CNS	2015		0	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	36.83	0.89	1
8434	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2015	I	135	37.4	Stable	No	No	Signature.7	ATR | RAD54L	Yes	0	48.69	16.03	1
8435	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2015	III	299	51.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	MSH6	No	1	38.11	12.35	1
8436	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	IV	301	12.3	Stable	No	Yes or Unknown	Signature.4		No	1	23.85	10.02	1
8437	ICI-treated	ICI as first line	61 - 65	Male	Colorectal	2015	IV	20	89.5	Unstable	No	No	Signature.6	ARID1A | CHEK2 | ERCC3 | MSH2 | RAD50	No	0	46.36	2	1
8438	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	13	6.1		Yes or Unknown	Yes or Unknown			No	1	10.09	6.57	1
8439	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2015	IV	232	3	Stable	No	Yes or Unknown			No	1	12.12	9.4	1
8440	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	III	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	17.84	13.96	1
8441	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	379	34.4	Stable	No	Yes or Unknown	Signature.4		No	0	49.25	14.29	1
8442	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2015	IV	271	7.9	Indeterminate	No	Yes or Unknown	Signature.4		No	1	21.59	14.65	1
8443	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	350	1	Stable	No	Yes or Unknown			No	1	26.81	12.91	1
8444	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	1	6.21	4.83	1
8445	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	3	Stable	No	No			No	1	15.9	5.62	1
8446	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2015	IV	29	4.9	Stable	No	Yes or Unknown			No	1	14.19	12.45	1
8447	ICI-treated	ICI as subsequent line	36 - 40	Male	Head & Neck	2015	IV	125	1	Stable	No	Yes or Unknown			No	1	20.57	17.15	1
8448	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		17	3	Stable	Yes or Unknown	Yes or Unknown			No	1	17.25	12.71	1
8449	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2015	III	16	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	49.68	12.06	1
8450	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2015	IV	677	5.3	Stable	No	Yes or Unknown	Signature.8		No	1	27.47	1.35	1
8451	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	IV	27	5.9	Stable	No	No			No	1	14.75	11.66	1
8452	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	45	6.9	Stable	No	No	Signature.1		No	0	31.01	19.19	1
8453	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2015	IV	188	2.6	Stable	No	Yes or Unknown			No	0	49.31	20.44	1
8454	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	IV	271	4.9	Stable	No	Yes or Unknown		MSH6	No	0	49.38	21.32	1
8455	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		5	1	Stable	Yes or Unknown	Yes or Unknown			No	1	19.06	10.02	1
8456	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	623	5.3	Stable	No	Yes or Unknown		MDC1	No	1	38.51	26.41	1
8457	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2015	IV	0	26.6	Stable	No	No	Signature.7	ATR | MRE11A	No	0	35.15	0.39	1
8458	ICI-treated	ICI as subsequent line	36 - 40	Female	Renal	2015	IV	0	4.9	Stable	No	Yes or Unknown	Signature.3		No	0	49.91	37.16	1
8459	ICI-treated	ICI as subsequent line	56 - 60	Female	Hepatobiliary	2015	IV	0	1.8	Stable	No	Yes or Unknown			No	1	28.06	18.76	1
8460	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	69	17.7	Indeterminate	No	No	Signature.4		No	1	32.82	11.01	1
8461	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2015	IV	9	3.9	Stable	No	No	Signature.13	MDC1	No	1	25.66	16.59	1
8462	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2015	III	55	4.9	Stable	No	No	Signature.24		No	1	28.12	26.61	1
8463	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		1	3	Stable	Yes or Unknown	Yes or Unknown			No	1	22.7	0.95	1
8464	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	672	5.3	Stable	No	Yes or Unknown			No	1	36.67	22.54	1
8465	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	0	0.9		No	No			No	1	16.23	7.1	1
8466	ICI-treated	ICI - unknown sequence	66 - 70	Female	Hepatobiliary	2015	II	0	2	Stable	No	Yes or Unknown			No	0	38.7	36.67	1
8467	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	0	20.7	Stable	No	No	Signature.4	ARID1A	No	0	48.56	11.3	1
8468	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	218	10.8	Stable	No	Yes or Unknown	Signature.4		No	1	9.69	7.79	1
8469	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	243	3.9	Stable	No	Yes or Unknown			No	1	34.5	2.66	1
8470	ICI-treated	ICI as first line	51 - 55	Male	Renal	2015	IV	162	1	Stable	No	Yes or Unknown			Yes	0	45.7	2	1
8471	ICI-treated	ICI as subsequent line	31 - 35	Male	Sarcoma	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	47.54	24.28	1
8472	ICI-treated	ICI - unknown sequence	71 - 75	Female	CNS	2015		5	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.9	0.82	1
8473	ICI-treated	ICI as subsequent line	61 - 65	Male	Cutaneous Melanoma 	2015	IV	0	43.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | BRCA1 | FANCA	No	1	13.44	5.62	1
8474	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	162	5.9	Indeterminate	No	Yes or Unknown	Signature.18	MRE11A	No	1	21.45	6.67	1
8475	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	1144	16.7	Stable	No	No	Signature.7		No	1	44.39	38.67	1
8476	ICI-treated	ICI as subsequent line	76 - 80	Female	Esophageal	2015	IV	24	4.9	Stable	No	No	Signature.3		No	1	14.06	12.68	1
8477	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	0	1	Indeterminate	No	No			No	1	42.22	24.51	1
8478	ICI-treated	ICI as first line	56 - 60	Male	CNS	2015		146	3.9	Stable	No	Yes or Unknown			No	1	22.87	1.05	1
8479	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		0	2	Stable	No	Yes or Unknown			No	1	25.89	24.18	1
8480	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	37	2	Stable	No	No			No	1	7.95	7.03	1
8481	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	III	574	14.8		No	Yes or Unknown	Signature.4	FANCA	No	1	31.54	27.79	1
8482	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	III	0	3.9	Stable	No	Yes or Unknown			No	1	41.13	5.78	1
8483	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	437	12.3		No	Yes or Unknown	Signature.4	BRCA2	No	1	31.24	15.01	1
8484	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2015	III	0	6.9	Stable	No	No	Signature.20	BLM	No	0	47.57	11.63	1
8485	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	I	1031	1.8	Stable	No	Yes or Unknown			No	1	40.74	34.23	1
8486	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	40	13.8	Unstable	No	No	Signature.4		No	1	6.74	4.04	1
8487	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	20	0	Stable	No	No			No	1	46.78	40.44	1
8488	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2015	IV	207	4.9	Stable	No	Yes or Unknown			No	1	39.89	25.69	1
8489	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	53	18.7	Stable	No	Yes or Unknown	Signature.4	MDC1	No	0	47.61	18.17	1
8490	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2015	IV	706	0.9	Stable	No	Yes or Unknown			No	0	49.35	18.33	1
8491	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2015	III	44	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	18.14	4.83	1
8492	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	3.9	Stable	No	No	Signature.4		No	1	23.06	8.08	1
8493	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2015	IV	153	49.2	Unstable	No	Yes or Unknown	Signature.1	ARID1A | BRIP1 | MSH2 | MSH3 | SLX4	No	0	47.11	20.21	1
8494	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	19	22.6	Stable	No	No	Signature.4	ARID1A | BRIP1 | MRE11A	No	0	48.99	10.58	1
8495	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2015	IV	0	10.8	Stable	No	No			No	1	31.47	20.86	1
8496	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2015	II	330	5.9	Stable	No	Yes or Unknown		ARID1A	No	1	20.9	17.05	1
8497	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	39	2	Stable	No	No		ARID1A	No	1	16.16	12.52	1
8498	ICI-treated	ICI as subsequent line	21 - 25	Female	Gastric	2015	IV	0	1	Stable	No	No			No	1	12.19	11.96	1
8499	ICI-treated	ICI as subsequent line	51 - 55	Male	Pancreatic	2015	II	31	3.9	Stable	No	No		ATM	No	1	40.67	32.2	1
8500	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2015	III	123	10.8	Stable	No	Yes or Unknown	Signature.29		No	1	16.92	6.28	1
8501	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	9	10.8	Stable	No	No	Signature.4	ARID1A | MUTYH | PALB2	No	1	9.79	3.71	1
8502	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2015		6	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	22.54	12.85	1
8503	ICI-treated	ICI as subsequent line	15-Nov	Male	Hepatobiliary	2015	IV	9	0	Stable	No	Yes or Unknown			No	1	19.84	7.69	1
8504	ICI-treated	ICI as subsequent line	15-Nov	Female	Renal	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	7.95	0.72	1
8505	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2015		34	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.09	13.63	1
8506	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2015	I	43	7.9	Stable	No	Yes or Unknown	Signature.5		No	1	29.21	27.01	1
8507	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	III	143	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MRE11A	No	1	26.84	14.69	1
8508	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	17	0	Stable	No	No	Signature.26		No	0	35.19	8.28	1
8509	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	I	592	8.8		No	Yes or Unknown	Signature.8		No	1	28.62	27.01	1
8510	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	21	3	Stable	No	Yes or Unknown			No	0	50.33	5.52	1
8511	ICI-treated	ICI as first line	66 - 70	Female	Hepatobiliary	2015	III	35	2		No	No	Signature.25		Yes	0	46.62	10.51	1
8512	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	333	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	27.47	19.25	1
8513	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	0	2	Stable	No	No			No	0	46.75	6.54	1
8514	ICI-treated	ICI as subsequent line	61 - 65	Male	Colorectal	2015	III	8	153.5	Stable	No	No	Signature.10	ARID1A | ATM | ATR | BLM | BRCA2 | ERCC5 | MLH1 | MSH6 | PMS1 | RAD50	No	1	14.82	13.14	1
8515	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2015	III	358	8.8		Yes or Unknown	Yes or Unknown	Signature.25	BRCA1 | MRE11A	No	1	26.55	11.79	1
8516	ICI-treated	ICI as subsequent line	71 - 75	Male	Esophageal	2015	III	137	12.3	Stable	No	Yes or Unknown	Signature.19		No	1	33.12	32.66	1
8517	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2015	IV	0	15.7	Stable	No	No	Signature.7		Yes	0	47.31	0.95	1
8518	ICI-treated	ICI as subsequent line	31 - 35	Male	Pancreatic	2015	IV	0	3.9	Stable	No	No		BRCA1 | BRIP1	No	0	32.79	28.88	1
8519	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	5.9	Stable	No	No		ATM	No	1	12.32	3.75	1
8520	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2015		18	0	Stable	No	No			No	1	42.05	31.28	1
8521	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		4	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	20.99	18.2	1
8522	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2015	IV	407	10.5		No	Yes or Unknown	Signature.13	NBN	No	0	46.69	16.03	1
8523	ICI-treated	ICI as subsequent line	86 - 90	Male	Sarcoma	2015		35	35.4	Stable	No	Yes or Unknown	Signature.7	ATM | BRCA1	No	1	25.63	22.97	1
8524	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2015	II	862	4.4	Stable	No	Yes or Unknown			No	1	30.09	29.11	1
8525	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2015	IV	19	6.9	Stable	No	No		ARID1A	No	1	38.14	1.38	1
8526	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	2	23.6	Stable	No	No	Signature.4	ARID1A | MDC1	No	0	46.23	11.17	1
8527	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		28	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	14.75	13.08	1
8528	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	IV	18	5.9	Stable	No	Yes or Unknown	Signature.24		No	0	46.82	10.32	1
8529	ICI-treated	ICI as subsequent line	46 - 50	Female	Head & Neck	2015	IV	337	3.5	Stable	No	Yes or Unknown			No	0	47.38	11.5	1
8530	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2015	IV	0	47.2	Unstable	No	No	Signature.6	ARID1A | ATM | MRE11A	No	1	16.53	11.6	1
8531	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	IV	45	3	Stable	No	Yes or Unknown			No	1	20.8	2.4	1
8532	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	III	379	7.9	Stable	No	Yes or Unknown	Signature.13	BLM	No	1	31.51	28.48	1
8533	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2015	II	971	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	47.9	33.61	1
8534	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	0	20.7	Stable	No	No	Signature.4	ATM | BRIP1	No	1	27.43	13.31	1
8535	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	65	7.9	Stable	No	No	Signature.24		No	0	47.15	10.61	1
8536	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2015		7	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	47.01	15.74	1
8537	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	III	242	3.5		No	Yes or Unknown			No	1	28.25	20.01	1
8538	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2015		3	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.65	17.51	1
8539	ICI-treated	ICI as first line	61 - 65	Female	Renal	2015	IV	0	3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	20.96	2.17	1
8540	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2015	IV	0	0	Stable	No	Yes or Unknown			No	1	17.54	16.53	1
8541	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2015	III	1114	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	41.36	16.72	1
8542	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		6	4.4		Yes or Unknown	Yes or Unknown			No	1	30.85	16.72	1
8543	ICI-treated	ICI - unknown sequence	51 - 55	Female	Cutaneous Melanoma 	2015	III	649	4.4		Yes or Unknown	Yes or Unknown	Signature.3		No	1	28.78	14.59	1
8544	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	34	0	Stable	No	No			No	1	32.49	14	1
8545	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	III	277	2	Stable	No	No			No	1	24.34	18.14	1
8546	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2015		4	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.34	8.31	1
8547	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	0	3	Stable	No	No			No	1	35.32	22.14	1
8548	ICI-treated	ICI as subsequent line	31 - 35	Male	Head & Neck	2015	IV	38	4.9	Unstable	No	No	Signature.1		No	1	12.91	9.92	1
8549	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2015	IV	39	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	28.68	20.73	1
8550	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2015	III	463	6.1	Stable	No	Yes or Unknown	Signature.28		No	1	25.36	23.72	1
8551	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	9.8	Stable	No	No	Signature.13		No	1	38.31	24.87	1
8552	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	III	0	1	Stable	No	No			No	0	49.48	10.55	1
8553	ICI-treated	ICI as subsequent line	36 - 40	Male	Colorectal	2015	IV	0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	18.46	6.44	1
8554	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	II	0	8.9	Stable	No	No	Signature.4		No	1	20.44	14.55	1
8555	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2015	IV	7	1	Stable	No	Yes or Unknown			No	0	33.97	33.28	1
8556	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	II	48	49.2	Stable	No	No	Signature.4	BLM | CHEK2 | PMS2	No	0	20.6	7.98	1
8557	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	0	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	15.38	8.64	1
8558	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	161	8.8	Stable	No	Yes or Unknown		ARID1A	No	1	20.9	20.47	1
8559	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	13	10.8	Stable	No	No	Signature.13		No	1	13.08	7.33	1
8560	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2015	IV	98	2	Stable	No	Yes or Unknown			No	0	45.93	33.05	1
8561	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2015	I	0	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	0	51.61	11.14	1
8562	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	18	4.9	Stable	No	No		ATR	No	1	24.54	3.06	1
8563	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	0	13.8	Stable	No	No	Signature.13		No	1	5.32	2.83	1
8564	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	34	4.9	Stable	No	No			No	1	21.75	10.41	1
8565	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		43	2	Stable	Yes or Unknown	Yes or Unknown			No	1	43.63	38.97	1
8566	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2015	IV	0	3.9	Stable	No	No			No	1	19.58	18.69	1
8567	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2015	I	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	47.93	40.84	1
8568	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	I	122	11.8	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	1	17.74	11.47	1
8569	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	306	7.9	Stable	No	No	Signature.3	MSH2	Yes	0	47.44	2.79	1
8570	ICI-treated	ICI as subsequent line	76 - 80	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	27.89	23.26	1
8571	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	III	89	18.7	Stable	No	Yes or Unknown	Signature.18		No	0	46.46	28.52	1
8572	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2015	III	0	7.9	Stable	No	Yes or Unknown			No	1	43.07	18.56	1
8573	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	44	8.9	Stable	No	No	Signature.4	BRCA2 | PALB2	No	1	4.6	3.91	1
8574	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	II	106	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | BRCA1	No	1	12.58	8.28	1
8575	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2015		24	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	10.58	1.18	1
8576	ICI-treated	ICI as subsequent line	41 - 45	Male	Hepatobiliary	2015	IV	0	3.9	Stable	No	No			No	1	20.73	19.78	1
8577	ICI-treated	ICI as subsequent line	41 - 45	Female	Pancreatic	2015	II	28	2	Stable	No	No			No	0	45.24	15.57	1
8578	ICI-treated	ICI as subsequent line	36 - 40	Female	NSCLC	2015	IV	319	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	27.73	3.75	1
8579	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	III	111	15.7	Stable	No	No	Signature.7		No	1	17.05	6.64	1
8580	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2015	IV	199	0	Stable	No	No			No	0	47.97	13.31	1
8581	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	IV	0	3.9	Stable	No	No			No	1	11.14	6.21	1
8582	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	IV	43	5.3	Stable	No	No		PMS2	No	1	29.67	22.08	1
8583	ICI-treated	ICI as subsequent line	36 - 40	Female	Breast	2015	IV	0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	38.34	37.62	1
8584	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	66	10.8	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	4.76	3.91	1
8585	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	III	11	6.9	Stable	No	No	Signature.7		No	0	45.86	11.96	1
8586	ICI-treated	ICI as first line	66 - 70	Female	Renal	2015	III	0	5.3	Stable	Yes or Unknown	Yes or Unknown		ATM | CHEK2	Yes	0	44.48	22.83	1
8587	ICI-treated	ICI as subsequent line	61 - 65	Female	Cutaneous Melanoma 	2015		516	5.3	Stable	No	Yes or Unknown			No	1	30.13	16.56	1
8588	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	IV	0	6.9	Stable	No	No			No	1	12.29	5.09	1
8589	ICI-treated	ICI as subsequent line	51 - 55	Female	CNS	2015		6	5.9	Stable	No	No			No	1	30.59	19.25	1
8590	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2015	IV	8	0	Stable	No	Yes or Unknown			No	1	8.64	5.72	1
8591	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	801	0	Stable	No	Yes or Unknown			No	1	27.2	19.78	1
8592	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2015	IV	0	4.9	Stable	No	No	Signature.2	ARID1A	No	1	28.25	14.42	1
8593	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		117	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	10.38	1.05	1
8594	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	19.7	Stable	No	No	Signature.4	MLH1 | MUTYH | PMS2	No	1	42.12	16.53	1
8595	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	IV	0	9.7		No	No	Signature.5		No	1	41.3	36.83	1
8596	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2015		687	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	33.15	0.92	1
8597	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	76	18.7	Stable	No	No	Signature.4	MDC1 | MSH2 | RAD50	No	0	45.24	21.39	1
8598	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2015	IV	27	4.9	Stable	No	Yes or Unknown	Signature.4		No	0	24.74	20.11	1
8599	ICI-treated	ICI as subsequent line	51 - 55	Female	Head & Neck	2015	I	389	3.5		Yes or Unknown	Yes or Unknown	Signature.1		No	0	49.97	23.06	1
8600	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	22	16.7	Stable	No	No	Signature.4		No	0	44.91	6.41	1
8601	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2015	IV	18	5.3		No	Yes or Unknown	Signature.29		No	0	19.15	18.07	1
8602	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	71	11.8	Stable	No	No	Signature.18	ATM | ERCC4	No	0	24.94	5.29	1
8603	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	27	5.9	Stable	No	No			No	1	10.45	4.4	1
8604	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	892	14	Stable	No	Yes or Unknown	Signature.7	ARID1A	No	0	45.27	22.54	1
8605	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2015	III	33	3	Stable	No	No	Signature.13		No	0	45.73	2.5	1
8606	ICI-treated	ICI as subsequent line	71 - 75	Female	Head & Neck	2015	III	464	7		No	Yes or Unknown	Signature.1		No	0	44.22	17.71	1
8607	ICI-treated	ICI as subsequent line	51 - 55	Female	SCLC	2015	IV	211	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A	No	1	13.77	11.5	1
8608	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	III	195	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	1	7.85	7.66	1
8609	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	III	40	5.9	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.18		No	1	46.46	21.88	1
8610	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2015	III	0	3.9	Stable	No	Yes or Unknown	Signature.16	ATM	No	1	32.66	19.75	1
8611	ICI-treated	ICI - unknown sequence	51 - 55	Male	Prostatic	2015	III	0	3	Stable	No	Yes or Unknown			No	1	27.96	27.4	1
8612	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	I	0	0.9		Yes or Unknown	Yes or Unknown			No	0	48	11.56	1
8613	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	II	23	48.2	Unstable	No	No	Signature.6	ARID1A | MRE11A | RAD51C	No	0	43.5	16.56	1
8614	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2015		13	3	Stable	Yes or Unknown	Yes or Unknown			No	1	17.08	0.99	1
8615	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	III	48	7	Stable	No	No			No	0	45.73	20.96	1
8616	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2015		14	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	17.97	0.99	1
8617	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	703	3.5	Stable	No	Yes or Unknown		ATM	No	1	33.74	23.62	1
8618	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2015	IV	0	9.8	Stable	No	No	Signature.26		No	0	44.91	3.25	1
8619	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2015	IV	65	4.4	Stable	No	Yes or Unknown			No	0	45.31	8.34	1
8620	ICI-treated	ICI as first line	61 - 65	Male	Sarcoma	2015	III	13	3.5	Stable	No	Yes or Unknown			No	0	40.41	25.89	1
8621	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	III	22	4.9	Stable	No	Yes or Unknown			No	0	44.91	28.39	1
8622	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	31	3.5	Stable	No	No		SLX4	No	0	45.11	27.14	1
8623	ICI-treated	ICI as subsequent line	56 - 60	Male	Sarcoma	2015	I	14	0	Stable	No	Yes or Unknown			No	0	44.71	35.91	1
8624	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	III	167	5.9	Stable	No	Yes or Unknown	Signature.13	CHEK2	No	1	25.79	25.03	1
8625	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	20	15.7	Stable	No	No	Signature.4		No	1	11.96	7.13	1
8626	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	III	377	10.8		No	Yes or Unknown	Signature.13		No	1	28.81	25.3	1
8627	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2015	IV	433	0		No	Yes or Unknown			No	1	44.78	15.8	1
8628	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2015	II	1064	7	Stable	No	No	Signature.19	ERCC2	Yes	1	37.82	35.42	1
8629	ICI-treated	ICI as first line	61 - 65	Male	Renal	2015	IV	0	7.9	Stable	No	Yes or Unknown	Signature.15		No	1	25.56	2.07	1
8630	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2015	III	27	51.8	Unstable	No	Yes or Unknown	Signature.1	ARID1A | ATM | BRCA2 | MSH3 | PARP1 | RAD54L	No	0	46.32	31.61	1
8631	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	III	623	1.8	Stable	No	No			No	1	35.98	22.24	1
8632	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	IV	284	0		No	Yes or Unknown			No	1	21.62	12.98	1
8633	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	II	491	4.4	Stable	No	Yes or Unknown			No	1	44.25	20.04	1
8634	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2015	I	30	3.5	Stable	No	No			No	0	45.08	35.32	1
8635	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	IV	32	43.3	Stable	No	No	Signature.7	ARID1A | MSH2 | PALB2	No	0	45.31	1.58	1
8636	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	II	391	28.1		No	No	Signature.7	ATM | BLM | ERCC5 | MDC1 | NBN	Yes	1	16.3	13.14	1
8637	ICI-treated	ICI as subsequent line	36 - 40	Female	Breast	2015	II	512	4.4	Stable	No	Yes or Unknown	Signature.3		No	1	25.72	20.53	1
8638	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2015	IV	21	4.9	Stable	No	Yes or Unknown		ATM	No	1	27.96	7.33	1
8639	ICI-treated	ICI as subsequent line	36 - 40	Male	Bladder	2015	IV	229	23.6	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	20.21	7.72	1
8640	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	II	21	8.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ATM	No	0	52.53	12.22	1
8641	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2015	I	234	3.5		No	Yes or Unknown	Signature.13		Yes	1	25.49	24.41	1
8642	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2015	IV	385	1	Stable	No	Yes or Unknown			No	1	15.51	4.4	1
8643	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2015	IV	27	3	Stable	No	No			No	1	8.48	1.35	1
8644	ICI-treated	ICI - unknown sequence	0 - 5	Male	CNS	2015		471	0		Yes or Unknown	Yes or Unknown			No	0	44.19	24.41	1
8645	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2015	III	0	23.6	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	0	43.47	18.37	1
8646	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2015		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	17.71	8.15	1
8647	ICI-treated	ICI as first line	51 - 55	Female	Endometrial	2015	IV	344	31.5	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ERCC5	No	0	49.48	11.33	1
8648	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		6	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.79	0.85	1
8649	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	58	6.9	Stable	No	Yes or Unknown	Signature.5	ERCC4	No	1	12.55	9.46	1
8650	ICI-treated	ICI as subsequent line	51 - 55	Male	Prostatic	2015	IV	47	1	Stable	No	No			No	1	12.65	11.99	1
8651	ICI-treated	ICI as subsequent line	76 - 80	Female	Hepatobiliary	2015	IV	182	1	Stable	No	Yes or Unknown			No	1	32.49	11.17	1
8652	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2015	IV	658	7	Stable	No	Yes or Unknown	Signature.7		No	1	28.78	22.08	1
8653	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	0	6.9	Stable	No	No	Signature.4	ARID1A	No	0	43.14	7.52	1
8654	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	253	8.9	Stable	No	Yes or Unknown	Signature.4		No	0	43.79	8.54	1
8655	ICI-treated	ICI - unknown sequence	36 - 40	Male	CNS	2015		3	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	21.72	8.48	1
8656	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	0	1	Stable	No	No			No	1	16.16	15.9	1
8657	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2015	IV	0	7.9	Stable	No	No			No	1	38.37	27.2	1
8658	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2015	II	0	3.9	Stable	No	No	Signature.1		No	1	13.8	7.82	1
8659	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2015	IV	459	5.3		No	Yes or Unknown	Signature.1	MSH6	No	1	31.38	20.73	1
8660	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2015	III	35	3.9	Stable	Yes or Unknown	Yes or Unknown			No	0	46.62	30.75	1
8661	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2015	IV	0	4.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	30.23	2.1	1
8662	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2015	III	5	3	Stable	No	No		CHEK2	No	1	21.95	14.59	1
8663	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	25	32.5	Stable	No	No	Signature.4		No	1	42.28	6.7	1
8664	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	298	1.8		No	Yes or Unknown			No	1	19.45	10.22	1
8665	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2015	IV	53	3	Stable	No	No			No	0	10.78	7.23	1
8666	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	III	319	4.4		No	Yes or Unknown	Signature.5	CHEK2	No	1	25.66	12.85	1
8667	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2015	II	488	23.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ERCC2 | MDC1	No	0	44.45	31.57	1
8668	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2015		8	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	11.01	0.99	1
8669	ICI-treated	ICI as first line	66 - 70	Male	Renal	2015	IV	0	3.9	Stable	No	No			No	1	10.97	1.51	1
8670	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2015	II	168	16.7	Stable	No	Yes or Unknown	Signature.2	CHEK1 | MDC1	No	1	8.54	8.25	1
8671	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	III	509	6.1	Stable	No	Yes or Unknown			No	0	21.29	9.56	1
8672	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	654	10.5	Stable	No	Yes or Unknown	Signature.2	ARID1A	No	0	44.91	21.95	1
8673	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	224	3.9	Stable	No	Yes or Unknown	Signature.2		No	1	23.46	19.12	1
8674	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	18	0	Stable	No	No		BRCA2	No	0	23.03	22.44	1
8675	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	IV	138	0	Stable	No	Yes or Unknown			No	1	25.59	17.02	1
8676	ICI-treated	ICI as subsequent line	76 - 80	Male	Head & Neck	2015	IV	456	5.3		No	Yes or Unknown			No	1	43.6	27.86	1
8677	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015	III	523	15.8	Stable	No	No	Signature.7	ARID1A | BLM | BRIP1 | ERCC5	No	0	44.09	14.23	1
8678	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	38	6.9	Stable	No	No			No	0	9.86	6.67	1
8679	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2015	III	27	4.9	Stable	No	Yes or Unknown			No	1	21.45	19.32	1
8680	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	301	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | BRCA2 | ERCC4 | MSH6	No	1	31.9	13.83	1
8681	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	0	4.4		No	No		BRCA2	No	1	39.72	6.74	1
8682	ICI-treated	ICI as subsequent line	21 - 25	Female	Colorectal	2015	IV	127	4.9	Stable	No	Yes or Unknown		ATR	No	1	15.11	10.64	1
8683	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2015	IV	15	6.9	Stable	No	No	Signature.13	ATM	No	1	35.32	20.5	1
8684	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	0	10.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	29.67	7.92	1
8685	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	38	11.8	Stable	No	No	Signature.24	MDC1 | PARP1	No	1	10.61	9.13	1
8686	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2015	IV	0	3	Indeterminate	No	No			No	1	29.8	21.85	1
8687	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	102	26.3		No	No	Signature.7	ERCC5 | MSH2	Yes	0	43.89	8.94	1
8688	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	IV	21	7.9	Stable	No	No	Signature.24		No	1	33.12	23.46	1
8689	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2015	IV	22	2	Stable	No	Yes or Unknown			No	1	31.77	2.04	1
8690	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2015	II	71	0	Stable	No	No			No	0	41.03	1.25	1
8691	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	0	5.9	Stable	No	Yes or Unknown	Signature.24		No	1	9.86	4.5	1
8692	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2015	IV	0	4.9	Stable	No	No			No	1	34.17	27.7	1
8693	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	21	11.8	Stable	No	No	Signature.4		No	0	43.37	11.86	1
8694	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	498	5.3	Stable	No	Yes or Unknown			No	1	24.87	20.24	1
8695	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2015	IV	293	1		No	No			No	1	24.31	1.61	1
8696	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	III	44	14.9		No	No	Signature.4	MDC1 | MSH3 | SLX4	No	1	27.5	9.49	1
8697	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	25	3	Stable	No	Yes or Unknown			No	1	18.86	14.62	1
8698	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	376	13.2		No	Yes or Unknown	Signature.4		No	1	27.79	12.85	1
8699	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	II	552	35.1	Stable	No	No	Signature.7	MSH2	Yes	0	42.61	18.66	1
8700	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	2	7.9	Stable	No	No	Signature.4		No	1	7.89	4.44	1
8701	ICI-treated	ICI as subsequent line	46 - 50	Female	Breast	2015	II	37	4.4		Yes or Unknown	Yes or Unknown	Signature.1		No	1	13.96	12.55	1
8702	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2015	III	14	22.6	Stable	No	No	Signature.7		Yes	1	37.82	1.22	1
8703	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2015	IV	22	3.9	Stable	No	No			No	1	6.28	1.38	1
8704	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2015	IV	12	3.9	Stable	No	No			No	1	3.81	2.96	1
8705	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	IV	53	7.9	Stable	No	No	Signature.3		No	1	12.65	7.92	1
8706	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	II	21	25.6		No	No	Signature.7		Yes	0	27.43	5.32	1
8707	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	8	11.8	Stable	No	No	Signature.4		No	1	13.37	6.01	1
8708	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2015	IV	3	2	Stable	No	No			No	0	23.29	19.84	1
8709	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	III	384	70.2		No	No	Signature.7	ATM | ATR | BRCA1 | MRE11A	Yes	0	43.24	17.08	1
8710	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2015	II	112	1	Stable	No	Yes or Unknown			No	1	40.31	11.24	1
8711	ICI-treated	ICI as subsequent line	41 - 45	Female	Hepatobiliary	2015	IV	2	13.8	Stable	No	No	Signature.6	ARID1A	No	0	42.71	19.98	1
8712	ICI-treated	ICI - unknown sequence	76 - 80	Female	CNS	2015		8	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	15.9	1.02	1
8713	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	IV	39	9.8	Stable	No	No	Signature.4	ATR	No	0	42.45	15.8	1
8714	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	III	74	6.9	Stable	No	No	Signature.3		No	1	16.76	13.44	1
8715	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2015	IV	15	40.3	Stable	No	No	Signature.7	MSH6 | XRCC2	Yes	0	39.33	1.38	1
8716	ICI-treated	ICI as subsequent line	71 - 75	Female	SCLC	2015	IV	3	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | ATR | MSH2	No	1	8.51	7.79	1
8717	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	II	28	5.9	Stable	No	No			No	0	42.18	32.66	1
8718	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	IV	0	6.9	Stable	No	No	Signature.1		No	1	26.45	16.53	1
8719	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	59	16.7	Stable	No	Yes or Unknown	Signature.4	BRCA1 | ERCC5	No	0	43.89	19.81	1
8720	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	0	43.63	10.32	1
8721	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	IV	11	5.9	Stable	No	No			No	1	10.28	8.74	1
8722	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2015		6	7.9	Stable	No	No	Signature.1		No	1	18.92	1.08	1
8723	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	I	36	8.8		No	No	Signature.13		No	1	32.43	19.09	1
8724	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2016	IV	0	3.5		No	No	Signature.8	BRIP1	No	1	13.73	12.06	1
8725	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	III	36	8.8	Stable	No	Yes or Unknown	Signature.2	ATM	No	1	40.84	33.08	1
8726	ICI-treated	ICI as first line	36 - 40	Male	Colorectal	2015	IV	162	8.8	Stable	No	No		RAD50	No	0	43.43	28.09	1
8727	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2015	III	181	17.6		No	Yes or Unknown	Signature.13	MSH3 | MSH6	No	1	15.7	14.29	1
8728	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	IV	0	47.2	Stable	No	No	Signature.13	CHEK2 | ERCC5 | FANCA | RAD50	No	1	17.64	6.93	1
8729	ICI-treated	ICI as first line	26 - 30	Female	Cutaneous Melanoma 	2015	IV	11	15.7	Indeterminate	No	No	Signature.7		Yes	1	1.58	0.56	1
8730	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2015	I	731	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	28.22	25.53	1
8731	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2015	IV	32	29.5	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	31.57	15.15	1
8732	ICI-treated	ICI as subsequent line	46 - 50	Female	Esophageal	2015	IV	0	3.9	Stable	No	No			No	1	29.67	25.76	1
8733	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2015	II	668	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	42.32	26.45	1
8734	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	193	2	Stable	No	Yes or Unknown			No	1	33.58	5.32	1
8735	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2015	IV	7	2	Stable	No	No			No	1	9.07	1.12	1
8736	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2015	III	0	1.8	Stable	No	No			No	0	42.74	30.06	1
8737	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2015	III	287	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	25.63	9.89	1
8738	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	IV	34	12.8	Stable	No	No	Signature.7	ARID1A	No	1	12.22	11.43	1
8739	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2015	IV	258	5.3		Yes or Unknown	Yes or Unknown	Signature.24		No	1	19.32	10.32	1
8740	ICI-treated	ICI as subsequent line	61 - 65	Female	Bladder	2015	II	0	5.9	Stable	No	No		ARID1A	No	0	42.71	4.99	1
8741	ICI-treated	ICI as subsequent line	81 - 85	Female	Colorectal	2015	III	149	43.3	Unstable	No	Yes or Unknown	Signature.21	ARID1A	No	0	42.87	11.83	1
8742	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2016	III	0	5.3		No	No	Signature.19		No	1	11.99	10.68	1
8743	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	III	427	8.8		No	No	Signature.7	ATM | BRCA1	No	0	40.64	14.26	1
8744	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2015	IV	15	3.9	Indeterminate	No	No	Signature.1	ERCC2	No	1	16.26	9.66	1
8745	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	II	500	64.1	Stable	No	Yes or Unknown	Signature.7	ARID1A | CHEK2 | ERCC2 | MDC1 | MLH1 | PMS2 | RAD50	No	0	42.64	17.22	1
8746	ICI-treated	ICI as first line	66 - 70	Male	CNS	2015		38	3	Stable	No	No			No	1	18.5	2.17	1
8747	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	21	10.8	Stable	No	No	Signature.13		No	0	41.89	12.48	1
8748	ICI-treated	ICI as first line	36 - 40	Female	Cutaneous Melanoma 	2015	III	486	0.9	Stable	No	No			No	0	43.24	28.71	1
8749	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2015	I	0	3	Stable	No	Yes or Unknown			No	1	23.16	16.39	1
8750	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2015	IV	4	2	Stable	No	No			No	1	13.04	9.17	1
8751	ICI-treated	ICI as first line	26 - 30	Female	Cutaneous Melanoma 	2015	III	28	0		No	No			No	1	29.4	8.48	1
8752	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	III	22	9.8	Stable	No	No	Signature.1	RAD54L	No	1	16.72	7.79	1
8753	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	IV	0	17.6	Stable	No	No	Signature.4	ATM | ERCC4	No	0	42.74	7.92	1
8754	ICI-treated	ICI as first line	51 - 55	Male	CNS	2015		0	6.9	Stable	No	No			No	1	15.28	1.12	1
8755	ICI-treated	ICI as first line	66 - 70	Male	SCLC	2015	IV	106	8.9	Stable	No	No	Signature.16	BRCA2	No	1	14.06	3.68	1
8756	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	IV	376	5.3	Stable	No	Yes or Unknown		PARP1	No	0	42.55	19.78	1
8757	ICI-treated	ICI as subsequent line	10-Jun	Female	CNS	2015		710	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	28.81	24.02	1
8758	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	III	261	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	46.52	9.1	1
8759	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2015	II	30	1.8		No	No			No	0	31.74	9.72	1
8760	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2015	I	612	129	Stable	No	No	Signature.7	ARID1A | BRCA2 | FANCA | MDC1 | MSH2 | RAD52 | RAD54L | TP53BP1	No	0	35.91	34.53	1
8761	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2015	IV	8	5.9	Stable	No	No			No	1	4.21	3.22	1
8762	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2015	IV	36	4.9	Stable	No	No			No	1	9.99	4.6	1
8763	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	52	17.7	Stable	No	No	Signature.4	MSH2	No	0	43.4	12.85	1
8764	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	II	360	14.9		Yes or Unknown	Yes or Unknown	Signature.7		Yes	0	39.23	12.55	1
8765	ICI-treated	ICI as first line	71 - 75	Male	Hepatobiliary	2015	III	133	6.9	Stable	No	No		ARID1A	No	1	10.18	4.86	1
8766	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2015		2	5.9	Stable	Yes or Unknown	Yes or Unknown	Signature.8		No	1	13.54	0.85	1
8767	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2015	III	0	0.9		No	No			No	0	21.88	16.36	1
8768	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2015	III	57	20.7	Stable	No	No	Signature.13		No	1	29.21	15.28	1
8769	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	4	2	Indeterminate	No	Yes or Unknown			No	1	35.35	12.09	1
8770	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2015	IV	25	8.9	Stable	No	No	Signature.4	ARID1A	No	1	29.47	1.68	1
8771	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		11	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	17.45	10.25	1
8772	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	III	244	0.9		No	Yes or Unknown			No	1	31.15	28.29	1
8773	ICI-treated	ICI as subsequent line	66 - 70	Male	Gastric	2015	IV	0	3.9	Stable	Yes or Unknown	Yes or Unknown	Signature.6		No	1	21.85	20.9	1
8774	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	22	22.6	Stable	No	No	Signature.4	ATR | MDC1	No	0	41.49	8.9	1
8775	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2016	IV	0	3	Stable	No	No		BRCA2	No	1	8.71	6.67	1
8776	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	460	12.3	Stable	No	Yes or Unknown	Signature.24		No	1	20.83	8.51	1
8777	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2015		28	3.9	Stable	No	Yes or Unknown			No	0	43.5	26.74	1
8778	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	24	4.4		No	No	Signature.4	FANCC	No	1	33.08	11.83	1
8779	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2016	IV	183	8.8		No	Yes or Unknown	Signature.13		No	1	9.79	8.18	1
8780	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2015	IV	29	5.9	Stable	No	No	Signature.13		No	1	7.43	3.88	1
8781	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	7.9	Indeterminate	No	No	Signature.16	BRCA1 | CHEK2	No	1	6.21	4.8	1
8782	ICI-treated	ICI as first line	66 - 70	Male	SCLC	2015	IV	276	9.8	Stable	No	No	Signature.29	ATR	No	1	31.74	23.33	1
8783	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	IV	910	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.11	ARID1A | ATM	No	0	41.2	29.7	1
8784	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2015	II	981	28.1	Stable	No	No	Signature.7		Yes	0	41.92	32.46	1
8785	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2016	IV	88	2	Stable	Yes or Unknown	Yes or Unknown			No	0	16.56	7.36	1
8786	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2015	IV	456	93	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | BLM | BRCA1 | BRCA2 | MLH1 | MSH2 | MSH3 | MSH6 | PARP1 | TP53BP1	No	1	21.29	20.53	1
8787	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	16.7	Stable	No	No	Signature.4	ARID1A | ATM	No	1	36.86	15.67	1
8788	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	11	11.8	Stable	No	No	Signature.4		No	1	31.61	25.43	1
8789	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.1	FANCA | PALB2	No	1	5.39	4.47	1
8790	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2016	IV	10	5.9	Stable	No	No			No	1	7.66	4.34	1
8791	ICI-treated	ICI as first line	46 - 50	Male	Renal	2016	IV	0	5.3	Stable	No	Yes or Unknown			No	1	30.39	1.87	1
8792	ICI-treated	ICI - unknown sequence	56 - 60	Male	Prostatic	2015	IV	6	1	Stable	No	Yes or Unknown		ATM	No	1	32.99	30.88	1
8793	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2016	IV	51	7	Stable	No	No			No	1	27.2	16.82	1
8794	ICI-treated	ICI as subsequent line	16 - 20	Female	Sarcoma	2015	III	104	2	Stable	Yes or Unknown	Yes or Unknown			No	1	41.86	21.45	1
8795	ICI-treated	ICI as subsequent line	46 - 50	Male	Hepatobiliary	2016	II	36	1.8		No	No			No	1	21.45	10.78	1
8796	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		13	3	Stable	Yes or Unknown	Yes or Unknown			No	0	31.64	24.34	1
8797	ICI-treated	ICI as subsequent line	31 - 35	Male	Head & Neck	2015	II	429	8.8		Yes or Unknown	Yes or Unknown	Signature.24	ARID1A	No	0	23.49	16.53	1
8798	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	IV	1	7	Stable	No	No	Signature.4		No	1	30.88	21.65	1
8799	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	II	17	4.9	Stable	No	No			No	1	39.39	20.01	1
8800	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	0	69.8	Stable	No	No	Signature.7	ERCC5 | MDC1 | MRE11A | NBN | RAD51C	No	0	39.72	1.51	1
8801	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	32	7.9	Stable	No	Yes or Unknown	Signature.24	ATM	No	1	24.67	8.61	1
8802	ICI-treated	ICI as subsequent line	31 - 35	Male	Hepatobiliary	2016	IV	0	10.8	Stable	No	No	Signature.3	ARID1A | BRCA2 | RAD51C	No	1	18.66	15.41	1
8803	ICI-treated	ICI as subsequent line	41 - 45	Female	Sarcoma	2015	IV	242	0.9		No	Yes or Unknown			No	0	28.16	24.61	1
8804	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	21	3	Stable	No	No			No	1	22.97	10.12	1
8805	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	17	1	Stable	No	No			No	1	28.19	15.28	1
8806	ICI-treated	ICI as subsequent line	31 - 35	Female	Ovarian	2016	II	292	1.8		No	Yes or Unknown	Signature.1		No	1	12.94	12.35	1
8807	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2016	IV	234	5.3		No	Yes or Unknown	Signature.5		No	1	14.16	12.39	1
8808	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	7	5.9	Stable	No	No	Signature.4		No	1	19.32	2.83	1
8809	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	360	0		No	Yes or Unknown			No	0	39.56	11.5	1
8810	ICI-treated	ICI - unknown sequence	66 - 70	Male	Prostatic	2016	III	53	44.8	Unstable	No	Yes or Unknown	Signature.6	BRCA2 | MSH3	No	0	40.97	19.25	1
8811	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2016	IV	0	1	Indeterminate	No	No			No	0	41.1	29.01	1
8812	ICI-treated	ICI as subsequent line	26 - 30	Male	Pancreatic	2016	IV	0	12.8	Stable	No	No		CHEK2	No	1	16.46	14.92	1
8813	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	29	3.9	Stable	No	Yes or Unknown			No	0	40.51	10.84	1
8814	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	41.17	0.89	1
8815	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	30	9.8	Stable	No	No	Signature.4		No	1	5.32	4.93	1
8816	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	299	10.5		No	No	Signature.7	PMS1	Yes	0	40.15	10.51	1
8817	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	7	6.9	Stable	No	No	Signature.4		No	1	3.25	1.41	1
8818	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	47	5.9	Stable	No	No	Signature.4		No	1	10.55	8.64	1
8819	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	IV	0	1.8		Yes or Unknown	Yes or Unknown			No	0	41.33	7.75	1
8820	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2016	III	585	2.6	Stable	No	Yes or Unknown			No	0	41.07	32.76	1
8821	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	3	Stable	No	No			No	1	7.23	4.57	1
8822	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2016	IV	0	1	Stable	No	No			No	0	37.72	0.66	1
8823	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2016	IV	233	1.8		No	Yes or Unknown			No	1	19.48	9.89	1
8824	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	0	20.2		No	No	Signature.4	ARID1A	No	1	15.67	9.23	1
8825	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2015	IV	219	6.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.71	6.9	1
8826	ICI-treated	ICI as first line	66 - 70	Male	Renal	2016	IV	5	5.3	Indeterminate	No	No			Yes	0	40.15	9.33	1
8827	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	20	5.3	Stable	No	No	Signature.7	ARID1A	Yes	0	39.33	20.53	1
8828	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2016		0	1	Stable	Yes or Unknown	Yes or Unknown			No	1	20.86	6.01	1
8829	ICI-treated	ICI as subsequent line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	9	11.8	Stable	No	Yes or Unknown	Signature.7	ATR	No	0	40.44	9.49	1
8830	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2016	IV	54	14		No	No	Signature.4	ATM | MUTYH	No	1	22.6	8.28	1
8831	ICI-treated	ICI as subsequent line	21 - 25	Female	Ovarian	2016	IV	0	0.9	Stable	No	No			No	0	29.67	21.62	1
8832	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	79	2	Stable	No	No	Signature.4		No	1	23.75	6.08	1
8833	ICI-treated	ICI as subsequent line	56 - 60	Male	Sarcoma	2016	IV	360	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	14.78	13.9	1
8834	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2016	II	643	1.8	Stable	No	No			No	1	32.85	25.63	1
8835	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2015	IV	0	5.9	Stable	Yes or Unknown	Yes or Unknown			No	1	40.21	13.6	1
8836	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	38	2	Stable	No	No			No	0	39.82	22.8	1
8837	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	0	93.5	Stable	No	No	Signature.7	BRCA2 | MDC1 | PMS2	Yes	0	39.85	26.15	1
8838	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	28	2	Stable	No	No			No	0	40.71	17.08	1
8839	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	II	0	19.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM	No	0	51.91	12.39	1
8840	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2015	III	0	15.8		Yes or Unknown	Yes or Unknown	Signature.13		No	1	22.24	8.74	1
8841	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2016	IV	124	0	Stable	No	No			Yes	1	6.47	4.17	1
8842	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	II	193	88.6		No	No	Signature.7	ATM | BRCA2 | ERCC3 | FANCA | SLX4	No	0	40.71	21.26	1
8843	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2016	IV	20	53.1	Stable	No	No	Signature.7	ERCC4 | PALB2	Yes	0	40.28	0.92	1
8844	ICI-treated	ICI as subsequent line	71 - 75	Male	CNS	2016		6	6.9	Stable	No	No	Signature.1		No	1	11.24	6.41	1
8845	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	46	0	Stable	No	No			No	0	39.75	0.49	1
8846	ICI-treated	ICI as first line	61 - 65	Male	Head & Neck	2016	I	542	6.1	Stable	No	Yes or Unknown	Signature.13	SLX4	Yes	0	40.34	18.56	1
8847	ICI-treated	ICI as subsequent line	71 - 75	Male	Bladder	2015	I	968	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	52.96	37.68	1
8848	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	9	50.2	Indeterminate	No	No	Signature.4	ATM | BLM | ERCC5	No	0	39.75	8.25	1
8849	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	21.6	Stable	No	No	Signature.4	CHEK2	No	0	39.62	23.52	1
8850	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	29	3.9	Stable	No	No	Signature.26		No	1	10.41	7.49	1
8851	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	I	27	6.9	Stable	No	No			No	0	39.43	17.84	1
8852	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	3	Stable	No	No	Signature.8		No	1	15.8	7.66	1
8853	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	373	49.2	Stable	No	Yes or Unknown	Signature.4	ARID1A | MUTYH	No	1	28.02	13.27	1
8854	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	26	10.8	Stable	No	No	Signature.4		No	1	5.55	3.22	1
8855	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2016	IV	37	3.9	Stable	No	No		ARID1A	No	1	37.13	4.11	1
8856	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	29	6.9	Stable	No	No	Signature.4		No	1	17.64	10.48	1
8857	ICI-treated	ICI as first line	21 - 25	Male	Sarcoma	2015	IV	153	0	Stable	No	No			No	1	19.02	7.82	1
8858	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016	II	22	30.7		No	No	Signature.7	ATM	No	1	24.31	6.51	1
8859	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2016	IV	18	19.7	Stable	No	No	Signature.4	ARID1A | BLM | PALB2	No	1	13.34	0.82	1
8860	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	III	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	40.28	25.1	1
8861	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2016	IV	62	0		No	No			No	1	36.63	14.36	1
8862	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2016	IV	9	0	Stable	No	Yes or Unknown			Yes	1	3.35	2.99	1
8863	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	32	15.7	Stable	No	No	Signature.4	ERCC4	No	0	40.15	17.35	1
8864	ICI-treated	ICI as subsequent line	41 - 45	Female	Sarcoma	2016	IV	0	1.8		No	No			No	1	12.35	11.07	1
8865	ICI-treated	ICI as subsequent line	31 - 35	Female	Renal	2016	I	17	0	Stable	Yes or Unknown	Yes or Unknown			No	1	21.62	20.83	1
8866	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2016		3	3	Stable	Yes or Unknown	Yes or Unknown			No	1	19.88	1.02	1
8867	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	9.8	Stable	No	No	Signature.4		No	0	38.77	28.75	1
8868	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	I	59	2.6	Stable	No	No			No	0	39.23	10.78	1
8869	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	0	9.8	Stable	No	No	Signature.4		No	1	14.32	10.15	1
8870	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	0	3	Stable	No	Yes or Unknown			No	0	39.29	22.7	1
8871	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	57	6.9	Stable	No	No	Signature.4		No	1	10.81	9.92	1
8872	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	30	1	Stable	No	No			Yes	1	3.42	2.79	1
8873	ICI-treated	ICI as subsequent line	41 - 45	Female	Renal	2016	IV	0	3	Stable	No	Yes or Unknown		CHEK2	No	0	36.24	2.33	1
8874	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2016	III	299	61.4	Unstable	No	Yes or Unknown	Signature.6	BRCA1 | CHEK2 | MDC1 | MSH2 | MSH6 | MUTYH | TP53BP1	No	0	39.33	20.5	1
8875	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	III	399	3.5	Stable	No	No		FANCA | RAD50	Yes	0	38.11	14.16	1
8876	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	39	41.3	Stable	No	No	Signature.4	ATM | BLM | MLH1 | MRE11A	No	1	16.33	11.27	1
8877	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2016	III	12	3	Stable	No	No			No	1	24.67	18.73	1
8878	ICI-treated	ICI - unknown sequence	66 - 70	Male	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown		MDC1	No	1	13.93	0.79	1
8879	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2016	IV	15	3.9	Stable	No	No			No	1	24.41	13.37	1
8880	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	III	12	1	Stable	No	No			No	0	37.55	0.79	1
8881	ICI-treated	ICI as first line	56 - 60	Male	Renal	2016	IV	18	2.6		No	Yes or Unknown		ARID1A | BRCA2	No	1	24.77	4.47	1
8882	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	3	Stable	No	No			No	1	18.46	7.06	1
8883	ICI-treated	ICI as subsequent line	46 - 50	Male	Sarcoma	2016	III	25	1.8		No	No			No	0	12.62	11.96	1
8884	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	II	0	0	Stable	No	No			No	1	10.94	10.55	1
8885	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	4.4		No	No		CHEK2	No	0	39.49	23.39	1
8886	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	637	3.5	Stable	No	No			No	0	40.02	30.42	1
8887	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	4.9	Stable	No	No	Signature.13		No	0	38.31	10.02	1
8888	ICI-treated	ICI as subsequent line	76 - 80	Male	SCLC	2016	IV	18	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ERCC2	No	1	26.55	7.46	1
8889	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	IV	0	1	Stable	No	No			No	1	11.27	9.03	1
8890	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2016	II	0	5.9	Stable	No	No	Signature.18		No	1	38.24	15.15	1
8891	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	27	9.8	Indeterminate	No	No	Signature.4		No	0	11.17	7.95	1
8892	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	28	3	Stable	No	Yes or Unknown			No	1	33.87	31.31	1
8893	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	407	2.6	Stable	No	Yes or Unknown	Signature.2		No	1	24.51	20.96	1
8894	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	16	5.9	Stable	No	No	Signature.29	ARID1A	No	1	20.07	11.83	1
8895	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	7	11.8	Stable	No	No	Signature.4	ATM	No	1	10.51	6.31	1
8896	ICI-treated	ICI as subsequent line	46 - 50	Female	Cutaneous Melanoma 	2016	IV	0	17.7	Stable	No	Yes or Unknown	Signature.7	ERCC5	No	1	25.79	18.92	1
8897	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	2	7.9	Stable	No	No	Signature.2		No	1	13.17	6.74	1
8898	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2015	IV	56	0	Stable	No	No			No	1	31.31	4.01	1
8899	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	IV	249	6.1	Stable	No	Yes or Unknown			No	1	30.36	17.64	1
8900	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	13	3.9	Indeterminate	No	No			No	0	39	19.02	1
8901	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	III	62	3.9	Stable	No	No	Signature.6		No	1	8.74	0.72	1
8902	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	0	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4	PALB2	No	1	27.76	8.74	1
8903	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	II	376	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | ATM | BRIP1	No	1	39.95	12.42	1
8904	ICI-treated	ICI as subsequent line	71 - 75	Male	Renal	2015	III	222	2.6		Yes or Unknown	Yes or Unknown		ATM	No	0	45.5	12.91	1
8905	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	IV	121	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	16.36	11.53	1
8906	ICI-treated	ICI as first line	71 - 75	Male	Sarcoma	2016	IV	155	1.8		No	No			No	1	38.37	18.46	1
8907	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	III	23	5.9	Stable	No	No	Signature.4		No	1	19.06	15.44	1
8908	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2015	III	434	7		No	Yes or Unknown	Signature.16		No	1	25.1	14.52	1
8909	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	16	3.9	Stable	No	No			Yes	0	20.21	1.51	1
8910	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	8.9	Stable	No	No	Signature.4		No	1	6.21	3.94	1
8911	ICI-treated	ICI as first line	51 - 55	Female	Cutaneous Melanoma 	2016	I	36	0	Stable	No	Yes or Unknown			No	1	35.19	6.87	1
8912	ICI-treated	ICI as first line	51 - 55	Female	SCLC	2016	IV	29	14.8	Stable	No	No	Signature.4		No	0	38.8	1.12	1
8913	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	161	9.7		No	Yes or Unknown	Signature.16	SLX4	No	1	13.04	5.52	1
8914	ICI-treated	ICI as first line	56 - 60	Female	Sarcoma	2016	III	868	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	38.83	28.65	1
8915	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2015	IV	0	25.6	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	20.6	7.1	1
8916	ICI-treated	ICI as subsequent line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	0	15.7	Stable	No	No	Signature.7	ATM	No	0	35.65	1.87	1
8917	ICI-treated	ICI as subsequent line	0 - 5	Male	Hepatobiliary	2016	IV	0	2	Stable	No	Yes or Unknown			No	1	28.91	14.06	1
8918	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2016	IV	27	3.5	Stable	No	No			No	0	21.29	16.46	1
8919	ICI-treated	ICI as subsequent line	81 - 85	Female	Endometrial	2016	III	35	56.1	Unstable	No	No	Signature.1	ARID1A | ATM | BRCA1 | ERCC4 | MDC1 | MLH1 | MSH6	No	0	39.2	31.11	1
8920	ICI-treated	ICI as subsequent line	26 - 30	Male	Gastric	2016	IV	3	0		No	No			No	1	19.68	17.68	1
8921	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	161	111.5	Unstable	No	Yes or Unknown	Signature.6	ARID1A | MLH1 | MSH3 | PMS2 | RAD50 | SLX4	No	1	12.45	9.49	1
8922	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2016	IV	121	1.8	Stable	No	No			No	1	21.52	17.15	1
8923	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	III	21	7.9	Stable	No	No	Signature.1	CHEK2 | PMS2	No	1	24.28	22.31	1
8924	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2016	IV	371	12.3	Stable	No	Yes or Unknown	Signature.16	BRCA2	No	1	15.24	10.15	1
8925	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	IV	238	19.3		No	No	Signature.4	ARID1A | MDC1 | NBN	No	1	25.17	1.97	1
8926	ICI-treated	ICI as subsequent line	41 - 45	Female	Hepatobiliary	2016	IV	0	2	Stable	Yes or Unknown	Yes or Unknown			No	1	17.38	12.22	1
8927	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	0	4.9	Stable	No	No			No	0	38.77	1.41	1
8928	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2016	IV	0	53.1	Unstable	No	No	Signature.6	ARID1A | BRIP1 | MLH1 | RAD54L	No	0	38.28	2.86	1
8929	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	14	22.8		No	No	Signature.2	ATR | FANCA | MDC1 | PMS1	No	1	14.75	5.55	1
8930	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	0	5.3		No	No			No	0	32.62	8.74	1
8931	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	1	5.9	Stable	No	No		PMS1	No	1	3.02	2.37	1
8932	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2016	II	387	5.3	Stable	No	Yes or Unknown		RAD50	No	0	38.51	13.37	1
8933	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	26	1	Stable	No	Yes or Unknown			No	0	38.57	1.81	1
8934	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2016	IV	39	10.8	Stable	No	No	Signature.4	ATR	No	0	35.78	1.61	1
8935	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	241	2.6		No	Yes or Unknown	Signature.1		No	1	19.22	18.69	1
8936	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	IV	15	3	Stable	Yes or Unknown	Yes or Unknown			No	1	28.32	23.75	1
8937	ICI-treated	ICI as subsequent line	41 - 45	Male	SCLC	2015	IV	3	4.9	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	1	9.63	6.93	1
8938	ICI-treated	ICI as subsequent line	21 - 25	Male	Gastric	2016	IV	26	3	Stable	No	No			No	1	12.98	12.29	1
8939	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		5	2		Yes or Unknown	Yes or Unknown			No	1	18.86	0.95	1
8940	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	34	11.8	Stable	No	No	Signature.7	PALB2	Yes	0	38.28	2.79	1
8941	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	39	4.9		No	No		MLH1	No	1	21.29	1.48	1
8942	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	II	358	2	Stable	Yes or Unknown	Yes or Unknown			No	0	50.17	22.97	1
8943	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2016	III	146	2.6	Stable	No	Yes or Unknown			No	0	38.18	14.75	1
8944	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	I	14	3	Stable	No	No			No	0	38.05	22.7	1
8945	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	363	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	36.07	12.65	1
8946	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	IV	516	7	Stable	No	Yes or Unknown	Signature.1		No	1	20.57	17.97	1
8947	ICI-treated	ICI as subsequent line	71 - 75	Male	Sarcoma	2016	III	273	1.8		No	Yes or Unknown			No	1	34.27	16.79	1
8948	ICI-treated	ICI - unknown sequence	46 - 50	Male	Head & Neck	2016	IV	77	7.9	Stable	No	No	Signature.4		No	1	12.09	1.61	1
8949	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2016	IV	22	2	Stable	No	Yes or Unknown			No	1	11.5	5.32	1
8950	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	438	4.4	Stable	No	Yes or Unknown	Signature.7		No	0	38.24	14.78	1
8951	ICI-treated	ICI as subsequent line	26 - 30	Male	Head & Neck	2016	IV	336	4.4	Stable	No	Yes or Unknown	Signature.30		No	1	21.85	11.96	1
8952	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	I	0	16.7	Stable	No	No	Signature.4		No	1	13.14	4.01	1
8953	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	4	1	Stable	No	Yes or Unknown			No	1	33.58	19.75	1
8954	ICI-treated	ICI as subsequent line	56 - 60	Female	Cutaneous Melanoma 	2015	IV	246	13.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BRCA1	No	1	39.23	11.1	1
8955	ICI-treated	ICI as subsequent line	66 - 70	Female	Head & Neck	2016	IV	52	10.5	Stable	No	No	Signature.13		No	1	16.03	14.46	1
8956	ICI-treated	ICI as subsequent line	41 - 45	Male	Esophageal	2016	IV	553	3.5	Stable	No	Yes or Unknown	Signature.15	FANCA	No	1	34.37	19.12	1
8957	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	III	9	5.9	Stable	No	Yes or Unknown	Signature.4		No	1	15.87	10.18	1
8958	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015		561	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	44.65	27.93	1
8959	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2016	IV	4	3.5	Stable	No	No			No	1	30.95	6.77	1
8960	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	3	Stable	No	No			No	1	29.37	24.87	1
8961	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	9	6.9	Stable	No	No			No	1	15.34	6.14	1
8962	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	7.9	Stable	No	No	Signature.4		No	1	36.7	9.53	1
8963	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2016	I	0	0	Stable	No	No			No	0	32.82	2.27	1
8964	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	5.9	Stable	No	No		ARID1A | PMS2	No	1	8.57	5.78	1
8965	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	4.9	Stable	No	No			No	1	26.45	10.28	1
8966	ICI-treated	ICI - unknown sequence	26 - 30	Female	Sarcoma	2016	I	592	11.4	Stable	No	No	Signature.7	RAD50	No	0	36.9	25.63	1
8967	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2016	III	330	7.9	Stable	No	Yes or Unknown	Signature.7		No	0	36.86	1.12	1
8968	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	1	3.9	Stable	No	No	Signature.4		No	1	9.43	4.7	1
8969	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.39	14.52	1
8970	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2015	II	686	0	Stable	Yes or Unknown	Yes or Unknown			No	1	35.25	32.62	1
8971	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	1	5.9	Stable	No	No	Signature.4	ERCC4	Yes	1	1.25	0.76	1
8972	ICI-treated	ICI as subsequent line	61 - 65	Female	Colorectal	2016	IV	21	9.8	Indeterminate	No	No	Signature.1	ERCC4	No	1	16.79	9.82	1
8973	ICI-treated	ICI as subsequent line	46 - 50	Male	Bladder	2015	IV	226	6.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	9.46	7.62	1
8974	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	0	12.3		Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	0	37.75	14.95	1
8975	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2016	IV	0	11.8	Stable	No	Yes or Unknown	Signature.7		No	1	6.05	2.5	1
8976	ICI-treated	ICI as first line	31 - 35	Female	Cutaneous Melanoma 	2016	III	217	9.7		No	No	Signature.7		Yes	0	36.17	7.69	1
8977	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	III	312	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	16.79	14.16	1
8978	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2015		497	3.9	Stable	Yes or Unknown	Yes or Unknown		ERCC5	No	1	21.95	17.97	1
8979	ICI-treated	ICI as subsequent line	71 - 75	Male	Sarcoma	2016	III	614	4.4	Stable	No	Yes or Unknown	Signature.3		No	0	36.7	25.89	1
8980	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	II	314	1.8	Stable	No	Yes or Unknown			No	1	22.34	13.37	1
8981	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	166	41.3		Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | BRCA1 | BRCA2 | FANCA	No	0	36.96	8.25	1
8982	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	0	33.4	Stable	Yes or Unknown	Yes or Unknown	Signature.7	BRCA1 | ERCC3	Yes	1	10.87	5.75	1
8983	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	4	5.9	Stable	No	No	Signature.24	BRIP1	Yes	0	4.96	1.48	1
8984	ICI-treated	ICI - unknown sequence	66 - 70	Female	Cutaneous Melanoma 	2016	III	35	15.8	Stable	No	No	Signature.7	ERCC4	No	0	34.46	3.42	1
8985	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	II	412	0.9		Yes or Unknown	Yes or Unknown			No	1	31.44	14.36	1
8986	ICI-treated	ICI as subsequent line	56 - 60	Male	Esophageal	2016	IV	0	6.1	Stable	No	No		ATM	No	1	16.36	11.99	1
8987	ICI-treated	ICI as subsequent line	56 - 60	Male	SCLC	2016	IV	232	8.9		No	Yes or Unknown	Signature.4	PMS1	No	0	37.26	7.85	1
8988	ICI-treated	ICI as subsequent line	31 - 35	Female	Ovarian	2015	III	226	9.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	1	19.94	16.13	1
8989	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2016	IV	0	6.1	Indeterminate	No	No	Signature.18		No	1	19.75	16.99	1
8990	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	38	8.9	Stable	No	No	Signature.13	BRCA2	No	1	9.46	1.64	1
8991	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	IV	0	4.9	Stable	No	No	Signature.4		No	1	11.07	2.56	1
8992	ICI-treated	ICI as subsequent line	15-Nov	Female	Sarcoma	2016	IV	0	2	Indeterminate	No	No			No	0	36.9	25.4	1
8993	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	231	2.6		No	Yes or Unknown			No	1	24.38	0.92	1
8994	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	4.9	Stable	No	Yes or Unknown			No	1	26.91	0.82	1
8995	ICI-treated	ICI as subsequent line	16 - 20	Female	Hepatobiliary	2016	IV	9	0	Stable	No	No			No	0	36.8	6.77	1
8996	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	0	Stable	No	No			No	1	14.32	11.93	1
8997	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	5.3		No	No		MSH6	No	1	9.13	3.19	1
8998	ICI-treated	ICI - unknown sequence	56 - 60	Female	Renal	2016	III	61	5.3		No	No			No	0	4.9	0.2	1
8999	ICI-treated	ICI as subsequent line	16 - 20	Male	NSCLC	2016	IV	16	2	Stable	No	No			No	0	36.96	4.63	1
9000	ICI-treated	ICI as first line	61 - 65	Male	Sarcoma	2016	IV	41	0	Stable	No	No			No	0	35.32	28.42	1
9001	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2016	I	276	14	Stable	No	No	Signature.7		No	0	36.11	20.01	1
9002	ICI-treated	ICI as subsequent line	56 - 60	Male	Prostatic	2016	IV	747	3.5	Stable	No	Yes or Unknown			No	0	38.11	26.28	1
9003	ICI-treated	ICI as subsequent line	86 - 90	Female	NSCLC	2016	IV	20	5.3		No	No			No	0	20.11	4.11	1
9004	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2016	IV	9	9.8	Stable	No	Yes or Unknown	Signature.4	BRCA1 | XRCC2	No	0	35.88	1.64	1
9005	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	IV	255	0		Yes or Unknown	Yes or Unknown			No	1	19.58	5.32	1
9006	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	39	3.9	Stable	No	No	Signature.6		No	0	36.73	18.56	1
9007	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	47.2		No	No	Signature.4	ATM | ERCC4	No	1	10.38	8.44	1
9008	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	20	10.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MLH1	No	1	15.05	14.59	1
9009	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2016		0	3.9	Stable	Yes or Unknown	Yes or Unknown			No	1	13.4	0.46	1
9010	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	III	0	9.7		No	No	Signature.2		No	1	10.74	6.44	1
9011	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	0	11.4		No	No	Signature.4		Yes	1	5.91	1.77	1
9012	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	II	586	1.8	Stable	No	No	Signature.7	MSH3	No	0	36.73	16.89	1
9013	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	326	21.1	Stable	No	Yes or Unknown	Signature.13	MSH6	No	1	27.04	17.25	1
9014	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	16.7		No	No	Signature.30	ARID1A	No	1	7.56	6.31	1
9015	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	I	152	3.5		No	No			No	0	36.5	5.91	1
9016	ICI-treated	ICI as subsequent line	41 - 45	Female	Gastric	2016	II	275	3.5	Stable	No	Yes or Unknown			No	1	12.29	8.41	1
9017	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2016	IV	0	18.7		No	No	Signature.4	CHEK2 | MDC1	No	1	13.83	4.5	1
9018	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	36	5.3		No	No	Signature.25		No	1	6.34	5.29	1
9019	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		28	2	Stable	Yes or Unknown	Yes or Unknown			No	1	16.33	1.58	1
9020	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	III	132	2.6	Stable	No	Yes or Unknown			No	0	34.5	17.94	1
9021	ICI-treated	ICI as subsequent line	36 - 40	Male	Sarcoma	2016	IV	32	0		No	No			No	1	26.48	13.7	1
9022	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	III	0	4.4	Stable	No	Yes or Unknown			No	1	24.28	12.29	1
9023	ICI-treated	ICI as first line	31 - 35	Female	Cutaneous Melanoma 	2016	III	673	15.8	Stable	No	No	Signature.7	BRCA2	Yes	0	35.45	6.14	1
9024	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	1.8		Yes or Unknown	Yes or Unknown			No	1	27.96	1.02	1
9025	ICI-treated	ICI - unknown sequence	56 - 60	Male	CNS	2016		0	3	Stable	Yes or Unknown	Yes or Unknown			No	1	19.02	0.92	1
9026	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2015	III	162	8.9		Yes or Unknown	Yes or Unknown	Signature.19		No	1	23.06	14.98	1
9027	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	94	16.7	Stable	No	No	Signature.4	BRCA2	No	0	38.31	26.81	1
9028	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2015	I	360	32.5	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	41.95	30.36	1
9029	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	4.9	Stable	Yes or Unknown	Yes or Unknown			No	1	34.83	5.39	1
9030	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	III	87	0		No	No			No	0	36.57	1.91	1
9031	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2016	IV	0	10.5		Yes or Unknown	Yes or Unknown	Signature.3	FANCA	No	1	11.43	7.79	1
9032	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	12	14		No	No	Signature.24	BRCA1	No	1	24.61	2.56	1
9033	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2016	IV	201	3.5	Stable	No	Yes or Unknown			No	1	26.97	24.48	1
9034	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2016	II	22	3.5	Stable	No	No			No	0	35.68	17.25	1
9035	ICI-treated	ICI as subsequent line	21 - 25	Female	Sarcoma	2016	II	37	0.9	Stable	No	No			No	1	12.29	8.8	1
9036	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	7	5.9	Stable	No	No	Signature.3	PALB2	No	0	35.32	17.84	1
9037	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	III	0	4.9		No	No			No	1	14.55	7.2	1
9038	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	IV	9	1.8	Stable	No	No			No	1	29.27	15.51	1
9039	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2016	IV	0	1.8		No	No			No	0	31.74	0.79	1
9040	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	524	3.5	Indeterminate	No	Yes or Unknown	Signature.19	RAD50	No	1	29.57	12.19	1
9041	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2016	IV	281	7	Stable	No	Yes or Unknown	Signature.4	MSH3	No	1	12.42	2.33	1
9042	ICI-treated	ICI as first line	76 - 80	Female	Bladder	2016	III	0	14	Stable	No	No	Signature.13	ATR | BRIP1	Yes	0	24.64	12.55	1
9043	ICI-treated	ICI as subsequent line	46 - 50	Male	CNS	2016		9	3.5		No	No			No	1	31.61	25.82	1
9044	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	I	299	7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	25.33	21.52	1
9045	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2016	IV	263	5.3	Stable	No	Yes or Unknown			No	1	24.38	23.33	1
9046	ICI-treated	ICI as subsequent line	76 - 80	Male	Esophageal	2016	IV	0	4.4		Yes or Unknown	Yes or Unknown	Signature.6	BRCA2	No	1	15.01	12.25	1
9047	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2016	III	59	2.6		No	No			No	1	14.88	7.26	1
9048	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	0	16.03	1.02	1
9049	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	15.8		No	No	Signature.13	NTHL1	No	1	14.52	8.54	1
9050	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	0	57.9	Unstable	No	No	Signature.1	ARID1A | ATM | ATR | MSH2 | MSH3 | MSH6	No	1	10.02	2.5	1
9051	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	III	0	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ERCC4	Yes	0	40.87	7.59	1
9052	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2015	III	0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	0	49.18	31.38	1
9053	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	128	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.1	12.19	1
9054	ICI-treated	ICI - unknown sequence	26 - 30	Male	CNS	2016		13	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	9.82	1.28	1
9055	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2016	IV	13	2.6	Stable	No	No			No	1	23.89	18.37	1
9056	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2015	IV	264	11.8	Stable	Yes or Unknown	Yes or Unknown	Signature.7		Yes	1	18	9.66	1
9057	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2016	IV	159	8.8	Stable	No	Yes or Unknown			No	0	35.81	20.4	1
9058	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	0	6.1		No	No	Signature.9	FANCA	No	1	10.38	6.41	1
9059	ICI-treated	ICI as first line	51 - 55	Female	CNS	2016		5	5.3	Stable	No	No			Yes	1	16.07	0.92	1
9060	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	IV	16	12.3		No	No	Signature.18		No	0	35.71	25.79	1
9061	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	I	572	8.8	Stable	No	Yes or Unknown	Signature.18	ARID1A | MSH6	No	0	33.28	18.53	1
9062	ICI-treated	ICI as subsequent line	26 - 30	Female	Sarcoma	2016	I	0	1.8		Yes or Unknown	Yes or Unknown			No	1	19.29	15.28	1
9063	ICI-treated	ICI as subsequent line	31 - 35	Female	CNS	2015		0	3.5		Yes or Unknown	Yes or Unknown			No	1	32	27.2	1
9064	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	I	208	32.5	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | RAD54L	No	0	33.25	7.29	1
9065	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2016	IV	0	2.6		No	No			No	0	35.12	14.06	1
9066	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	III	57	0.9		No	No			No	0	35.45	7.2	1
9067	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	495	24.6	Indeterminate	No	Yes or Unknown	Signature.4		No	1	30.69	9.33	1
9068	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	I	14	5.3		No	No			Yes	0	35.29	10.22	1
9069	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2015	IV	619	10.5		Yes or Unknown	Yes or Unknown	Signature.4		No	1	38.64	21.45	1
9070	ICI-treated	ICI as subsequent line	66 - 70	Male	Cutaneous Melanoma 	2016	III	844	41.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | MRE11A | NBN | SLX4 | TP53BP1	No	0	37.19	28.35	1
9071	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016	IV	0	8.8		No	No	Signature.2		No	0	34.2	5.55	1
9072	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2016	IV	264	7	Stable	No	Yes or Unknown			No	1	11.99	10.48	1
9073	ICI-treated	ICI as subsequent line	36 - 40	Male	Head & Neck	2016	IV	32	6.1		No	No	Signature.13		No	1	18.17	8.71	1
9074	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2016	IV	9	11.4		No	No	Signature.4	ARID1A	No	1	10.94	5.09	1
9075	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2016	III	23	0		Yes or Unknown	Yes or Unknown			Yes	0	34.99	16.56	1
9076	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	19	1.8		No	No			No	1	10.32	8.18	1
9077	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	IV	0	7.9		No	No	Signature.4		No	1	5.09	3.12	1
9078	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2015	III	409	7	Stable	Yes or Unknown	Yes or Unknown	Signature.6	MSH6	No	1	37.85	31.24	1
9079	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	II	364	14	Stable	No	Yes or Unknown	Signature.4	MSH6	No	0	35.94	13.83	1
9080	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	5.3		Yes or Unknown	Yes or Unknown	Signature.1		No	1	19.91	1.15	1
9081	ICI-treated	ICI as subsequent line	56 - 60	Female	Colorectal	2016	IV	0	91.3	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | CHEK2 | ERCC3 | MSH2 | NTHL1 | PMS2 | RAD52	No	1	15.8	8.05	1
9082	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		185	5.3		Yes or Unknown	Yes or Unknown			No	1	10.48	6.83	1
9083	ICI-treated	ICI as first line	66 - 70	Male	CNS	2016		10	5.9		No	No	Signature.5		Yes	1	7.33	1.15	1
9084	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	0	6.1	Stable	No	Yes or Unknown			No	1	26.15	11.89	1
9085	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2017	II	141	2.6	Stable	No	No			No	0	28.32	18.63	1
9086	ICI-treated	ICI as subsequent line	36 - 40	Male	Renal	2016	IV	0	1.8		No	Yes or Unknown			No	0	34.37	6.77	1
9087	ICI-treated	ICI as first line	76 - 80	Female	Endometrial	2016	I	36	7	Stable	No	No		ARID1A | SLX4	Yes	0	32.99	23.79	1
9088	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2016	I	407	5.3	Stable	No	No	Signature.13		No	1	25.53	17.81	1
9089	ICI-treated	ICI - unknown sequence	76 - 80	Female	CNS	2016		13	3.9		Yes or Unknown	Yes or Unknown		BLM	No	1	7.39	1.54	1
9090	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2015	III	451	11.4		Yes or Unknown	Yes or Unknown	Signature.7		No	0	46.16	13.27	1
9091	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2016		0	11.4		No	No	Signature.7	MSH3 | SLX4	No	0	23.33	16.69	1
9092	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	IV	701	11.4	Stable	No	No	Signature.4	SLX4	Yes	1	29.31	2.99	1
9093	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2016	IV	11	14	Unstable	No	No	Signature.6	BRIP1 | PALB2 | PARP1	No	1	14.09	6.31	1
9094	ICI-treated	ICI as subsequent line	26 - 30	Male	Sarcoma	2016	IV	0	3.5		Yes or Unknown	Yes or Unknown	Signature.5		No	0	22.64	21.06	1
9095	ICI-treated	ICI as subsequent line	56 - 60	Male	Bladder	2016	IV	202	0.9	Stable	No	Yes or Unknown			No	1	22.74	15.84	1
9096	ICI-treated	ICI as first line	66 - 70	Female	Renal	2016	III	58	7		No	No			Yes	0	31.8	0.23	1
9097	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	IV	51	1.8		No	No	Signature.6	BRCA1	No	1	12.91	1.94	1
9098	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	27	4.4		No	No	Signature.30		No	1	6.87	5.39	1
9099	ICI-treated	ICI as first line	41 - 45	Female	NSCLC	2016	IV	167	6.1		No	Yes or Unknown		MSH6	No	1	32.72	0.99	1
9100	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	6.1		No	No	Signature.16		No	1	23.06	10.71	1
9101	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	15.8		No	No	Signature.25		No	1	16.33	2.2	1
9102	ICI-treated	ICI as first line	66 - 70	Male	Renal	2016	IV	0	4.4	Stable	No	Yes or Unknown	Signature.5	TP53BP1	No	0	34.37	3.68	1
9103	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	117	6.1		No	Yes or Unknown			No	1	13.67	4.57	1
9104	ICI-treated	ICI as subsequent line	51 - 55	Female	CNS	2016		4	4.4		No	No			No	1	28.71	27.07	1
9105	ICI-treated	ICI - unknown sequence	56 - 60	Male	Prostatic	2016	IV	0	2.6		No	Yes or Unknown			No	1	27.14	24.84	1
9106	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2016	IV	0	7.9		No	No	Signature.13	ARID1A	No	0	34.27	11.7	1
9107	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2016	IV	49	7		No	No	Signature.2	ATM	Yes	0	35.25	2.14	1
9108	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	108	1.8		No	No			No	1	12.91	12.09	1
9109	ICI-treated	ICI as subsequent line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	10	19.7		No	No	Signature.7	BRIP1 | ERCC2	No	1	4.21	2.63	1
9110	ICI-treated	ICI as first line	56 - 60	Male	Colorectal	2016	III	34	30.7	Unstable	No	No	Signature.1	MLH1 | MSH2 | NBN | PARP1	Yes	0	34.27	12.88	1
9111	ICI-treated	ICI as subsequent line	81 - 85	Male	SCLC	2016	IV	0	5.9		No	No	Signature.18	ARID1A | ATR | FANCC	No	1	7.52	6.24	1
9112	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	III	0	2.6		No	No			No	1	17.45	13.11	1
9113	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	III	692	4.4	Stable	No	Yes or Unknown	Signature.16		No	1	31.38	19.58	1
9114	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016		112	3.5		No	No		BRCA2	No	1	23.46	4.76	1
9115	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	II	193	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	19.61	16.26	1
9116	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	I	406	7.9		Yes or Unknown	Yes or Unknown	Signature.24		No	0	46.85	28.29	1
9117	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	1	1.8		No	No			No	1	17.41	15.57	1
9118	ICI-treated	ICI as subsequent line	61 - 65	Female	Renal	2016	IV	0	0.9		No	Yes or Unknown			No	0	32.72	7.59	1
9119	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2016	I	19	6.1	Stable	No	No		ARID1A	No	1	26.15	18.66	1
9120	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	0	5.3		No	No	Signature.5		No	1	4.3	3.52	1
9121	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2016		0	2.6		Yes or Unknown	Yes or Unknown			No	1	20.63	0.99	1
9122	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	III	26	6.1	Stable	No	Yes or Unknown	Signature.2		No	0	34.66	17.22	1
9123	ICI-treated	ICI as first line	21 - 25	Male	Cutaneous Melanoma 	2016	IV	17	16.7		No	No	Signature.7	ARID1A	No	0	34.27	4.47	1
9124	ICI-treated	ICI as subsequent line	46 - 50	Male	Gastric	2016	IV	4	8.8	Stable	No	Yes or Unknown	Signature.1	BRCA2	No	1	29.27	14.75	1
9125	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2016	IV	361	50.9	Unstable	No	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | MSH2 | NBN | SLX4	No	0	35.06	14.42	1
9126	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2016	IV	4	5.3		No	No		MDC1	No	1	8.71	8.38	1
9127	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2016	IV	129	7	Stable	Yes or Unknown	Yes or Unknown			No	1	21.55	14.88	1
9128	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	432	6.1	Stable	No	Yes or Unknown	Signature.5		No	1	15.15	13.8	1
9129	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	IV	19	9.7	Stable	No	No	Signature.4	ARID1A	No	1	31.93	13.86	1
9130	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	44	20.2		No	No	Signature.4	ERCC4	Yes	0	34	1.87	1
9131	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2016	III	145	5.3	Stable	No	Yes or Unknown	Signature.6	ARID1A	No	1	27.4	24.54	1
9132	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	II	345	1.8		Yes or Unknown	Yes or Unknown			No	1	26.48	16.59	1
9133	ICI-treated	ICI as subsequent line	26 - 30	Female	Sarcoma	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	0	34.73	22.08	1
9134	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	3	6.1	Stable	No	No	Signature.4		No	1	27.53	9.07	1
9135	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	0	1.8		No	Yes or Unknown			No	0	19.55	5.68	1
9136	ICI-treated	ICI as first line	16 - 20	Male	Cutaneous Melanoma 	2016	IV	147	1.8	Stable	No	Yes or Unknown			No	0	34.56	5.42	1
9137	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	III	332	16.7	Stable	No	Yes or Unknown	Signature.4	ATM | ATR | CHEK1 | ERCC3	No	1	23.66	11.04	1
9138	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2016	IV	448	7.9	Stable	No	Yes or Unknown	Signature.5		No	0	34.76	25.13	1
9139	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2016	IV	261	7.9	Stable	No	Yes or Unknown	Signature.5		No	1	14.82	9.53	1
9140	ICI-treated	ICI - unknown sequence	71 - 75	Male	CNS	2016		2	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	17.08	1.48	1
9141	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	0	4.4		No	No			No	1	26.84	0.79	1
9142	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	IV	0	100.1		No	No	Signature.7	ARID1A | ATR | BLM | ERCC2 | ERCC4 | TP53BP1	Yes	0	33.41	1.61	1
9143	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	0	7.9		No	Yes or Unknown	Signature.4		No	1	2.46	2.14	1
9144	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	220	3.5	Stable	No	Yes or Unknown			No	1	9.33	5.39	1
9145	ICI-treated	ICI as subsequent line	61 - 65	Female	Bladder	2016	IV	26	6.1	Stable	No	No	Signature.1	BRCA1	No	1	28.91	10.64	1
9146	ICI-treated	ICI as first line	46 - 50	Male	Head & Neck	2016	IV	60	8.8		No	No	Signature.24		No	0	33.61	0.99	1
9147	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	I	678	51.8	Stable	No	No	Signature.7	ARID1A | BLM | ERCC4 | RAD50 | SLX4	Yes	0	33.84	22.51	1
9148	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2016	III	0	29	Stable	No	No	Signature.13	ATR | CHEK1 | MDC1 | TP53BP1	No	1	26.74	3.19	1
9149	ICI-treated	ICI as subsequent line	16 - 20	Female	Esophageal	2016	III	0	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.2	BLM	No	0	33.41	26.91	1
9150	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	41	10.5		No	No	Signature.4		No	1	16.07	9.1	1
9151	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	III	34	5.3	Stable	No	No		PALB2	No	0	33.84	21.82	1
9152	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	IV	203	0.9		Yes or Unknown	Yes or Unknown			No	1	17.12	7.16	1
9153	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	13.2		No	No	Signature.24	ATM	No	1	12.91	10.28	1
9154	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	IV	0	3.5	Stable	No	Yes or Unknown		ARID1A	No	0	34.14	21.29	1
9155	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	0	19.3		No	No	Signature.4	ARID1A | CHEK1	No	1	11.76	5.88	1
9156	ICI-treated	ICI as first line	41 - 45	Male	Head & Neck	2016	IV	40	7.9		No	No		ARID1A | ATR | PMS1	No	0	30.49	0.46	1
9157	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	29	69.3		No	No	Signature.7	FANCC | MDC1 | PMS1	No	0	33.51	1.77	1
9158	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2016	II	614	5.3	Stable	No	Yes or Unknown	Signature.3		No	0	30.29	26.94	1
9159	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	19.3		Yes or Unknown	Yes or Unknown	Signature.4		No	0	39.52	20.04	1
9160	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		15	1.8		Yes or Unknown	Yes or Unknown			No	1	21.78	11.47	1
9161	ICI-treated	ICI as subsequent line	36 - 40	Female	Ovarian	2015	IV	0	1.8		Yes or Unknown	Yes or Unknown			No	0	29.11	24.94	1
9162	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	2	29.8		No	No	Signature.4	ERCC5	Yes	0	32.26	1.38	1
9163	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	10.5		No	No	Signature.4	BRCA1	No	0	34.43	16.99	1
9164	ICI-treated	ICI as subsequent line	61 - 65	Male	CNS	2016		8	1.8		No	No			No	1	30.42	17.74	1
9165	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		6	4.4		Yes or Unknown	Yes or Unknown			No	1	11.89	7.06	1
9166	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	238	8.8	Stable	No	Yes or Unknown	Signature.4	ATR	No	1	16.59	8.05	1
9167	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	II	199	2.6	Stable	No	No		BRCA1	Yes	1	17.84	17.35	1
9168	ICI-treated	ICI as first line	41 - 45	Female	Hepatobiliary	2016	II	221	2.6	Stable	No	No			Yes	0	33.71	8.02	1
9169	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2015	IV	616	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA2	No	1	25.89	21.39	1
9170	ICI-treated	ICI - unknown sequence	66 - 70	Female	CNS	2016		0	3.5		Yes or Unknown	Yes or Unknown			No	0	31.84	10.45	1
9171	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2016	IV	0	14.9		No	No	Signature.4	ARID1A | ERCC2	No	1	24.67	3.65	1
9172	ICI-treated	ICI as subsequent line	61 - 65	Male	Prostatic	2016	IV	99	57.1	Unstable	No	Yes or Unknown	Signature.6	ATM | BLM | BRCA2 | ERCC2 | MSH3 | TP53BP1	No	0	33.15	14.75	1
9173	ICI-treated	ICI as first line	51 - 55	Male	Colorectal	2015	IV	925	4.4	Stable	No	No			No	1	40.57	30.52	1
9174	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	IV	1	10.5		No	No	Signature.7	PALB2	Yes	0	21.19	1.05	1
9175	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	IV	10	16.7		No	No	Signature.13		No	0	33.18	8.8	1
9176	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2016	IV	22	2.6	Stable	No	Yes or Unknown			No	1	22.7	20.5	1
9177	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2016	IV	332	0.9	Stable	No	Yes or Unknown			No	0	32.39	1.05	1
9178	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	0	24.6		No	No	Signature.4	BLM	No	1	15.67	2.63	1
9179	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2016	IV	138	10.5		No	Yes or Unknown	Signature.4		No	0	32.79	1.58	1
9180	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	IV	15	79.9		No	No	Signature.7	BRCA2 | ERCC4 | MLH1 | MSH6 | NBN | PALB2 | PMS1	No	1	6.14	1.18	1
9181	ICI-treated	ICI as first line	31 - 35	Female	Ovarian	2016	I	51	33.4	Unstable	No	No	Signature.6	ARID1A | MSH2 | RAD50	Yes	0	33.48	12.48	1
9182	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	827	3.5	Stable	Yes or Unknown	Yes or Unknown		ATM	No	0	41.33	32.59	1
9183	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	35	10.5	Stable	No	No	Signature.4	ARID1A	No	0	36.47	23.52	1
9184	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	7		No	No	Signature.18	ATR	No	1	8.28	5.98	1
9185	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	31	7		No	No			Yes	1	15.41	1.64	1
9186	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2016	IV	24	29.8		No	No	Signature.4	ERCC2 | MRE11A | MSH6	Yes	0	31.61	1.81	1
9187	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	IV	0	7.9		No	No	Signature.14		No	1	7.33	3.15	1
9188	ICI-treated	ICI as subsequent line	36 - 40	Male	Renal	2015	I	0	1.8	Stable	Yes or Unknown	Yes or Unknown	Signature.12		No	1	40.97	16.36	1
9189	ICI-treated	ICI as first line	86 - 90	Female	NSCLC	2016	IV	4	5.3		No	No			Yes	0	13.9	1.12	1
9190	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2016	II	272	7.9	Stable	No	Yes or Unknown	Signature.19	ARID1A	No	1	13.14	9.43	1
9191	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2016	III	41	15.8		No	Yes or Unknown	Signature.7	FANCA	No	1	12.22	4.8	1
9192	ICI-treated	ICI - unknown sequence	21 - 25	Male	CNS	2016		46	2.6		No	No			No	0	34.83	2.63	1
9193	ICI-treated	ICI - unknown sequence	76 - 80	Male	NSCLC	2016	III	33	3.5		No	No	Signature.4	PMS1	No	0	36.96	10.28	1
9194	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	III	24	51.8		No	Yes or Unknown	Signature.7		Yes	0	33.87	2.14	1
9195	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	I	287	131.7	Stable	No	No	Signature.7	ARID1A | BRCA1 | BRCA2 | ERCC2	No	0	33.02	9.79	1
9196	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	196	36.9	Stable	No	No	Signature.7	ARID1A | ATM | BRIP1 | PALB2	Yes	0	33.08	7	1
9197	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2016	IV	28	4.4		No	Yes or Unknown	Signature.3		No	0	32.85	16.07	1
9198	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2016	IV	46	16.7		No	Yes or Unknown	Signature.13	RAD52	No	1	4.76	4.6	1
9199	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2016	IV	26	9.7		No	No	Signature.5		No	0	34.3	14.65	1
9200	ICI-treated	ICI as first line	71 - 75	Female	Cutaneous Melanoma 	2016	III	17	2.6		No	No			No	1	11.76	6.9	1
9201	ICI-treated	ICI as first line	31 - 35	Male	Cutaneous Melanoma 	2016	IV	0	13.2		No	No	Signature.7		No	0	33.22	1.15	1
9202	ICI-treated	ICI as subsequent line	41 - 45	Female	Pancreatic	2016	IV	15	1.8		No	No			No	1	16.72	13.34	1
9203	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2016	IV	19	7	Stable	No	No	Signature.30		No	1	9.82	5.29	1
9204	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	70	9.7		No	No	Signature.18	PALB2	Yes	0	32.92	5.42	1
9205	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	232	2.6	Stable	No	Yes or Unknown	Signature.3	BRCA2	No	1	11.6	10.87	1
9206	ICI-treated	ICI as subsequent line	16 - 20	Female	Head & Neck	2016	IV	0	0.9		No	No			No	1	17.68	8.71	1
9207	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	44	4.4		No	No			No	0	33.54	1.61	1
9208	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2016	II	175	12.3	Stable	No	No	Signature.7	PALB2	Yes	0	31.47	6.7	1
9209	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2016	III	27	0.9	Stable	No	Yes or Unknown			No	0	32.2	15.87	1
9210	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	0	4.4		No	No			No	0	33.12	5.52	1
9211	ICI-treated	ICI as subsequent line	56 - 60	Female	Hepatobiliary	2015	II	133	4.4		Yes or Unknown	Yes or Unknown		ARID1A	No	0	42.22	18.6	1
9212	ICI-treated	ICI as subsequent line	36 - 40	Male	Gastric	2016	IV	148	2.6	Stable	No	Yes or Unknown			No	0	33.51	18.73	1
9213	ICI-treated	ICI as first line	61 - 65	Female	Renal	2016	IV	28	3.5	Stable	No	Yes or Unknown			No	0	33.35	2.27	1
9214	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2016	II	208	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	20.67	15.57	1
9215	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2016	IV	16	36.9		No	No	Signature.7	ARID1A | ATM | FANCA | MDC1 | TP53BP1	Yes	1	3.98	2.14	1
9216	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2016	IV	19	26.3		No	Yes or Unknown	Signature.7		No	1	16.03	8.61	1
9217	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	18.4		No	No	Signature.4	BRCA1	No	0	32.49	6.21	1
9218	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2016	IV	12	4.4	Stable	No	No	Signature.16		No	0	8.8	7.89	1
9219	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2016	IV	0	2.6		No	No			No	0	2.73	1.18	1
9220	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	624	3.5	Stable	No	Yes or Unknown	Signature.3		No	0	33.48	20.4	1
9221	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2016	IV	0	8.9		No	No	Signature.1		Yes	1	4.67	1.08	1
9222	ICI-treated	ICI as first line	86 - 90	Female	Cutaneous Melanoma 	2016	III	0	36.9		No	No	Signature.7		No	0	32.95	4.67	1
9223	ICI-treated	ICI as subsequent line	61 - 65	Male	Cutaneous Melanoma 	2016	IV	0	14.9		No	No	Signature.7	BRCA2 | NBN	No	1	5.91	5.55	1
9224	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2016	IV	210	4.4	Stable	No	Yes or Unknown	Signature.1		No	1	9.07	7	1
9225	ICI-treated	ICI - unknown sequence	71 - 75	Female	Head & Neck	2016	I	47	23.7		No	No	Signature.2	BLM | NBN | SLX4	No	0	32.49	1.61	1
9226	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	IV	9	11.4		No	No	Signature.4	ERCC5 | NBN	No	1	15.61	9.43	1
9227	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	0	3.5		No	No	Signature.4	ATR	Yes	1	5.13	0.76	1
9228	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2016		1	3.5		No	No		PMS1	No	0	27.2	23.52	1
9229	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2016	IV	153	32.5	Stable	No	Yes or Unknown	Signature.6	ARID1A | BLM	No	0	33.54	11.17	1
9230	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2015	IV	657	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.2	SLX4	No	1	33.84	22.54	1
9231	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	I	654	73.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | ATM | BLM | MUTYH | PMS1 | RAD52	Yes	0	41.46	22.08	1
9232	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2016	III	0	22.8	Stable	No	No	Signature.7	RAD50	No	0	32.26	5.09	1
9233	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2015	II	533	7.9		Yes or Unknown	Yes or Unknown	Signature.2	MSH6	No	0	49.87	22.28	1
9234	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2016	IV	0	8.8		No	No			No	0	32.39	11.66	1
9235	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	IV	0	14		No	No	Signature.4	ATM	No	0	11.47	9.13	1
9236	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016	IV	26	1.8	Stable	No	Yes or Unknown			No	1	17.05	4.6	1
9237	ICI-treated	ICI as first line	51 - 55	Male	Renal	2016	IV	53	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	32.56	3.68	1
9238	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2016	II	0	5.3		No	No	Signature.5		No	1	19.19	16.79	1
9239	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	162	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	MSH2	No	1	37.32	22.64	1
9240	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2017	IV	0	2.6	Stable	No	Yes or Unknown			No	1	12.39	9.89	1
9241	ICI-treated	ICI as subsequent line	81 - 85	Male	Head & Neck	2016	IV	410	8.8	Stable	No	Yes or Unknown	Signature.2		No	0	32.89	16.46	1
9242	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	12.3		No	No	Signature.4		No	1	13.77	6.64	1
9243	ICI-treated	ICI as subsequent line	56 - 60	Female	Esophageal	2016	III	146	6.1	Stable	No	Yes or Unknown	Signature.1	RAD51C	No	1	17.81	14.92	1
9244	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2016	IV	0	7	Stable	No	No		ATM	No	1	16.62	9.03	1
9245	ICI-treated	ICI as first line	56 - 60	Female	Hepatobiliary	2016	II	23	11.4	Stable	No	Yes or Unknown	Signature.5	ARID1A | ATM	No	1	23.82	6.8	1
9246	ICI-treated	ICI as first line	61 - 65	Female	Renal	2016	III	51	1.8	Stable	No	No		RAD51C	Yes	0	27.83	0.49	1
9247	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2016	IV	0	6.1	Stable	No	No	Signature.15	ARID1A	No	1	31.01	12.98	1
9248	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	III	0	14		No	No	Signature.7		Yes	0	26.94	1.15	1
9249	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	II	193	27.2	Stable	No	No	Signature.7		Yes	0	30.65	9.49	1
9250	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	II	0	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	33.18	23.89	1
9251	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	29	9.7		No	No	Signature.4		No	1	12.29	5.16	1
9252	ICI-treated	ICI as first line	51 - 55	Male	CNS	2016		0	1.8		No	No			No	1	16.56	1.15	1
9253	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2016	IV	2	5.9		No	No	Signature.15		No	1	7.46	6.8	1
9254	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	30	7		No	No			No	1	9.59	6.67	1
9255	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2016	IV	553	3.5	Stable	No	Yes or Unknown	Signature.13	PMS1	No	0	32.1	19.22	1
9256	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2016	IV	33	21.9		No	No	Signature.6	MSH2	No	0	5.49	1.81	1
9257	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	610	5.3	Stable	No	Yes or Unknown	Signature.18		No	0	32.66	11.17	1
9258	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2016		0	5.3		No	No		BRCA2	No	1	12.55	1.38	1
9259	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	IV	34	2.6		No	Yes or Unknown	Signature.26		No	0	16.56	1.84	1
9260	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2016	IV	31	4.4	Stable	No	No	Signature.1	PALB2	No	1	16.59	15.01	1
9261	ICI-treated	ICI as first line	61 - 65	Male	Bladder	2016	IV	0	11.4		No	No	Signature.13	FANCA | RAD51	Yes	0	31.8	1.68	1
9262	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2016	IV	0	4.4		No	Yes or Unknown			No	1	18.17	11.07	1
9263	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	III	0	8.8		No	No	Signature.24		No	0	10.97	9.99	1
9264	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	15	20.2	Stable	No	No	Signature.4	MDC1	No	0	29.27	13.4	1
9265	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2015	III	0	21.6	Stable	Yes or Unknown	Yes or Unknown	Signature.4	ARID1A | CHEK2 | RAD54L	No	0	35.12	5.88	1
9266	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2016	IV	0	6.1	Stable	No	No	Signature.2	BRCA2	No	1	15.74	1.25	1
9267	ICI-treated	ICI as subsequent line	46 - 50	Female	Renal	2016	IV	10	4.4		No	No	Signature.19	MDC1	No	0	7.36	5.19	1
9268	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	I	0	24.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BRCA2	No	0	44.12	18.37	1
9269	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2016	IV	12	2.6		No	No		ARID1A	No	1	3.88	2.5	1
9270	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	8.8		No	No	Signature.4	ATM | MSH6	No	0	6.9	4.73	1
9271	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	IV	175	1.8		Yes or Unknown	Yes or Unknown			No	1	22.54	14.46	1
9272	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	182	6.1	Stable	No	Yes or Unknown			No	1	7.85	6.11	1
9273	ICI-treated	ICI as subsequent line	61 - 65	Female	Gastric	2016	I	627	2.6	Stable	No	Yes or Unknown			No	0	31.61	20.9	1
9274	ICI-treated	ICI as first line	56 - 60	Male	Colorectal	2016	II	4	44.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA2 | MRE11A | PMS1	Yes	0	27.17	5.85	1
9275	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2016		209	4.4	Stable	Yes or Unknown	Yes or Unknown		PALB2	No	1	12.16	8.74	1
9276	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	IV	0	44.8	Unstable	No	No	Signature.6	ARID1A | ATM | ERCC5 | MSH6	No	1	20.3	14.03	1
9277	ICI-treated	ICI as subsequent line	76 - 80	Male	Bladder	2015	II	54	21.9		Yes or Unknown	Yes or Unknown	Signature.2		No	0	47.84	25.1	1
9278	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	III	452	7	Stable	No	No	Signature.7		No	0	31.51	11.66	1
9279	ICI-treated	ICI - unknown sequence	56 - 60	Female	CNS	2016		0	1.8		Yes or Unknown	Yes or Unknown			No	1	18.04	9.46	1
9280	ICI-treated	ICI as subsequent line	76 - 80	Male	Colorectal	2016	III	291	12.3	Stable	No	Yes or Unknown	Signature.1	BRCA1	No	0	31.64	16.16	1
9281	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	III	81	5.3	Stable	No	No			No	1	16.92	12.88	1
9282	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	III	11	20.2	Unstable	No	No	Signature.1	ARID1A	No	1	27.04	17.15	1
9283	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2016		0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	22.67	16.36	1
9284	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	18	4.4	Stable	No	No	Signature.4		No	1	6.7	4.01	1
9285	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	IV	20	10.5		No	No	Signature.24		No	0	30.62	8.48	1
9286	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	0	1.8	Stable	No	No			No	0	24.38	9.86	1
9287	ICI-treated	ICI as subsequent line	26 - 30	Male	SCLC	2016	IV	70	5.3		No	Yes or Unknown			No	1	2.96	2.14	1
9288	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	73	4.4		No	No			No	1	8.64	0.79	1
9289	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	17	8.8	Stable	No	No	Signature.4	ATM | ATR | BRCA2	No	0	23.89	0.79	1
9290	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	III	294	6.1	Stable	No	Yes or Unknown	Signature.16	BRCA1 | MSH3	No	1	13.17	9.23	1
9291	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	5.3		No	No	Signature.26	ARID1A	No	0	29.4	14.75	1
9292	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016	IV	29	8.8		No	No	Signature.7	MLH1	No	1	22.54	12.78	1
9293	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	I	40	4.4	Stable	No	No			No	0	31.47	20.27	1
9294	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	15	14.9		No	No	Signature.4	ARID1A	No	1	18.76	17.58	1
9295	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	19	6.1		No	No		ATM	No	1	3.75	3.35	1
9296	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	14	1.8		No	Yes or Unknown			No	1	13.17	6.8	1
9297	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	0	4.4		No	Yes or Unknown	Signature.8	ATR	No	1	4.99	3.48	1
9298	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016		0	21.9	Stable	No	No	Signature.7	ARID1A	No	0	32.39	16.99	1
9299	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	167	14	Stable	No	Yes or Unknown	Signature.13	ARID1A	No	1	29.27	12.39	1
9300	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2016	IV	499	2.6	Stable	No	Yes or Unknown		ATM	No	0	30	21.98	1
9301	ICI-treated	ICI as first line	41 - 45	Male	Sarcoma	2016	III	277	1.8	Stable	No	Yes or Unknown			No	0	30.26	10.18	1
9302	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2016	IV	105	37.7	Unstable	No	Yes or Unknown	Signature.1	ARID1A | BRCA1 | BRIP1 | CHEK2 | ERCC3 | MSH3 | RAD54L	No	0	31.21	6.21	1
9303	ICI-treated	ICI as subsequent line	46 - 50	Male	Gastric	2016	IV	301	4.4	Stable	No	Yes or Unknown			No	0	30.92	11.89	1
9304	ICI-treated	ICI - unknown sequence	31 - 35	Male	CNS	2016		218	301		Yes or Unknown	Yes or Unknown	Signature.1	ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK2 | ERCC2 | ERCC3 | ERCC5 | FANCA | MSH6 | MUTYH | NBN | PMS2 | RAD50 | RAD51C | RAD52 | RAD54L | XRCC2	No	1	19.71	12.91	1
9305	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2016	III	423	7	Stable	No	No	Signature.7	ATM	No	0	30.36	14.88	1
9306	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	26	7		No	No	Signature.24	ATM	No	1	2.73	1.77	1
9307	ICI-treated	ICI as subsequent line	66 - 70	Female	Head & Neck	2016	IV	36	5.3		No	No			No	1	9.79	8.28	1
9308	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	III	0	3.5	Stable	No	No			No	1	20.37	19.78	1
9309	ICI-treated	ICI as first line	46 - 50	Female	Gastric	2016	IV	31	7.9	Stable	No	No	Signature.1	BRIP1	No	1	25.86	1.61	1
9310	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2016	IV	35	9.7	Stable	No	No	Signature.4		No	1	15.8	7.36	1
9311	ICI-treated	ICI as first line	66 - 70	Female	Gastric	2016	IV	15	7	Stable	No	Yes or Unknown	Signature.17	PMS1	No	1	25.53	0.99	1
9312	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2016	IV	39	4.4		No	No			Yes	1	2.86	1.71	1
9313	ICI-treated	ICI as subsequent line	56 - 60	Female	Bladder	2016	IV	7	4.4	Stable	No	No		ARID1A	No	1	19.81	9.92	1
9314	ICI-treated	ICI - unknown sequence	61 - 65	Male	CNS	2016		0	204.5	Indeterminate	No	No	Signature.14	ARID1A | ATM | ATR | BRCA2 | BRIP1 | CHEK1 | CHEK2 | ERCC5 | FANCA | FANCC | MDC1 | MRE11A | MSH3 | MSH6 | NBN | NTHL1 | PMS1 | RAD51C | RAD54L | SLX4 | TP53BP1	No	1	21.36	1.28	1
9315	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2016		0	0.9	Stable	No	No			No	1	18.17	13.67	1
9316	ICI-treated	ICI as first line	66 - 70	Male	Esophageal	2016	III	44	4.4		No	No	Signature.1		No	0	31.51	2.07	1
9317	ICI-treated	ICI as subsequent line	31 - 35	Female	NSCLC	2016	IV	0	3.5		No	No			No	0	30.32	22.74	1
9318	ICI-treated	ICI as subsequent line	41 - 45	Male	Colorectal	2016	IV	0	7.9	Stable	No	No	Signature.1		No	1	10.84	9.49	1
9319	ICI-treated	ICI as first line	81 - 85	Male	CNS	2016		0	1.8	Stable	No	No			No	1	5.32	1.45	1
9320	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	218	12.3	Stable	No	Yes or Unknown	Signature.4	MDC1	No	1	21.29	7.43	1
9321	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	25	1		No	No			No	1	16.72	14.06	1
9322	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2016	I	298	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | MRE11A	Yes	0	15.87	11.5	1
9323	ICI-treated	ICI as subsequent line	81 - 85	Female	Gastric	2016	IV	6	9.7	Stable	No	No	Signature.4		No	0	17.22	16.3	1
9324	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	66	2.6		No	No			No	1	9.43	3.98	1
9325	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2016	II	196	0		No	No			No	0	30	8.38	1
9326	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	I	504	29.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH6	No	0	46.32	22.87	1
9327	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	IV	0	12.3		No	No	Signature.24		No	1	18.2	9.56	1
9328	ICI-treated	ICI as first line	66 - 70	Male	Gastric	2016	IV	655	14	Stable	No	Yes or Unknown	Signature.17	ARID1A | MRE11A | TP53BP1	No	1	28.94	1.61	1
9329	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2016	IV	15	9.7	Stable	No	No	Signature.4		No	1	30.23	1.94	1
9330	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2016	II	42	21.9	Stable	No	No	Signature.7	ATR	Yes	0	30.39	11.99	1
9331	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	0	7.9		No	No			No	1	21.13	10.05	1
9332	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	10	31.6	Stable	No	No	Signature.4	BRCA1 | MRE11A | RAD54L	No	1	15.44	9.63	1
9333	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2016	IV	0	0.9		No	No			No	0	29.6	10.15	1
9334	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	III	252	77.2	Stable	No	No	Signature.7	ARID1A | BLM | ERCC4 | SLX4	Yes	0	31.21	8.9	1
9335	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	III	272	7.9	Stable	No	Yes or Unknown	Signature.4	ATM	No	1	27.24	19.12	1
9336	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2017	IV	7	0.9	Stable	No	No		ERCC4	No	1	20.27	11.27	1
9337	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017		0	0		No	No			No	0	26.58	13.67	1
9338	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	138	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	9.82	6.47	1
9339	ICI-treated	ICI as subsequent line	41 - 45	Male	Renal	2017	IV	0	1.8	Stable	No	Yes or Unknown			No	1	4.99	4.37	1
9340	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2015	IV	114	4.4	Stable	Yes or Unknown	Yes or Unknown		ERCC5	No	1	43.96	26.71	1
9341	ICI-treated	ICI as first line	71 - 75	Male	Hepatobiliary	2017	II	0	4.4	Stable	No	Yes or Unknown	Signature.12	ARID1A	No	0	29.34	11.14	1
9342	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2017	IV	0	10.5		No	No	Signature.4		No	1	10.71	9.63	1
9343	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	IV	46	19.3	Stable	No	No	Signature.4	ARID1A | MDC1 | RAD50	No	0	30.46	10.55	1
9344	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2016	III	125	30.7	Stable	No	No	Signature.7		Yes	0	29.93	14.26	1
9345	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	IV	13	11.4		No	No	Signature.4		No	0	5.95	4.04	1
9346	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2016	I	545	2.6	Stable	No	Yes or Unknown	Signature.9		No	0	30.26	18.4	1
9347	ICI-treated	ICI as first line	71 - 75	Female	Esophageal	2017	IV	5	10.5	Stable	No	No	Signature.1	ARID1A	No	0	29.67	0.89	1
9348	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	III	136	3.5	Stable	No	Yes or Unknown	Signature.24	ARID1A	No	1	23.26	20.07	1
9349	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2016	IV	0	9.8		No	Yes or Unknown	Signature.4	FANCA	No	1	17.68	1.05	1
9350	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	97	42.1	Unstable	No	Yes or Unknown	Signature.6	BRCA1 | CHEK1 | ERCC5 | MLH1 | MSH3 | MSH6 | PMS2	No	1	4.21	3.68	1
9351	ICI-treated	ICI as first line	76 - 80	Male	Sarcoma	2016	IV	29	0.9		No	No			No	0	30.29	0.76	1
9352	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2016		85	15.8	Stable	No	No	Signature.4	ATM | MSH2	No	1	13.93	8.34	1
9353	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2017	IV	21	3.5	Stable	No	No			No	0	24.54	21.78	1
9354	ICI-treated	ICI as subsequent line	41 - 45	Female	Bladder	2017	III	105	7	Stable	No	No		BRCA1 | TP53BP1	No	1	16.82	16.3	1
9355	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2016	IV	16	2.6		No	No			No	1	23.33	11.1	1
9356	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2015	III	0	1.8		Yes or Unknown	Yes or Unknown			No	1	35.61	15.64	1
9357	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	0	16.7		No	No	Signature.5		No	1	10.32	5.06	1
9358	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2017	IV	280	6.1	Stable	No	Yes or Unknown		SLX4	No	0	29.6	9.72	1
9359	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	0	3.5		No	No	Signature.1		No	1	21.26	1.51	1
9360	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	25	6.1		No	No	Signature.4	MRE11A | TP53BP1	No	1	16.39	10.02	1
9361	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	5.3		No	No	Signature.3		No	1	4.04	0.62	1
9362	ICI-treated	ICI as subsequent line	36 - 40	Female	Endometrial	2016	IV	32	3.5	Stable	No	No		ARID1A | ATM | BRCA2	No	0	30.26	10.32	1
9363	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	II	480	2.6	Stable	No	No			Yes	0	29.37	16.46	1
9364	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	18	5.3	Stable	No	No	Signature.1		No	0	29.9	0.92	1
9365	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2016	IV	301	3.5		Yes or Unknown	Yes or Unknown			No	1	24.84	20.04	1
9366	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2016	IV	0	8.8	Stable	No	Yes or Unknown	Signature.24		No	1	6.9	4.17	1
9367	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	20	48.3		No	Yes or Unknown	Signature.4	ATM | BLM | MRE11A | RAD51C | RAD54L	No	0	22.83	2.04	1
9368	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2016	II	0	9.7	Stable	No	No	Signature.2		No	1	17.25	15.18	1
9369	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	41	3.5		No	Yes or Unknown			No	1	9.56	7.85	1
9370	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2017	III	42	17.6		No	No	Signature.7	BRCA1 | MDC1 | MSH6 | SLX4	No	0	26.74	1.61	1
9371	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	0	10.5		No	No	Signature.13		Yes	1	4.9	0.46	1
9372	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2016		1	2.6		Yes or Unknown	Yes or Unknown			No	1	13.8	10.81	1
9373	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.1		No	1	14.75	1.18	1
9374	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2015	I	459	10.5		Yes or Unknown	Yes or Unknown	Signature.7	BRCA2 | ERCC5 | TP53BP1	No	1	38.28	19.98	1
9375	ICI-treated	ICI as subsequent line	51 - 55	Male	SCLC	2017	IV	0	9.7		No	No	Signature.5	RAD52	No	0	29.6	3.65	1
9376	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2016	IV	456	5.3	Stable	No	Yes or Unknown	Signature.1		No	1	23.75	14.52	1
9377	ICI-treated	ICI as subsequent line	76 - 80	Male	Head & Neck	2017	IV	490	2.6	Stable	No	Yes or Unknown	Signature.2		No	0	29.17	16.39	1
9378	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	1	7.9		No	No	Signature.4		Yes	1	1.02	0.59	1
9379	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	II	15	7.9	Stable	No	No	Signature.4	ATM | MSH3	No	0	26.94	21.88	1
9380	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2015	I	494	8.8		Yes or Unknown	Yes or Unknown	Signature.7		No	0	44.78	17.12	1
9381	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2017	III	6	14		No	No	Signature.4	ERCC5 | NTHL1	No	0	28.02	12.42	1
9382	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2017	IV	0	1.8	Stable	No	No			No	1	8.8	7.89	1
9383	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	III	42	0		No	No			No	0	30.29	19.58	1
9384	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2016	III	33	0.9	Stable	No	No			Yes	1	7.92	4.37	1
9385	ICI-treated	ICI as subsequent line	51 - 55	Female	Breast	2016	II	231	2.6		Yes or Unknown	Yes or Unknown			No	1	35.25	28.81	1
9386	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2016	I	608	8.8	Stable	No	Yes or Unknown	Signature.3		No	1	24.11	20.96	1
9387	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	30	7	Stable	No	Yes or Unknown	Signature.13	BLM	No	1	7.56	4.11	1
9388	ICI-treated	ICI as subsequent line	31 - 35	Female	Renal	2017	IV	57	0.9	Stable	No	No			No	1	28.78	14.36	1
9389	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	III	59	3.5	Stable	No	Yes or Unknown			No	0	29.21	16.92	1
9390	ICI-treated	ICI as subsequent line	26 - 30	Male	Colorectal	2017	IV	4	8.8	Stable	No	Yes or Unknown	Signature.1		No	0	13.63	10.87	1
9391	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2016	IV	419	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	17.25	13.96	1
9392	ICI-treated	ICI as first line	76 - 80	Female	Cutaneous Melanoma 	2017	III	45	17.6	Stable	No	No	Signature.7		Yes	0	23.49	18.2	1
9393	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	I	0	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	25.33	24.54	1
9394	ICI-treated	ICI - unknown sequence	56 - 60	Male	Renal	2017	III	73	2.6	Stable	No	No			No	0	29.21	0.79	1
9395	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2016	IV	0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.3	MSH3	No	1	25.4	8.11	1
9396	ICI-treated	ICI as subsequent line	66 - 70	Female	Gastric	2017	II	143	3.5	Stable	No	Yes or Unknown			No	1	17.68	13.7	1
9397	ICI-treated	ICI as subsequent line	41 - 45	Female	CNS	2017		5	6.1		No	No		PARP1	No	1	16.82	8.25	1
9398	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	4	2.6	Stable	No	No			No	1	18.69	14.39	1
9399	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.3	MUTYH	No	1	14.49	7.1	1
9400	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	18	6.1	Stable	No	Yes or Unknown		ARID1A	No	0	28.94	14.23	1
9401	ICI-treated	ICI as subsequent line	41 - 45	Male	Sarcoma	2016	I	825	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	29.27	27.37	1
9402	ICI-treated	ICI as subsequent line	51 - 55	Female	Renal	2017	IV	19	1.8	Stable	No	Yes or Unknown			No	0	29.86	19.94	1
9403	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2015	II	465	22.8		Yes or Unknown	Yes or Unknown	Signature.7	BRCA1 | ERCC3 | MDC1 | MSH3	No	1	31.87	28.29	1
9404	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	0	4.4	Stable	No	No			No	0	28.58	12.42	1
9405	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		7	7		Yes or Unknown	Yes or Unknown		FANCA	No	1	19.22	12.42	1
9406	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	ATM	No	1	26.51	16.3	1
9407	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	III	0	6.1	Stable	No	No	Signature.29	ATM	No	0	27.17	16.79	1
9408	ICI-treated	ICI - unknown sequence	41 - 45	Female	Head & Neck	2017	II	42	4.4	Stable	No	No			No	0	28.81	0.72	1
9409	ICI-treated	ICI as first line	56 - 60	Male	Renal	2017	IV	37	7	Stable	No	No		ATM	Yes	0	28.98	3.78	1
9410	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2017	III	22	6.1	Stable	No	No		MDC1	No	0	28.16	8.74	1
9411	ICI-treated	ICI as subsequent line	56 - 60	Female	Renal	2017	IV	19	5.3	Stable	No	Yes or Unknown		BRCA1 | BRCA2	No	1	13.9	7.56	1
9412	ICI-treated	ICI as first line	46 - 50	Female	CNS	2017		0	2.6	Stable	No	No			No	1	23.92	0.69	1
9413	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	221	2.6	Stable	No	Yes or Unknown			No	1	14.72	8.9	1
9414	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2017	IV	2	19.3	Stable	No	Yes or Unknown	Signature.4	BLM | MUTYH	No	0	28.39	9.49	1
9415	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	74	0		No	No			No	0	29.96	18.89	1
9416	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	III	36	6.1	Stable	No	No	Signature.13		No	1	23.92	9.63	1
9417	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	27	4.4		No	No		SLX4	Yes	1	2	1.54	1
9418	ICI-treated	ICI as subsequent line	36 - 40	Male	Pancreatic	2016	II	24	3.5	Stable	No	No			No	0	31.67	22.64	1
9419	ICI-treated	ICI as subsequent line	61 - 65	Male	Pancreatic	2017	IV	11	1.8		No	No			No	1	23.62	12.02	1
9420	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	7	10.5		No	No	Signature.1	BRIP1 | MLH1 | MUTYH	No	1	5.45	3.91	1
9421	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2017	III	419	5.3	Stable	No	No	Signature.7		No	0	28.48	14.19	1
9422	ICI-treated	ICI as first line	81 - 85	Female	Cutaneous Melanoma 	2016	II	290	178.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | ATR | BRCA2 | ERCC3 | ERCC4 | MDC1 | MSH3 | NTHL1 | SLX4 | XRCC2	Yes	0	37.09	10.18	1
9423	ICI-treated	ICI as subsequent line	10-Jun	Male	Sarcoma	2017	IV	0	0.9	Indeterminate	No	No			No	1	22.24	13.4	1
9424	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	0	7	Stable	No	No	Signature.2	BRCA2	No	1	15.67	7.85	1
9425	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2017	IV	28	11.4	Stable	No	No	Signature.2		Yes	1	6.21	1.58	1
9426	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2016	III	0	4.4	Stable	Yes or Unknown	Yes or Unknown		MRE11A	No	1	14.49	6.44	1
9427	ICI-treated	ICI as subsequent line	51 - 55	Female	Bladder	2017	IV	34	16.7	Stable	No	No	Signature.4	MDC1 | SLX4	No	1	23.79	8.21	1
9428	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2016	III	0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	32.95	10.78	1
9429	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	IV	0	1.8	Stable	No	No			No	1	18.99	17.71	1
9430	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2015	I	38	7	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	1	32.76	16.43	1
9431	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	11	4.4	Stable	No	No			No	0	28.65	1.08	1
9432	ICI-treated	ICI as subsequent line	51 - 55	Male	Gastric	2017	IV	16	8.8	Stable	No	No	Signature.17	ATM	No	1	22.08	7.59	1
9433	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	43	55.3	Stable	No	Yes or Unknown	Signature.7	ARID1A | BRCA1 | ERCC4 | MDC1 | MLH1 | PMS1	No	1	12.75	1.05	1
9434	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	13	15.8	Stable	No	Yes or Unknown	Signature.4	CHEK2 | ERCC3	No	1	9.79	8.21	1
9435	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2016	IV	0	1.8	Indeterminate	Yes or Unknown	Yes or Unknown			No	1	18.2	14.36	1
9436	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	0	26.3	Stable	No	No	Signature.4	ATM | BRCA2 | MDC1 | SLX4	No	0	28.81	16.82	1
9437	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2017	III	41	18.4	Stable	No	No	Signature.7		Yes	0	28.29	3.68	1
9438	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2015	IV	701	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	31.41	23.06	1
9439	ICI-treated	ICI as first line	56 - 60	Female	Cutaneous Melanoma 	2017	II	29	37.7	Stable	No	No	Signature.7	ARID1A | MLH1 | TP53BP1	Yes	0	28.91	1.41	1
9440	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	34	0	Stable	No	No			No	1	11.93	2.07	1
9441	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2016	III	259	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.14		No	0	18.23	13.34	1
9442	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	III	16	7.9	Stable	No	No	Signature.4	BRCA1	No	1	21.39	15.61	1
9443	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2017		0	7	Stable	Yes or Unknown	Yes or Unknown			No	0	28.48	13.57	1
9444	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2017		0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	24.71	10.48	1
9445	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2015	III	29	7	Stable	Yes or Unknown	Yes or Unknown			No	0	45.34	17.87	1
9446	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	III	0	0	Stable	No	No			No	0	28.78	12.52	1
9447	ICI-treated	ICI as subsequent line	46 - 50	Female	Pancreatic	2016	II	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	34.56	26.91	1
9448	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2017	IV	55	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ATM	No	1	20.17	10.97	1
9449	ICI-treated	ICI - unknown sequence	56 - 60	Female	Renal	2017	III	70	3.5	Stable	No	No			No	0	26.71	0.59	1
9450	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	0	21.1	Stable	No	No	Signature.4	ERCC3	No	0	27.56	14.19	1
9451	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017		453	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	27.83	16.1	1
9452	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2016	IV	75	0		No	No			No	0	31.11	14.13	1
9453	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2017		14	6.1	Stable	No	No		FANCA	No	0	27.6	1.12	1
9454	ICI-treated	ICI as subsequent line	41 - 45	Male	Head & Neck	2017	II	0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	29.86	13.34	1
9455	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2016	IV	0	58.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ATM | ATR | BRCA2 | MLH1 | PMS1	No	1	27.24	5.52	1
9456	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2017	IV	10	14	Stable	No	No	Signature.13		No	0	27.7	11.83	1
9457	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2017	IV	279	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	16.1	14.16	1
9458	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	I	19	36.9	Stable	No	No	Signature.4		No	0	26.84	8.51	1
9459	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2016	III	311	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	28.98	25.36	1
9460	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2017	IV	22	4.4	Stable	No	No	Signature.2		No	0	28.65	19.52	1
9461	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2017	IV	0	7	Stable	No	No	Signature.13	ARID1A	No	1	12.52	5.75	1
9462	ICI-treated	ICI as subsequent line	66 - 70	Male	Renal	2017	III	0	4.4	Stable	No	No			No	1	14.42	5.42	1
9463	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	0	2.6	Stable	No	No			Yes	1	10.28	1.15	1
9464	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	26	23.7	Stable	No	No	Signature.4	ARID1A | BLM	No	0	27.83	15.41	1
9465	ICI-treated	ICI as subsequent line	21 - 25	Female	Renal	2017	IV	0	0.9	Stable	No	Yes or Unknown		ATM	No	1	22.28	4.86	1
9466	ICI-treated	ICI as subsequent line	26 - 30	Male	Esophageal	2016	III	0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	35.35	13.08	1
9467	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2016	III	0	8.8	Stable	No	No	Signature.4		No	1	11.93	11.27	1
9468	ICI-treated	ICI as subsequent line	71 - 75	Female	Renal	2017	IV	36	6.1	Stable	No	Yes or Unknown	Signature.3	SLX4	No	1	17.41	11.73	1
9469	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	1	13.2	Stable	No	No	Signature.26		No	1	24.08	6.57	1
9470	ICI-treated	ICI as first line	76 - 80	Male	Hepatobiliary	2017	IV	171	3.5	Stable	No	No			Yes	0	29.14	6.14	1
9471	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2017	IV	0	5.3	Stable	No	No	Signature.7	BRCA1	No	0	27.56	0.89	1
9472	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2017	IV	209	14	Stable	No	Yes or Unknown	Signature.4	ARID1A	No	1	12.71	7.52	1
9473	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2017	IV	20	0.9	Stable	No	No			No	1	6.11	0.89	1
9474	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		1	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	17.54	9.95	1
9475	ICI-treated	ICI as subsequent line	36 - 40	Female	Hepatobiliary	2017	IV	0	1.8	Stable	No	No			No	1	8.08	6.14	1
9476	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2016	IV	3	6.1	Stable	No	Yes or Unknown	Signature.4	MDC1	No	0	31.38	4.3	1
9477	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	III	274	7	Stable	No	Yes or Unknown			No	0	24.87	18.04	1
9478	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	IV	22	55.3	Stable	No	No	Signature.7	ATM | BLM | CHEK1	No	0	18.63	7.82	1
9479	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2017	III	56	9.7	Stable	No	No			No	1	11.3	6.9	1
9480	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	14	0.9	Stable	No	No			No	1	21.39	1.02	1
9481	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	III	0	10.5	Stable	No	No	Signature.4	BRCA2 | MSH2	No	0	27.56	6.24	1
9482	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	4	5.3	Stable	No	No			Yes	1	6.57	5.49	1
9483	ICI-treated	ICI as first line	66 - 70	Male	Hepatobiliary	2016	II	322	7	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	1	19.45	10.97	1
9484	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	32	6.1	Stable	No	No		ARID1A	No	1	20.76	18.2	1
9485	ICI-treated	ICI as first line	61 - 65	Female	Bladder	2017	IV	0	22.8	Stable	No	No	Signature.2	ATM | CHEK2	No	0	26.87	1.12	1
9486	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2017	II	131	4.4	Stable	No	Yes or Unknown			No	1	7.52	6.6	1
9487	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	II	454	7	Stable	No	Yes or Unknown	Signature.4		No	1	16.82	6.24	1
9488	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2017	III	388	1.8	Stable	Yes or Unknown	Yes or Unknown		MDC1	No	0	23.06	14.09	1
9489	ICI-treated	ICI as subsequent line	21 - 25	Male	Renal	2017	IV	29	0.9	Stable	No	Yes or Unknown			No	1	21.49	15.74	1
9490	ICI-treated	ICI as subsequent line	56 - 60	Female	CNS	2017		17	3.5	Stable	No	No		BRCA1	No	1	19.25	10.97	1
9491	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2017	II	27	11.4	Stable	No	No	Signature.4		Yes	0	27.6	20.14	1
9492	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	7	13.2	Stable	No	No	Signature.4	XRCC2	No	1	14.88	6.87	1
9493	ICI-treated	ICI as subsequent line	26 - 30	Female	Breast	2016	IV	277	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.5	BRCA2	No	0	36.24	9.33	1
9494	ICI-treated	ICI as subsequent line	66 - 70	Female	Breast	2017	IV	22	4.4	Stable	No	No	Signature.1		No	0	26.94	15.9	1
9495	ICI-treated	ICI - unknown sequence	41 - 45	Female	CNS	2016		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	19.91	5.85	1
9496	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2017	IV	11	12.3	Stable	No	No	Signature.13	ARID1A	No	1	7.39	0.92	1
9497	ICI-treated	ICI - unknown sequence	61 - 65	Female	CNS	2017		5	22.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ATR | MSH2	No	0	26.94	11.79	1
9498	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	409	4.4	Stable	No	Yes or Unknown			No	0	27.53	14.65	1
9499	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2016	IV	540	6.1	Stable	Yes or Unknown	Yes or Unknown		BLM	No	0	36.8	18.2	1
9500	ICI-treated	ICI as first line	66 - 70	Male	Esophageal	2017	II	15	4.4	Stable	No	No	Signature.1	ARID1A	No	0	27.47	0.69	1
9501	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	21	9.7	Stable	No	No	Signature.4		No	1	14.92	2.46	1
9502	ICI-treated	ICI as first line	56 - 60	Male	Esophageal	2017	III	176	9.7	Stable	No	Yes or Unknown			No	0	27.89	1.12	1
9503	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	II	0	12.3	Stable	No	No	Signature.4		No	0	24.77	14.06	1
9504	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	II	0	13.2	Stable	No	No	Signature.4		No	0	25.79	0.49	1
9505	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	186	2.6	Stable	No	Yes or Unknown	Signature.5		No	1	10.84	3.81	1
9506	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2017	III	0	8.8	Stable	No	No		ARID1A | PARP1	No	1	15.97	8.97	1
9507	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	3	21.9	Indeterminate	No	No	Signature.4	TP53BP1	No	1	7.75	6.14	1
9508	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2017	II	213	3.5	Stable	No	Yes or Unknown	Signature.1	ARID1A	No	1	22.67	7.33	1
9509	ICI-treated	ICI as first line	46 - 50	Male	Esophageal	2017	III	0	0.9	Stable	No	No			No	1	15.77	0.92	1
9510	ICI-treated	ICI as subsequent line	51 - 55	Female	Gastric	2017	III	15	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	17.48	15.34	1
9511	ICI-treated	ICI as subsequent line	21 - 25	Male	Sarcoma	2017	IV	113	0.9	Stable	No	No			No	0	28.48	14.13	1
9512	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown			No	1	7.23	6.01	1
9513	ICI-treated	ICI as subsequent line	46 - 50	Female	Endometrial	2017	III	19	37.7	Unstable	No	No	Signature.6	ARID1A | BLM | BRCA2 | ERCC5 | MLH1 | PARP1	No	0	25.26	13.67	1
9514	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2017	IV	4	4.4	Stable	No	No		BLM | PARP1	No	1	9.46	5.29	1
9515	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	IV	110	0		No	Yes or Unknown			No	0	27.37	11.96	1
9516	ICI-treated	ICI - unknown sequence	51 - 55	Male	CNS	2017		9	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	13.67	11.1	1
9517	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2015	IV	844	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATM | BRCA1	No	0	53.06	36.44	1
9518	ICI-treated	ICI as subsequent line	26 - 30	Male	Renal	2017	IV	15	0.9	Stable	No	Yes or Unknown			No	1	13.77	12.88	1
9519	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	I	46	8.8	Stable	No	No	Signature.4		Yes	0	27.47	16.2	1
9520	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.13		No	0	9.76	5.03	1
9521	ICI-treated	ICI as first line	61 - 65	Male	Head & Neck	2017	IV	33	1.8	Stable	No	No	Signature.1	ARID1A	No	0	26.58	1.74	1
9522	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	0	12.3	Stable	No	No	Signature.4	ERCC2 | ERCC5	No	1	13.54	3.91	1
9523	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	0	15.8	Stable	No	No	Signature.4		No	0	27.56	8.51	1
9524	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	32	1.8	Stable	No	No			No	0	3.35	1.41	1
9525	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2015	III	582	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ARID1A | ATM | FANCA	No	0	48.33	22.34	1
9526	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2017	III	4	3.5	Stable	No	No			No	0	26.61	5.29	1
9527	ICI-treated	ICI as subsequent line	41 - 45	Female	Colorectal	2017	IV	11	5.3	Stable	No	No			No	1	22.64	17.64	1
9528	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	8	3.5	Stable	No	Yes or Unknown			No	1	25.72	16.2	1
9529	ICI-treated	ICI as subsequent line	31 - 35	Female	Sarcoma	2016	II	133	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	14.29	13.86	1
9530	ICI-treated	ICI as first line	36 - 40	Male	NSCLC	2017	IV	81	3.5	Stable	No	No			No	0	27.3	3.38	1
9531	ICI-treated	ICI as subsequent line	51 - 55	Female	SCLC	2017	III	0	7.9	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.20	SLX4	No	0	26.61	7.29	1
9532	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	18.4	Stable	No	Yes or Unknown	Signature.4	ATM | BRIP1 | PALB2 | TP53BP1	No	0	26.22	0.82	1
9533	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2017	IV	63	1.8	Stable	No	No			No	1	15.18	0.72	1
9534	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	21	9.7	Stable	No	No	Signature.3	ARID1A	Yes	1	6.21	1.38	1
9535	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	0	0		No	No			No	0	26.68	0.95	1
9536	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2015	III	96	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	27.1	25.23	1
9537	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	46	13.2	Stable	No	No	Signature.4	ATM | BRCA1 | CHEK2 | FANCA | PALB2	Yes	0	27.14	2.1	1
9538	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	316	7	Stable	No	Yes or Unknown	Signature.16	ATM | BRCA2	No	0	25.72	11.47	1
9539	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2017	II	181	3.5	Stable	No	Yes or Unknown	Signature.3	ARID1A	No	1	17.08	15.31	1
9540	ICI-treated	ICI as subsequent line	71 - 75	Male	Head & Neck	2015	IV	635	7	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | ATR	No	1	34.63	23.75	1
9541	ICI-treated	ICI as subsequent line	31 - 35	Male	Esophageal	2016	II	109	43	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH2	No	1	25.63	24.8	1
9542	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	1.8	Stable	No	No			Yes	1	2.07	1.08	1
9543	ICI-treated	ICI as subsequent line	26 - 30	Male	NSCLC	2017	IV	31	1.8	Stable	No	No			No	0	27.3	10.18	1
9544	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.3	PMS2	No	1	5.16	1.08	1
9545	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	0	7	Stable	No	Yes or Unknown		ARID1A | ATM	No	1	15.34	11.63	1
9546	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.3		No	1	9.95	0.92	1
9547	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	96	17.6	Stable	Yes or Unknown	Yes or Unknown	Signature.5	ERCC5 | NTHL1	No	1	13.8	4.7	1
9548	ICI-treated	ICI as subsequent line	46 - 50	Female	Pancreatic	2016	II	303	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	22.01	19.94	1
9549	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	127	9.7	Stable	No	Yes or Unknown	Signature.4	RAD50	No	1	5.42	4.47	1
9550	ICI-treated	ICI as subsequent line	71 - 75	Male	SCLC	2016	IV	0	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	SLX4	No	1	24.15	9.2	1
9551	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2017	III	45	7.9	Stable	No	No	Signature.2		No	1	20.11	0.92	1
9552	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	BRCA2 | MSH2 | NBN | SLX4	No	0	26.58	13.77	1
9553	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	231	0.9	Stable	No	Yes or Unknown			No	1	17.28	14.13	1
9554	ICI-treated	ICI as subsequent line	26 - 30	Female	Ovarian	2017	IV	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	19.42	7.72	1
9555	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2015	II	12	79.9	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATM | ATR | ERCC5 | MRE11A | MSH3	Yes	1	26.48	19.75	1
9556	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	10	16.7	Stable	No	No	Signature.4	MSH2	No	0	25.95	3.52	1
9557	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	431	7	Stable	No	Yes or Unknown	Signature.4		No	1	23.2	1.68	1
9558	ICI-treated	ICI as subsequent line	36 - 40	Female	Colorectal	2016	IV	426	6.1	Stable	Yes or Unknown	Yes or Unknown			No	0	37.88	23.52	1
9559	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	I	373	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.24		Yes	0	25.33	12.81	1
9560	ICI-treated	ICI as first line	61 - 65	Female	Gastric	2017	IV	0	4.4	Stable	No	No	Signature.8	ATR | MDC1	Yes	1	9.33	1.45	1
9561	ICI-treated	ICI as subsequent line	46 - 50	Male	Breast	2017	II	532	36	Stable	No	Yes or Unknown	Signature.7	ATM | ATR | RAD52	No	0	26.97	18.2	1
9562	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2017	I	41	1.8	Stable	No	No			Yes	1	18.73	15.05	1
9563	ICI-treated	ICI as subsequent line	41 - 45	Female	Head & Neck	2017	II	55	4.4	Stable	No	No	Signature.13		No	0	24.11	18.96	1
9564	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	IV	21	44.8	Stable	No	No	Signature.7	MDC1 | MLH1	No	1	13.6	2.69	1
9565	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2015	III	16	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	32.85	20.11	1
9566	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	0	1.8	Stable	No	No			No	1	18	7.72	1
9567	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2017	IV	87	3.5	Stable	No	Yes or Unknown	Signature.5		No	0	25.2	0.82	1
9568	ICI-treated	ICI as subsequent line	71 - 75	Male	SCLC	2017	IV	170	15.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	TP53BP1	No	1	6.77	6.41	1
9569	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	II	252	17.6	Stable	No	No	Signature.7	ARID1A | PALB2	No	0	25.59	6.67	1
9570	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	II	93	11.4	Stable	No	No	Signature.13	BRCA1	No	0	28.35	10.18	1
9571	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2017	IV	5	43.9	Unstable	No	No	Signature.1	ARID1A | CHEK2 | FANCA | MSH6	No	1	24.05	17.68	1
9572	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	0	21.1	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | TP53BP1	No	0	22.74	8.41	1
9573	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2017	I	0	7	Stable	No	No			No	0	22.37	1.25	1
9574	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	41	6.1	Stable	No	No	Signature.2	ARID1A	No	1	7.1	6.11	1
9575	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	III	15	17.6	Stable	No	No	Signature.7	BLM | BRCA2 | ERCC5 | MDC1	Yes	0	25.53	3.19	1
9576	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	II	202	31.6	Stable	No	No	Signature.7	ARID1A	Yes	0	22.54	7.2	1
9577	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	II	403	41.3	Stable	No	No	Signature.7	BRCA2 | CHEK2	Yes	0	25.46	13.27	1
9578	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	II	453	0	Stable	Yes or Unknown	Yes or Unknown			No	0	23.66	13.21	1
9579	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	I	71	7.9	Stable	No	No		ARID1A	No	0	28.75	16.16	1
9580	ICI-treated	ICI as subsequent line	51 - 55	Female	Cutaneous Melanoma 	2017		28	14.9	Stable	No	No	Signature.7	SLX4	No	0	26.02	15.9	1
9581	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	I	29	52.7	Unstable	No	No	Signature.6	MLH1	No	0	25.95	12.68	1
9582	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	17	0.9	Stable	No	No			No	1	8.77	6.54	1
9583	ICI-treated	ICI as subsequent line	51 - 55	Female	Esophageal	2017	III	0	43.9	Unstable	No	No	Signature.6	ARID1A | BRIP1 | RAD50	No	0	25.72	6.64	1
9584	ICI-treated	ICI - unknown sequence	46 - 50	Male	CNS	2017		5	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	22.51	11.53	1
9585	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	269	2.6	Stable	No	Yes or Unknown	Signature.3		No	0	25.86	12.45	1
9586	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2017	III	21	1.8	Stable	No	No			No	0	25.69	0.89	1
9587	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	28	5.3	Stable	No	No	Signature.4		No	1	11.4	9.59	1
9588	ICI-treated	ICI as subsequent line	66 - 70	Female	Esophageal	2017	IV	21	33.4	Unstable	No	Yes or Unknown	Signature.6	BLM | MDC1 | TP53BP1	No	0	8.44	6.9	1
9589	ICI-treated	ICI as subsequent line	46 - 50	Female	Colorectal	2017	III	88	2.6	Stable	Yes or Unknown	Yes or Unknown		MLH1	No	1	13.34	3.75	1
9590	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2017	I	0	7	Stable	No	No	Signature.5		No	0	24.84	5.68	1
9591	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	IV	34	3.5	Stable	No	No	Signature.24		No	1	24.05	9.63	1
9592	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	II	370	6.1	Stable	No	Yes or Unknown	Signature.24	ATM	No	1	25.99	9.82	1
9593	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	0	7.9	Stable	No	No	Signature.18		No	0	24.15	5.72	1
9594	ICI-treated	ICI as subsequent line	71 - 75	Female	Pancreatic	2017	IV	0	10.5	Stable	No	No	Signature.1	ARID1A | ERCC3	No	1	22.24	18.1	1
9595	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	0	5.3	Stable	No	No	Signature.7		No	0	25.26	0.39	1
9596	ICI-treated	ICI as first line	86 - 90	Male	Cutaneous Melanoma 	2017	IV	39	52.7	Stable	No	No	Signature.7	ERCC5 | MSH6 | SLX4	Yes	0	25.53	1.58	1
9597	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2017	III	28	13.2	Stable	No	No	Signature.7	MLH1	No	0	24.51	5.19	1
9598	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	III	344	14.9	Stable	No	Yes or Unknown	Signature.4	MSH2	No	0	26.87	11.7	1
9599	ICI-treated	ICI as subsequent line	66 - 70	Male	Hepatobiliary	2017	II	0	0	Stable	No	No			No	0	10.41	10.41	1
9600	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	17	7	Stable	No	No	Signature.7		Yes	0	20.9	1.35	1
9601	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	613	6.1	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.1		No	0	44.32	24.97	1
9602	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	IV	0	6.1	Stable	No	No	Signature.8		No	0	24.25	16.33	1
9603	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	26	8.8	Indeterminate	No	No	Signature.4		Yes	1	3.29	2	1
9604	ICI-treated	ICI as subsequent line	51 - 55	Male	Head & Neck	2015	IV	1182	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	44.45	40.9	1
9605	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	I	141	29.8	Unstable	No	Yes or Unknown	Signature.6	ARID1A | MRE11A	No	1	16.82	4.9	1
9606	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	22	0.9	Stable	No	No			No	1	11.37	9.56	1
9607	ICI-treated	ICI as subsequent line	36 - 40	Male	Sarcoma	2017	II	292	0	Stable	No	No			No	1	19.88	13.01	1
9608	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	I	0	3.5	Stable	No	No			No	0	25.13	2.5	1
9609	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	22	7.9	Stable	No	No	Signature.4		No	0	24.64	14.49	1
9610	ICI-treated	ICI as first line	76 - 80	Female	Bladder	2017	III	78	6.1	Stable	Yes or Unknown	Yes or Unknown			Yes	0	28.78	6.41	1
9611	ICI-treated	ICI as subsequent line	61 - 65	Male	Renal	2017	IV	176	4.4	Stable	No	Yes or Unknown		ARID1A	No	0	25.46	4.63	1
9612	ICI-treated	ICI as first line	46 - 50	Male	Gastric	2017	IV	1	4.4	Stable	No	No			No	1	23.23	1.28	1
9613	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	27	75.5	Stable	No	No	Signature.7	ATR | PMS1 | PMS2	No	0	24.67	7.66	1
9614	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	26	5.3	Stable	No	No	Signature.24		No	0	26.32	6.31	1
9615	ICI-treated	ICI as subsequent line	26 - 30	Female	Head & Neck	2017	IV	2	4.4	Stable	No	No	Signature.3		No	1	18.33	14.29	1
9616	ICI-treated	ICI as subsequent line	31 - 35	Male	Cutaneous Melanoma 	2017	III	0	11.4	Indeterminate	No	No	Signature.7		No	1	19.91	13.34	1
9617	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2015	III	165	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	38.18	33.84	1
9618	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	16	5.3	Stable	No	No	Signature.4		No	1	9.89	5.91	1
9619	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2017	IV	46	1.8	Stable	No	Yes or Unknown			No	1	10.28	4.07	1
9620	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2017	IV	0	6.1	Indeterminate	No	No	Signature.1		No	1	9.46	8.61	1
9621	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2017	III	67	17.6	Stable	No	No	Signature.4	ATM	No	1	21.75	0.72	1
9622	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	I	11	2.6	Stable	No	No			Yes	0	22.93	9.49	1
9623	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	10	0.9	Stable	No	No			No	0	24.15	10.05	1
9624	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	84	0.9	Stable	No	No	Signature.3		No	0	27.47	16.23	1
9625	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2016	II	281	36	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	33.41	12.25	1
9626	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2017	IV	0	2.6	Stable	No	No			No	1	17.64	6.77	1
9627	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2016	I	530	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	40.84	24.94	1
9628	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2016	I	399	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	30.72	26.48	1
9629	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2017	IV	280	5.3	Stable	No	Yes or Unknown		ATR	No	0	24.41	15.44	1
9630	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017	III	41	1.8	Stable	No	No	Signature.7		No	0	23.69	4.4	1
9631	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	0	6.1	Indeterminate	No	No	Signature.4	ATM	No	1	15.28	10.81	1
9632	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.4	CHEK1	No	1	13.5	5.49	1
9633	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	22	12.3	Stable	No	No	Signature.4		No	1	8.11	6.9	1
9634	ICI-treated	ICI as first line	76 - 80	Female	Gastric	2017	IV	392	2.6	Stable	No	Yes or Unknown		CHEK2	No	0	24.84	1.45	1
9635	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	18.4	Stable	No	No	Signature.4		No	1	6.9	3.02	1
9636	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	0	48.3	Stable	No	No	Signature.7	BRCA1 | BRCA2 | BRIP1 | PALB2 | RAD50	Yes	0	20.7	1.15	1
9637	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	0	23.7	Stable	No	No	Signature.4		No	0	24.28	8.87	1
9638	ICI-treated	ICI as subsequent line	16 - 20	Male	Sarcoma	2017	IV	7	0	Stable	No	No			No	1	13.73	9	1
9639	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	II	15	24.6	Stable	No	No	Signature.4	ARID1A | PMS1	No	0	23	1.22	1
9640	ICI-treated	ICI as subsequent line	36 - 40	Male	SCLC	2016	IV	0	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	1	16.53	7.46	1
9641	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	III	13	8.8	Stable	No	No	Signature.4		No	0	23.16	0.89	1
9642	ICI-treated	ICI as first line	46 - 50	Male	Bladder	2017	IV	40	0.9	Stable	No	No			Yes	1	3.61	2.04	1
9643	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2017	IV	0	2.6	Stable	No	No			No	0	19.84	17.68	1
9644	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	14	3.5	Stable	No	No		RAD50	No	0	23.36	5.68	1
9645	ICI-treated	ICI as first line	41 - 45	Male	Bladder	2017	IV	38	17.6	Stable	No	No	Signature.13	MDC1	Yes	0	24.41	1.35	1
9646	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2017	IV	0	7	Stable	No	No	Signature.4	ARID1A | ATM	No	0	6.64	0.95	1
9647	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		7	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	18.63	16.1	1
9648	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2016	III	370	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	36.17	23.95	1
9649	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	12	14	Stable	No	No	Signature.4	ARID1A | BRCA1 | MSH3	No	0	23.23	8.05	1
9650	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	11	5.3	Stable	No	No		FANCA	No	1	13.6	10.02	1
9651	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	I	28	0		Yes or Unknown	Yes or Unknown			No	0	24.57	14.69	1
9652	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	44	4.4	Stable	No	No		BRCA1	Yes	1	2.6	2.23	1
9653	ICI-treated	ICI as subsequent line	71 - 75	Female	SCLC	2017	I	294	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	1	17.94	14.26	1
9654	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2016	IV	49	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	19.29	16.76	1
9655	ICI-treated	ICI as subsequent line	46 - 50	Male	Colorectal	2017	IV	26	4.4	Stable	No	No			No	0	25.4	15.57	1
9656	ICI-treated	ICI - unknown sequence	71 - 75	Male	Cutaneous Melanoma 	2017	III	0	39.5	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | ATM | MRE11A | PARP1	No	0	23.79	4.93	1
9657	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	IV	14	17.6	Stable	No	No	Signature.4		No	0	23.43	12.35	1
9658	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017		0	5.3	Stable	Yes or Unknown	Yes or Unknown	Signature.13	ERCC5	No	1	17.05	12.06	1
9659	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	248	1.8	Stable	No	Yes or Unknown			No	1	16.89	10.35	1
9660	ICI-treated	ICI - unknown sequence	76 - 80	Male	NSCLC	2017	III	0	11.4	Stable	No	No	Signature.24	NBN | SLX4	No	0	22.51	0.2	1
9661	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2017	IV	0	8.8	Stable	No	No	Signature.8		No	1	13.9	7.23	1
9662	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	5	1.8	Stable	No	No			No	1	7.92	2.89	1
9663	ICI-treated	ICI as first line	61 - 65	Female	Cutaneous Melanoma 	2017	IV	5	13.2	Stable	No	No	Signature.7		Yes	0	22.7	1.31	1
9664	ICI-treated	ICI as subsequent line	56 - 60	Male	SCLC	2017	IV	2	6.1	Stable	No	Yes or Unknown	Signature.24		No	1	8.97	7.75	1
9665	ICI-treated	ICI as first line	31 - 35	Female	Gastric	2017	IV	17	2.6	Stable	No	No			No	0	19.19	1.94	1
9666	ICI-treated	ICI as first line	46 - 50	Female	Cutaneous Melanoma 	2017		0	2.6	Stable	No	No			No	1	9.69	0.79	1
9667	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	0	36.9	Stable	No	No	Signature.7	BRCA2 | ERCC3 | MLH1 | PMS2	No	1	14.42	1.05	1
9668	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	7	4.4	Stable	No	No	Signature.4		No	1	3.42	2.14	1
9669	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	10	3.5	Stable	No	No	Signature.17	ATM	No	1	18.76	1.15	1
9670	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	16	18.4	Stable	No	No	Signature.4		Yes	0	23.06	1.25	1
9671	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	II	33	3.5	Stable	No	No			No	1	18.79	8.44	1
9672	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	37	8.8	Stable	No	Yes or Unknown	Signature.4	ARID1A | SLX4	No	0	22.51	1.41	1
9673	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	0	2.6	Indeterminate	No	No	Signature.1	MSH2	No	0	13.73	7	1
9674	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2017	III	8	1.8	Stable	No	No			No	1	11.24	8.05	1
9675	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	II	209	47.4	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ATR | BRIP1 | ERCC4 | RAD51	No	0	24.51	7.1	1
9676	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.13	ATM | MSH6	No	0	22.05	10.48	1
9677	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		3	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	16.39	12.42	1
9678	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	IV	2	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	21.26	15.74	1
9679	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	III	118	0.9	Stable	No	No			No	0	24.25	2.43	1
9680	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2016	IV	754	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.2	BRCA1 | RAD50	No	1	29.93	25.63	1
9681	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	0	11.4	Stable	No	No	Signature.3		No	1	7.56	5.68	1
9682	ICI-treated	ICI as first line	46 - 50	Male	Cutaneous Melanoma 	2017	III	87	4.4	Stable	No	No			No	1	22.54	8.25	1
9683	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2017	I	20	1.8	Stable	No	No			No	0	23.16	11.07	1
9684	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	II	91	5.3	Stable	No	No	Signature.18	BRCA1	No	0	24.54	17.58	1
9685	ICI-treated	ICI as subsequent line	66 - 70	Male	Colorectal	2017	IV	24	22.8	Indeterminate	No	No	Signature.1	ATM	No	0	24.84	11.86	1
9686	ICI-treated	ICI as first line	36 - 40	Male	Renal	2017	IV	75	3.5	Stable	No	No			Yes	0	24.11	7.52	1
9687	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2017	II	112	14.9	Stable	No	Yes or Unknown	Signature.7		No	0	23.36	4.01	1
9688	ICI-treated	ICI as subsequent line	56 - 60	Male	Head & Neck	2016	II	239	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ATM | MSH3	No	0	29.67	9.89	1
9689	ICI-treated	ICI as subsequent line	46 - 50	Male	Cutaneous Melanoma 	2015	IV	43	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	1	36.27	36.04	1
9690	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	18	2.6	Stable	No	No	Signature.22		No	1	7.49	0.99	1
9691	ICI-treated	ICI as first line	71 - 75	Male	Esophageal	2017	IV	0	0.9	Stable	No	No	Signature.5		Yes	0	19.98	1.18	1
9692	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	III	18	14	Stable	No	No	Signature.7		No	0	22.74	3.12	1
9693	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	IV	162	40.4	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | BRCA2 | BRIP1 | SLX4	No	0	29.17	7.23	1
9694	ICI-treated	ICI as subsequent line	66 - 70	Female	Breast	2017	II	274	3.5	Indeterminate	No	Yes or Unknown	Signature.5	PMS2	No	0	24.38	9.69	1
9695	ICI-treated	ICI as subsequent line	41 - 45	Female	Endometrial	2017	IV	53	0.9	Stable	No	No			No	1	15.57	6.54	1
9696	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	0	8.8	Stable	No	No	Signature.24		No	1	8.71	1.38	1
9697	ICI-treated	ICI as first line	46 - 50	Male	Renal	2017	III	0	2.6	Stable	No	No			Yes	0	22.47	1.81	1
9698	ICI-treated	ICI as subsequent line	86 - 90	Male	Sarcoma	2017	IV	133	1.8	Stable	No	Yes or Unknown			No	0	22.74	4.47	1
9699	ICI-treated	ICI as subsequent line	46 - 50	Male	Renal	2017	IV	1	1.8	Stable	No	Yes or Unknown			No	0	22.87	3.09	1
9700	ICI-treated	ICI - unknown sequence	66 - 70	Female	Breast	2017	I	114	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	22.54	13.17	1
9701	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2017	IV	24	3.5	Stable	No	No			No	1	19.91	14.46	1
9702	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2017	II	194	6.1	Stable	No	No	Signature.7	MDC1	Yes	1	12.94	8.41	1
9703	ICI-treated	ICI as first line	76 - 80	Male	Bladder	2017	I	106	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	1	11.86	8.94	1
9704	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017		0	0		Yes or Unknown	Yes or Unknown			No	1	20.21	11.14	1
9705	ICI-treated	ICI as subsequent line	66 - 70	Male	Prostatic	2016	IV	342	65.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATM | ERCC4 | ERCC5 | MRE11A | MSH6	No	0	31.7	14.29	1
9706	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	0	7	Stable	No	No	Signature.24		No	0	20.3	0.23	1
9707	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2017	II	320	0	Stable	Yes or Unknown	Yes or Unknown			No	1	29.11	9.86	1
9708	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2017		23	99.2	Stable	Yes or Unknown	Yes or Unknown	Signature.7	ARID1A | BLM | BRCA2 | MDC1 | PALB2	No	0	23.06	10.87	1
9709	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	201	42.1	Stable	No	No	Signature.7	ATM | ATR | BRIP1 | ERCC2	No	0	21.39	1.38	1
9710	ICI-treated	ICI as first line	86 - 90	Male	Bladder	2017	IV	138	6.1	Stable	No	Yes or Unknown	Signature.2		Yes	1	5.72	1.64	1
9711	ICI-treated	ICI as subsequent line	51 - 55	Female	Pancreatic	2017	II	155	3.5	Stable	No	Yes or Unknown			No	1	11.66	6.24	1
9712	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			Yes	0	20.73	1.31	1
9713	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	24.6	Stable	No	No	Signature.4		No	1	9.26	8.34	1
9714	ICI-treated	ICI as subsequent line	31 - 35	Female	Sarcoma	2017	IV	224	7		No	Yes or Unknown	Signature.5	ERCC2	No	0	21.88	6.24	1
9715	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	41	6.1	Stable	No	No			No	0	23.16	14.32	1
9716	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	2	6.1		No	No	Signature.26		No	1	5.85	3.38	1
9717	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	22	14.9	Stable	No	No	Signature.13	ATM	No	0	22.54	2.66	1
9718	ICI-treated	ICI - unknown sequence	36 - 40	Male	Cutaneous Melanoma 	2017	I	348	29	Stable	No	No	Signature.7	ARID1A | ERCC2 | MSH3 | RAD51C	No	0	21.85	12.19	1
9719	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2017	II	0	16.7	Stable	No	No	Signature.4	CHEK2	No	0	19.06	1.54	1
9720	ICI-treated	ICI as subsequent line	46 - 50	Male	Head & Neck	2017	IV	0	5.3	Stable	No	No			No	0	9.2	8.38	1
9721	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2017	II	13	9.7	Stable	No	No	Signature.30		No	1	10.45	7.75	1
9722	ICI-treated	ICI as subsequent line	71 - 75	Male	Prostatic	2017	IV	0	2.6	Stable	No	No			No	0	17.31	14.55	1
9723	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	0	3.5	Stable	No	No			No	1	9.86	6.18	1
9724	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	13.2	Stable	No	No	Signature.13		No	0	22.14	4.44	1
9725	ICI-treated	ICI as subsequent line	61 - 65	Female	Sarcoma	2017	III	18	4.4	Stable	No	No			No	1	17.87	11.07	1
9726	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	21	2.6	Stable	No	Yes or Unknown			No	1	12.09	7.56	1
9727	ICI-treated	ICI as subsequent line	56 - 60	Male	Gastric	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	1	27.07	14.75	1
9728	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2017	IV	0	19.3	Stable	No	No	Signature.4	BRCA2 | ERCC4 | MRE11A	No	1	19.09	0.72	1
9729	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2017	IV	39	15.8	Stable	No	No	Signature.29		No	1	7.82	6.83	1
9730	ICI-treated	ICI as first line	31 - 35	Female	NSCLC	2017	IV	3	4.4	Stable	No	No	Signature.5		No	1	7.79	0.56	1
9731	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	29	5.3	Stable	No	No	Signature.5	BRCA2 | BRIP1	No	1	7.26	6.47	1
9732	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	IV	633	7	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	33.64	18.92	1
9733	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	III	16	12.3	Stable	No	No	Signature.4	ARID1A | ATM	No	1	7.46	5.06	1
9734	ICI-treated	ICI as subsequent line	71 - 75	Male	NSCLC	2017	IV	14	5.3	Stable	No	No	Signature.2		No	0	21.85	10.09	1
9735	ICI-treated	ICI as subsequent line	61 - 65	Male	Head & Neck	2017	IV	21	17.6	Stable	Yes or Unknown	Yes or Unknown	Signature.29	NTHL1 | PALB2	No	1	22.67	13.21	1
9736	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	III	58	4.4	Stable	No	No			No	0	23.2	2.1	1
9737	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	0	8.8	Stable	No	No	Signature.5	CHEK1 | FANCA | PALB2	No	0	18.4	3.68	1
9738	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	332	1.8	Stable	No	Yes or Unknown	Signature.1		No	0	22.97	11.27	1
9739	ICI-treated	ICI as first line	46 - 50	Male	Gastric	2017	IV	0	13.2	Stable	No	No	Signature.9		Yes	0	6.6	0.85	1
9740	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2017	IV	64	16.7	Indeterminate	No	No	Signature.6	ARID1A | PARP1	No	0	22.41	7.39	1
9741	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	III	0	13.2	Stable	No	No	Signature.4	PMS2	No	0	22.05	15.05	1
9742	ICI-treated	ICI as first line	56 - 60	Male	Sarcoma	2017	IV	19	16.7	Stable	No	No	Signature.4	ATR | MRE11A	Yes	0	22.64	1.94	1
9743	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2016	II	271	6.1	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.3	ATR | MRE11A	No	0	30.23	18.5	1
9744	ICI-treated	ICI - unknown sequence	41 - 45	Female	Cutaneous Melanoma 	2017	III	43	1.8	Stable	No	No			No	0	21.85	5.45	1
9745	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.4	MDC1	No	0	20.9	4.5	1
9746	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	16	10.5	Stable	No	No	Signature.4	ARID1A | ERCC4	No	1	13.57	6.01	1
9747	ICI-treated	ICI as subsequent line	76 - 80	Male	Hepatobiliary	2017	III	355	4.4	Stable	No	Yes or Unknown			No	0	22.05	7.82	1
9748	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2017	IV	39	7	Stable	No	Yes or Unknown	Signature.4		No	1	13.4	1.81	1
9749	ICI-treated	ICI as subsequent line	86 - 90	Male	NSCLC	2017	IV	0	6.1	Stable	No	No	Signature.2	RAD52	No	1	13.11	12.55	1
9750	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	0	3.5	Stable	No	No		CHEK1	No	1	11.33	3.35	1
9751	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2017	IV	30	6.1	Stable	No	No	Signature.13		No	1	10.38	1.81	1
9752	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	III	12	5.3	Stable	No	No	Signature.18	ERCC3	No	0	20.67	4.14	1
9753	ICI-treated	ICI as first line	26 - 30	Male	NSCLC	2017	IV	8	4.4	Stable	No	No			No	0	20.34	0.46	1
9754	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	192	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	14.82	8.02	1
9755	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	7	15.8	Stable	No	No	Signature.24	ARID1A | ERCC4	No	0	18.5	0.69	1
9756	ICI-treated	ICI as first line	56 - 60	Male	Gastric	2017	IV	0	6.1	Stable	No	No	Signature.3	PARP1	No	1	8.8	1.64	1
9757	ICI-treated	ICI as first line	56 - 60	Female	Bladder	2017	IV	5	19.3	Stable	No	No	Signature.13	ARID1A	No	0	19.61	1.45	1
9758	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	26	9.7	Stable	No	No	Signature.4	ATM | ERCC2	No	0	21.09	1.58	1
9759	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	11	12.3	Stable	No	No	Signature.30		Yes	0	20.86	0.59	1
9760	ICI-treated	ICI as first line	36 - 40	Male	Sarcoma	2017		0	0.9	Stable	No	No			No	0	21.49	1.15	1
9761	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	133	0		No	Yes or Unknown			No	1	11.47	8.94	1
9762	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	7	12.3	Stable	No	No	Signature.4	ERCC5 | MSH2	No	0	21.39	8.38	1
9763	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2017	IV	126	2.6	Stable	No	Yes or Unknown			No	0	6.93	4.21	1
9764	ICI-treated	ICI - unknown sequence	41 - 45	Male	CNS	2017		5	20.2	Stable	Yes or Unknown	Yes or Unknown	Signature.1	BRCA1	No	0	22.21	3.84	1
9765	ICI-treated	ICI as subsequent line	81 - 85	Female	Gastric	2017	IV	0	2.6	Stable	No	Yes or Unknown		PMS1	No	1	18.83	13.27	1
9766	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2017	IV	117	7.9	Stable	No	Yes or Unknown	Signature.1		No	1	18.92	9.33	1
9767	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	IV	117	24.6	Stable	No	No	Signature.4		Yes	0	21.45	7.39	1
9768	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	22	144.8	Stable	No	No	Signature.7	ARID1A | BLM | BRCA2 | MDC1 | PARP1 | SLX4 | TP53BP1	Yes	1	1.68	1.45	1
9769	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2016	IV	416	59.7	Stable	Yes or Unknown	Yes or Unknown	Signature.13	BRCA1 | BRCA2 | ERCC4 | MDC1 | MUTYH | NBN | PALB2 | PMS1 | TP53BP1	No	0	34.07	14.46	1
9770	ICI-treated	ICI as subsequent line	51 - 55	Male	Renal	2017	IV	0	3.5	Stable	No	No			No	1	11.76	7.92	1
9771	ICI-treated	ICI as subsequent line	51 - 55	Female	Hepatobiliary	2017	IV	0	10.5	Stable	No	No	Signature.13	ARID1A | CHEK2 | SLX4	No	1	15.44	12.35	1
9772	ICI-treated	ICI as subsequent line	36 - 40	Male	NSCLC	2016	III	141	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	30.32	11.17	1
9773	ICI-treated	ICI as first line	51 - 55	Male	Gastric	2017	IV	17	47.4	Unstable	No	No	Signature.26	ARID1A | ERCC2 | MSH6 | TP53BP1	Yes	0	20.83	1.25	1
9774	ICI-treated	ICI as first line	66 - 70	Female	Cutaneous Melanoma 	2017	IV	392	4.4	Stable	No	No			Yes	0	21.62	2.46	1
9775	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	IV	14	6.1	Stable	No	Yes or Unknown	Signature.4		No	1	19.52	4.96	1
9776	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2017	IV	9	2.6	Stable	No	Yes or Unknown			No	1	19.75	10.74	1
9777	ICI-treated	ICI as subsequent line	61 - 65	Male	Prostatic	2017	II	246	2.6	Stable	No	Yes or Unknown			No	0	22.05	12.22	1
9778	ICI-treated	ICI as first line	36 - 40	Male	Cutaneous Melanoma 	2017	IV	111	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	22.87	4.01	1
9779	ICI-treated	ICI - unknown sequence	51 - 55	Male	Cutaneous Melanoma 	2017	III	83	0.9	Stable	No	No			No	0	14.32	6.51	1
9780	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	7	8.8	Stable	No	No	Signature.5	BRCA2 | MRE11A	No	1	14.92	7.56	1
9781	ICI-treated	ICI as first line	31 - 35	Male	Colorectal	2017	III	130	368.6	Unstable	No	No	Signature.20	ARID1A | ATM | ATR | BLM | BRCA1 | BRCA2 | BRIP1 | CHEK1 | ERCC5 | FANCA | FANCC | MDC1 | MLH1 | MSH2 | MSH3 | MSH6 | MUTYH | NBN | PALB2 | PARP1 | PMS1 | RAD50 | RAD54L | SLX4 | TP53BP1	Yes	0	20.93	4.34	1
9782	ICI-treated	ICI as subsequent line	41 - 45	Male	Gastric	2017	IV	0	7.9	Stable	No	No	Signature.6	CHEK2	No	0	20.96	6.7	1
9783	ICI-treated	ICI as first line	81 - 85	Male	Cutaneous Melanoma 	2017		132	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.16		No	1	17.58	5.78	1
9784	ICI-treated	ICI as subsequent line	71 - 75	Female	Gastric	2017	IV	24	6.1	Indeterminate	No	No	Signature.5	ATM	No	0	12.06	11.89	1
9785	ICI-treated	ICI as subsequent line	56 - 60	Male	Renal	2016	IV	694	3.5	Stable	Yes or Unknown	Yes or Unknown			No	1	27.43	21.42	1
9786	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2017	IV	3	1.8	Stable	No	No		FANCA	No	1	17.18	8.28	1
9787	ICI-treated	ICI as subsequent line	66 - 70	Male	CNS	2017		7	1.8	Stable	No	No	Signature.26		No	0	20.63	9.36	1
9788	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2017	III	28	0	Stable	No	No			No	0	21.13	3.98	1
9789	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	III	32	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	22.54	11.27	1
9790	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	IV	0	4.4	Stable	No	No			No	1	10.51	4.93	1
9791	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	259	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	17.48	6.67	1
9792	ICI-treated	ICI as subsequent line	41 - 45	Male	NSCLC	2017	IV	397	11.4	Stable	No	Yes or Unknown	Signature.4	MSH3	No	1	19.52	3.84	1
9793	ICI-treated	ICI as subsequent line	46 - 50	Female	Breast	2017	III	0	2.6	Stable	No	No			No	1	10.25	9.26	1
9794	ICI-treated	ICI as subsequent line	66 - 70	Male	Cutaneous Melanoma 	2017	IV	75	3.5		Yes or Unknown	Yes or Unknown	Signature.1		No	1	3.45	2.14	1
9795	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2017	IV	0	5.3	Stable	No	No			No	1	18.43	1.15	1
9796	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2017	IV	0	12.3	Stable	No	No	Signature.7	SLX4	Yes	0	20.8	1.25	1
9797	ICI-treated	ICI as subsequent line	81 - 85	Male	NSCLC	2017	IV	0	7.9	Stable	No	No	Signature.24	ARID1A | ATM	No	1	16.62	3.75	1
9798	ICI-treated	ICI as subsequent line	66 - 70	Female	Hepatobiliary	2017	IV	0	2.6	Stable	No	No			No	1	12.71	11.96	1
9799	ICI-treated	ICI - unknown sequence	61 - 65	Female	Renal	2017	III	65	0.9	Stable	No	No			No	0	14.52	0.26	1
9800	ICI-treated	ICI - unknown sequence	66 - 70	Female	NSCLC	2017	I	52	25.5	Stable	No	No	Signature.4	MLH1	No	0	15.97	1.87	1
9801	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	IV	7	4.4	Stable	No	Yes or Unknown			No	0	20.93	12.12	1
9802	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	245	5.3	Stable	No	Yes or Unknown	Signature.4		No	0	15.44	1.31	1
9803	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	33	4.4	Stable	No	No	Signature.5	RAD50	No	1	9	0.92	1
9804	ICI-treated	ICI as subsequent line	46 - 50	Male	Hepatobiliary	2017	IV	0	3.5	Stable	No	No			No	0	10.41	8.11	1
9805	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	0	4.4	Stable	No	Yes or Unknown	Signature.2	ARID1A | BRCA2	No	0	22.24	2.07	1
9806	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2016	II	892	5.3	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.17	BRCA1	No	0	41.59	30.88	1
9807	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	0	27.2	Stable	No	No	Signature.4	FANCC	No	0	20.01	4.3	1
9808	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	8	20.2	Stable	No	No	Signature.4	SLX4	No	0	20.44	0.76	1
9809	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	IV	189	31.6	Unstable	No	Yes or Unknown	Signature.1	ARID1A | MSH2 | XRCC2	No	0	20.3	7.89	1
9810	ICI-treated	ICI as subsequent line	66 - 70	Female	SCLC	2017	IV	0	4.4	Stable	No	No	Signature.16		No	0	12.55	7.49	1
9811	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	IV	0	51.8	Stable	No	No	Signature.7	PMS1 | TP53BP1	Yes	0	20.8	4.7	1
9812	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	203	2.6	Stable	No	Yes or Unknown			No	0	19.32	7.1	1
9813	ICI-treated	ICI as first line	56 - 60	Male	Cutaneous Melanoma 	2017	IV	55	19.3	Stable	No	No	Signature.7		Yes	1	3.19	0.79	1
9814	ICI-treated	ICI as subsequent line	76 - 80	Male	Hepatobiliary	2017	IV	0	8.8	Stable	No	No	Signature.5		No	0	1.64	1.15	1
9815	ICI-treated	ICI as first line	46 - 50	Male	Renal	2017	III	151	7	Stable	Yes or Unknown	Yes or Unknown		ATM	Yes	0	24.77	14.65	1
9816	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	IV	23	4.4	Stable	No	No	Signature.4		No	0	20.17	0.79	1
9817	ICI-treated	ICI as subsequent line	56 - 60	Female	Pancreatic	2017	IV	12	2.6	Stable	No	No			No	1	7	4.99	1
9818	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	I	0	13.2	Stable	No	No	Signature.2	PMS2	No	0	20.37	8.41	1
9819	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	62	13.2	Stable	No	No	Signature.4	CHEK2 | RAD51C	No	1	8.57	2.76	1
9820	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	28	5.3	Stable	No	No		RAD50	Yes	1	1.84	1.74	1
9821	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	IV	60	11.4	Stable	No	No	Signature.29		Yes	0	21.39	7.13	1
9822	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2017	III	47	8.8	Stable	No	No	Signature.7		No	1	12.52	2.76	1
9823	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2017	IV	15	2.6	Stable	No	Yes or Unknown			No	0	20.27	1.18	1
9824	ICI-treated	ICI as first line	71 - 75	Male	Gastric	2017	IV	7	6.1	Stable	No	No	Signature.1		Yes	0	12.39	1.35	1
9825	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	III	26	9.7	Stable	No	No	Signature.7		No	0	20.37	3.35	1
9826	ICI-treated	ICI as subsequent line	46 - 50	Female	NSCLC	2017	IV	67	2.6	Stable	No	No			No	1	14.62	12.58	1
9827	ICI-treated	ICI as subsequent line	26 - 30	Male	Head & Neck	2017	IV	464	0	Stable	Yes or Unknown	Yes or Unknown			No	1	16.82	16.2	1
9828	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	II	20	7	Stable	No	No	Signature.29		No	0	19.68	1.74	1
9829	ICI-treated	ICI as subsequent line	86 - 90	Male	Bladder	2016	I	618	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	1	33.81	29.67	1
9830	ICI-treated	ICI as first line	41 - 45	Male	Cutaneous Melanoma 	2016	II	534	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.30		No	0	37.98	18.89	1
9831	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2017	IV	0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	1	9.69	7.79	1
9832	ICI-treated	ICI - unknown sequence	56 - 60	Male	Cutaneous Melanoma 	2017		2	33.4	Stable	No	No	Signature.7	BLM | RAD52	No	0	17.22	4.76	1
9833	ICI-treated	ICI as first line	46 - 50	Male	Head & Neck	2016	IV	411	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	33.58	14.23	1
9834	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2017	IV	0	12.3	Stable	No	No	Signature.8	ATM | CHEK2	No	1	8.02	7.59	1
9835	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2017	III	35	6.1	Indeterminate	No	No		BRCA1	No	0	20.04	8.08	1
9836	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	818	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	41.13	37.62	1
9837	ICI-treated	ICI as first line	71 - 75	Female	Esophageal	2017	IV	19	4.4	Stable	No	Yes or Unknown	Signature.6		No	0	20.01	1.15	1
9838	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	17	7.9	Stable	No	No	Signature.4	ATM	No	1	6.41	1.35	1
9839	ICI-treated	ICI as subsequent line	76 - 80	Female	NSCLC	2017	IV	14	24.6	Stable	No	No	Signature.4	BRCA1	No	1	7.49	1.64	1
9840	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	13	1.8	Stable	No	No			Yes	1	12.02	1.08	1
9841	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	III	222	32.5	Stable	No	Yes or Unknown	Signature.2	ERCC5 | TP53BP1	No	1	14.46	4.04	1
9842	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2017	IV	0	4.4	Stable	No	No	Signature.1		No	1	4.24	3.42	1
9843	ICI-treated	ICI as first line	61 - 65	Female	Hepatobiliary	2016	I	60	2.6	Stable	Yes or Unknown	Yes or Unknown			Yes	0	30.03	12.52	1
9844	ICI-treated	ICI as subsequent line	41 - 45	Male	Cutaneous Melanoma 	2017	III	27	0	Stable	No	No			No	0	18.89	2.56	1
9845	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2016	IV	0	32.5	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MSH2	No	0	32.16	13.6	1
9846	ICI-treated	ICI as subsequent line	66 - 70	Male	Pancreatic	2017	I	12	3.5	Stable	No	No		BRCA1	No	0	11.47	8.87	1
9847	ICI-treated	ICI as subsequent line	51 - 55	Male	NSCLC	2017	IV	45	2.6	Stable	No	No			No	0	20.11	11.24	1
9848	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2016	II	409	12.3	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	32.3	13.57	1
9849	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	49	30.7	Indeterminate	No	No	Signature.4	FANCC	No	1	10.05	5.62	1
9850	ICI-treated	ICI - unknown sequence	66 - 70	Male	Renal	2017	II	66	1.8	Stable	No	Yes or Unknown		BLM	No	0	18.07	0.36	1
9851	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	0	12.3	Stable	No	No	Signature.4	MSH2 | PMS1	No	0	19.09	6.7	1
9852	ICI-treated	ICI as subsequent line	76 - 80	Male	Esophageal	2017	II	209	8.8	Stable	No	Yes or Unknown	Signature.1		No	1	8.74	7.56	1
9853	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	10	14	Stable	No	No	Signature.4		No	0	18.4	4.8	1
9854	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2017	IV	0	7.9	Stable	No	Yes or Unknown	Signature.6	MDC1	No	0	20.17	1.31	1
9855	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	3	0	Stable	No	No			No	1	16.49	8.87	1
9856	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2017	I	130	0.9	Stable	Yes or Unknown	Yes or Unknown		CHEK2 | MUTYH	No	0	20.24	9.33	1
9857	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	27	3.5	Stable	No	No			No	1	9.79	1.51	1
9858	ICI-treated	ICI as subsequent line	66 - 70	Male	Bladder	2017	III	117	5.3	Stable	No	Yes or Unknown	Signature.13		No	0	8.41	6.34	1
9859	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	34	3.5	Stable	No	No		ERCC3	No	1	12.91	1.64	1
9860	ICI-treated	ICI as subsequent line	91 - 95	Male	NSCLC	2017	IV	18	10.5	Stable	No	Yes or Unknown	Signature.13	RAD52	No	1	1.61	1.48	1
9861	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2017	IV	0	59.7	Stable	No	No	Signature.7	ATR | BRCA2 | CHEK1 | CHEK2 | TP53BP1	Yes	0	18.23	0.49	1
9862	ICI-treated	ICI as subsequent line	81 - 85	Male	SCLC	2017	IV	0	10.5	Stable	No	No	Signature.9	ATR	No	1	7.62	5.49	1
9863	ICI-treated	ICI as subsequent line	56 - 60	Female	Gastric	2017	IV	80	0	Stable	No	No			No	0	20.24	5.52	1
9864	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2017	III	80	7	Stable	No	No	Signature.5	PALB2	No	0	8.9	1.05	1
9865	ICI-treated	ICI as first line	36 - 40	Female	NSCLC	2017	IV	1	1.8	Stable	No	No			No	1	11.24	1.84	1
9866	ICI-treated	ICI as subsequent line	71 - 75	Male	Gastric	2017	IV	25	0.9	Stable	No	No	Signature.1		No	1	5.55	4.47	1
9867	ICI-treated	ICI - unknown sequence	61 - 65	Male	Prostatic	2017	IV	279	4.4	Stable	No	Yes or Unknown			No	1	18.99	12.09	1
9868	ICI-treated	ICI as subsequent line	56 - 60	Female	Endometrial	2017	III	34	31.6	Unstable	No	No	Signature.1	ARID1A | ATR | ERCC2	No	0	19.48	8.34	1
9869	ICI-treated	ICI as subsequent line	56 - 60	Female	SCLC	2017	IV	4	5.3	Indeterminate	No	No			No	1	7.85	7.03	1
9870	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2017	IV	14	10.5	Stable	No	No	Signature.4	ATM	No	0	19.71	1.58	1
9871	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	23.7	Stable	No	No	Signature.4	ARID1A | ATM	No	0	19.88	10.78	1
9872	ICI-treated	ICI as first line	36 - 40	Female	NSCLC	2017	IV	7	5.3	Stable	No	No	Signature.2	NTHL1	Yes	0	18.04	0.79	1
9873	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	0	4.4	Stable	No	No	Signature.26		No	1	3.29	0.36	1
9874	ICI-treated	ICI as subsequent line	56 - 60	Male	Hepatobiliary	2016	IV	615	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	21.75	21.09	1
9875	ICI-treated	ICI as first line	76 - 80	Female	Ovarian	2017	IV	135	0	Stable	No	Yes or Unknown			Yes	0	19.45	0.99	1
9876	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2017	IV	0	7.9	Stable	No	No	Signature.2	MUTYH	No	1	13.37	0.43	1
9877	ICI-treated	ICI as first line	56 - 60	Female	Pancreatic	2017	IV	13	2.6	Stable	No	No			No	0	18.86	1.81	1
9878	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2017	IV	14	0.9	Stable	No	No			No	1	14	10.32	1
9879	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	49	12.3	Stable	No	No	Signature.4	ATR	No	1	7.69	5.75	1
9880	ICI-treated	ICI as subsequent line	56 - 60	Female	Head & Neck	2017	IV	0	4.4	Stable	No	No			No	0	11.73	9.95	1
9881	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	41	3.5	Stable	No	No		BRIP1 | PALB2	No	0	19.42	1.94	1
9882	ICI-treated	ICI as subsequent line	16 - 20	Female	Sarcoma	2016	IV	0	0	Stable	Yes or Unknown	Yes or Unknown			No	1	27.17	25.26	1
9883	ICI-treated	ICI as first line	51 - 55	Male	Cutaneous Melanoma 	2017	IV	14	19.3	Stable	No	No	Signature.7	ATR | MDC1 | MRE11A	No	1	9.36	1.38	1
9884	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	III	160	14.9	Stable	No	Yes or Unknown	Signature.5	PMS1 | TP53BP1	No	1	14.03	6.18	1
9885	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	110	15.8	Indeterminate	No	Yes or Unknown	Signature.4	MDC1	No	1	13.5	7.56	1
9886	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2017	IV	25	3.5	Stable	No	No			No	1	9.53	6.31	1
9887	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	25	4.4	Stable	No	No		BRIP1	No	1	14.16	11.2	1
9888	ICI-treated	ICI as subsequent line	71 - 75	Male	Pancreatic	2017	IV	34	1.8	Stable	No	No		BRCA2	No	0	18.73	9.66	1
9889	ICI-treated	ICI as first line	41 - 45	Female	NSCLC	2017	IV	0	0.9	Stable	No	No			No	0	19.06	5.85	1
9890	ICI-treated	ICI as subsequent line	61 - 65	Male	SCLC	2017	IV	3	3.5	Stable	No	No	Signature.4	TP53BP1	No	1	13.21	8.87	1
9891	ICI-treated	ICI as subsequent line	31 - 35	Female	Gastric	2017	IV	0	3.5	Stable	No	No			No	0	6.18	2.56	1
9892	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	164	15.8	Stable	No	Yes or Unknown	Signature.4	ARID1A | MDC1	No	1	10.78	1.68	1
9893	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	5	8.8	Stable	No	No	Signature.4	RAD51C	No	1	6.67	3.55	1
9894	ICI-treated	ICI as subsequent line	71 - 75	Female	Bladder	2017	IV	79	14	Stable	No	No	Signature.13	ATM | PARP1	No	1	10.97	5.29	1
9895	ICI-treated	ICI as subsequent line	61 - 65	Female	Head & Neck	2017	IV	54	4.4	Indeterminate	No	Yes or Unknown			No	1	12.06	8.05	1
9896	ICI-treated	ICI as subsequent line	51 - 55	Female	Hepatobiliary	2017	IV	3	3.5	Stable	No	No			No	1	15.47	7.39	1
9897	ICI-treated	ICI - unknown sequence	76 - 80	Male	Cutaneous Melanoma 	2017		94	18.4	Stable	No	No	Signature.7	MSH3	No	1	7.16	3.48	1
9898	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2017	III	313	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A	No	1	20.63	8.97	1
9899	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	23	0		No	No			No	1	10.87	7.72	1
9900	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	III	70	13.2	Stable	No	No	Signature.4	TP53BP1	No	1	12.62	7.79	1
9901	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2017	IV	70	3.5	Stable	No	Yes or Unknown			No	0	10.97	4.83	1
9902	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2016	I	560	6.1	Stable	Yes or Unknown	Yes or Unknown	Signature.4		Yes	1	34.3	20.86	1
9903	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2015	I	953	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	41.95	34.53	1
9904	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2017	IV	3	4.4	Stable	No	No	Signature.24		Yes	0	18.53	1.38	1
9905	ICI-treated	ICI - unknown sequence	66 - 70	Male	Cutaneous Melanoma 	2017	III	256	24.6	Stable	No	No	Signature.7	ATR | BLM	No	0	18.66	9.3	1
9906	ICI-treated	ICI as first line	91 - 95	Male	Bladder	2017	II	139	18.4	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A | FANCA	No	1	11.14	5.29	1
9907	ICI-treated	ICI - unknown sequence	41 - 45	Male	Cutaneous Melanoma 	2017	III	32	27.2	Stable	No	No	Signature.7	FANCA | PARP1 | RAD50	No	0	18.07	2.2	1
9908	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		319	4.4	Stable	Yes or Unknown	Yes or Unknown			No	1	16.62	6.14	1
9909	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	24	0	Stable	Yes or Unknown	Yes or Unknown			No	1	13.93	4.9	1
9910	ICI-treated	ICI as subsequent line	51 - 55	Male	Prostatic	2017	IV	0	23.7	Unstable	No	No	Signature.1	MUTYH | PALB2 | PARP1	No	0	19.58	10.81	1
9911	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	16	5.3	Stable	No	No			No	1	13.21	5.06	1
9912	ICI-treated	ICI as subsequent line	51 - 55	Male	Esophageal	2017	IV	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	20.5	17.84	1
9913	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2017	IV	72	6.1	Stable	No	No		ATM	No	0	19.55	6.01	1
9914	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2016	IV	667	9.7	Indeterminate	Yes or Unknown	Yes or Unknown	Signature.24		No	1	32.53	25.72	1
9915	ICI-treated	ICI as first line	81 - 85	Male	Gastric	2017	IV	62	43	Unstable	No	No	Signature.6	ARID1A | ATM | ATR | FANCC | RAD50 | SLX4	Yes	1	7.49	4.86	1
9916	ICI-treated	ICI as first line	41 - 45	Male	NSCLC	2018	IV	14	1.8	Stable	No	No			Yes	1	2.4	1.45	1
9917	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	7	4.4	Stable	No	No	Signature.24		No	1	9	5.55	1
9918	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2016	II	28	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	33.51	21.13	1
9919	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	III	0	31.6	Stable	No	No	Signature.4	ERCC2 | PMS1 | PMS2	No	0	15.41	0.69	1
9920	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2017	IV	0	1.8	Stable	No	No			No	1	13.47	0.92	1
9921	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2017	IV	0	17.6	Stable	No	No	Signature.24	SLX4	Yes	0	16.69	1.51	1
9922	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2017	IV	19	1.8	Stable	No	No			No	0	18.37	8.87	1
9923	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	IV	35	26.3	Unstable	No	No	Signature.6	ARID1A | BLM	No	0	19.71	8.9	1
9924	ICI-treated	ICI as subsequent line	71 - 75	Female	Cutaneous Melanoma 	2016	IV	254	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	21.78	16.85	1
9925	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2015	III	3	7	Indeterminate	Yes or Unknown	Yes or Unknown		ERCC3 | TP53BP1	No	1	35.91	34.5	1
9926	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	IV	16	9.7	Stable	No	No	Signature.13		No	0	18.46	4.96	1
9927	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2017	IV	112	102.7	Unstable	No	Yes or Unknown	Signature.6	ARID1A | BLM | BRCA2 | BRIP1 | ERCC3 | FANCA | NBN | PMS2 | RAD54L | SLX4	No	1	7.69	5.36	1
9928	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	IV	22	1.8	Stable	No	No	Signature.12		No	1	14.92	4.8	1
9929	ICI-treated	ICI as subsequent line	31 - 35	Female	Hepatobiliary	2017	IV	43	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.11	ARID1A	No	1	11.83	10.28	1
9930	ICI-treated	ICI as first line	41 - 45	Female	Cutaneous Melanoma 	2018	IV	4	26.3	Stable	No	No	Signature.7	ARID1A | PALB2	Yes	0	17.28	1.25	1
9931	ICI-treated	ICI as first line	41 - 45	Male	Esophageal	2017	IV	38	0.9	Stable	No	No	Signature.13		No	0	18.46	1.71	1
9932	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	IV	0	4.4	Stable	No	No		BRCA2	No	1	5.68	0.79	1
9933	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	IV	0	0		No	No			No	1	11.27	3.06	1
9934	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	12	0.9	Stable	No	No			Yes	0	17.38	1.05	1
9935	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	IV	305	2.6	Stable	No	Yes or Unknown			No	0	17.58	9.86	1
9936	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	0	7	Stable	No	No	Signature.16		No	1	8.38	5.52	1
9937	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2018	II	313	5.3	Stable	No	Yes or Unknown	Signature.7		No	1	11.14	1.61	1
9938	ICI-treated	ICI as subsequent line	41 - 45	Female	NSCLC	2018	III	24	2.6	Stable	No	No			No	0	15.44	8.08	1
9939	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2017	IV	345	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	27.47	11.56	1
9940	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2016	III	100	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	23.1	14.78	1
9941	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	344	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.1		No	0	25.13	11.47	1
9942	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	10	4.4	Stable	No	No	Signature.5	FANCA	Yes	1	3.78	1.12	1
9943	ICI-treated	ICI as first line	36 - 40	Female	Cutaneous Melanoma 	2015	III	837	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	37.91	32.49	1
9944	ICI-treated	ICI as subsequent line	56 - 60	Female	Sarcoma	2015	I	892	0.9	Stable	Yes or Unknown	Yes or Unknown			No	1	35.94	35.42	1
9945	ICI-treated	ICI as subsequent line	76 - 80	Male	Prostatic	2017	IV	0	74.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.1	ARID1A | ATR | BRIP1 | CHEK2 | ERCC3 | MSH3 | NBN | RAD50 | SLX4	No	0	20.24	11.04	1
9946	ICI-treated	ICI as first line	46 - 50	Male	NSCLC	2018	IV	4	27.2	Stable	No	No	Signature.4	ATR | BLM | ERCC5 | RAD50	Yes	0	15.08	2.14	1
9947	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	21	16.7	Stable	No	No	Signature.4	MSH3 | PMS2	No	0	17.18	2.46	1
9948	ICI-treated	ICI - unknown sequence	61 - 65	Female	Endometrial	2016	I	731	28.1	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | MSH3 | MSH6 | SLX4	No	0	29.54	29.54	1
9949	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	12	8.8	Stable	No	No	Signature.4		Yes	0	16.79	1.12	1
9950	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	0	31.6	Stable	No	No	Signature.4	BRIP1 | CHEK1 | CHEK2 | ERCC5 | RAD50 | RAD54L	Yes	0	16.46	0.95	1
9951	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2018	IV	22	30.7	Stable	No	No	Signature.7	ATR	Yes	0	16.56	0.69	1
9952	ICI-treated	ICI as first line	51 - 55	Male	Renal	2018	III	0	5.3	Stable	Yes or Unknown	Yes or Unknown			Yes	0	17.08	9.26	1
9953	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	III	61	5.3	Stable	No	No	Signature.4		No	0	17.81	2.3	1
9954	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	III	0	13.2	Stable	No	Yes or Unknown	Signature.4	MRE11A	No	1	12.88	3.22	1
9955	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	125	7.9	Stable	No	Yes or Unknown	Signature.3	MSH3 | PMS2	No	1	11.2	5.19	1
9956	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	13	5.3	Stable	No	No			No	0	16.82	2.83	1
9957	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	30	8.8	Stable	No	No	Signature.2		No	0	16.85	1.22	1
9958	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	0	7	Stable	No	No	Signature.24		No	1	5.75	0.69	1
9959	ICI-treated	ICI as subsequent line	66 - 70	Male	SCLC	2017	IV	185	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	FANCA	No	1	20.5	5.91	1
9960	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	27	7.9	Stable	No	No			No	1	10.87	4.21	1
9961	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	14	5.3	Stable	No	Yes or Unknown			No	0	15.38	1.08	1
9962	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2018	IV	21	6.1	Stable	No	No	Signature.1		No	1	8.44	4.34	1
9963	ICI-treated	ICI as first line	46 - 50	Male	Bladder	2018	IV	329	2.6	Stable	No	Yes or Unknown			No	1	14.16	2.2	1
9964	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	4	10.5	Stable	No	No	Signature.13		No	0	16.1	0.92	1
9965	ICI-treated	ICI as first line	46 - 50	Male	Renal	2018	III	0	3.5	Stable	No	Yes or Unknown			No	0	15.18	5.09	1
9966	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	17	16.7	Stable	No	No	Signature.4	MDC1	No	1	6.64	5.29	1
9967	ICI-treated	ICI as subsequent line	66 - 70	Female	Sarcoma	2015	IV	216	2.6	Stable	Yes or Unknown	Yes or Unknown	Signature.1	BRIP1	No	1	34.14	27.17	1
9968	ICI-treated	ICI as subsequent line	61 - 65	Male	Esophageal	2018	IV	0	5.3	Stable	No	No			No	1	8.44	3.25	1
9969	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4	PMS1	No	1	8.31	3.02	1
9970	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2018	IV	1	3.5	Stable	No	No	Signature.4		Yes	0	16.95	1.41	1
9971	ICI-treated	ICI - unknown sequence	61 - 65	Male	NSCLC	2018	III	22	6.1	Stable	No	No	Signature.24		No	1	2.6	0.79	1
9972	ICI-treated	ICI as first line	91 - 95	Male	Cutaneous Melanoma 	2018	III	0	158.9	Stable	No	No	Signature.7	ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC4 | ERCC5 | FANCA | MDC1 | PMS2 | SLX4 | TP53BP1	Yes	0	8.64	1.77	1
9973	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	III	0	8.8	Stable	No	No	Signature.4	NBN	No	0	16.43	4.47	1
9974	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	III	26	22.8	Stable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | PALB2	No	0	23.46	8.28	1
9975	ICI-treated	ICI as subsequent line	51 - 55	Female	Endometrial	2016	I	0	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	30.39	15.24	1
9976	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2018	IV	5	29.8	Stable	No	No	Signature.7	ARID1A | BRCA2 | MDC1 | PALB2	Yes	0	15.57	1.05	1
9977	ICI-treated	ICI as subsequent line	66 - 70	Male	Sarcoma	2017	IV	0	7		Yes or Unknown	Yes or Unknown	Signature.5	ARID1A	No	0	22.74	9.66	1
9978	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	58	11.4	Stable	No	No	Signature.4	MRE11A | SLX4	No	0	17.08	2.53	1
9979	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2018	IV	13	6.1	Indeterminate	No	Yes or Unknown	Signature.13		No	0	15.93	0.99	1
9980	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	15	3.5	Stable	No	No			No	1	11.76	1.77	1
9981	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	20	11.4	Stable	No	No	Signature.1	MUTYH	Yes	0	16.23	1.28	1
9982	ICI-treated	ICI as subsequent line	71 - 75	Male	Esophageal	2017	IV	0	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	8.84	7.52	1
9983	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	IV	150	4.4	Stable	No	Yes or Unknown		FANCA	No	1	11.83	2.99	1
9984	ICI-treated	ICI as subsequent line	31 - 35	Female	Endometrial	2018	IV	11	15.8	Unstable	No	Yes or Unknown	Signature.6	BRCA2	No	0	16.1	7.98	1
9985	ICI-treated	ICI as subsequent line	76 - 80	Female	Colorectal	2018	IV	18	44.8	Unstable	No	No	Signature.6	BRCA2 | MUTYH	No	1	13.01	4.7	1
9986	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2017	IV	235	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	22.77	12.52	1
9987	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.18	ARID1A | ATM | BRCA2	No	0	15.41	0.69	1
9988	ICI-treated	ICI as subsequent line	61 - 65	Male	Hepatobiliary	2018	IV	15	7.9	Stable	No	Yes or Unknown	Signature.16	BRIP1	No	1	13.14	6.21	1
9989	ICI-treated	ICI as subsequent line	21 - 25	Male	Colorectal	2017	III	201	65.8	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | ERCC3 | ERCC4 | MLH1 | SLX4	No	0	21.65	7.16	1
9990	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	28	8.8	Stable	No	No	Signature.4	BRCA2	Yes	0	15.54	1.74	1
9991	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	36	26.3	Stable	No	No	Signature.4	ATR | MUTYH	Yes	0	15.67	1.87	1
9992	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	I	0	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4		No	0	24.57	14.78	1
9993	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	6	4.4	Stable	No	No			Yes	1	2.6	1.31	1
9994	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	11.4	Stable	No	No	Signature.4	ARID1A | ATM | PALB2	No	1	13.27	1.84	1
9995	ICI-treated	ICI as subsequent line	81 - 85	Female	NSCLC	2016	I	505	5.3	Stable	Yes or Unknown	Yes or Unknown			No	1	27.7	21.32	1
9996	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	0	25.5	Stable	No	No	Signature.4	TP53BP1	Yes	0	14.55	0.69	1
9997	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	10	14.9	Stable	No	No	Signature.24	BRCA1	Yes	0	15.01	1.68	1
9998	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	IV	28	5.3	Stable	No	No	Signature.24		No	1	6.97	4.83	1
9999	ICI-treated	ICI as first line	46 - 50	Female	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.24		Yes	0	15.01	0.53	1
10000	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2018	III	22	39.5	Stable	No	No	Signature.4	ARID1A | PARP1 | TP53BP1	No	0	15.28	4.4	1
10001	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	20	5.3	Stable	No	No	Signature.3		Yes	0	15.01	1.22	1
10002	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	II	111	7	Stable	No	No	Signature.24		No	1	6.6	2.46	1
10003	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	13	15.8	Stable	No	No	Signature.13	ATR	No	1	4.14	1.54	1
10004	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2018	III	70	21.9	Stable	No	No	Signature.7	BRCA1	Yes	0	12.91	7.1	1
10005	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	26	7	Stable	No	No	Signature.8		Yes	1	6.64	2.07	1
10006	ICI-treated	ICI as subsequent line	81 - 85	Female	Colorectal	2018	IV	8	78.1	Unstable	No	No	Signature.6	BLM | BRCA2 | FANCA | MLH1 | MSH2 | RAD50 | TP53BP1	No	1	4.53	3.65	1
10007	ICI-treated	ICI as first line	71 - 75	Male	Sarcoma	2018	IV	13	6.1	Stable	No	No	Signature.6		No	1	13.04	0.92	1
10008	ICI-treated	ICI as subsequent line	61 - 65	Female	Pancreatic	2018	IV	14	2.6	Stable	No	No			No	1	10.09	7.59	1
10009	ICI-treated	ICI as first line	71 - 75	Male	Cutaneous Melanoma 	2018	IV	18	0.9	Stable	No	No			Yes	1	1.64	1.15	1
10010	ICI-treated	ICI - unknown sequence	46 - 50	Female	Cutaneous Melanoma 	2016	I	546	23.7	Stable	Yes or Unknown	Yes or Unknown	Signature.7	TP53BP1	No	0	31.97	18.17	1
10011	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	7	13.2	Stable	No	No	Signature.3		Yes	0	14.69	1.15	1
10012	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.24	PALB2	Yes	0	16.43	2.4	1
10013	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			Yes	0	14.49	0.79	1
10014	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	IV	0	4.4	Stable	No	No			No	1	7.03	1.22	1
10015	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2018	IV	47	0.9	Stable	No	No			No	1	14.78	4.07	1
10016	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	2	2.6	Stable	No	No			No	1	7.72	1.64	1
10017	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	35	47.4	Unstable	No	No	Signature.1	ARID1A | ATR | BRCA2 | BRIP1 | MLH1 | NBN | PARP1 | PMS1	Yes	1	3.52	1.77	1
10018	ICI-treated	ICI as subsequent line	56 - 60	Male	NSCLC	2018	II	0	2.6	Stable	No	No			No	0	13.24	5.22	1
10019	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	III	618	38.6	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | BRCA2 | MSH3	No	0	34.63	21.49	1
10020	ICI-treated	ICI as first line	61 - 65	Male	Colorectal	2018	IV	0	17.6	Stable	No	No	Signature.1	MSH2	No	1	5.42	1.97	1
10021	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	0	3.5	Stable	No	No	Signature.17		No	0	14.72	1.38	1
10022	ICI-treated	ICI as first line	51 - 55	Male	NSCLC	2018	IV	0	1.8	Stable	No	No		ARID1A	No	0	14.42	1.51	1
10023	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	8	7.9	Stable	No	No	Signature.3	ATM | NBN	Yes	0	15.64	1.61	1
10024	ICI-treated	ICI - unknown sequence	71 - 75	Female	Cutaneous Melanoma 	2018	II	43	2.6	Stable	No	No	Signature.3		No	0	14.16	2.14	1
10025	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	5	0	Stable	No	No			Yes	1	2.04	1.22	1
10026	ICI-treated	ICI as subsequent line	76 - 80	Male	NSCLC	2017	II	298	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.4	FANCA | PARP1	No	0	20.37	13.47	1
10027	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	53	12.3	Stable	No	No	Signature.4	PMS1	No	0	15.18	4.99	1
10028	ICI-treated	ICI as first line	86 - 90	Male	NSCLC	2018	IV	14	9.7	Stable	No	No	Signature.4		Yes	1	3.12	1.58	1
10029	ICI-treated	ICI as first line	76 - 80	Female	NSCLC	2018	IV	54	7	Stable	No	No	Signature.29	ATM	Yes	0	16.2	2.76	1
10030	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	8	3.5	Stable	No	No	Signature.19		No	0	14.06	1.25	1
10031	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	0	13.2	Stable	No	No	Signature.4	MDC1 | RAD50	No	0	15.97	8.15	1
10032	ICI-treated	ICI as subsequent line	46 - 50	Male	NSCLC	2015	III	657	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.2		No	1	40.11	36.96	1
10033	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2018	III	12	8.8	Stable	No	No	Signature.4		No	0	13.93	4.11	1
10034	ICI-treated	ICI as subsequent line	66 - 70	Female	Bladder	2017	IV	0	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.13	FANCA	No	0	19.55	6.08	1
10035	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	III	50	14.9	Stable	No	No	Signature.13	BRCA1	No	0	14.92	4.8	1
10036	ICI-treated	ICI as subsequent line	76 - 80	Female	Endometrial	2016	I	738	7.9	Stable	Yes or Unknown	Yes or Unknown			No	1	34.33	24.94	1
10037	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	0	7.9	Stable	No	No	Signature.24		No	0	13.83	0.49	1
10038	ICI-treated	ICI as first line	61 - 65	Male	Cutaneous Melanoma 	2018	III	20	17.6	Stable	No	No	Signature.7	ARID1A | MSH2	Yes	0	11.47	3.61	1
10039	ICI-treated	ICI as subsequent line	61 - 65	Male	Sarcoma	2018	IV	35	0	Stable	No	No			No	0	13.7	5.29	1
10040	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	21	13.2	Stable	No	No	Signature.24	ARID1A	Yes	1	6.6	1.94	1
10041	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	9.7	Stable	No	No	Signature.8	ERCC2	Yes	0	13.11	1.15	1
10042	ICI-treated	ICI as first line	66 - 70	Male	Cutaneous Melanoma 	2018	IV	11	2.6	Stable	No	No			No	1	3.22	0.43	1
10043	ICI-treated	ICI as first line	71 - 75	Male	Bladder	2018	IV	31	7	Stable	No	No	Signature.2	ATM | BLM | ERCC5	Yes	0	14.52	2.4	1
10044	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2017	IV	127	14	Stable	Yes or Unknown	Yes or Unknown	Signature.4	MLH1 | PMS1	No	0	23.26	10.71	1
10045	ICI-treated	ICI - unknown sequence	61 - 65	Male	Cutaneous Melanoma 	2017		460	0	Stable	Yes or Unknown	Yes or Unknown			No	0	28.09	15.9	1
10046	ICI-treated	ICI - unknown sequence	46 - 50	Female	CNS	2017		0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	19.55	7.13	1
10047	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	8	3.5	Stable	No	No			No	1	7.39	1.41	1
10048	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2018	III	76	8.8		No	Yes or Unknown	Signature.5	TP53BP1	No	0	14.82	1.31	1
10049	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	8	12.3	Stable	No	No	Signature.4	ATR	Yes	0	12.45	0.89	1
10050	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	37	9.7	Stable	No	No	Signature.18		No	0	13.54	1.45	1
10051	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	15	2.6	Stable	No	No			No	0	12.81	1.87	1
10052	ICI-treated	ICI as subsequent line	66 - 70	Female	Colorectal	2018	III	0	7.9	Stable	No	No	Signature.1	ATM | MLH1 | PALB2	No	0	5.75	2.23	1
10053	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	21	1.8	Stable	No	No			No	0	14.19	1.38	1
10054	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2015	II	969	0	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	40.44	33.81	1
10055	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	16	9.7	Stable	No	No		MUTYH	No	1	2.56	0.95	1
10056	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2018	IV	0	13.2	Stable	No	No	Signature.13	MSH6 | TP53BP1	No	1	10.51	5.45	1
10057	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	22	5.3	Stable	No	No	Signature.4	RAD51C	Yes	1	5.22	1.77	1
10058	ICI-treated	ICI as first line	76 - 80	Male	Cutaneous Melanoma 	2016	III	705	1.8	Stable	Yes or Unknown	Yes or Unknown			Yes	0	34.69	24.08	1
10059	ICI-treated	ICI as subsequent line	81 - 85	Female	SCLC	2018	IV	10	7.9	Stable	No	No	Signature.3	ERCC5	No	0	13.08	5.98	1
10060	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2017	I	19	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	28.22	16.82	1
10061	ICI-treated	ICI as subsequent line	51 - 55	Female	NSCLC	2018	III	16	0.9	Stable	No	No			No	0	13.54	2.23	1
10062	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2016	II	45	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	23.59	22.08	1
10063	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	0	3.5	Stable	No	No	Signature.4		No	0	13.34	1.31	1
10064	ICI-treated	ICI - unknown sequence	56 - 60	Female	NSCLC	2018	IV	0	11.4	Stable	No	No	Signature.4	BRIP1	No	0	2.76	0.99	1
10065	ICI-treated	ICI as subsequent line	56 - 60	Female	NSCLC	2018	IV	0	2.6	Stable	No	No	Signature.13		No	1	6.8	5.09	1
10066	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	19	4.4	Stable	No	No			No	1	9.63	1.51	1
10067	ICI-treated	ICI - unknown sequence	71 - 75	Male	NSCLC	2018	I	27	4.4	Stable	No	No	Signature.29		No	0	10.32	1.05	1
10068	ICI-treated	ICI - unknown sequence	71 - 75	Female	NSCLC	2018	III	0	10.5	Stable	No	No	Signature.4	ARID1A	No	0	14.36	1.74	1
10069	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	1	16.7	Stable	Yes or Unknown	Yes or Unknown	Signature.4	CHEK1	Yes	1	2.07	1.94	1
10070	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	IV	19	12.3	Stable	No	No	Signature.8	ATR | NBN	No	0	13.5	1.31	1
10071	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	12	16.7	Stable	No	No	Signature.4	ARID1A | ATR | FANCA	Yes	0	12.25	1.15	1
10072	ICI-treated	ICI as subsequent line	61 - 65	Female	SCLC	2018	IV	0	10.5	Stable	Yes or Unknown	Yes or Unknown	Signature.4	PALB2	No	0	14.69	5.72	1
10073	ICI-treated	ICI - unknown sequence	61 - 65	Female	Cutaneous Melanoma 	2018	III	0	15.8	Stable	No	No	Signature.7		No	0	13.54	3.22	1
10074	ICI-treated	ICI as subsequent line	26 - 30	Female	NSCLC	2018	III	28	1.8	Stable	No	No			No	1	12.65	2.63	1
10075	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2015	II	1056	13.2	Stable	Yes or Unknown	Yes or Unknown	Signature.4	TP53BP1	No	0	46.36	37.36	1
10076	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	19	14.9	Stable	No	No	Signature.4	PALB2	Yes	0	13.04	1.35	1
10077	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	71	8.8	Stable	No	No	Signature.6		No	0	13.01	2.53	1
10078	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2017	I	0	14.9	Stable	Yes or Unknown	Yes or Unknown	Signature.4	BRCA1	No	1	24.84	14.52	1
10079	ICI-treated	ICI as first line	71 - 75	Female	NSCLC	2018	IV	0	0.9	Stable	No	No			Yes	1	4.07	1.41	1
10080	ICI-treated	ICI as subsequent line	51 - 55	Female	Colorectal	2016	III	123	6.1	Stable	Yes or Unknown	Yes or Unknown			No	1	29.96	28.16	1
10081	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	71	3.5	Stable	No	No		BRIP1	Yes	0	13.6	2.56	1
10082	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	0	2.6	Stable	No	No			No	0	12.65	1.18	1
10083	ICI-treated	ICI as subsequent line	61 - 65	Female	NSCLC	2017	II	361	4.4	Stable	Yes or Unknown	Yes or Unknown	Signature.29		No	0	22.77	13.17	1
10084	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2017	II	0	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	21.16	13.96	1
10085	ICI-treated	ICI as first line	61 - 65	Female	NSCLC	2018	IV	71	1.8	Stable	No	Yes or Unknown			No	1	11.1	3.48	1
10086	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	52	7	Stable	No	No	Signature.29	ARID1A | ATM	Yes	0	12.65	2.27	1
10087	ICI-treated	ICI as first line	51 - 55	Male	Esophageal	2018	IV	0	6.1	Stable	No	No	Signature.1	NBN	Yes	0	12.71	1.68	1
10088	ICI-treated	ICI as subsequent line	66 - 70	Male	Head & Neck	2017	IV	28	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	20.01	11.7	1
10089	ICI-treated	ICI as subsequent line	71 - 75	Female	Endometrial	2017	I	13	149.2	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATM | ATR | BRCA1 | BRCA2 | CHEK2 | ERCC5 | FANCA | MDC1 | MLH1 | MRE11A | MSH2 | MSH6 | PARP1 | SLX4 | TP53BP1	No	1	22.87	15.11	1
10090	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	7	12.3	Stable	No	No	Signature.4	BRIP1	Yes	0	12.55	1.05	1
10091	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	47	0	Stable	No	No			Yes	0	12.58	2.79	1
10092	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	0	21.9	Stable	No	No	Signature.2	ATM | PALB2 | RAD51	Yes	0	7.33	1.15	1
10093	ICI-treated	ICI as first line	66 - 70	Male	NSCLC	2018	IV	11	15.8	Stable	No	No	Signature.4		Yes	1	5.29	2.69	1
10094	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	18	7.9	Stable	No	No	Signature.24	ERCC2	No	0	12.85	1.77	1
10095	ICI-treated	ICI as subsequent line	61 - 65	Male	NSCLC	2018	III	25	7.9	Stable	No	No	Signature.2		No	0	12.81	4.07	1
10096	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	0	4.4	Stable	No	No			No	0	11.7	1.12	1
10097	ICI-treated	ICI as first line	81 - 85	Male	NSCLC	2018	IV	13	8.8	Stable	No	No	Signature.4	ATR | MDC1	No	0	13.31	2.04	1
10098	ICI-treated	ICI as subsequent line	66 - 70	Male	NSCLC	2018	III	0	5.3	Stable	No	No	Signature.20	ERCC4 | FANCA | MSH3	No	0	10.45	1.35	1
10099	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2017	III	0	34.2	Unstable	Yes or Unknown	Yes or Unknown	Signature.6	ARID1A | ATR | MSH3 | MUTYH | PMS1	No	0	23.79	13.04	1
10100	ICI-treated	ICI as subsequent line	61 - 65	Female	Endometrial	2018	IV	22	1.8	Stable	Yes or Unknown	Yes or Unknown			No	1	6.57	4.6	1
10101	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	7	76.4	Stable	No	No	Signature.7	BRCA2 | FANCA	Yes	1	4.57	0.92	1
10102	ICI-treated	ICI as subsequent line	66 - 70	Female	Endometrial	2016	IV	0	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	31.51	21.78	1
10103	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	10.5	Stable	No	No	Signature.4	FANCA	No	0	11.01	0.59	1
10104	ICI-treated	ICI as subsequent line	51 - 55	Male	Sarcoma	2017	III	358	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.3		No	0	22.47	11.93	1
10105	ICI-treated	ICI as subsequent line	71 - 75	Female	NSCLC	2017	I	42	5.3	Stable	Yes or Unknown	Yes or Unknown			No	0	20.9	11.96	1
10106	ICI-treated	ICI as first line	66 - 70	Female	NSCLC	2018	III	52	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.18		Yes	0	14.55	6.97	1
10107	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	17	7.9	Stable	No	Yes or Unknown	Signature.4		No	0	11.07	1.05	1
10108	ICI-treated	ICI - unknown sequence	71 - 75	Female	CNS	2018		0	7	Stable	Yes or Unknown	Yes or Unknown	Signature.5		No	1	8.38	1.02	1
10109	ICI-treated	ICI as first line	56 - 60	Female	NSCLC	2018	IV	2	6.1	Stable	No	No	Signature.4	BRCA2	Yes	1	3.71	1.28	1
10110	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	76	8.8	Stable	No	No	Signature.4		No	0	13.5	5.09	1
10111	ICI-treated	ICI as subsequent line	46 - 50	Male	Pancreatic	2018	IV	3	0	Stable	No	No			No	0	10.97	2.92	1
10112	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	0	4.4	Stable	No	No			Yes	0	12.78	3.12	1
10113	ICI-treated	ICI as first line	61 - 65	Female	Hepatobiliary	2018	III	0	6.1	Stable	No	No		ARID1A	Yes	1	6.97	5.45	1
10114	ICI-treated	ICI as subsequent line	66 - 70	Female	NSCLC	2018	IV	29	8.8	Stable	Yes or Unknown	Yes or Unknown	Signature.24		No	0	16	6.34	1
10115	ICI-treated	ICI as first line	71 - 75	Male	NSCLC	2018	IV	36	20.2	Stable	No	No	Signature.4	ARID1A | ATM | ERCC4 | NBN	No	0	10.64	2.14	1
10116	ICI-treated	ICI - unknown sequence	46 - 50	Female	Cutaneous Melanoma 	2018	III	45	0		No	No			No	0	11.73	4.11	1
10117	ICI-treated	ICI as first line	61 - 65	Male	Esophageal	2018	IV	0	5.3	Stable	No	No	Signature.3	ARID1A | BRIP1	No	0	10.94	0.69	1
10118	ICI-treated	ICI as first line	61 - 65	Male	NSCLC	2018	IV	0	17.6	Stable	No	No	Signature.4	ARID1A	Yes	1	1.45	0.49	1
10119	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	7	9.7	Stable	No	No	Signature.4		No	1	1.81	0.92	1
10120	ICI-treated	ICI as subsequent line	66 - 70	Male	Esophageal	2018	III	16	5.3	Stable	No	No	Signature.17		No	0	10.45	2.14	1
10121	ICI-treated	ICI - unknown sequence	76 - 80	Female	Cutaneous Melanoma 	2018		0	51.8	Stable	No	No	Signature.7	BRIP1 | MDC1 | MSH2	No	0	9.49	1.15	1
10122	ICI-treated	ICI as first line	76 - 80	Male	NSCLC	2018	IV	0	5.3	Stable	No	No	Signature.2		Yes	1	3.84	0.89	1
10123	ICI-treated	ICI as first line	56 - 60	Male	NSCLC	2018	IV	27	14	Stable	No	No	Signature.24	ATR	No	0	10.94	1.28	1
10124	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	0	8.8	Stable	No	No	Signature.1		No	0	10.12	1.41	1
10125	ICI-treated	ICI as first line	81 - 85	Female	NSCLC	2018	IV	0	4.4	Stable	No	No	Signature.24		No	0	8.87	1.22	1
10126	ICI-treated	ICI as first line	51 - 55	Female	NSCLC	2018	IV	7	2.6	Stable	No	No			No	0	10.12	1.61	1
10127	ICI-treated	ICI as first line	61 - 65	Male	Gastric	2018	IV	30	4.4	Stable	No	No			No	0	10.05	1.54	1
10128	ICI-treated	ICI as subsequent line	51 - 55	Male	Colorectal	2015	III	27	3	Stable	No	No			No	0	56.51	39.95	1
10129	ICI-treated	ICI - unknown sequence	56 - 60	Female	Ovarian	2015	III	0	2	Indeterminate	No	No			No	1	6.41	5.09	1
10130	ICI-treated	ICI - unknown sequence	71 - 75	Female	Bladder	2016		15	20.2	Stable	No	No	Signature.13	ARID1A | BRCA1 | BRCA2 | PALB2	No	0	36.11	1.22	1
10131	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	IV	28	8.9	Stable	No	Yes or Unknown	Signature.5		No	1	42.64	36.27	1
10132	ICI-treated	ICI - unknown sequence	81 - 85	Male	Bladder	2015	I	32	0	Stable	No	No			No	0	53.65	1.91	1
10133	ICI-treated	ICI as subsequent line	66 - 70	Female	Ovarian	2018	III	10	2.6	Stable	No	No	Signature.1	BRCA1	No	0	20.04	6.67	1
10134	ICI-treated	ICI as subsequent line	71 - 75	Female	Sarcoma	2015	I	39	2.6	Stable	No	No			No	0	40.71	30.03	1
10135	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		0	9.8	Stable	No	No	Signature.13	ARID1A | PMS1	No	0	18.92	0.82	1
10136	ICI-treated	ICI - unknown sequence	66 - 70	Female	Bladder	2015	I	60	40.3	Stable	No	No	Signature.2	ATM | ATR | ERCC2	No	0	54.01	3.38	1
10137	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2015		132	44.8	Stable	No	No	Signature.2	ERCC2 | MRE11A | RAD51C | TP53BP1	Yes	0	52.01	19.12	1
10138	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		0	29.8	Stable	No	No	Signature.2	ATR | ERCC2 | MSH6 | RAD51C	No	0	33.15	1.45	1
10139	ICI-treated	ICI - unknown sequence	81 - 85	Male	Bladder	2015	I	421	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.2		No	0	53.75	5.68	1
10140	ICI-treated	ICI as subsequent line	46 - 50	Female	Bladder	2015		22	6.9	Stable	No	No	Signature.13		No	0	52.83	8.41	1
10141	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	IV	0	3	Stable	No	No			No	1	22.11	10.94	1
10142	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		472	13.2	Stable	No	No	Signature.2	BRCA2	No	0	51.09	1.87	1
10143	ICI-treated	ICI - unknown sequence	36 - 40	Female	Breast	2015	IV	0	3.9	Stable	No	Yes or Unknown			No	1	40.44	5.26	1
10144	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2015		375	6.1	Stable	No	No	Signature.13		No	0	47.05	13.08	1
10145	ICI-treated	ICI as subsequent line	31 - 35	Female	Colorectal	2015	IV	132	2	Stable	No	Yes or Unknown			No	1	40.15	35.91	1
10146	ICI-treated	ICI as subsequent line	66 - 70	Female	Pancreatic	2015	IV	0	6.9	Stable	No	No	Signature.3		No	1	16.39	15.51	1
10147	ICI-treated	ICI as subsequent line	61 - 65	Female	Breast	2015	IV	28	3.9	Stable	No	Yes or Unknown			No	1	20.4	4.14	1
10148	ICI-treated	ICI as subsequent line	61 - 65	Female	Pancreatic	2015	II	14	3.9	Stable	No	No	Signature.3	BRCA2	No	1	27.6	26.71	1
10149	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2017		229	9.7	Stable	Yes or Unknown	Yes or Unknown	Signature.2	ARID1A	No	0	26.84	8.54	1
10150	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2015		43	0	Stable	No	Yes or Unknown			No	0	45.96	2.1	1
10151	ICI-treated	ICI as subsequent line	56 - 60	Male	Prostatic	2015	III	69	0		Yes or Unknown	Yes or Unknown			No	0	52.4	30.52	1
10152	ICI-treated	ICI - unknown sequence	71 - 75	Female	Pancreatic	2015	II	9	5.9	Stable	No	Yes or Unknown			No	1	41.92	29.96	1
10153	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2015		209	7.9	Stable	No	No	Signature.2	ERCC4	No	0	42.48	7.85	1
10154	ICI-treated	ICI - unknown sequence	15-Nov	Female	Sarcoma	2015	II	892	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	54.14	31.05	1
10155	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2015	IV	560	0	Stable	No	Yes or Unknown			No	0	43.83	20.11	1
10156	ICI-treated	ICI as subsequent line	56 - 60	Male	Colorectal	2015	IV	3	4.4	Stable	No	No		ATM	No	1	31.05	27.56	1
10157	ICI-treated	ICI - unknown sequence	56 - 60	Female	Pancreatic	2015	IV	7	3	Stable	No	Yes or Unknown			No	1	19.78	19.29	1
10158	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2016		0	35.1	Stable	No	No	Signature.2	BLM | ERCC2 | FANCA | MSH2 | RAD50 | RAD51C	No	0	42.97	0.95	1
10159	ICI-treated	ICI - unknown sequence	76 - 80	Male	Bladder	2016		0	10.5	Stable	No	No	Signature.13	SLX4	No	0	41.46	0.76	1
10160	ICI-treated	ICI as subsequent line	81 - 85	Male	Prostatic	2015	IV	354	10.5		No	Yes or Unknown	Signature.1		No	1	29.63	20.8	1
10161	ICI-treated	ICI as first line	10-Jun	Male	CNS	2016		27	7.9	Stable	No	No			No	1	14.59	2.04	1
10162	ICI-treated	ICI as subsequent line	61 - 65	Female	Hepatobiliary	2016	II	0	1	Stable	No	No			No	1	25.07	20.76	1
10163	ICI-treated	ICI as subsequent line	16 - 20	Male	Sarcoma	2016	IV	0	1	Stable	No	No			No	0	41.92	28.19	1
10164	ICI-treated	ICI as first line	41 - 45	Female	Sarcoma	2016	IV	94	2	Stable	No	No			No	1	29.4	4.99	1
10165	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2016		0	17.6	Stable	No	No	Signature.2	MSH6	No	0	43.6	2.86	1
10166	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		105	9.7	Stable	No	No	Signature.13	ATM | MUTYH	No	0	20.83	4.04	1
10167	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		0	10.5	Stable	No	No	Signature.13		No	0	38.05	1.84	1
10168	ICI-treated	ICI as subsequent line	31 - 35	Female	Breast	2015	II	578	2.6		Yes or Unknown	Yes or Unknown			No	1	26.35	19.12	1
10169	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2015		1004	4.4	Stable	Yes or Unknown	Yes or Unknown			No	0	45.14	6.8	1
10170	ICI-treated	ICI - unknown sequence	46 - 50	Female	Bladder	2016		231	8.8	Stable	No	No	Signature.1	ARID1A	No	0	37.32	1.94	1
10171	ICI-treated	ICI as subsequent line	61 - 65	Male	Bladder	2016		452	10.5	Stable	No	Yes or Unknown	Signature.7		No	0	38.93	11.76	1
10172	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		195	7	Stable	No	No	Signature.13		No	0	33.05	3.42	1
10173	ICI-treated	ICI - unknown sequence	66 - 70	Male	Pancreatic	2015		0	2		Yes or Unknown	Yes or Unknown			No	1	18.76	17.08	1
10174	ICI-treated	ICI as subsequent line	61 - 65	Male	Gastric	2016	III	0	2.6	Stable	No	No			No	0	39.26	12.55	1
10175	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2016	II	87	1.8		No	Yes or Unknown			No	0	38.41	20.44	1
10176	ICI-treated	ICI as subsequent line	26 - 30	Female	Colorectal	2016	IV	2	4.4	Stable	No	No			No	1	30.55	25.63	1
10177	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		0	7	Stable	No	No	Signature.2		No	0	33.48	0.82	1
10178	ICI-treated	ICI as subsequent line	36 - 40	Male	Colorectal	2016	III	18	5.3	Stable	No	No	Signature.1		No	0	17.38	16.26	1
10179	ICI-treated	ICI - unknown sequence	56 - 60	Female	SCLC	2016	IV	541	7.9	Stable	Yes or Unknown	Yes or Unknown			No	1	22.31	18.66	1
10180	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2017	III	17	3.5	Stable	No	No		BRCA2	No	0	32.72	15.9	1
10181	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		0	6.1	Stable	No	No	Signature.13		No	0	35.32	0.69	1
10182	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016	III	17	4.4		No	No	Signature.2	ARID1A	No	0	35.25	11.96	1
10183	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2016		172	2.6	Stable	Yes or Unknown	Yes or Unknown			No	0	34.56	2.1	1
10184	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		1045	7.9	Stable	Yes or Unknown	Yes or Unknown	Signature.13	BRCA2	No	0	37.85	4.44	1
10185	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2016		1015	17.6	Stable	No	No	Signature.2	ARID1A | ATM	No	0	35.15	1.35	1
10186	ICI-treated	ICI as subsequent line	41 - 45	Female	Breast	2015	I	636	2.6	Stable	Yes or Unknown	Yes or Unknown			No	1	42.09	25	1
10187	ICI-treated	ICI as subsequent line	46 - 50	Female	Ovarian	2016	IV	89	5.3	Stable	No	Yes or Unknown		ARID1A	No	1	23.98	18.1	1
10188	ICI-treated	ICI as first line	15-Nov	Male	Sarcoma	2016	II	637	0.9	Stable	No	No			No	0	35.75	22.64	1
10189	ICI-treated	ICI - unknown sequence	51 - 55	Female	Colorectal	2016	IV	0	5.3		Yes or Unknown	Yes or Unknown			No	0	17.84	15.93	1
10190	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2016		0	4.4	Stable	Yes or Unknown	Yes or Unknown		ATR	No	0	39.59	11.01	1
10191	ICI-treated	ICI - unknown sequence	41 - 45	Female	Breast	2016	III	279	5.3		Yes or Unknown	Yes or Unknown		SLX4	No	1	15.47	14.65	1
10192	ICI-treated	ICI as subsequent line	56 - 60	Female	Breast	2015	I	840	11.4	Stable	Yes or Unknown	Yes or Unknown	Signature.30	ARID1A	No	1	36.5	29.01	1
10193	ICI-treated	ICI - unknown sequence	46 - 50	Female	Bladder	2016		305	7	Stable	Yes or Unknown	Yes or Unknown	Signature.7		No	0	34.63	5.68	1
10194	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2017	I	43	10.5	Stable	No	No	Signature.13	ERCC3	No	0	27.01	3.81	1
10195	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2017		0	78.1	Stable	No	No	Signature.2	BRCA1 | BRCA2 | ERCC2 | ERCC5 | MDC1 | PARP1 | PMS1 | SLX4 | TP53BP1	No	0	28.22	1.58	1
10196	ICI-treated	ICI as subsequent line	51 - 55	Female	Sarcoma	2017	II	46	5.3	Stable	No	No	Signature.1		No	1	11.04	10.58	1
10197	ICI-treated	ICI as subsequent line	51 - 55	Male	Bladder	2017	III	52	2.6	Stable	No	No			No	0	28.29	15.7	1
10198	ICI-treated	ICI as subsequent line	76 - 80	Female	Bladder	2017	I	62	0.9	Stable	No	No			No	0	27.33	10.15	1
10199	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017	I	0	3.5	Stable	No	No	Signature.13		No	0	23.62	1.84	1
10200	ICI-treated	ICI as subsequent line	71 - 75	Female	Ovarian	2017	IV	676	7	Stable	No	Yes or Unknown	Signature.1	ARID1A | ATM	No	0	26.87	7.36	1
10201	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017		142	7	Stable	Yes or Unknown	Yes or Unknown	Signature.13		No	0	28.02	5.85	1
10202	ICI-treated	ICI as subsequent line	56 - 60	Male	Pancreatic	2017	II	140	5.3	Stable	No	Yes or Unknown			No	1	10.74	10.02	1
10203	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	12	3.5	Stable	No	No			No	0	25.43	5.98	1
10204	ICI-treated	ICI - unknown sequence	51 - 55	Female	Bladder	2017	IV	25	10.5	Stable	No	No	Signature.2	TP53BP1	No	0	24.31	8.77	1
10205	ICI-treated	ICI - unknown sequence	61 - 65	Female	Bladder	2017		0	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	14.39	7.79	1
10206	ICI-treated	ICI as subsequent line	15-Nov	Male	Sarcoma	2017	IV	0	0	Stable	No	No			No	0	24.05	14.16	1
10207	ICI-treated	ICI as subsequent line	56 - 60	Female	Ovarian	2017	IV	91	4.4	Stable	No	Yes or Unknown			No	0	23.06	8.31	1
10208	ICI-treated	ICI as subsequent line	51 - 55	Female	Ovarian	2017	IV	4	3.5	Stable	No	No		BRCA1	No	0	21.95	6.74	1
10209	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2017	I	463	31.6	Stable	No	No	Signature.13	CHEK2 | MDC1 | TP53BP1	No	0	23.69	2.89	1
10210	ICI-treated	ICI as subsequent line	41 - 45	Female	Ovarian	2017	IV	18	1.8	Indeterminate	No	No			No	0	22.08	8.18	1
10211	ICI-treated	ICI - unknown sequence	51 - 55	Female	CNS	2017		0	3.5	Stable	Yes or Unknown	Yes or Unknown	Signature.25		No	1	26.32	8.8	1
10212	ICI-treated	ICI - unknown sequence	46 - 50	Male	Bladder	2017		0	8.8	Stable	No	No	Signature.13		No	0	20.04	1.94	1
10213	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2017	I	47	1.8	Stable	No	No			No	0	20.9	9.03	1
10214	ICI-treated	ICI - unknown sequence	71 - 75	Male	Bladder	2016		620	0.9	Stable	Yes or Unknown	Yes or Unknown			No	0	39.33	22.01	1
10215	ICI-treated	ICI - unknown sequence	76 - 80	Female	Bladder	2017		350	14	Stable	No	No	Signature.2	PALB2	No	0	16.33	3.35	1
10216	ICI-treated	ICI - unknown sequence	16 - 20	Male	Sarcoma	2016	IV	453	2.6	Stable	Yes or Unknown	Yes or Unknown		MUTYH	No	0	24.38	16.03	1
10217	ICI-treated	ICI - unknown sequence	56 - 60	Male	Bladder	2017		0	30.7	Stable	No	No	Signature.2	ERCC2 | ERCC4 | XRCC2	No	0	20.47	2.83	1
10218	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2018		0	5.3	Stable	No	No	Signature.19	BRCA1	No	0	18.92	6.47	1
10219	ICI-treated	ICI - unknown sequence	46 - 50	Male	Bladder	2018		6	7.9	Stable	No	No	Signature.13	FANCA	No	0	17.18	1.87	1
10220	ICI-treated	ICI - unknown sequence	46 - 50	Male	Colorectal	2018	IV	0	5.3	Stable	No	Yes or Unknown	Signature.10		No	1	7.72	6.8	1
10221	ICI-treated	ICI as subsequent line	61 - 65	Female	Ovarian	2018	III	28	5.3	Stable	No	No		BRCA1	No	0	16.66	8.08	1
10222	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2018		35	13.2	Stable	No	No	Signature.2	ARID1A | BRCA2 | PMS2	No	0	14.16	1.84	1
10223	ICI-treated	ICI - unknown sequence	41 - 45	Male	Bladder	2018		71	7.9	Stable	No	No	Signature.13	ARID1A | ATM	No	0	17.22	3.45	1
10224	ICI-treated	ICI - unknown sequence	51 - 55	Male	Bladder	2018	I	0	18.4	Stable	No	No	Signature.2	ARID1A | ATM | ERCC2	No	0	16.76	3.94	1
10225	ICI-treated	ICI as subsequent line	36 - 40	Female	Bladder	2018	I	0	28.1	Stable	No	No	Signature.2	ARID1A | ERCC2 | MDC1 | SLX4	No	0	16.03	0.85	1
10226	ICI-treated	ICI - unknown sequence	36 - 40	Male	Bladder	2017	I	0	4.4	Stable	Yes or Unknown	Yes or Unknown		ARID1A	No	0	29.67	18.27	1
10227	ICI-treated	ICI as first line	56 - 60	Male	Bladder	2018		240	16.7	Stable	No	No	Signature.13	ATR | FANCA | RAD50	No	0	16.13	2.76	1
10228	ICI-treated	ICI - unknown sequence	61 - 65	Male	Bladder	2018	I	28	6.1	Stable	No	No		ERCC2 | FANCA	No	0	10.71	1.54	1
10229	ICI-treated	ICI as first line	66 - 70	Male	Bladder	2018	I	182	7.9	Stable	No	No	Signature.13		No	0	13.5	2.73	1
10230	ICI-treated	ICI - unknown sequence	21 - 25	Male	Sarcoma	2015	I	968	1.8	Stable	Yes or Unknown	Yes or Unknown			No	0	44.91	33.58	1
10231	ICI-treated	ICI - unknown sequence	51 - 55	Male	Bladder	2018		0	37.7	Stable	No	No	Signature.2	ARID1A | ATR | BLM | BRCA1 | BRIP1 | CHEK2 | MDC1 | NBN | TP53BP1	No	0	12.35	0.99	1
10232	ICI-treated	ICI - unknown sequence	66 - 70	Male	Bladder	2018	I	262	5.3	Stable	No	Yes or Unknown		ARID1A	No	0	14.06	1.87	1
10233	ICI-treated	ICI - unknown sequence	51 - 55	Male	Pancreatic	2017	IV	224	1.8	Stable	Yes or Unknown	Yes or Unknown		BLM	No	1	19.55	17.61	1
